{"cells":[{"cell_type":"markdown","source":["List Files in the Filestore"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{},"nuid":"999b61ce-de19-49df-ac03-07418ce521e2","inputWidgets":{},"title":""}}},{"cell_type":"code","source":["dbutils.fs.ls(\"/FileStore/tables/openpayment/\")"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{},"nuid":"7aa8da05-7de5-43c5-acd6-330beb9b4550","inputWidgets":{},"title":""}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[4]: [FileInfo(path='dbfs:/FileStore/tables/openpayment/OP_DTL_RSRCH_PGYR2021_P06302022.csv', name='OP_DTL_RSRCH_PGYR2021_P06302022.csv', size=708631888, modificationTime=1673839363000)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[4]: [FileInfo(path='dbfs:/FileStore/tables/openpayment/OP_DTL_RSRCH_PGYR2021_P06302022.csv', name='OP_DTL_RSRCH_PGYR2021_P06302022.csv', size=708631888, modificationTime=1673839363000)]"]}}],"execution_count":0},{"cell_type":"markdown","source":["Read a Single file from above list"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{},"nuid":"0e6e4840-f2ae-4165-8e57-9572202e9622","inputWidgets":{},"title":""}}},{"cell_type":"code","source":["df = spark.read.format(\"csv\").options(inferSchema=\"True\",sep=\",\",header=\"True\").load(\"/FileStore/tables/openpayment/OP_DTL_RSRCH_PGYR2021_P06302022.csv\")"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{},"nuid":"e8dded88-04ea-4c9e-a41f-a72c4d0e2aa5","inputWidgets":{},"title":""}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["print(df.count())\ndisplay(df)"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{},"nuid":"c339623d-b89f-4650-be36-851877f82b28","inputWidgets":{},"title":""}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"672907\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["672907\n"]}},{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"overflow":true,"datasetInfos":[],"data":[["NEW","Covered Recipient Teaching Hospital",null,460009,11165,"U Of U Hospitals & Clinics",null,null,null,null,null,null,"50 North Medical Drive",null,"Salt Lake City","UT","84132","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",608915,1639269251,"MARY","BETH","SCHOLAND",null,"50 N MEDICAL DR",null,"SALT LAKE CITY","UT","84132-0001","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease",null,null,null,null,null,"UT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Boehringer Ingelheim USA, Inc.",100000010823,"Boehringer Ingelheim Pharma GmbH & Co.KG",null,"Germany","Yes","Covered","Drug","RESPIRATORY","OFEV","0597-0143-60",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,122.86,"2021-01-01","In-kind items and services",null,null,null,null,null,null,"No","No","Extension","No","827034085","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,53302,11301,"Childrens Hospital Los Angeles",null,null,null,null,null,null,"4650 W SUNSET BLVD MS 97",null,"LOS ANGELES","CA","90027","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",855234,1316039647,"THOMAS","G","KEENS",null,"4650 W SUNSET BLVD",null,"LOS ANGELES","CA","90027","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Pulmonology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Boehringer Ingelheim Pharmaceuticals, Inc.",100000000234,"Boehringer Ingelheim Pharmaceuticals, Inc.","CT","United States","Yes","Covered","Drug","RESPIRATORY","OFEV","0597-0145-60",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,41766.54,"2021-04-20","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Pediatric ILD program","No","840492839","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,140276,10474,"Loyola University Medical Center",null,null,null,null,null,null,"2160 S 1ST AVE",null,"MAYWOOD","IL","60153","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",210327,1659358539,"DANIEL",null,"DILLING",null,"2160 S 1ST AVE",null,"MAYWOOD","IL","60153","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Boehringer Ingelheim Pharmaceuticals, Inc.",100000000234,"Boehringer Ingelheim Pharmaceuticals, Inc.","CT","United States","Yes","Covered","Drug","RESPIRATORY","OFEV","0597-0145-60",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2498.79,"2021-03-25","In-kind items and services",null,null,null,null,null,null,"No","No","DCRI Registry Study","No","840493101","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,393303,10215,"THE CHILDRENS HOSPITAL OF PHILADELP",null,null,null,null,null,null,"34th  Civic Center Blvd","PARC Business Services","Philadelphia","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",248791,1497738389,"ALICE",null,"LEE",null,"111 E 210TH ST",null,"BRONX","NY","10467","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","IBRANCE","0069-0187-21",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3300.0,"2021-12-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PHASE 1 STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF PALBOCICLIB IBRANCEREGISTERED IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE AND IN COMBINATION WITH TOPOTECAN AND CYCLOPHOSPHAMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS","No","832586683","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,110010,10785,"Emory University Hospital",null,null,null,null,null,null,"1599 CLIFTON RD NE",null,"ATLANTA","GA","30322","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",718297,1457550782,"HEBA","NAGI","ISKANDAR",null,"1364 CLIFTON RD NE",null,"ATLANTA","GA","30322","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"GA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Boehringer Ingelheim Pharmaceuticals, Inc.",100000000234,"Boehringer Ingelheim Pharmaceuticals, Inc.","CT","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,8277.13,"2021-02-24","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Phase II III in UC patients","No","840493361","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,143300,10439,"Ann & Robert H. Lurie Childrens Hos",null,null,null,null,null,null,"1121 TECHNY RD",null,"NORTHBROOK","IL","60062","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",769058,1245458496,"SONALI",null,"CHAUDHURY",null,"225 E Chicago Ave","BOX 30","Chicago","IL","60611","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alexion Pharmaceuticals, Inc.",100000005462,"Alexion Pharmaceuticals, Inc.","MA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,500.0,"2021-04-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Ravulizumab in Adult and Adolescent Participants Who Have Thrombotic Microangiopathy (TMA) After Hematopoietic Stem Cell Transplant (HSCT)","No","781386437","2021","06/30/2022","NCT04543591",null,null],["NEW","Covered Recipient Teaching Hospital",null,110010,10785,"Emory University Hospital",null,null,null,null,null,null,"1821 Clifton Rd Ne",null,"Atlanta","GA","30302","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1237355,1700907276,"BRADLEY","C","CARTHON",null,"1365C CLIFTON RD NE STE C3009B",null,"ATLANTA","GA","30322","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"GA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","XTANDI","0469-0125-99",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1866.0,"2021-04-06","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 3 RANDOMIZED EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE PLUS LEUPROLIDE ENZALUTAMIDE MONOTHERAPY AND PLACEBO PLUS LEUPROLIDE IN MEN WITH HIGHRISK NONMETASTATIC PROSTATE CANCER PROGRESSING AFTER DEFINITIVE THERAPY","No","832910123","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50047,11215,"CALIFORNIA PACIFIC MEDICAL CENTER",null,null,null,null,null,null,"2333 BUCHANAN STREET",null,"SAN FRANCISCO","CA","94115","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",262565,1780664136,"FOREST","H","MEALEY",null,"411 30TH ST",null,"OAKLAND","CA","94609","United States",null,null,"Doctor of Osteopathy",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2120.0,"2021-03-27","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PHII IL22FC ANTI ST2 IN SEVERE COVID 19 PNEUMONIA","No","835907999","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,53302,11301,"Childrens Hospital Los Angeles",null,null,null,null,null,null,"4650 W Sunset Blvd",null,"Los Angeles","CA","90027","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1146597,1508031352,"LILY",null,"CHAO",null,"3701 WILSHIRE BLVD",null,"LOS ANGELES","CA","90010","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,72.0,"2021-08-05","In-kind items and services",null,null,null,null,null,null,"No","No","NN9924-4437","No","811631115","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,140158,10438,"Mercy Hospital & Medical Center",null,null,null,null,null,null,"2525 S Michigan Ave",null,"Chicago","IL","60616","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1287150,1073732459,"AZAZUDDIN","A","AHMED",null,"2555 S MARTIN LUTHER KING DRIVE",null,"CHICAGO","IL","60616","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","Ozempic","0169-4132-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2.75,"2021-12-29","In-kind items and services",null,null,null,null,null,null,"No","No","NN9535-4352","No","811892967","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500008,11198,"UNIVERSITY OF WASHINGTON MED CTR",null,null,null,null,null,null,"1959 Ne Pacific St",null,"Seattle","WA","98195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",834505,1558467506,"NICOLE","MARIE","EHRHARDT",null,"1959 NE PACIFIC ST",null,"SEATTLE","WA","98195-3201","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"DC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"DEXCOM, INC.",100000010478,"DEXCOM, INC.","CA","United States","Yes","Covered","Device","ENDOCRINOLOGY","DEXCOM G6 TRANSMITTER",null,"00386270000385",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1404.95,"2021-03-25","In-kind items and services",null,null,null,null,null,null,"No","No","REAL- TIME CONTINUOUS GLUCOSE MONITORING IN GESTATIONAL DIABETES","No","845254341","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,363300,10334,"CHILDRENS HOSPITAL MEDICAL CENTER",null,null,null,null,null,null,"3333 BURNET AVE",null,"CINCINNATI","OH","45229","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",217163,1780764035,"STUART",null,"GOLDSTEIN",null,"3333 BURNET AVE",null,"CINCINNATI","OH","45229","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Nephrology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,16000.0,"2021-10-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","CROVALIMAB IN AHUS ADULT AND ADOLESCENT PATIENTS","No","835909131","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,470003,9973,"University Of Vermont Medical Center",null,null,null,null,null,null,"111 COLCHESTER AVE",null,"BURLINGTON","VT","05401","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",240025,1285737429,"DAVID",null,"SCHNEIDER",null,"111 COLCHESTER AVE","MCCLURE LEVEL 1","BURLINGTON","VT","05401-1473","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Amryt Pharma Holdings Ltd",100000576811,"Amryt Pharma Holdings Ltd",null,"Ireland","Yes","Covered","Drug","Cardiology/Vascular Diseases","JUXTAPID","76431-105-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,111.36,"2021-07-28","Cash or cash equivalent",null,null,null,null,null,null,"No","No","LOWER: Lomitapide Observational Worldwide Evaluation Registry","No","831207867","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,10033,10929,"UNIVERSITY OF ALABAMA HOSPITAL",null,null,null,null,null,null,"619 19th St S",null,"Birmingham","AL","35249","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1303605,1437309283,"REBECCA",null,"AREND",null,"619 19TH ST S",null,"BIRMINGHAM","AL","35249-3720","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology",null,null,null,null,null,"AL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,650.0,"2021-10-23","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 1B 2 STUDY OF REBASTINIB DCC-2036 IN COMBINATION WITH PACLITAXEL IN PATIENTS WITH ADVANCED OR METASTATIC SOLID TUMORS","No","827889301","2021","06/30/2022","NCT03601897",null,null],["NEW","Covered Recipient Physician",null,null,null,null,288980,1356570758,"BOB",null,"GENG",null,"9500 GILMAN DR","ALLERGY","LA JOLLA","CA","92093","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Allergy & Immunology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","DERMATOLOGY","EUCRISA","55724-211-21",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1400.0,"2021-05-10","In-kind items and services",null,null,null,null,null,null,"No","No","CRISABOROLE CLINICAL PUBLICATION PROGRAM","No","832556637","2021","06/30/2022",null,null,"No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication."],["NEW","Covered Recipient Teaching Hospital",null,450018,11030,"THE UNIVERSITY OF TEXAS MEDICAL BR.",null,null,null,null,null,null,"301 University Blvd",null,"Galveston","TX","77555","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",497426,1700893625,"RICHARD","E","RUPP",null,"301 UNIVERSITY BLVD",null,"GALVESTON","TX","77555","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Adolescent Medicine",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Biological","VACCINES","COMIRNATY","0069-1000-03",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2658.5,"2021-10-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS","No","832878833","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,100271,10837,"MOFFITT CANCER CENTER",null,null,null,null,null,null,"12902 Magnolia Dr",null,"Tampa","FL","33612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",709029,1124227780,"JINGSONG",null,"ZHANG",null,"12902 USF MAGNOLIA DR","H LEE MOFFITT CANCER CENTER","TAMPA","FL","33612-9416","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,904.02,"2021-05-14","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 1/2 STUDY OF REGN5678 (ANTI-PSMAXCD28) WITH CEMIPLIMAB (ANTI-PD-1) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER","No","793088127","2021","06/30/2022","NCT03972657",null,null],["NEW","Covered Recipient Teaching Hospital",null,380009,11212,"Ohsu Hospital And Clinics",null,null,null,null,null,null,"3181 Sw Sam Jackson Park Rd",null,"Portland","OR","97239","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1196656,1295933729,"ELIE","ABRAHAM","TRAER",null,"3181 SW SAM JACKSON PARK RD # L586",null,"PORTLAND","OR","97239","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"OR",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AstraZeneca Pharmaceuticals LP",100000196872,"Acerta Pharma LLC","CA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,8317.0,"2021-07-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","This study is a multicenter open label nonrandomized sequential group dose escalation study to assess safety tolerability pharmacokinetics and preliminary anti tumor activity of ascending doses of AZD5991 in subjects with relapsed or refractory hematologic malignancies","No","826491561","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,490063,10733,"Inova Fairfax Hospital",null,null,null,null,null,null,"3300 GALLOWS RD",null,"FALLS CHURCH","VA","22042","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1244062,1942412564,"SEKWON",null,"JANG",null,"8081 INNOVATION PARK DR",null,"FAIRFAX","VA","22031","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"VA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,30.4,"2021-11-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 2 Study of INCMGA00012 in Participants With Metastatic Merkel Cell Carcinoma","No","831068787","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Physician",null,null,null,null,731500,1912947086,"JOHN","W.","ROSE",null,"50 N MEDICAL DR","3C444","SALT LAKE CITY","UT","84132","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"UT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000005656,"F. Hoffmann-La Roche AG",null,"Switzerland","Yes","Covered","Biological","Immunology","Enspryng","50242-007-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,163.21,"2021-03-31","In-kind items and services",null,null,null,null,null,null,"No","No","DEMOGRAPHIC AND RELAPSE CORRELATES OF TREATMENT CHANGE IN NMOSD PATIENTS ANALYSIS OF THE CIRCLES STUDY","No","835901319","2021","06/30/2022",null,null,"Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician"],["NEW","Covered Recipient Teaching Hospital",null,50424,11298,"Scripps Green Hospital",null,null,null,null,null,null,"10666 N TORREY PINES RD",null,"LA JOLLA","CA","92037","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1272652,1962408260,"WALTER","L.","BIFFL",null,"777 Bannock St",null,"Denver","CO","80204","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Surgery",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alexion Pharmaceuticals, Inc.",100000005462,"Alexion Pharmaceuticals, Inc.","MA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,10250.0,"2021-05-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Prospective, Open-Label Clinical Study of Andexanet Alfa in Patients Receiving FXa (Activated Factor X) Inhibitor Who Require Urgent Surgery","No","781386733","2021","06/30/2022","NCT04233073",null,null],["NEW","Covered Recipient Teaching Hospital",null,220071,9988,"Massachusetts General Hospital",null,null,null,null,null,null,"55 FRUIT ST","BULFINCH 360","BOSTON","MA","02114","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1046854,1003942426,"CRISTINA",null,"CUSIN",null,"55 FRUIT ST","ACC 812","BOSTON","MA","02114-2621","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"LivaNova USA, Inc.",100000176739,"LivaNova USA, Inc.","TX","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","VNS - Symmetry",null,"5425025750504",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1508.0,"2021-09-30","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression","No","844267881","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,110010,10785,"EMORY UNIVERSITY HOSPITAL",null,null,null,null,null,null,"1821 Clifton Rd Ne",null,"Atlanta","GA","30329","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1154580,1780791533,"LEONARD","T","HEFFNER JR",null,"1365 CLIFTON RD NE",null,"ATLANTA","GA","30322-1013","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"GA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pharmacyclics LLC, an AbbVie Company",100000136439,"Pharmacyclics LLC, An AbbVie Company","CA","United States","Yes","Covered","Drug","ONCOLOGY","IMBRUVICA","57962-420-28",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,444.17,"2021-09-27","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.","No","786498505","2021","06/30/2022","NCT03229200",null,"PCYC-1145-LT"],["NEW","Covered Recipient Teaching Hospital",null,450056,11002,"Ascension Seton Medical Center",null,null,null,null,null,null,"1201 W 38th St",null,"Austin","TX","78705","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",3958,1073710067,"MAURICIO","F","HONG",null,"1400 N IH 35","SUITE 300","AUSTIN","TX","78701-1926","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"OH","TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Abbott Laboratories",100000010680,"Abbott Laboratories","IL","United States","Yes","Covered","Device","Cardiac Rhythm Management","Confirm Rx",null,"05415067027320",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,5301.96,"2021-05-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Confirm Rx Insertable Cardiac Monitor SMART Registry","No","827578961","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,360137,10389,"Uh Cleveland Medical Center",null,null,null,null,null,null,"11100 Euclid Ave",null,"Cleveland","OH","44106","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",349965,1700864089,"William","J","Flynn",null,"5430 Fredericksburg Rd","Suite 100","San Antonio","TX","78229-3539","United States",null,null,"Doctor of Optometry",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Ophthalmology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Glaukos Corporation",100000000102,"Glaukos Corporation","CA","United States","Yes","Covered","Device","Glaucoma","iStent",null,"00853704002012",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,615.0,"2021-03-29","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Prospective, Randomized, Controlled, Parallel Groups, Multicenter Post-Approval Study of the Glaukos iStent Trabecular Micro-Bypass Stent System in Conjunction with Cataract Surgery","No","854377647","2021","06/30/2022","NCT01841450",null,null],["NEW","Covered Recipient Physician",null,null,null,null,991192,1043326044,"MARC",null,"CHIMOWITZ",null,"96 Jonathan Lucas St",null,"CHARLESTON","SC","29425","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"SC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Medtronic, Inc.",100000000106,"Medtronic, Inc.","MN","United States","Yes","Covered","Device","Liquid Embolics","Onyx",null,"00847536006171",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2000.0,"2021-12-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","EMBOLISE","No","800999611","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,260141,10617,"Univ Of Missouri Health Care",null,null,null,null,null,null,"ONE HOSPITAL DRIVE",null,"COLUMBIA","MO","65212","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",851198,1144585340,"SYED","A.","SHAH",null,"PO BOX 843966",null,"KANSAS CITY","MO","64184-3966","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alexion Pharmaceuticals, Inc.",100000005462,"Alexion Pharmaceuticals, Inc.","MA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2530.0,"2021-10-14","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Nave Adult Patients With Generalized Myasthenia Gravis","No","781387035","2021","06/30/2022","NCT03920293",null,null],["NEW","Covered Recipient Teaching Hospital",null,230297,10146,"KARMANOS CANCER HOSPITAL",null,null,null,null,null,null,"4100 John R St",null,"Detroit","MI","48201","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1381910,1821344656,"DIPENKUMAR","KANAIYALAL","MODI",null,"4100 JOHN R ST",null,"DETROIT","MI","48201-2013","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pharmacyclics LLC, an AbbVie Company",100000136439,"Pharmacyclics LLC, An AbbVie Company","CA","United States","Yes","Covered","Drug","ONCOLOGY","IMBRUVICA","57962-420-28",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,53.46,"2021-04-20","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (SYMPATICO)","No","786500277","2021","06/30/2022","NCT03112174",null,"PCYC-1143-CA"],["NEW","Covered Recipient Teaching Hospital",null,240010,10582,"Mayo Clinic Hospital Rochester",null,null,null,null,null,null,"1216 2nd St Sw",null,"Rochester","MN","55902","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",785744,1831396712,"Matthew",null,"Carlson",null,"200 1st St SW",null,"Rochester","MN","55905","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Otolaryngology",null,null,null,null,null,"MN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Cochlear Ltd",100000005734,"Cochlear Americas","CO","United States","Yes","Covered","Device","Implantable hearing solution","Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode",null,"09321502036580",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3007.38,"2021-11-08","In-kind items and services",null,null,null,null,null,null,"No","No","Complete Cochlear Implant Care (CCIC Requiring a Single On-Site Visit: A Prospective Pilot Study for Highly Coordinated Health Care)","No","828074361","2021","06/30/2022",null,null,"Research Support"],["NEW","Covered Recipient Teaching Hospital",null,360180,10373,"CLEVELAND CLINIC HOSPITAL",null,null,null,null,null,null,"9500 EUCLID AVE",null,"CLEVELAND","OH","44195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1251558,1215197892,"LE","HANH","HUA",null,"888 W BONNEVILLE AVE",null,"LAS VEGAS","NV","89106","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"AZ","CA","NV",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Covered","Biological","Immunology","OCREVUS","50242-150-01",null,"Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,49085.0,"2021-06-23","Cash or cash equivalent",null,null,null,null,null,null,"No","No","OCRELIZUMAB VACCINATION STUDY","No","835909991","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,20759,1467472647,"DUNCAN",null,"SZE-TU",null,"415 HOOPER RD",null,"ENDWELL","NY","13760","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Family Medicine",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1324.0,"2021-06-11","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PREVENTIVE TREATMENT OF MIGRAINE: OUTCOMES FOR PATIENTS IN REAL-WORLD HEALTHCARE SYSTEMS (TRIUMPH)","No","819443169","2021","06/30/2022",null,null,"The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"],["NEW","Covered Recipient Teaching Hospital",null,54144,11286,"LANGLEY PORTER PSYCHIATRIC HOSPITAL",null,null,null,null,null,null,"405 PARNASUS",null,"SAN FRANCISCO","CA","94143","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",770871,1285860858,"ALEXIS",null,"MELTON",null,"550 16TH ST # 434",null,"SAN FRANCISCO","CA","94158","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"JAZZ PHARMACEUTICALS INC.",100000005637,"JAZZ PHARMACEUTICALS INC.","CA","United States","Yes","Covered","Drug","HEMATOLOGY/ONCOLOGY","DEFITELIO","68727-800-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,625.1,"2021-08-03","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 3, RANDOMIZED, ADAPTIVE STUDY COMPARING THE EFFICACY AND SAFETY OF DEFIBROTIDE VS BEST SUPPORTIVE CARE IN THE PREVENTION OF HEPATIC VENO-OCCLUSIVE DISEASE IN ADULT AND PEDIATRIC PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANT","No","838142943","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,360180,10373,"CLEVELAND CLINIC HOSPITAL",null,null,null,null,null,null,"9500 EUCLID AVE",null,"CLEVELAND","OH","44195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1122.82,"2021-09-20","Cash or cash equivalent",null,null,null,null,null,null,"No","No","VA2 PHIII","No","835910751","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,393303,10215,"The Childrens Hospital Of Philadelp",null,null,null,null,null,null,"34th & Civic Center Blvd","Parc Business Services","Philadelphia","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Fresenius Kabi USA, LLC",100000010706,"Fresenius Kabi USA, LLC","IL","United States","Yes","Covered","Drug","Parental Nutrition","Smoflipid","63323-820-00",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1000.0,"2021-04-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","SMOF-018-CP3","No","845838781","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,220110,9985,"Brigham And Womens Hospital",null,null,null,null,null,null,"75 Francis St",null,"Boston","MA","02115","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",116914,1588748883,"VANITA","R","ARODA",null,"221 LONGWOOD AVE","# RFB-2","BOSTON","MA","02115","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"CA","MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","Ozempic","0169-4132-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,180.0,"2021-04-16","In-kind items and services",null,null,null,null,null,null,"No","No","NN9535-4352","No","811507793","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,276270,1083614879,"ILEANA","JOSEFINA","TANDRON",null,"2240 GAUSE BLVD E",null,"SLIDELL","LA","70461","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"LA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,390.0,"2021-02-24","Cash or cash equivalent",null,null,null,null,null,null,"No","No","EX9924-4473","No","811762381","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,100271,10837,"MOFFITT CANCER CENTER",null,null,null,null,null,null,"12902 Magnolia Dr",null,"Tampa","FL","33612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1342407,1760614739,"ZEYNEP",null,"EROGLU",null,"12902 USF MAGNOLIA DR",null,"TAMPA","FL","33612-9416","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","ONCOLOGY","LIBTAYO","61755-008-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2000.0,"2021-10-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 2 STUDY OF REGN2810, A FULLY HUMAN MONOCLONAL ANTIBODY TO PROGRAMMED DEATH-1, IN PATIENTS WITH ADVANCED BASAL CELL CARCINOMA WHO EXPERIENCED PROGRESSION OF DISEASE ON HEDGEHOG PATHWAY INHIBITOR THERAPY, OR WERE INTOLERANT OF PRIOR HEDGEHOG PATHWAY INHIBITOR THERAPY","No","793088383","2021","06/30/2022","NCT03132636",null,null],["NEW","Covered Recipient Teaching Hospital",null,100087,10843,"Sarasota Memorial Hospital",null,null,null,null,null,null,"1700 S Tamiami Trl",null,"Sarasota","FL","34239","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1340862,1932497245,"BEVERLY","J","LONG",null,"1888 HILLVIEW ST","1888 HILLVIEW ST","SARASOTA","FL","34239-3605","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology",null,null,null,null,null,"DC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Merck Sharp & Dohme Corporation",100000000053,"Merck Sharp & Dohme Corporation","NJ","United States","Yes","Covered","Biological","ONCOLOGY","KEYTRUDA","0006-3029-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,39096.78,"2021-12-31","In-kind items and services",null,null,null,null,null,null,"No","No","A Phase 3, Randomized, Double-Blind Study of Pembrolizumab versus Placebo in Combination With Paclitaxel With or Without Bevacizumab for the Treatment of Platinum-resistant Recurrent Ovarian Cancer KEYNOTE-B96 , ENGOT-ov65","No","848750625","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,9765,1205898681,"WILLIAM","A","MAXWELL",null,"1360 E HERNDON AVE","SUITE 401","FRESNO","CA","93720-3326","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Ophthalmology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alcon Research LLC",100000000218,"Alcon Research LLC","TX","United States","Yes","Covered","Device","Ophthalmology","Acrysof IQ ReSTOR IOL",null,"00380652268752",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,309.9,"2021-11-24","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Approval Study of the AcrySof IQ ReSTOR Toric IOL","No","807672745","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50146,11296,"CITY OF HOPE NATIONAL MEDICAL CTR",null,null,null,null,null,null,"1500 E Duarte Rd",null,"Duarte","CA","91010","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",737093,1124030028,"LIHUA","ELIZABETH","BUDDE",null,"1500 DUARTE RD",null,"DUARTE","CA","91010-3012","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pharmacyclics LLC, an AbbVie Company",100000136439,"Pharmacyclics LLC, An AbbVie Company","CA","United States","Yes","Covered","Drug","ONCOLOGY","IMBRUVICA","57962-420-28",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,130.0,"2021-05-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (SYMPATICO)","No","786496575","2021","06/30/2022","NCT03112174",null,"PCYC-1143-CA"],["NEW","Covered Recipient Physician",null,null,null,null,279584,1154398642,"LALE",null,"KOSTAKOGLU SHIELDS",null,"1215 LEE ST",null,"CHARLOTTESVILLE","VA","22908","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Radiology|Nuclear Radiology",null,null,null,null,null,"NY","VA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000005656,"F. Hoffmann-La Roche AG",null,"Switzerland","Yes","Covered","Biological","BioOncology","GAZYVA","50242-070-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,634.63,"2021-03-31","In-kind items and services",null,null,null,null,null,null,"No","No","A PHASE III, MULTICENTER, OPEN-LABEL, RANDOMIZED TRIAL COMPARING THE EFFICACY OF GA101 RO5072759 IN COMBINATION WITH CHOP G-CHOP VERSUS RITUXIMAB AND CHOP R-CHOP IN PREVIOUSLY UNTREATED PATIENTS WITH CD20-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA DLBCL","No","835902147","2021","06/30/2022",null,null,"Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician"],["NEW","Covered Recipient Teaching Hospital",null,220031,9996,"Boston Medical Center",null,null,null,null,null,null,"10 Gove St",null,"East Boston","MA","02128","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",518436,1447562814,"DEVIN","W","STEENKAMP",null,"732 HARRISON AVE","# 2","BOSTON","MA","02118","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","Ozempic","0169-4132-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3.8,"2021-03-04","In-kind items and services",null,null,null,null,null,null,"No","No","NN9535-4352","No","811765305","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,360137,10389,"Uh Cleveland Medical Center",null,null,null,null,null,null,"11100 Euclid Ave",null,"Cleveland","OH","44106","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Glaukos Corporation",100000000102,"Glaukos Corporation","CA","United States","Yes","Covered","Device","Glaucoma","iStent inject",null,"00853704002203",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,180.0,"2021-09-29","Cash or cash equivalent",null,null,null,null,null,null,"No","No","iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study","No","854378573","2021","06/30/2022","NCT04624698",null,null],["NEW","Covered Recipient Teaching Hospital",null,330182,10053,"St. Francis Hospital",null,null,null,null,null,null,"100 Port Washington Blvd",null,"Roslyn","NY","11576","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",354880,1811140627,"RITA","A","JERMYN",null,"475 SEAVIEW AVE",null,"STATEN ISLAND","NY","10305","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2.65,"2021-07-22","In-kind items and services",null,null,null,null,null,null,"No","No","EX9536-4665","No","811621657","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,306223,1760412563,"HAIMANOT",null,"WASSE",null,"1717 W Congress Pkwy",null,"CHICAGO","IL","60612","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology",null,null,null,null,null,"GA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Medtronic, Inc.",100000000106,"Medtronic, Inc.","MN","United States","Yes","Covered","Device","Catheters","Ellipsys",null,"00763000496975",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2475.0,"2021-06-29","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Ellipsys PS","No","800999823","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,250001,10938,"UNIVERSITY OF MISSISSIPPI MEDICAL",null,null,null,null,null,null,"2500 N STATE ST",null,"JACKSON","MS","39216","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",272075,1992892020,"ANDERSON","B","COLLIER","III","2500 N STATE ST",null,"JACKSON","MS","39216","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology",null,null,null,null,null,"MS",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","IBRANCE","0069-0187-21",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,422.28,"2021-12-02","In-kind items and services",null,null,null,null,null,null,"No","No","PHASE 1 STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF PALBOCICLIB IBRANCEREGISTERED IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE AND IN COMBINATION WITH TOPOTECAN AND CYCLOPHOSPHAMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS","No","832592873","2021","06/30/2022",null,null,"Study Drug"],["NEW","Covered Recipient Teaching Hospital",null,30024,11263,"St. Josephs Hospital & Medical Ctr",null,null,null,null,null,null,"7300 N 99TH AVE",null,"GLENDALE","AZ","85305","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",37360,1831297274,"DAVID","Z.","WANG",null,"240 W THOMAS RD # 400",null,"PHOENIX","AZ","85013-4407","United States",null,null,"Doctor of Osteopathy",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alexion Pharmaceuticals, Inc.",100000005462,"Alexion Pharmaceuticals, Inc.","MA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3192.0,"2021-12-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor Xa Inhibitor","No","781387919","2021","06/30/2022","NCT03661528",null,null],["NEW","Covered Recipient Teaching Hospital",null,340047,10759,"North Carolina Baptist Hospital",null,null,null,null,null,null,"2295 E 14th St","Suite 100","Winston Salem","NC","27157","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",8802549,1114243987,"DAVID","ERIC","KRAM",null,"MEDICAL CENTER BLVD",null,"WINSTON SALEM","NC","27157","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","IBRANCE","0069-0187-21",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,375.2,"2021-12-16","In-kind items and services",null,null,null,null,null,null,"No","No","PHASE 1 STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF PALBOCICLIB IBRANCEREGISTERED IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE AND IN COMBINATION WITH TOPOTECAN AND CYCLOPHOSPHAMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS","No","832594059","2021","06/30/2022",null,null,"Study Drug"],["NEW","Covered Recipient Teaching Hospital",null,150084,10407,"St. Vincent Hospital & Hcc",null,null,null,null,null,null,"9613 E Us Highway 36",null,"Avon","IN","46123","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",2600750,1861626038,"SUNIT-PREET","SINGH","CHAUDHRY",null,"8333 NAAB RD",null,"INDIANAPOLIS","IN","46260","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Advanced Heart Failure and Transplant Cardiology",null,null,null,null,null,"IN","RI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3.05,"2021-07-20","In-kind items and services",null,null,null,null,null,null,"No","No","EX9536-4665","No","811870303","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,54144,11286,"Langley Porter Psychiatric Hospital",null,null,null,null,null,null,"401 PARNASSUS AVE",null,"SAN FRANCISCO","CA","94143","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",126128,1790732543,"FLAVIO","G.","VINCENTI",null,"505 Parnassus Ave Rm 884",null,"San Francisco","CA","94143","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Sanofi and Genzyme US Companies",100000000067,"SANOFI US SERVICES INC.","NJ","United States","Yes","Covered","Biological","Oncology","SARCLISA","0024-0654-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,58037.56,"2021-06-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 1b/2 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab (SAR650984) in Patients Awaiting Kidney Transplantation","No","838656015","2021","06/30/2022","NCT04294459",null,null],["NEW","Covered Recipient Physician",null,null,null,null,284457,1275770414,"BELKIS",null,"DELGADO",null,"5900 NW 183RD ST",null,"MIAMI GARDENS","FL","33015","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1678.03,"2021-12-08","In-kind items and services",null,null,null,null,null,null,"No","No","A STUDY OF DONANEMAB VERSUS PLACEBO IN PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE OF ALZHEIMER'S DISEASE","No","819443437","2021","06/30/2022","NCT05026866","https://clinicaltrials.gov/ct2/show/NCT05026866","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor in connection with clinical studies during the reporting period.  For available study details,"],["NEW","Covered Recipient Teaching Hospital",null,33302,11161,"PHOENIX CHILDRENS HOSPITAL",null,null,null,null,null,null,"1919 E. THOMAS ROAD",null,"PHOENIX","AZ","85016","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",845102,1932182771,"ROBERTA","H","ADAMS",null,"13400 E SHEA BLVD",null,"SCOTTSDALE","AZ","85259","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"JAZZ PHARMACEUTICALS INC.",100000005637,"JAZZ PHARMACEUTICALS INC.","CA","United States","Yes","Covered","Drug","HEMATOLOGY/ONCOLOGY","DEFITELIO","68727-800-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,400.0,"2021-07-06","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 3, RANDOMIZED, ADAPTIVE STUDY COMPARING THE EFFICACY AND SAFETY OF DEFIBROTIDE VS BEST SUPPORTIVE CARE IN THE PREVENTION OF HEPATIC VENO-OCCLUSIVE DISEASE IN ADULT AND PEDIATRIC PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANT","No","838143135","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,60011,11146,"DENVER HEALTH MEDICAL CENTER",null,null,null,null,null,null,"145 PARSENN ROAD",null,"WINTER PARK","CO","80482","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",934154,1053321893,"ERNEST","E","MOORE",null,"777 BANNOCK ST",null,"DENVER","CO","80204","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Surgery",null,null,null,null,null,"CO",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Covered","Biological","Metabolism & Primary Care","Activase","50242-085-27",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,452181.2,"2021-01-06","Cash or cash equivalent",null,null,null,null,null,null,"No","No","ACTIVASE FOR COVID 19","No","835911595","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,125274,1770599029,"DAVID","J","DIBENEDETTO",null,"85 1ST AVE",null,"WALTHAM","MA","02451","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pain Medicine|Interventional Pain Medicine",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,626.59,"2021-03-12","In-kind items and services",null,null,null,null,null,null,"No","No","ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE","No","819443697","2021","06/30/2022","NCT04437511","https://www.clinicaltrials.gov/ct2/show/NCT04437511","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"],["NEW","Covered Recipient Teaching Hospital",null,440039,10425,"Vanderbilt University Medical Center",null,null,null,null,null,null,"1211 Medical Center Drive",null,"Nashville","TN","37232","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",35427,1790736759,"JOSHUA","A","BECKMAN",null,"2200 PIERCE AVE",null,"NASHVILLE","TN","37232","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"MA","TN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","Ozempic","0169-4132-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,5.3,"2021-04-30","In-kind items and services",null,null,null,null,null,null,"No","No","NN9535-4533","No","811888683","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,280040,10660,"NEBRASKA METHODIST HOSPITAL",null,null,null,null,null,null,"8303 Dodge Street",null,"Omaha","NE","68114","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",111494,1457322166,"YUNGPO","B","SU",null,"7500 MERCY RD","SUITE 1300","OMAHA","NE","68124-2319","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"NE",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","ONCOLOGY","LIBTAYO","61755-008-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1383.77,"2021-08-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF ADJUVANT CEMIPLIMAB VERSUS PLACEBO AFTER SURGERY AND RADIATION THERAPY IN PATIENTS WITH HIGH RISK CUTANEOUS SQUAMOUS CELL CARCINOMA","No","793088639","2021","06/30/2022","NCT03969004",null,null],["NEW","Covered Recipient Teaching Hospital",null,170122,10684,"VIA CHRISTI HOSPITAL WICHITA",null,null,null,null,null,null,"929 N Saint Francis St",null,"Wichita","KS","67214","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",58157,1295770832,"WILLIAM","RANSOM","KILGORE",null,"1947 N FOUNDERS CIR",null,"WICHITA","KS","67206-3548","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"KS",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Vanda Pharmaceuticals Inc.",100000071361,"Vanda Pharmaceuticals Inc.","DC","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,14518.0,"2021-11-17","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS","No","838907037","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,330483,1285843672,"MICHAEL","URBAN","CALLAGHAN",null,"3901 BEAUBIEN ST",null,"DETROIT","MI","48201","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000005656,"F. Hoffmann-La Roche AG",null,"Switzerland","Yes","Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,648.85,"2021-06-18","In-kind items and services",null,null,null,null,null,null,"No","No","A PHASE 1B STUDY OF CROVALIMAB IN MANAGEMENT OF ACUTE VOC IN SICKLE CELL DISEASE","No","835903055","2021","06/30/2022",null,null,"Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician"],["NEW","Covered Recipient Teaching Hospital",null,470003,9973,"University Of Vermont Medical Center",null,null,null,null,null,null,"111 Colchester Ave",null,"Burlington","VT","05401","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",138989,1073634531,"MATTHEW","P","GILBERT",null,"62 TILLEY DR","STE 202","SOUTH BURLINGTON","VT","05403","United States",null,null,"Doctor of Osteopathy",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"VT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1085.76,"2021-07-28","Cash or cash equivalent",null,null,null,null,null,null,"No","No","EX9924-4473","No","811819743","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,450076,11031,"Ut Md Anderson Cancer Center",null,null,null,null,null,null,"1515 HOLCOMBE BLVD",null,"HOUSTON","TX","77030","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",58875,1306932074,"FUNDA",null,"MERIC-BERNSTAM",null,"1515 Holcombe Blvd",null,"Houston","TX","77030-4009","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Surgery|Surgical Oncology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Taiho Oncology, Inc.",100000146541,"Taiho Oncology, Inc.","NJ","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2123.28,"2021-12-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","AN OPEN-LABEL EXPANDED ACCESS PROGRAM OF FUTIBATINIB (TAS-120) IN PATIENTS WITH ADVANCED CHOLANGIOCARCINOMA HARBORING FGFR2 GENE REARRANGEMENTS","No","841942487","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,460009,11165,"U OF U HOSPITALS & CLINICS",null,null,null,null,null,null,"50 N Medical Dr",null,"Salt Lake City","UT","84132","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",437632,1609955277,"JOHN","F","BOHNSACK",null,"295 S CHIPETA WAY",null,"SALT LAKE CITY","UT","84108","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Rheumatology",null,null,null,null,null,"UT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT","XELJANZ","0069-1001-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,11665.6,"2021-04-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","EFFICACY SAFETY TOLERABILITY AND PHARMACOKINETICS OF TOFACITINIB FOR TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS SJIA WITH ACTIVE SYSTEMIC FEATURES IN CHILDREN AND ADOLESCENT SUBJECTS","No","832882451","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,240010,10582,"Mayo Clinic Hospital Rochester",null,null,null,null,null,null,"1216 2ND ST SW",null,"ROCHESTER","MN","55902","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Varian Medical Systems, Inc.",100000010850,"Varian Medical Systems, Inc.","CA","United States","Yes","Covered","Device","Oncology","Eclipse Treatment Planning System for External Beam Radiation Therapy",null,"00855141006035",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,50000.0,"2021-02-17","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Improv. to GPU-Based Monte Carlo, 3D Dose Analysis","No","845840945","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,90011,10708,"Washington Hospital Center",null,null,null,null,null,null,"110 IRVING ST NW",null,"WASHINGTON","DC","20010","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",147731,1255381778,"LOWELL",null,"SATLER",null,"110 IRVING ST NW","ROOM 4B-1","WASHINGTON","DC","20010-2976","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology",null,null,null,null,null,"DC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"LivaNova USA, Inc.",100000176739,"LivaNova USA, Inc.","TX","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","TMVR",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,936.0,"2021-06-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Prelude/Interlude","No","844268999","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,460009,11165,"U Of U Hospitals & Clinics",null,null,null,null,null,null,"50 N Medical Dr",null,"Salt Lake City","UT","84132","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",645465,1902991144,"CRAIG","H","SELZMAN",null,"PO BOX 413035",null,"SALT LAKE CITY","UT","84141-3035","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery",null,null,null,null,null,"NC","UT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Abbott Laboratories",100000010680,"Abbott Laboratories","IL","United States","Yes","Covered","Device","Electrophysiology","EnSite Derexi",null,"05415067026217",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,7000.0,"2021-05-20","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Implantation of the HeartMate 3 in Subjects with Heart Failure using Surgical Techniques Other Than Full Median Sternotomy","No","827579989","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50696,11289,"KECK HOSPITAL OF USC",null,null,null,null,null,null,"1500 San Pablo Street",null,"Los Angeles","CA","90033","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",838537,1700814209,"HEINZ-JOSEF",null,"LENZ",null,"1441 EASTLAKE AVE STE 3440",null,"LOS ANGELES","CA","90089","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","BRAFTOVI","70255-025-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,450.24,"2021-11-17","In-kind items and services",null,null,null,null,null,null,"No","No","AN OPENLABEL MULTICENTER RANDOMIZED PHASE 3 STUDY OF FIRSTLINE ENCORAFENIB PLUS CETUXIMAB WITH OR WITHOUT CHEMOTHERAPY VERSUS STANDARD OF CARE THERAPY WITH A SAFETY LEADIN OF ENCORAFENIB AND CETUXIMAB PLUS CHEMOTHERAPY IN PARTICIPANTS WITH METASTATIC BRAF V600EMUTANT COLORECTAL CANCER","No","832595251","2021","06/30/2022",null,null,"Study Drug"],["NEW","Covered Recipient Teaching Hospital",null,53302,11301,"Childrens Hospital Los Angeles",null,null,null,null,null,null,"4650 W Sunset Blvd",null,"Los Angeles","CA","90027","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1146597,1508031352,"LILY",null,"CHAO",null,"3701 WILSHIRE BLVD",null,"LOS ANGELES","CA","90010","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3.25,"2021-08-31","In-kind items and services",null,null,null,null,null,null,"No","No","NN9924-4437","No","811623157","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,450076,11031,"UT MD ANDERSON CANCER CENTER",null,null,null,null,null,null,"1515 Holcombe Blvd",null,"Houston","TX","77030","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",2776390,1942743216,"TIMOTHY","A","YAP",null,"1515 HOLCOMBE BLVD","455","HOUSTON","TX","77030","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1939.06,"2021-03-01","In-kind items and services",null,null,null,null,null,null,"No","No","PHASE 12A DOSE ESCALATION AND EXPANSION STUDY EVALUATING SAFETY TOLERABILITY PHARMACOKINETIC PHARMACODYNAMICS AND ANTITUMOR ACTIVITY OF PF06873600 AS A SINGLE AGENT AND IN COMBINATION WITH ENDOCRINE THERAPY","No","832918609","2021","06/30/2022",null,null,"Study Drug"],["NEW","Covered Recipient Teaching Hospital",null,140010,10431,"Northshore University Healthsystem",null,null,null,null,null,null,"2650 Ridge Ave",null,"Evanston","IL","60201","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",376100,1457528101,"LIANA","K","BILLINGS",null,"9977 WOODS DR","STE 300","SKOKIE","IL","60077","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"IL","MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Non-Covered","Drug","Diabetes",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,22.76,"2021-09-03","In-kind items and services",null,null,null,null,null,null,"No","No","EX9536-4388","No","810797523","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,230297,10146,"Karmanos Cancer Hospital",null,null,null,null,null,null,"4100 John R St",null,"Detroit","MI","48201","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",728247,1790982031,"IRA",null,"WINER",null,"4100 JOHN R","KARMANOS CANCER CENTER","DETROIT","MI","48201-2013","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alkermes, Inc.",100000000255,"Alkermes, Inc.","MA","United States","Yes","Non-Covered",null,null,null,null,null,"Covered","Drug","Oncology","KEYTRUDA","0006-3026-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1751.81,"2021-01-26","In-kind items and services",null,null,null,null,null,null,"No","No","A Phase 1/2 Study of ALKS 4230 Administered Intravenously as Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors - ARTISTRY-1","No","797819087","2021","06/30/2022","NCT02799095",null,null],["NEW","Covered Recipient Teaching Hospital",null,310001,10178,"HACKENSACK UNIVERSITY MEDICAL CENTER",null,null,null,null,null,null,"30 PROSPECT AVE",null,"HACKENSACK","NJ","07601","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",191659,1215992912,"ANDRE","H","GOY",null,"92 2ND ST",null,"HACKENSACK","NJ","07601","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"DC","NJ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Covered","Biological","Immunology","Actemra","50242-137-01",null,"Covered","Biological","BioOncology","GAZYVA","50242-070-01",null,"Covered","Biological","BioOncology","TECENTRIQ","50242-917-01",null,"Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,891.45,"2021-11-29","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PH1 DOSE FINDING OF CD20 CD3 TDB IN B CELL NHL","No","835912531","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500008,11198,"UNIVERSITY OF WASHINGTON MED CTR",null,null,null,null,null,null,"1959 Ne Pacific St",null,"Seattle","WA","98195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1322052,1023317898,"MICHAEL","J","WAGNER",null,"825 EASTLAKE AVE E",null,"SEATTLE","WA","98109-4405","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Covered","Drug","ONCOLOGY","QINLOCK","73207-101-31",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,63.5,"2021-07-01","Cash or cash equivalent",null,null,null,null,null,null,"No","No","INTRIGUE A STUDY OF DCC-2618 VS SUNITINIB IN ADVANCED GIST PATIENTS AFTER TREATMENT WITH IMATINIB INTRIGUE","No","827889699","2021","06/30/2022","NCT03673501",null,null],["NEW","Covered Recipient Teaching Hospital",null,10033,10929,"UNIVERSITY OF ALABAMA HOSPITAL",null,null,null,null,null,null,"619 19th St S",null,"Birmingham","AL","35249","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",6366202,1982921268,"NATHANIEL",null,"ERDMANN",null,"619 19TH ST S","619 19TH ST S","BIRMINGHAM","AL","35249-1900","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"AL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Merck Sharp & Dohme Corporation",100000000053,"Merck Sharp & Dohme Corporation","NJ","United States","Yes","Covered","Drug","INFECTIOUS DISEASE","PREVYMIS","0006-5004-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,17296.15,"2021-07-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Letermovir Versus Valganciclovir for the Prevention of Human Cytomegalovirus CMV Disease in Adult Kidney Transplant Recipients","No","848756655","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,248828,1497711238,"EMIL","FRANK","VALLE",null,"11440 COMMERCE PARK DR STE LL4",null,"RESTON","VA","20191","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"VA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1096.08,"2021-02-16","In-kind items and services",null,null,null,null,null,null,"No","No","AN ADAPTIVE PHASE 2, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF LY3471851 (NKTR 358) IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS","No","819443957","2021","06/30/2022","NCT04677179","https://clinicaltrials.gov/ct2/show/NCT04677179","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"],["NEW","Covered Recipient Teaching Hospital",null,260141,10617,"Univ Of Missouri Health Care",null,null,null,null,null,null,"One Hospital Drive",null,"Columbia","MO","65212","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alkermes, Inc.",100000000255,"Alkermes, Inc.","MA","United States","Yes","Covered","Drug","CNS","OLANZAPINE","0093-5245-65",null,"Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1990.9,"2021-02-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Study to Evaluate the Effect of ALKS 3831 Compared to OLANZAPINE on Body Weight in Young Adults with Schizophrenia, Schizophreniform, or Bipolar I Disorder Who are Early in Their Illness","No","797819343","2021","06/30/2022","NCT03187769",null,null],["NEW","Covered Recipient Teaching Hospital",null,380009,11212,"OHSU HOSPITAL AND CLINICS",null,null,null,null,null,null,"3181 Sw Sam Jackson Park Rd",null,"Portland","OR","97239","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",147563,1265448864,"PAUL","B","DUELL",null,"3181 SW SAM JACKSON PARK RD",null,"PORTLAND","OR","97239-3011","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"OR",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","CARDIOVASCULAR AND METABOLISM","EVKEEZA","61755-010-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,384.0,"2021-04-16","Cash or cash equivalent",null,null,null,null,null,null,"No","No","AN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF EVINACUMAB IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA","No","793088907","2021","06/30/2022","NCT03409744",null,null],["NEW","Covered Recipient Teaching Hospital",null,523300,10556,"Childrens Hospital Of Wisconsin",null,null,null,null,null,null,"9000 W Wisconsin Ave",null,"Milwaukee","WI","53226","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",999419,1336253822,"Robert","A","Niebler",null,"9000 W Wisconsin Ave",null,"Milwaukee","WI","53226","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics",null,null,null,null,null,"WI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Daiichi Sankyo Inc.",100000000195,"Daiichi Sankyo Inc.","NJ","United States","Yes","Covered","Drug","Thrombosis","SAVAYSA","65597-201-07",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,8.95,"2021-07-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","DU176b-D-U312","No","835064695","2021","06/30/2022","NCT02798471",null,null],["NEW","Covered Recipient Teaching Hospital",null,160058,10604,"UNIVERSITY OF IOWA HOSP & CLINICS",null,null,null,null,null,null,"200 Hawkins Dr",null,"Iowa City","IA","52242","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",698436,1760464143,"WARREN","N","SCHMIDT",null,"200 HAWKINS DR",null,"IOWA CITY","IA","52242-1009","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"IA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Allergan, Inc.",100000000278,"Allergan, Inc.","NJ","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,945.0,"2021-06-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (NASH)","No","789015481","2021","06/30/2022",null,null,"3152-201-002"],["NEW","Covered Recipient Physician",null,null,null,null,306129,1750447660,"RISHI","P","SINGH",null,"9500 EUCLID AVE",null,"CLEVELAND","OH","44195","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Ophthalmology",null,null,null,null,null,"FL","OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000005656,"F. Hoffmann-La Roche AG",null,"Switzerland","Yes","Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,344.07,"2021-05-28","In-kind items and services",null,null,null,null,null,null,"No","No","A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, ACTIVE COMPARATOR CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RO6867461 IN PATIENTS WITH DIABETIC MACULAR EDEMA YOSEMITE, A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, ACTIVE COMPARATORCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RO6867461 IN PATIENTS WITH DIABETIC MACULAR EDEMA RHINE","No","835903907","2021","06/30/2022",null,null,"Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician"],["NEW","Covered Recipient Teaching Hospital",null,33302,11161,"PHOENIX CHILDRENS HOSPITAL",null,null,null,null,null,null,"1919 E Thomas Rd",null,"Phoenix","AZ","85016","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",524930,1679708002,"SHAUNA","R","SCHROEDER",null,"1919 E THOMAS RD",null,"PHOENIX","AZ","85016-7710","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","INFLAMMATION AND  IMMUNOLOGY","DUPIXENT","0024-5914-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1134.69,"2021-08-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN PEDIATRIC PATIENTS WITH ACTIVE EOSINOPHILIC ESOPHAGITIS","No","793089163","2021","06/30/2022","NCT04394351",null,null],["NEW","Covered Recipient Physician",null,null,null,null,1081628,1235206285,"EHAB","L","ATALLAH",null,"9200 W WISCONSIN AVE","NEOPLASTIC DISEASES","MILWAUKEE","WI","53226-3522","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"WI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Astellas Pharma Global Development",100000005406,"Astellas Pharma Global Development","IL","United States","Yes","Covered","Drug","ONCOLOGY","XOSPATA","0469-1425-90",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,68.52,"2021-09-21","In-kind items and services",null,null,null,null,null,null,"No","No","A Phase 3 Open-label Multicenter Randomized Study of ASP2215 versus Salvage Chemotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with FLT3 Mutation.","No","801077531","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,450076,11031,"UT MD ANDERSON CANCER CENTER",null,null,null,null,null,null,"1515 Holcombe Blvd",null,"Houston","TX","77030","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",2776390,1942743216,"TIMOTHY","A","YAP",null,"1515 HOLCOMBE BLVD","455","HOUSTON","TX","77030","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,38051.88,"2021-03-04","In-kind items and services",null,null,null,null,null,null,"No","No","A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY EVALUATING SAFETY TOLERABILITY AND PHARMACOKINETICS OF PF 06952229 IN ADULT PATIENTS WITH ADVANCED SOLID TUMORS","No","832919827","2021","06/30/2022",null,null,"Study Drug"],["NEW","Covered Recipient Teaching Hospital",null,390196,10211,"AMERICAN ONCOLOGIC HOSPIAL",null,null,null,null,null,null,"333 Cottman Ave",null,"Philadelphia","PA","19111","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",233516,1144243858,"MARGARET",null,"VON MEHREN",null,"333 COTTMAN AVE",null,"PHILADELPHIA","PA","19111","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Covered","Drug","ONCOLOGY","QINLOCK","73207-101-31",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1742.3,"2021-05-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A SAFETY TOLERABILITY AND PK STUDY OF DCC-2618 IN PATIENTS WITH ADVANCED MALIGNANCIES","No","827885689","2021","06/30/2022","NCT02571036",null,null],["NEW","Covered Recipient Teaching Hospital",null,340040,10762,"Pitt County Memorial Hospital",null,null,null,null,null,null,"2100 STANTONSBURG RD",null,"GREENVILLE","NC","27834","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",6956,1134388051,"VIJAY",null,"CHAUDHARY",null,"2100 Stantonsburg Rd",null,"GREENVILLE","NC","27834","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Seagen Inc.",100000000279,"Seagen Inc.","WA","United States","Yes","Covered","Biological","Oncology","PADCEV","51144-030-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,675.0,"2021-07-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Dose-escalation and Dose-expansion Study of Enfortumab Vedotin (ASG-22CE) in Combination With Pembrolizumab and/or Chemotherapy for Treatment of Patients With Locally Advanced or Metastatic Urothelial Cancer","No","792654759","2021","06/30/2022","NCT03288545","https://clinicaltrials.gov/ct2/show/NCT03288545",null],["NEW","Covered Recipient Teaching Hospital",null,53302,11301,"Childrens Hospital Los Angeles",null,null,null,null,null,null,"4650 W Sunset Blvd",null,"Los Angeles","CA","90027","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1146597,1508031352,"LILY",null,"CHAO",null,"3701 WILSHIRE BLVD",null,"LOS ANGELES","CA","90010","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4.5,"2021-11-19","In-kind items and services",null,null,null,null,null,null,"No","No","NN9924-4437","No","811624157","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,363305,10350,"NATIONWIDE CHILDRENS HOSPITAL",null,null,null,null,null,null,"700 Childrens Dr",null,"COLUMBUS","OH","43205","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",852810,1205824331,"MARK","A","RANALLI",null,"5209 MILLER PAUL RD",null,"WESTERVILLE","OH","43082","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","IBRANCE","0069-0187-21",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,99.85,"2021-03-08","In-kind items and services",null,null,null,null,null,null,"No","No","PHASE 1 STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF PALBOCICLIB IBRANCEREGISTERED IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE AND IN COMBINATION WITH TOPOTECAN AND CYCLOPHOSPHAMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS","No","832921037","2021","06/30/2022",null,null,"Study Drug"],["NEW","Covered Recipient Teaching Hospital",null,30087,11159,"HONORHEALTH SCOTTSDALE SHEA MED CTR",null,null,null,null,null,null,"9003 E Shea Blvd",null,"Scottsdale","AZ","85260","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",277405,1114929114,"MICHAEL","S","GORDON",null,"9055 E DEL CAMINO DR","SUITE 100","SCOTTSDALE","AZ","85258-2351","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Covered","Drug","ONCOLOGY","QINLOCK","73207-101-31",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,101.25,"2021-04-03","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A SAFETY TOLERABILITY AND PK STUDY OF DCC-2618 IN PATIENTS WITH ADVANCED MALIGNANCIES","No","827885947","2021","06/30/2022","NCT02571036",null,null],["NEW","Covered Recipient Teaching Hospital",null,30087,11159,"HONORHEALTH SCOTTSDALE SHEA MED CTR",null,null,null,null,null,null,"9003 E SHEA BLVD",null,"SCOTTSDALE","AZ","85260","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",277405,1114929114,"MICHAEL","S","GORDON",null,"9055 E DEL CAMINO DR","SUITE 100","SCOTTSDALE","AZ","85258","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Covered","Biological","BioOncology","TECENTRIQ","50242-917-01",null,"Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1941.94,"2021-02-17","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE IA IB OPEN LABEL DOSE ESCALATION STUDY OF THE SAFETY AND PHARMACOKINETICS OF XMAB24306 ALO","No","835913491","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,763950,1063764207,"GILBERT","ANTONIO","JENOURI",null,"679 MAIN ST",null,"JOHNSON CITY","NY","13790","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,18725.0,"2021-08-24","Cash or cash equivalent",null,null,null,null,null,null,"No","No","RANDOMIZED, PLACEBO CONTROLLED, PHASE 2 CLINICAL TRIAL TO EVALUATE LY3556050 FOR THE TREATMENT OF OSTEOARTHRITIS PAIN","No","819444217","2021","06/30/2022","NCT04627038","https://www.clinicaltrials.gov/ct2/show/NCT04627038","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"],["NEW","Covered Recipient Teaching Hospital",null,160058,10604,"University Of Iowa Hosp & Clinics",null,null,null,null,null,null,"200 HAWKINS DR",null,"IOWA CITY","IA","52242","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1299200,1326207978,"MARIKO",null,"SATO",null,"100 N MARIO CAPECCHI DR",null,"SALT LAKE CITY","UT","84113","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology",null,null,null,null,null,"IA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,37.08,"2021-09-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearranged and or JAK Pathway Mutant Acute Lymphoblastic Leukemia","No","831112787","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Teaching Hospital",null,230297,10146,"KARMANOS CANCER HOSPITAL",null,null,null,null,null,null,"4100 JOHN R ST",null,"DETROIT","MI","48201","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",945091,1437446820,"HIRVA","MANSURALI","MAMDANI",null,"4100 JOHN R ST",null,"DETROIT","MI","48201","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"IN","MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Covered","Biological","BioOncology","TECENTRIQ","50242-917-01",null,"Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4344.8,"2021-12-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PHII PLACEBO CONTROLLED OF TIRAGOLUMAB AND ATEZO IN NSCLC","No","835914485","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,220110,9985,"Brigham And Womens Hospital",null,null,null,null,null,null,"75 Francis St",null,"Boston","MA","02115","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",838542,1700877982,"GARY","M","HUNNINGHAKE",null,"55 FRUIT ST","BUL 148","BOSTON","MA","02114-2621","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Boehringer Ingelheim USA, Inc.",100000061372,"Boehringer Ingelheim Limited",null,"Great Britain (Uk)","Yes","Covered","Drug","RESPIRATORY","OFEV","0597-0143-60",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,23.32,"2021-01-26","In-kind items and services",null,null,null,null,null,null,"No","No","Nintedanib in PF-ILD (extension)","No","827034729","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,240960,1326011255,"JOEL",null,"ROSH",null,"100 MADISON AVE",null,"MORRISTOWN","NJ","07960","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology",null,null,null,null,null,"NJ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,369.54,"2021-04-27","In-kind items and services",null,null,null,null,null,null,"No","No","MULTICENTER, OPEN-LABEL PK STUDY OF MIRIKIZUMAB IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS","No","819444477","2021","06/30/2022","NCT04004611","https://clinicaltrials.gov/ct2/show/NCT04004611","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor in connection with clinical studies during the reporting period.  For available study details, please visit clinicaltrials.gov."],["NEW","Covered Recipient Teaching Hospital",null,50696,11289,"KECK HOSPITAL OF USC",null,null,null,null,null,null,"1500 SAN PABLO STREET",null,"LOS ANGELES","CA","90033","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",285051,1285822445,"MAY","ANNE","KIM-TENSER",null,"1540 ALCAZAR ST","204M","LOS ANGELES","CA","90089","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurocritical Care",null,null,null,null,null,"AZ","CA","FL","GA","IN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1042.2,"2021-02-17","Cash or cash equivalent",null,null,null,null,null,null,"No","No","TENECTEPLASE IN STROKE PATIENTS BETWEEN 4 5 AND 24 HOURS","No","835915369","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,110010,10785,"Emory University Hospital",null,null,null,null,null,null,"1821 CLIFTON RD NE",null,"ATLANTA","GA","30329","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",585635,1811160609,"HONG",null,"LI",null,"OFFICE FOR CLINICAL RESEARCH",null,"ATLANTA","GA","30322","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Medical Genetics|Clinical Genetics (M.D.)",null,null,null,null,null,"GA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Moderna TX, Inc.",100000961851,"Moderna TX, Inc.","MA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1390.0,"2021-10-20","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A longitudinal, exploratory, natural history study to further characterize and describe the signs and symptoms of patients with organic acidemias.","No","806342189","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,31926,1700996931,"STEPHEN","L.","HAUSER",null,"1651 4TH ST",null,"SAN FRANCISCO","CA","94143","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000005656,"F. Hoffmann-La Roche AG",null,"Switzerland","Yes","Covered","Biological","Immunology","OCREVUS","50242-150-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2556.62,"2021-07-21","In-kind items and services",null,null,null,null,null,null,"No","No","LONG-TERM SUPPRESSION OF MRI DISEASE ACTIVITY AND REDUCTION OF GLOBALREGIONAL VOLUME LOSS RESULTS FROM OPERA III AND ORATORIO OPEN-LABEL EXTENSION","No","835904721","2021","06/30/2022",null,null,"Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician"],["NEW","Covered Recipient Teaching Hospital",null,390133,10231,"Lehigh Valley",null,null,null,null,null,null,"1200 S CEDAR CREST BLVD",null,"ALLENTOWN","PA","18103","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",40820,1891812905,"ERIC","OWEN","MUELLER",null,"1230 S Cedar Crest Blvd","Ste 201","ALLENTOWN","PA","18103","United States",null,null,"Doctor of Osteopathy",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Medtronic, Inc.",100000000106,"Medtronic, Inc.","MN","United States","Yes","Covered","Device","Pacemakers","Micra",null,"00643169711761","Covered","Device","Leads","Sprint Quattro",null,"00643169690042","Covered","Device","Leads","SelectSecure",null,"00643169535848","Covered","Device","Leads","Capsure Sense",null,643169590519,"Covered","Device","Implantable Cardioverter Defibrillators (ICDs)","Cobalt",null,763000178390,750.0,"2021-09-14","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PSR-CVG","No","800997357","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,440039,10425,"Vanderbilt University Medical Center",null,null,null,null,null,null,"1211 MEDICAL CENTER DRIVE",null,"NASHVILLE","TN","37232","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1269688,1851488985,"KATHRYN","M.","DAHIR",null,"1215 21st Ave S Ste 8210",null,"Nashville","TN","37232","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"TN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alexion Pharmaceuticals, Inc.",100000005462,"Alexion Pharmaceuticals, Inc.","MA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,634.0,"2021-04-20","Cash or cash equivalent",null,null,null,null,null,null,"No","No","An Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)","No","781380205","2021","06/30/2022","NCT02306720",null,null],["NEW","Covered Recipient Teaching Hospital",null,410007,10008,"RHODE ISLAND HOSPITAL",null,null,null,null,null,null,"593 Eddy Street",null,"Providence","RI","02914","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",72892,1629041074,"ELEFTHERI","E","MYLONAKIS",null,"164 SUMMIT AVE",null,"PROVIDENCE","RI","02906-2853","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"RI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,12672.95,"2021-10-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A MASTER PROTOCOL ASSESSING THE SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-SPIKE (S) SARS-COV-2 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF AMBULATORY PATIENTS WITH COVID-19","No","793089419","2021","06/30/2022","NCT04425629",null,null],["NEW","Covered Recipient Physician",null,null,null,null,146932,1245316199,"MAHA","HADI","HUSSAIN",null,"1500 EAST MEDICAL CENTER DR","B1 FLOOR CANCER CTR RECP D","ANN ARBOR","MI","48109-5913","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Astellas Pharma Global Development",100000005406,"Astellas Pharma Global Development","IL","United States","Yes","Covered","Drug","ONCOLOGY","XTANDI","0469-0125-99",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,963.51,"2021-04-15","In-kind items and services",null,null,null,null,null,null,"No","No","Matching-adjusted indirect treatment comparison of the efficacy of enzalutamide for the treatment of non-metastatic castration-resistant prostate cancer","No","801077793","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,390111,10224,"Hospital Of The Univ Of Penna",null,null,null,null,null,null,"3701 Market St",null,"Phila","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",866275,1689608572,"MARK",null,"MORGAN",null,"800 SPRUCE STREET",null,"PHILADELPHIA","PA","19107","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology",null,null,null,null,null,"NJ","PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Clovis Oncology, Inc.",100000191752,"Clovis Oncology, Inc.","CO","United States","Yes","Covered","Drug","ONCOLOGY","Rubraca","69660-201-91",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,17468.75,"2021-01-04","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy (ATHENA)","No","796700063","2021","06/30/2022","NCT03522246",null,"CO-338-087"],["NEW","Covered Recipient Teaching Hospital",null,220086,9982,"Beth Israel Deaconess Medical Center",null,null,null,null,null,null,"330 Brookline Ave","St 207","Boston","MA","02215","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1238506,1750366977,"DOUGLAS","M","BEACH",null,"330 BROOKLINE AVE",null,"BOSTON","MA","02215","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AstraZeneca Pharmaceuticals LP",100000000146,"AstraZeneca Pharmaceuticals LP","DE","United States","Yes","Covered","Biological","Respiratory","FASENRA","0310-1730-30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,13500.0,"2021-02-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Randomised, Double-blind, Active-controlled 52-week Study with an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab Compared to Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA) in Patients Receiving Standard of Care Therapy","No","826501103","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50660,11290,"Usc Norris Cancer Hospital",null,null,null,null,null,null,"1441 Eastlake Ave",null,"Los Angeles","CA","90089","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",266439,1881629566,"MARK","JOSEPH","CUNNINGHAM",null,"PO BOX 31309",null,"LOS ANGELES","CA","90031-0309","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery)",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Abbott Laboratories",100000010680,"Abbott Laboratories","IL","United States","Yes","Covered","Device","Vascular","Xience Sierra Coronary Stent",null,"08717648227547",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1096.0,"2021-11-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO)","No","827581017","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,30103,11162,"MAYO CLINIC HOSPITAL",null,null,null,null,null,null,"5777 E Mayo Blvd",null,"Phoenix","AZ","85054","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",203751,1487781175,"MAHESH",null,"SEETHARAM",null,"5777 E MAYO BLVD",null,"PHOENIX","AZ","85054-4502","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Covered","Drug","ONCOLOGY","QINLOCK","73207-101-31",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2221.0,"2021-07-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","INTRIGUE A STUDY OF DCC-2618 VS SUNITINIB IN ADVANCED GIST PATIENTS AFTER TREATMENT WITH IMATINIB INTRIGUE","No","827886203","2021","06/30/2022","NCT03673501",null,null],["NEW","Covered Recipient Teaching Hospital",null,100271,10837,"Moffitt Cancer Center",null,null,null,null,null,null,"12902 MAGNOLIA DR",null,"TAMPA","FL","33612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",360901,1942266929,"RAMI","S.","KOMROKJI",null,"12902 USF MAGNOLIA DR",null,"TAMPA","FL","33612","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,10.98,"2021-01-11","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY","No","831097711","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Teaching Hospital",null,450051,11035,"Methodist Dallas Medical Center",null,null,null,null,null,null,"1441 N Beckley Ave",null,"Dallas","TX","75203","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",123736,1720042070,"Islam",null,"Shahin",null,"1750 N HAMPTON RD",null,"DESOTO","TX","75115","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Sirtex Medical Inc",100000010918,"Sirtex Medical Inc","MA","United States","Yes","Covered","Device","Interventional Oncology","SIR-Spheres Microspheres",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,150.0,"2021-04-01","Cash or cash equivalent","Patient Care",null,null,null,null,null,"Yes","No","Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Study","No","855363111","2021","06/30/2022","NCT02685631",null,null],["NEW","Covered Recipient Teaching Hospital",null,100271,10837,"MOFFITT CANCER CENTER",null,null,null,null,null,null,"12902 Magnolia Dr",null,"Tampa","FL","33612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1294667,1073707170,"MIHAELA",null,"DRUTA",null,"12902 USF MAGNOLIA DR",null,"TAMPA","FL","33612-9416","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Covered","Drug","ONCOLOGY","QINLOCK","73207-101-31",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,544.0,"2021-04-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","INTRIGUE A STUDY OF DCC-2618 VS SUNITINIB IN ADVANCED GIST PATIENTS AFTER TREATMENT WITH IMATINIB INTRIGUE","No","827886459","2021","06/30/2022","NCT03673501",null,null],["NEW","Covered Recipient Teaching Hospital",null,380009,11212,"OHSU HOSPITAL AND CLINICS",null,null,null,null,null,null,"3181 Sw Sam Jackson Park Rd",null,"Portland","OR","97239","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",362051,1972511426,"ERIC","L","SIMPSON",null,"3181 SW SAM JACKSON PARK RD",null,"PORTLAND","OR","97239-3011","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"OR",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Kyowa Kirin, Inc.",100000010604,"Kyowa Kirin, Inc.","NJ","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1000.0,"2021-07-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo controlled Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects with Moderate to Severe Atopic Dermatitis (AD)","No","853000333","2021","06/30/2022",null,null,"4083-006"],["NEW","Covered Recipient Physician",null,null,null,null,348274,1689669293,"JENNIFER","MARIE","BELLUCCI JACKSON",null,"425 LAKE ST",null,"ANTIOCH","IL","60002","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Family Medicine",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,810.0,"2021-06-11","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PREVENTIVE TREATMENT OF MIGRAINE: OUTCOMES FOR PATIENTS IN REAL-WORLD HEALTHCARE SYSTEMS (TRIUMPH)","No","819444739","2021","06/30/2022",null,null,"The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"],["NEW","Covered Recipient Teaching Hospital",null,224007,9987,"Mclean Hospital",null,null,null,null,null,null,"115 Mill St",null,"Belmont","MA","02478","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alkermes, Inc.",100000000255,"Alkermes, Inc.","MA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,24530.44,"2021-03-01","Cash or cash equivalent",null,null,null,null,null,null,"No","No","In vivo research observing brain lactate changes in first-episode schizophrenia using 3-T magnetic resonance spectroscopy","No","797820111","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50696,11289,"Keck Hospital Of Usc",null,null,null,null,null,null,"1500 SAN PABLO STREET",null,"LOS ANGELES","CA","90033","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",102763,1275578957,"ANN","F.","MOHRBACHER",null,"1441 EASTLAKE AVE","STE 162","LOS ANGELES","CA","90089","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,47.0,"2021-09-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 1b/2a Basket Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Combination Therapy With the Anti CD19 Monoclonal Antibody Tafasitamab and the PI3Kd Inhibitor Parsaclisib in Adult Participants With Relapsed/Refractory Non Hodgkin Lymphoma or Chronic Lymphocytic Leukemia","No","831114315","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Teaching Hospital",null,54144,11286,"LANGLEY PORTER PSYCHIATRIC HOSPITAL",null,null,null,null,null,null,"401 PARNASSUS AVE",null,"SAN FRANCISCO","CA","94143","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1137763,1205009115,"JEFFREY","MARC","GELFAND",null,"505 PARNASSUS AVE","39","SAN FRANCISCO","CA","94143","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Covered","Biological","Immunology","OCREVUS","50242-150-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,7020.0,"2021-09-20","Cash or cash equivalent",null,null,null,null,null,null,"No","No","MNT OBOE","No","835916447","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50625,11293,"Cedars-Sinai Medical Center",null,null,null,null,null,null,"8700 Beverly Blvd",null,"West Hollywood","CA","90048","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",467133,1649290248,"KAREN",null,"RECKAMP",null,"1500 E. DUARTE RD",null,"DUARTE","CA","91010","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Janssen Research & Development, LLC",100000005592,"Janssen Research & Development, LLC","NJ","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,32832.26,"2021-09-27","Cash or cash equivalent",null,null,null,null,null,null,"No","No","An Open label Phase 11b Study to Evaluate the Safety and Pharmacokinetics of JNJ73841937 Lazertinib a Third Generation EGFRTKI as Monotherapy or in Combinations With JNJ61186372 a Human Bispecific EGFR and cMet Antibody in Participants With Advanced Non Sm","No","787577909","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,390111,10224,"HOSPITAL OF THE UNIV OF PENNA",null,null,null,null,null,null,"3701 MARKET ST",null,"PHILA","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",179546,1962546952,"SUSAN","C","TAYLOR",null,"800 WALNUT ST",null,"PHILADELPHIA","PA","19107","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1889.62,"2021-02-08","In-kind items and services",null,null,null,null,null,null,"No","No","A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, OPERATIONALLY SEAMLESS, ADAPTIVE PHASE 2/3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BARICITINIB IN ADULT PATIENTS WITH SEVERE OR VERY SEVERE ALOPECIA AREATA","No","819448081","2021","06/30/2022","NCT03570749","https://clinicaltrials.gov/ct2/show/NCT03570749","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"],["NEW","Covered Recipient Teaching Hospital",null,500054,10477,"Prov Sacred Heart Medical Center",null,null,null,null,null,null,"101 W. 8th Ave.",null,"Spokane","WA","99220","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",249693,1508905522,"ALMA",null,"CHAVEZ",null,"105 W 8TH AVE",null,"SPOKANE","WA","99204","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Pulmonology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"VERTEX PHARMACEUTICALS INCORPORATED",100000000184,"VERTEX PHARMACEUTICALS INCORPORATED","MA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,19117.03,"2021-01-01","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Study Evaluating the Long-term Safety of VX-445 Combination Therapy","No","793094287","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,220162,9984,"Dana-Farber Cancer Institute",null,null,null,null,null,null,"450 BROOKLINE AVE",null,"BOSTON","MA","02215","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",260575,1730156324,"FRANK","STEPHEN","HODI",null,"44 BINNEY ST","RM DLI","BOSTON","MA","02115","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,35.16,"2021-01-11","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 1 Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Select Advanced Solid Tumors","No","831072557","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Physician",null,null,null,null,97323,1144275827,"THOMAS","ROBERT","MURPHY",null,"415 FISH TALE RD",null,"DANIEL ISLAND","SC","29492","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Allergy & Immunology",null,null,null,null,null,"SC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000005656,"F. Hoffmann-La Roche AG",null,"Switzerland","Yes","Covered","Biological","Immunology","Xolair","50242-040-62",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3100.0,"2021-04-16","In-kind items and services",null,null,null,null,null,null,"No","No","COVID-19 OUTCOMES IN PATIENTS WITH ASTHMA WITH OR WITHOUT EVIDENCE OF ALLERGY","No","835905523","2021","06/30/2022",null,null,"Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician"],["NEW","Covered Recipient Physician",null,null,null,null,26119,1588677736,"HENRY","W","TRAYLOR","JR.","1615 DOCTORS CIR",null,"WILMINGTON","NC","28401","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,6.5,"2021-08-04","In-kind items and services",null,null,null,null,null,null,"No","No","EX9924-4473","No","810917185","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,440039,10425,"VANDERBILT UNIVERSITY MEDICAL CENTER",null,null,null,null,null,null,"1211 Medical Center Drive",null,"Nashville","TN","37232","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",319378,1033206149,"MICHAEL",null,"PORAYKO",null,"1301 MEDICAL CENTER DR",null,"NASHVILLE","TN","37232","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"TN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,9180.4,"2021-11-24","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 2 RANDOMIZED DOUBLEBLIND DOUBLEDUMMY PLACEBOCONTROLLED DOSERANGING DOSEFINDING PARALLEL GROUP STUDY TO ASSESS EFFICACY AND SAFETY OF PF06865571 DGAT2I ALONE AND WHEN COADMINISTERED WITH PF05221304 ACCI IN ADULT PARTICIPANTS WITH BIOPSYCONFIRMED NONALCOHOLIC STEATOHEPATITIS AND FIBROSIS STAGE 2 OR 3","No","832885949","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,100087,10843,"SARASOTA MEMORIAL HOSPITAL",null,null,null,null,null,null,"1700 S Tamiami Trl",null,"Sarasota","FL","34239","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",333556,1346347887,"MANUEL","E","GORDILLO",null,"1425 S OSPREY AVE","STE 1","SARASOTA","FL","34239","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3778.0,"2021-04-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A MASTER PROTOCOL ASSESSING THE SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-SPIKE (S) SARS-COV-2 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF AMBULATORY PATIENTS WITH COVID-19","No","793089675","2021","06/30/2022","NCT04425629",null,null],["NEW","Covered Recipient Teaching Hospital",null,100007,10819,"Adventhealth Orlando",null,null,null,null,null,null,"601 E ROLLINS ST",null,"ORLANDO","FL","32803","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",306919,1770576258,"CARLOS","A.","ALEMANY",null,"2501 N Orange Ave",null,"ORLANDO","FL","32804","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Seagen Inc.",100000000279,"Seagen Inc.","WA","United States","Yes","Covered","Drug","Oncology","TUKYSA","51144-001-60",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,17929.35,"2021-02-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer","No","792655531","2021","06/30/2022","NCT03975647","https://clinicaltrials.gov/ct2/show/NCT03975647","This study is designed to evaluate the efficacy and safety of tucatinib in combination with T-DM1 in subjects with unresectable locally-advanced or metastatic HER2+ breast cancer who have had prior treatment with a taxane and trastuzumab in any setting. Prior pertuzumab treatment is permitted, but not required. Subjects will be randomized in a 1:1 manner to receive 21-day cycles of either tucatinib or placebo in combination with T-DM1."],["NEW","Covered Recipient Teaching Hospital",null,50077,11300,"Scripps Mercy Hospital",null,null,null,null,null,null,"4077 5th Ave",null,"San Diego","CA","92103","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",13194,1285612457,"JAMES","T","HEYWOOD",null,"10790 RANCHO BERNARDO RD",null,"SAN DIEGO","CA","92127-5705","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Advanced Heart Failure and Transplant Cardiology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Abbott Laboratories",100000010680,"Abbott Laboratories","IL","United States","Yes","Covered","Device","Heart Failure","CardioMEMS HF System",null,"05414734509800",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2000.0,"2021-01-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","INvesTigation to OptimizE Hemodynamic Management of HeartMate II Left VentricuLar Assist DEvice Patients using the CardioMEMS Pulmonary ArTery Pressure Sensor in Advanced Heart Failure (INTELLECT 2-HF)","No","827581531","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,100087,10843,"Sarasota Memorial Hospital",null,null,null,null,null,null,"1700 S. Tamiami Trail",null,"Sarasota","FL","34239","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",227609,1023086501,"Justin",null,"Lee",null,"1700 S TAMIAMI TRL",null,"SARASOTA","FL","34239","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Sirtex Medical Inc",100000010918,"Sirtex Medical Inc","MA","United States","Yes","Covered","Device","Interventional Oncology","SIR-Spheres Microspheres",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,100.0,"2021-09-28","Cash or cash equivalent","Patient Care",null,null,null,null,null,"Yes","No","Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Study","No","855363367","2021","06/30/2022","NCT02685631",null,null],["NEW","Covered Recipient Teaching Hospital",null,330182,10053,"St. Francis Hospital",null,null,null,null,null,null,"100 Port Washington Blvd",null,"Roslyn","NY","11576","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",354880,1811140627,"RITA","A","JERMYN",null,"475 SEAVIEW AVE",null,"STATEN ISLAND","NY","10305","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2.65,"2021-07-22","In-kind items and services",null,null,null,null,null,null,"No","No","EX9536-4665","No","811891925","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,450018,11030,"THE UNIVERSITY OF TEXAS MEDICAL BR.",null,null,null,null,null,null,"301 University Blvd",null,"Galveston","TX","77555","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,100000.0,"2021-01-21","Cash or cash equivalent",null,null,null,null,null,null,"No","No","REPORTER SARSCOV2 VIRUS NEUTRALIZATION ASSAY","No","832925047","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,100271,10837,"MOFFITT CANCER CENTER",null,null,null,null,null,null,"12902 Magnolia Dr",null,"Tampa","FL","33612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1294667,1073707170,"MIHAELA",null,"DRUTA",null,"12902 USF MAGNOLIA DR",null,"TAMPA","FL","33612-9416","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Covered","Drug","ONCOLOGY","QINLOCK","73207-101-31",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,312.8,"2021-06-11","Cash or cash equivalent",null,null,null,null,null,null,"No","No","INTRIGUE A STUDY OF DCC-2618 VS SUNITINIB IN ADVANCED GIST PATIENTS AFTER TREATMENT WITH IMATINIB INTRIGUE","No","827886715","2021","06/30/2022","NCT03673501",null,null],["NEW","Covered Recipient Teaching Hospital",null,450056,11002,"ASCENSION SETON MEDICAL CENTER",null,null,null,null,null,null,"1201 W 38TH ST",null,"DALLAS","TX","78705","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1252953,1255507943,"POOJA",null,"VARSHNEY",null,"1301 BARBARA JORDAN BLVD","SUITE 200","AUSTIN","TX","78723-3077","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Allergy/Immunology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AIMMUNE THERAPEUTICS, INC.",100000776814,"AIMMUNE THERAPEUTICS, INC.","CA","United States","Yes","Covered","Biological","ALLERGY","PALFORZIA","71881-113-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,27.34,"2021-06-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY","No","849611705","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,490009,10745,"University Of Virginia Medical Cente",null,null,null,null,null,null,"1215 LEE ST PFS",null,"CHARLOTTESVILLE","VA","22908","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",767059,1174812010,"MICHAEL","E.","DEVITT",null,"590 Peter Jefferson Pkwy",null,"CHARLOTTESVILLE","VA","22911","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"VA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Seagen Inc.",100000000279,"Seagen Inc.","WA","United States","Yes","Covered","Biological","Oncology","PADCEV","51144-030-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,29592.0,"2021-08-16","In-kind items and services",null,null,null,null,null,null,"No","No","Open-label, Randomized, Controlled Phase 3 Study of Enfortumab Vedotin in Combination With Pembrolizumab With or Without Chemotherapy, Versus Chemotherapy Alone in Previously Untreated Locally Advanced or Metastatic Urothelial Cancer","No","792665011","2021","06/30/2022","NCT04223856","https://clinicaltrials.gov/ct2/show/NCT04223856","This study is being conducted to evaluate the combination of enfortumab vedotin + pembrolizumab, with or without platinum-containing chemotherapy, versus standard of care gemcitabine + platinum-containing chemotherapy, in subjects with previously untreated locally advanced or metastatic urothelial cancer."],["NEW","Covered Recipient Teaching Hospital",null,54009,11327,"RESNICK NEUROPSYCHIATRIC HOSPITAL AT",null,null,null,null,null,null,"150 UCLA MEDICAL PLAZA",null,"LOS ANGELES","CA","90095","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1381878,1174808224,"SANDY",null,"LIU",null,"15503 VENTURA BLVD","370","ENCINO","CA","91436","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Covered","Biological","BioOncology","TECENTRIQ","50242-917-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,8370.0,"2021-05-05","Cash or cash equivalent",null,null,null,null,null,null,"No","No","CONTACT03","No","835923331","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,363300,10334,"Childrens Hospital Medical Center",null,null,null,null,null,null,"3333 BURNET AVE",null,"CINCINNATI","OH","45229","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",368012,1164578761,"SHEHARYAR","RIZWAN","DURRANI",null,"3333 Burnet Avenue.,mlc 2000",null,"Cincinnati","OH","45229","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Allergy/Immunology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Sanofi and Genzyme US Companies",100000000067,"SANOFI US SERVICES INC.","NJ","United States","Yes","Covered","Biological","Immunology","DUPIXENT","0024-5914-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4575.0,"2021-05-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","One Year Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Pediatric Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study","No","838660919","2021","06/30/2022","NCT03560466",null,null],["NEW","Covered Recipient Teaching Hospital",null,220162,9984,"DANA-FARBER CANCER INSTITUTE",null,null,null,null,null,null,"450 Brookline Ave",null,"Boston","MA","02215","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",31442,1689891129,"JORGE","J","CASTILLO",null,"450 BROOKLINE AVE","M221","BOSTON","MA","02215","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"ABBVIE INC.",100000000204,"ABBVIE INC.","IL","United States","Yes","Covered","Drug","ONCOLOGY","VENCLEXTA","0074-0576-22",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,387216.0,"2021-05-04","In-kind items and services",null,null,null,null,null,null,"No","No","Phase II study on the combination of ibrutinib and venetoclax in treatment na?ve patients with Waldenstr?m Macroglobulinemia","No","792382589","2021","06/30/2022",null,null,"A19-325"],["NEW","Covered Recipient Physician",null,null,null,null,1164196,1134106487,"SANDRO",null,"BACCHELLI",null,"750 S FEDERAL HWY",null,"HOLLYWOOD","FL","33020","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Family Medicine",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,14415.78,"2021-06-08","In-kind items and services",null,null,null,null,null,null,"No","No","A PHASE 2 STUDY OF ONCE-WEEKLY LY3437943 COMPARED WITH PLACEBO AND DULAGLUTIDE IN PARTICIPANTS WITH TYPE 2 DIABETES","No","819446541","2021","06/30/2022","NCT04867785","https://clinicaltrials.gov/ct2/show/NCT04867785","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"],["NEW","Covered Recipient Teaching Hospital",null,360137,10389,"Uh Cleveland Medical Center",null,null,null,null,null,null,"11100 EUCLID AVE",null,"CLEVELAND","OH","44106","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",861978,1528084852,"AFSHIN",null,"DOWLATI",null,"11100 Euclid Ave",null,"CLEVELAND","OH","44106","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Seagen Inc.",100000000279,"Seagen Inc.","WA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,68616.42,"2021-02-03","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 1 Study of SGN-B6A in Advanced Solid Tumors","No","792665683","2021","06/30/2022","NCT04389632",null,null],["NEW","Covered Recipient Teaching Hospital",null,140119,10441,"RUSH UNIVERSITY MEDICAL CENTER",null,null,null,null,null,null,"1653 W CONGRESS PKWY",null,"CHICAGO","IL","60612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Covered","Biological","BioOncology","Avastin","50242-061-01",null,"Covered","Biological","BioOncology","TECENTRIQ","50242-917-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,750.0,"2021-05-19","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PH2 STUDY OF ATEZOLIZUMAB WITH OR W O BEVACIZUMAB","No","835924405","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,83300,10812,"Alfred I Dupont Hosp For Children",null,null,null,null,null,null,"1600 Rockland Rd",null,"Wilmington","DE","19899","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",740847,1255422531,"MICHAEL",null,"BOBER",null,"AI DUPONT HOSPITAL FOR CHILDREN","1600 ROCKLAND ROAD","WILMINGTON","DE","19803","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Medical Genetics|Clinical Genetics (M.D.)",null,null,null,null,null,"DE","FL","OH","PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BioMarin Pharmaceutical Inc.",100000010405,"BioMarin Pharmaceutical Inc.","CA","United States","Yes","Covered","Biological","MPS IVA","Vimizim","68135-100-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,6000.0,"2021-03-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Morquio A Registry Study MARS)","No","831382151","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,931148,1952301632,"LUIS","Z","OSTROSKY",null,"6431 FANNIN ST","MSB 2112","HOUSTON","TX","77030-1501","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Astellas Pharma Global Development",100000005406,"Astellas Pharma Global Development","IL","United States","Yes","Covered","Drug","HOSPITAL AND TRANSPLANT","CRESEMBA","0469-0420-99",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,175.38,"2021-08-17","In-kind items and services",null,null,null,null,null,null,"No","No","A Non-Interventional Registry Study of Systemic Antifungal Therapy in Adult Subjects with Invasive Mucormycosis or Invasive Aspergillosis Caused by a Non-fumigatus Species","No","801078055","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,30087,11159,"HONORHEALTH SCOTTSDALE SHEA MED CTR",null,null,null,null,null,null,"9003 E SHEA BLVD",null,"SCOTTSDALE","AZ","85260","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",287588,1336128859,"TODD","D","LEVINE",null,"5090 N 40TH ST","STE 250","PHOENIX","AZ","85018","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000005656,"F. Hoffmann-La Roche AG",null,"Switzerland","Yes","Covered","Biological","Immunology","OCREVUS","50242-150-01",null,"Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,6980.0,"2021-02-23","Cash or cash equivalent",null,null,null,null,null,null,"No","No","STUDY OF OCRELIZUMAB IN PPMS PATIENTS ASSESSING UPPER LIMB FUNCTION","No","835913545","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,215989,1770549099,"RAJENDRA","H","MEHTA",null,"214 N WEST AVE",null,"JACKSON","MI","49201","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Obesity","Wegovy","0169-4525-14",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4975.0,"2021-06-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","EX9536-4388","No","810764285","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500152,11176,"SWEDISH ISSAQUAH",null,null,null,null,null,null,"751 Ne Blakely Dr",null,"Issaquah","WA","98029","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",953859,1740436609,"JASON","D","GOLDMAN",null,"747 BROADWAY",null,"SEATTLE","WA","98122-4379","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,101.25,"2021-01-21","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A MASTER PROTOCOL ASSESSING THE SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-SPIKE (S) SARS-COV-2 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF HOSPITALIZED PATIENTS WITH COVID-19","No","793089931","2021","06/30/2022","NCT04426695",null,null],["NEW","Covered Recipient Teaching Hospital",null,53302,11301,"Childrens Hospital Los Angeles",null,null,null,null,null,null,"4650 W Sunset Blvd",null,"Los Angeles","CA","90027","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",460192,1396942470,"Julie","Ann","Jaffray",null,"4650 W Sunset Blvd",null,"Los Angeles","CA","90027","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Daiichi Sankyo Inc.",100000000195,"Daiichi Sankyo Inc.","NJ","United States","Yes","Covered","Drug","Thrombosis","SAVAYSA","65597-201-07",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,15.4,"2021-09-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","DU176b-D-U312","No","835065069","2021","06/30/2022","NCT02798471",null,null],["NEW","Covered Recipient Physician",null,null,null,null,88255,1942268073,"JONATHAN","E","ROSENBERG",null,"353 E 68TH ST",null,"NEW YORK","NY","10065","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Astellas Pharma Global Development",100000005406,"Astellas Pharma Global Development","IL","United States","Yes","Covered","Drug","ONCOLOGY","PADCEV","51144-020-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,227.5,"2021-03-11","In-kind items and services",null,null,null,null,null,null,"No","No","An Open-Label, Randomized Phase 3 Study to Evaluate Enfortumab Vedotin vs Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)","No","801078313","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,220071,9988,"Massachusetts General Hospital",null,null,null,null,null,null,"55 Fruit St","Bulfinch 360","Boston","MA","02114","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1326119,1487929634,"SARA",null,"BOUBERHAN",null,"55 FRUIT ST",null,"BOSTON","MA","02114","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"CT","MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Clovis Oncology, Inc.",100000191752,"Clovis Oncology, Inc.","CO","United States","Yes","Covered","Drug","ONCOLOGY","Rubraca","69660-201-91",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,30.0,"2021-08-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients With Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer","No","796700575","2021","06/30/2022","NCT01968213",null,"CO-338-014"],["NEW","Covered Recipient Teaching Hospital",null,503300,11178,"Seattle Childrens Hospital",null,null,null,null,null,null,"4800 Sandpoint Way Ne","5371","Seattle","WA","98105","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",265829,1861507113,"ROBERT",null,"SIDBURY",null,"4800 SAND POINT WAY NE","SEATTLE CHILDREN'S HOSPITAL A7916","SEATTLE","WA","98105-3901","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology|Pediatric Dermatology",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"UCB, Inc.",100000010773,"UCB SA",null,"Belgium","Yes","Covered","Drug","Immunology","Cimzia","50474-710-79",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2041.0,"2021-04-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","MULTICENTER, RANDOMIZED, PARALLEL GROUP, DOUBLE BLIND, PLACEBO-CONTROLLED (12 17 YEARS) INCLUDING A SINGLE OPEN LABEL ARM (6 11 YEARS) STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF CERTOLIZUMAB PEGOL (CZP) IN PEDIATRIC STU","No","844224161","2021","06/30/2022","NCT04123795",null,null],["NEW","Covered Recipient Teaching Hospital",null,60010,11138,"Poudre Valley Hospital",null,null,null,null,null,null,"2121 E HARMONY RD UNIT 200",null,"FORT COLLINS","CO","80528","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1303361,1083660708,"DIANA",null,"MEDGYESY",null,"2121 E Harmony Rd",null,"FORT COLLINS","CO","80528","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"CO",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Seagen Inc.",100000000279,"Seagen Inc.","WA","United States","Yes","Covered","Drug","Oncology","TUKYSA","51144-001-60",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1401.3,"2021-08-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer","No","792655787","2021","06/30/2022","NCT03975647","https://clinicaltrials.gov/ct2/show/NCT03975647","This study is designed to evaluate the efficacy and safety of tucatinib in combination with T-DM1 in subjects with unresectable locally-advanced or metastatic HER2+ breast cancer who have had prior treatment with a taxane and trastuzumab in any setting. Prior pertuzumab treatment is permitted, but not required. Subjects will be randomized in a 1:1 manner to receive 21-day cycles of either tucatinib or placebo in combination with T-DM1."],["NEW","Covered Recipient Teaching Hospital",null,140223,10437,"ADVOCATE LUTHERAN GENERAL HOSPITAL",null,null,null,null,null,null,"1775 DEMPSTER STREET",null,"PARK RIDGE","IL","60068","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1306500,1477811610,"KENNETH","W","DODD",null,"701 PARK AVENUE","HENNEPIN COUNTY MEDICAL CENTER EM IM","MINNEAPOLIS","MN","55415","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Critical Care Medicine",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000005726,"Hoffmann-La Roche Limited",null,"Canada","Yes","Covered","Biological","Immunology","Actemra","50242-137-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2992.0,"2021-11-16","Cash or cash equivalent",null,null,null,null,null,null,"No","No","SAFETY EFFICACY OF A COMBINATION OF REMDESIVIR TOCILIZUMAB IN SEVERE COVID 19 PNEUMONIA","No","835906209","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,230053,10500,"HENRY FORD HOSPITAL",null,null,null,null,null,null,"2799 W GRAND BLVD",null,"DETROIT","MI","48202","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",134239,1952341414,"DING",null,"WANG",null,"KARMANOS CANCER CENTER","4100 JOHN R HWCRC 4TH FL","DETROIT","MI","48201","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Amgen Inc.",100000000203,"Amgen Inc.","CA","United States","Yes","Covered","Drug","Oncology","LUMAKRAS","55513-488-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,23334.04,"2021-02-23","Cash or cash equivalent",null,null,null,null,null,null,"No","No","AMG 510_P1/2 Monotherapy NSCLC/CRC/Tumor Agnostic_20170543","No","830979573","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,100271,10837,"MOFFITT CANCER CENTER",null,null,null,null,null,null,"12902 Magnolia Dr",null,"Tampa","FL","33612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1294667,1073707170,"MIHAELA",null,"DRUTA",null,"12902 USF MAGNOLIA DR",null,"TAMPA","FL","33612-9416","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Covered","Drug","ONCOLOGY","QINLOCK","73207-101-31",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,544.0,"2021-10-16","Cash or cash equivalent",null,null,null,null,null,null,"No","No","INTRIGUE A STUDY OF DCC-2618 VS SUNITINIB IN ADVANCED GIST PATIENTS AFTER TREATMENT WITH IMATINIB INTRIGUE","No","827886971","2021","06/30/2022","NCT03673501",null,null],["NEW","Covered Recipient Teaching Hospital",null,30038,11158,"Honorhealth Scottsdale Osborn Med Ct",null,null,null,null,null,null,"7400 E Osborn Road",null,"Scottsdale","AZ","85251","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",277405,1114929114,"Michael","S","Gordon",null,"10510 N 92nd St Ste 200",null,"Scottsdale","AZ","85258","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Daiichi Sankyo Inc.",100000000195,"Daiichi Sankyo Inc.","NJ","United States","Yes","Covered","Drug","ONCOLOGY","Turalio","65597-402-20",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,375.0,"2021-11-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PL3397-A-U126","No","835068129","2021","06/30/2022","NCT03291288",null,null],["NEW","Covered Recipient Teaching Hospital",null,100271,10837,"Moffitt Cancer Center",null,null,null,null,null,null,"12902 Magnolia Dr",null,"Tampa","FL","33612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",3589499,1982139655,"MICHAEL","DAVID","JAIN",null,"12902 USF MAGNOLIA DR",null,"TAMPA","FL","33612","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Kite Pharma, Inc.",100000216809,"Kite Pharma, Inc.","CA","United States","Yes","Covered","Drug","CELLT","Yescarta","71287-119-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,22780.0,"2021-05-24","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 1-2 Study Evaluating the Safety and Efficacy of KTE-C19 in Combination with 4-1BB DLBCL","No","826574951","2021","06/30/2022",null,null,";KTE-C19-111;KP26836;593238634;12983510"],["NEW","Covered Recipient Physician",null,null,null,null,54063,1184829723,"MARVIN",null,"KALAFER",null,"815 GREENWOOD AVE STE 12",null,"JENKINTOWN","PA","19046","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Obstetrics & Gynecology",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,29.0,"2021-08-20","In-kind items and services",null,null,null,null,null,null,"No","No","A STUDY OF DONANEMAB VERSUS PLACEBO IN PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE OF ALZHEIMER'S DISEASE","No","819444997","2021","06/30/2022","NCT05026866","https://clinicaltrials.gov/ct2/show/NCT05026866","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor in connection with clinical studies during the reporting period.  For available study details,"],["NEW","Covered Recipient Teaching Hospital",null,110087,10799,"Northside Hospital Gwinnett",null,null,null,null,null,null,"3620 HOWELL FERRY ROAD",null,"DULUTH","GA","30096","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",211716,1679697791,"AMELIA","B.","ZELNAK",null,"1505 Northside Blvd",null,"CUMMING","GA","30041","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"GA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Seagen Inc.",100000000279,"Seagen Inc.","WA","United States","Yes","Covered","Drug","Oncology","TUKYSA","51144-001-60",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4101.67,"2021-09-07","In-kind items and services",null,null,null,null,null,null,"No","No","Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer","No","792661575","2021","06/30/2022","NCT03975647","https://clinicaltrials.gov/ct2/show/NCT03975647","This study is designed to evaluate the efficacy and safety of tucatinib in combination with T-DM1 in subjects with unresectable locally-advanced or metastatic HER2+ breast cancer who have had prior treatment with a taxane and trastuzumab in any setting. Prior pertuzumab treatment is permitted, but not required. Subjects will be randomized in a 1:1 manner to receive 21-day cycles of either tucatinib or placebo in combination with T-DM1."],["NEW","Covered Recipient Teaching Hospital",null,300003,9970,"MARY HITCHCOCK MEMORIAL HOSP",null,null,null,null,null,null,"ONE MEDICAL CENTER DR",null,"LEBANON","NH","03756","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",197685,1366598955,"GABRIEL","ARNE","BROOKS",null,"1 MEDICAL CENTER DR",null,"LEBANON","NH","03756","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"MA","NH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Covered","Biological","BioOncology","Avastin","50242-061-01",null,"Covered","Biological","BioOncology","TECENTRIQ","50242-917-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2630.0,"2021-07-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","TECENTRIQ PLUS AVASTIN FOLLOWING CURATIVE RESECTION IN PATIENTS AT HIGH RISK OF RECURRENCE","No","835917871","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50077,11300,"Scripps Mercy Hospital",null,null,null,null,null,null,"4077 5th Ave",null,"San Diego","CA","92103","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",959048,1922105964,"ATHENA",null,"PHILIS-TSIMIKAS",null,"10140 CAMPUS POINT DR","STE 200","SAN DIEGO","CA","92121","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","Ozempic","0169-4132-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,180.0,"2021-02-16","In-kind items and services",null,null,null,null,null,null,"No","No","NN9535-4352","No","811450465","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,3421,1063465284,"MATTHEW","DAVID","MCCOLLOUGH",null,"2630 GRANT LINE RD",null,"NEW ALBANY","IN","47150","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"IN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2750.0,"2021-04-01","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-ARM, PLACEBO-CONTROLLED MAINTENANCE STUDY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (LUCENT 2)","No","819445253","2021","06/30/2022","NCT03524092","https://clinicaltrials.gov/ct2/show/NCT03524092","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"],["NEW","Covered Recipient Teaching Hospital",null,140119,10441,"RUSH UNIVERSITY MEDICAL CENTER",null,null,null,null,null,null,"1653 W CONGRESS PKWY",null,"CHICAGO","IL","60612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",664388,1578661781,"ADRIENNE","L.","ADAMS",null,"2150 W HARRISON ST",null,"CHICAGO","IL","60612","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Child & Adolescent Psychiatry",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000005656,"F. Hoffmann-La Roche AG",null,"Switzerland","Yes","Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1000.0,"2021-03-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","V1A 2 IN PEDIATRIC AUTISM","No","835924609","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,393303,10215,"THE CHILDRENS HOSPITAL OF PHILADELP",null,null,null,null,null,null,"34th & Civic Center Blvd","Parc Business Services","Philadelphia","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",137580,1043226996,"JONATHAN","M","SPERGEL",null,"3550 MARKET ST FL 3","CHILDREN'S HOSPITAL OF PHILADELPHIA - ALLERGY & IMMUN","PHILADELPHIA","PA","19104-3365","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Allergy/Immunology",null,null,null,null,null,"NJ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","INFLAMMATION AND  IMMUNOLOGY","DUPIXENT","0024-5914-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1000.0,"2021-12-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN PEDIATRIC PATIENTS WITH ACTIVE EOSINOPHILIC ESOPHAGITIS","No","793090187","2021","06/30/2022","NCT04394351",null,null],["NEW","Covered Recipient Physician",null,null,null,null,1089207,1508029703,"RUSSELL","Z","SZMULEWITZ",null,"5841 S MARYLAND AVE","MC 2115","CHICAGO","IL","60637-1447","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Astellas Pharma Global Development",100000005406,"Astellas Pharma Global Development","IL","United States","Yes","Covered","Drug","ONCOLOGY","XTANDI","0469-0125-99",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,165.53,"2021-02-28","In-kind items and services",null,null,null,null,null,null,"No","No","A Multinational Phase 3 Randomized Double-blind Placebo-controlled Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC)","No","801078569","2021","06/30/2022","NCT02677896",null,null],["NEW","Covered Recipient Teaching Hospital",null,263302,10622,"Childrens Mercy Hospital",null,null,null,null,null,null,"2401 Gillham Road",null,"Kansas City","MO","64108","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1358279,1699003590,"ALVIN",null,"SINGH",null,"2401 GILLHAM RD",null,"KANSAS CITY","MO","64108","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Pulmonology",null,null,null,null,null,"KS",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"VERTEX PHARMACEUTICALS INCORPORATED",100000000184,"VERTEX PHARMACEUTICALS INCORPORATED","MA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,40938.28,"2021-07-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years","No","793095911","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,220110,9985,"Brigham And Womens Hospital",null,null,null,null,null,null,"75 Francis St",null,"Boston","MA","02115","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",116914,1588748883,"VANITA","R","ARODA",null,"221 LONGWOOD AVE","# RFB-2","BOSTON","MA","02115","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"CA","MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","Ozempic","0169-4132-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,22.76,"2021-03-16","In-kind items and services",null,null,null,null,null,null,"No","No","NN9535-4352","No","811821291","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,460009,11165,"U OF U HOSPITALS & CLINICS",null,null,null,null,null,null,"50 N Medical Dr",null,"Salt Lake City","UT","84132","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",821548,1104093392,"JAMIE",null,"RHOADS",null,"6095 S FASHION BLVD",null,"MURRAY","UT","84107-7397","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"HI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","INFLAMMATION AND  IMMUNOLOGY","DUPIXENT","0024-5914-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3934.05,"2021-11-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT PATIENTS WITH BULLOUS PEMPHIGOID","No","793090445","2021","06/30/2022","NCT04206553",null,null],["NEW","Covered Recipient Teaching Hospital",null,450056,11002,"ASCENSION SETON MEDICAL CENTER",null,null,null,null,null,null,"1201 W 38TH ST",null,"DALLAS","TX","78705","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1252953,1255507943,"POOJA",null,"VARSHNEY",null,"1301 BARBARA JORDAN BLVD","SUITE 200","AUSTIN","TX","78723-3077","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Allergy/Immunology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AIMMUNE THERAPEUTICS, INC.",100000776814,"AIMMUNE THERAPEUTICS, INC.","CA","United States","Yes","Covered","Biological","ALLERGY","PALFORZIA","71881-113-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,30.38,"2021-06-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY","No","849612469","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500008,11198,"University Of Washington Med Ctr",null,null,null,null,null,null,"1959 NE PACIFIC ST",null,"SEATTLE","WA","98195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",10408,1225041791,"SHAILENDER",null,"BHATIA",null,"825 EASTLAKE AVE E",null,"SEATTLE","WA","98109","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,23.4,"2021-11-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 2 Study of INCMGA00012 in Participants With Metastatic Merkel Cell Carcinoma","No","831099993","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Teaching Hospital",null,450051,11035,"METHODIST DALLAS MEDICAL CENTER",null,null,null,null,null,null,"1441 N BECKLEY AVE",null,"DALLAS","TX","75203","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",80276,1770528697,"PARVEZ",null,"MANTRY",null,"1411 N BECKLEY AVE","464","DALLAS","TX","75203","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hepatology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000005726,"Hoffmann-La Roche Limited",null,"Canada","Yes","Covered","Biological","Immunology","Actemra","50242-137-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,47.0,"2021-07-01","Cash or cash equivalent",null,null,null,null,null,null,"No","No","SAFETY EFFICACY OF A COMBINATION OF REMDESIVIR TOCILIZUMAB IN SEVERE COVID 19 PNEUMONIA","No","835918885","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,330059,10070,"MONTEFIORE MEDICAL CENTER",null,null,null,null,null,null,"111 E 210th St",null,"Bronx","NY","10467","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",276583,1104906692,"SANJAY",null,"GOEL",null,"AECOM","1825 EASTCHESTER RD","BRONX","NY","10461","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1798.0,"2021-07-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 1B 2 STUDY OF REBASTINIB DCC-2036 IN COMBINATION WITH PACLITAXEL IN PATIENTS WITH ADVANCED OR METASTATIC SOLID TUMORS","No","827887227","2021","06/30/2022","NCT03601897",null,null],["NEW","Covered Recipient Teaching Hospital",null,290001,11167,"Renown Regional Medical Center",null,null,null,null,null,null,"1155 Mill Street",null,"Reno","NV","89502","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",775678,1477783264,"Christopher","James","Rowan",null,"1500 E 2nd St Ste 400",null,"Reno","NV","89502","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"NV",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Daiichi Sankyo Inc.",100000000195,"Daiichi Sankyo Inc.","NJ","United States","Yes","Covered","Drug","Thrombosis","SAVAYSA","65597-201-07",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,750.0,"2021-12-04","Cash or cash equivalent",null,null,null,null,null,null,"No","No","ENVISAGE","No","835068223","2021","06/30/2022","NCT02943785",null,null],["NEW","Covered Recipient Teaching Hospital",null,363300,10334,"CHILDRENS HOSPITAL MEDICAL CENTER",null,null,null,null,null,null,"3333 BURNET AVE",null,"CINCINNATI","OH","45229","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",658528,1366491821,"AMAL","H","ASSAAD",null,"3333 BURNET AVE","ML 2000","CINCINNATI","OH","45229-3039","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Allergy/Immunology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AIMMUNE THERAPEUTICS, INC.",100000776814,"AIMMUNE THERAPEUTICS, INC.","CA","United States","Yes","Covered","Biological","ALLERGY","PALFORZIA","71881-113-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,6789.0,"2021-05-11","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY","No","849613229","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,100007,10819,"Adventhealth Orlando",null,null,null,null,null,null,"601 E Rollins St",null,"Orlando","FL","32803","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Janssen Research & Development, LLC",100000005592,"Janssen Research & Development, LLC","NJ","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,27165.0,"2021-03-29","Cash or cash equivalent",null,null,null,null,null,null,"No","No","COVID-19 Phase 3 Vaccine Trial Readiness Cohorts - Advent Health Orlando","No","787574801","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,330270,10067,"Hospital For Special Surgery",null,null,null,null,null,null,"535 East 70th Street",null,"New York","NY","10021","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",159366,1528038841,"DALE","J","LANGE",null,"535 E 70TH ST",null,"NEW YORK","NY","10021-4823","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"UCB SA",100000010773,"UCB SA",null,"Belgium","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,133.65,"2021-01-25","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 3, RANDOMIZED, DOUBL-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING EFFICACY AND SAFETY OF ROZANOLIXIZUMAB IN ADULT PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS","No","844222213","2021","06/30/2022","NCT03971422",null,null],["NEW","Covered Recipient Teaching Hospital",null,220162,9984,"DANA-FARBER CANCER INSTITUTE",null,null,null,null,null,null,"450 Brookline Ave",null,"Boston","MA","02215","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1305770,1417116674,"ZOFIA",null,"PIOTROWSKA",null,"55 FRUIT ST","YAWKEY 7B","BOSTON","MA","02114-2621","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"ABBVIE INC.",100000000204,"ABBVIE INC.","IL","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2444.0,"2021-07-29","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase I Study of ABBV-011 as a Single-Agent and in Combination with Budigalimab (ABBV-181) in Subjects with Relapsed or Refractory Small Cell Lung Cancer","No","792382749","2021","06/30/2022","NCT03639194",null,"M17-327"],["NEW","Covered Recipient Physician",null,null,null,null,626005,1235161563,"WAYNE","W","CHEN",null,"555 ANTON PKWY STE 800",null,"COSTA MESA","CA","92626","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,59417.5,"2021-01-04","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 AND LY3832479 IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS","No","819446797","2021","06/30/2022","NCT04427501","https://www.clinicaltrials.gov/ct2/show/NCT04427501","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"],["NEW","Covered Recipient Teaching Hospital",null,360137,10389,"Uh Cleveland Medical Center",null,null,null,null,null,null,"11100 EUCLID AVE",null,"CLEVELAND","OH","44106","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",461071,1437100302,"DEBORA","S.","BRUNO",null,"11100 EUCLID AVE",null,"CLEVELAND","OH","44106","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Seagen Inc.",100000000279,"Seagen Inc.","WA","United States","Yes","Covered","Drug","Oncology","TUKYSA","51144-001-60",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4091.0,"2021-12-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 2 Basket Study of Tucatinib in Combination With Trastuzumab in Subjects With Previously Treated, Locally Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations","No","792665939","2021","06/30/2022","NCT04579380",null,null],["NEW","Covered Recipient Teaching Hospital",null,50424,11298,"SCRIPPS GREEN HOSPITAL",null,null,null,null,null,null,"10666 N TORREY PINES RD",null,"LA JOLLA","CA","92037","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",258693,1700959426,"CHARLES","RAYMOND","SMITH",null,"10666 N TORREY PINES RD","113","LA JOLLA","CA","92037","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Covered","Biological","Immunology","OCREVUS","50242-150-01",null,"Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,9384.0,"2021-05-21","Cash or cash equivalent",null,null,null,null,null,null,"No","No","OCRELIZUMAB VACCINATION STUDY","No","835925339","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,450076,11031,"UT MD ANDERSON CANCER CENTER",null,null,null,null,null,null,"1515 Holcombe Blvd",null,"Houston","TX","77030","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",612216,1740584507,"FILIP",null,"JANKU",null,"1515 HOLCOMBE BLVD",null,"HOUSTON","TX","77030-4009","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Covered","Drug","ONCOLOGY","QINLOCK","73207-101-31",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,491.04,"2021-05-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A SAFETY TOLERABILITY AND PK STUDY OF DCC-2618 IN PATIENTS WITH ADVANCED MALIGNANCIES","No","827890921","2021","06/30/2022","NCT02571036",null,null],["NEW","Covered Recipient Teaching Hospital",null,110010,10785,"EMORY UNIVERSITY HOSPITAL",null,null,null,null,null,null,"1821 Clifton Rd Ne",null,"Atlanta","GA","30329","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",317132,1992741938,"JIONG",null,"YAN",null,"1365B CLIFTON RD NE","BUILDING B RM 2401","ATLANTA","GA","30322","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Ophthalmology",null,null,null,null,null,"GA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Astellas Pharma Global Development",100000005406,"Astellas Pharma Global Development","IL","United States","Yes","Covered","Drug","HOSPITAL AND TRANSPLANT","TACROLIMUS","45802-390-00",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2110.0,"2021-02-04","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Staged Study Incorporating a Phase 1b, Multicenter, Unmasked, Dose Escalation Evaluation of Safety and Tolerability and a Phase 2, Multicenter, Unmasked, Randomized, Parallel-group, Controlled, Proof of Concept Investigation of Efficacy and Safety of ASP7317 for Atrophy Secondary to Age-related Macular Degeneration","No","801078829","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,100227,1205922655,"IAN","C.","WEBER",null,"80 HEALTH PARK DR STE 230",null,"LOUISVILLE","CO","80027-4644","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Orthopaedic Surgery|Adult Reconstructive Orthopaedic Surgery",null,null,null,null,null,"CO",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Zimmer Biomet Holdings, Inc.",100000000103,"Zimmer Biomet Holdings, Inc.","IN","United States","Yes","Covered","Device","Knees","ROSA-Knee",null,"889024619401",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2079.0,"2021-02-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","ROSA Total Knee Post Market Study","No","834036305","2021","06/30/2022",null,"http://medispend.com",null],["NEW","Covered Recipient Teaching Hospital",null,450076,11031,"Ut Md Anderson Cancer Center",null,null,null,null,null,null,"1515 HOLCOMBE BLVD",null,"HOUSTON","TX","77030","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",79465,1740422823,"NAVAL","G.","DAVER",null,"1515 HOLCOMBE BLVD","# 0448","HOUSTON","TX","77030","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,338.0,"2021-08-03","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis","No","831075481","2021","06/30/2022",null,null,"Transfer of value for editorial and or medical writing services. These services were funded by Incyte Corporation and paid to a third-party vendor to assist with the development of a publication at the direction of the authors. No payments were made directly to the authors for these editorial and or medical writing services."],["NEW","Covered Recipient Teaching Hospital",null,210029,10710,"JOHNS HOPKINS BAYVIEW MED. CTR.",null,null,null,null,null,null,"4940 EASTERN AVE BLDG FLR1",null,"BALTIMORE","MD","21224","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",263515,1801803127,"JOE",null,"POUZAR",null,"1045 GEMINI ST STE 200B",null,"HOUSTON","TX","77058","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Family Medicine",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Organon LLC",100000866821,"Organon LLC","NJ","United States","Yes","Covered","Drug","CONTRACEPTIVES","IMPLANON","0052-0272-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,376.43,"2021-07-09","Cash or cash equivalent","Patient Care",null,null,null,null,null,"No","No","8415-8415-060-PN060-Extended Duration Study (Celanese + 2 years)-Contraception-SC-imp-Supplemental Registration-USA-LD-B","No","836234935","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,230046,10547,"UNIV OF MI HOSPITALS & HLTH CTRS",null,null,null,null,null,null,"1500 East Medical Center Drive",null,"Ann Arbor","MI","48109","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",258698,1700962677,"FRANCIS","PAUL","WORDEN",null,"1500 EAST MEDICAL CENTER DR","B1 FLOOR CANCER CTR RECP C","ANN ARBOR","MI","48109-5912","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","ONCOLOGY","LIBTAYO","61755-008-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3000.0,"2021-09-29","Cash or cash equivalent",null,null,null,null,null,null,"No","No","CEMIPLIMAB SURVIVORSHIP EPIDEMIOLOGY (CASE) STUDY","No","793090701","2021","06/30/2022","NCT03836105",null,null],["NEW","Covered Recipient Teaching Hospital",null,50262,11328,"RONALD REAGAN UCLA",null,null,null,null,null,null,"757 Westwood Plz",null,"Los Angeles","CA","90095","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",38213,1851311930,"GARY","J","SCHILLER",null,"200 MEDICAL PLAZA","365530420120","LOS ANGELES","CA","90095","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Astellas Pharma Global Development",100000005406,"Astellas Pharma Global Development","IL","United States","Yes","Covered","Drug","ONCOLOGY","XOSPATA","0469-1425-90",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,800.0,"2021-11-04","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Randomized Trial of Gilteritinib vs Midostaurin in FL T3 Mutated Acute Myeloid Leukemia","No","801079085","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,460009,11165,"U Of U Hospitals & Clinics",null,null,null,null,null,null,"50 N MEDICAL DR",null,"SALT LAKE CITY","UT","84132","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1071739,1881849669,"JEREMY","MARK","GILILLAND",null,"590 S WAKARA WAY",null,"SALT LAKE CITY","UT","84108","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Orthopaedic Surgery",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Zimmer Biomet Holdings, Inc.",100000000103,"Zimmer Biomet Holdings, Inc.","IN","United States","Yes","Covered","Device","Knees","Knees-MyMobility",null,"887868517747","Covered","Device","Hips","Hips-MyMobility",null,"887868517747",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1823.0,"2021-09-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","myMobility Phase 0 Clinical Study","No","834036421","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,828537,1346655099,"BENJAMIN","LOUIS","HELLER",null,"515 W BUCKEYE RD STE 104",null,"PHOENIX","AZ","85003","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Ophthalmology",null,null,null,null,null,"AZ","CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alcon Research LLC",100000000218,"Alcon Research LLC","TX","United States","Yes","Covered","Device","Ophthalmology","Acrysof IQ ReSTOR IOL",null,"00380652268752",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,379.5,"2021-11-04","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Approval Study of the AcrySof IQ ReSTOR Toric IOL","No","807675057","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,390111,10224,"Hospital Of The Univ Of Penna",null,null,null,null,null,null,"3400 Spruce Street",null,"Philadelphia","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",986382,1871657882,"ALEXIS","R","OGDIE-BEATTY",null,"3400 SPRUCE STREET","828 PENN TOWER","PHILADELPHIA","PA","19104-4206","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"UCB, Inc.",100000010773,"UCB SA",null,"Belgium","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1000.0,"2021-06-24","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A MULTICENTER, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS","No","844224771","2021","06/30/2022","NCT03896581",null,null],["NEW","Covered Recipient Teaching Hospital",null,230046,10547,"Univ Of Mi Hospitals & Hlth Ctrs",null,null,null,null,null,null,"1500 East Medical Center Drive",null,"Ann Arbor","MI","48109","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1032474,1497979678,"AJJAI","SHIVARAM","ALVA",null,"1500 E MEDICAL CENTER DR",null,"ANN ARBOR","MI","48109","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AstraZeneca Pharmaceuticals LP",100000000146,"AstraZeneca Pharmaceuticals LP","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,824.14,"2021-12-31","In-kind items and services",null,null,null,null,null,null,"No","No","Study of MEDI4736 Durvalumab With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer","No","826503045","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500008,11198,"University Of Washington Med Ctr",null,null,null,null,null,null,"1959 NE PACIFIC ST",null,"SEATTLE","WA","98195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1143552,1386965952,"RYAN","CHRISTOPHER","LYNCH",null,"825 EASTLAKE AVE E",null,"SEATTLE","WA","98109","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Hospitalist",null,null,null,null,null,"MO",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,768.0,"2021-06-25","Cash or cash equivalent",null,null,null,null,null,null,"No","No","An Open Label, Randomized Study Comparing INCB050465 to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL 203)","No","831100747","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Teaching Hospital",null,250001,10938,"University Of Mississippi Medical",null,null,null,null,null,null,"2500 N STATE ST",null,"JACKSON","MS","39216","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Draeger Medical Systems, Inc",100000000330,"Draeger Medical Systems, Inc","PA","United States","Yes","Covered","Device","Ventilation","BABYLOG VN500",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,5542.99,"2021-01-29","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Babylog VN500 HFOV study","No","836742977","2021","06/30/2022","NCT02445040",null,null],["NEW","Covered Recipient Teaching Hospital",null,50008,11217,"Cpmc-R.K. Davies Medical Center",null,null,null,null,null,null,"45 Castro St",null,"San Francisco","CA","94114","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",170475,1740460088,"CHRISTOPHER","E","WOODS",null,"325 DISTEL CIR",null,"LOS ALTOS","CA","94022-1408","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Abbott Laboratories",100000010680,"Abbott Laboratories","IL","United States","Yes","Covered","Device","Electrophysiology","Agilis HisPro",null,"05415067032287",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,150.0,"2021-09-23","Cash or cash equivalent",null,null,null,null,null,null,"No","No","His Bundle Pacing Pacemaker Mapping Registry","No","827582301","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,130006,11100,"ST. LUKES REGIONAL MEDICAL CENTER",null,null,null,null,null,null,"190 E BANNOCK ST",null,"BOISE","ID","83712","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",73913,1629117619,"KAREN","S","MILLER",null,"2347 E GALA ST",null,"MERIDIAN","ID","83642","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease",null,null,null,null,null,"ID",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000005726,"Hoffmann-La Roche Limited",null,"Canada","Yes","Covered","Biological","Immunology","Actemra","50242-137-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,21.02,"2021-05-25","Cash or cash equivalent",null,null,null,null,null,null,"No","No","SAFETY EFFICACY OF A COMBINATION OF REMDESIVIR TOCILIZUMAB IN SEVERE COVID 19 PNEUMONIA","No","835926433","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,380009,11212,"OHSU HOSPITAL AND CLINICS",null,null,null,null,null,null,"3181 Sw Sam Jackson Park Rd",null,"Portland","OR","97239","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",341933,1548278005,"MICHAEL","C","HEINRICH",null,"3181 SW SAM JACKSON PARK RD",null,"PORTLAND","OR","97239-3011","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"OR",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Covered","Drug","ONCOLOGY","QINLOCK","73207-101-31",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,200.0,"2021-03-04","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A SAFETY TOLERABILITY AND PK STUDY OF DCC-2618 IN PATIENTS WITH ADVANCED MALIGNANCIES","No","827887483","2021","06/30/2022","NCT02571036",null,null],["NEW","Covered Recipient Physician",null,null,null,null,1114056,1366586521,"HUNG",null,"KHONG",null,"PO BOX 413033",null,"SALT LAKE CITY","UT","84141-3033","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Radius Health, Inc.",100000181748,"Radius Health, Inc.","MA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,648.97,"2021-12-22","In-kind items and services",null,null,null,null,null,null,"No","No","NEJM EMERALD manuscript","No","830711935","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,100271,10837,"MOFFITT CANCER CENTER",null,null,null,null,null,null,"12902 MAGNOLIA DR",null,"TAMPA","FL","33612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",6130378,1992096028,"MICHAEL","RAHMAN","SHAFIQUE",null,"12902 USF MAGNOLIA DR",null,"TAMPA","FL","33612","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Covered","Biological","BioOncology","Avastin","50242-061-01",null,"Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4676.4,"2021-04-05","Cash or cash equivalent",null,null,null,null,null,null,"No","No","TECENTRIQ ONCOLOGY EXTENSION STUDY","No","835919095","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,63301,11125,"Childrens Hospital Colorado",null,null,null,null,null,null,"860 N POTOMAC CIR.",null,"AURORA","CO","80011","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",743817,1356426092,"TIMOTHY","A.","BENKE",null,"13123 E 16th Ave # B155",null,"Aurora","CO","80045","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology",null,null,null,null,null,"CO",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"GW Pharmaceuticals plc",100000486820,"GW Research Limited",null,"Great Britain (Uk)","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,331.05,"2021-06-25","Cash or cash equivalent",null,null,null,null,null,null,"No","No","GWND18064","No","841423013","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,82021,1811984727,"RAMON","G","REYES ALMODOVAR",null,"12952 BANDERA RD STE 105",null,"HELOTES","TX","78023","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Family Medicine",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2275.62,"2021-09-09","In-kind items and services",null,null,null,null,null,null,"No","No","A PHASE 2 STUDY OF ONCE-DAILY LY3502970 COMPARED WITH PLACEBO AND ONCE-WEEKLY DULAGLUTIDE IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS","No","819445511","2021","06/30/2022","NCT05048719","https://clinicaltrials.gov/ct2/show/NCT05048719","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor in connection with clinical studies during the reporting period. For available study details,"],["NEW","Covered Recipient Teaching Hospital",null,100271,10837,"MOFFITT CANCER CENTER",null,null,null,null,null,null,"12902 MAGNOLIA DR",null,"TAMPA","FL","33612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",17284,1376599340,"JHANELLE",null,"GRAY",null,"12902 USF MAGNOLIA DR",null,"TAMPA","FL","33612","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Covered","Biological","Immunology","Esbriet","50242-121-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,728.0,"2021-01-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PIRFENIDONE COMBINED WITH STANDARD FIRST LINE CHEMOTHERAPY IN ADVANCED STAGE LUNG NSCLC","No","835919943","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,230046,10547,"Univ Of Mi Hospitals & Hlth Ctrs",null,null,null,null,null,null,"1500 East Medical Center Drive",null,"Ann Arbor","MI","48109","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",11050,1235211764,"RODICA","P","BUSUI",null,"4029 AVE MARIA ST","STE 1300","ANN ARBOR","MI","48105","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"MI","OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Non-Covered","Drug","Diabetes",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,45.52,"2021-10-28","In-kind items and services",null,null,null,null,null,null,"No","No","EX9536-4388","No","811768723","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50625,11293,"Cedars-Sinai Medical Center",null,null,null,null,null,null,"8700 BEVERLY BLVD",null,"WEST HOLLYWOOD","CA","90048","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",5691235,1841516184,"ARTAK",null,"LABADZHYAN",null,"8700 BEVERLY BLVD",null,"WEST HOLLYWOOD","CA","90048-1804","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Chiasma, Inc.",100000801820,"Chiasma, Inc.","MA","United States","Yes","Covered","Drug","Endocrinology","MYCAPSSA","69880-120-28",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2155.44,"2021-02-12","Cash or cash equivalent",null,null,null,null,null,null,"No","No","OOC-AMC-303","No","816011637","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,1008481,1659459113,"NITIN",null,"JAIN",null,"1515 HOLCOMBE BLVD",null,"HOUSTON","TX","77030","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Amgen Inc.",100000000203,"Amgen Inc.","CA","United States","Yes","Covered","Biological","Oncology","Blincyto","55513-160-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,22.38,"2021-06-24","In-kind items and services",null,null,null,null,null,null,"No","No","Ph3 Adult ALLRandomised Confirmatory Study - TOWER study","No","831024783","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,440015,10348,"UNIVERSITY OF TENNESSEE MEDICAL CENT",null,null,null,null,null,null,"1924 Alcoa Hwy",null,"Knoxville","TN","37920","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",172406,1801908223,"TIMOTHY","J","PANELLA",null,"1926 ALCOA HWY STE 410",null,"KNOXVILLE","TN","37920-1545","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"TN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","ONCOLOGY","LIBTAYO","61755-008-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,984.81,"2021-11-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","CEMIPLIMAB SURVIVORSHIP EPIDEMIOLOGY (CASE) STUDY","No","793090969","2021","06/30/2022","NCT03836105",null,null],["NEW","Covered Recipient Teaching Hospital",null,140209,10485,"Methodist Medical Ctr Of Illinois",null,null,null,null,null,null,"221 NE Glen Oak Ave",null,"Peoria","IL","61636","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",313517,1912929118,"Alexander",null,"Adler",null,"112 NE Crescent 2nd Floor",null,"Peoria","IL","61603","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Vifor (International) Ltd.",100000081386,"Vifor (International) Ltd.",null,"Switzerland","Yes","Covered","Drug","Potassium Binder","Veltassa","53436-168-30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,732.37,"2021-07-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PAT-CR-302","No","840513003","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,230046,10547,"Univ Of Mi Hospitals & Hlth Ctrs",null,null,null,null,null,null,"1500 EAST MEDICAL CENTER DRIVE",null,"ANN ARBOR","MI","48109","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BioNTech SE",100000971889,"BioNTech SE",null,"Germany","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,21937.67,"2021-04-07","Cash or cash equivalent",null,null,null,null,null,null,"Yes","No",null,"No","851137359","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,210011,10696,"St. Agnes Hospital",null,null,null,null,null,null,"900 CATON AVE",null,"BALTIMORE","MD","21229","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",20019,1457310856,"CAROLE","B.","MILLER",null,"900 CATON AVE","STE 60","BALTIMORE","MD","21229","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"MD",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,32.94,"2021-10-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY","No","831076995","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Physician",null,null,null,null,10686,1245258045,"SCOTT","T","TAGAWA",null,"68 TH STPO  525 E","BOX 403","NEW YORK","NY","10044","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","XTANDI","0469-0125-99",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,780.0,"2021-07-02","In-kind items and services",null,null,null,null,null,null,"No","No","ENZALUTAMIDE CLINICAL PUBLICATION PROGRAM","No","832570979","2021","06/30/2022",null,null,"No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication."],["NEW","Covered Recipient Teaching Hospital",null,230130,10522,"WILLIAM BEAUMONT HOSPITAL- ROYAL OAK",null,null,null,null,null,null,"3601 W 13 Mile Rd",null,"Royal Oak","MI","48073","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",281724,1205863859,"MICHAEL","T","TRESE",null,"3555 W 13 MILE RD","LL-20","ROYAL OAK","MI","48073-6710","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Ophthalmology|Retina Specialist",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","OPHTHALMOLOGY","EYLEA","61755-005-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4365.88,"2021-07-12","Cash or cash equivalent",null,null,null,null,null,null,"No","No","RANDOMIZED, CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF INTRAVITREAL AFLIBERCEPT COMPARED TO LASER PHOTOCOAGULATION IN PATIENTS WITH RETINOPATHY OF PREMATURITY","No","793091227","2021","06/30/2022","NCT04101721",null,null],["NEW","Covered Recipient Teaching Hospital",null,100009,10836,"University Of Miami Hospital",null,null,null,null,null,null,"1400 NW 12TH AVE",null,"MIAMI","FL","33136","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1238846,1750517959,"JUSTIN",null,"WATTS",null,"1120 NW 14TH ST","# 1182","MIAMI","FL","33136","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,7973.1,"2021-05-05","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis","No","831101503","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Teaching Hospital",null,53302,11301,"Childrens Hospital Los Angeles",null,null,null,null,null,null,"4650 W Sunset Blvd",null,"Los Angeles","CA","90027","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1146597,1508031352,"LILY",null,"CHAO",null,"3701 WILSHIRE BLVD",null,"LOS ANGELES","CA","90010","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3.25,"2021-11-19","In-kind items and services",null,null,null,null,null,null,"No","No","NN9924-4437","No","811033407","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,230053,10500,"Henry Ford Hospital",null,null,null,null,null,null,"2799 W GRAND BLVD",null,"DETROIT","MI","48202","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Beckman Coulter, Inc.",100000010876,"Beckman Coulter, Inc.","CA","United States","Yes","Covered","Device","Devices","DXH 900",null,"15099590701574",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,25000.0,"2021-03-31","Cash or cash equivalent",null,null,null,null,null,null,"No","No","COVID-19 Neutralizing Antibodies","No","844946691","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,380009,11212,"OHSU HOSPITAL AND CLINICS",null,null,null,null,null,null,"3181 Sw Sam Jackson Park Rd",null,"Portland","OR","97239","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",183323,1033127584,"CHRISTOPHER","W","RYAN",null,"3303 SW BOND AVE","7TH FLOOR","PORTLAND","OR","97239-4501","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"OR",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,28.82,"2021-04-28","Cash or cash equivalent",null,null,null,null,null,null,"No","No","STUDY OF DCC-3014 IN PATIENTS WITH ADVANCED TUMORS AND TENOSYNOVIAL GIANT CELL TUMOR","No","827887739","2021","06/30/2022","NCT03069469",null,null],["NEW","Covered Recipient Teaching Hospital",null,363300,10334,"Childrens Hospital Medical Center",null,null,null,null,null,null,"3333 Burnet Avenue  Mlc  4900",null,"Cincinnati","OH","45229","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",464149,1538322755,"CHRISTOPHER",null,"TOWE",null,"3333 BURNET AVE","MLC 2021","CINCINNATI","OH","45229-3026","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Pulmonology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Boehringer Ingelheim USA, Inc.",100000136460,"Boehringer Ingelheim Italia S.p.A.",null,"Italy","Yes","Covered","Drug","RESPIRATORY","OFEV","0597-0143-60",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,315.14,"2021-03-25","In-kind items and services",null,null,null,null,null,null,"No","No","Pediatric ILD program","No","827025781","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,363300,10334,"CHILDRENS HOSPITAL MEDICAL CENTER",null,null,null,null,null,null,"3333 BURNET AVE",null,"CINCINNATI","OH","45229","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",658528,1366491821,"AMAL","H","ASSAAD",null,"3333 BURNET AVE","ML 2000","CINCINNATI","OH","45229-3039","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Allergy/Immunology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AIMMUNE THERAPEUTICS, INC.",100000776814,"AIMMUNE THERAPEUTICS, INC.","CA","United States","Yes","Covered","Biological","ALLERGY","PALFORZIA","71881-113-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,24275.7,"2021-03-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY","No","849614627","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,230165,10504,"ST JOHN HOSPITAL & MEDICAL CENTER",null,null,null,null,null,null,"22101 Moross",null,"Detroit","MI","48236","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",169543,1740302850,"DANIEL",null,"LEBOVIC",null,"19229 MACK AVE","SUITE 24","GROSSE POINTE WOODS","MI","48236-2858","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pharmacyclics LLC, an AbbVie Company",100000136439,"Pharmacyclics LLC, An AbbVie Company","CA","United States","Yes","Covered","Drug","ONCOLOGY","IMBRUVICA","57962-420-28",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,158.0,"2021-06-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","informCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL)","No","786499617","2021","06/30/2022","NCT02582879",null,"PCYC-1134M-CA"],["NEW","Covered Recipient Teaching Hospital",null,220086,9982,"Beth Israel Deaconess Medical Center",null,null,null,null,null,null,"330 Brookline Ave","St 207","Boston","MA","02215","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",204021,1508884024,"GEORGE",null,"TSOKOS",null,"330 BROOKLINE AVE # CLS-937","BETH ISRAEL DEACONESS MEDICAL","BOSTON","MA","02215-5400","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Janssen Research & Development, LLC",100000005592,"Janssen Research & Development, LLC","NJ","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,71500.0,"2021-07-06","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Harvard/George Tsokos RFA IL12 vs. IL23","No","787575431","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,310001,10178,"HACKENSACK UNIVERSITY MEDICAL CENTER",null,null,null,null,null,null,"30 Prospect Ave",null,"Hackensack","NJ","07601","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",914264,1366402893,"SCOTT","D","ROWLEY",null,"92 2ND ST",null,"HACKENSACK","NJ","07601-2105","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"DC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pharmacyclics LLC, an AbbVie Company",100000136439,"Pharmacyclics LLC, An AbbVie Company","CA","United States","Yes","Covered","Drug","ONCOLOGY","IMBRUVICA","57962-420-28",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1270.0,"2021-04-01","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Subjects With New Onset cGVHD","No","786501341","2021","06/30/2022","NCT02959944",null,"PCYC-1140-IM"],["NEW","Covered Recipient Teaching Hospital",null,390111,10224,"HOSPITAL OF THE UNIV OF PENNA",null,null,null,null,null,null,"3701 MARKET ST",null,"PHILA","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",421699,1053348367,"DEVRAJ",null,"BASU",null,"3400 SPRUCE ST FL 5","RAVDIN SILVERSTEIN","PHILADELPHIA","PA","19104","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Otolaryngology",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,30451.95,"2021-10-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 1 STUDY OF ORAL LOXO-292 IN ADULT PATIENTS WITH ADVANCED SOLID TUMORS HARBORING RET ALTERATIONS","No","819447055","2021","06/30/2022",null,null,"The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor in connection with clinical studies during the reporting period.  For available study details, please visit clinicaltrials.gov."],["NEW","Covered Recipient Teaching Hospital",null,340113,10768,"CAROLINAS MEDICAL CENTER",null,null,null,null,null,null,"1000 BLYTHE BLVD","32861","CHARLOTTE","NC","28232","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",969299,1306063128,"JOEL","A","KAPLAN",null,"1001 BLYTHE BLVD","MEDICAL CENTER PLAZA STE 601","CHARLOTTE","NC","28203","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"JAZZ PHARMACEUTICALS INC.",100000005637,"JAZZ PHARMACEUTICALS INC.","CA","United States","Yes","Covered","Drug","HEMATOLOGY/ONCOLOGY","VYXEOS","68727-745-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,133381.05,"2021-04-20","In-kind items and services",null,null,null,null,null,null,"No","No","A STUDY TO COMPARE STANDARD CHEMOTHERAPY TO THERAPY WITH CPX-351 AND/OR GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED AML WITH OR WITHOUT FLT3 MUTATIONS","No","838145847","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,360180,10373,"Cleveland Clinic Hospital",null,null,null,null,null,null,"9500 EUCLID AVE",null,"CLEVELAND","OH","44195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",343069,1548455355,"SHILPA",null,"GUPTA",null,"9500 Euclid Ave",null,"CLEVELAND","OH","44195","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Seagen Inc.",100000000279,"Seagen Inc.","WA","United States","Yes","Covered","Biological","Oncology","PADCEV","51144-030-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,39480.0,"2021-11-03","In-kind items and services",null,null,null,null,null,null,"No","No","Open-label, Randomized, Controlled Phase 3 Study of Enfortumab Vedotin in Combination With Pembrolizumab With or Without Chemotherapy, Versus Chemotherapy Alone in Previously Untreated Locally Advanced or Metastatic Urothelial Cancer","No","792666195","2021","06/30/2022","NCT04223856","https://clinicaltrials.gov/ct2/show/NCT04223856","This study is being conducted to evaluate the combination of enfortumab vedotin + pembrolizumab, with or without platinum-containing chemotherapy, versus standard of care gemcitabine + platinum-containing chemotherapy, in subjects with previously untreated locally advanced or metastatic urothelial cancer."],["NEW","Covered Recipient Teaching Hospital",null,330285,10135,"STRONG MEMORIAL HOSPITAL",null,null,null,null,null,null,"601 ELMWOOD AVE","BOX 684","ROCHESTER","NY","14642","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Covered","Biological","BioOncology","TECENTRIQ","50242-917-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1500.0,"2021-08-17","Cash or cash equivalent",null,null,null,null,null,null,"No","No","STUDY OF CABOZANTINIB WITH ATEZOLIZUMAB AS NEOADJUVANT TREATMENT FOR MUSCLE INVASIVE BLADDER CA","No","835926543","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,63301,11125,"Childrens Hospital Colorado",null,null,null,null,null,null,"860 N Potomac Cir.",null,"Aurora","CO","80011","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",743375,1336303585,"Emily","Anne","Mccourt",null,"12605 E 16th Ave",null,"AURORA","CO","80045","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|General Practice",null,null,null,null,null,"CO",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Travere Therapeutics, Inc.",100000061305,"Travere Therapeutics, Inc.","CA","United States","Yes","Covered","Drug","Hepatology","Chenodal","68974-876-40",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,670.64,"2021-08-31","Cash or cash equivalent","Other",null,null,null,null,null,"No","No","CTX Prevalence: CTX Observational study in patients with early onset bilateral cateracts","No","849335753","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,286917,1316957350,"SATISH","S","MODI",null,"23 DAVIS AVENUE",null,"POUGHKEEPSIE","NY","12603","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Ophthalmology",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alcon Research LLC",100000000218,"Alcon Research LLC","TX","United States","Yes","Covered","Device","Ophthalmology","Acrysof IQ ReSTOR IOL",null,"00380652268752",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,635.85,"2021-12-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Approval Study of the AcrySof IQ ReSTOR Toric IOL","No","807675825","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,53214,1184676371,"RAJU","S.","GHATE",null,"680 N LAKE SHORE DR STE 924",null,"CHICAGO","IL","60611-8701","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Orthopaedic Surgery",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Zimmer Biomet Holdings, Inc.",100000000103,"Zimmer Biomet Holdings, Inc.","IN","United States","Yes","Covered","Device","Knees","PSI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2500.0,"2021-06-23","Cash or cash equivalent",null,null,null,null,null,null,"No","No","CSU2015-12K Evaluation of Zimmer CAS XPSI","No","834036883","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,116924,1598704371,"BRADLEY","N","HINES",null,"3445 POPLAR AVE","SUITE 7","MEMPHIS","TN","38111-4667","United States",null,null,"Doctor of Optometry",null,null,null,null,null,"Eye and Vision Services Providers|Optometrist",null,null,null,null,null,"TN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alcon Research LLC",100000000218,"Alcon Research LLC","TX","United States","Yes","Covered","Device","Ophthalmology","Precision 1 for Astigmatism",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,250.0,"2021-12-23","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Clinical Comparison of 2 Daily Disposable Toric Soft Contact Lenses","No","807676083","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,190036,10978,"OCHSNER CLINIC FOUNDATION",null,null,null,null,null,null,"1516 Jefferson Hwy",null,"New Orleans","LA","70121","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",411712,1700844594,"JULIA","B","GARCIA-DIAZ",null,"1514 JEFFERSON HWY",null,"NEW ORLEANS","LA","70121","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"LA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Biological","VACCINES","COMIRNATY","0069-1000-03",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1838.7,"2021-12-04","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 2B OPENLABEL STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF VACCINE CANDIDATE BNT162B2 IN IMMUNOCOMPROMISED PARTICIPANTS 2 YEARS OF AGE","No","832574625","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,460009,11165,"U Of U Hospitals & Clinics",null,null,null,null,null,null,"50 N MEDICAL DR",null,"SALT LAKE CITY","UT","84132","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",363468,1003906603,"SUMATI","V.","GUPTA",null,"2000 CIRCLE OF HOPE DR","STE 2100","SALT LAKE CITY","UT","84112","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"UT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,465.0,"2021-06-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 2, Open Label, Single Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations","No","831080023","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Teaching Hospital",null,160058,10604,"University Of Iowa Hosp & Clinics",null,null,null,null,null,null,"200 Hawkins Dr",null,"Iowa City","IA","52242","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1224086,1235421140,"MARCELO","L","CORREIA",null,"200 HAWKINS DR","# 2857","IOWA CITY","IA","52242","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"IA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Obesity","Wegovy","0169-4525-14",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,130.5,"2021-04-22","In-kind items and services",null,null,null,null,null,null,"No","No","EX9536-4388","No","811844557","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,340061,10767,"University Of North Carolina Hosp.",null,null,null,null,null,null,"101 MANNING DR",null,"CHAPEL HILL","NC","27514","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",713628,1265688493,"BRANDI","N.","REEVES",null,"101 MANNING DR",null,"CHAPEL HILL","NC","27514","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,20.26,"2021-03-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis","No","831102261","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Teaching Hospital",null,53302,11301,"Childrens Hospital Los Angeles",null,null,null,null,null,null,"4650 W Sunset Blvd",null,"Los Angeles","CA","90027","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1146597,1508031352,"LILY",null,"CHAO",null,"3701 WILSHIRE BLVD",null,"LOS ANGELES","CA","90010","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,40.0,"2021-10-08","In-kind items and services",null,null,null,null,null,null,"No","No","NN9924-4437","No","811628143","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500027,11177,"Swedish Medical Center",null,null,null,null,null,null,"747 BROADWAY",null,"SEATTLE","WA","98122","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",296106,1518986199,"MICHAEL","A.","ELLIOTT",null,"1100 9th Ave","PO Box 900","Seattle","WA","98101","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alexion Pharmaceuticals, Inc.",100000005462,"Alexion Pharmaceuticals, Inc.","MA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,5308.6,"2021-01-12","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Study With an Open-Label Extension to Evaluate the Efficacy and Safety of Ravulizumab in Patients With Amyotrophic Lateral Sclerosis (ALS)","No","781390757","2021","06/30/2022","NCT04248465",null,null],["NEW","Covered Recipient Teaching Hospital",null,380009,11212,"OHSU HOSPITAL AND CLINICS",null,null,null,null,null,null,"3181 Sw Sam Jackson Park Rd",null,"Portland","OR","97239","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",341933,1548278005,"MICHAEL","C","HEINRICH",null,"3181 SW SAM JACKSON PARK RD",null,"PORTLAND","OR","97239-3011","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"OR",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Covered","Drug","ONCOLOGY","QINLOCK","73207-101-31",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,153.6,"2021-07-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A SAFETY TOLERABILITY AND PK STUDY OF DCC-2618 IN PATIENTS WITH ADVANCED MALIGNANCIES","No","827887997","2021","06/30/2022","NCT02571036",null,null],["NEW","Covered Recipient Teaching Hospital",null,390111,10224,"Hospital Of The Univ Of Penna",null,null,null,null,null,null,"3701 MARKET ST",null,"PHILA","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",719238,1487842100,"JENNIFER",null,"EADS",null,"3400 CIVIC CENTER BLVD FL 3",null,"PHILADELPHIA","PA","19104-5127","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Seagen Inc.",100000000279,"Seagen Inc.","WA","United States","Yes","Covered","Drug","Oncology","TUKYSA","51144-001-60",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,20200.0,"2021-04-14","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Randomized, Double-blind, Placebo-controlled, Active Comparator Phase 2/3 Study of Tucatinib in Combination With Trastuzumab, Ramucirumab, and Paclitaxel in Subjects With Previously Treated, Locally-advanced Unresectable or Metastatic HER2+ Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)","No","792657069","2021","06/30/2022","NCT04499924",null,null],["NEW","Covered Recipient Teaching Hospital",null,390028,10267,"Upmc Mercy Hospital",null,null,null,null,null,null,"1400 Locust St",null,"Pittsburgh","PA","15219","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",347278,1649242033,"SILVA","A","ARSLANIAN",null,"5230 CENTRE AVE","FL 2","PITTSBURGH","PA","15232","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4.5,"2021-12-13","In-kind items and services",null,null,null,null,null,null,"No","No","NN9924-4437","No","811824681","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,220071,9988,"MASSACHUSETTS GENERAL HOSPITAL",null,null,null,null,null,null,"55 Fruit St","Bulfinch 360","Boston","MA","02114","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1250600,1184608176,"LEE","S","COHEN",null,"185 CAMBRIDGE STREET","SUITE 220","BOSTON","MA","02114","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Otsuka Pharmaceutical Development & Commercialization, Inc.",100000010725,"Otsuka Pharmaceutical Development & Commercialization, Inc.","NJ","United States","Yes","Covered","Drug","PSYCHIATRY","REXULTI","59148-037-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,56938.5,"2021-11-03","Cash or cash equivalent",null,null,null,null,null,null,"No","No","NATIONAL PREGNANCY REGISTRY FOR PSYCHIATRIC MEDICATIONS","No","844171111","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,605795,1518292960,"MICHELLE","MARIE","MANGUAL-GARCIA",null,"HOSPITAL MUNICIPAL DE SAN JUAN","GOBERNADOR PINERO PISO  NBR  4TO","SAN JUAN","PR","00921","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"PR",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4423.27,"2021-06-08","In-kind items and services",null,null,null,null,null,null,"No","No","A PHASE 2 STUDY OF ONCE-WEEKLY LY3437943 COMPARED WITH PLACEBO IN PARTICIPANTS WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT-RELATED COMORBIDITIES","No","819445771","2021","06/30/2022","NCT04881760","https://clinicaltrials.gov/ct2/show/NCT04881760","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"],["NEW","Covered Recipient Teaching Hospital",null,110087,10799,"NORTHSIDE HOSPITAL GWINNETT",null,null,null,null,null,null,"3620 HOWELL FERRY ROAD",null,"DULUTH","GA","30096","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",267951,1912988445,"PAUL","D","BOYCE",null,"960 JOHNSON FERRY RD","SUITE 500","ATLANTA","GA","30342","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease",null,null,null,null,null,"GA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2500.0,"2021-03-27","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PHII IL22FC ANTI ST2 IN SEVERE COVID 19 PNEUMONIA","No","835920997","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,127674,1821050238,"IMRAN","A","SIDDIQUI",null,"2425 COUNTY ROAD 90",null,"PEARLAND","TX","77584","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"OH","TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","Ozempic","0169-4132-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,17.07,"2021-05-14","In-kind items and services",null,null,null,null,null,null,"No","No","NN9535-4352","No","811712545","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,360044,1922060219,"RICHARD","S.","CHERLIN",null,"15899 LOS GATOS ALMADEN RD STE 12",null,"LOS GATOS","CA","95032","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Chiasma, Inc.",100000801820,"Chiasma, Inc.","MA","United States","Yes","Covered","Drug","Endocrinology","MYCAPSSA","69880-120-28",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,733.58,"2021-02-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","MACRO Registry","No","816012411","2021","06/30/2022",null,null,"INVESTIGATOR FEES"],["NEW","Covered Recipient Teaching Hospital",null,100007,10819,"ADVENTHEALTH ORLANDO",null,null,null,null,null,null,"601 E ROLLINS ST",null,"ORLANDO","FL","32803","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",330415,1285829564,"ELVIS",null,"CASTILLO GARCIA",null,"36819 EILAND BLVD 33542 SUITE 1",null,"ZEPHYRHILLS","FL","33542","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2211.21,"2021-01-26","In-kind items and services",null,null,null,null,null,null,"No","No","A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 AND LY3832479 IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS","No","819446027","2021","06/30/2022","NCT04427501","https://www.clinicaltrials.gov/ct2/show/NCT04427501","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"],["NEW","Covered Recipient Physician",null,null,null,null,120995,1679670822,"STUART","L.","SILVERMAN",null,"8641 WILSHIRE BLVD","STE 301","BEVERLY HILLS","CA","90211","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Radius Health, Inc.",100000181748,"Radius Health, Inc.","MA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,9413.0,"2021-05-20","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Study Concepts on Patient Preference - to support the value story of ABL's MTS","No","830713281","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,470003,9973,"University Of Vermont Medical Center",null,null,null,null,null,null,"111 COLCHESTER AVE",null,"BURLINGTON","VT","05401","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",409563,1629241336,"DMITRIY","G.","AKSELROD",null,"111 COLCHESTER AVE","UVM MEDICAL CENTER, DEPT OF RADIOLOGY","BURLINGTON","VT","05401-1473","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology",null,null,null,null,null,"ID",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Blue Earth Diagnostics Limited",100000151603,"Blue Earth Diagnostics Limited",null,"Great Britain (Uk)","Yes","Covered","Drug","Diagnostic Imaging","Axumin","69932-001-30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4800.0,"2021-03-17","In-kind items and services",null,null,null,null,null,null,"No","No","Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy","No","844376563","2021","06/30/2022","NCT04234399","https://clinicaltrials.gov/ct2/show/NCT04234399","Product_ISS Study"],["NEW","Covered Recipient Physician",null,null,null,null,639274,1699971556,"SANJIV","J","SHAH",null,"675 N SAINT CLAIR ST STE 19250",null,"CHICAGO","IL","60611","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","CARDIOVASCULAR","VYNDAQEL","0069-8729-55",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,940.0,"2021-09-13","In-kind items and services",null,null,null,null,null,null,"No","No","TAFAMIDIS CLINICAL PUBLICATION PROGRAM","No","832575789","2021","06/30/2022",null,null,"No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication."],["NEW","Covered Recipient Physician",null,null,null,null,828537,1346655099,"BENJAMIN","LOUIS","HELLER",null,"515 W BUCKEYE RD STE 104",null,"PHOENIX","AZ","85003","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Ophthalmology",null,null,null,null,null,"AZ","CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alcon Research LLC",100000000218,"Alcon Research LLC","TX","United States","Yes","Covered","Device","Ophthalmology","Acrysof IQ ReSTOR IOL",null,"00380652268752",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,379.5,"2021-12-16","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Approval Study of the AcrySof IQ ReSTOR Toric IOL","No","807676601","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500008,11198,"UNIVERSITY OF WASHINGTON MED CTR",null,null,null,null,null,null,"1959 NE PACIFIC ST",null,"SEATTLE","WA","98195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",184405,1073637732,"JEANNE","E","POOLE",null,"1959 NE PACIFIC ST",null,"SEATTLE","WA","98195-0001","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"ATRICURE, INC.",100000005372,"AtriCure, Inc.","OH","United States","Yes","Covered","Device","CARDIOVASCULAR","ATRICURE CRYOSURGICAL SYSTEM",null,"10840143902543",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,200.0,"2021-03-19","Cash or cash equivalent",null,null,null,null,null,null,"No","No","ATRICURE CRYOICE LESIONS FOR PERSISTENT AND LONG-STANDING PERSISTENT ATRIAL FIBRILLATION TREATMENT DURING CONCOMITANT ON-PUMP ENDO/EPICARDIAL CARDIAC SURGERY","No","849539979","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,140150,10495,"Board Of Trustees Of The University",null,null,null,null,null,null,"1740 W TAYLOR ST","MC 732","CHICAGO","IL","60612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1009675,1699986158,"IRUM","H.","KHAN",null,"840 S WOOD ST",null,"CHICAGO","IL","60612","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,11.4,"2021-01-11","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY","No","831080783","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Teaching Hospital",null,30103,11162,"MAYO CLINIC HOSPITAL",null,null,null,null,null,null,"5777 E Mayo Blvd",null,"Phoenix","AZ","85054","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1291170,1376832196,"AARON","R","MANGOLD",null,"13400 E SHEA BLVD",null,"SCOTTSDALE","AZ","85259","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,7200.0,"2021-12-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 2A DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF PF06823859 IN ADULT SUBJECTS WITH DERMATOMYOSITIS","No","832577007","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50262,11328,"RONALD REAGAN UCLA",null,null,null,null,null,null,"757 Westwood Plz",null,"Los Angeles","CA","90095","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",6606,1154356053,"TIMOTHY","F","CLOUGHESY",null,"300 MEDICAL PLAZA SUITE B-200",null,"LOS ANGELES","CA","90095-0001","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Covered","Drug","ONCOLOGY","QINLOCK","73207-101-31",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,18.9,"2021-03-04","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A SAFETY TOLERABILITY AND PK STUDY OF DCC-2618 IN PATIENTS WITH ADVANCED MALIGNANCIES","No","827888253","2021","06/30/2022","NCT02571036",null,null],["NEW","Covered Recipient Teaching Hospital",null,230046,10547,"UNIV OF MI HOSPITALS & HLTH CTRS",null,null,null,null,null,null,"1500 EAST MEDICAL CENTER DRIVE",null,"ANN ARBOR","MI","48109","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1167066,1235228107,"GEORGIANA","M","SANDERS",null,"24 FRANK LLOYD WRIGHT DR","SUITE H-2100","ANN ARBOR","MI","48105-9484","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Allergy & Immunology",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AIMMUNE THERAPEUTICS, INC.",100000776814,"AIMMUNE THERAPEUTICS, INC.","CA","United States","Yes","Covered","Biological","ALLERGY","PALFORZIA","71881-113-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,21.42,"2021-12-31","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PEANUT ORAL IMMUNOTHERAPY STUDY OF EARLY INTERVENTION FOR DESENSITIZATION (POSEIDON)","No","849615143","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500008,11198,"University Of Washington Med Ctr",null,null,null,null,null,null,"1959 Ne Pacific St",null,"Seattle","WA","98195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",637484,1639269582,"MICHAEL","DAVID","WEISS",null,"UNIVERSITY OF WASHINGTON MEDICAL CTR","1959 NE PACIFIC ST","SEATTLE","WA","98195-6166","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"UCB, Inc.",100000010773,"UCB SA",null,"Belgium","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,17400.0,"2021-03-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Phase 3, Multicenter, Open-Label Extension Study of Zilucoplan in Subjects with Generalized Myasthenia Gravis","No","844225935","2021","06/30/2022","NCT04225871",null,null],["NEW","Covered Recipient Teaching Hospital",null,54144,11286,"Langley Porter Psychiatric Hospital",null,null,null,null,null,null,"401 PARNASSUS AVE",null,"SAN FRANCISCO","CA","94143","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",532154,1922242932,"AMY","JO","CHIEN",null,"550 16th St",null,"SAN FRANCISCO","CA","94158","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Seagen Inc.",100000000279,"Seagen Inc.","WA","United States","Yes","Covered","Drug","Oncology","TUKYSA","51144-001-60",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,5946.19,"2021-10-06","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer","No","792657327","2021","06/30/2022","NCT03975647","https://clinicaltrials.gov/ct2/show/NCT03975647","This study is designed to evaluate the efficacy and safety of tucatinib in combination with T-DM1 in subjects with unresectable locally-advanced or metastatic HER2+ breast cancer who have had prior treatment with a taxane and trastuzumab in any setting. Prior pertuzumab treatment is permitted, but not required. Subjects will be randomized in a 1:1 manner to receive 21-day cycles of either tucatinib or placebo in combination with T-DM1."],["NEW","Covered Recipient Teaching Hospital",null,390028,10267,"Upmc Mercy Hospital",null,null,null,null,null,null,"1400 Locust St",null,"Pittsburgh","PA","15219","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",347278,1649242033,"SILVA","A","ARSLANIAN",null,"5230 CENTRE AVE","FL 2","PITTSBURGH","PA","15232","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3.25,"2021-11-19","In-kind items and services",null,null,null,null,null,null,"No","No","NN9924-4437","No","811824765","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,310014,10167,"Cooper University Hospital",null,null,null,null,null,null,"1000 S 10TH ST",null,"CAMDEN","NJ","08103","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",2787297,1477825891,"TANYA","SONALI","EGODAGE",null,"1 FEDERAL ST # 100",null,"CAMDEN","NJ","08103-1088","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Surgery|Trauma Surgery",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alexion Pharmaceuticals, Inc.",100000005462,"Alexion Pharmaceuticals, Inc.","MA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3750.0,"2021-11-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Prospective, Open-Label Clinical Study of Andexanet Alfa in Patients Receiving FXa (Activated Factor X) Inhibitor Who Require Urgent Surgery","No","781391219","2021","06/30/2022","NCT04233073",null,null],["NEW","Covered Recipient Teaching Hospital",null,360180,10373,"CLEVELAND CLINIC HOSPITAL",null,null,null,null,null,null,"9500 EUCLID AVE",null,"CLEVELAND","OH","44195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",6038,1124251871,"JITENDRA",null,"SHARMA",null,"513 BROOKWOOD BLVD STE 372",null,"BIRMINGHAM","AL","35209","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Vascular Neurology",null,null,null,null,null,"AL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,50.0,"2021-03-31","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 3, RANDOMIZED, OPEN-LABEL TRIAL COMPARING EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS SEMAGLUTIDE ONCE WEEKLY AS ADD-ON THERAPY TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES","No","819447311","2021","06/30/2022","NCT03987919","https://clinicaltrials.gov/ct2/show/NCT03987919","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"],["NEW","Covered Recipient Teaching Hospital",null,503300,11178,"SEATTLE CHILDRENS HOSPITAL",null,null,null,null,null,null,"4800 SANDPOINT WAY NE","5371","SEATTLE","WA","98105","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1002112,1427268416,"SARAH","E","LEARY",null,"4800 SAND POINT WAY NE","MAILSTOP B-6553","SEATTLE","WA","98105","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"JAZZ PHARMACEUTICALS INC.",100000005637,"JAZZ PHARMACEUTICALS INC.","CA","United States","Yes","Covered","Drug","HEMATOLOGY/ONCOLOGY","VYXEOS","68727-745-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,133381.05,"2021-02-23","In-kind items and services",null,null,null,null,null,null,"No","No","A STUDY TO COMPARE STANDARD CHEMOTHERAPY TO THERAPY WITH CPX-351 AND/OR GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED AML WITH OR WITHOUT FLT3 MUTATIONS","No","838146031","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,360239,10330,"SYCAMORE HOSPITAL",null,null,null,null,null,null,"4000 MIAMISBURG CENTERVILLE RD",null,"MIAMISBURG","OH","45342","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",55915,1245296409,"THOMAS","J A","REID",null,"30 E APPLE ST","5258","DAYTON","OH","45409","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Covered","Biological","BioOncology","Avastin","50242-061-01",null,"Covered","Biological","BioOncology","TECENTRIQ","50242-917-01",null,"Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,12560.0,"2021-09-13","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM","No","835927485","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,30087,11159,"HONORHEALTH SCOTTSDALE SHEA MED CTR",null,null,null,null,null,null,"10450 N 92ND STREET",null,"SCOTTSDALE","AZ","85258","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Plexxikon Inc.",100000010983,"Plexxikon Inc.","CA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,9089.1,"2021-06-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Study of PLX2853 in Advanced Malignancies","No","854605295","2021","06/30/2022","NCT03297424",null,null],["NEW","Covered Recipient Teaching Hospital",null,50348,11307,"UCI MEDICAL CENTER",null,null,null,null,null,null,"101 THE CITY DR S",null,"ORANGE","CA","92868","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1297481,1942463377,"ZAHRA",null,"PAKBAZ",null,"26520 CACTUS AVE",null,"MORENO VALLEY","CA","92555","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Amgen Inc.",100000000203,"Amgen Inc.","CA","United States","Yes","Covered","Biological","Hematology","Nplate","55513-221-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,20255.1,"2021-05-10","In-kind items and services",null,null,null,null,null,null,"No","No","LCM:A Phase 3 Randomized Placebo Controlled Study of the Treatment of CIT for Solid Tumors- Study 1","No","830983295","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,340001,10755,"Carolinas Healthcare System Northeas",null,null,null,null,null,null,"920 Church St N",null,"Concord","NC","28025","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",817790,1962601526,"SAAD",null,"USMANI",null,"1021 MOREHEAD MEDICAL DR","STE A","CHARLOTTE","NC","28204-2990","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Janssen Research & Development, LLC",100000005592,"Janssen Research & Development, LLC","NJ","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2940.0,"2021-03-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 3 Study Comparing Daratumumab VELCADE bortezomib Lenalidomide and Dexamethasone DVRd with VELCADE Lenalidomide and Dexamethasone VRd in Subjects with Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initi","No","787576735","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,110107,10804,"Medical Center of Central Georgia",null,null,null,null,null,null,"777 Hemlock Street, MSC 53",null,"Macon","GA","31201","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",309422,1811976053,"Michael",null,"Klyachkin",null,"688 Walnut St","STE 200","Macon","GA","31201","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery",null,null,null,null,null,"GA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Phraxis, Inc.",100000151551,"Phraxis, Inc.","MN","United States","Yes","Covered","Device","Access for Hemodialysis","Venous InterGraft",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4668.96,"2021-03-31","In-kind items and services","Patient Care",null,null,null,null,null,"No","No","Clinical Evaluation of a Vascular Anastomotic Connector System for Minimally Invasive Connection of an Arteriovenous Graft for Hemodialysis","No","831382977","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,390111,10224,"Hospital Of The Univ Of Penna",null,null,null,null,null,null,"3701 MARKET ST",null,"PHILADELPHIA","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1229960,1447282728,"HARVEY","M","FRIEDMAN",null,"3400 SPRUCE STREET",null,"PHILADELPHIA","PA","19104","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BioNTech SE",100000971889,"BioNTech SE",null,"Germany","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,465.0,"2021-11-11","Cash or cash equivalent",null,null,null,null,null,null,"Yes","No","BNT163-01_HSV-2","No","851139181","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,110064,10795,"Piedmont Columbus Regional Midtown",null,null,null,null,null,null,"710 CENTER ST",null,"COLUMBUS","GA","31901","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",309861,1831262922,"ANDREW","W.","PIPPAS",null,"1831 5TH AVE",null,"COLUMBUS","GA","31904","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"GA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,20.0,"2021-05-27","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY","No","831082301","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Teaching Hospital",null,100007,10819,"Adventhealth Orlando",null,null,null,null,null,null,"601 E ROLLINS ST",null,"ORLANDO","FL","32803","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",135898,1992752372,"REGINO",null,"GONZALEZ-PERALTA",null,"1600 SW Archer Rd",null,"Gainesville","FL","32610","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alexion Pharmaceuticals, Inc.",100000005462,"Alexion Pharmaceuticals, Inc.","MA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,11500.0,"2021-02-17","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate the Efficacy and Safety of ALXN1840 Administered For 48 Weeks Versus Standard of Care in Patients With Wilson Disease Aged 12 Years and Older With an Extension Period of Up To 60 Months","No","781384347","2021","06/30/2022","NCT03403205",null,null],["NEW","Covered Recipient Teaching Hospital",null,390111,10224,"HOSPITAL OF THE UNIV OF PENNA",null,null,null,null,null,null,"3701 Market St",null,"Phila","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",66131,1457414625,"ADAM",null,"CUKER",null,"3400 SPRUCE ST",null,"PHILADELPHIA","PA","19104","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,24866.14,"2021-07-14","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PHASE 3 OPEN LABEL SINGLE ARM STUDY TO EVALUATE EFFICACY AND SAFETY OF FIX GENE TRANSFER WITH PF06838435 RAAVSPARK100HFIXPADUA IN ADULT MALE PARTICIPANTS WITH MODERATELY SEVERE TO SEVERE HEMOPHILIA B FIXC LT2 BENEGENE2","No","832901317","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,450054,11012,"Scott And White Memorial Hospital",null,null,null,null,null,null,"1901 Sw H K Dodgen Loop",null,"Temple","TX","76502","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",488699,1396933370,"SHERRONDA",null,"HENDERSON",null,"2401 S 31ST ST",null,"TEMPLE","TX","76508-3666","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Merck Sharp & Dohme Corporation",100000000053,"Merck Sharp & Dohme Corporation","NJ","United States","Yes","Covered","Drug","ONCOLOGY","WELIREG","0006-5331-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,8687.05,"2021-12-31","In-kind items and services",null,null,null,null,null,null,"No","No","Phase 2 Study of MK-6482 in Participants With Advanced Renal Cell Carcinoma","No","848752469","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50262,11328,"RONALD REAGAN UCLA",null,null,null,null,null,null,"757 Westwood Plz",null,"Los Angeles","CA","90095","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",6606,1154356053,"TIMOTHY","F","CLOUGHESY",null,"300 MEDICAL PLAZA SUITE B-200",null,"LOS ANGELES","CA","90095-0001","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Covered","Drug","ONCOLOGY","QINLOCK","73207-101-31",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,18.9,"2021-03-04","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A SAFETY TOLERABILITY AND PK STUDY OF DCC-2618 IN PATIENTS WITH ADVANCED MALIGNANCIES","No","827888509","2021","06/30/2022","NCT02571036",null,null],["NEW","Covered Recipient Teaching Hospital",null,330285,10135,"STRONG MEMORIAL HOSPITAL",null,null,null,null,null,null,"601 Elmwood Ave","Box 684","Rochester","NY","14642","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",776949,1528200300,"RICHARD","F","DUNNE",null,"601 ELMWOOD AVE","601 ELMWOOD AVE","ROCHESTER","NY","14642-0001","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Merck Sharp & Dohme Corporation",100000000053,"Merck Sharp & Dohme Corporation","NJ","United States","Yes","Covered","Drug","ONCOLOGY","LENVIMA","62856-712-30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4228.56,"2021-12-31","In-kind items and services",null,null,null,null,null,null,"No","No","A Phase 3 Multicenter, Randomized, Double-blinded, Active-controlled, Clinical Study to Evaluate the Safety and Efficacy of Lenvatinib E7080,MK-7902 in Combination with Pembrolizumab MK-3475 Versus Lenvatinib in First-line Therapy of Participants with Advanced Hepatocellular Carcinoma LEAP-002","No","848755661","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,390111,10224,"Hospital Of The Univ Of Penna",null,null,null,null,null,null,"3701 Market Street",null,"Philadelphia","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1186987,1942256797,"Daniel",null,"Yoshor","MD","South Pavilion, 2nd Floor","3400 Civic Center Boulevard","Philadelphia","PA","19104","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Neurological Surgery",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Second Sight Medical Products, Inc.",100000041253,"Second Sight Medical Products, Inc.","CA","United States","Yes","Non-Covered","Device","Cortical Visual Prosthesis","Orion",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,27874.27,"2021-09-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Early Feasibility Clinical Trial of a Visual Cortical Prosthesis","No","790256149","2021","06/30/2022","NCT03344848","https://www.clinicaltrials.gov/ct2/show/NCT03344848?term=Orion&draw=2&rank=1","Orion Visual Cortical Prosthesis"],["NEW","Covered Recipient Physician",null,null,null,null,357686,1881661270,"ANTERPREET",null,"DUA",null,"1120 15th St",null,"AUGUSTA","GA","30905","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Anesthesiology",null,null,null,null,null,"SC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Nevro Corp.",100000136428,"Nevro Corp.","CA","United States","Yes","Covered","Device","Spinal Cord Stimulator","Senza II",null,"00813426020510",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,375.0,"2021-10-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Market Observational Study","No","832288077","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,180067,10869,"University Hospital",null,null,null,null,null,null,"800 Rose St",null,"Lexington","KY","40536","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1381979,1902193147,"AMAN",null,"CHAUHAN",null,"800 ROSE ST","UK DIVISION OF MEDICAL ONCOLOGY","LEXINGTON","KY","40536","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"KY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alkermes, Inc.",100000000255,"Alkermes, Inc.","MA","United States","Yes","Non-Covered",null,null,null,null,null,"Covered","Drug","Oncology","KEYTRUDA","0006-3026-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,14804.23,"2021-02-11","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 1/2 Study of ALKS 4230 Administered Intravenously as Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors - ARTISTRY-1","No","797816783","2021","06/30/2022","NCT02799095",null,null],["NEW","Covered Recipient Teaching Hospital",null,460009,11165,"U OF U HOSPITALS & CLINICS",null,null,null,null,null,null,"50 N Medical Dr",null,"Salt Lake City","UT","84132","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1002319,1437258498,"HOWARD",null,"COLMAN",null,"2000 CIRCLE OF HOPE DR","DEPT OF NEUROSURGERY AND HUNTSMAN CANCER INSTITUTE","SALT LAKE CITY","UT","84112-5550","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"UT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Covered","Drug","ONCOLOGY","QINLOCK","73207-101-31",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,327.0,"2021-11-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A SAFETY TOLERABILITY AND PK STUDY OF DCC-2618 IN PATIENTS WITH ADVANCED MALIGNANCIES","No","827888765","2021","06/30/2022","NCT02571036",null,null],["NEW","Covered Recipient Teaching Hospital",null,30038,11158,"Honorhealth Scottsdale Osborn Med Ct",null,null,null,null,null,null,"7400 E Osborn Road",null,"Scottsdale","AZ","85251","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",277405,1114929114,"Michael","S","Gordon",null,"10510 N 92nd St Ste 200",null,"Scottsdale","AZ","85258","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Daiichi Sankyo Inc.",100000000195,"Daiichi Sankyo Inc.","NJ","United States","Yes","Covered","Drug","ONCOLOGY","Turalio","65597-402-20",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,715.0,"2021-11-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PL3397-A-U126","No","835068789","2021","06/30/2022","NCT03291288",null,null],["NEW","Covered Recipient Teaching Hospital",null,310001,10178,"Hackensack University Medical Center",null,null,null,null,null,null,"30 PROSPECT AVE",null,"HACKENSACK","NJ","07601","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",297826,1578528089,"TATYANA",null,"FELDMAN",null,"92 2nd St",null,"HACKENSACK","NJ","07601","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology",null,null,null,null,null,"NJ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Seagen Inc.",100000000279,"Seagen Inc.","WA","United States","Yes","Covered","Biological","Oncology","ADCETRIS","51144-050-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,780.0,"2021-09-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 1/2 Study Evaluating Brentuximab Vedotin in Combination With Nivolumab in Patients With Relapsed or Refractory Hodgkin Lymphoma After Failure of Frontline Therapy","No","792664339","2021","06/30/2022","NCT02572167","https://clinicaltrials.gov/ct2/show/NCT02572167",null],["NEW","Covered Recipient Teaching Hospital",null,33302,11161,"PHOENIX CHILDRENS HOSPITAL",null,null,null,null,null,null,"1919 E THOMAS RD",null,"PHOENIX","AZ","85016","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Covered","Biological","Hematology","HEMLIBRA","50242-920-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,18150.0,"2021-11-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","AN OPEN LABEL STUDY TO DETERMINE PK AND PD OF HEMLIBRA IN SEVERE HEMOPHILIA A WITHOUT INHIBITORS","No","835922093","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,490052,10707,"RIVERSIDE REGIONAL MEDICAL CENTER",null,null,null,null,null,null,"500 J Clyde Morris Blvd",null,"Newport News","VA","23601","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",310664,1851325328,"KERMIT","A","LLOYD",null,"12200 WARWICK BLVD","SUITE 110","NEWPORT NEWS","VA","23601-2344","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"VA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Adamas Pharmaceuticals, Inc.",100000226811,"Adamas Pharmaceuticals, Inc.","CA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1012.37,"2021-11-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A MULTICENTER OPEN-LABEL SAFETY AND EFFICACY STUDY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN PATIENTS WITH MULTIPLE SCLEROSIS AND WALKING IMPAIRMENT","No","837698485","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,140158,10438,"Mercy Hospital & Medical Center",null,null,null,null,null,null,"2525 S Michigan Ave",null,"Chicago","IL","60616","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1287150,1073732459,"AZAZUDDIN","A","AHMED",null,"2555 S MARTIN LUTHER KING DRIVE",null,"CHICAGO","IL","60616","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","Ozempic","0169-4132-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,9.0,"2021-07-14","In-kind items and services",null,null,null,null,null,null,"No","No","NN9535-4352","No","811635379","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500027,11177,"Swedish Medical Center",null,null,null,null,null,null,"747 Broadway",null,"Seattle","WA","98122","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",60322,1336218171,"PHILIP","J","MEASE",null,"1101 MADISON ST STE 1000",null,"SEATTLE","WA","98104-3556","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"UCB, Inc.",100000010773,"UCB SA",null,"Belgium","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,450.0,"2021-11-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A MULTICENTER, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS","No","844231713","2021","06/30/2022","NCT03896581",null,null],["NEW","Covered Recipient Physician",null,null,null,null,1064246,1629285150,"RAVIKUMAR","K","PATEL",null,"509 BILTMORE AVE",null,"ASHEVILLE","NC","28801","United States",null,null,"Doctor of Osteopathy",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"SC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,39.59,"2021-04-16","In-kind items and services",null,null,null,null,null,null,"No","No","A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 AND LY3832479 IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS","No","819446283","2021","06/30/2022","NCT04427501","https://www.clinicaltrials.gov/ct2/show/NCT04427501","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"],["NEW","Covered Recipient Teaching Hospital",null,110010,10785,"Emory University Hospital",null,null,null,null,null,null,"1821 CLIFTON RD NE",null,"ATLANTA","GA","30329","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",262408,1780998229,"BRIAN","THOMAS","CABANISS",null,"12 Executive Park Dr Ne",null,"ATLANTA","GA","30329","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Medtronic, Inc.",100000000106,"Medtronic, Inc.","MN","United States","Yes","Covered","Device","MRI-guided laser ablation","VISUALASE",null,"00643169792890",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,760.74,"2021-12-01","Cash or cash equivalent",null,null,null,null,null,null,"No","No","SLATE","No","800998821","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50348,11307,"Uci Medical Center",null,null,null,null,null,null,"101 THE CITY DR S",null,"ORANGE","CA","92868","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",60796,1356421515,"TAHSEEN",null,"MOZAFFAR",null,"200 S Manchester Ave Ste 110",null,"Orange","CA","92868","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alexion Pharmaceuticals, Inc.",100000005462,"Alexion Pharmaceuticals, Inc.","MA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,10619.0,"2021-02-04","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Long-Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies","No","781384609","2021","06/30/2022","NCT04202341",null,null],["NEW","Covered Recipient Teaching Hospital",null,230046,10547,"UNIV OF MI HOSPITALS & HLTH CTRS",null,null,null,null,null,null,"1500 East Medical Center Drive",null,"Ann Arbor","MI","48105","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",91194,1013094853,"SCOTT","L","HUMMEL",null,"1500 E MEDICAL CENTER DR",null,"ANN ARBOR","MI","48109","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","CARDIOVASCULAR","VYNDAQEL","0069-8729-55",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,279.93,"2021-03-05","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 3 MULTICENTER OPENLABEL STUDY TO EVALUATE THE SAFETY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE PF0629182683 20 MG OR 80 MG OR TAFAMIDIS PF0629182600 61 MG IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY ATTRCM","No","832902501","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,340113,10768,"CAROLINAS MEDICAL CENTER",null,null,null,null,null,null,"2001 Vail Ave",null,"Charlotte","NC","28207","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1223061,1205035466,"NILANJAN",null,"GHOSH",null,"1021 MOREHEAD MEDICAL DR","STE A","CHARLOTTE","NC","28204-2990","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pharmacyclics LLC, an AbbVie Company",100000136439,"Pharmacyclics LLC, An AbbVie Company","CA","United States","Yes","Covered","Drug","ONCOLOGY","IMBRUVICA","57962-420-28",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2146.71,"2021-03-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (SYMPATICO)","No","786497989","2021","06/30/2022","NCT03112174",null,"PCYC-1143-CA"],["NEW","Covered Recipient Teaching Hospital",null,370028,10993,"Integris Baptist Medical Center",null,null,null,null,null,null,"2601 Spencer Rd",null,"Spencer","OK","73084","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",221153,1881688760,"DOUGLAS",null,"HORSTMANSHOF",null,"5300 N INDEPENDENCE AVE","SUITE 280","OKLAHOMA CITY","OK","73112-5556","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"KS","OK",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Abbott Laboratories",100000010680,"Abbott Laboratories","IL","United States","Yes","Covered","Device","Heart Failure","HeartMate 3 Left Ventricular Assist Device",null,"00813024013297",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1190.0,"2021-05-05","Cash or cash equivalent",null,null,null,null,null,null,"No","No","MOMENTUM 3 Extended Follow-up Post Approval Study","No","827577163","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,220071,9988,"Massachusetts General Hospital",null,null,null,null,null,null,"55 Fruit St","Bulfinch 360","Boston","MA","02114","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",130235,1881696003,"RYAN","J","SULLIVAN",null,"55 FRUIT ST",null,"BOSTON","MA","02114","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000231820,"ARRAY BIOPHARMA INC","CO","United States","Yes","Covered","Drug","ONCOLOGY","BRAFTOVI","70255-025-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,14790.3,"2021-01-15","In-kind items and services",null,null,null,null,null,null,"No","No","A PHASE 2 OPENLABEL RANDOMIZED MULTICENTER TRIAL OF ENCORAFENIB  BINIMETINIB EVALUATING A STANDARDDOSE AND A HIGHDOSE REGIMEN IN PATIENTS WITH BRAFV600MUTANT MELANOMA BRAIN METASTASIS","No","832515465","2021","06/30/2022",null,null,"Study Drug"],["NEW","Covered Recipient Teaching Hospital",null,190036,10978,"OCHSNER CLINIC FOUNDATION",null,null,null,null,null,null,"1516 Jefferson Hwy",null,"New Orleans","LA","70121","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",411712,1700844594,"JULIA","B","GARCIA-DIAZ",null,"1514 JEFFERSON HWY",null,"NEW ORLEANS","LA","70121","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"LA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Biological","VACCINES","COMIRNATY","0069-1000-03",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,17697.83,"2021-02-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS","No","832903691","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,220071,9988,"MASSACHUSETTS GENERAL HOSPITAL",null,null,null,null,null,null,"55 FRUIT ST","BULFINCH 360","BOSTON","MA","02241","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",482329,1174592448,"WAYNE","GLENN","SHREFFLER",null,"1 GUSTAVE L LEVY PL","BOX 1200","NEW YORK","NY","10029-6500","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Allergy/Immunology",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AIMMUNE THERAPEUTICS, INC.",100000776814,"AIMMUNE THERAPEUTICS, INC.","CA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1171.3,"2021-12-01","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY","No","849615661","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,450690,11068,"Ut Health Center At Tyler",null,null,null,null,null,null,"11937 US HIGHWAY 271",null,"TYLER","TX","75708","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",161258,1558344903,"JAMES",null,"STOCKS",null,"11937 US Highway 271",null,"Tyler","TX","75708","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Grifols Shared Services North America, Inc.",100000005422,"Grifols Therapeutics LLC","CA","United States","Yes","Non-Covered","Biological","Pulmonology","Prolastin-C",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,812.0,"2021-06-30","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens 60 mgkg and 120 mgkg of Weekly Intravenous Alpha1 Proteinase Inhibitor Human in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin D","No","845837001","2021","06/30/2022","NCT01983241",null,null],["NEW","Covered Recipient Teaching Hospital",null,10033,10929,"UNIVERSITY OF ALABAMA HOSPITAL",null,null,null,null,null,null,"619 19th St S",null,"Birmingham","AL","35249","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1303605,1437309283,"REBECCA",null,"AREND",null,"619 19TH ST S",null,"BIRMINGHAM","AL","35249-3720","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology",null,null,null,null,null,"AL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2072.0,"2021-03-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 1B 2 STUDY OF REBASTINIB DCC-2036 IN COMBINATION WITH PACLITAXEL IN PATIENTS WITH ADVANCED OR METASTATIC SOLID TUMORS","No","827888893","2021","06/30/2022","NCT03601897",null,null],["NEW","Covered Recipient Teaching Hospital",null,450051,11035,"METHODIST DALLAS MEDICAL CENTER",null,null,null,null,null,null,"1441 N Beckley Ave",null,"Dallas","TX","75203","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",80276,1770528697,"PARVEZ","S","MANTRY",null,"1411 N BECKLEY AVE","PAVILION III STE 268","DALLAS","TX","75203-1259","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Allergan, Inc.",100000000278,"Allergan, Inc.","NJ","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,10000.0,"2021-07-12","Cash or cash equivalent",null,null,null,null,null,null,"No","No","AURORA: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis","No","789018615","2021","06/30/2022",null,null,"3152-301-002"],["NEW","Covered Recipient Teaching Hospital",null,230297,10146,"Karmanos Cancer Hospital",null,null,null,null,null,null,"4100 John R St",null,"Detroit","MI","48201","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",728247,1790982031,"IRA",null,"WINER",null,"4100 JOHN R","KARMANOS CANCER CENTER","DETROIT","MI","48201-2013","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alkermes, Inc.",100000000255,"Alkermes, Inc.","MA","United States","Yes","Non-Covered",null,null,null,null,null,"Covered","Drug","Oncology","KEYTRUDA","0006-3026-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,15710.0,"2021-08-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 1/2 Study of ALKS 4230 Administered Intravenously as Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors - ARTISTRY-1","No","797817295","2021","06/30/2022","NCT02799095",null,null],["NEW","Covered Recipient Physician",null,null,null,null,1226491,1316999642,"DAVID","JEAN","WILSON",null,"3375 SW TERWILLIGER BLVD",null,"PORTLAND","OR","97239","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Ophthalmology|Retina Specialist",null,null,null,null,null,"OR","WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2053.33,"2021-06-24","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE III STUDY TO EVALUATE FARICIMAB IN PATIENTS WITH BRANCH RETINAL VEIN OCCLUSION","No","835899065","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,10033,10929,"UNIVERSITY OF ALABAMA HOSPITAL",null,null,null,null,null,null,"619 19th St S",null,"Birmingham","AL","35249","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1303605,1437309283,"REBECCA",null,"AREND",null,"619 19TH ST S",null,"BIRMINGHAM","AL","35249-3720","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology",null,null,null,null,null,"AL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Deciphera Pharmaceuticals Inc.",100000776815,"Deciphera Pharmaceuticals Inc.","MA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2212.0,"2021-05-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 1B 2 STUDY OF REBASTINIB DCC-2036 IN COMBINATION WITH PACLITAXEL IN PATIENTS WITH ADVANCED OR METASTATIC SOLID TUMORS","No","827888997","2021","06/30/2022","NCT03601897",null,null],["NEW","Covered Recipient Teaching Hospital",null,263302,10622,"CHILDRENS MERCY HOSPITAL",null,null,null,null,null,null,"2401 GILLHAM RD",null,"KANSAS CITY","MO","64108","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",814133,1851322069,"JENNIFER","J","DILTS",null,"2401 GILLHAM RD",null,"KANSAS CITY","MO","64108","United States",null,null,"Doctor of Osteopathy",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics",null,null,null,null,null,"MO",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,28072.0,"2021-07-13","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF GALCANEZUMAB IN PATIENTS 6 TO 17 YEARS OF AGE WITH EPISODIC MIGRAINE - THE REBUILD STUDY","No","819447567","2021","06/30/2022","NCT03432286","https://clinicaltrials.gov/ct2/show/NCT03432286","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"],["NEW","Covered Recipient Teaching Hospital",null,230046,10547,"UNIV OF MI HOSPITALS & HLTH CTRS",null,null,null,null,null,null,"1500 EAST MEDICAL CENTER DRIVE",null,"ANN ARBOR","MI","48109","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",251084,1548270176,"RAJEN",null,"MODY",null,"1500 E MEDICAL CENTER DR",null,"ANN ARBOR","MI","48109","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Amgen Inc.",100000000203,"Amgen Inc.","CA","United States","Yes","Covered","Biological","Oncology","Blincyto","55513-160-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2100.0,"2021-05-21","In-kind items and services",null,null,null,null,null,null,"No","No","Long-term Safety in Paediatric Patients B-precursor ALL Treated with Blincyto or SOC then Transplant","No","830983419","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,100271,10837,"Moffitt Cancer Center",null,null,null,null,null,null,"12902 Magnolia Dr",null,"Tampa","FL","33612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1011346,1750543948,"JULIO",null,"CHAVEZ",null,"12902 USF MAGNOLIA DR",null,"TAMPA","FL","33612","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|General Practice",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Kite Pharma, Inc.",100000216809,"Kite Pharma, Inc.","CA","United States","Yes","Covered","Drug","CELLT","Yescarta","71287-119-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,15724.94,"2021-08-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (ZUMA 5)","No","826576637","2021","06/30/2022",null,null,";KTE-C19-105;KP27304;593238634;11612756"],["NEW","Covered Recipient Teaching Hospital",null,340001,10755,"Carolinas Healthcare System Northeas",null,null,null,null,null,null,"920 Church St N",null,"Concord","NC","28025","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Janssen Research & Development, LLC",100000005592,"Janssen Research & Development, LLC","NJ","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3510.0,"2021-12-21","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 2 Study of Erdafitinib in Subjects with Advanced Solid Tumors and FGFR Gene Alterations","No","787577385","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,54144,11286,"LANGLEY PORTER PSYCHIATRIC HOSPITAL",null,null,null,null,null,null,"401 PARNASSUS AVE",null,"SAN FRANCISCO","CA","94143","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",183398,1033176581,"HOPE","S","RUGO",null,"1825 4TH ST FL 3",null,"SAN FRANCISCO","CA","94143","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eli Lilly and Company",100000000088,"Eli Lilly and Company","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,86889.0,"2021-09-27","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 1A/1B STUDY OF LY3484356 ADMINISTERED AS MONOTHERAPY AND IN COMBINATION WITH ABEMACICLIB TO PATIENTS WITH ER+, HER2- LOCALLY ADVANCED OR METASTATIC BREAST CANCER","No","819447825","2021","06/30/2022","NCT04188548","https://clinicaltrials.gov/ct2/show/NCT04188548","The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"],["NEW","Covered Recipient Teaching Hospital",null,53303,11302,"RADY CHILDRENS HOSPITAL - SAN DIEGO",null,null,null,null,null,null,"3020 CHILDRENS WAY",null,"SAN DIEGO","CA","92123","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",712383,1245302561,"WILLIAM","D","ROBERTS",null,"3010 CHILDRENS WAY","2-WEST","SAN DIEGO","CA","92123","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"JAZZ PHARMACEUTICALS INC.",100000005637,"JAZZ PHARMACEUTICALS INC.","CA","United States","Yes","Covered","Drug","HEMATOLOGY/ONCOLOGY","VYXEOS","68727-745-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,97812.77,"2021-11-19","In-kind items and services",null,null,null,null,null,null,"No","No","A STUDY TO COMPARE STANDARD CHEMOTHERAPY TO THERAPY WITH CPX-351 AND/OR GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED AML WITH OR WITHOUT FLT3 MUTATIONS","No","838146405","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,390111,10224,"Hospital Of The Univ Of Penna",null,null,null,null,null,null,"3400 Spruce Street",null,"Philadelphia","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",350973,1740278704,"NAMRATA",null,"PATEL",null,"3600 SPRUCE ST","8TH FLOOR","PHILADELPHIA","PA","19104","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Boehringer Ingelheim USA, Inc.",100000010823,"Boehringer Ingelheim Pharma GmbH & Co.KG",null,"Germany","Yes","Covered","Drug","RESPIRATORY","OFEV","0597-0143-60",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,79.92,"2021-10-26","In-kind items and services",null,null,null,null,null,null,"No","No","Extension","No","827033569","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,360137,10389,"Uh Cleveland Medical Center",null,null,null,null,null,null,"11100 EUCLID AVE",null,"CLEVELAND","OH","44106","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1381936,1750677613,"MOLLY",null,"GALLOGLY",null,"11100 EUCLID AVE",null,"CLEVELAND","OH","44106","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,23.4,"2021-10-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","GRAVITAS 309-A Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease","No","831085743","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Physician",null,null,null,null,200249,1417038910,"ALICE","T","SHAW",null,"32 FRUIT ST STE 7B",null,"BOSTON","MA","02114","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","LORBRENA","0069-0227-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,940.0,"2021-09-21","In-kind items and services",null,null,null,null,null,null,"No","No","LORLATINIB CLINICAL PUBLICATION PROGRAM","No","832583029","2021","06/30/2022",null,null,"No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication."],["NEW","Covered Recipient Teaching Hospital",null,450076,11031,"Ut Md Anderson Cancer Center",null,null,null,null,null,null,"1515 Holcombe Blvd",null,"Houston","TX","77030","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",956458,1831300318,"SHUBHAM",null,"PANT",null,"1515 HOLCOMBE BLVD",null,"HOUSTON","TX","77030-4000","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Boehringer Ingelheim USA, Inc.",100000010823,"Boehringer Ingelheim Pharma GmbH & Co.KG",null,"Germany","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,382.36,"2021-04-27","In-kind items and services",null,null,null,null,null,null,"No","No","Phase Ia/b study with expansion cohorts","No","827033825","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,60011,11146,"Denver Health Medical Center",null,null,null,null,null,null,"145 PARSENN ROAD",null,"WINTER PARK","CO","80482","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",669368,1730482977,"CYRIL",null,"MAUFFREY",null,"777 BANNOCK ST",null,"DENVER","CO","80204-4507","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Orthopaedic Surgery|Orthopaedic Trauma",null,null,null,null,null,"CO",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Zimmer Biomet Holdings, Inc.",100000000103,"Zimmer Biomet Holdings, Inc.","IN","United States","Yes","Covered","Device","Hips","Continuum",null,"889024151192",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1398.0,"2021-05-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","CMU2010-02H, Continuum MoP PMCF","No","834037713","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50348,11307,"UCI MEDICAL CENTER",null,null,null,null,null,null,"101 The City Dr S",null,"Orange","CA","92868","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",722137,1588744635,"JOHN","P","FRUEHAUF",null,"101 THE CITY DR S BLDG 23",null,"ORANGE","CA","92868","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000231820,"ARRAY BIOPHARMA INC","CO","United States","Yes","Covered","Drug","ONCOLOGY","BRAFTOVI","70255-025-01",null,"Covered","Drug","ONCOLOGY","MEKTOVI","70255-010-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2264.0,"2021-10-21","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 2 OPENLABEL RANDOMIZED MULTICENTER TRIAL OF ENCORAFENIB  BINIMETINIB EVALUATING A STANDARDDOSE AND A HIGHDOSE REGIMEN IN PATIENTS WITH BRAFV600MUTANT MELANOMA BRAIN METASTASIS","No","832685473","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,235443,1194794602,"DEBASISH",null,"TRIPATHY",null,"1515 HOLCOMBE BLVD","1354","HOUSTON","TX","77030","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","IBRANCE","0069-0187-21",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,330.0,"2021-07-08","In-kind items and services",null,null,null,null,null,null,"No","No","PALBOCICLIB CLINICAL PUBLICATION PROGRAM","No","832584241","2021","06/30/2022",null,null,"No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication."],["NEW","Covered Recipient Teaching Hospital",null,330057,10103,"ST. PETERS HOSPITAL",null,null,null,null,null,null,"315 South Manning Blvd","Suite 6408a","Albany","NY","12208","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",678147,1043484736,"AJAZ","MOHIUDDIN","KHAN",null,"317 S MANNING BLVD STE 220","317 S MANNING BLVD STE 220","ALBANY","NY","12208","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"IL",null,null,null,null,"Covered Recipient Physician",141543,1114183795,"Shail",null,"Maingi",null,"317 S Manning Blvd., Suite 220",null,"Albany","NY","12208","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Merck Sharp & Dohme Corporation",100000000053,"Merck Sharp & Dohme Corporation","NJ","United States","Yes","Covered","Drug","ONCOLOGY","LENVIMA","62856-712-30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,15696.47,"2021-12-31","In-kind items and services",null,null,null,null,null,null,"No","No","A Phase 3 Randomized, Double-blind Study to Compare the Efficacy and Safety of Pembrolizumab MK-3475 in Combination with  Lenvatinib E7080,MK-7902 versus Pembrolizumab and Placebo as First Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma in Cisplatin-ineligible Participants Whose Tumors Express PD-L1, and in Participants Ineligible for Any Platinum-containing Chemotherapy Regardless of PD-L1 Expression LEAP-011","No","848755971","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,220071,9988,"Massachusetts General Hospital",null,null,null,null,null,null,"55 Fruit St","Bulfinch 360","Boston","MA","02114","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",582913,1710977038,"OLIVER",null,"FREUDENREICH",null,"55 FRUIT ST","LIN PSYCHIATRY ASSOCIATES INPATIENT CONSULT","BOSTON","MA","02114-2696","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alkermes, Inc.",100000000255,"Alkermes, Inc.","MA","United States","Yes","Covered","Drug","CNS","ARISTADA","65757-401-03",null,"Covered","Drug","CNS","INVEGA SUSTENNA","50458-563-01",null,"Covered","Drug","CNS","Abilify Maintena","59148-018-71",null,"Covered","Drug","CNS","RISPERDAL CONSTA","50458-306-11",null,null,null,null,null,null,null,1996.0,"2021-08-06","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)","No","797817551","2021","06/30/2022","NCT03919994",null,null],["NEW","Covered Recipient Teaching Hospital",null,330204,10075,"BELLEVUE HOSPITAL CENTER",null,null,null,null,null,null,"462 1ST AVE","C   D BUILDING RM 342","NEW YORK","NY","10016","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",349764,1710082847,"JAZILA",null,"MANTIS",null,"8268 164TH ST",null,"JAMAICA","NY","11432","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000089,"Genentech, Inc.","CA","United States","Yes","Covered","Biological","Immunology","Actemra","50242-137-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,500.0,"2021-02-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","TOCILIZUMAB THERAPY FOR COVID 19 PNEUMONIA IN HOSPITALIZED PATIENTS","No","835906991","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,53302,11301,"Childrens Hospital Los Angeles",null,null,null,null,null,null,"4650 W Sunset Blvd",null,"Los Angeles","CA","90027","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1146597,1508031352,"LILY",null,"CHAO",null,"3701 WILSHIRE BLVD",null,"LOS ANGELES","CA","90010","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1.5,"2021-12-01","In-kind items and services",null,null,null,null,null,null,"No","No","NN9924-4437","No","811036201","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,30022,11163,"Valleywise Health Medical Center",null,null,null,null,null,null,"2601 E Roosevelt St",null,"PHOENIX","AZ","85008","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",843543,1871533000,"MARC","R","MATTHEWS",null,"2929 E THOMAS RD",null,"PHOENIX","AZ","85016","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Surgery|Surgical Critical Care",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"KCI USA, Inc.",100000010396,"KCI USA, Inc.","TX","United States","Yes","Covered","Device","Negative Pressure Systems & Dressings","V.A.C. VERAFLO",null,"849554001299",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,8950.0,"2021-05-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Retrospective Post Market Clinical F/u (PMCF) Survey of V.A.C. VERAFLTM Therapy in Burns","No","770939808","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,220071,9988,"MASSACHUSETTS GENERAL HOSPITAL",null,null,null,null,null,null,"55 Fruit St","Bulfinch 360","Boston","MA","02114","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",109003,1417083122,"MELISSA","S","PUTMAN",null,"MASSACHUSETTS GENERAL HOSPITAL","55 FRUIT STREET","BOSTON","MA","02114","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"DEXCOM, INC.",100000010478,"DEXCOM, INC.","CA","United States","Yes","Covered","Device","ENDOCRINOLOGY","DEXCOM G6 TRANSMITTER",null,"00386270000385",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,316.18,"2021-08-30","In-kind items and services",null,null,null,null,null,null,"No","No","CONTINUOUS GLUCOSE MONITORING IN HOSPITALIZED PATIENTS: AN OBSERVATIONAL STUDY","No","845253439","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,230077,10498,"ST. MARYS OF MICHIGAN",null,null,null,null,null,null,"800 S Washington Ave",null,"Saginaw","MI","48601","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",110236,1427089200,"VIPIN",null,"KHETARPAL",null,"1015 S WASHINGTON AVE",null,"SAGINAW","MI","48601-2556","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Esperion Therapeutics, Inc.",100000771817,"Esperion Therapeutics, Inc.","MI","United States","Yes","Covered","Drug","ANTILIPEMIC AGENTS","NEXLETOL","72426-118-03",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,100.0,"2021-01-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH, OR AT HIGH RISK FOR, CARDIOVASCULAR DISEASE WHO ARE STATIN INTOLERANT","No","838382705","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,53302,11301,"Childrens Hospital Los Angeles",null,null,null,null,null,null,"4650 W Sunset Blvd",null,"Los Angeles","CA","90027","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1146597,1508031352,"LILY",null,"CHAO",null,"3701 WILSHIRE BLVD",null,"LOS ANGELES","CA","90010","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2.85,"2021-11-19","In-kind items and services",null,null,null,null,null,null,"No","No","NN9924-4437","No","811746775","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,330285,10135,"STRONG MEMORIAL HOSPITAL",null,null,null,null,null,null,"601 Elmwood Ave","Box 684","Rochester","NY","14642","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",407818,1568766731,"ANGELA","R","BRANCHE",null,"601 ELMWOOD AVE",null,"ROCHESTER","NY","14642-0001","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.","IL","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,792.0,"2021-05-11","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 2, LONG-TERM IMMUNOGENICITY FOLLOW-UP TRIAL OF ADULT AND ELDERLY SUBJECTS WHO HAVE PREVIOUSLY RECEIVED AN INTRAMUSCULAR INJECTION OF NOROVIRUS GI.1/GII.4 BIVALENT VIRUS-LIKE PARTICLE VACCINE","No","816665709","2021","06/30/2022","NCT03039790",null,null],["NEW","Covered Recipient Teaching Hospital",null,100069,10824,"Adventhealth Carrollwood",null,null,null,null,null,null,"7171 N DALE MABRY HWY",null,"TAMPA","FL","33614","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",118841,1619291994,"PAUL","Z.","GERCZUK",null,"14320 BRUCE B DOWNS BLVD",null,"TAMPA","FL","33613","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Acticor",null,"04035479156701","Covered","Device","Cardiology/Vascular Diseases","Solia",null,"04035479118266","Covered","Device","Cardiology/Vascular Diseases","Rivacor",null,"04035479156794","Covered","Device","Cardiology/Vascular Diseases","Plexa",null,4035479140014,"Covered","Device","Cardiology/Vascular Diseases","Sentus",null,4035479148942,50.0,"2021-12-14","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIO-LIBRA","No","843814579","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,440039,10425,"Vanderbilt University Medical Center",null,null,null,null,null,null,"1211 Medical Center Drive",null,"Nashville","TN","37232","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",4683914,1992148696,"NATALIE",null,"MCCALL",null,"719 THOMPSON LN",null,"NASHVILLE","TN","37204","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology",null,null,null,null,null,"TN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","Ozempic","0169-4132-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4.5,"2021-03-24","In-kind items and services",null,null,null,null,null,null,"No","No","NN9535-4321","No","849762281","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,230077,10498,"ST. MARYS OF MICHIGAN",null,null,null,null,null,null,"800 S Washington Ave",null,"Saginaw","MI","48601","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",110236,1427089200,"VIPIN",null,"KHETARPAL",null,"1015 S WASHINGTON AVE",null,"SAGINAW","MI","48601-2556","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Esperion Therapeutics, Inc.",100000771817,"Esperion Therapeutics, Inc.","MI","United States","Yes","Covered","Drug","ANTILIPEMIC AGENTS","NEXLETOL","72426-118-03",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,224.0,"2021-06-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH, OR AT HIGH RISK FOR, CARDIOVASCULAR DISEASE WHO ARE STATIN INTOLERANT","No","838383107","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,230046,10547,"Univ Of Mi Hospitals & Hlth Ctrs",null,null,null,null,null,null,"1500 East Medical Center Drive",null,"Ann Arbor","MI","48109","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",11050,1235211764,"RODICA","P","BUSUI",null,"4029 AVE MARIA ST","STE 1300","ANN ARBOR","MI","48105","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"MI","OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Non-Covered","Drug","Diabetes",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,26.0,"2021-10-28","In-kind items and services",null,null,null,null,null,null,"No","No","EX9536-4388","No","810993713","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,150113,10414,"Community Hospital Anderson",null,null,null,null,null,null,"1515 N Madison Ave",null,"Anderson","IN","46011","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",102864,1275552481,"WA'EL",null,"BAKDASH",null,"1515 S MADISON AVE",null,"ANDERSON","IN","46016","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"IN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Non-Covered","Drug","Diabetes",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,56.9,"2021-10-28","In-kind items and services",null,null,null,null,null,null,"No","No","EX9536-4388","No","811271289","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50760,11221,"KFH - ANTIOCH",null,null,null,null,null,null,"4501 Sand Creek Road",null,"Antioch","CA","94531","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",651669,1124233317,"ELIZABETH","G","LILES",null,"10060 NE EVERGREEN PKWY",null,"HILLSBORO","OR","97124","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"OR",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2160.0,"2021-08-12","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER","No","832826057","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,460009,11165,"U Of U Hospitals & Clinics",null,null,null,null,null,null,"50 N MEDICAL DR",null,"SALT LAKE CITY","UT","84132","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",2790582,1699076224,"ANGELA","Y.","PETERS",null,"UNIVERSITY OF UTAH DEPT OF NEUROLOGY","175 N MEDICAL DRIVE EAST","SALT LAKE CITY","UT","84132-0001","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Clinical Neurophysiology",null,null,null,null,null,"ID",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"NEUROPACE, INC.",100000010697,"NEUROPACE, INC.","CA","United States","Yes","Covered","Device","Epilepsy","RNS System",null,"00855547005267",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,50.0,"2021-04-05","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Approval Study","No","851397533","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,260196,1740256452,"SAIMA","KANWAL","JEHANGIR",null,"3407 GLENVIEW AVE",null,"AUSTIN","TX","78703-1448","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Obstetrics & Gynecology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"ABBVIE INC.",100000000204,"ABBVIE INC.","IL","United States","Yes","Covered","Drug","WOMENS HEALTH","ORILISSA","0074-0038-28",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,305.0,"2021-07-29","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Estradiol/Norethindrone Acetate in Subjects with Moderate to Severe Endometriosis-Associated Pain","No","792403809","2021","06/30/2022","NCT03213457",null,"M14-702"],["NEW","Covered Recipient Teaching Hospital",null,50146,11296,"City Of Hope National Medical Ctr",null,null,null,null,null,null,"1500 E Duarte Rd",null,"Duarte","CA","91010","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",534797,1023147014,"JAE","YUL","KIM",null,"1500 DUARTE RD",null,"DUARTE","CA","91010","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery)",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AstraZeneca Pharmaceuticals LP",100000000146,"AstraZeneca Pharmaceuticals LP","DE","United States","Yes","Covered","Biological","Oncology","IMFINZI","0310-4500-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,56882.5,"2021-01-21","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase III, Double-blind, Placebo-controlled, Multi-center International Study of Neoadjuvant/adjuvant Durvalumab for the Treatment of Patients with Resectable Stages II and III Non-small Cell Lung Cancer","No","826473111","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,140119,10441,"Rush University Medical Center",null,null,null,null,null,null,"1653 W. Congress Parkway",null,"Chicago","IL","60612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",310662,1851325088,"TIMOTHY","M","KUZEL",null,"675 N SAINT CLAIR ST","GALTER 21-100","CHICAGO","IL","60611-5975","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eisai Inc.",100000000136,"Eisai Inc.","NJ","United States","Yes","Covered","Drug","Oncology","Ontak","62856-603-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,846.95,"2021-05-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Clinical Study to Demonstrate Safety and Efficacy of E7777 (Denileukin Diftitox) in Persistent or Recurrent Cutaneous T-Cell Lymphoma","No","836178729","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,460009,11165,"U Of U Hospitals & Clinics",null,null,null,null,null,null,"50 N MEDICAL DR",null,"SALT LAKE CITY","UT","84132","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",2790582,1699076224,"ANGELA","Y.","PETERS",null,"UNIVERSITY OF UTAH DEPT OF NEUROLOGY","175 N MEDICAL DRIVE EAST","SALT LAKE CITY","UT","84132-0001","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Clinical Neurophysiology",null,null,null,null,null,"ID",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"NEUROPACE, INC.",100000010697,"NEUROPACE, INC.","CA","United States","Yes","Covered","Device","Epilepsy","RNS System",null,"00855547005267",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,475.0,"2021-07-12","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Approval Study","No","851397641","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,220162,9984,"Dana-Farber Cancer Institute",null,null,null,null,null,null,"450 BROOKLINE AVE",null,"BOSTON","MA","02215","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",314270,1922086487,"JACOB","P.","LAUBACH",null,"44 Binney St D1B30",null,"Boston","MA","02115","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Bristol Myers Squibb Company",100000005499,"E.R. Squibb & Sons, L.L.C.","NJ","United States","Yes","Covered","Biological","Oncology","OPDIVO","0003-3774-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,953.75,"2021-03-12","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Ph I Hematology CA210-003","No","819887963","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,30024,11263,"ST. JOSEPHS HOSPITAL & MEDICAL CTR",null,null,null,null,null,null,"7300 N 99TH AVE",null,"GLENDALE","AZ","85305","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",5702859,1588074207,"SANA",null,"ASLAM",null,"240 W THOMAS RD STE 301",null,"PHOENIX","AZ","85013","United States",null,null,"Doctor of Osteopathy",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000000166,"Roche TCRC, Inc.","NY","United States","Yes","Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1757.7,"2021-02-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PHASE II STUDY IN EARLY STAGE PARKINSON S DISEASE PATIENTS","No","835926067","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,180103,10847,"Baptist Health Lexington",null,null,null,null,null,null,"1740 NICHOLASVILLE RD",null,"LEXINGTON","KY","40503","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",32625,1730127994,"CRAIG","JENNINGS","MCCOTTER",null,"1720 NICHOLASVILLE RD STE 601",null,"LEXINGTON","KY","40503","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"KY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Plexa",null,"04035479140014","Covered","Device","Cardiology/Vascular Diseases","Acticor",null,"04035479156701","Covered","Device","Cardiology/Vascular Diseases","Solia",null,"04035479118266","Covered","Device","Cardiology/Vascular Diseases","Rivacor",null,4035479156794,"Covered","Device","Cardiology/Vascular Diseases","Sentus",null,4035479148942,26.25,"2021-11-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIO-LIBRA","No","843839939","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,223302,9992,"CHILDRENS HOSPITAL CORPORATION",null,null,null,null,null,null,"300 Longwood Ave","Patient Financial Services Atn Steven Nicoll","Boston","MA","02115","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",987029,1891891826,"LYNDA","C","SCHNEIDER",null,"300 LONGWOOD AVE",null,"BOSTON","MA","02115-5724","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Allergy & Immunology|Clinical & Laboratory Immunology",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","INFLAMMATION AND  IMMUNOLOGY","DUPIXENT","0024-5914-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1539.72,"2021-04-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 2/3 STUDY INVESTIGATING THE PHARMACOKINETICS, SAFETY, AND EFFICACY OF DUPILUMAB IN PATIENTS AGED >=6 MONTHS TO <6 YEARS WITH SEVERE ATOPIC DERMATITIS","No","793086073","2021","06/30/2022","NCT03346434",null,null],["NEW","Covered Recipient Physician",null,null,null,null,992195,1083608038,"RISHI","K","AGRAWAL",null,"2300 N CHILDRENS PLZ","OUTREACH PHYSICIAN SERVICES","CHICAGO","IL","60614-3363","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pharmacyclics LLC, An AbbVie Company",100000136439,"Pharmacyclics LLC, An AbbVie Company","CA","United States","Yes","Covered","Drug","ONCOLOGY","IMBRUVICA","57962-420-28",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,400.0,"2021-09-27","Cash or cash equivalent",null,null,null,null,null,null,"No","No","IbrutiNib in SARS CoV-2 Induced Pulmonary Injury and Respiratory failure (iNSPIRE)","No","810151823","2021","06/30/2022","NCT04375397",null,"M20-310"],["NEW","Covered Recipient Teaching Hospital",null,450647,10892,"Medical City Dallas",null,null,null,null,null,null,"7777 FOREST LN",null,"DALLAS","TX","75230","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",330777,1285677138,"VIKAS",null,"BHUSHAN",null,"7777 FOREST LN","BLDG D","DALLAS","TX","75230","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1033.0,"2021-07-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","GRAVITAS 309-A Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease","No","831062779","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Teaching Hospital",null,440015,10348,"University Of Tennessee Medical Cent",null,null,null,null,null,null,"1924 Alcoa Hwy",null,"Knoxville","TN","37920","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",4219198,1528293701,"ANDREW","DAVID","NICHOLSON",null,"1932 ALCOA HWY STE C360",null,"KNOXVILLE","TN","37920","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology",null,null,null,null,null,"TN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Penumbra, Inc.",100000010583,"Penumbra, Inc.","CA","United States","Yes","Covered","Device","Neurointervention","Smart Coil",null,"00814548015286",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,75.0,"2021-09-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","SURF","No","840451475","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,70034,10026,"Norwalk Hospital",null,null,null,null,null,null,"34 Maple St",null,"Norwalk","CT","06856","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",234804,1174515803,"RICHARD",null,"FRANK",null,"40 CROSS ST","4TH FL","NORWALK","CT","06851","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"CT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"EMD Serono, Inc.",100000000127,"EMD Serono, Inc.","MA","United States","Yes","Covered","Drug","Oncology","Bavencio","44087-3535-1",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,420.0,"2021-04-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","MS100070_0176","No","842923011","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,3258410,1487017059,"JESUS",null,"VARGAS",null,"111 S FRONT ST",null,"HARRISBURG","PA","17101-2010","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novartis Pharmaceuticals Corporation",100000000228,"Novartis Pharmaceuticals Corporation","NJ","United States","Yes","Covered","Biological","NEUROSCIENCE","AIMOVIG","55513-841-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,5625.0,"2021-10-25","In-kind items and services",null,null,null,null,null,null,"No","No","PUBLICATION SUPPORT PROVIDED IN CONNECTION WITH AIMOVIG RESEARCH","No","800639399","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,220086,9982,"BETH ISRAEL DEACONESS MEDICAL CENTER",null,null,null,null,null,null,"330 Brookline Ave","St 207","Boston","MA","02215","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",349276,1689892481,"EVANGELOS",null,"MESSARIS",null,"330 BROOKLINE AVE  6",null,"BOSTON","MA","02215","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Colon & Rectal Surgery",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.","IL","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,16150.0,"2021-12-20","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE-III, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, INTERNATIONAL, MULTICENTRE STUDY TO ASSESS EFFICACY AND SAFETY OF CX601, ADULT ALLOGENEIC EXPANDED ADIPOSE-DERIVED STEM CELLS (EASC) FOR THE TREATMENT OF COMPLEX PERIANAL FISTULA(S) IN PATIENTS WITH CROHN'S DISEASE OVER A PERIOD OF 24 WEEKS AND A FOLLOW-UP PERIOD UP TO 52 WEEKS","No","816648859","2021","06/30/2022","NCT03279081",null,null],["NEW","Covered Recipient Teaching Hospital",null,50348,11307,"Uci Medical Center",null,null,null,null,null,null,"101 The City Drive South",null,"Orange","CA","92868","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",62653,1376710434,"FARSHID",null,"DAYYANI",null,"2946 E BANNER GATEWAY DR",null,"GILBERT","AZ","85234-2165","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Ipsen Bioscience Inc",100000005526,"Ipsen Bioscience Inc","MA","United States","Yes","Covered","Drug","Oncology","ONIVYDE","15054-0043-1",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,45213.85,"2021-06-14","Cash or cash equivalent",null,null,null,null,null,null,"No","No","An Open-label, Randomised, Multicentre, Phase III Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Leucovorin Versus Nab-paclitaxel Plus Gemcitabine in Subjects Who Have Not Previously Received Chemotherapy for Metastatic Adenocarcinoma of the Pancreas","No","771547968","2021","06/30/2022","NCT04083235",null,null],["NEW","Covered Recipient Teaching Hospital",null,360180,10373,"Cleveland Clinic Hospital",null,null,null,null,null,null,"9500 Euclid Ave",null,"Cleveland","OH","44195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",41807,1922293547,"KEVIN","M","PANTALONE",null,"29800 BAINBRIDGE RD","# SO40","SOLON","OH","44139","United States",null,null,"Doctor of Osteopathy",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,23.06,"2021-04-01","In-kind items and services",null,null,null,null,null,null,"No","No","EX9924-4473","No","811404955","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,137094,1013902444,"MARK",null,"LEBWOHL",null,"5 E 98TH ST",null,"NEW YORK","NY","10029-6501","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novartis Pharmaceuticals Corporation",100000000228,"Novartis Pharmaceuticals Corporation","NJ","United States","Yes","Covered","Biological","IMMUNOLOGY","COSENTYX","0078-0639-41",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,964.0,"2021-10-21","In-kind items and services",null,null,null,null,null,null,"No","No","THE EVOLVING TREATMENT APPROACH OF SECUKINUMAB IN BIOLOGIC-EXPERIENCED AND BIOLOGIC-NAIVE PATIENTS WITH PSORIASIS: KEY CLINICAL AND PATIENT CHARACTERISTICS BY YEAR OF TREATMENT INITIATION IN A US-BASED REGISTRY","No","800640167","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,160058,10604,"University Of Iowa Hosp & Clinics",null,null,null,null,null,null,"200 Hawkins Dr",null,"Iowa City","IA","52242","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1251566,1215167648,"PASHTOON","MURTAZA","KASI",null,"UIHC-DEPT OF INTERNAL MEDI",null,"IOWA CITY","IA","52242","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"IA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AstraZeneca Pharmaceuticals LP",100000000146,"AstraZeneca Pharmaceuticals LP","DE","United States","Yes","Covered","Biological","Oncology","IMFINZI","0310-4500-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,74399.6,"2021-11-30","In-kind items and services",null,null,null,null,null,null,"No","No","Feasibility and safety of Yttrium Y-90 radioembolization combined with PD-L1 blockade in the treatment of liver-predominant metastatic colorectal cancer. A Phase I study","No","826473285","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,230046,10547,"Univ Of Mi Hospitals & Hlth Ctrs",null,null,null,null,null,null,"1500 EAST MEDICAL CENTER DRIVE",null,"ANN ARBOR","MI","48109","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",811997,1760648109,"RAKESH",null,"LATCHAMSETTY",null,"1500 E MEDICAL CENTER DR",null,"ANN ARBOR","MI","48109","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Sentus",null,"04035479148942","Covered","Device","Cardiology/Vascular Diseases","Acticor",null,"04035479156701","Covered","Device","Cardiology/Vascular Diseases","Solia",null,"04035479118266","Covered","Device","Cardiology/Vascular Diseases","Rivacor",null,4035479156794,"Covered","Device","Cardiology/Vascular Diseases","Plexa",null,4035479140014,67.21,"2021-05-12","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIO-LIBRA","No","843821039","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,132483,1932115524,"MICHAEL","W","DEININGER",null,"2000 CIRCLE OF HOPE DR RM 4280",null,"SALT LAKE CITY","UT","84112","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"UT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","METABOLIC DISEASE;ONCOLOGY","BOSULIF","0069-0135-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,330.0,"2021-02-17","In-kind items and services",null,null,null,null,null,null,"No","No","BOSUTINIB CLINICAL PUBLICATION PROGRAM","No","832501927","2021","06/30/2022",null,null,"No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication."],["NEW","Covered Recipient Teaching Hospital",null,30103,11162,"Mayo Clinic Hospital",null,null,null,null,null,null,"5777 E MAYO BLVD",null,"PHOENIX","AZ","85054","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",693270,1578904173,"MOHAMAD","B.","SONBOL",null,"13400 E SHEA BLVD",null,"SCOTTSDALE","AZ","85259-5452","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Bavarian Nordic A/S",100000796825,"Bavarian Nordic A/S",null,"Denmark","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1331.0,"2021-05-28","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Bavarian Nordic TAEK-VAC-HerBy-001","No","771321326","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,219025,1831178151,"STEPHEN","B.","TATTER",null,"PO BOX 344",null,"WINSTON SALEM","NC","27102-0344","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Neurological Surgery",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"ARBOR PHARMACEUTICALS, INC.",100000005507,"ARBOR PHARMACEUTICALS, INC.","GA","United States","Yes","Covered","Drug","Neurology","Gliadel","24338-050-08",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3225.6,"2021-11-24","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry (VIGILANT)","No","813747303","2021","06/30/2022","NCT02684838","https://www.clinicaltrials.gov/ct2/show/NCT02684838","Phase IV"],["NEW","Covered Recipient Teaching Hospital",null,100007,10819,"Adventhealth Orlando",null,null,null,null,null,null,"601 E Rollins St",null,"Orlando","FL","32803","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1266401,1740341726,"MARK","A","SOCINSKI",null,"601 E Rollins St","PO Box 37","Orlando","FL","32803","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"FL","NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BeiGene, Ltd.",100000826833,"BeiGene, Ltd.",null,"Cayman Islands","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,12750.0,"2021-07-28","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Randomized, Controlled, Open-label, Global Phase 3 Study Comparing the Efficacy of the Anti-PD-1 Antibody Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Patients With Advanced Unresectable/Metastatic Esophageal Squamous Cell Carcinoma","No","843873819","2021","06/30/2022","NCT03430843",null,null],["NEW","Covered Recipient Teaching Hospital",null,490009,10745,"UNIVERSITY OF VIRGINIA MEDICAL CENTE",null,null,null,null,null,null,"1215 Lee St Pfs",null,"Charlottesville","VA","22908","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",441192,1720379019,"MATTHEW","J","REILLEY",null,"1240 LEE ST",null,"CHARLOTTESVILLE","VA","22908-4000","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"VA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.","IL","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1300.0,"2021-09-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 1B/2 STUDY OF TAK-981 PLUS PEMBROLIZUMAB TO EVALUATE THE SAFETY, TOLERABILITY, AND ANTITUMOR ACTIVITY OF THE COMBINATION IN PATIENTS WITH SELECT ADVANCED OR METASTATIC SOLID TUMORS","No","816674583","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,381202,1639259062,"CATHERINE","M","BOLLARD",null,"111 MICHIGAN AVE NW","5TH FLOOR MAIN, SUI","WASHINGTON","DC","20010","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology",null,null,null,null,null,"DC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"SWEDISH ORPHAN BIOVITRUM AB",100000081405,"SWEDISH ORPHAN BIOVITRUM AB",null,"Sweden","Yes","Covered","Drug","HEMATOLOGY","GAMIFANT","72171-505-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,957.9,"2021-04-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","NI-0501 PROGRAM","No","833643573","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,360180,10373,"Cleveland Clinic Hospital",null,null,null,null,null,null,"9500 Euclid Ave",null,"Cleveland","OH","44195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",41807,1922293547,"KEVIN","M","PANTALONE",null,"29800 BAINBRIDGE RD","# SO40","SOLON","OH","44139","United States",null,null,"Doctor of Osteopathy",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,28.5,"2021-10-08","In-kind items and services",null,null,null,null,null,null,"No","No","EX9924-4473","No","811592659","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,83300,10812,"Alfred I Dupont Hosp For Children",null,null,null,null,null,null,"1600 ROCKLAND RD",null,"WILMINGTON","DE","19899","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",740847,1255422531,"MICHAEL","B","BOBER",null,"THE NEMOURS FOUNDAT",null,"WILMINGTON","DE","19803","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Medical Genetics|Clinical Genetics (M.D.)",null,null,null,null,null,"DE",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"SWEDISH ORPHAN BIOVITRUM AB",100000081405,"SWEDISH ORPHAN BIOVITRUM AB",null,"Sweden","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,175.0,"2021-02-04","Cash or cash equivalent",null,null,null,null,null,null,"No","No","SOBI003-002","No","833650833","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,450076,11031,"Ut Md Anderson Cancer Center",null,null,null,null,null,null,"1515 Holcombe Blvd",null,"Houston","TX","77030","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",134212,1952497687,"ALESSANDRA",null,"FERRAJOLI",null,"1515 Holcombe Blvd",null,"Houston","TX","77030","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BeiGene, Ltd.",100000826833,"BeiGene, Ltd.",null,"Cayman Islands","Yes","Covered","Drug","Oncology","BRUKINSA","72579-011-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,47000.0,"2021-08-09","In-kind items and services",null,null,null,null,null,null,"No","No","A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared With Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","No","843878015","2021","06/30/2022","NCT03734016",null,null],["NEW","Covered Recipient Teaching Hospital",null,363300,10334,"Childrens Hospital Medical Center",null,null,null,null,null,null,"3333 BURNET AVE",null,"CINCINNATI","OH","45229","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",609767,1669537478,"MICHAEL","BRIAN","JORDAN",null,"3333 BURNET AVENUE",null,"CINCINNATI","OH","45229","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"SWEDISH ORPHAN BIOVITRUM AB",100000081405,"SWEDISH ORPHAN BIOVITRUM AB",null,"Sweden","Yes","Covered","Drug","HEMATOLOGY","GAMIFANT","72171-505-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1500.0,"2021-11-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","NI-0501-04","No","833651091","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,230046,10547,"Univ Of Mi Hospitals & Hlth Ctrs",null,null,null,null,null,null,"1500 EAST MEDICAL CENTER DRIVE",null,"ANN ARBOR","MI","48109","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",89197,1972695344,"GEORGE","M.","DEEB",null,"1500 E Medical Center Dr",null,"ANN ARBOR","MI","48109","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery)",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Medtronic, Inc.",100000000106,"Medtronic, Inc.","MN","United States","Yes","Covered","Device","Transcatheter Valve Systems","CoreValve Evolut",null,"00643169565623",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4408.0,"2021-03-05","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Optimize Pro","No","800994217","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,100007,10819,"Adventhealth Orlando",null,null,null,null,null,null,"601 E Rollins St",null,"Orlando","FL","32803","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1266401,1740341726,"MARK","A","SOCINSKI",null,"2501 N ORANGE AVE STE 689",null,"ORLANDO","FL","32804","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,17800.0,"2021-06-04","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 1 STUDY TO EVALUATE THE SAFETY PHARMACOKINETICS AND PHARMACODYNAMICS OF ESCALATING DOSES OF PF06939999 PRMT5 INHIBITOR IN PARTICIPANTS WITH ADVANCED OR METASTATIC NONSMALL CELL LUNG CANCER HEAD AND NECK SQUAMOUS CELL CARCINOMA ESOPHAGEAL CANCER ENDOMETRIAL CANCER CERVICAL CANCER AND BLADDER CANCER","No","832845865","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,130007,11101,"St. Alphonsus Regional Med Center",null,null,null,null,null,null,"1055 N CURTIS RD",null,"BOISE","ID","83706","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",53341,1174517775,"MARGOT","E.","VLOKA",null,"6140 W CURTISIAN AVE STE 200",null,"BOISE","ID","83704","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"ID",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Sentus",null,"04035479148942","Covered","Device","Cardiology/Vascular Diseases","Acticor",null,"04035479156701","Covered","Device","Cardiology/Vascular Diseases","Solia",null,"04035479118266","Covered","Device","Cardiology/Vascular Diseases","Rivacor",null,4035479156794,"Covered","Device","Cardiology/Vascular Diseases","Plexa",null,4035479140014,150.53,"2021-07-13","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIO-LIBRA","No","843840553","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50696,11289,"KECK HOSPITAL OF USC",null,null,null,null,null,null,"1500 San Pablo Street",null,"Los Angeles","CA","90033","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",838537,1700814209,"HEINZ-JOSEF",null,"LENZ",null,"1441 EASTLAKE AVE STE 3440",null,"LOS ANGELES","CA","90089","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","BRAFTOVI","70255-025-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,12580.11,"2021-07-21","Cash or cash equivalent",null,null,null,null,null,null,"No","No","AN OPENLABEL MULTICENTER RANDOMIZED PHASE 3 STUDY OF FIRSTLINE ENCORAFENIB PLUS CETUXIMAB WITH OR WITHOUT CHEMOTHERAPY VERSUS STANDARD OF CARE THERAPY WITH A SAFETY LEADIN OF ENCORAFENIB AND CETUXIMAB PLUS CHEMOTHERAPY IN PARTICIPANTS WITH METASTATIC BRAF V600EMUTANT COLORECTAL CANCER","No","832870269","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,363300,10334,"CHILDRENS HOSPITAL MEDICAL CENTER",null,null,null,null,null,null,"3333 Burnet Ave",null,"Cincinnati","OH","45229","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","INFLAMMATION AND  IMMUNOLOGY","DUPIXENT","0024-5914-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,152901.0,"2021-04-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE)","No","793086329","2021","06/30/2022","NCT03633617",null,null],["NEW","Covered Recipient Teaching Hospital",null,100151,10818,"MAYO CLINIC FLORIDA",null,null,null,null,null,null,"4500 SAN PABLO RD S",null,"JACKSONVILLE","FL","32224","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",439558,1679737563,"IVAN","E","PORTER","JR.","4500 SAN PABLO RD S",null,"JACKSONVILLE","FL","32224","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"GlaxoSmithKline, LLC.",100000005449,"GlaxoSmithKline, LLC.","NC","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2547.5,"2021-03-03","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P","No","809534933","2021","06/30/2022",null,null,"HCP did not receive direct payment from GSK. HCP was listed as the Primary Investigator in accordance with the Sunshine Act requirements."],["NEW","Covered Recipient Teaching Hospital",null,230046,10547,"Univ Of Mi Hospitals & Hlth Ctrs",null,null,null,null,null,null,"1500 EAST MEDICAL CENTER DRIVE",null,"ANN ARBOR","MI","48109","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1261230,1568607653,"TYCEL","J.","PHILLIPS",null,"1500 E MEDICAL CENTER DR",null,"ANN ARBOR","MI","48109","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,390.0,"2021-11-19","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 2, Open Label, 2 Cohort Study of INCB050465, a PI3Kd Inhibitor, in Subjects With Relapsed or Refractory Marginal Zone Lymphoma With or Without Prior Exposure to a BTK Inhibitor, CITADEL 204","No","831063545","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Teaching Hospital",null,223302,9992,"Childrens Hospital Corporation",null,null,null,null,null,null,"300 LONGWOOD AVE","PATIENT FINANCIAL SERVICES ATN STEVEN NICOLL","BOSTON","MA","02115","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Bristol Myers Squibb Company",100000005499,"E.R. Squibb & Sons, L.L.C.","NJ","United States","Yes","Covered","Biological","Immunology","ORENCIA","0003-2187-10",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,271980.0,"2021-07-06","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A RANDOMIZED DOUBLE-BLIND TRIAL OF ABATACEPT EXTENDED DOSING VERSUS ABATACEPT SHORT-TERM DOSING FOR GRAFT VERSUS HOST DISEASE PROPHYLAXIS ABA3","No","819888563","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,140150,10495,"BOARD OF TRUSTEES OF THE UNIVERSITY",null,null,null,null,null,null,"1740 W Taylor St","Mc 732","Chicago","IL","60612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",137803,1033270046,"VICTOR","R","GORDEUK",null,"820 S WOOD ST","SICKLE CELL CTR SUITE 172 CLINICAL SCIENCES BUILDING","CHICAGO","IL","60612-4325","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.","IL","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2216.0,"2021-10-25","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 1/2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, ASCENDING DOSE, SAFETY AND PK/PD STUDY OF SHP655 (RADAMTS13) IN SICKLE CELL DISEASE AT BASELINE HEALTH AND DURING ACUTE VASO-OCCLUSIVE CRISIS","No","816649317","2021","06/30/2022","NCT03997760",null,null],["NEW","Covered Recipient Teaching Hospital",null,330285,10135,"Strong Memorial Hospital",null,null,null,null,null,null,"601 ELMWOOD AVE","BOX 684","ROCHESTER","NY","14642","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",904734,1023280906,"JESSICA","F.","ROBB",null,"1351 Mount Hope Ave Ste 116",null,"Rochester","NY","14620","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Sanofi and Genzyme US Companies",100000000297,"GENZYME CORPORATION","MA","United States","Yes","Covered","Biological","Neurology","LEMTRADA","58468-0200-1",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,909.0,"2021-04-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Prospective 24-Month Observational Study of Neurocognitive Function and Safety in Patients with Relapsing Multiple Sclerosis Who Are Initiating LEMTRADA Treatment","No","838664441","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,440039,10425,"VANDERBILT UNIVERSITY MEDICAL CENTER",null,null,null,null,null,null,"1211 Medical Center Drive",null,"Nashville","TN","37232","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",340977,1508801556,"JEFFREY","L","NEUL",null,"2200 CHILDREN'S WAY","SUITE 30330","NASHVILLE","TN","37232","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"ACADIA Pharmaceuticals Inc",100000141529,"ACADIA Pharmaceuticals Inc","CA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,6426.0,"2021-11-29","Cash or cash equivalent",null,null,null,null,null,null,"No","No","ACP-2566-004","No","837697047","2021","06/30/2022","NCT04279314",null,null],["NEW","Covered Recipient Teaching Hospital",null,190036,10978,"OCHSNER CLINIC FOUNDATION",null,null,null,null,null,null,"1516 Jefferson Hwy",null,"New Orleans","LA","70121","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",52540,1154639839,"SARAVANAN",null,"THIAGARAJAN",null,"9001 SUMMA AVE",null,"BATON ROUGE","LA","70809-3726","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"LA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"ABBVIE INC.",100000000204,"ABBVIE INC.","IL","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,80.0,"2021-09-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 3, Randomized, Active-Controlled, Double Blind Study Comparing Upadacitinib (ABT-494) to Abatacept in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or Intolerance to Biologic DMARDs (bDMARDs) on Stable Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs (csDMARDs)","No","792395781","2021","06/30/2022","NCT03086343",null,"M15-925"],["NEW","Covered Recipient Physician",null,null,null,null,357629,1881743748,"REGINA","R.","BERKOVICH",null,"8727 Beverly Blvd, Ste B",null,"West Hollywood","CA","90048","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"EMD Serono, Inc.",100000000127,"EMD Serono, Inc.","MA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,23601.6,"2021-05-25","Cash or cash equivalent",null,null,null,null,null,null,"No","No","MS200527_0082","No","842924517","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,223302,9992,"Childrens Hospital Corporation",null,null,null,null,null,null,"300 LONGWOOD AVE","PATIENT FINANCIAL SERVICES ATN STEVEN NICOLL","BOSTON","MA","02115","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Sanofi and Genzyme US Companies",100000000297,"GENZYME CORPORATION","MA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,187.5,"2021-08-23","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Pompe LSD Data Registry","No","838665143","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,380009,11212,"OHSU HOSPITAL AND CLINICS",null,null,null,null,null,null,"3181 SW Sam Jackson Park Rd",null,"Portland","OR","97239","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",237710,1235160011,"ADDA",null,"GRIMBERG",null,"3500 CIVIC CENTER BLVD",null,"PHILADELPHIA","PA","19104","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","CARDIOVASCULAR","VYNDAQEL","0069-8729-55",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,76595.2,"2021-03-19","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PRACTICAL STRATEGIES TO SCREEN FOR TRANSTHYRETIN AMYLOID CARDIOMYOPATHY IN PATIENTS WITH AORTIC STENOSIS","No","832765653","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,490046,10737,"Sentara Leigh Hospital",null,null,null,null,null,null,"830 KEMPSVILLE RD",null,"NORFOLK","VA","23502","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",79249,1760451611,"DEEPAK","R.","TALREJA",null,"3241 WESTERN BRANCH BLVD",null,"CHESAPEAKE","VA","23321","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Orsiro",null,"07640130455948",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,213.75,"2021-04-13","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIOFLOW-V","No","843821649","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,235443,1194794602,"DEBASISH",null,"TRIPATHY",null,"1515 HOLCOMBE BLVD","1354","HOUSTON","TX","77030","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","IBRANCE","0069-0187-21",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,330.0,"2021-02-03","In-kind items and services",null,null,null,null,null,null,"No","No","PALBOCICLIB CLINICAL PUBLICATION PROGRAM","No","832503547","2021","06/30/2022",null,null,"No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication."],["NEW","Covered Recipient Teaching Hospital",null,220071,9988,"Massachusetts General Hospital",null,null,null,null,null,null,"55 FRUIT ST","BULFINCH 360","BOSTON","MA","02114","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1394077,1174848279,"ANAHITA",null,"DUA",null,"55 FRUIT ST",null,"BOSTON","MA","02114","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Haemonetics Corporation",100000000340,"Haemonetics Corporation","MA","United States","Yes","Covered","Device","Devices","TEG6s HEMOSTASIS SYSTEM",null,"30812747018351",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,289.32,"2021-12-31","In-kind items and services",null,null,null,null,null,null,"No","No","Utilization of Thromboelastography to Predict Arterial Thromboembolic Events in Revascularized Trauma and Peripheral Vascular Disease Patients","No","839385309","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,1180072,1700024494,"RISH",null,"PAI",null,"13400 E SHEA BLVD",null,"SCOTTSDALE","AZ","85259-5452","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pathology|Clinical Pathology/Laboratory Medicine",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"ABBVIE INC.",100000000204,"ABBVIE INC.","IL","United States","Yes","Covered","Biological","IMMUNOLOGY","SKYRIZI","0074-2042-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4200.0,"2021-07-29","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Assess the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Crohns Disease Who Failed Prior Biologic Treatment","No","792404599","2021","06/30/2022","NCT03104413",null,"M15-991"],["NEW","Covered Recipient Physician",null,null,null,null,349209,1689687147,"WILLIAM","F","WILEY",null,"2740 CARNEGIE AVE",null,"CLEVELAND","OH","44115","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Ophthalmology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"RxSight Inc",100000676811,"RxSight Inc","CA","United States","Yes","Covered","Device","Ophthalmology","LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1945.0,"2021-06-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS OF THE RXSIGHT LIGHT ADJUSTABLE LENS (LAL) IN SUBJECTS DESIRING AN EXTENDED DEPTH OF FOCUS","No","854610495","2021","06/30/2022","NCT04177771",null,"Evaluate, for the visual correction of aphakia and presbyopia, the safety and effectiveness of the RxSight Light Adjustable Lens (LAL) to provide an extended depth of focus (improve intermediate and near visual acuity without compromising distance visual acuity) in subjects who have undergone bilateral implantation with the LAL and subsequent light treatments for refractive and presbyopia correction (LAL group)."],["NEW","Covered Recipient Teaching Hospital",null,160058,10604,"University Of Iowa Hosp & Clinics",null,null,null,null,null,null,"200 HAWKINS DR",null,"IOWA CITY","IA","52242","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",77182,1710172515,"ALEXANDER",null,"MAZUR",null,"200 HAWKINS DR",null,"IOWA CITY","IA","52242","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"IA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Solia",null,"04035479118266","Covered","Device","Cardiology/Vascular Diseases","Plexa",null,"04035479140014","Covered","Device","Cardiology/Vascular Diseases","Rivacor",null,"04035479156794","Covered","Device","Cardiology/Vascular Diseases","Sentus",null,4035479148942,"Covered","Device","Cardiology/Vascular Diseases","Acticor",null,4035479156701,25.2,"2021-07-13","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIO-LIBRA","No","843822391","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500005,11179,"Virginia Mason Medical Center",null,null,null,null,null,null,"925 Seneca Street","1930","Seattle","WA","98111","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",830279,1407902083,"SARA","O","WEISS",null,"1100 9TH AVE",null,"SEATTLE","WA","98101-2756","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Boehringer Ingelheim USA, Inc.",100000005541,"Boehringer Ingelheim International GmbH",null,"Germany","Yes","Covered","Drug","DIABETES","JARDIANCE","0597-0152-30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,22.72,"2021-01-05","In-kind items and services",null,null,null,null,null,null,"No","No","Empagliflozin and heart failure (HFpEF)","No","828340685","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,360180,10373,"Cleveland Clinic Hospital",null,null,null,null,null,null,"9500 EUCLID AVE",null,"CLEVELAND","OH","44195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",906598,1093743718,"DILEEP","RAVI","NAIR",null,"9500 EUCLID AVE",null,"CLEVELAND","OH","44195-0001","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"NEUROPACE, INC.",100000010697,"NEUROPACE, INC.","CA","United States","Yes","Covered","Device","Epilepsy","RNS System",null,"00855547005267",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,50.0,"2021-04-05","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Approval Study","No","851399621","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,450076,11031,"Ut Md Anderson Cancer Center",null,null,null,null,null,null,"1515 Holcombe Blvd",null,"Houston","TX","77030","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",3085405,1578981221,"PREETESH",null,"JAIN",null,"C 1515 Holcombe Blvd",null,"Houston","TX","77030","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BeiGene, Ltd.",100000826833,"BeiGene, Ltd.",null,"Cayman Islands","Yes","Covered","Drug","Oncology","BRUKINSA","72579-011-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,15032.32,"2021-04-13","In-kind items and services",null,null,null,null,null,null,"No","No","Phase 3 Randomized, Open -Label, Multicenter Study Comparing Zanubrutinib (BGB-3111) plus Rituximab Versus Bendamustine plus Rituximab in Patients with Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation","No","843878745","2021","06/30/2022","NCT04002297",null,null],["NEW","Covered Recipient Teaching Hospital",null,140119,10441,"Rush University Medical Center",null,null,null,null,null,null,"1653 W CONGRESS PKWY",null,"CHICAGO","IL","60612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",318704,1013996701,"FRANK",null,"PHILLIPS",null,"1611 W HARRISON ST",null,"CHICAGO","IL","60612-4861","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Orthopaedic Surgery",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"NuVasive, Inc.",100000010655,"NuVasive, Inc.","CA","United States","Yes","Covered","Device","Spine/Spine Surgery","XLIF",null,"00887517804112",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,8625.53,"2021-08-03","Cash or cash equivalent",null,null,null,null,null,null,"No","No","NUVA.X1801: A Prospective Multicenter Study Evaluating the Effect of Implant Material and/or Surface Structure on Progression of Fusion in XLIF?? Surgery","No","853300725","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500008,11198,"University Of Washington Med Ctr",null,null,null,null,null,null,"1959 NE PACIFIC ST",null,"SEATTLE","WA","98195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",844023,1891750808,"ELENA","GABRIELA","CHIOREAN",null,"1959 NE Pacific St Fl 3",null,"Seattle","WA","98195","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"IN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Bristol Myers Squibb Company",100000005499,"E.R. Squibb & Sons, L.L.C.","NJ","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,7451.5,"2021-04-12","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Phase II Nivo Combo - Advanced Pancreatic Cancer","No","819882577","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,490009,10745,"University Of Virginia Medical Cente",null,null,null,null,null,null,"1215 LEE ST PFS",null,"CHARLOTTESVILLE","VA","22908","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",601536,1376609610,"MICHAEL",null,"RAGOSTA",null,"1215 LEE ST",null,"CHARLOTTESVILLE","VA","22908","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"VA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Linoxsmart",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,471.25,"2021-03-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIOFLOW-VII","No","843830181","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,845647,1942337670,"KATHARINE",null,"BAR",null,"3400 SPRUCE STREET","8 PENN TOWER","PHILADELPHIA","PA","19104-4206","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,151.08,"2021-09-10","In-kind items and services",null,null,null,null,null,null,"No","No","A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ASSESSING THE EFFICACY AND SAFETY OF ANTI-SPIKE SARS-COV-2 MONOCLONAL ANTIBODIES IN PREVENTING SARS-COV-2 INFECTION IN HOUSEHOLD CONTACTS OF INDIVIDUALS INFECTED WITH SARS-COV-2","No","793081347","2021","06/30/2022","NCT04452318",null,"The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication."],["NEW","Covered Recipient Teaching Hospital",null,360180,10373,"CLEVELAND CLINIC HOSPITAL",null,null,null,null,null,null,"9500 Euclid Ave",null,"Cleveland","OH","44195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",754264,1720131766,"DEEPA",null,"JAGADEESH",null,"119 BELMONT ST","DEPT OF HOSPITAL MEDICINE","WORCESTER","MA","01605-2903","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4375.42,"2021-10-14","Cash or cash equivalent",null,null,null,null,null,null,"No","No","AN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND SAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA","No","793086585","2021","06/30/2022","NCT03888105",null,null],["NEW","Covered Recipient Teaching Hospital",null,50180,11269,"John Muir Medical Center - Wc",null,null,null,null,null,null,"1601 Ygnacio Valley Rd",null,"Walnut Creek","CA","94598","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",703467,1942249388,"BABAK",null,"EDRAKI",null,"1479 YGNACIO VALLEY RD STE 100",null,"WALNUT CREEK","CA","94598","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Obstetrics & Gynecology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AstraZeneca Pharmaceuticals LP",100000000146,"AstraZeneca Pharmaceuticals LP","DE","United States","Yes","Covered","Drug","Oncology","LYNPARZA","0310-0657-58",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,70.82,"2021-12-31","In-kind items and services",null,null,null,null,null,null,"No","No","\"\"\";A Phase III"," Randomised"," Double Blind"," Placebo Controlled"," Multicentre Study of Olaparib Maintenance Monotherapy in Patients with a germline BRCA mutation and Stage III-IV Ovarian Cancer who are in Complete or Partial Response Following First Line Platinum Based Chemotherapy\\\"\";\"","No","826485917","2021"],["NEW","Covered Recipient Teaching Hospital",null,340001,10755,"Carolinas Healthcare System Northeas",null,null,null,null,null,null,"920 CHURCH ST N",null,"CONCORD","NC","28025","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",332827,1326151424,"JOHN","D.","SYMANSKI",null,"1237 Harding Pl Ste 3100",null,"Charlotte","NC","28204","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Bristol Myers Squibb Company",100000005499,"E.R. Squibb & Sons, L.L.C.","NJ","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,24821.77,"2021-03-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM","No","819888869","2021","06/30/2022","NCT03723655",null,null],["NEW","Covered Recipient Teaching Hospital",null,70036,10025,"John Dempsey Hospital",null,null,null,null,null,null,"263 Farmington Avenue",null,"Farmington","CT","06030","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",533924,1982868550,"ALEX",null,"MERKULOV",null,"168 CENTRAL LN",null,"SECAUCUS","NJ","07094","United States",null,null,"Doctor of Osteopathy",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology",null,null,null,null,null,"CT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"GUERBET LLC",100000010729,"GUERBET LLC","NJ","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,21226.0,"2021-01-28","Cash or cash equivalent","Patient Care",null,null,null,null,null,"No","No","Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)","No","842725345","2021","06/30/2022","NCT03986138",null,null],["NEW","Covered Recipient Teaching Hospital",null,330240,10077,"HARLEM HOSPITAL CENTER",null,null,null,null,null,null,"506 Malcolm X Blvd","Onr Room 101","New York","NY","10037","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",394616,1114011285,"VIDYA","P","MENON",null,"1717 S J ST",null,"TACOMA","WA","98405-4933","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,48047.61,"2021-01-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A MASTER PROTOCOL ASSESSING THE SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-SPIKE (S) SARS-COV-2 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF HOSPITALIZED PATIENTS WITH COVID-19","No","793086845","2021","06/30/2022","NCT04426695",null,null],["NEW","Covered Recipient Teaching Hospital",null,100007,10819,"ADVENTHEALTH ORLANDO",null,null,null,null,null,null,"601 E Rollins St",null,"Orlando","FL","32803","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",306919,1770576258,"CARLOS","A","ALEMANY",null,"2501 N ORANGE AVE","2501 N ORANGE AVE","ORLANDO","FL","32804-4603","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Merck Sharp & Dohme Corporation",100000000053,"Merck Sharp & Dohme Corporation","NJ","United States","Yes","Covered","Biological","ONCOLOGY","KEYTRUDA","0006-3029-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,8750.0,"2021-06-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase III, Randomized, Double-blind, Matching Placebo-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab MK-3475 in Combination With Chemoradiotherapy CRT versus CRT Alone in Participants with Muscle-invasive Bladder Cancer MIBC KEYNOTE-992","No","848750019","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50625,11293,"Cedars-Sinai Medical Center",null,null,null,null,null,null,"8700 Beverly Blvd",null,"West Hollywood","CA","90048","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",625711,1225100183,"PETER",null,"CHEN",null,"11311 BRIDGEPORT WAY SW",null,"LAKEWOOD","WA","98499","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Gilead Sciences, Inc.",100000000108,"Gilead Sciences, Inc.","CA","United States","Yes","Covered","Drug","COVID-19","Veklury","61958-2901-2",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,7692.0,"2021-08-16","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 1b/2a study in A Phase 1b/2a Study in Participants with Early Stage COVID-19 to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation","No","803513543","2021","06/30/2022",null,null,";GS-US-553-9020;G2760872;IPP;951644600;10601013"],["NEW","Covered Recipient Teaching Hospital",null,500044,11187,"Deaconess Medical Center",null,null,null,null,null,null,"800 W 5th Ave",null,"Spokane","WA","99204","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",19189,1437178266,"DANIEL",null,"COULSTON",null,"910 W 5TH AVE STE 1001",null,"SPOKANE","WA","99204","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Gilead Sciences, Inc.",100000000108,"Gilead Sciences, Inc.","CA","United States","Yes","Covered","Drug","COVID-19","Veklury","61958-2901-2",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,18864.0,"2021-05-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Remdesivir in Participants with Severely Reduced Kidney Function who are Hospitalized for COVID-19","No","803513799","2021","06/30/2022",null,null,";GS-US-540-5912;G2757529;GILDA;911352172;10049437"],["NEW","Covered Recipient Teaching Hospital",null,310019,10183,"St. Josephs University Medical Cent",null,null,null,null,null,null,"703 MAIN ST",null,"PATERSON","NJ","07503","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Sanofi and Genzyme US Companies",100000000297,"GENZYME CORPORATION","MA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,850.0,"2021-08-23","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Gaucher LSD Data Registry","No","838667105","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,390111,10224,"Hospital Of The Univ Of Penna",null,null,null,null,null,null,"3701 Market St",null,"Phila","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",271387,1992848519,"KUCHIKULA","RAJENDER","REDDY",null,"3400 SPRUCE ST FL 3",null,"PHILADELPHIA","PA","19104","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Gilead Sciences, Inc.",100000000108,"Gilead Sciences, Inc.","CA","United States","Yes","Covered","Drug","HCV","Harvoni","61958-1801-1",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4044.0,"2021-08-23","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Long Term Follow-up Registry for Subjects with Cirrhosis Who Achieve a Sustained Virologic Response to Treatment for HCV Infection in Gilead-Sponsored Trials","No","803514055","2021","06/30/2022",null,null,";GS-US-337-1431;G2759861;GILDA;231352685;10077792"],["NEW","Covered Recipient Teaching Hospital",null,50262,11328,"Ronald Reagan Ucla",null,null,null,null,null,null,"757 Westwood Plz",null,"Los Angeles","CA","90095","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",6760,1144373739,"GEOFFREY","PHILIP","COLBY",null,"300 MEDICAL PLAZA",null,"LOS ANGELES","CA","90095","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Neurological Surgery",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Penumbra, Inc.",100000010583,"Penumbra, Inc.","CA","United States","Yes","Covered","Device","Neurosurgery","Artemis",null,"00814548017877",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4000.0,"2021-11-04","Cash or cash equivalent",null,null,null,null,null,null,"No","No","MIND","No","840456285","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,223302,9992,"CHILDRENS HOSPITAL CORPORATION",null,null,null,null,null,null,"300 Longwood Ave","Patient Financial Services Atn Steven Nicoll","Boston","MA","02115","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1023620,1184980864,"LISSETTE",null,"JIMENEZ",null,"300 LONGWOOD AVE",null,"BOSTON","MA","02115","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.","IL","United States","Yes","Covered","Drug","INTERNAL MEDICINE","GATTEX","68875-0101-2",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,659343.48,"2021-11-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","CLINICAL USE OF TEDUGLUTIDE IN CHILDREN WITH SHORT BOWEL SYNDROME: A MULTI-CENTER POST-MARKETING EVALUATION","No","816651623","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,340130,10756,"Carolinas Healthcare System Union",null,null,null,null,null,null,"600 HOSPITAL DR",null,"MONROE","NC","28112","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",997485,1275557571,"SHERRY","JOUEI","SAXONHOUSE",null,"100 MEDICAL PARK DR STE 210",null,"CONCORD","NC","28025","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Solia",null,"04035479118266","Covered","Device","Cardiology/Vascular Diseases","Plexa",null,"04035479140014","Covered","Device","Cardiology/Vascular Diseases","Rivacor",null,"04035479156794","Covered","Device","Cardiology/Vascular Diseases","Sentus",null,4035479148942,"Covered","Device","Cardiology/Vascular Diseases","Acticor",null,4035479156701,217.14,"2021-02-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIO-LIBRA","No","843805635","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,833679,1528160199,"ANDREW","J","ARMSTRONG",null,"DUKE UNIVERSITY MED CTR",null,"DURHAM","NC","27710","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","XTANDI","0469-0125-99",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,940.0,"2021-02-13","In-kind items and services",null,null,null,null,null,null,"No","No","ENZALUTAMIDE CLINICAL PUBLICATION PROGRAM","No","832505018","2021","06/30/2022",null,null,"No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication."],["NEW","Covered Recipient Teaching Hospital",null,420004,10780,"MEDICAL UNIVERSITY OF SOUTH CAROLINA",null,null,null,null,null,null,"169 ASHLEY AVE",null,"CHARLESTON","SC","29403","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",10635,1245223452,"RICHARD","JOEL","FRIEDMAN",null,"171 ASHLEY AVE",null,"CHARLESTON","SC","29425-8908","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Orthopaedic Surgery|Adult Reconstructive Orthopaedic Surgery",null,null,null,null,null,"SC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"EXACTECH, INC.",100000010981,"EXACTECH, INC.","FL","United States","Yes","Covered","Device","ORTHOPAEDIC","ALTEON",null,"10885862549181",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1125.0,"2021-10-19","Cash or cash equivalent",null,null,null,null,null,null,"Yes","No",null,"No","852891909","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,450076,11031,"UT MD ANDERSON CANCER CENTER",null,null,null,null,null,null,"1515 Holcombe Blvd",null,"Houston","TX","77030","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",6525,1144470758,"HANS","CHULHEE","LEE",null,"1515 HOLCOMBE BLVD",null,"HOUSTON","TX","77030-4009","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.","IL","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,14343.75,"2021-05-11","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A GLOBAL, PROSPECTIVE, NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF PRESENTATION, TREATMENT PATTERNS, AND OUTCOMES IN MULTIPLE MYELOMA PATIENTS - THE INSIGHT - MM STUDY","No","816675537","2021","06/30/2022","NCT02761187",null,null],["NEW","Covered Recipient Teaching Hospital",null,360068,10396,"The Toledo Hospital",null,null,null,null,null,null,"2142 N COVE BLVD",null,"TOLEDO","OH","43606","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",70978,1568487726,"MARK",null,"RICHARDS",null,"2940 N MCCORD RD",null,"TOLEDO","OH","43615","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"ID",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Sentus",null,"04035479148942","Covered","Device","Cardiology/Vascular Diseases","Acticor",null,"04035479156701","Covered","Device","Cardiology/Vascular Diseases","Solia",null,"04035479118266","Covered","Device","Cardiology/Vascular Diseases","Rivacor",null,4035479156794,"Covered","Device","Cardiology/Vascular Diseases","Plexa",null,4035479140014,20.0,"2021-03-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIO-LIBRA","No","843823011","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,801942,1417078221,"NEERAJ",null,"AGARWAL",null,"2000 CIRCLE OF HOPE DR STE 5726",null,"SALT LAKE CITY","UT","84112","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"UT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","XTANDI","0469-0125-99",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,330.0,"2021-02-17","In-kind items and services",null,null,null,null,null,null,"No","No","ENZALUTAMIDE CLINICAL PUBLICATION PROGRAM","No","832506717","2021","06/30/2022",null,null,"No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication."],["NEW","Covered Recipient Physician",null,null,null,null,140212,1083662894,"ISAAC",null,"THOMAS",null,"3915 OGLESBY AVE",null,"GURNEE","IL","60031-3358","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"ABBVIE INC.",100000000204,"ABBVIE INC.","IL","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,72.0,"2021-01-14","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A First in Human, Single and Multiple Ascending Dose and Food Effect Study for the Assessment of Pharmacokinetics and Safety of ABBV-119","No","792405127","2021","06/30/2022",null,null,"M19-775"],["NEW","Covered Recipient Teaching Hospital",null,310015,10713,"Morristown Medical Center",null,null,null,null,null,null,"100 Madison Ave",null,"Morristown","NJ","07960","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",324458,1144218215,"CHARLES","M","FARBER",null,"100 Madison Ave",null,"Morristown","NJ","07960","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"NJ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BeiGene, Ltd.",100000826833,"BeiGene, Ltd.",null,"Cayman Islands","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,500.0,"2021-08-27","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Single-Arm, Expanded Access Study of Zanubrutinib (BGB-3111) in Patients with B-cell Malignancies","No","843874643","2021","06/30/2022","NCT04052854",null,null],["NEW","Covered Recipient Teaching Hospital",null,360180,10373,"Cleveland Clinic Hospital",null,null,null,null,null,null,"9500 EUCLID AVE",null,"CLEVELAND","OH","44195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",906598,1093743718,"DILEEP","RAVI","NAIR",null,"9500 EUCLID AVE",null,"CLEVELAND","OH","44195-0001","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"NEUROPACE, INC.",100000010697,"NEUROPACE, INC.","CA","United States","Yes","Covered","Device","Epilepsy","RNS System",null,"00855547005267",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,360.5,"2021-07-19","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Approval Study","No","851399729","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,60024,11137,"University Of Co Hospital",null,null,null,null,null,null,"100 COOK STREET, SUITE 204",null,"DENVER","CO","80206","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",667077,1659576163,"SARAH","L.","DAVIS",null,"1665 Aurora Ct",null,"Aurora","CO","80045","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"CO",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Bristol Myers Squibb Company",100000005499,"E.R. Squibb & Sons, L.L.C.","NJ","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1280.0,"2021-05-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Ph II Study Gastric 1L, multi-cohort all comers lag3 nivo","No","819882877","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,100088,10820,"BAPTIST MEDICAL CENTER",null,null,null,null,null,null,"800 PRUDENTIAL DR",null,"JACKSONVILLE","FL","32207","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",90104,1992017735,"JENNIFER","ANN","CROZIER",null,"1301 W PALM AVE","210","JACKSONVILLE","FL","32254","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000010364,"Roche Products Limited",null,"Great Britain (Uk)","Yes","Covered","Biological","BioOncology","TECENTRIQ","50242-917-01",null,"Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,154.0,"2021-12-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE III MULTICENTER RANDOMIZED OPEN LABEL STUDY COMPARING ATEZOLIZUMAB ANTI PD L1 ANTIBODY","No","835906647","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,314007,1932115425,"ANDREW",null,"BLAUVELT",null,"9495 SW LOCUST STREET","SUITE A","PORTLAND","OR","97223-6683","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"OR",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","INFLAMMATION AND  IMMUNOLOGY","DUPIXENT","0024-5914-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,251.4,"2021-10-04","In-kind items and services",null,null,null,null,null,null,"No","No","AN OPEN-LABEL STUDY OF DUPILUMAB IN PATIENTS WITH ATOPIC DERMATITIS WHO PARTICIPATED IN PREVIOUS DUPILUMAB CLINICAL TRIALS","No","793081603","2021","06/30/2022","NCT01949311",null,"The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication."],["NEW","Covered Recipient Teaching Hospital",null,500005,11179,"Virginia Mason Medical Center",null,null,null,null,null,null,"925 Seneca Street","1930","Seattle","WA","98111","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",830279,1407902083,"SARA","O","WEISS",null,"1100 9TH AVE",null,"SEATTLE","WA","98101-2756","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Boehringer Ingelheim USA, Inc.",100000005541,"Boehringer Ingelheim International GmbH",null,"Germany","Yes","Covered","Drug","DIABETES","JARDIANCE","0597-0152-30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,21.75,"2021-03-03","In-kind items and services",null,null,null,null,null,null,"No","No","Empagliflozin and heart failure (HFpEF)","No","828341197","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,140119,10441,"Rush University Medical Center",null,null,null,null,null,null,"1653 W Congress Pkwy",null,"Chicago","IL","60612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1209197,1710253992,"SEO-HYUN",null,"KIM",null,"1653 W CONGRESS PKWY","301 JONES","CHICAGO","IL","60612","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BeiGene, Ltd.",100000826833,"BeiGene, Ltd.",null,"Cayman Islands","Yes","Covered","Drug","Oncology","BRUKINSA","72579-011-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,56400.0,"2021-09-13","In-kind items and services",null,null,null,null,null,null,"No","No","Phase 3 Randomized, Open -Label, Multicenter Study Comparing Zanubrutinib (BGB-3111) plus Rituximab Versus Bendamustine plus Rituximab in Patients with Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation","No","843879483","2021","06/30/2022","NCT04002297",null,null],["NEW","Covered Recipient Teaching Hospital",null,190036,10978,"Ochsner Clinic Foundation",null,null,null,null,null,null,"1516 Jefferson Highway",null,"New Orleans","LA","70121","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",345054,1598958316,"MARC","R","MATRANA",null,"1514 JEFFERSON HIGHWAY",null,"NEW ORLEANS","LA","70121","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"LA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eisai Inc.",100000000136,"Eisai Inc.","NJ","United States","Yes","Covered","Drug","Oncology","Lenvima","62856-710-30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2084.11,"2021-01-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination With Everolimus or Pembrolizumab Versus Sunitinib Alone in First-Line Treatment of Subjects With Advanced Renal Cell Carcinoma (CLEAR)","No","836180651","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,310001,10178,"Hackensack University Medical Center",null,null,null,null,null,null,"30 PROSPECT AVE",null,"HACKENSACK","NJ","07601","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",184727,1063489243,"BINDU",null,"BALANI",null,"20 Prospect Ave Ste 507",null,"Hackensack","NJ","07601","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"NJ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Moderna TX, Inc.",100000961851,"Moderna TX, Inc.","MA","United States","Yes","Covered","Biological","Infections and Infectious Diseases","Moderna Covid-19 Vaccine","80777-273-99",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,32705.7,"2021-07-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older","No","806335389","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,220086,9982,"Beth Israel Deaconess Medical Center",null,null,null,null,null,null,"330 BROOKLINE AVE","ST 207","BOSTON","MA","02215","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Bristol Myers Squibb Company",100000005499,"E.R. Squibb & Sons, L.L.C.","NJ","United States","Yes","Covered","Biological","Oncology","OPDIVO","0003-3774-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,59109.0,"2021-10-27","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Treatment Free Interval Melanoma","No","819889177","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,914590,1366754954,"ALAN","P.","ZAUSNER SKARBNIK",null,"125 QUEENS RD","250","CHARLOTTE","NC","28204","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"NC","NJ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000005656,"F. Hoffmann-La Roche AG",null,"Switzerland","Yes","Covered","Biological","Immunology","Actemra","50242-137-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,417.86,"2021-06-29","In-kind items and services",null,null,null,null,null,null,"No","No","TOCILIZUMAB AND REMDESIVIR IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA A RANDOMIZED CLINICAL TRIAL","No","835897265","2021","06/30/2022",null,null,"Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician"],["NEW","Covered Recipient Physician",null,null,null,null,276270,1083614879,"ILEANA","JOSEFINA","TANDRON",null,"2240 GAUSE BLVD E",null,"SLIDELL","LA","70461","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"LA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,26.5,"2021-07-19","In-kind items and services",null,null,null,null,null,null,"No","No","EX9924-4473","No","811761853","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,440039,10425,"Vanderbilt University Medical Center",null,null,null,null,null,null,"1211 Medical Center Drive",null,"Nashville","TN","37232","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",35427,1790736759,"JOSHUA","A","BECKMAN",null,"2200 PIERCE AVE",null,"NASHVILLE","TN","37232","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"MA","TN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","Ozempic","0169-4132-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3.05,"2021-04-30","In-kind items and services",null,null,null,null,null,null,"No","No","NN9535-4533","No","811865225","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,390111,10224,"HOSPITAL OF THE UNIV OF PENNA",null,null,null,null,null,null,"3701 Market St",null,"Phila","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",104812,1316979610,"DANIEL","J","RADER",null,"3400 CIVIC CENTER BLVD","EAST PAVILION 2ND FLOOR","PHILADELPHIA","PA","19104","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","CARDIOVASCULAR AND METABOLISM","EVKEEZA","61755-010-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,49275.0,"2021-07-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF SAFETY AND EFFICACY, FOLLOWING REPEAT-DOSE ADMINISTRATION OF EVINACUMAB (ANTI-ANGPTL3) IN PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA (SHTG) AT RISK FOR ACUTE PANCREATITIS","No","793087101","2021","06/30/2022","NCT03452228",null,null],["NEW","Covered Recipient Physician",null,null,null,null,116924,1598704371,"BRADLEY","N","HINES",null,"3445 POPLAR AVE","SUITE 7","MEMPHIS","TN","38111-4667","United States",null,null,"Doctor of Optometry",null,null,null,null,null,"Eye and Vision Services Providers|Optometrist",null,null,null,null,null,"TN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alcon Research LLC",100000000218,"Alcon Research LLC","TX","United States","Yes","Covered","Device","Ophthamology","TOTAL 30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,511.2,"2021-11-12","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Clinical Assessment of Two Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lenses","No","807671461","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50625,11293,"Cedars-Sinai Medical Center",null,null,null,null,null,null,"8700 Beverly Blvd",null,"West Hollywood","CA","90048","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",294911,1508959800,"HOWARD","M","SANDLER",null,"8700 BEVERLY BLVD",null,"WEST HOLLYWOOD","CA","90048","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","XTANDI","0469-0125-99",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1000.0,"2021-01-25","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A RANDOMIZED PHASE II TRIAL OF SALVAGE RADIOTHERAPY WITH STANDARD VS ENHANCED ANDROGEN DEPRIVATION THERAPY WITH ENZALUTAMIDE IN PATIENTS WITH POSTPROSTATECTOMY PSA RECURRENCES WITH AGGRESSIVE DISEASE FEATURES","No","832769239","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,160058,10604,"University Of Iowa Hosp & Clinics",null,null,null,null,null,null,"200 HAWKINS DR",null,"IOWA CITY","IA","52242","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Sanofi and Genzyme US Companies",100000000297,"GENZYME CORPORATION","MA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,32350.5,"2021-09-13","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Fabry LSD Data Registry","No","838667611","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,240115,10464,"Mercy Hospital",null,null,null,null,null,null,"3960 Coon Rapids Blvd Nw Ste 220",null,"Coon Rapids","MN","55433","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",81430,1801872502,"MICHAELA","L","TSAI",null,"910 E 26TH ST STE 100200",null,"MINNEAPOLIS","MN","55404","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Gilead Sciences, Inc.",100000000108,"Gilead Sciences, Inc.","CA","United States","Yes","Covered","Drug","ONC","Trodelvy","55135-132-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4608.9,"2021-10-12","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Phase III Study of Sacituzumab Govitecan (IMMU-132) in Refractory/Relapsed Triple-Negative Breast Cancer","No","803514313","2021","06/30/2022",null,null,";IMMU-132-05;G2799457;CLINENT;363261413;10223249"],["NEW","Covered Recipient Teaching Hospital",null,70034,10026,"Norwalk Hospital",null,null,null,null,null,null,"34 Maple St",null,"Norwalk","CT","06856","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",234804,1174515803,"RICHARD",null,"FRANK",null,"40 CROSS ST","4TH FL","NORWALK","CT","06851","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"CT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"EMD Serono, Inc.",100000000127,"EMD Serono, Inc.","MA","United States","Yes","Covered","Drug","Oncology","Bavencio","44087-3535-1",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,52.0,"2021-04-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","MS100070_0176","No","842928265","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,150113,10414,"Community Hospital Anderson",null,null,null,null,null,null,"1515 N Madison Ave",null,"Anderson","IN","46011","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",102864,1275552481,"WA'EL",null,"BAKDASH",null,"1515 S MADISON AVE",null,"ANDERSON","IN","46016","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"IN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Non-Covered","Drug","Diabetes",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,28.45,"2021-06-24","In-kind items and services",null,null,null,null,null,null,"No","No","EX9536-4388","No","811332325","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,360180,10373,"Cleveland Clinic Hospital",null,null,null,null,null,null,"9500 Euclid Ave",null,"Cleveland","OH","44195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",41807,1922293547,"KEVIN","M","PANTALONE",null,"29800 BAINBRIDGE RD","# SO40","SOLON","OH","44139","United States",null,null,"Doctor of Osteopathy",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2844.89,"2021-06-28","Cash or cash equivalent",null,null,null,null,null,null,"No","No","EX9924-4473","No","811406733","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,340130,10756,"Carolinas Healthcare System Union",null,null,null,null,null,null,"600 HOSPITAL DR",null,"MONROE","NC","28112","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",997485,1275557571,"SHERRY","JOUEI","SAXONHOUSE",null,"100 MEDICAL PARK DR STE 210",null,"CONCORD","NC","28025","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Rivacor",null,"04035479156794","Covered","Device","Cardiology/Vascular Diseases","Plexa",null,"04035479140014","Covered","Device","Cardiology/Vascular Diseases","Sentus",null,"04035479148942","Covered","Device","Cardiology/Vascular Diseases","Solia",null,4035479118266,"Covered","Device","Cardiology/Vascular Diseases","Acticor",null,4035479156701,276.89,"2021-12-14","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIO-LIBRA","No","843805891","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,400016,10952,"Auxilio Mutuo Hospital",null,null,null,null,null,null,"Ponce De Leon","191227","San Juan","PR","00919","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",728419,1811052707,"FERNANDO",null,"CABANILLAS",null,"725 PONCE DE LEON","PARADA 37","SAN JUAN","PR","00918","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"PR",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eisai Inc.",100000000136,"Eisai Inc.","NJ","United States","Yes","Covered","Drug","Oncology","Ontak","62856-603-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,847.36,"2021-05-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Clinical Study to Demonstrate Safety and Efficacy of E7777 (Denileukin Diftitox) in Persistent or Recurrent Cutaneous T-Cell Lymphoma","No","836179271","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,360180,10373,"Cleveland Clinic Hospital",null,null,null,null,null,null,"9500 Euclid Ave",null,"Cleveland","OH","44195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",41807,1922293547,"KEVIN","M","PANTALONE",null,"29800 BAINBRIDGE RD","# SO40","SOLON","OH","44139","United States",null,null,"Doctor of Osteopathy",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,900.0,"2021-03-10","In-kind items and services",null,null,null,null,null,null,"No","No","EX9924-4473","No","811588807","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,390028,10267,"Upmc Mercy Hospital",null,null,null,null,null,null,"1400 Locust St",null,"Pittsburgh","PA","15219","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",347278,1649242033,"SILVA","A","ARSLANIAN",null,"5230 CENTRE AVE","FL 2","PITTSBURGH","PA","15232","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,5.7,"2021-12-20","In-kind items and services",null,null,null,null,null,null,"No","No","NN9924-4437","No","811785299","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,276270,1083614879,"ILEANA","JOSEFINA","TANDRON",null,"2240 GAUSE BLVD E",null,"SLIDELL","LA","70461","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"LA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,7.95,"2021-03-08","In-kind items and services",null,null,null,null,null,null,"No","No","EX9924-4473","No","811812531","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,440039,10425,"VANDERBILT UNIVERSITY MEDICAL CENTER",null,null,null,null,null,null,"1211 Medical Center Drive",null,"Nashville","TN","37232","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",193914,1265551295,"SARA","NICOLE","HORST",null,"1211 21ST AVE S","SUITE 210","NASHVILLE","TN","37212-2717","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.","IL","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2000.0,"2021-01-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 3B OPEN-LABEL STUDY TO DETERMINE THE LONG-TERM SAFETY AND EFFICACY OF VEDOLIZUMAB SUBCUTANEOUS IN SUBJECTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE","No","816676017","2021","06/30/2022","NCT02620046",null,null],["NEW","Covered Recipient Physician",null,null,null,null,274057,1033132097,"VICENTA",null,"SALANOVA",null,"550 UNIVERSITY BLVD",null,"INDIANAPOLIS","IN","46202-5149","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"IN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"NEUROPACE, INC.",100000010697,"NEUROPACE, INC.","CA","United States","Yes","Covered","Device","Epilepsy","RNS System",null,"00855547005267",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,530.0,"2021-07-04","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Approval Study","No","851398247","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,310015,10713,"Morristown Medical Center",null,null,null,null,null,null,"100 Madison Ave",null,"Morristown","NJ","07960","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",332771,1336113653,"LAWRENCE","A","SILVERMAN",null,"100 MADISON AVE",null,"MORRISTOWN","NJ","07960","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology",null,null,null,null,null,"NJ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,701.44,"2021-01-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","NN8640-4263","No","811862329","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,230053,10500,"HENRY FORD HOSPITAL",null,null,null,null,null,null,"2799 W Grand Blvd",null,"Detroit","MI","48202","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",215472,1750434114,"PETER","A","LE WITT",null,"6777 W MAPLE RD",null,"WEST BLOOMFIELD","MI","48322-3013","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Amneal Pharmaceuticals LLC",100000126368,"Amneal Pharmaceuticals LLC","NJ","United States","Yes","Covered","Drug","NEUROLOGY","CARBIDOPA AND LEVODOPA","0378-0085-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1546.87,"2021-04-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in Parkinson's Disease Patients With Motor Fluctuations","No","830757643","2021","06/30/2022","NCT03670953",null,null],["NEW","Covered Recipient Teaching Hospital",null,500008,11198,"University Of Washington Med Ctr",null,null,null,null,null,null,"1959 NE PACIFIC ST",null,"SEATTLE","WA","98195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1143552,1386965952,"RYAN","CHRISTOPHER","LYNCH",null,"825 EASTLAKE AVE E",null,"SEATTLE","WA","98109","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Hospitalist",null,null,null,null,null,"MO",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,315.0,"2021-08-03","Cash or cash equivalent",null,null,null,null,null,null,"No","No","An Open Label, Randomized Study Comparing INCB050465 to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL 203)","No","831049973","2021","06/30/2022",null,null,"Transfer of value for editorial and or medical writing services. These services were funded by Incyte Corporation and paid to a third-party vendor to assist with the development of a publication at the direction of the authors. No payments were made directly to the authors for these editorial and or medical writing services."],["NEW","Covered Recipient Teaching Hospital",null,50180,11269,"JOHN MUIR MEDICAL CENTER - WC",null,null,null,null,null,null,"1601 YGNACIO VALLEY RD",null,"WALNUT CREEK","CA","94598","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",82179,1821073636,"GIGI","QIQI","CHEN",null,"400 TAYLOR BLVD",null,"PLEASANT HILL","CA","94523","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000010364,"Roche Products Limited",null,"Great Britain (Uk)","Yes","Covered","Biological","BioOncology","TECENTRIQ","50242-917-01",null,"Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,5845.5,"2021-08-16","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE III MULTICENTER RANDOMIZED OPEN LABEL STUDY COMPARING ATEZOLIZUMAB ANTI PD L1 ANTIBODY","No","835914227","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,1231721,1508944794,"RHONDA","M","BENTLEY-LEWIS",null,"50 STANIFORD ST",null,"BOSTON","MA","02114","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Non-Covered","Drug","Diabetes",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2720.0,"2021-06-16","Cash or cash equivalent",null,null,null,null,null,null,"No","No","NN9535-4352","No","811841043","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,227087,1013049188,"ANNE","L","CHANG",null,"300 PASTEUR DR",null,"STANFORD","CA","94305-2200","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","ONCOLOGY","LIBTAYO","61755-008-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,136.01,"2021-09-08","In-kind items and services",null,null,null,null,null,null,"No","No","LIBTAYO CLINICAL PUBLICATION PROGRAM","No","793081861","2021","06/30/2022",null,null,"The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication."],["NEW","Covered Recipient Teaching Hospital",null,300003,9970,"Mary Hitchcock Memorial Hosp",null,null,null,null,null,null,"ONE MEDICAL CENTER DR",null,"LEBANON","NH","03756","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",263383,1790876696,"BARBARA","C.","JOBST",null,"1 MEDICAL CENTER DR",null,"LEBANON","NH","03756-1000","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"NH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"NEUROPACE, INC.",100000010697,"NEUROPACE, INC.","CA","United States","Yes","Covered","Device","Epilepsy","RNS System",null,"00855547005267",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,15.0,"2021-02-01","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Approval Study","No","851399945","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,450076,11031,"Ut Md Anderson Cancer Center",null,null,null,null,null,null,"1515 Holcombe Blvd",null,"Houston","TX","77030","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",727133,1760701445,"AMISHI","Y","SHAH",null,"1515 HOLCOMBE BLVD",null,"HOUSTON","TX","77030-4009","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eisai Inc.",100000000136,"Eisai Inc.","NJ","United States","Yes","Covered","Drug","Oncology","Lenvima","62856-710-30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2773.0,"2021-03-31","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors","No","836180757","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,149687,1306872288,"CHRISTOPHER",null,"BUATTI",null,"2251 N SQUIRREL RD","SUITE 200","AUBURN HILLS","MI","48326","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"MI",null,null,null,null,"Covered Recipient Physician",282902,1245353366,"EMMY",null,"GRABER",null,"486 STUART ST, SUITE 404",null,"BOSTON","MA","02116","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"MA",null,null,null,null,"Covered Recipient Physician",269961,1962496265,"HILARY",null,"BALDWIN",null,"142 JORALEMON STREET, SUITE 800",null,"BROOKLYN","NY","11201","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Almirall LLC",100000011034,"Almirall LLC","PA","United States","Yes","Covered","Drug","Dermatology","Seysara","16110-247-30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4350.0,"2021-11-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES)","No","819668565","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500129,11189,"Tacoma General Allenmore Hospital",null,null,null,null,null,null,"315 MARTIN LUTHER KING JR WAY",null,"TACOMA","WA","98405","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1364649,1790014595,"ANURADHA","A.","BELUR",null,"121 N DIVISION ST",null,"AUBURN","WA","98001","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,13.42,"2021-04-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)","No","831066531","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Physician",null,null,null,null,122454,1710904172,"DARREN","D.","BRENNAN",null,"157 Union St",null,"Marlborough","MA","01752","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Bristol Myers Squibb Company",100000005499,"E.R. Squibb & Sons, L.L.C.","NJ","United States","Yes","Covered","Biological","Oncology","OPDIVO","0003-3774-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,5940.0,"2021-03-11","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Phase III Nivo Ipi vs Placebo in Adjuvant RCC","No","819889861","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,1167345,1245294206,"CRISTINE",null,"RADOJICIC",null,"1821 HILLANDALE RD",null,"DURHAM","NC","27705","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Allergy & Immunology",null,null,null,null,null,"NC","OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000005656,"F. Hoffmann-La Roche AG",null,"Switzerland","Yes","Covered","Biological","Immunology","Xolair","50242-040-62",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1331.11,"2021-05-18","In-kind items and services",null,null,null,null,null,null,"No","No","RETROSPECTIVE COHORT STUDY OF PREGNANT WOMEN WITH MODERATE TO SEVERE ASTHMA IN THE QUEBEC DATABASE AN EXTERNAL ASTHMA COMPARATOR COHORT FOR THE XOLAIR PREGNANCY REGISTRY EXPECT","No","835898843","2021","06/30/2022",null,null,"Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician"],["NEW","Covered Recipient Teaching Hospital",null,54144,11286,"LANGLEY PORTER PSYCHIATRIC HOSPITAL",null,null,null,null,null,null,"401 Parnassus Ave",null,"San Francisco","CA","94143","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1245547,1003028580,"ALEJANDRA",null,"DE ALBA CAMPOMANES",null,"400 PARNASSUS AVE",null,"SAN FRANCISCO","CA","94143-2202","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Ophthalmology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","OPHTHALMOLOGY","EYLEA","61755-005-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4923.5,"2021-02-25","Cash or cash equivalent",null,null,null,null,null,null,"No","No","RANDOMIZED, CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF INTRAVITREAL AFLIBERCEPT COMPARED TO LASER PHOTOCOAGULATION IN PATIENTS WITH RETINOPATHY OF PREMATURITY","No","793087613","2021","06/30/2022","NCT04101721",null,null],["NEW","Covered Recipient Teaching Hospital",null,54144,11286,"Langley Porter Psychiatric Hospital",null,null,null,null,null,null,"401 Parnassus Ave",null,"San Francisco","CA","94143","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",183398,1033176581,"Hope","S","Rugo",null,"1825 4th St Fl 3",null,"San Francisco","CA","94143","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Daiichi Sankyo Inc.",100000000195,"Daiichi Sankyo Inc.","NJ","United States","Yes","Covered","Drug","ONCOLOGY","Enhertu","65597-406-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,65.0,"2021-07-27","Cash or cash equivalent",null,null,null,null,null,null,"No","No","DS8201-A-U303","No","835064219","2021","06/30/2022","NCT03734029",null,null],["NEW","Covered Recipient Teaching Hospital",null,50146,11296,"CITY OF HOPE NATIONAL MEDICAL CTR",null,null,null,null,null,null,"1500 E Duarte Rd",null,"Duarte","CA","91010","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",259259,1700938180,"SUMANTA","K","PAL",null,"1500 DUARTE RD",null,"DUARTE","CA","91010","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,54507.95,"2021-04-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY TO EVALUATE SAFETY TOLERABILITY PHARMACOKINETIC PHARMACODYNAMIC AND ANTITUMOR ACTIVITY OF PF07209960 IN PARTICIPANTS WITH ADVANCED OR METASTATIC SOLID TUMORS","No","832770463","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,363302,10388,"Rainbow Babies & Childrens Hospital",null,null,null,null,null,null,"5805 Euclid Ave Ste 100",null,"Cleveland","OH","44103","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",7218624,1700229812,"LEILA",null,"HOJAT",null,"11100 EUCLID AVE",null,"CLEVELAND","OH","44106","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics",null,null,null,null,null,"CO",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Gilead Sciences, Inc.",100000000108,"Gilead Sciences, Inc.","CA","United States","Yes","Covered","Drug","COVID-19","Veklury","61958-2901-2",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1500.0,"2021-03-17","Cash or cash equivalent",null,null,null,null,null,null,"No","No","The Simple Study in Coronavirus, Severe Subjects","No","803514569","2021","06/30/2022",null,null,";GS-US-540-5773;G2757100;IPP;341567805;11860198"],["NEW","Covered Recipient Teaching Hospital",null,450076,11031,"UT MD ANDERSON CANCER CENTER",null,null,null,null,null,null,"1515 Holcombe Blvd",null,"Houston","TX","77030","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",58837,1316000771,"COURTNEY","D","DINARDO",null,"1515 HOLCOMBE BLVD",null,"HOUSTON","TX","77030-4009","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"ABBVIE INC.",100000000204,"ABBVIE INC.","IL","United States","Yes","Covered","Drug","ONCOLOGY","VENCLEXTA","0074-0576-22",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,34419.2,"2021-10-21","In-kind items and services",null,null,null,null,null,null,"No","No","Phase Ib/II Investigator Sponsored Study of the IDH1-mutant inhibitor AG120 with the BCL2 inhibitor Venetoclax in IDH1-mutated hematologic malignancies","No","792396675","2021","06/30/2022",null,null,"A16-338"],["NEW","Covered Recipient Teaching Hospital",null,230053,10500,"Henry Ford Hospital",null,null,null,null,null,null,"2799 W GRAND BLVD",null,"DETROIT","MI","48202","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",76692,1689864779,"JIAN",null,"LI",null,"2799 W GRAND BLVD",null,"DETROIT","MI","48202-2608","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AKEBIA THERAPEUTICS INC",100000521827,"AKEBIA THERAPEUTICS INC","MA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,34.0,"2021-04-06","Cash or cash equivalent",null,null,null,null,null,null,"No","No","AKB-6548-CI-0015","No","855448081","2021","06/30/2022","NCT02680574","https://clinicaltrials.gov/ct2/show/NCT02680574",null],["NEW","Covered Recipient Teaching Hospital",null,270051,10252,"Kalispell Regional Medical Center",null,null,null,null,null,null,"75 CLAREMONT ST","SUITE E","KALISPELL","MT","59901","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",54041,1184823643,"JONATHAN","M.","BRUNSON",null,"310 SUNNYVIEW LN",null,"KALISPELL","MT","59901","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"MT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Rivacor",null,"04035479156794","Covered","Device","Cardiology/Vascular Diseases","Plexa",null,"04035479140014","Covered","Device","Cardiology/Vascular Diseases","Sentus",null,"04035479148942","Covered","Device","Cardiology/Vascular Diseases","Acticor",null,4035479156701,"Covered","Device","Cardiology/Vascular Diseases","Solia",null,4035479118266,21.13,"2021-03-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIO-LIBRA","No","843806151","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,10033,10929,"University Of Alabama Hospital",null,null,null,null,null,null,"619 19th St S",null,"Birmingham","AL","35233","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",775991,1497775241,"ALAN","T","TITA",null,"1700 6TH AVE S STE 10270",null,"BIRMINGHAM","AL","35233","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Obstetrics & Gynecology",null,null,null,null,null,"AL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,7228.45,"2021-04-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY","No","832771699","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50599,11287,"Uc Davis Medical Center",null,null,null,null,null,null,"2315 Stockton Blvd",null,"Sacramento","CA","95817","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",2145394,1376832550,"SARAH",null,"WALDMAN",null,"4150 V ST STE 1110",null,"SACRAMENTO","CA","95817","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Gilead Sciences, Inc.",100000000108,"Gilead Sciences, Inc.","CA","United States","Yes","Covered","Drug","HIV","Biktarvy","61958-2501-1",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,945.0,"2021-01-20","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9883/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in HIV-1 Infected, Antiretroviral Treatment-Naive Adults","No","803514825","2021","06/30/2022",null,null,";GS-US-380-1489;G2755216;GILDA;946036494;11477909"],["NEW","Covered Recipient Teaching Hospital",null,50599,11287,"Uc Davis Medical Center",null,null,null,null,null,null,"2315 STOCKTON BLVD",null,"SACRAMENTO","CA","95817","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",27304,1598747800,"UMA","N.","SRIVATSA",null,"4860 Y ST",null,"SACRAMENTO","CA","95817","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Solia",null,"04035479118266","Covered","Device","Cardiology/Vascular Diseases","Rivacor",null,"04035479156794","Covered","Device","Cardiology/Vascular Diseases","Acticor",null,"04035479156701","Covered","Device","Cardiology/Vascular Diseases","Sentus",null,4035479148942,"Covered","Device","Cardiology/Vascular Diseases","Plexa",null,4035479140014,243.26,"2021-05-12","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIO-LIBRA","No","843824113","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,73300,10017,"Connecticut Childrens Medical Center",null,null,null,null,null,null,"282 Washington St",null,"Hartford","CT","06106","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",14760,1316108913,"HEATHER","O","TORY",null,"282 WASHINGTON ST",null,"HARTFORD","CT","06106","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Rheumatology",null,null,null,null,null,"CT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT","XELJANZ","0069-1001-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1252.48,"2021-06-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A LONGTERM OPENLABEL FOLLOWUP STUDY OF TOFACITINIB FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS JIA","No","832510163","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,490009,10745,"University Of Virginia Medical Cente",null,null,null,null,null,null,"1215 Lee St Pfs",null,"Charlottesville","VA","22908","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",631489,1427218205,"CRAIG","A","PORTELL",null,"PO Box 9007",null,"Charlottesville","VA","22906","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"VA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BeiGene, Ltd.",100000826833,"BeiGene, Ltd.",null,"Cayman Islands","Yes","Covered","Drug","Oncology","BRUKINSA","72579-011-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,48405.53,"2021-05-24","Cash or cash equivalent",null,null,null,null,null,null,"No","No","An International, Phase 3, Open-Label, Randomized Study of BGB-3111 Compared With Bendamustine Plus Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL)","No","843875209","2021","06/30/2022","NCT03336333",null,null],["NEW","Covered Recipient Teaching Hospital",null,110010,10785,"Emory University Hospital",null,null,null,null,null,null,"1364 Clifton Road",null,"Atlanta","GA","30302","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",717921,1447432471,"VALERIA",null,"MONCAYO",null,"1364 CLIFTON RD NE",null,"ATLANTA","GA","30322-1059","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Nuclear Medicine",null,null,null,null,null,"GA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"GE HEALTHCARE",100000005511,"GE Healthcare","WI","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1670.0,"2021-10-21","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 3 Open label Multicenter Study of Flurpiridaz (18F) Injection for Positive Emission Tomography (PET) Imaging for Assessment of Myocardial perfusion in patients referred for Invasive coronary angiography because of suspected coronary artery disease","No","839212039","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,320386,1073570586,"ANGELA","E","SCHEUERLE",null,"PO BOX 845347","MC 9036","DALLAS","TX","75284-5347","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Mylan Specialty L.P.",100000005574,"Mylan Technologies Inc.","VT","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,16.67,"2021-12-01","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Antiretroviral Pregnancy Registry (APR)","No","851443589","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,310002,10198,"Newark Beth Israel Medical Center",null,null,null,null,null,null,"201 Lyons Ave",null,"Newark","NJ","07112","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",16411,1376510578,"MARC",null,"COHEN",null,"201 LYONS AVE",null,"NEWARK","NJ","07112-2027","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"NJ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Abbott Laboratories",100000010680,"Abbott Laboratories","IL","United States","Yes","Covered","Device","Structural Heart","MitraClip System",null,"08717648231025",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1330.0,"2021-07-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","AMPLATZER PFO Occluder Post Approval Study","No","827562793","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,310001,10178,"Hackensack University Medical Center",null,null,null,null,null,null,"30 Prospect Ave",null,"Hackensack","NJ","07601","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",171721,1790773356,"DAVID","H","VESOLE",null,"92 2ND ST STE 340",null,"HACKENSACK","NJ","07601","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"NJ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,21200.0,"2021-05-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","MAGNETISMM3 AN OPENLABEL MULTICENTER NONRANDOMIZED PHASE 2 STUDY OF ELRANATAMAB PF06863135 MONOTHERAPY IN PARTICIPANTS WITH MULTIPLE MYELOMA WHO ARE REFRACTORY TO AT LEAST ONE PROTEASOME INHIBITOR ONE IMMUNOMODULATORY DRUG AND ONE ANTICD38 ANTIBODY","No","832511549","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,195456,1295829927,"WILLIAM",null,"RAND",null,"RAND EYE INSTITUTE","5 WEST SAMPLE ROAD","POMPANO BEACH","FL","33064-3542","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Ophthalmology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alcon Research LLC",100000000218,"Alcon Research LLC","TX","United States","Yes","Covered","Device","Ophthalmology","Acrysof IQ ReSTOR IOL",null,"00380652268752",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,362.5,"2021-09-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Approval Study of the AcrySof IQ ReSTOR Toric IOL","No","807663489","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,310015,10713,"MORRISTOWN MEDICAL CENTER",null,null,null,null,null,null,"100 MADISON AVE",null,"MORRISTOWN","NJ","07960","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",444356,1831349745,"ANGELA","TATIANA","ALISTAR",null,"300 S HAWTHORNE RD",null,"WINSTON SALEM","NC","27103","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"NC","NJ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000010364,"Roche Products Limited",null,"Great Britain (Uk)","Yes","Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,6981.0,"2021-08-16","Cash or cash equivalent",null,null,null,null,null,null,"No","No","MORPHEUS PANCREATIC","No","835920511","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,892108,1588788921,"MADHAV",null,"DHODAPKAR",null,"1365 CLIFTON RD NE",null,"ATLANTA","GA","30322-1013","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology",null,null,null,null,null,"CT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,236.23,"2021-04-22","In-kind items and services",null,null,null,null,null,null,"No","No","PHASE 1/2 FIH STUDY OF REGN5458 (ANTI-BCMA X ANTI-CD3 BISPECIFIC ANTIBODY) IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA","No","793082117","2021","06/30/2022","NCT03761108",null,"The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication."],["NEW","Covered Recipient Teaching Hospital",null,220162,9984,"Dana-Farber Cancer Institute",null,null,null,null,null,null,"450 Brookline Ave",null,"Boston","MA","02215","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",88160,1942259098,"ROBERT","I","HADDAD",null,"44 BINNEY ST","44 BINNEY ST","BOSTON","MA","02115","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Merck Sharp & Dohme Corporation",100000000053,"Merck Sharp & Dohme Corporation","NJ","United States","Yes","Covered","Biological","ONCOLOGY","KEYTRUDA","0006-3029-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,12755.03,"2021-12-31","In-kind items and services",null,null,null,null,null,null,"No","No","A Phase III, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma LA HNSCC","No","848748197","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,360180,10373,"Cleveland Clinic Hospital",null,null,null,null,null,null,"9500 Euclid Avenue",null,"Cleveland","OH","44195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",151679,1356438014,"SAMIR","RAMESH","KAPADIA",null,"9500 EUCLID AVE",null,"CLEVELAND","OH","44195-0001","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Siemens Medical Solutions USA, Inc.",100000010755,"Siemens Medical Solutions USA, Inc.","PA","United States","Yes","Covered","Device","AT - Fixed interventional x-ray/angiography fluoroscopy","Artis zee multi-purpose",null,"04056869010076",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3464.0,"2021-12-31","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Cardiac Clinical AT Fusion","No","768161692","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,393303,10215,"The Childrens Hospital Of Philadelp",null,null,null,null,null,null,"34TH & CIVIC CENTER BLVD","PARC BUSINESS SERVICES","PHILADELPHIA","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Bristol Myers Squibb Company",100000005499,"E.R. Squibb & Sons, L.L.C.","NJ","United States","Yes","Covered","Biological","Oncology","OPDIVO","0003-3774-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,245110.41,"2021-01-28","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Phase IIA Nivo in HL Pediatric nivo bv","No","819883799","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500027,11177,"SWEDISH MEDICAL CENTER",null,null,null,null,null,null,"747 BROADWAY",null,"SEATTLE","WA","98122","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",430197,1346484821,"KRISH",null,"PATEL",null,"1221 MADISON ST",null,"SEATTLE","WA","98104","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000010364,"Roche Products Limited",null,"Great Britain (Uk)","Yes","Covered","Biological","Immunology","Actemra","50242-137-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,567.0,"2021-01-21","Cash or cash equivalent",null,null,null,null,null,null,"No","No","COVACTA ACTEMRA COVID 19 PNEUMONIA STUDY","No","835927085","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,330285,10135,"Strong Memorial Hospital",null,null,null,null,null,null,"601 ELMWOOD AVE","BOX 684","ROCHESTER","NY","14642","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",105456,1336177310,"PETER","A.","KNIGHT",null,"601 Elmwood Ave",null,"ROCHESTER","NY","14642","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery)",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Medtronic, Inc.",100000000106,"Medtronic, Inc.","MN","United States","Yes","Covered","Device","Transcatheter Valve Systems","CoreValve Evolut",null,"00643169565623",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,450.0,"2021-04-20","Cash or cash equivalent",null,null,null,null,null,null,"No","No","TAVR Low Risk","No","800994735","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500008,11198,"University Of Washington Med Ctr",null,null,null,null,null,null,"1959 Ne Pacific St",null,"Seattle","WA","98195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",184535,1063745727,"LAURA","QUAN MAN","CHOW",null,"1601 TRINITY ST STOP Z1100",null,"AUSTIN","TX","78712","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AstraZeneca Pharmaceuticals LP",100000000146,"AstraZeneca Pharmaceuticals LP","DE","United States","Yes","Covered","Drug","Oncology","IRESSA","0310-0482-30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,861.02,"2021-12-31","In-kind items and services",null,null,null,null,null,null,"No","No","IRESSA PD L1 combination Phase 1 study","No","826487463","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,428904,1285614461,"LINDA",null,"DANIEU",null,"40 W Park Pl Apt 509",null,"Morristown","NJ","07960","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"NJ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Bristol Myers Squibb Company",100000005499,"E.R. Squibb & Sons, L.L.C.","NJ","United States","Yes","Covered","Biological","Oncology","OPDIVO","0003-3774-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,135.0,"2021-05-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Phase III Peri-Adjuvant NSCLC Nivo Mono","No","819890301","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,151158,1336221241,"FERNANDO","J","MARTINEZ",null,"525 E 68TH ST",null,"NEW YORK","NY","10065","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Critical Care Medicine",null,null,null,null,null,"MI","NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000005656,"F. Hoffmann-La Roche AG",null,"Switzerland","Yes","Non-Covered","Drug",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,388.33,"2021-10-18","In-kind items and services",null,null,null,null,null,null,"No","No","A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS IPF","No","835899687","2021","06/30/2022",null,null,"Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician"],["NEW","Covered Recipient Teaching Hospital",null,30103,11162,"MAYO CLINIC HOSPITAL",null,null,null,null,null,null,"5777 E Mayo Blvd",null,"Phoenix","AZ","85054","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1291170,1376832196,"AARON","R","MANGOLD",null,"13400 E SHEA BLVD",null,"SCOTTSDALE","AZ","85259-5452","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","INFLAMMATION AND  IMMUNOLOGY","DUPIXENT","0024-5914-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4000.0,"2021-06-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT PATIENTS WITH BULLOUS PEMPHIGOID","No","793087871","2021","06/30/2022","NCT04206553",null,null],["NEW","Covered Recipient Teaching Hospital",null,220046,9994,"BERKSHIRE MEDICAL CENTER",null,null,null,null,null,null,"725 North St",null,"Pittsfield","MA","01201","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1217019,1982821906,"TREVOR","J","BAYLISS",null,"165 TOR CT",null,"PITTSFIELD","MA","01201-3001","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pharmacyclics LLC, an AbbVie Company",100000136439,"Pharmacyclics LLC, An AbbVie Company","CA","United States","Yes","Covered","Drug","ONCOLOGY","IMBRUVICA","57962-420-28",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,150.0,"2021-02-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","informCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL)","No","786496423","2021","06/30/2022","NCT02582879",null,"PCYC-1134M-CA"],["NEW","Covered Recipient Physician",null,null,null,null,779536,1619110038,"VIVIANNE","C.","BEYER",null,"1025 S 6th St",null,"Springfield","IL","62703","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Bristol Myers Squibb Company",100000005499,"E.R. Squibb & Sons, L.L.C.","NJ","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2606.33,"2021-04-13","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Multi-Center, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase 3 Study to Evaluate the Clinical Efficacy and Safety of BMS-986165 in Subjects with Moderate to Severe Psoriasis","No","819890701","2021","06/30/2022","NCT03624127",null,null],["NEW","Covered Recipient Physician",null,null,null,null,4227411,1255719597,"IVAN",null,"LEE",null,"65 HARRISON AVE","308","BOSTON","MA","02111","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Allergy & Immunology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000005656,"F. Hoffmann-La Roche AG",null,"Switzerland","Yes","Covered","Biological","Immunology","Actemra","50242-137-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,474.32,"2021-06-14","In-kind items and services",null,null,null,null,null,null,"No","No","A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA","No","835900499","2021","06/30/2022",null,null,"Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician"],["NEW","Covered Recipient Teaching Hospital",null,130006,11100,"St. Lukes Regional Medical Center",null,null,null,null,null,null,"190 E BANNOCK ST",null,"BOISE","ID","83712","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",836390,1629248661,"CONG ZHI",null,"ZHAO",null,"520 S EAGLE RD",null,"MERIDIAN","ID","83642","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BOSTON SCIENTIFIC CORPORATION",100000005674,"Boston Scientific Corporation","MA","United States","Yes","Covered","Device","DBS","Vercise",null,"8.71473E+12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,371.52,"2021-06-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","REGISTRY OF DEEP BRAIN STIMULATION WITH THE VERCISE SYSTEM:","No","800042915","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,490063,10733,"Inova Fairfax Hospital",null,null,null,null,null,null,"3300 Gallows Rd",null,"Falls Church","VA","22042","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",303786,1689895153,"HENRY","AN","TRAN",null,"3580 JOSEPH SIEWICK DR","STE 401","FAIRFAX","VA","22033","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"NY","VA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Non-Covered","Drug","Diabetes",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,16.25,"2021-05-28","In-kind items and services",null,null,null,null,null,null,"No","No","EX9536-4388","No","811780173","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,270051,10252,"Kalispell Regional Medical Center",null,null,null,null,null,null,"75 CLAREMONT ST","SUITE E","KALISPELL","MT","59901","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",54041,1184823643,"JONATHAN","M.","BRUNSON",null,"310 SUNNYVIEW LN",null,"KALISPELL","MT","59901","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"MT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Acticor",null,"04035479156701","Covered","Device","Cardiology/Vascular Diseases","Plexa",null,"04035479140014","Covered","Device","Cardiology/Vascular Diseases","Rivacor",null,"04035479156794","Covered","Device","Cardiology/Vascular Diseases","Solia",null,4035479118266,"Covered","Device","Cardiology/Vascular Diseases","Sentus",null,4035479148942,21.13,"2021-09-14","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIO-LIBRA","No","843806413","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,291335,1427255876,"JONATHAN","MATTHEW","VIGDORCHIK",null,"535 E 70TH ST",null,"NEW YORK","NY","10021","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Orthopaedic Surgery|Adult Reconstructive Orthopaedic Surgery",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"OMNIlife science, Inc",100000010553,"OMNIlife science, Inc","MA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,20000.0,"2021-10-20","Cash or cash equivalent",null,null,null,null,null,null,"No","No","COC","No","855325381","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,100039,10842,"Broward Health Medical Center",null,null,null,null,null,null,"201 E SAMPLE RD",null,"POMPANO BEACH","FL","33064","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",185658,1104815943,"AHMED",null,"OSMAN",null,"1841 NE 45TH ST",null,"FORT LAUDERDALE","FL","33308","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BOSTON SCIENTIFIC CORPORATION",100000005674,"Boston Scientific Corporation","MA","United States","Yes","Non-Covered","Device","Therapies","General Therapies",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,600.0,"2021-03-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","INTERRUPT AF","No","800043719","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,360180,10373,"CLEVELAND CLINIC HOSPITAL",null,null,null,null,null,null,"9500 Euclid Ave",null,"Cleveland","OH","44195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",752399,1669482790,"YUEBING",null,"LI",null,"9500 EUCLID AVE  DESKS90",null,"CLEVELAND","OH","44195-1754","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.","IL","United States","Yes","Covered","Biological","IMMUNOLOGY","HYQVIA","0944-2510-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,451.6,"2021-12-16","Cash or cash equivalent",null,null,null,null,null,null,"No","No","THIS IS A PHASE III, PROSPECTIVE, MULTICENTER STUDY WITH TWO STUDY PARTS (EPOCHS) TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF HYQVIA/HYQVIA (IGI, 10% WITH RECOMBINANT HUMAN HYALURONIDASE (RHUPH20) ADMINISTERED SUBCUTANEOUSLY) FOR MAINTENANCE THERAPY TO PREVENT RELAPSE (EPOCH 1) AND GAMMAGARD LIQUID/KIOVIG (IMMUNOGLOBULIN G INTRAVENOUS (IGIV) 10% ADMINISTERED INTRAVENOUSLY) FOR THE TREATMENT OF CIDP (EPOCH 2)","No","816653657","2021","06/30/2022","NCT02549170",null,null],["NEW","Covered Recipient Teaching Hospital",null,450076,11031,"UT MD ANDERSON CANCER CENTER",null,null,null,null,null,null,"1515 Holcombe Blvd",null,"Houston","TX","77030","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",2776390,1942743216,"TIMOTHY","A","YAP",null,"1515 HOLCOMBE BLVD","455","HOUSTON","TX","77030","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,5201.27,"2021-11-05","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY EVALUATING SAFETY TOLERABILITY AND PHARMACOKINETICS OF PF 06952229 IN ADULT PATIENTS WITH ADVANCED SOLID TUMORS","No","832774167","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,410007,10008,"Rhode Island Hospital",null,null,null,null,null,null,"593 Eddy Street",null,"Providence","RI","02901","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",72892,1629041074,"ELEFTHERI","E","MYLONAKIS",null,"593 EDDY ST",null,"PROVIDENCE","RI","02903","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"RI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,12500.0,"2021-09-03","Cash or cash equivalent",null,null,null,null,null,null,"No","No","AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS","No","832512911","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,460009,11165,"U OF U HOSPITALS & CLINICS",null,null,null,null,null,null,"50 N Medical Dr",null,"Salt Lake City","UT","84132","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",454156,1184899460,"KEVIN","MICHAEL","WATT",null,"295 S CHIPETA WAY",null,"SALT LAKE CITY","UT","84108","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Critical Care Medicine",null,null,null,null,null,"UT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,16320.0,"2021-05-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 1 OPENLABEL SINGLEDOSE STUDY TO ASSESS THE PHARMACOKINETICS SAFETY AND TOLERABILITY OF CEFTAZIDIMEAVIBACTAM CAZAVI IN CHILDREN FROM 3 MONTHS TO LESS THAN 18 YEARS OF AGE WHO ARE HOSPITALIZED AND RECEIVING SYSTEMIC ANTIBIOTIC THERAPY FOR SUSPECTED OR CONFIRMED NOSOCOMIAL PNEUMONIA INCLUDING VENTILATORASSOCIATED PNEUMONIA","No","832837289","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,100007,10819,"Adventhealth Orlando",null,null,null,null,null,null,"601 E Rollins St",null,"Orlando","FL","32803","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1266401,1740341726,"Mark","A","Socinski",null,"2501 N Orange Ave Ste 689",null,"Orlando","FL","32804","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Daiichi Sankyo Inc.",100000000195,"Daiichi Sankyo Inc.","NJ","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,20550.0,"2021-04-28","Cash or cash equivalent",null,null,null,null,null,null,"No","No","U3-1402-A-U201","No","835061157","2021","06/30/2022","NCT03260491",null,null],["NEW","Covered Recipient Physician",null,null,null,null,1003306,1467789107,"PATRICIA","C.","DUGAN",null,"223 E 34TH ST",null,"NEW YORK","NY","10016-4852","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Clinical Neurophysiology",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"NEUROPACE, INC.",100000010697,"NEUROPACE, INC.","CA","United States","Yes","Covered","Device","Epilepsy","RNS System",null,"00855547005267",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,50.0,"2021-07-04","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Approval Study","No","851398667","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,1295309,1942245147,"DIONISIO","B","YORRO","JR.","68 AMBROGIO DR","SUITE 104","GURNEE","IL","60031-3339","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Emergency Medicine",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"ABBVIE INC.",100000000204,"ABBVIE INC.","IL","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4624.0,"2021-08-12","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Assessment of Multiple-Dose Pharmacokinetics and Safety of the Co-administration of Galicaftor, Navocaftor and ABBV-119 and Potential of Navocaftor and ABBV-119 on CYP3A Induction in Healthy Volunteers","No","792406179","2021","06/30/2022",null,null,"M20-065"],["NEW","Covered Recipient Teaching Hospital",null,450076,11031,"Ut Md Anderson Cancer Center",null,null,null,null,null,null,"1515 Holcombe Blvd",null,"Houston","TX","77030","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",727133,1760701445,"AMISHI","Y","SHAH",null,"1515 HOLCOMBE BLVD",null,"HOUSTON","TX","77030-4009","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eisai Inc.",100000000136,"Eisai Inc.","NJ","United States","Yes","Covered","Drug","Oncology","Lenvima","62856-710-30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2773.0,"2021-06-11","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors","No","836179693","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,410007,10008,"Rhode Island Hospital",null,null,null,null,null,null,"593 Eddy Street",null,"Providence","RI","02901","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",72892,1629041074,"ELEFTHERI","E","MYLONAKIS",null,"593 EDDY ST",null,"PROVIDENCE","RI","02903","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"RI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,920.0,"2021-09-20","In-kind items and services",null,null,null,null,null,null,"No","No","A PHASE 23 RANDOMIZED DOUBLEBLIND DOUBLEDUMMY PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF 2 REGIMENS OF ORALLY ADMINISTERED PF 07321332RITONAVIR IN PREVENTING SYMPTOMATIC SARSCOV2 INFECTION IN ADULT HOUSEHOLD CONTACTS OF AN INDIVIDUAL WITH SYMPTOMATIC COVID19","No","832514377","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,767675,1194837476,"RICHARD",null,"PRATLEY",null,"2415 N ORANGE AVE STE 502",null,"ORLANDO","FL","32804","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","CARDIOVASCULAR","STEGLATRO","0006-5363-03",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,940.0,"2021-11-15","In-kind items and services",null,null,null,null,null,null,"No","No","ERTUGLIFLOZIN CLINICAL PUBLICATION PROGRAM","No","832529225","2021","06/30/2022",null,null,"No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication."],["NEW","Covered Recipient Physician",null,null,null,null,40468,1891834016,"RHONDA","W","GENTRY",null,"8901 CARTI WAY",null,"LITTLE ROCK","AR","72205-6523","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"AR",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","ONCOLOGY","LIBTAYO","61755-008-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,37.46,"2021-01-18","In-kind items and services",null,null,null,null,null,null,"No","No","LIBTAYO CLINICAL PUBLICATION PROGRAM","No","793082387","2021","06/30/2022",null,null,"The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication."],["NEW","Covered Recipient Teaching Hospital",null,440039,10425,"Vanderbilt University Medical Center",null,null,null,null,null,null,"1211 MEDICAL CENTER DRIVE",null,"NASHVILLE","TN","37232","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",930543,1932153244,"NANCY","B.","DAVIS",null,"2220 PIERCE AVE",null,"NASHVILLE","TN","37232","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"TN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2000.0,"2021-02-19","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib Plus Pembrolizumab Versus Pemigatinib Alone Versus Standard of Care as First-Line Treatment for Metastatic or Unresectable Urothelial Carcinoma in Cisplatin-Ineligible Participants Whose Tumors Express FGFR3 Mutation or Rearrangement (FIGHT-205)","No","831052245","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Teaching Hospital",null,490007,10738,"Sentara Norfolk General Hospital",null,null,null,null,null,null,"600 Gresham Dr",null,"Norfolk","VA","23507","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1382945,1184913501,"ERICH","LEARNED","KIEHL",null,"1031 LOFTIS BLVD STE 100",null,"NEWPORT NEWS","VA","23606-2981","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"OH","VA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Abbott Laboratories",100000010680,"Abbott Laboratories","IL","United States","Yes","Covered","Device","Structural Heart","Amplatzer Amulet LAA Occluder",null,"00811806013527",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,21414.0,"2021-05-26","Cash or cash equivalent",null,null,null,null,null,null,"No","No","The Sync AV Post-Market Trail is a prospective, randomized, multi-center trail","No","827566385","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,1136517,1154421485,"JULIAN",null,"MACKAY-WIGGAN",null,"9897 HAGEN RANCH RD  9897",null,"BOYNTON BEACH","FL","33437","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,940.0,"2021-11-06","In-kind items and services",null,null,null,null,null,null,"No","No","RITLECITINIB CLINICAL PUBLICATION PROGRAM","No","832530443","2021","06/30/2022",null,null,"No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication."],["NEW","Covered Recipient Physician",null,null,null,null,27882,1619192911,"JUNE",null,"HOU",null,"1695 EASTCHESTER RD","601","BRONX","NY","10461-2374","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,390.58,"2021-03-19","In-kind items and services",null,null,null,null,null,null,"No","No","A PHASE 1/2 STUDY OF REGN4018 (A MUC16XCD3 BISPECIFIC ANTIBODY) ADMINISTERED ALONE OR IN COMBINATION WITH CEMIPLIMAB IN PATIENTS WITH RECURRENT OVARIAN CANCER","No","793082643","2021","06/30/2022","NCT03564340",null,"The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication."],["NEW","Covered Recipient Teaching Hospital",null,230053,10500,"Henry Ford Hospital",null,null,null,null,null,null,"2799 W GRAND BLVD",null,"DETROIT","MI","48202","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",353670,1780752220,"MARCUS","J.","ZERVOS",null,"3601 W 13 Mile Rd",null,"Royal Oak","MI","48073","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Moderna TX, Inc.",100000961851,"Moderna TX, Inc.","MA","United States","Yes","Covered","Biological","Infections and Infectious Diseases","Moderna Covid-19 Vaccine","80777-273-99",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1530.02,"2021-08-25","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older","No","806336137","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,450076,11031,"Ut Md Anderson Cancer Center",null,null,null,null,null,null,"1515 HOLCOMBE BLVD",null,"HOUSTON","TX","77030","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",892588,1598864100,"SRDAN",null,"VERSTOVSEK",null,"1515 HOLCOMBE BLVD","UNIT 428","HOUSTON","TX","77030","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,77.6,"2021-04-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 1/2 Open-Label, Multicenter Study of INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders","No","831065775","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Physician",null,null,null,null,117176,1588641591,"BRIAN","G","WEINSHENKER",null,"200 1ST ST SW",null,"ROCHESTER","MN","55905","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"FL","MN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Genentech, Inc.",100000005656,"F. Hoffmann-La Roche AG",null,"Switzerland","Yes","Covered","Biological","Immunology","Enspryng","50242-007-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,678.45,"2021-06-30","In-kind items and services",null,null,null,null,null,null,"No","No","EFFICACY AND SAFETY STUDY AS ADD-ON THERAPY OF SATRALIZUMAB SA237 TO TREAT NMO AND NMOSD, A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SA237 AS MONOTHERAPY IN PATIENTS WITH NEUROMYELITIS OPTICA NMO AND NMO SPECTRUM DISORDER NMOSD","No","835898059","2021","06/30/2022",null,null,"Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician"],["NEW","Covered Recipient Physician",null,null,null,null,276270,1083614879,"ILEANA","JOSEFINA","TANDRON",null,"2240 GAUSE BLVD E",null,"SLIDELL","LA","70461","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"LA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,45.0,"2021-05-24","In-kind items and services",null,null,null,null,null,null,"No","No","EX9924-4473","No","811761965","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,10033,10929,"University Of Alabama Hospital",null,null,null,null,null,null,"619 19th St S",null,"Birmingham","AL","35233","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",991339,1043572191,"TIFFANY","T","MAYO",null,"500 22ND STREET SOUTH","DEPARTMENT OF DERMATOLOGY SUITE 3400","BIRMINGHAM","AL","35223","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"AL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,30810.0,"2021-08-05","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 2A MULTICENTER RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED 16WEEK STUDY EVALUATING THE SAFETY AND EFFICACY OF PF06650833 PF06700841 AND PF06826647 IN ADULTS WITH MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA","No","832875181","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,230297,10146,"KARMANOS CANCER HOSPITAL",null,null,null,null,null,null,"4100 John R St",null,"Detroit","MI","48201","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",157764,1467611475,"STEVEN","D","DAVELUY",null,"18100 OAKWOOD BLVD","SUITE 300","DEARBORN","MI","48124-4085","United States",null,null,"Doctor of Osteopathy",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","ONCOLOGY","LIBTAYO","61755-008-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1500.0,"2021-04-01","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 2 STUDY OF REGN2810, A FULLY HUMAN MONOCLONAL ANTIBODY TO PROGRAMMED DEATH-1 (PD-1), IN PATIENTS WITH ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA","No","793087357","2021","06/30/2022","NCT02760498",null,null],["NEW","Covered Recipient Physician",null,null,null,null,195456,1295829927,"WILLIAM",null,"RAND",null,"RAND EYE INSTITUTE","5 WEST SAMPLE ROAD","POMPANO BEACH","FL","33064-3542","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Ophthalmology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alcon Research LLC",100000000218,"Alcon Research LLC","TX","United States","Yes","Covered","Device","Ophthalmology","Acrysof IQ ReSTOR IOL",null,"00380652268752",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,362.5,"2021-06-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Approval Study of the AcrySof IQ ReSTOR Toric IOL","No","807651647","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,160083,10594,"Mercy Medical Center-Des Moines",null,null,null,null,null,null,"PO BOX 9170",null,"DES MOINES","IA","50306","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",129569,1861601841,"DWAYNE",null,"CAMPBELL",null,"5880 UNIVERSITY AVE",null,"WEST DES MOINES","IA","50266","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"IA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BOSTON SCIENTIFIC CORPORATION",100000005674,"Boston Scientific Corporation","MA","United States","Yes","Non-Covered","Device","Clinical Trial Product","VARIOUS RELEASED ICD FAMILIES",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,915.75,"2021-03-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","APPRAISE ATP","No","800044545","2021","06/30/2022","NCT02923726",null,null],["NEW","Covered Recipient Teaching Hospital",null,50599,11287,"UC DAVIS MEDICAL CENTER",null,null,null,null,null,null,"2315 Stockton Blvd",null,"Sacramento","CA","95817","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",740262,1235174822,"HERMAN","L","HEDRIANA",null,"4860 Y ST STE 2500",null,"SACRAMENTO","CA","95817","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,26334.0,"2021-09-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY","No","832775363","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,220162,9984,"Dana-Farber Cancer Institute",null,null,null,null,null,null,"450 Brookline Ave",null,"Boston","MA","02215","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1037285,1669765988,"HANNY",null,"AL-SAMKARI",null,"55 FRUIT ST",null,"BOSTON","MA","02114-2696","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Agios Pharmaceuticals, Inc.",100000181751,"Agios Pharmaceuticals, Inc.","MA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1950.0,"2021-01-28","Cash or cash equivalent",null,null,null,null,null,null,"No","No","An Open-Label, Multicenter, Extension Study Of AG-348 In Adult Subjects With Pyruvate Kinase Deficiency Previously Enrolled In AG-348 Studies","No","849456765","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,303222,1679551444,"BRADLEY","S","GIEDD",null,"1928 HOWELL BRANCH RD",null,"WINTER PARK","FL","32792-1013","United States",null,null,"Doctor of Optometry",null,null,null,null,null,"Eye and Vision Services Providers|Optometrist",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alcon Research LLC",100000000218,"Alcon Research LLC","TX","United States","Yes","Non-Covered","Device","Ophthalmology","DAILIES Total1 for Astigmatism",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,369.3,"2021-06-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Dispensing Clinical Performance Evaluation of Silicone Hydrogel Soft Toric Contact Lenses","No","807651911","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,310015,10713,"Morristown Medical Center",null,null,null,null,null,null,"PO BOX 48328",null,"NEWARK","NJ","07101","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",148398,1275527707,"BARRY",null,"COHEN",null,"211 MOUNTAIN AVE",null,"SPRINGFIELD","NJ","07081","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology",null,null,null,null,null,"NJ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BOSTON SCIENTIFIC CORPORATION",100000005674,"Boston Scientific Corporation","MA","United States","Yes","Non-Covered","Device","CLINICAL TRIAL PRODUCT","CLINICAL TRIAL PRODUCT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1000.0,"2021-09-07","Cash or cash equivalent",null,null,null,null,null,null,"No","No","REPRISE III","No","800044923","2021","06/30/2022","NCT02202434",null,null],["NEW","Covered Recipient Teaching Hospital",null,110010,10785,"EMORY UNIVERSITY HOSPITAL",null,null,null,null,null,null,"1821 Clifton Rd Ne",null,"Atlanta","GA","30329","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1201336,1447437538,"ANA","G","ANTUN",null,"1670 CLAIRMONT RD",null,"DECATUR","GA","30033-4004","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"GA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.","IL","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,707.81,"2021-03-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 3, RANDOMIZED, CONTROLLED STUDY OF PROPHYLACTIC AND ON-DEMAND TREATMENT OF CTTP WITH BAX 930 (RADAMTS13)","No","816654595","2021","06/30/2022","NCT03393975",null,null],["NEW","Covered Recipient Teaching Hospital",null,380007,11204,"Legacy Emanuel Hospital & Health Ctr",null,null,null,null,null,null,"1225 NE 2ND AVE",null,"PORTLAND","OR","97232","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,6095.1,"2021-06-15","Cash or cash equivalent",null,null,null,null,null,null,"Yes","No","iLP - Leadless Pacer","No","843807189","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,360137,10389,"Uh Cleveland Medical Center",null,null,null,null,null,null,"11100 Euclid Avenue",null,"Cleveland","OH","44106","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",461071,1437100302,"Debora","Santos","Bruno",null,"11100 Euclid Ave",null,"Cleveland","OH","44106","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Daiichi Sankyo Inc.",100000000195,"Daiichi Sankyo Inc.","NJ","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,23700.0,"2021-04-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","DS1062-A-U301","No","835061257","2021","06/30/2022","NCT04656652",null,null],["NEW","Covered Recipient Non-Physician Practitioner",null,null,null,null,10703716,1124012596,"BRIAN","KIETH","BONOMO",null,"525 N DACIE PT",null,"LECANTO","FL","34461-8399","United States",null,null,"Physician Assistant",null,null,null,null,null,"Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"ABBVIE INC.",100000000204,"ABBVIE INC.","IL","United States","Yes","Covered","Biological","IMMUNOLOGY","HUMIRA","0074-0554-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,430.0,"2021-06-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA (Adalimumab) in Adult Patients with Chronic Plaque Psoriasis (PS)","No","792406399","2021","06/30/2022","NCT00799877",null,"P10-023"],["NEW","Covered Recipient Teaching Hospital",null,330154,10065,"Memorial Hospital For Cancer And All",null,null,null,null,null,null,"1275 York Avenue",null,"New York","NY","10065","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",789835,1972769800,"VICKY",null,"MAKKER",null,"1275 YORK AVENUE",null,"NEW YORK","NY","10065","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eisai Inc.",100000000136,"Eisai Inc.","NJ","United States","Yes","Covered","Drug","Oncology","Lenvima","62856-710-30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1267.65,"2021-07-14","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors","No","836179801","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500044,11187,"Deaconess Medical Center",null,null,null,null,null,null,"800 West Fifth Avenue",null,"Spokane","WA","99210","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",622375,1104832351,"STEVEN","A","PHILLIPS",null,"315 MARTIN LUTHER KING JR WAY",null,"TACOMA","WA","98405-4234","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eisai Inc.",100000000136,"Eisai Inc.","NJ","United States","Yes","Covered","Drug","Neurology","Fycompa","62856-272-30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2783.0,"2021-09-13","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase of Perampanel as Adjunctive Treatment in Subjects at Least 2 Years of Age With Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome","No","836179907","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,450076,11031,"UT MD ANDERSON CANCER CENTER",null,null,null,null,null,null,"1515 Holcombe Blvd",null,"Houston","TX","77030","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",2776390,1942743216,"TIMOTHY","A","YAP",null,"1515 HOLCOMBE BLVD","455","HOUSTON","TX","77030","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,122746.51,"2021-05-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 11B STUDY EVALUATING THE SAFETY TOLERABILITY PHARMACOKINETICS PHARMACODYNAMICS AND ANTITUMOR ACTIVITY OF PF07220060 AS A SINGLE AGENT AND AS PART OF COMBINATION THERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS","No","832840889","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,330154,10065,"Memorial Hospital For Cancer And All",null,null,null,null,null,null,"1275 York Avenue",null,"New York","NY","10065","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",789835,1972769800,"VICKY",null,"MAKKER",null,"1275 YORK AVENUE",null,"NEW YORK","NY","10065","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Eisai Inc.",100000000136,"Eisai Inc.","NJ","United States","Yes","Covered","Drug","Oncology","Lenvima","62856-710-30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1267.65,"2021-09-30","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors","No","836180013","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,360137,10389,"Uh Cleveland Medical Center",null,null,null,null,null,null,"11100 Euclid Avenue",null,"Cleveland","OH","44106","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",265659,1841266756,"Norman",null,"Kumins",null,"3999 RICHMOND RD",null,"BEACHWOOD","OH","44122","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Bolton Medical Inc",100000005629,"Bolton Medical Inc","FL","United States","Yes","Non-Covered","Device","Device","RelayPro?A",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1506.0,"2021-10-14","Cash or cash equivalent","Medical Research Writing or Publication",null,null,null,null,null,"No","No","RelayPro?A","No","850457909","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,1458973,1306139597,"TIFFANY","L.","FISHER",null,"30 HOPE DR # EC037",null,"HERSHEY","PA","17033-2036","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"NEUROPACE, INC.",100000010697,"NEUROPACE, INC.","CA","United States","Yes","Covered","Device","Epilepsy","RNS System",null,"00855547005267",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,150.0,"2021-03-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Approval Study","No","851400285","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,440039,10425,"Vanderbilt University Medical Center",null,null,null,null,null,null,"1211 MEDICAL CENTER DRIVE",null,"NASHVILLE","TN","37232","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",853101,1215193255,"SANJAY","R.","MOHAN",null,"1301 MEDICAL CENTER DR","STE 3927","NASHVILLE","TN","37232","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"TN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2.84,"2021-08-09","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A 2-Part, Phase 2, Open-Label Study of the Safety, Tolerability, and Efficacy of Itacitinib Immediate Release in Participants With Primary Myelofibrosis or Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis or Post-Essential Thrombocythemia Myelofibrosis) Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy","No","831053007","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Teaching Hospital",null,380061,11205,"Providence Portland Medical Center",null,null,null,null,null,null,"2705 E BURNSIDE ST","SUITE 114","PORTLAND","OR","97214","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",258695,1700960671,"GINA","M.","VACCARO",null,"9135 SW Barnes Rd Ste 261",null,"Portland","OR","97225","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Bristol Myers Squibb Company",100000005499,"E.R. Squibb & Sons, L.L.C.","NJ","United States","Yes","Covered","Biological","Oncology","OPDIVO","0003-3774-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4800.0,"2021-02-23","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Phase III Adjuvant HCC mono vs placebo","No","819884395","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,1139881,1255594206,"NOMEN",null,"AZEEM",null,"9360 BALM RIVERVIEW RD",null,"RIVERVIEW","FL","33569-5104","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pain Medicine|Interventional Pain Medicine",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"PAINTEQ LLC",100000966847,"PAINTEQ LLC","FL","United States","Yes","Covered","Device","PAIN MANAGEMENT","PAINTEQ",null,"00190776149833",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1140.0,"2021-02-25","Cash or cash equivalent",null,null,null,null,null,null,"No","No","SECURE Study","No","852953179","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,390100,10225,"Lancaster General Hospital",null,null,null,null,null,null,"950 OCTORARA TRAIL",null,"PARKESBURG","PA","19365","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",84134,1861586133,"SANDEEP",null,"BANSAL",null,"217 Harrisburg Ave",null,"LANCASTER","PA","17603","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Medtronic, Inc.",100000000106,"Medtronic, Inc.","MN","United States","Yes","Covered","Device","Cardiac Diagnostics and Monitoring","Reveal LINQ",null,"00643169845749",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,405.0,"2021-08-12","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Stroke AF","No","800994923","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,1058656,1427258367,"ALI",null,"JABBARI",null,"200 HAWKINS DR",null,"IOWA CITY","IA","52242","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"IA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,940.0,"2021-11-06","In-kind items and services",null,null,null,null,null,null,"No","No","RITLECITINIB CLINICAL PUBLICATION PROGRAM","No","832531725","2021","06/30/2022",null,null,"No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication."],["NEW","Covered Recipient Physician",null,null,null,null,1393487,1174943013,"WALTER",null,"LE",null,"9209 COLIMA RD STE 1000",null,"WHITTIER","CA","90605-1813","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,250.0,"2021-03-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of REGN6490 in Healthy Japanese Volunteers","No","793082905","2021","06/30/2022","NCT04616105",null,null],["NEW","Covered Recipient Non-Physician Practitioner",null,null,null,null,11153537,1346774866,"MEGHAN","G.","GOLSON",null,"832 Princeton Ave Sw",null,"Birmingham","AL","35211","United States",null,null,"Nurse Practitioner",null,null,null,null,null,"Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner",null,null,null,null,null,"AL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Sanofi Pasteur Inc.",100000000299,"SANOFI PASTEUR INC.","PA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,40.0,"2021-10-27","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Parallel-group, Phase III, Multi-stage, Modified Double-blind, Multi-armed Study to Assess the Efficacy, Safety, and Immunogenicity of Two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (Monovalent and Bivalent) for Prevention Against COVID-19 in Adults 18 Years of Age and Older","No","838359925","2021","06/30/2022","NCT04904549",null,null],["NEW","Covered Recipient Physician",null,null,null,null,270963,1972734119,"VLADIMIR",null,"ROYTER",null,"125 MALL DR STE 209B",null,"HANFORD","CA","93230","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"EMD Serono, Inc.",100000000127,"EMD Serono, Inc.","MA","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,85.0,"2021-09-30","Cash or cash equivalent",null,null,null,null,null,null,"No","No","MS200527_0082","No","842905219","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,778816,1588912869,"LUCIA",null,"SEMINARIO VIDAL",null,"12901 BRUCE B DOWNS BLVD",null,"TAMPA","FL","33612","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Dermatology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Ichnos Sciences Inc.",100000806847,"Ichnos Sciences Inc.","NY","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1750.0,"2021-01-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","GBR830-204","No","834357095","2021","06/30/2022",null,null,"GBR830-204"],["NEW","Covered Recipient Teaching Hospital",null,450051,11035,"Methodist Dallas Medical Center",null,null,null,null,null,null,"1441 N Beckley Ave",null,"Dallas","TX","75203","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",75418,1659573780,"PAUL","MICHAEL","DEROSE",null,"2805 E PRESIDENT GEORGE BUSH HWY",null,"RICHARDSON","TX","75082","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novocure Inc.",100000005413,"Novocure Inc.","NH","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,250.0,"2021-09-30","Cash or cash equivalent",null,null,null,null,null,null,"No","No","EF-27 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 150lHz) concomitant with gemcitabine and nab-paclitaxel) for front-line treatment of locally-advanced pancreatic adenocarcinoma","No","827905927","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,90004,10716,"GEORGETOWN UNIVERSITY HOSPITAL",null,null,null,null,null,null,"3800 Reservoir Rd NW",null,"Washington","DC","20007","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",766528,1164414751,"CLAUDINE","J","ISAACS",null,"3800 RESERVOIR RD NW",null,"WASHINGTON","DC","20007","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"DC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","IBRANCE","0069-0187-21",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,9.0,"2021-05-06","In-kind items and services",null,null,null,null,null,null,"No","No","A RANDOMIZED MULTICENTER DOUBLEBLIND PHASE 3 STUDY OF PD0332991 ORAL CDK 46 INHIBITOR PLUS LETROZOLE VERSUS PLACEBO PLUS LETROZOLE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ER  HER2  BREAST CANCER WHO HAVE NOT RECEIVED ANY PRIOR SYSTEMIC ANTI CANCER TREATMENT FOR ADVANCED DISEASE","No","832732557","2021","06/30/2022",null,null,"Study Drug"],["NEW","Covered Recipient Teaching Hospital",null,230046,10547,"Univ Of Mi Hospitals & Hlth Ctrs",null,null,null,null,null,null,"2301 Commonwealth Blvd",null,"Ann Arbor","MI","48105","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1201996,1467517797,"RYAN","W","STIDHAM",null,"1500 E MEDICAL CENTER DR",null,"ANN ARBOR","MI","48109-5000","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"UCB Biosciences Inc.",100000010780,"UCB Biosciences Inc.","NC","United States","Yes","Covered","Drug","Immunology","Cimzia","50474-710-79",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,100.0,"2021-06-21","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Non-Interventional, Long term, Post-Marketing Registry of Patients Treated with Certolizumab Pegol (CIMZIA) For Crohn's Disease","No","844213153","2021","06/30/2022","NCT00844285",null,null],["NEW","Covered Recipient Physician",null,null,null,null,853101,1215193255,"Sanjay","R","Mohan",null,"3601 THE VANDERBILT CLINIC",null,"NASHVILLE","TN","37232-0001","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"TN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Ichnos Sciences Inc.",100000806847,"Ichnos Sciences Inc.","NY","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,34214.4,"2021-11-01","Cash or cash equivalent",null,null,null,null,null,null,"No","No","ISB 1342-101","No","834357809","2021","06/30/2022",null,null,"ISB 1342-101"],["NEW","Covered Recipient Teaching Hospital",null,503300,11178,"Seattle Childrens Hospital",null,null,null,null,null,null,"4800 Sand Point Way Ne",null,"Seattle","WA","98105","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",606125,1538326632,"NAVIN","R","PINTO",null,"8246 15TH AVE NE MB8501",null,"SEATTLE","WA","98115","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","IBRANCE","0069-0187-21",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2137.6,"2021-05-24","In-kind items and services",null,null,null,null,null,null,"No","No","PHASE 1 STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF PALBOCICLIB IBRANCEREGISTERED IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE AND IN COMBINATION WITH TOPOTECAN AND CYCLOPHOSPHAMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS","No","832776589","2021","06/30/2022",null,null,"Study Drug"],["NEW","Covered Recipient Teaching Hospital",null,50146,11296,"City Of Hope National Medical Ctr",null,null,null,null,null,null,"1500 E DUARTE RD",null,"DUARTE","CA","91010","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",156689,1467408948,"TANYA",null,"SIDDIQI",null,"1500 Duarte Rd",null,"Duarte","CA","91010","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Celgene Corporation",100000000343,"Celgene Corporation","NY","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,23017.0,"2021-01-15","Cash or cash equivalent",null,null,null,null,null,null,"No","No","LONG-TERM FOLLOW-UP PROTOCOL FOR SUBJECTS TREATED","No","807111773","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500025,11175,"Swedish Medical Center Cherry Hill",null,null,null,null,null,null,"PO BOX 94085",null,"SEATTLE","WA","98124","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",710172,1164614731,"MING",null,"ZHANG",null,"550 17TH AVE",null,"SEATTLE","WA","98122","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BOSTON SCIENTIFIC CORPORATION",100000005674,"Boston Scientific Corporation","MA","United States","Yes","Non-Covered","Device","CLINICAL TRIAL PRODUCT","CLINICAL TRIAL PRODUCT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1477.0,"2021-11-01","Cash or cash equivalent",null,null,null,null,null,null,"No","No","REPRISE IV","No","800045709","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,110010,10785,"EMORY UNIVERSITY HOSPITAL",null,null,null,null,null,null,"1821 Clifton Rd Ne",null,"Atlanta","GA","30329","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1016783,1942336920,"LEON",null,"BERNAL",null,"80 JESSE HILL JR DR SE",null,"ATLANTA","GA","30303-3031","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"GA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.","IL","United States","Yes","Covered","Drug","ONCOLOGY","NINLARO","63020-078-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1560.0,"2021-05-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","AN OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY TO EVALUATE THE EFFECTIVENESS AND SAFETY OF IXAZOMIB (NINLARO?) IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE (IRD) IN PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY RECEIVING A BORTEZOMIB-BASED INDUCTION REGIMEN (US MM-6)","No","816655075","2021","06/30/2022","NCT03173092",null,null],["NEW","Covered Recipient Physician",null,null,null,null,910828,1245284348,"GARY","L.","CUTTER",null,"1100 Marshall Way",null,"Placerville","CA","95667","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Anesthesiology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Celgene Corporation",100000000343,"Celgene Corporation","NY","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1800.0,"2021-05-03","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Multi-Center, Multi-National, Randomized, Double","No","807112685","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,360068,10396,"The Toledo Hospital",null,null,null,null,null,null,"2142 North Cove Blvd.",null,"Toledo","OH","43606","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",65449,1447202163,"RISHI",null,"GUPTA",null,"61 WHITCHER ST","SUITE 3110","MARIETTA","GA","30060","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Neurological Surgery",null,null,null,null,null,"GA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"ZOLL Circulation Inc",100000010423,"ZOLL Circulation Inc","CA","United States","Yes","Non-Covered","Device","Temperature Management","Temperature Management System",null,"Temperature Management System","Non-Covered","Device","Temperature Management","Catheter",null,"Catheter","Non-Covered","Device","Temperature Management","Temperature Management System Start-Up Kit",null,"Temperature Management System Start-Up Kit",null,null,null,null,null,null,null,null,null,null,null,null,17179.81,"2021-08-25","Cash or cash equivalent",null,null,null,null,null,null,"No","No","ReCCLAIM II","No","837669553","2021","06/30/2022","NCT03804060",null,null],["NEW","Covered Recipient Teaching Hospital",null,310001,10178,"HACKENSACK UNIVERSITY MEDICAL CENTER",null,null,null,null,null,null,"30 Prospect Ave",null,"Hackensack","NJ","07601","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",282795,1215983382,"HELIO","FERNAN","PEDRO",null,"185 S ORANGE AVE","MSB F-653","NEWARK","NJ","07103-2757","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"NJ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.","IL","United States","Yes","Covered","Biological","GENETIC DISEASE","ELAPRASE","54092-700-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,12169.5,"2021-04-30","Cash or cash equivalent",null,null,null,null,null,null,"No","No","AN OPEN LABEL EXTENSION OF STUDY HGT-HIT-094 EVALUATING LONG TERM SAFETY AND CLINICAL OUTCOMES OF INTRATHECAL IDURSULFASE ADMINISTERED IN CONJUNCTION WITH ELAPRASE IN PATIENTS WITH HUNTER SYNDROME AND COGNITIVE IMPAIRMENT","No","816655910","2021","06/30/2022","NCT02412787",null,null],["NEW","Covered Recipient Teaching Hospital",null,360180,10373,"Cleveland Clinic Hospital",null,null,null,null,null,null,"9500 Euclid Ave",null,"Cleveland","OH","44195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",618396,1962510826,"Alberto","J","Montero",null,"11100 Euclid Ave",null,"Cleveland","OH","44106","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Daiichi Sankyo Inc.",100000000195,"Daiichi Sankyo Inc.","NJ","United States","Yes","Covered","Drug","ONCOLOGY","Enhertu","65597-406-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,13971.6,"2021-03-24","Cash or cash equivalent",null,null,null,null,null,null,"Yes","No",null,"No","835056645","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,500008,11198,"University Of Washington Med Ctr",null,null,null,null,null,null,"1959 Ne Pacific St",null,"Seattle","WA","98195","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",1005961,1568758431,"DAVID","BING","ZHEN",null,"1959 NE PACIFIC ST",null,"SEATTLE","WA","98195","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"WA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AstraZeneca Pharmaceuticals LP",100000000146,"AstraZeneca Pharmaceuticals LP","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,255709.16,"2021-01-14","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Durvalumab or Placebo in Combination With Gemcitabine Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer TOPAZ-1","No","826467939","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,10033,10929,"University Of Alabama Hospital",null,null,null,null,null,null,"619 19th St S",null,"Birmingham","AL","35249","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",697259,1710085782,"MICHAEL",null,"STALVEY",null,"100 KIMEL FOREST DR",null,"WINSTON SALEM","NC","27103","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology",null,null,null,null,null,"AL","NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1084.59,"2021-08-25","Cash or cash equivalent",null,null,null,null,null,null,"No","No","NN8640-4263","No","810994117","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,330285,10135,"Strong Memorial Hospital",null,null,null,null,null,null,"601 ELMWOOD AVE","BOX 684","ROCHESTER","NY","14642","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",307547,1790713477,"DAVID","T.","HUANG",null,"601 ELMWOOD AVE","BOX 679","ROCHESTER","NY","14642","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Plexa",null,"04035479140014","Covered","Device","Cardiology/Vascular Diseases","Rivacor",null,"04035479156794","Covered","Device","Cardiology/Vascular Diseases","Acticor",null,"04035479156701","Covered","Device","Cardiology/Vascular Diseases","Solia",null,4035479118266,"Covered","Device","Cardiology/Vascular Diseases","Sentus",null,4035479148942,21.13,"2021-04-13","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIO-LIBRA","No","843815033","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50047,11215,"California Pacific Medical Center",null,null,null,null,null,null,"2333 Buchanan Street",null,"San Francisco","CA","94115","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",84421,1851485056,"KEVIN",null,"KIM",null,"2100 WEBSTER ST STE 326","2100 WEBSTER ST STE 326","SAN FRANCISCO","CA","94115-2378","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Merck Sharp & Dohme Corporation",100000000053,"Merck Sharp & Dohme Corporation","NJ","United States","Yes","Covered","Biological","ONCOLOGY","KEYTRUDA","0006-3029-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,28085.3,"2021-12-21","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Adjuvant immunotherapy with anti-PD-1 monoclonal antibody Pembrolizumab MK-3475 versus placebo after complete resection of high-risk Stage III melanoma A randomized, double- blind Phase 3 trial of the EORTC Melanoma Group","No","848743877","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,340091,10794,"THE MOSES H. CONE MEMORIAL HOSPITAL",null,null,null,null,null,null,"1200 N Elm St",null,"Greensboro","NC","27401","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",50029,1093778227,"BRIAN","S","CRENSHAW",null,"3200 NORTHLINE AVE STE 250",null,"GREENSBORO","NC","27408-7619","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Esperion Therapeutics, Inc.",100000771817,"Esperion Therapeutics, Inc.","MI","United States","Yes","Covered","Drug","ANTILIPEMIC AGENTS","NEXLETOL","72426-118-03",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,572.0,"2021-01-21","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH, OR AT HIGH RISK FOR, CARDIOVASCULAR DISEASE WHO ARE STATIN INTOLERANT","No","838383873","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,83300,10812,"ALFRED I DUPONT HOSP FOR CHILDREN",null,null,null,null,null,null,"1600 Rockland Rd",null,"Wilmington","DE","19803","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",244579,1407051527,"KATHERINE","E","MCGOOGAN",null,"807 CHILDRENS WAY","NEMOURS CHILDRENS CLINIC","JACKSONVILLE","FL","32207-8426","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Allergan, Inc.",100000000278,"Allergan, Inc.","NJ","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,6000.0,"2021-12-01","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Clinical Trial (LIN-MD-66: PED Longterm safety study)","No","789009801","2021","06/30/2022",null,null,"LIN-MD-66"],["NEW","Covered Recipient Physician",null,null,null,null,1458973,1306139597,"TIFFANY","L.","FISHER",null,"30 HOPE DR # EC037",null,"HERSHEY","PA","17033-2036","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"NEUROPACE, INC.",100000010697,"NEUROPACE, INC.","CA","United States","Yes","Covered","Device","Epilepsy","RNS System",null,"00855547005267",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,425.0,"2021-10-03","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Approval Study","No","851400427","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,420027,10777,"Anmed Health",null,null,null,null,null,null,"800 N FANT ST",null,"ANDERSON","SC","29621","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",260312,1740266725,"BRENT","TINDAL","MCLAURIN",null,"100 PERPETUAL SQ",null,"ANDERSON","SC","29621","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"GA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Orsiro",null,"07640130455948",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,48.75,"2021-07-13","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIOFLOW-VII","No","843833987","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,520098,10572,"University Of Wi Hospitals & Clinics",null,null,null,null,null,null,"600 Highland Ave",null,"Madison","WI","53792","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",722976,1629039078,"GLENN",null,"LIU",null,"600 HIGHLAND AVE",null,"MADISON","WI","53792","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"WI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","TALZENNA","0069-0296-30",null,"Covered","Drug","ONCOLOGY","XTANDI","0469-0125-99",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,38051.88,"2021-05-30","In-kind items and services",null,null,null,null,null,null,"No","No","A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY OF TALAZOPARIB WITH ENZALUTAMIDE IN METASTATIC CASTRATIONRESISTANT PROSTATE CANCER","No","832533079","2021","06/30/2022",null,null,"Study Drug"],["NEW","Covered Recipient Physician",null,null,null,null,716637,1407152283,"DANIELE",null,"MARIN",null,"2100 ERWIN RD",null,"DURHAM","NC","27705-3941","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","ONCOLOGY","LIBTAYO","61755-008-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,3622.5,"2021-06-10","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A TWO-PART RANDOMIZED, PHASE 3 STUDY OF COMBINATIONS OF CEMIPLIMAB (ANTI-PD-1 ANTIBODY) AND PLATINUM-BASED DOUBLET CHEMOTHERAPY IN FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER","No","793083171","2021","06/30/2022","NCT03409614",null,"Payment made to RADMD LLC"],["NEW","Covered Recipient Physician",null,null,null,null,9765,1205898681,"WILLIAM","A","MAXWELL",null,"1360 E HERNDON AVE","SUITE 401","FRESNO","CA","93720-3326","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Ophthalmology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alcon Research LLC",100000000218,"Alcon Research LLC","TX","United States","Yes","Covered","Device","Ophthalmology","Acrysof IQ ReSTOR IOL",null,"00380652268752",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,248.4,"2021-10-13","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Post Approval Study of the AcrySof IQ ReSTOR Toric IOL","No","807667601","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,100271,10837,"Moffitt Cancer Center",null,null,null,null,null,null,"12902 MAGNOLIA DR",null,"TAMPA","FL","33612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",218562,1811934755,"AHMAD",null,"TARHINI",null,"12902 USF MAGNOLIA DR",null,"TAMPA","FL","33612","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Incyte Corporation",100000000263,"Incyte Corporation","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,20.26,"2021-04-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase 1-2 Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies","No","831054523","2021","06/30/2022",null,null,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."],["NEW","Covered Recipient Teaching Hospital",null,340002,11122,"Mission Hospital  Inc",null,null,null,null,null,null,"509 Biltmore Ave",null,"Asheville","NC","28801","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",244210,1376690362,"MARK","A","GROH",null,"257 MCDOWELL ST",null,"ASHEVILLE","NC","28803-2606","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery)",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Abbott Laboratories",100000010680,"Abbott Laboratories","IL","United States","Yes","Covered","Device","Vascular","Xience Sierra Coronary Stent",null,"08717648227547",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,6807.69,"2021-01-20","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO)","No","827567155","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,393303,10215,"THE CHILDRENS HOSPITAL OF PHILADELP",null,null,null,null,null,null,"34TH STREET & CIVIC CENTER BLVD",null,"PHILADELPHIA","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",2091068,1336438464,"SAMUEL",null,"JOHN",null,"5323 HARRY HINES BOULEVARD",null,"DALLAS","TX","75390-7201","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novartis Pharmaceuticals Corporation",100000000228,"Novartis Pharmaceuticals Corporation","NJ","United States","Yes","Covered","Biological","ONCOLOGY","KYMRIAH","0078-0846-19",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,23447.88,"2021-02-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A SINGLE ARM PHASE II TRIAL IN FIRST LINE HIGH RISK HR PEDIATRIC AND YOUNG ADULT PATIENTS WITH BCELL ACUTE LYMPHOBLASTIC LEUKEMIA ALL WHO ARE MINIMAL RESIDUAL DISEASE MRD POSITIVE AT END OF CONSOLIDATION EOC THERAPY","No","800616829","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,140010,10431,"Northshore University Healthsystem",null,null,null,null,null,null,"2650 Ridge Ave",null,"Evanston","IL","60201","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",376100,1457528101,"LIANA","K","BILLINGS",null,"9977 WOODS DR","STE 300","SKOKIE","IL","60077","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"IL","MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","Ozempic","0169-4132-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,4.5,"2021-03-08","In-kind items and services",null,null,null,null,null,null,"No","No","NN9535-4321","No","811249707","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,263302,10622,"Childrens Mercy Hospital",null,null,null,null,null,null,"2401 GILLHAM RD",null,"KANSAS CITY","MO","64108","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",913107,1326099714,"DOUGLAS","S.","SWANSON",null,"2401 Gillham Rd",null,"Kansas City","MO","64108","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Infectious Diseases",null,null,null,null,null,"KS",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Sanofi Pasteur Inc.",100000000299,"SANOFI PASTEUR INC.","PA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,7124.0,"2021-03-03","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PSK0008 Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine (PCV) when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Toddlers and Infants","No","838362961","2021","06/30/2022","NCT04398706",null,null],["NEW","Covered Recipient Teaching Hospital",null,393303,10215,"THE CHILDRENS HOSPITAL OF PHILADELP",null,null,null,null,null,null,"34th & Civic Center Blvd","Parc Business Services","Philadelphia","PA","19104","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",187891,1154339570,"STEPHAN","A","GRUPP",null,"3401 CIVIC CENTER BLVD","CHILDREN'S HOSPITAL OF PHILADELPHIA - HEMONC","PHILADELPHIA","PA","19104-4319","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Servier Pharmaceuticals LLC",100000291815,"Institut de Recherches Internationales Servier",null,"France","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1300.0,"2021-05-12","Cash or cash equivalent",null,null,null,null,null,null,"No","No","STUDY OF UCART19 IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA (PALL)","No","851687627","2021","06/30/2022","NCT02808442","https://clinicaltrials.gov/ct2/show/NCT02808442",null],["NEW","Covered Recipient Physician",null,null,null,null,68772,1528102670,"JAMES",null,"TATUM",null,"1820 PRESTON PARK BLVD",null,"PLANO","TX","75093","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Neurological Surgery",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"MicroVention, Inc.",100000010928,"MicroVention, Inc.","CA","United States","Yes","Covered","Device","Neurological Product","HydroCoil Helical",null,"00812636021409",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2950.0,"2021-09-09","Cash or cash equivalent",null,null,null,null,null,null,"Yes","No","NULL","No","843596669","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,303222,1679551444,"BRADLEY","S","GIEDD",null,"1928 HOWELL BRANCH RD",null,"WINTER PARK","FL","32792-1013","United States",null,null,"Doctor of Optometry",null,null,null,null,null,"Eye and Vision Services Providers|Optometrist",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alcon Research LLC",100000000218,"Alcon Research LLC","TX","United States","Yes","Non-Covered","Device","Ophthalmology","Mercury Silicone Hydrogel (SiHy) Sphere",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,329.0,"2021-03-24","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Clinical Characterization of an Investigational Frequent Replacement Daily Wear Silicone Hydrogel Sphere Contact Lens","No","807643919","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,26119,1588677736,"HENRY","W","TRAYLOR","JR.","1615 DOCTORS CIR",null,"WILMINGTON","NC","28401","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,10.6,"2021-08-04","In-kind items and services",null,null,null,null,null,null,"No","No","EX9924-4473","No","811658781","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,460009,11165,"U Of U Hospitals & Clinics",null,null,null,null,null,null,"175N MARIO CAPECCHI DR",null,"SALT LAKE CITY","UT","84132","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",358775,1891748687,"DOUGLAS",null,"ADLER",null,"1525 W 2100 S",null,"SALT LAKE CITY","UT","84119","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"CO",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BOSTON SCIENTIFIC CORPORATION",100000005674,"Boston Scientific Corporation","MA","United States","Yes","Covered","Device","Clinical Trial Product","AXIOS Stent and Electrocautery Enhanced Delivery System",null,"8.71473E+12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,620.0,"2021-06-21","Cash or cash equivalent",null,null,null,null,null,null,"No","No","POCS IN PSC","No","800047429","2021","06/30/2022","NCT03766035",null,null],["NEW","Covered Recipient Teaching Hospital",null,440039,10425,"VANDERBILT UNIVERSITY MEDICAL CENTER",null,null,null,null,null,null,"1211 Medical Center Drive",null,"Nashville","TN","37232","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",156923,1457331803,"ROBERT","J","CORNELL",null,"1315 ST JOSEPH PKWY STE 1700",null,"HOUSTON","TX","77002","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Urology",null,null,null,null,null,"TX",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,81040.64,"2021-05-20","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE I OPEN LABEL STUDY TO EVALUATE THE SAFETY PHARMACOKINETIC PHARMACODYNAMIC AND CLINICAL ACTIVITY OF PF06863135 A BCELL MATURATION ANTIGEN BCMA  CD3 BISPECIFIC ANTIBODY AS A SINGLE AGENT AND IN COMBINATION WITH IMMUNOMODULATORY AGENTS IN PATIENTS WITH RELAPSEDREFRACTORY ADVANCED MULTIPLE MYELOMA MM","No","832781557","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,223302,9992,"CHILDRENS HOSPITAL CORPORATION",null,null,null,null,null,null,"300 Longwood Ave","Patient Financial Services Atn Steven Nicoll","Boston","MA","02115","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",801431,1396790788,"IRINA",null,"ANSELM",null,"300 LONGWOOD AVE","FEGAN 11","BOSTON","MA","02115-5724","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology",null,null,null,null,null,"MA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"PTC Therapeutics, Inc.",100000191753,"PTC Therapeutics, Inc.","NJ","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,11083.19,"2021-09-06","Cash or cash equivalent",null,null,null,null,null,null,"No","No","EFFICACY AND SAFETY STUDY OF VATIQUINONE FOR THE TREATMENT OF MITOCHONDRIAL DISEASE SUBJECTS WITH REFRACTORY EPILEPSY","No","849319527","2021","06/30/2022","NCT04378075",null,null],["NEW","Covered Recipient Teaching Hospital",null,464009,11166,"U OF UTAH NEUROPSYCHIATRIC INSTITUTE",null,null,null,null,null,null,"50 N Medical Dr",null,"Salt Lake City","UT","84132","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",913884,1346330966,"WALLACE","L","AKERLEY",null,"1950 CIRCLE OF HOPE","CLINIC 1A","SALT LAKE CITY","UT","84112-5500","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"UT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"ABBVIE INC.",100000000204,"ABBVIE INC.","IL","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,5215.0,"2021-05-03","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Phase I Study of ABBV-011 as a Single-Agent and in Combination with Budigalimab (ABBV-181) in Subjects with Relapsed or Refractory Small Cell Lung Cancer","No","792398011","2021","06/30/2022","NCT03639194",null,"M17-327"],["NEW","Covered Recipient Teaching Hospital",null,100271,10837,"MOFFITT CANCER CENTER",null,null,null,null,null,null,"12902 MAGNOLIA DR",null,"TAMPA","FL","33612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",344689,1609810779,"RICHARD","D","KIM",null,"12902 USF MAGNOLIA DR",null,"TAMPA","FL","33612","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"GlaxoSmithKline, LLC.",100000005449,"GlaxoSmithKline, LLC.","NC","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2200.0,"2021-05-11","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 1 DOSE ESCALATION AND COHORT EXPANSION STUDY OF TSR-033, AN AN","No","809491759","2021","06/30/2022",null,null,"HCP did not receive direct payment from GSK. HCP was listed as the Primary Investigator in accordance with the Sunshine Act requirements."],["NEW","Covered Recipient Teaching Hospital",null,70034,10026,"NORWALK HOSPITAL",null,null,null,null,null,null,"34 Maple St",null,"Norwalk","CT","06856","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",234804,1174515803,"RICHARD","C","FRANK",null,"34 MAPLE ST",null,"NORWALK","CT","06850","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"CT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,6224.86,"2021-11-20","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE I DOSE ESCALATION AND EXPANDED COHORT STUDY OF PF06821497 IN THE TREATMENT OF ADULT PATIENTS WITH RELAPSEDREFRACTORY SMALL CELL LUNG CANCER SCLC CASTRATION RESISTANT PROSTATE CANCER CRPC AND FOLLICULAR LYMPHOMA FL","No","832782757","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,230089,10520,"Beaumont Hospital  Grosse Pointe",null,null,null,null,null,null,"468 Cadieux Rd",null,"Grosse Pointe","MI","48230","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",904085,1003875600,"CHRISTOPHER","FRANCIS","CARPENTER",null,"3601 W 13 MILE RD",null,"ROYAL OAK","MI","48073","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AstraZeneca Pharmaceuticals LP",100000000146,"AstraZeneca Pharmaceuticals LP","DE","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,38795.28,"2021-12-31","In-kind items and services",null,null,null,null,null,null,"No","No","A Phase III Randomized Double-blind Placebo-controlled Multicenter Study in Adults to Determine the Safety Efficacy and Immunogenicity of AZD1222 a Non-replicating ChAdOx1 Vector Vaccine for the Prevention of COVID-19","No","826468331","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,117983,1598924995,"JULIUS","M","WILDER",null,"2301 ERWIN RD",null,"DURHAM","NC","27705","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","RYBELSUS","0169-4303-13",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,250.0,"2021-06-18","Cash or cash equivalent",null,null,null,null,null,null,"No","No","EX9924-4473","No","810687377","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,100069,10824,"Adventhealth Carrollwood",null,null,null,null,null,null,"7171 N DALE MABRY HWY",null,"TAMPA","FL","33614","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",162269,1588730113,"VASCO","M.","MARQUES",null,"3010 E 138TH AVE STE 12",null,"TAMPA","FL","33613","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Orsiro",null,"07640130455948",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,81.25,"2021-12-14","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIOFLOW-VII","No","843815263","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,100271,10837,"Moffitt Cancer Center",null,null,null,null,null,null,"12902 MAGNOLIA DR",null,"TAMPA","FL","33612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",158609,1487736856,"JAVIER","A.","PINILLA-IBARZ",null,"12902 Usf Magnolia Dr",null,"Tampa","FL","33612","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology",null,null,null,null,null,"FL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"TG Therapeutics, Inc.",100000961857,"TG Therapeutics, Inc.","NY","United States","Yes","Covered","Drug","Hematology","UKONIQ","73150-200-12",null,"Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,258.0,"2021-09-01","Cash or cash equivalent",null,null,null,null,null,null,"No","No","ULTRA-V: Phase 2/3 Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL)","No","850450923","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,340091,10794,"THE MOSES H. CONE MEMORIAL HOSPITAL",null,null,null,null,null,null,"1200 N Elm St",null,"Greensboro","NC","27401","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",50029,1093778227,"BRIAN","S","CRENSHAW",null,"3200 NORTHLINE AVE STE 250",null,"GREENSBORO","NC","27408-7619","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"NC",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Esperion Therapeutics, Inc.",100000771817,"Esperion Therapeutics, Inc.","MI","United States","Yes","Covered","Drug","ANTILIPEMIC AGENTS","NEXLETOL","72426-118-03",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,200.0,"2021-07-22","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH, OR AT HIGH RISK FOR, CARDIOVASCULAR DISEASE WHO ARE STATIN INTOLERANT","No","838384649","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,470003,9973,"University Of Vermont Medical Center",null,null,null,null,null,null,"111 Colchester Ave",null,"Burlington","VT","05401","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",138989,1073634531,"MATTHEW","P","GILBERT",null,"62 TILLEY DR","STE 202","SOUTH BURLINGTON","VT","05403","United States",null,null,"Doctor of Osteopathy",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",null,null,null,null,null,"VT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Novo Nordisk AS",100000000163,"Novo Nordisk AS",null,"Denmark","Yes","Covered","Drug","Diabetes","Ozempic","0169-4132-12",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,13.5,"2021-04-16","In-kind items and services",null,null,null,null,null,null,"No","No","NN9535-4321","No","810893545","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,230236,10496,"Metropolitan Hospital",null,null,null,null,null,null,"5900 BYRON CENTER AVE SW",null,"WYOMING","MI","49519","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",192983,1255312302,"MATTHEW","W.","SEVENSMA",null,"5900 BYRON CENTER AVE SW",null,"WYOMING","MI","49519","United States",null,null,"Doctor of Osteopathy",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease",null,null,null,null,null,"MI",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"BIOTRONIK INC.",100000010579,"BIOTRONIK INC.","OR","United States","Yes","Covered","Device","Cardiology/Vascular Diseases","Plexa",null,"04035479140014","Covered","Device","Cardiology/Vascular Diseases","Solia",null,"04035479118266","Covered","Device","Cardiology/Vascular Diseases","Rivacor",null,"04035479156794","Covered","Device","Cardiology/Vascular Diseases","Sentus",null,4035479148942,"Covered","Device","Cardiology/Vascular Diseases","Acticor",null,4035479156701,65.0,"2021-04-13","Cash or cash equivalent",null,null,null,null,null,null,"No","No","BIO-LIBRA","No","843815671","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,60107,11020,"National Jewish Health",null,null,null,null,null,null,"1400 JACKSON ST",null,"DENVER","CO","80206","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Bristol Myers Squibb Company",100000005499,"E.R. Squibb & Sons, L.L.C.","NJ","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,54447.0,"2021-01-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Identification of Disease Progression Biomarkers in the National Jewish Health IPF cohort","No","819884983","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,1125287,1750480950,"FRANCIS","J","GILES",null,"175 E DELAWARE PL APT 7204",null,"CHICAGO","IL","60611","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","METABOLIC DISEASE;ONCOLOGY","BOSULIF","0069-0135-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,620.0,"2021-12-14","In-kind items and services",null,null,null,null,null,null,"No","No","BOSUTINIB CLINICAL PUBLICATION PROGRAM","No","832534339","2021","06/30/2022",null,null,"No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication."],["NEW","Covered Recipient Physician",null,null,null,null,249435,1487734646,"BRADLEY","J","MONK",null,"2222 E HIGHLAND AVE","SUITE 400","PHOENIX","AZ","85016-4872","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology",null,null,null,null,null,"AZ",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","ONCOLOGY","LIBTAYO","61755-008-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,343.5,"2021-05-12","In-kind items and services",null,null,null,null,null,null,"No","No","LIBTAYO CLINICAL PUBLICATION PROGRAM","No","793083445","2021","06/30/2022",null,null,"The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication."],["NEW","Covered Recipient Physician",null,null,null,null,116924,1598704371,"BRADLEY","N","HINES",null,"3445 POPLAR AVE","SUITE 7","MEMPHIS","TN","38111-4667","United States",null,null,"Doctor of Optometry",null,null,null,null,null,"Eye and Vision Services Providers|Optometrist",null,null,null,null,null,"TN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alcon Research LLC",100000000218,"Alcon Research LLC","TX","United States","Yes","Covered","Device","Ophthamology","TOTAL 30",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,475.2,"2021-10-14","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Clinical Assessment of Two Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lenses","No","807667857","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,311623,1861452815,"AMY","SUSAN","PALLER",null,"2515 N CLARK",null,"CHICAGO","IL","60614","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Pediatrics",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.","NY","United States","Yes","Covered","Biological","INFLAMMATION AND  IMMUNOLOGY","DUPIXENT","0024-5914-01",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,429.83,"2021-04-23","In-kind items and services",null,null,null,null,null,null,"No","No","A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB ADMINISTERED CONCOMITANTLY WITH TOPICAL CORTICOSTEROIDS IN PATIENTS, >=6 YEARS TO <12 YEARS OF AGE, WITH SEVERE ATOPIC DERMATITIS","No","793083703","2021","06/30/2022","NCT03345914",null,"The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication."],["NEW","Covered Recipient Teaching Hospital",null,360027,10369,"Akron General Medical Center",null,null,null,null,null,null,"1 Akron General Ave",null,"Akron","OH","44307","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",150131,1295939734,"Rupesh",null,"Raina",null,"155 5th St Ne",null,"BARBERTON","OH","44203","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|General Practice",null,null,null,null,null,"OH",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Travere Therapeutics, Inc.",100000061305,"Travere Therapeutics, Inc.","CA","United States","Yes","Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,939.0,"2021-04-12","Cash or cash equivalent","Other",null,null,null,null,null,"No","No","DUET","No","849330003","2021","06/30/2022","NCT01613118",null,null],["NEW","Covered Recipient Physician",null,null,null,null,166155,1659372043,"SATISH","C","MULUK",null,"320 E NORTH AVE",null,"PITTSBURGH","PA","15212","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Surgery|Surgical Critical Care",null,null,null,null,null,"PA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Cook Medical LLC",100000005386,"Cook Research Incorporated","IN","United States","Yes","Covered","Device","Aortic Intervention","Zenith Spiral-Z",null,"10827002552385",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,250.0,"2021-06-08","Cash or cash equivalent",null,null,null,null,null,null,"No","No","PRESERVE: Zenith Iliac Branch System Clinical Study","No","842541251","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,440015,10348,"University Of Tennessee Medical Cent",null,null,null,null,null,null,"1924 Alcoa Hwy",null,"Knoxville","TN","37920","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",172406,1801908223,"TIMOTHY","J","PANELLA",null,"1926 ALCOA HWY STE 350",null,"KNOXVILLE","TN","37920","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology",null,null,null,null,null,"TN",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Pfizer Inc.",100000000286,"PFIZER INC.","NY","United States","Yes","Covered","Drug","ONCOLOGY","BRAFTOVI","70255-025-01",null,"Covered","Drug","ONCOLOGY","MEKTOVI","70255-010-02",null,"Non-Covered",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2372.96,"2021-08-20","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A PHASE 3 RANDOMIZED DOUBLEBLIND STUDY OF ENCORAFENIB AND BINIMETINIB PLUS PEMBROLIZUMAB VERSUS PLACEBO PLUS PEMBROLIZUMAB IN PARTICIPANTS WITH BRAF V600EK MUTATIONPOSITIVE METASTATIC OR UNRESECTABLE LOCALLY ADVANCED MELANOMA","No","832738659","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50075,11228,"Kfh - Oakland",null,null,null,null,null,null,"280 W Macarthur Blvd",null,"Oakland","CA","94611","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",616253,1891810305,"SYLVIA","K","FOWLER",null,"13652 CANTARA ST","13652 CANTARA ST","PANORAMA CITY","CA","91402-5423","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Merck Sharp & Dohme Corporation",100000000053,"Merck Sharp & Dohme Corporation","NJ","United States","Yes","Covered","Biological","ONCOLOGY","KEYTRUDA","0006-3029-02",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,180.0,"2021-12-31","Cash or cash equivalent",null,null,null,null,null,null,"No","No","A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with  1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy","No","848738895","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Physician",null,null,null,null,157483,1477547206,"THOMAS",null,"MALDONADO",null,"530 1ST AVE","6 F","NEW YORK","NY","10016","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery",null,null,null,null,null,"NY",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Cook Medical LLC",100000005386,"Cook Research Incorporated","IN","United States","Yes","Covered","Device","Aortic Intervention","Cook Medical Advanced Tech",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,815.0,"2021-02-17","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Zenith p-Branch Endovascular Graft - Pivotal Study","No","842541515","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,50625,11293,"Cedars-Sinai Medical Center",null,null,null,null,null,null,"8700 Beverly Blvd",null,"West Hollywood","CA","90048","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",316955,1982815262,"SRINIVAS",null,"GADDAM",null,"8700 BEVERLY BLVD",null,"WEST HOLLYWOOD","CA","90048","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology",null,null,null,null,null,"CA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Cook Medical LLC",100000005386,"Cook Research Incorporated","IN","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,10450.0,"2021-11-02","Cash or cash equivalent",null,null,null,null,null,null,"No","No","Gastral Jejunal Feeding Tubes Study","No","842541805","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,330270,10067,"HOSPITAL FOR SPECIAL SURGERY",null,null,null,null,null,null,"532-560 WEST 33RD STREET",null,"NEW YORK","NY","10001","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",108062,1376710665,"HAN","JO","KIM",null,"535 E 70TH ST",null,"NEW YORK","NY","10021-4823","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Orthopaedic Surgery|Orthopaedic Surgery of the Spine",null,null,null,null,null,"MO",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"SI-BONE, INC.",100000011102,"SI-BONE, Inc.","CA","United States","Yes","Covered","Device","SACROILIAC JOINT DYSFUNCTION","IFUSE IMPLANT",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,810.0,"2021-12-31","Cash or cash equivalent",null,null,null,null,null,null,"No","No","SILVIA","No","845529711","2021","06/30/2022",null,null,null],["NEW","Covered Recipient Teaching Hospital",null,160058,10604,"University Of Iowa Hosp & Clinics",null,null,null,null,null,null,"200 HAWKINS DR",null,"IOWA CITY","IA","52242","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",4895086,1215439708,"ERNESTO","ANIBAL","RUIZ DUQUE",null,"200 Hawkins Dr",null,"Iowa City","IA","52242-1009","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Internal Medicine",null,null,null,null,null,"IA",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Alnylam Pharmaceuticals Inc.",100000481817,"Alnylam Pharmaceuticals Inc.","MA","United States","Yes","Covered","Drug","Genetic Disease","ONPATTRO","71336-1000-1",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,1870.0,"2021-08-12","Cash or cash equivalent",null,null,null,null,null,null,"No","No","APOLLO-B: A Phase 3, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Patisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)","No","828416195","2021","06/30/2022","NCT03997383",null,null],["NEW","Covered Recipient Teaching Hospital",null,140119,10441,"RUSH UNIVERSITY MEDICAL CENTER",null,null,null,null,null,null,"1653 W Congress Pkwy",null,"Chicago","IL","60612","United States",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Covered Recipient Physician",755347,1760419311,"PETER","T","HEYDEMANN",null,"1725 W HARRISON ST","710","CHICAGO","IL","60612-3841","United States",null,null,"Medical Doctor",null,null,null,null,null,"Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology",null,null,null,null,null,"IL",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"PTC Therapeutics, Inc.",100000191753,"PTC Therapeutics, Inc.","NJ","United States","No",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,997.07,"2021-06-01","Cash or cash equivalent",null,null,null,null,null,null,"No","No","AN OPEN-LABEL, SAFETY STUDY FOR PREVIOUSLY TREATED ATALUREN PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY","No","849320037","2021","06/30/2022","NCT01247207",null,null]],"plotOptions":{"displayType":"table","customPlotOptions":{},"pivotColumns":null,"pivotAggregation":null,"xColumns":null,"yColumns":null},"columnCustomDisplayInfos":{},"aggType":"","isJsonSchema":true,"removedWidgets":[],"aggSchema":[],"schema":[{"name":"Change_Type","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Type","type":"\"string\"","metadata":"{}"},{"name":"Noncovered_Recipient_Entity_Name","type":"\"string\"","metadata":"{}"},{"name":"Teaching_Hospital_CCN","type":"\"integer\"","metadata":"{}"},{"name":"Teaching_Hospital_ID","type":"\"integer\"","metadata":"{}"},{"name":"Teaching_Hospital_Name","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Profile_ID","type":"\"integer\"","metadata":"{}"},{"name":"Covered_Recipient_NPI","type":"\"integer\"","metadata":"{}"},{"name":"Covered_Recipient_First_Name","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Middle_Name","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Last_Name","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Name_Suffix","type":"\"string\"","metadata":"{}"},{"name":"Recipient_Primary_Business_Street_Address_Line1","type":"\"string\"","metadata":"{}"},{"name":"Recipient_Primary_Business_Street_Address_Line2","type":"\"string\"","metadata":"{}"},{"name":"Recipient_City","type":"\"string\"","metadata":"{}"},{"name":"Recipient_State","type":"\"string\"","metadata":"{}"},{"name":"Recipient_Zip_Code","type":"\"string\"","metadata":"{}"},{"name":"Recipient_Country","type":"\"string\"","metadata":"{}"},{"name":"Recipient_Province","type":"\"string\"","metadata":"{}"},{"name":"Recipient_Postal_Code","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Primary_Type_1","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Primary_Type_2","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Primary_Type_3","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Primary_Type_4","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Primary_Type_5","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Primary_Type_6","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Specialty_1","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Specialty_2","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Specialty_3","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Specialty_4","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Specialty_5","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_Specialty_6","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_License_State_code1","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_License_State_code2","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_License_State_code3","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_License_State_code4","type":"\"string\"","metadata":"{}"},{"name":"Covered_Recipient_License_State_code5","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Covered_Recipient_Type","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Profile_ID","type":"\"integer\"","metadata":"{}"},{"name":"Principal_Investigator_1_NPI","type":"\"integer\"","metadata":"{}"},{"name":"Principal_Investigator_1_First_Name","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Middle_Name","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Last_Name","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Name_Suffix","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Business_Street_Address_Line1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Business_Street_Address_Line2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_City","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_State","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Zip_Code","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Country","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Province","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Postal_Code","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Primary_Type_1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Primary_Type_2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Primary_Type_3","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Primary_Type_4","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Primary_Type_5","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Primary_Type_6","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Specialty_1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Specialty_2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Specialty_3","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Specialty_4","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Specialty_5","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_Specialty_6","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_License_State_code1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_License_State_code2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_License_State_code3","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_License_State_code4","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_1_License_State_code5","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Covered_Recipient_Type","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Profile_ID","type":"\"integer\"","metadata":"{}"},{"name":"Principal_Investigator_2_NPI","type":"\"integer\"","metadata":"{}"},{"name":"Principal_Investigator_2_First_Name","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Middle_Name","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Last_Name","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Name_Suffix","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Business_Street_Address_Line1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Business_Street_Address_Line2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_City","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_State","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Zip_Code","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Country","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Province","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Postal_Code","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Primary_Type_1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Primary_Type_2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Primary_Type_3","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Primary_Type_4","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Primary_Type_5","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Primary_Type_6","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Specialty_1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Specialty_2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Specialty_3","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Specialty_4","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Specialty_5","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_Specialty_6","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_License_State_code1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_License_State_code2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_License_State_code3","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_License_State_code4","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_2_License_State_code5","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Covered_Recipient_Type","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Profile_ID","type":"\"integer\"","metadata":"{}"},{"name":"Principal_Investigator_3_NPI","type":"\"integer\"","metadata":"{}"},{"name":"Principal_Investigator_3_First_Name","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Middle_Name","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Last_Name","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Name_Suffix","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Business_Street_Address_Line1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Business_Street_Address_Line2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_City","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_State","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Zip_Code","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Country","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Province","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Postal_Code","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Primary_Type_1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Primary_Type_2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Primary_Type_3","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Primary_Type_4","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Primary_Type_5","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Primary_Type_6","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Specialty_1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Specialty_2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Specialty_3","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Specialty_4","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Specialty_5","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_Specialty_6","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_License_State_code1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_License_State_code2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_License_State_code3","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_License_State_code4","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_3_License_State_code5","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Covered_Recipient_Type","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Profile_ID","type":"\"integer\"","metadata":"{}"},{"name":"Principal_Investigator_4_NPI","type":"\"integer\"","metadata":"{}"},{"name":"Principal_Investigator_4_First_Name","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Middle_Name","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Last_Name","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Name_Suffix","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Business_Street_Address_Line1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Business_Street_Address_Line2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_City","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_State","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Zip_Code","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Country","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Province","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Postal_Code","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Primary_Type_1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Primary_Type_2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Primary_Type_3","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Primary_Type_4","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Primary_Type_5","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Primary_Type_6","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Specialty_1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Specialty_2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Specialty_3","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Specialty_4","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Specialty_5","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_Specialty_6","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_License_State_code1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_License_State_code2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_License_State_code3","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_License_State_code4","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_4_License_State_code5","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Covered_Recipient_Type","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Profile_ID","type":"\"integer\"","metadata":"{}"},{"name":"Principal_Investigator_5_NPI","type":"\"integer\"","metadata":"{}"},{"name":"Principal_Investigator_5_First_Name","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Middle_Name","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Last_Name","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Name_Suffix","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Business_Street_Address_Line1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Business_Street_Address_Line2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_City","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_State","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Zip_Code","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Country","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Province","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Postal_Code","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Primary_Type_1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Primary_Type_2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Primary_Type_3","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Primary_Type_4","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Primary_Type_5","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Primary_Type_6","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Specialty_1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Specialty_2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Specialty_3","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Specialty_4","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Specialty_5","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_Specialty_6","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_License_State_code1","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_License_State_code2","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_License_State_code3","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_License_State_code4","type":"\"string\"","metadata":"{}"},{"name":"Principal_Investigator_5_License_State_code5","type":"\"string\"","metadata":"{}"},{"name":"Submitting_Applicable_Manufacturer_or_Applicable_GPO_Name","type":"\"string\"","metadata":"{}"},{"name":"Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID","type":"\"long\"","metadata":"{}"},{"name":"Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name","type":"\"string\"","metadata":"{}"},{"name":"Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State","type":"\"string\"","metadata":"{}"},{"name":"Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Country","type":"\"string\"","metadata":"{}"},{"name":"Related_Product_Indicator","type":"\"string\"","metadata":"{}"},{"name":"Covered_or_Noncovered_Indicator_1","type":"\"string\"","metadata":"{}"},{"name":"Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_1","type":"\"string\"","metadata":"{}"},{"name":"Product_Category_or_Therapeutic_Area_1","type":"\"string\"","metadata":"{}"},{"name":"Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_1","type":"\"string\"","metadata":"{}"},{"name":"Associated_Drug_or_Biological_NDC_1","type":"\"string\"","metadata":"{}"},{"name":"Associated_Device_or_Medical_Supply_PDI_1","type":"\"string\"","metadata":"{}"},{"name":"Covered_or_Noncovered_Indicator_2","type":"\"string\"","metadata":"{}"},{"name":"Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_2","type":"\"string\"","metadata":"{}"},{"name":"Product_Category_or_Therapeutic_Area_2","type":"\"string\"","metadata":"{}"},{"name":"Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_2","type":"\"string\"","metadata":"{}"},{"name":"Associated_Drug_or_Biological_NDC_2","type":"\"string\"","metadata":"{}"},{"name":"Associated_Device_or_Medical_Supply_PDI_2","type":"\"string\"","metadata":"{}"},{"name":"Covered_or_Noncovered_Indicator_3","type":"\"string\"","metadata":"{}"},{"name":"Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_3","type":"\"string\"","metadata":"{}"},{"name":"Product_Category_or_Therapeutic_Area_3","type":"\"string\"","metadata":"{}"},{"name":"Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_3","type":"\"string\"","metadata":"{}"},{"name":"Associated_Drug_or_Biological_NDC_3","type":"\"string\"","metadata":"{}"},{"name":"Associated_Device_or_Medical_Supply_PDI_3","type":"\"string\"","metadata":"{}"},{"name":"Covered_or_Noncovered_Indicator_4","type":"\"string\"","metadata":"{}"},{"name":"Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_4","type":"\"string\"","metadata":"{}"},{"name":"Product_Category_or_Therapeutic_Area_4","type":"\"string\"","metadata":"{}"},{"name":"Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_4","type":"\"string\"","metadata":"{}"},{"name":"Associated_Drug_or_Biological_NDC_4","type":"\"string\"","metadata":"{}"},{"name":"Associated_Device_or_Medical_Supply_PDI_4","type":"\"long\"","metadata":"{}"},{"name":"Covered_or_Noncovered_Indicator_5","type":"\"string\"","metadata":"{}"},{"name":"Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_5","type":"\"string\"","metadata":"{}"},{"name":"Product_Category_or_Therapeutic_Area_5","type":"\"string\"","metadata":"{}"},{"name":"Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_5","type":"\"string\"","metadata":"{}"},{"name":"Associated_Drug_or_Biological_NDC_5","type":"\"string\"","metadata":"{}"},{"name":"Associated_Device_or_Medical_Supply_PDI_5","type":"\"long\"","metadata":"{}"},{"name":"Total_Amount_of_Payment_USDollars","type":"\"double\"","metadata":"{}"},{"name":"Date_of_Payment","type":"\"date\"","metadata":"{\"__detected_date_formats\":\"M/d/yyyy\"}"},{"name":"Form_of_Payment_or_Transfer_of_Value","type":"\"string\"","metadata":"{}"},{"name":"Expenditure_Category1","type":"\"string\"","metadata":"{}"},{"name":"Expenditure_Category2","type":"\"string\"","metadata":"{}"},{"name":"Expenditure_Category3","type":"\"string\"","metadata":"{}"},{"name":"Expenditure_Category4","type":"\"string\"","metadata":"{}"},{"name":"Expenditure_Category5","type":"\"string\"","metadata":"{}"},{"name":"Expenditure_Category6","type":"\"string\"","metadata":"{}"},{"name":"Preclinical_Research_Indicator","type":"\"string\"","metadata":"{}"},{"name":"Delay_in_Publication_Indicator","type":"\"string\"","metadata":"{}"},{"name":"Name_of_Study","type":"\"string\"","metadata":"{}"},{"name":"Dispute_Status_for_Publication","type":"\"string\"","metadata":"{}"},{"name":"Record_ID","type":"\"string\"","metadata":"{}"},{"name":"Program_Year","type":"\"string\"","metadata":"{}"},{"name":"Payment_Publication_Date","type":"\"string\"","metadata":"{}"},{"name":"ClinicalTrials_Gov_Identifier","type":"\"string\"","metadata":"{}"},{"name":"Research_Information_Link","type":"\"string\"","metadata":"{}"},{"name":"Context_of_Research","type":"\"string\"","metadata":"{}"}],"aggError":"","aggData":[],"addedWidgets":{},"metadata":{},"dbfsResultPath":null,"type":"table","aggOverflow":false,"aggSeriesLimitReached":false,"arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .table-result-container {\n    max-height: 300px;\n    overflow: auto;\n  }\n  table, th, td {\n    border: 1px solid black;\n    border-collapse: collapse;\n  }\n  th, td {\n    padding: 5px;\n  }\n  th {\n    text-align: left;\n  }\n</style><div class='table-result-container'><table class='table-result'><thead style='background-color: white'><tr><th>Change_Type</th><th>Covered_Recipient_Type</th><th>Noncovered_Recipient_Entity_Name</th><th>Teaching_Hospital_CCN</th><th>Teaching_Hospital_ID</th><th>Teaching_Hospital_Name</th><th>Covered_Recipient_Profile_ID</th><th>Covered_Recipient_NPI</th><th>Covered_Recipient_First_Name</th><th>Covered_Recipient_Middle_Name</th><th>Covered_Recipient_Last_Name</th><th>Covered_Recipient_Name_Suffix</th><th>Recipient_Primary_Business_Street_Address_Line1</th><th>Recipient_Primary_Business_Street_Address_Line2</th><th>Recipient_City</th><th>Recipient_State</th><th>Recipient_Zip_Code</th><th>Recipient_Country</th><th>Recipient_Province</th><th>Recipient_Postal_Code</th><th>Covered_Recipient_Primary_Type_1</th><th>Covered_Recipient_Primary_Type_2</th><th>Covered_Recipient_Primary_Type_3</th><th>Covered_Recipient_Primary_Type_4</th><th>Covered_Recipient_Primary_Type_5</th><th>Covered_Recipient_Primary_Type_6</th><th>Covered_Recipient_Specialty_1</th><th>Covered_Recipient_Specialty_2</th><th>Covered_Recipient_Specialty_3</th><th>Covered_Recipient_Specialty_4</th><th>Covered_Recipient_Specialty_5</th><th>Covered_Recipient_Specialty_6</th><th>Covered_Recipient_License_State_code1</th><th>Covered_Recipient_License_State_code2</th><th>Covered_Recipient_License_State_code3</th><th>Covered_Recipient_License_State_code4</th><th>Covered_Recipient_License_State_code5</th><th>Principal_Investigator_1_Covered_Recipient_Type</th><th>Principal_Investigator_1_Profile_ID</th><th>Principal_Investigator_1_NPI</th><th>Principal_Investigator_1_First_Name</th><th>Principal_Investigator_1_Middle_Name</th><th>Principal_Investigator_1_Last_Name</th><th>Principal_Investigator_1_Name_Suffix</th><th>Principal_Investigator_1_Business_Street_Address_Line1</th><th>Principal_Investigator_1_Business_Street_Address_Line2</th><th>Principal_Investigator_1_City</th><th>Principal_Investigator_1_State</th><th>Principal_Investigator_1_Zip_Code</th><th>Principal_Investigator_1_Country</th><th>Principal_Investigator_1_Province</th><th>Principal_Investigator_1_Postal_Code</th><th>Principal_Investigator_1_Primary_Type_1</th><th>Principal_Investigator_1_Primary_Type_2</th><th>Principal_Investigator_1_Primary_Type_3</th><th>Principal_Investigator_1_Primary_Type_4</th><th>Principal_Investigator_1_Primary_Type_5</th><th>Principal_Investigator_1_Primary_Type_6</th><th>Principal_Investigator_1_Specialty_1</th><th>Principal_Investigator_1_Specialty_2</th><th>Principal_Investigator_1_Specialty_3</th><th>Principal_Investigator_1_Specialty_4</th><th>Principal_Investigator_1_Specialty_5</th><th>Principal_Investigator_1_Specialty_6</th><th>Principal_Investigator_1_License_State_code1</th><th>Principal_Investigator_1_License_State_code2</th><th>Principal_Investigator_1_License_State_code3</th><th>Principal_Investigator_1_License_State_code4</th><th>Principal_Investigator_1_License_State_code5</th><th>Principal_Investigator_2_Covered_Recipient_Type</th><th>Principal_Investigator_2_Profile_ID</th><th>Principal_Investigator_2_NPI</th><th>Principal_Investigator_2_First_Name</th><th>Principal_Investigator_2_Middle_Name</th><th>Principal_Investigator_2_Last_Name</th><th>Principal_Investigator_2_Name_Suffix</th><th>Principal_Investigator_2_Business_Street_Address_Line1</th><th>Principal_Investigator_2_Business_Street_Address_Line2</th><th>Principal_Investigator_2_City</th><th>Principal_Investigator_2_State</th><th>Principal_Investigator_2_Zip_Code</th><th>Principal_Investigator_2_Country</th><th>Principal_Investigator_2_Province</th><th>Principal_Investigator_2_Postal_Code</th><th>Principal_Investigator_2_Primary_Type_1</th><th>Principal_Investigator_2_Primary_Type_2</th><th>Principal_Investigator_2_Primary_Type_3</th><th>Principal_Investigator_2_Primary_Type_4</th><th>Principal_Investigator_2_Primary_Type_5</th><th>Principal_Investigator_2_Primary_Type_6</th><th>Principal_Investigator_2_Specialty_1</th><th>Principal_Investigator_2_Specialty_2</th><th>Principal_Investigator_2_Specialty_3</th><th>Principal_Investigator_2_Specialty_4</th><th>Principal_Investigator_2_Specialty_5</th><th>Principal_Investigator_2_Specialty_6</th><th>Principal_Investigator_2_License_State_code1</th><th>Principal_Investigator_2_License_State_code2</th><th>Principal_Investigator_2_License_State_code3</th><th>Principal_Investigator_2_License_State_code4</th><th>Principal_Investigator_2_License_State_code5</th><th>Principal_Investigator_3_Covered_Recipient_Type</th><th>Principal_Investigator_3_Profile_ID</th><th>Principal_Investigator_3_NPI</th><th>Principal_Investigator_3_First_Name</th><th>Principal_Investigator_3_Middle_Name</th><th>Principal_Investigator_3_Last_Name</th><th>Principal_Investigator_3_Name_Suffix</th><th>Principal_Investigator_3_Business_Street_Address_Line1</th><th>Principal_Investigator_3_Business_Street_Address_Line2</th><th>Principal_Investigator_3_City</th><th>Principal_Investigator_3_State</th><th>Principal_Investigator_3_Zip_Code</th><th>Principal_Investigator_3_Country</th><th>Principal_Investigator_3_Province</th><th>Principal_Investigator_3_Postal_Code</th><th>Principal_Investigator_3_Primary_Type_1</th><th>Principal_Investigator_3_Primary_Type_2</th><th>Principal_Investigator_3_Primary_Type_3</th><th>Principal_Investigator_3_Primary_Type_4</th><th>Principal_Investigator_3_Primary_Type_5</th><th>Principal_Investigator_3_Primary_Type_6</th><th>Principal_Investigator_3_Specialty_1</th><th>Principal_Investigator_3_Specialty_2</th><th>Principal_Investigator_3_Specialty_3</th><th>Principal_Investigator_3_Specialty_4</th><th>Principal_Investigator_3_Specialty_5</th><th>Principal_Investigator_3_Specialty_6</th><th>Principal_Investigator_3_License_State_code1</th><th>Principal_Investigator_3_License_State_code2</th><th>Principal_Investigator_3_License_State_code3</th><th>Principal_Investigator_3_License_State_code4</th><th>Principal_Investigator_3_License_State_code5</th><th>Principal_Investigator_4_Covered_Recipient_Type</th><th>Principal_Investigator_4_Profile_ID</th><th>Principal_Investigator_4_NPI</th><th>Principal_Investigator_4_First_Name</th><th>Principal_Investigator_4_Middle_Name</th><th>Principal_Investigator_4_Last_Name</th><th>Principal_Investigator_4_Name_Suffix</th><th>Principal_Investigator_4_Business_Street_Address_Line1</th><th>Principal_Investigator_4_Business_Street_Address_Line2</th><th>Principal_Investigator_4_City</th><th>Principal_Investigator_4_State</th><th>Principal_Investigator_4_Zip_Code</th><th>Principal_Investigator_4_Country</th><th>Principal_Investigator_4_Province</th><th>Principal_Investigator_4_Postal_Code</th><th>Principal_Investigator_4_Primary_Type_1</th><th>Principal_Investigator_4_Primary_Type_2</th><th>Principal_Investigator_4_Primary_Type_3</th><th>Principal_Investigator_4_Primary_Type_4</th><th>Principal_Investigator_4_Primary_Type_5</th><th>Principal_Investigator_4_Primary_Type_6</th><th>Principal_Investigator_4_Specialty_1</th><th>Principal_Investigator_4_Specialty_2</th><th>Principal_Investigator_4_Specialty_3</th><th>Principal_Investigator_4_Specialty_4</th><th>Principal_Investigator_4_Specialty_5</th><th>Principal_Investigator_4_Specialty_6</th><th>Principal_Investigator_4_License_State_code1</th><th>Principal_Investigator_4_License_State_code2</th><th>Principal_Investigator_4_License_State_code3</th><th>Principal_Investigator_4_License_State_code4</th><th>Principal_Investigator_4_License_State_code5</th><th>Principal_Investigator_5_Covered_Recipient_Type</th><th>Principal_Investigator_5_Profile_ID</th><th>Principal_Investigator_5_NPI</th><th>Principal_Investigator_5_First_Name</th><th>Principal_Investigator_5_Middle_Name</th><th>Principal_Investigator_5_Last_Name</th><th>Principal_Investigator_5_Name_Suffix</th><th>Principal_Investigator_5_Business_Street_Address_Line1</th><th>Principal_Investigator_5_Business_Street_Address_Line2</th><th>Principal_Investigator_5_City</th><th>Principal_Investigator_5_State</th><th>Principal_Investigator_5_Zip_Code</th><th>Principal_Investigator_5_Country</th><th>Principal_Investigator_5_Province</th><th>Principal_Investigator_5_Postal_Code</th><th>Principal_Investigator_5_Primary_Type_1</th><th>Principal_Investigator_5_Primary_Type_2</th><th>Principal_Investigator_5_Primary_Type_3</th><th>Principal_Investigator_5_Primary_Type_4</th><th>Principal_Investigator_5_Primary_Type_5</th><th>Principal_Investigator_5_Primary_Type_6</th><th>Principal_Investigator_5_Specialty_1</th><th>Principal_Investigator_5_Specialty_2</th><th>Principal_Investigator_5_Specialty_3</th><th>Principal_Investigator_5_Specialty_4</th><th>Principal_Investigator_5_Specialty_5</th><th>Principal_Investigator_5_Specialty_6</th><th>Principal_Investigator_5_License_State_code1</th><th>Principal_Investigator_5_License_State_code2</th><th>Principal_Investigator_5_License_State_code3</th><th>Principal_Investigator_5_License_State_code4</th><th>Principal_Investigator_5_License_State_code5</th><th>Submitting_Applicable_Manufacturer_or_Applicable_GPO_Name</th><th>Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID</th><th>Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name</th><th>Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State</th><th>Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Country</th><th>Related_Product_Indicator</th><th>Covered_or_Noncovered_Indicator_1</th><th>Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_1</th><th>Product_Category_or_Therapeutic_Area_1</th><th>Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_1</th><th>Associated_Drug_or_Biological_NDC_1</th><th>Associated_Device_or_Medical_Supply_PDI_1</th><th>Covered_or_Noncovered_Indicator_2</th><th>Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_2</th><th>Product_Category_or_Therapeutic_Area_2</th><th>Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_2</th><th>Associated_Drug_or_Biological_NDC_2</th><th>Associated_Device_or_Medical_Supply_PDI_2</th><th>Covered_or_Noncovered_Indicator_3</th><th>Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_3</th><th>Product_Category_or_Therapeutic_Area_3</th><th>Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_3</th><th>Associated_Drug_or_Biological_NDC_3</th><th>Associated_Device_or_Medical_Supply_PDI_3</th><th>Covered_or_Noncovered_Indicator_4</th><th>Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_4</th><th>Product_Category_or_Therapeutic_Area_4</th><th>Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_4</th><th>Associated_Drug_or_Biological_NDC_4</th><th>Associated_Device_or_Medical_Supply_PDI_4</th><th>Covered_or_Noncovered_Indicator_5</th><th>Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_5</th><th>Product_Category_or_Therapeutic_Area_5</th><th>Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_5</th><th>Associated_Drug_or_Biological_NDC_5</th><th>Associated_Device_or_Medical_Supply_PDI_5</th><th>Total_Amount_of_Payment_USDollars</th><th>Date_of_Payment</th><th>Form_of_Payment_or_Transfer_of_Value</th><th>Expenditure_Category1</th><th>Expenditure_Category2</th><th>Expenditure_Category3</th><th>Expenditure_Category4</th><th>Expenditure_Category5</th><th>Expenditure_Category6</th><th>Preclinical_Research_Indicator</th><th>Delay_in_Publication_Indicator</th><th>Name_of_Study</th><th>Dispute_Status_for_Publication</th><th>Record_ID</th><th>Program_Year</th><th>Payment_Publication_Date</th><th>ClinicalTrials_Gov_Identifier</th><th>Research_Information_Link</th><th>Context_of_Research</th></tr></thead><tbody><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>460009</td><td>11165</td><td>U Of U Hospitals & Clinics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>50 North Medical Drive</td><td>null</td><td>Salt Lake City</td><td>UT</td><td>84132</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>608915</td><td>1639269251</td><td>MARY</td><td>BETH</td><td>SCHOLAND</td><td>null</td><td>50 N MEDICAL DR</td><td>null</td><td>SALT LAKE CITY</td><td>UT</td><td>84132-0001</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>UT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Boehringer Ingelheim USA, Inc.</td><td>100000010823</td><td>Boehringer Ingelheim Pharma GmbH & Co.KG</td><td>null</td><td>Germany</td><td>Yes</td><td>Covered</td><td>Drug</td><td>RESPIRATORY</td><td>OFEV</td><td>0597-0143-60</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>122.86</td><td>2021-01-01</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Extension</td><td>No</td><td>827034085</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>53302</td><td>11301</td><td>Childrens Hospital Los Angeles</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4650 W SUNSET BLVD MS 97</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90027</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>855234</td><td>1316039647</td><td>THOMAS</td><td>G</td><td>KEENS</td><td>null</td><td>4650 W SUNSET BLVD</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90027</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Pulmonology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Boehringer Ingelheim Pharmaceuticals, Inc.</td><td>100000000234</td><td>Boehringer Ingelheim Pharmaceuticals, Inc.</td><td>CT</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>RESPIRATORY</td><td>OFEV</td><td>0597-0145-60</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>41766.54</td><td>2021-04-20</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Pediatric ILD program</td><td>No</td><td>840492839</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>140276</td><td>10474</td><td>Loyola University Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2160 S 1ST AVE</td><td>null</td><td>MAYWOOD</td><td>IL</td><td>60153</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>210327</td><td>1659358539</td><td>DANIEL</td><td>null</td><td>DILLING</td><td>null</td><td>2160 S 1ST AVE</td><td>null</td><td>MAYWOOD</td><td>IL</td><td>60153</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Boehringer Ingelheim Pharmaceuticals, Inc.</td><td>100000000234</td><td>Boehringer Ingelheim Pharmaceuticals, Inc.</td><td>CT</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>RESPIRATORY</td><td>OFEV</td><td>0597-0145-60</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2498.79</td><td>2021-03-25</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>DCRI Registry Study</td><td>No</td><td>840493101</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>393303</td><td>10215</td><td>THE CHILDRENS HOSPITAL OF PHILADELP</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>34th  Civic Center Blvd</td><td>PARC Business Services</td><td>Philadelphia</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>248791</td><td>1497738389</td><td>ALICE</td><td>null</td><td>LEE</td><td>null</td><td>111 E 210TH ST</td><td>null</td><td>BRONX</td><td>NY</td><td>10467</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>IBRANCE</td><td>0069-0187-21</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3300.0</td><td>2021-12-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PHASE 1 STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF PALBOCICLIB IBRANCEREGISTERED IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE AND IN COMBINATION WITH TOPOTECAN AND CYCLOPHOSPHAMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS</td><td>No</td><td>832586683</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>110010</td><td>10785</td><td>Emory University Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1599 CLIFTON RD NE</td><td>null</td><td>ATLANTA</td><td>GA</td><td>30322</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>718297</td><td>1457550782</td><td>HEBA</td><td>NAGI</td><td>ISKANDAR</td><td>null</td><td>1364 CLIFTON RD NE</td><td>null</td><td>ATLANTA</td><td>GA</td><td>30322</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Boehringer Ingelheim Pharmaceuticals, Inc.</td><td>100000000234</td><td>Boehringer Ingelheim Pharmaceuticals, Inc.</td><td>CT</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>8277.13</td><td>2021-02-24</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Phase II III in UC patients</td><td>No</td><td>840493361</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>143300</td><td>10439</td><td>Ann & Robert H. Lurie Childrens Hos</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1121 TECHNY RD</td><td>null</td><td>NORTHBROOK</td><td>IL</td><td>60062</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>769058</td><td>1245458496</td><td>SONALI</td><td>null</td><td>CHAUDHURY</td><td>null</td><td>225 E Chicago Ave</td><td>BOX 30</td><td>Chicago</td><td>IL</td><td>60611</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alexion Pharmaceuticals, Inc.</td><td>100000005462</td><td>Alexion Pharmaceuticals, Inc.</td><td>MA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>500.0</td><td>2021-04-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Ravulizumab in Adult and Adolescent Participants Who Have Thrombotic Microangiopathy (TMA) After Hematopoietic Stem Cell Transplant (HSCT)</td><td>No</td><td>781386437</td><td>2021</td><td>06/30/2022</td><td>NCT04543591</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>110010</td><td>10785</td><td>Emory University Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1821 Clifton Rd Ne</td><td>null</td><td>Atlanta</td><td>GA</td><td>30302</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1237355</td><td>1700907276</td><td>BRADLEY</td><td>C</td><td>CARTHON</td><td>null</td><td>1365C CLIFTON RD NE STE C3009B</td><td>null</td><td>ATLANTA</td><td>GA</td><td>30322</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>XTANDI</td><td>0469-0125-99</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1866.0</td><td>2021-04-06</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3 RANDOMIZED EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE PLUS LEUPROLIDE ENZALUTAMIDE MONOTHERAPY AND PLACEBO PLUS LEUPROLIDE IN MEN WITH HIGHRISK NONMETASTATIC PROSTATE CANCER PROGRESSING AFTER DEFINITIVE THERAPY</td><td>No</td><td>832910123</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50047</td><td>11215</td><td>CALIFORNIA PACIFIC MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2333 BUCHANAN STREET</td><td>null</td><td>SAN FRANCISCO</td><td>CA</td><td>94115</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>262565</td><td>1780664136</td><td>FOREST</td><td>H</td><td>MEALEY</td><td>null</td><td>411 30TH ST</td><td>null</td><td>OAKLAND</td><td>CA</td><td>94609</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Osteopathy</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2120.0</td><td>2021-03-27</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PHII IL22FC ANTI ST2 IN SEVERE COVID 19 PNEUMONIA</td><td>No</td><td>835907999</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>53302</td><td>11301</td><td>Childrens Hospital Los Angeles</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4650 W Sunset Blvd</td><td>null</td><td>Los Angeles</td><td>CA</td><td>90027</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1146597</td><td>1508031352</td><td>LILY</td><td>null</td><td>CHAO</td><td>null</td><td>3701 WILSHIRE BLVD</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90010</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>72.0</td><td>2021-08-05</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9924-4437</td><td>No</td><td>811631115</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>140158</td><td>10438</td><td>Mercy Hospital & Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2525 S Michigan Ave</td><td>null</td><td>Chicago</td><td>IL</td><td>60616</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1287150</td><td>1073732459</td><td>AZAZUDDIN</td><td>A</td><td>AHMED</td><td>null</td><td>2555 S MARTIN LUTHER KING DRIVE</td><td>null</td><td>CHICAGO</td><td>IL</td><td>60616</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>Ozempic</td><td>0169-4132-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2.75</td><td>2021-12-29</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9535-4352</td><td>No</td><td>811892967</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500008</td><td>11198</td><td>UNIVERSITY OF WASHINGTON MED CTR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1959 Ne Pacific St</td><td>null</td><td>Seattle</td><td>WA</td><td>98195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>834505</td><td>1558467506</td><td>NICOLE</td><td>MARIE</td><td>EHRHARDT</td><td>null</td><td>1959 NE PACIFIC ST</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98195-3201</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>DC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>DEXCOM, INC.</td><td>100000010478</td><td>DEXCOM, INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>ENDOCRINOLOGY</td><td>DEXCOM G6 TRANSMITTER</td><td>null</td><td>00386270000385</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1404.95</td><td>2021-03-25</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>REAL- TIME CONTINUOUS GLUCOSE MONITORING IN GESTATIONAL DIABETES</td><td>No</td><td>845254341</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>363300</td><td>10334</td><td>CHILDRENS HOSPITAL MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3333 BURNET AVE</td><td>null</td><td>CINCINNATI</td><td>OH</td><td>45229</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>217163</td><td>1780764035</td><td>STUART</td><td>null</td><td>GOLDSTEIN</td><td>null</td><td>3333 BURNET AVE</td><td>null</td><td>CINCINNATI</td><td>OH</td><td>45229</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Nephrology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>16000.0</td><td>2021-10-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>CROVALIMAB IN AHUS ADULT AND ADOLESCENT PATIENTS</td><td>No</td><td>835909131</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>470003</td><td>9973</td><td>University Of Vermont Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>111 COLCHESTER AVE</td><td>null</td><td>BURLINGTON</td><td>VT</td><td>05401</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>240025</td><td>1285737429</td><td>DAVID</td><td>null</td><td>SCHNEIDER</td><td>null</td><td>111 COLCHESTER AVE</td><td>MCCLURE LEVEL 1</td><td>BURLINGTON</td><td>VT</td><td>05401-1473</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Amryt Pharma Holdings Ltd</td><td>100000576811</td><td>Amryt Pharma Holdings Ltd</td><td>null</td><td>Ireland</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Cardiology/Vascular Diseases</td><td>JUXTAPID</td><td>76431-105-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>111.36</td><td>2021-07-28</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>LOWER: Lomitapide Observational Worldwide Evaluation Registry</td><td>No</td><td>831207867</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>10033</td><td>10929</td><td>UNIVERSITY OF ALABAMA HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>619 19th St S</td><td>null</td><td>Birmingham</td><td>AL</td><td>35249</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1303605</td><td>1437309283</td><td>REBECCA</td><td>null</td><td>AREND</td><td>null</td><td>619 19TH ST S</td><td>null</td><td>BIRMINGHAM</td><td>AL</td><td>35249-3720</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>650.0</td><td>2021-10-23</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1B 2 STUDY OF REBASTINIB DCC-2036 IN COMBINATION WITH PACLITAXEL IN PATIENTS WITH ADVANCED OR METASTATIC SOLID TUMORS</td><td>No</td><td>827889301</td><td>2021</td><td>06/30/2022</td><td>NCT03601897</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>288980</td><td>1356570758</td><td>BOB</td><td>null</td><td>GENG</td><td>null</td><td>9500 GILMAN DR</td><td>ALLERGY</td><td>LA JOLLA</td><td>CA</td><td>92093</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Allergy & Immunology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>DERMATOLOGY</td><td>EUCRISA</td><td>55724-211-21</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1400.0</td><td>2021-05-10</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>CRISABOROLE CLINICAL PUBLICATION PROGRAM</td><td>No</td><td>832556637</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450018</td><td>11030</td><td>THE UNIVERSITY OF TEXAS MEDICAL BR.</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>301 University Blvd</td><td>null</td><td>Galveston</td><td>TX</td><td>77555</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>497426</td><td>1700893625</td><td>RICHARD</td><td>E</td><td>RUPP</td><td>null</td><td>301 UNIVERSITY BLVD</td><td>null</td><td>GALVESTON</td><td>TX</td><td>77555</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Adolescent Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>VACCINES</td><td>COMIRNATY</td><td>0069-1000-03</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2658.5</td><td>2021-10-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS</td><td>No</td><td>832878833</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100271</td><td>10837</td><td>MOFFITT CANCER CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12902 Magnolia Dr</td><td>null</td><td>Tampa</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>709029</td><td>1124227780</td><td>JINGSONG</td><td>null</td><td>ZHANG</td><td>null</td><td>12902 USF MAGNOLIA DR</td><td>H LEE MOFFITT CANCER CENTER</td><td>TAMPA</td><td>FL</td><td>33612-9416</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>904.02</td><td>2021-05-14</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1/2 STUDY OF REGN5678 (ANTI-PSMAXCD28) WITH CEMIPLIMAB (ANTI-PD-1) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER</td><td>No</td><td>793088127</td><td>2021</td><td>06/30/2022</td><td>NCT03972657</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>380009</td><td>11212</td><td>Ohsu Hospital And Clinics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3181 Sw Sam Jackson Park Rd</td><td>null</td><td>Portland</td><td>OR</td><td>97239</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1196656</td><td>1295933729</td><td>ELIE</td><td>ABRAHAM</td><td>TRAER</td><td>null</td><td>3181 SW SAM JACKSON PARK RD # L586</td><td>null</td><td>PORTLAND</td><td>OR</td><td>97239</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AstraZeneca Pharmaceuticals LP</td><td>100000196872</td><td>Acerta Pharma LLC</td><td>CA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>8317.0</td><td>2021-07-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>This study is a multicenter open label nonrandomized sequential group dose escalation study to assess safety tolerability pharmacokinetics and preliminary anti tumor activity of ascending doses of AZD5991 in subjects with relapsed or refractory hematologic malignancies</td><td>No</td><td>826491561</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>490063</td><td>10733</td><td>Inova Fairfax Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3300 GALLOWS RD</td><td>null</td><td>FALLS CHURCH</td><td>VA</td><td>22042</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1244062</td><td>1942412564</td><td>SEKWON</td><td>null</td><td>JANG</td><td>null</td><td>8081 INNOVATION PARK DR</td><td>null</td><td>FAIRFAX</td><td>VA</td><td>22031</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>VA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>30.4</td><td>2021-11-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 2 Study of INCMGA00012 in Participants With Metastatic Merkel Cell Carcinoma</td><td>No</td><td>831068787</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>731500</td><td>1912947086</td><td>JOHN</td><td>W.</td><td>ROSE</td><td>null</td><td>50 N MEDICAL DR</td><td>3C444</td><td>SALT LAKE CITY</td><td>UT</td><td>84132</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>UT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000005656</td><td>F. Hoffmann-La Roche AG</td><td>null</td><td>Switzerland</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>Enspryng</td><td>50242-007-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>163.21</td><td>2021-03-31</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>DEMOGRAPHIC AND RELAPSE CORRELATES OF TREATMENT CHANGE IN NMOSD PATIENTS ANALYSIS OF THE CIRCLES STUDY</td><td>No</td><td>835901319</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50424</td><td>11298</td><td>Scripps Green Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>10666 N TORREY PINES RD</td><td>null</td><td>LA JOLLA</td><td>CA</td><td>92037</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1272652</td><td>1962408260</td><td>WALTER</td><td>L.</td><td>BIFFL</td><td>null</td><td>777 Bannock St</td><td>null</td><td>Denver</td><td>CO</td><td>80204</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alexion Pharmaceuticals, Inc.</td><td>100000005462</td><td>Alexion Pharmaceuticals, Inc.</td><td>MA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>10250.0</td><td>2021-05-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Prospective, Open-Label Clinical Study of Andexanet Alfa in Patients Receiving FXa (Activated Factor X) Inhibitor Who Require Urgent Surgery</td><td>No</td><td>781386733</td><td>2021</td><td>06/30/2022</td><td>NCT04233073</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220071</td><td>9988</td><td>Massachusetts General Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>55 FRUIT ST</td><td>BULFINCH 360</td><td>BOSTON</td><td>MA</td><td>02114</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1046854</td><td>1003942426</td><td>CRISTINA</td><td>null</td><td>CUSIN</td><td>null</td><td>55 FRUIT ST</td><td>ACC 812</td><td>BOSTON</td><td>MA</td><td>02114-2621</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>LivaNova USA, Inc.</td><td>100000176739</td><td>LivaNova USA, Inc.</td><td>TX</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>VNS - Symmetry</td><td>null</td><td>5425025750504</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1508.0</td><td>2021-09-30</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression</td><td>No</td><td>844267881</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>110010</td><td>10785</td><td>EMORY UNIVERSITY HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1821 Clifton Rd Ne</td><td>null</td><td>Atlanta</td><td>GA</td><td>30329</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1154580</td><td>1780791533</td><td>LEONARD</td><td>T</td><td>HEFFNER JR</td><td>null</td><td>1365 CLIFTON RD NE</td><td>null</td><td>ATLANTA</td><td>GA</td><td>30322-1013</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pharmacyclics LLC, an AbbVie Company</td><td>100000136439</td><td>Pharmacyclics LLC, An AbbVie Company</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>IMBRUVICA</td><td>57962-420-28</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>444.17</td><td>2021-09-27</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.</td><td>No</td><td>786498505</td><td>2021</td><td>06/30/2022</td><td>NCT03229200</td><td>null</td><td>PCYC-1145-LT</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450056</td><td>11002</td><td>Ascension Seton Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1201 W 38th St</td><td>null</td><td>Austin</td><td>TX</td><td>78705</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>3958</td><td>1073710067</td><td>MAURICIO</td><td>F</td><td>HONG</td><td>null</td><td>1400 N IH 35</td><td>SUITE 300</td><td>AUSTIN</td><td>TX</td><td>78701-1926</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Abbott Laboratories</td><td>100000010680</td><td>Abbott Laboratories</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiac Rhythm Management</td><td>Confirm Rx</td><td>null</td><td>05415067027320</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5301.96</td><td>2021-05-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Confirm Rx Insertable Cardiac Monitor SMART Registry</td><td>No</td><td>827578961</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360137</td><td>10389</td><td>Uh Cleveland Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>11100 Euclid Ave</td><td>null</td><td>Cleveland</td><td>OH</td><td>44106</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>349965</td><td>1700864089</td><td>William</td><td>J</td><td>Flynn</td><td>null</td><td>5430 Fredericksburg Rd</td><td>Suite 100</td><td>San Antonio</td><td>TX</td><td>78229-3539</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Optometry</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Ophthalmology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Glaukos Corporation</td><td>100000000102</td><td>Glaukos Corporation</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Glaucoma</td><td>iStent</td><td>null</td><td>00853704002012</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>615.0</td><td>2021-03-29</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Prospective, Randomized, Controlled, Parallel Groups, Multicenter Post-Approval Study of the Glaukos iStent Trabecular Micro-Bypass Stent System in Conjunction with Cataract Surgery</td><td>No</td><td>854377647</td><td>2021</td><td>06/30/2022</td><td>NCT01841450</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>991192</td><td>1043326044</td><td>MARC</td><td>null</td><td>CHIMOWITZ</td><td>null</td><td>96 Jonathan Lucas St</td><td>null</td><td>CHARLESTON</td><td>SC</td><td>29425</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>SC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Medtronic, Inc.</td><td>100000000106</td><td>Medtronic, Inc.</td><td>MN</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Liquid Embolics</td><td>Onyx</td><td>null</td><td>00847536006171</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2000.0</td><td>2021-12-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EMBOLISE</td><td>No</td><td>800999611</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>260141</td><td>10617</td><td>Univ Of Missouri Health Care</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ONE HOSPITAL DRIVE</td><td>null</td><td>COLUMBIA</td><td>MO</td><td>65212</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>851198</td><td>1144585340</td><td>SYED</td><td>A.</td><td>SHAH</td><td>null</td><td>PO BOX 843966</td><td>null</td><td>KANSAS CITY</td><td>MO</td><td>64184-3966</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alexion Pharmaceuticals, Inc.</td><td>100000005462</td><td>Alexion Pharmaceuticals, Inc.</td><td>MA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2530.0</td><td>2021-10-14</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Nave Adult Patients With Generalized Myasthenia Gravis</td><td>No</td><td>781387035</td><td>2021</td><td>06/30/2022</td><td>NCT03920293</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230297</td><td>10146</td><td>KARMANOS CANCER HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4100 John R St</td><td>null</td><td>Detroit</td><td>MI</td><td>48201</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1381910</td><td>1821344656</td><td>DIPENKUMAR</td><td>KANAIYALAL</td><td>MODI</td><td>null</td><td>4100 JOHN R ST</td><td>null</td><td>DETROIT</td><td>MI</td><td>48201-2013</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pharmacyclics LLC, an AbbVie Company</td><td>100000136439</td><td>Pharmacyclics LLC, An AbbVie Company</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>IMBRUVICA</td><td>57962-420-28</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>53.46</td><td>2021-04-20</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (SYMPATICO)</td><td>No</td><td>786500277</td><td>2021</td><td>06/30/2022</td><td>NCT03112174</td><td>null</td><td>PCYC-1143-CA</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>240010</td><td>10582</td><td>Mayo Clinic Hospital Rochester</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1216 2nd St Sw</td><td>null</td><td>Rochester</td><td>MN</td><td>55902</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>785744</td><td>1831396712</td><td>Matthew</td><td>null</td><td>Carlson</td><td>null</td><td>200 1st St SW</td><td>null</td><td>Rochester</td><td>MN</td><td>55905</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Otolaryngology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Cochlear Ltd</td><td>100000005734</td><td>Cochlear Americas</td><td>CO</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Implantable hearing solution</td><td>Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode</td><td>null</td><td>09321502036580</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3007.38</td><td>2021-11-08</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Complete Cochlear Implant Care (CCIC Requiring a Single On-Site Visit: A Prospective Pilot Study for Highly Coordinated Health Care)</td><td>No</td><td>828074361</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Research Support</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360180</td><td>10373</td><td>CLEVELAND CLINIC HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9500 EUCLID AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1251558</td><td>1215197892</td><td>LE</td><td>HANH</td><td>HUA</td><td>null</td><td>888 W BONNEVILLE AVE</td><td>null</td><td>LAS VEGAS</td><td>NV</td><td>89106</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>CA</td><td>NV</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>OCREVUS</td><td>50242-150-01</td><td>null</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>49085.0</td><td>2021-06-23</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>OCRELIZUMAB VACCINATION STUDY</td><td>No</td><td>835909991</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>20759</td><td>1467472647</td><td>DUNCAN</td><td>null</td><td>SZE-TU</td><td>null</td><td>415 HOOPER RD</td><td>null</td><td>ENDWELL</td><td>NY</td><td>13760</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Family Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1324.0</td><td>2021-06-11</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PREVENTIVE TREATMENT OF MIGRAINE: OUTCOMES FOR PATIENTS IN REAL-WORLD HEALTHCARE SYSTEMS (TRIUMPH)</td><td>No</td><td>819443169</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>54144</td><td>11286</td><td>LANGLEY PORTER PSYCHIATRIC HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>405 PARNASUS</td><td>null</td><td>SAN FRANCISCO</td><td>CA</td><td>94143</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>770871</td><td>1285860858</td><td>ALEXIS</td><td>null</td><td>MELTON</td><td>null</td><td>550 16TH ST # 434</td><td>null</td><td>SAN FRANCISCO</td><td>CA</td><td>94158</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>JAZZ PHARMACEUTICALS INC.</td><td>100000005637</td><td>JAZZ PHARMACEUTICALS INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>HEMATOLOGY/ONCOLOGY</td><td>DEFITELIO</td><td>68727-800-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>625.1</td><td>2021-08-03</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3, RANDOMIZED, ADAPTIVE STUDY COMPARING THE EFFICACY AND SAFETY OF DEFIBROTIDE VS BEST SUPPORTIVE CARE IN THE PREVENTION OF HEPATIC VENO-OCCLUSIVE DISEASE IN ADULT AND PEDIATRIC PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANT</td><td>No</td><td>838142943</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360180</td><td>10373</td><td>CLEVELAND CLINIC HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9500 EUCLID AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1122.82</td><td>2021-09-20</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>VA2 PHIII</td><td>No</td><td>835910751</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>393303</td><td>10215</td><td>The Childrens Hospital Of Philadelp</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>34th & Civic Center Blvd</td><td>Parc Business Services</td><td>Philadelphia</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Fresenius Kabi USA, LLC</td><td>100000010706</td><td>Fresenius Kabi USA, LLC</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Parental Nutrition</td><td>Smoflipid</td><td>63323-820-00</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1000.0</td><td>2021-04-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>SMOF-018-CP3</td><td>No</td><td>845838781</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220110</td><td>9985</td><td>Brigham And Womens Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>75 Francis St</td><td>null</td><td>Boston</td><td>MA</td><td>02115</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>116914</td><td>1588748883</td><td>VANITA</td><td>R</td><td>ARODA</td><td>null</td><td>221 LONGWOOD AVE</td><td># RFB-2</td><td>BOSTON</td><td>MA</td><td>02115</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>Ozempic</td><td>0169-4132-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>180.0</td><td>2021-04-16</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9535-4352</td><td>No</td><td>811507793</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>276270</td><td>1083614879</td><td>ILEANA</td><td>JOSEFINA</td><td>TANDRON</td><td>null</td><td>2240 GAUSE BLVD E</td><td>null</td><td>SLIDELL</td><td>LA</td><td>70461</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>LA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>390.0</td><td>2021-02-24</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9924-4473</td><td>No</td><td>811762381</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100271</td><td>10837</td><td>MOFFITT CANCER CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12902 Magnolia Dr</td><td>null</td><td>Tampa</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1342407</td><td>1760614739</td><td>ZEYNEP</td><td>null</td><td>EROGLU</td><td>null</td><td>12902 USF MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612-9416</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ONCOLOGY</td><td>LIBTAYO</td><td>61755-008-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2000.0</td><td>2021-10-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 2 STUDY OF REGN2810, A FULLY HUMAN MONOCLONAL ANTIBODY TO PROGRAMMED DEATH-1, IN PATIENTS WITH ADVANCED BASAL CELL CARCINOMA WHO EXPERIENCED PROGRESSION OF DISEASE ON HEDGEHOG PATHWAY INHIBITOR THERAPY, OR WERE INTOLERANT OF PRIOR HEDGEHOG PATHWAY INHIBITOR THERAPY</td><td>No</td><td>793088383</td><td>2021</td><td>06/30/2022</td><td>NCT03132636</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100087</td><td>10843</td><td>Sarasota Memorial Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1700 S Tamiami Trl</td><td>null</td><td>Sarasota</td><td>FL</td><td>34239</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1340862</td><td>1932497245</td><td>BEVERLY</td><td>J</td><td>LONG</td><td>null</td><td>1888 HILLVIEW ST</td><td>1888 HILLVIEW ST</td><td>SARASOTA</td><td>FL</td><td>34239-3605</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>DC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Merck Sharp & Dohme Corporation</td><td>100000000053</td><td>Merck Sharp & Dohme Corporation</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ONCOLOGY</td><td>KEYTRUDA</td><td>0006-3029-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>39096.78</td><td>2021-12-31</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3, Randomized, Double-Blind Study of Pembrolizumab versus Placebo in Combination With Paclitaxel With or Without Bevacizumab for the Treatment of Platinum-resistant Recurrent Ovarian Cancer KEYNOTE-B96 , ENGOT-ov65</td><td>No</td><td>848750625</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9765</td><td>1205898681</td><td>WILLIAM</td><td>A</td><td>MAXWELL</td><td>null</td><td>1360 E HERNDON AVE</td><td>SUITE 401</td><td>FRESNO</td><td>CA</td><td>93720-3326</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Ophthalmology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alcon Research LLC</td><td>100000000218</td><td>Alcon Research LLC</td><td>TX</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Ophthalmology</td><td>Acrysof IQ ReSTOR IOL</td><td>null</td><td>00380652268752</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>309.9</td><td>2021-11-24</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Approval Study of the AcrySof IQ ReSTOR Toric IOL</td><td>No</td><td>807672745</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50146</td><td>11296</td><td>CITY OF HOPE NATIONAL MEDICAL CTR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 E Duarte Rd</td><td>null</td><td>Duarte</td><td>CA</td><td>91010</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>737093</td><td>1124030028</td><td>LIHUA</td><td>ELIZABETH</td><td>BUDDE</td><td>null</td><td>1500 DUARTE RD</td><td>null</td><td>DUARTE</td><td>CA</td><td>91010-3012</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pharmacyclics LLC, an AbbVie Company</td><td>100000136439</td><td>Pharmacyclics LLC, An AbbVie Company</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>IMBRUVICA</td><td>57962-420-28</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>130.0</td><td>2021-05-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (SYMPATICO)</td><td>No</td><td>786496575</td><td>2021</td><td>06/30/2022</td><td>NCT03112174</td><td>null</td><td>PCYC-1143-CA</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>279584</td><td>1154398642</td><td>LALE</td><td>null</td><td>KOSTAKOGLU SHIELDS</td><td>null</td><td>1215 LEE ST</td><td>null</td><td>CHARLOTTESVILLE</td><td>VA</td><td>22908</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Radiology|Nuclear Radiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>VA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000005656</td><td>F. Hoffmann-La Roche AG</td><td>null</td><td>Switzerland</td><td>Yes</td><td>Covered</td><td>Biological</td><td>BioOncology</td><td>GAZYVA</td><td>50242-070-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>634.63</td><td>2021-03-31</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE III, MULTICENTER, OPEN-LABEL, RANDOMIZED TRIAL COMPARING THE EFFICACY OF GA101 RO5072759 IN COMBINATION WITH CHOP G-CHOP VERSUS RITUXIMAB AND CHOP R-CHOP IN PREVIOUSLY UNTREATED PATIENTS WITH CD20-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA DLBCL</td><td>No</td><td>835902147</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220031</td><td>9996</td><td>Boston Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>10 Gove St</td><td>null</td><td>East Boston</td><td>MA</td><td>02128</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>518436</td><td>1447562814</td><td>DEVIN</td><td>W</td><td>STEENKAMP</td><td>null</td><td>732 HARRISON AVE</td><td># 2</td><td>BOSTON</td><td>MA</td><td>02118</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>Ozempic</td><td>0169-4132-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3.8</td><td>2021-03-04</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9535-4352</td><td>No</td><td>811765305</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360137</td><td>10389</td><td>Uh Cleveland Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>11100 Euclid Ave</td><td>null</td><td>Cleveland</td><td>OH</td><td>44106</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Glaukos Corporation</td><td>100000000102</td><td>Glaukos Corporation</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Glaucoma</td><td>iStent inject</td><td>null</td><td>00853704002203</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>180.0</td><td>2021-09-29</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study</td><td>No</td><td>854378573</td><td>2021</td><td>06/30/2022</td><td>NCT04624698</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>330182</td><td>10053</td><td>St. Francis Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>100 Port Washington Blvd</td><td>null</td><td>Roslyn</td><td>NY</td><td>11576</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>354880</td><td>1811140627</td><td>RITA</td><td>A</td><td>JERMYN</td><td>null</td><td>475 SEAVIEW AVE</td><td>null</td><td>STATEN ISLAND</td><td>NY</td><td>10305</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2.65</td><td>2021-07-22</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9536-4665</td><td>No</td><td>811621657</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>306223</td><td>1760412563</td><td>HAIMANOT</td><td>null</td><td>WASSE</td><td>null</td><td>1717 W Congress Pkwy</td><td>null</td><td>CHICAGO</td><td>IL</td><td>60612</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Medtronic, Inc.</td><td>100000000106</td><td>Medtronic, Inc.</td><td>MN</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Catheters</td><td>Ellipsys</td><td>null</td><td>00763000496975</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2475.0</td><td>2021-06-29</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Ellipsys PS</td><td>No</td><td>800999823</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>250001</td><td>10938</td><td>UNIVERSITY OF MISSISSIPPI MEDICAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2500 N STATE ST</td><td>null</td><td>JACKSON</td><td>MS</td><td>39216</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>272075</td><td>1992892020</td><td>ANDERSON</td><td>B</td><td>COLLIER</td><td>III</td><td>2500 N STATE ST</td><td>null</td><td>JACKSON</td><td>MS</td><td>39216</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>IBRANCE</td><td>0069-0187-21</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>422.28</td><td>2021-12-02</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PHASE 1 STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF PALBOCICLIB IBRANCEREGISTERED IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE AND IN COMBINATION WITH TOPOTECAN AND CYCLOPHOSPHAMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS</td><td>No</td><td>832592873</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Study Drug</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>30024</td><td>11263</td><td>St. Josephs Hospital & Medical Ctr</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>7300 N 99TH AVE</td><td>null</td><td>GLENDALE</td><td>AZ</td><td>85305</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>37360</td><td>1831297274</td><td>DAVID</td><td>Z.</td><td>WANG</td><td>null</td><td>240 W THOMAS RD # 400</td><td>null</td><td>PHOENIX</td><td>AZ</td><td>85013-4407</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Osteopathy</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alexion Pharmaceuticals, Inc.</td><td>100000005462</td><td>Alexion Pharmaceuticals, Inc.</td><td>MA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3192.0</td><td>2021-12-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor Xa Inhibitor</td><td>No</td><td>781387919</td><td>2021</td><td>06/30/2022</td><td>NCT03661528</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>340047</td><td>10759</td><td>North Carolina Baptist Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2295 E 14th St</td><td>Suite 100</td><td>Winston Salem</td><td>NC</td><td>27157</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>8802549</td><td>1114243987</td><td>DAVID</td><td>ERIC</td><td>KRAM</td><td>null</td><td>MEDICAL CENTER BLVD</td><td>null</td><td>WINSTON SALEM</td><td>NC</td><td>27157</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>IBRANCE</td><td>0069-0187-21</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>375.2</td><td>2021-12-16</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PHASE 1 STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF PALBOCICLIB IBRANCEREGISTERED IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE AND IN COMBINATION WITH TOPOTECAN AND CYCLOPHOSPHAMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS</td><td>No</td><td>832594059</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Study Drug</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>150084</td><td>10407</td><td>St. Vincent Hospital & Hcc</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9613 E Us Highway 36</td><td>null</td><td>Avon</td><td>IN</td><td>46123</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>2600750</td><td>1861626038</td><td>SUNIT-PREET</td><td>SINGH</td><td>CHAUDHRY</td><td>null</td><td>8333 NAAB RD</td><td>null</td><td>INDIANAPOLIS</td><td>IN</td><td>46260</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Advanced Heart Failure and Transplant Cardiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IN</td><td>RI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3.05</td><td>2021-07-20</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9536-4665</td><td>No</td><td>811870303</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>54144</td><td>11286</td><td>Langley Porter Psychiatric Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>401 PARNASSUS AVE</td><td>null</td><td>SAN FRANCISCO</td><td>CA</td><td>94143</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>126128</td><td>1790732543</td><td>FLAVIO</td><td>G.</td><td>VINCENTI</td><td>null</td><td>505 Parnassus Ave Rm 884</td><td>null</td><td>San Francisco</td><td>CA</td><td>94143</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Sanofi and Genzyme US Companies</td><td>100000000067</td><td>SANOFI US SERVICES INC.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Oncology</td><td>SARCLISA</td><td>0024-0654-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>58037.56</td><td>2021-06-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 1b/2 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab (SAR650984) in Patients Awaiting Kidney Transplantation</td><td>No</td><td>838656015</td><td>2021</td><td>06/30/2022</td><td>NCT04294459</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>284457</td><td>1275770414</td><td>BELKIS</td><td>null</td><td>DELGADO</td><td>null</td><td>5900 NW 183RD ST</td><td>null</td><td>MIAMI GARDENS</td><td>FL</td><td>33015</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1678.03</td><td>2021-12-08</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A STUDY OF DONANEMAB VERSUS PLACEBO IN PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE OF ALZHEIMER'S DISEASE</td><td>No</td><td>819443437</td><td>2021</td><td>06/30/2022</td><td>NCT05026866</td><td>https://clinicaltrials.gov/ct2/show/NCT05026866</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor in connection with clinical studies during the reporting period.  For available study details,</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>33302</td><td>11161</td><td>PHOENIX CHILDRENS HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1919 E. THOMAS ROAD</td><td>null</td><td>PHOENIX</td><td>AZ</td><td>85016</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>845102</td><td>1932182771</td><td>ROBERTA</td><td>H</td><td>ADAMS</td><td>null</td><td>13400 E SHEA BLVD</td><td>null</td><td>SCOTTSDALE</td><td>AZ</td><td>85259</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>JAZZ PHARMACEUTICALS INC.</td><td>100000005637</td><td>JAZZ PHARMACEUTICALS INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>HEMATOLOGY/ONCOLOGY</td><td>DEFITELIO</td><td>68727-800-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>400.0</td><td>2021-07-06</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3, RANDOMIZED, ADAPTIVE STUDY COMPARING THE EFFICACY AND SAFETY OF DEFIBROTIDE VS BEST SUPPORTIVE CARE IN THE PREVENTION OF HEPATIC VENO-OCCLUSIVE DISEASE IN ADULT AND PEDIATRIC PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANT</td><td>No</td><td>838143135</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>60011</td><td>11146</td><td>DENVER HEALTH MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>145 PARSENN ROAD</td><td>null</td><td>WINTER PARK</td><td>CO</td><td>80482</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>934154</td><td>1053321893</td><td>ERNEST</td><td>E</td><td>MOORE</td><td>null</td><td>777 BANNOCK ST</td><td>null</td><td>DENVER</td><td>CO</td><td>80204</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CO</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Metabolism & Primary Care</td><td>Activase</td><td>50242-085-27</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>452181.2</td><td>2021-01-06</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>ACTIVASE FOR COVID 19</td><td>No</td><td>835911595</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>125274</td><td>1770599029</td><td>DAVID</td><td>J</td><td>DIBENEDETTO</td><td>null</td><td>85 1ST AVE</td><td>null</td><td>WALTHAM</td><td>MA</td><td>02451</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pain Medicine|Interventional Pain Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>626.59</td><td>2021-03-12</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE</td><td>No</td><td>819443697</td><td>2021</td><td>06/30/2022</td><td>NCT04437511</td><td>https://www.clinicaltrials.gov/ct2/show/NCT04437511</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>440039</td><td>10425</td><td>Vanderbilt University Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1211 Medical Center Drive</td><td>null</td><td>Nashville</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>35427</td><td>1790736759</td><td>JOSHUA</td><td>A</td><td>BECKMAN</td><td>null</td><td>2200 PIERCE AVE</td><td>null</td><td>NASHVILLE</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>TN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>Ozempic</td><td>0169-4132-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5.3</td><td>2021-04-30</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9535-4533</td><td>No</td><td>811888683</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>280040</td><td>10660</td><td>NEBRASKA METHODIST HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>8303 Dodge Street</td><td>null</td><td>Omaha</td><td>NE</td><td>68114</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>111494</td><td>1457322166</td><td>YUNGPO</td><td>B</td><td>SU</td><td>null</td><td>7500 MERCY RD</td><td>SUITE 1300</td><td>OMAHA</td><td>NE</td><td>68124-2319</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NE</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ONCOLOGY</td><td>LIBTAYO</td><td>61755-008-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1383.77</td><td>2021-08-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF ADJUVANT CEMIPLIMAB VERSUS PLACEBO AFTER SURGERY AND RADIATION THERAPY IN PATIENTS WITH HIGH RISK CUTANEOUS SQUAMOUS CELL CARCINOMA</td><td>No</td><td>793088639</td><td>2021</td><td>06/30/2022</td><td>NCT03969004</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>170122</td><td>10684</td><td>VIA CHRISTI HOSPITAL WICHITA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>929 N Saint Francis St</td><td>null</td><td>Wichita</td><td>KS</td><td>67214</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>58157</td><td>1295770832</td><td>WILLIAM</td><td>RANSOM</td><td>KILGORE</td><td>null</td><td>1947 N FOUNDERS CIR</td><td>null</td><td>WICHITA</td><td>KS</td><td>67206-3548</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>KS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Vanda Pharmaceuticals Inc.</td><td>100000071361</td><td>Vanda Pharmaceuticals Inc.</td><td>DC</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>14518.0</td><td>2021-11-17</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO ASSESS THE EFFICACY OF TRADIPITANT IN RELIEVING SYMPTOMS OF GASTROPARESIS</td><td>No</td><td>838907037</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>330483</td><td>1285843672</td><td>MICHAEL</td><td>URBAN</td><td>CALLAGHAN</td><td>null</td><td>3901 BEAUBIEN ST</td><td>null</td><td>DETROIT</td><td>MI</td><td>48201</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000005656</td><td>F. Hoffmann-La Roche AG</td><td>null</td><td>Switzerland</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>648.85</td><td>2021-06-18</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1B STUDY OF CROVALIMAB IN MANAGEMENT OF ACUTE VOC IN SICKLE CELL DISEASE</td><td>No</td><td>835903055</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>470003</td><td>9973</td><td>University Of Vermont Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>111 Colchester Ave</td><td>null</td><td>Burlington</td><td>VT</td><td>05401</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>138989</td><td>1073634531</td><td>MATTHEW</td><td>P</td><td>GILBERT</td><td>null</td><td>62 TILLEY DR</td><td>STE 202</td><td>SOUTH BURLINGTON</td><td>VT</td><td>05403</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Osteopathy</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>VT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1085.76</td><td>2021-07-28</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9924-4473</td><td>No</td><td>811819743</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450076</td><td>11031</td><td>Ut Md Anderson Cancer Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>null</td><td>HOUSTON</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>58875</td><td>1306932074</td><td>FUNDA</td><td>null</td><td>MERIC-BERNSTAM</td><td>null</td><td>1515 Holcombe Blvd</td><td>null</td><td>Houston</td><td>TX</td><td>77030-4009</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Surgery|Surgical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Taiho Oncology, Inc.</td><td>100000146541</td><td>Taiho Oncology, Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2123.28</td><td>2021-12-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>AN OPEN-LABEL EXPANDED ACCESS PROGRAM OF FUTIBATINIB (TAS-120) IN PATIENTS WITH ADVANCED CHOLANGIOCARCINOMA HARBORING FGFR2 GENE REARRANGEMENTS</td><td>No</td><td>841942487</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>460009</td><td>11165</td><td>U OF U HOSPITALS & CLINICS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>50 N Medical Dr</td><td>null</td><td>Salt Lake City</td><td>UT</td><td>84132</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>437632</td><td>1609955277</td><td>JOHN</td><td>F</td><td>BOHNSACK</td><td>null</td><td>295 S CHIPETA WAY</td><td>null</td><td>SALT LAKE CITY</td><td>UT</td><td>84108</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Rheumatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>UT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT</td><td>XELJANZ</td><td>0069-1001-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>11665.6</td><td>2021-04-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EFFICACY SAFETY TOLERABILITY AND PHARMACOKINETICS OF TOFACITINIB FOR TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS SJIA WITH ACTIVE SYSTEMIC FEATURES IN CHILDREN AND ADOLESCENT SUBJECTS</td><td>No</td><td>832882451</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>240010</td><td>10582</td><td>Mayo Clinic Hospital Rochester</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1216 2ND ST SW</td><td>null</td><td>ROCHESTER</td><td>MN</td><td>55902</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Varian Medical Systems, Inc.</td><td>100000010850</td><td>Varian Medical Systems, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Oncology</td><td>Eclipse Treatment Planning System for External Beam Radiation Therapy</td><td>null</td><td>00855141006035</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>50000.0</td><td>2021-02-17</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Improv. to GPU-Based Monte Carlo, 3D Dose Analysis</td><td>No</td><td>845840945</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>90011</td><td>10708</td><td>Washington Hospital Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>110 IRVING ST NW</td><td>null</td><td>WASHINGTON</td><td>DC</td><td>20010</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>147731</td><td>1255381778</td><td>LOWELL</td><td>null</td><td>SATLER</td><td>null</td><td>110 IRVING ST NW</td><td>ROOM 4B-1</td><td>WASHINGTON</td><td>DC</td><td>20010-2976</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>DC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>LivaNova USA, Inc.</td><td>100000176739</td><td>LivaNova USA, Inc.</td><td>TX</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>TMVR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>936.0</td><td>2021-06-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Prelude/Interlude</td><td>No</td><td>844268999</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>460009</td><td>11165</td><td>U Of U Hospitals & Clinics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>50 N Medical Dr</td><td>null</td><td>Salt Lake City</td><td>UT</td><td>84132</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>645465</td><td>1902991144</td><td>CRAIG</td><td>H</td><td>SELZMAN</td><td>null</td><td>PO BOX 413035</td><td>null</td><td>SALT LAKE CITY</td><td>UT</td><td>84141-3035</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>UT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Abbott Laboratories</td><td>100000010680</td><td>Abbott Laboratories</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Electrophysiology</td><td>EnSite Derexi</td><td>null</td><td>05415067026217</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>7000.0</td><td>2021-05-20</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Implantation of the HeartMate 3 in Subjects with Heart Failure using Surgical Techniques Other Than Full Median Sternotomy</td><td>No</td><td>827579989</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50696</td><td>11289</td><td>KECK HOSPITAL OF USC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 San Pablo Street</td><td>null</td><td>Los Angeles</td><td>CA</td><td>90033</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>838537</td><td>1700814209</td><td>HEINZ-JOSEF</td><td>null</td><td>LENZ</td><td>null</td><td>1441 EASTLAKE AVE STE 3440</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90089</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>BRAFTOVI</td><td>70255-025-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>450.24</td><td>2021-11-17</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>AN OPENLABEL MULTICENTER RANDOMIZED PHASE 3 STUDY OF FIRSTLINE ENCORAFENIB PLUS CETUXIMAB WITH OR WITHOUT CHEMOTHERAPY VERSUS STANDARD OF CARE THERAPY WITH A SAFETY LEADIN OF ENCORAFENIB AND CETUXIMAB PLUS CHEMOTHERAPY IN PARTICIPANTS WITH METASTATIC BRAF V600EMUTANT COLORECTAL CANCER</td><td>No</td><td>832595251</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Study Drug</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>53302</td><td>11301</td><td>Childrens Hospital Los Angeles</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4650 W Sunset Blvd</td><td>null</td><td>Los Angeles</td><td>CA</td><td>90027</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1146597</td><td>1508031352</td><td>LILY</td><td>null</td><td>CHAO</td><td>null</td><td>3701 WILSHIRE BLVD</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90010</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3.25</td><td>2021-08-31</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9924-4437</td><td>No</td><td>811623157</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450076</td><td>11031</td><td>UT MD ANDERSON CANCER CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 Holcombe Blvd</td><td>null</td><td>Houston</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>2776390</td><td>1942743216</td><td>TIMOTHY</td><td>A</td><td>YAP</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>455</td><td>HOUSTON</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1939.06</td><td>2021-03-01</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PHASE 12A DOSE ESCALATION AND EXPANSION STUDY EVALUATING SAFETY TOLERABILITY PHARMACOKINETIC PHARMACODYNAMICS AND ANTITUMOR ACTIVITY OF PF06873600 AS A SINGLE AGENT AND IN COMBINATION WITH ENDOCRINE THERAPY</td><td>No</td><td>832918609</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Study Drug</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>140010</td><td>10431</td><td>Northshore University Healthsystem</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2650 Ridge Ave</td><td>null</td><td>Evanston</td><td>IL</td><td>60201</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>376100</td><td>1457528101</td><td>LIANA</td><td>K</td><td>BILLINGS</td><td>null</td><td>9977 WOODS DR</td><td>STE 300</td><td>SKOKIE</td><td>IL</td><td>60077</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>Diabetes</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>22.76</td><td>2021-09-03</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9536-4388</td><td>No</td><td>810797523</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230297</td><td>10146</td><td>Karmanos Cancer Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4100 John R St</td><td>null</td><td>Detroit</td><td>MI</td><td>48201</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>728247</td><td>1790982031</td><td>IRA</td><td>null</td><td>WINER</td><td>null</td><td>4100 JOHN R</td><td>KARMANOS CANCER CENTER</td><td>DETROIT</td><td>MI</td><td>48201-2013</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alkermes, Inc.</td><td>100000000255</td><td>Alkermes, Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>KEYTRUDA</td><td>0006-3026-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1751.81</td><td>2021-01-26</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 1/2 Study of ALKS 4230 Administered Intravenously as Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors - ARTISTRY-1</td><td>No</td><td>797819087</td><td>2021</td><td>06/30/2022</td><td>NCT02799095</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>310001</td><td>10178</td><td>HACKENSACK UNIVERSITY MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>30 PROSPECT AVE</td><td>null</td><td>HACKENSACK</td><td>NJ</td><td>07601</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>191659</td><td>1215992912</td><td>ANDRE</td><td>H</td><td>GOY</td><td>null</td><td>92 2ND ST</td><td>null</td><td>HACKENSACK</td><td>NJ</td><td>07601</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>DC</td><td>NJ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>Actemra</td><td>50242-137-01</td><td>null</td><td>Covered</td><td>Biological</td><td>BioOncology</td><td>GAZYVA</td><td>50242-070-01</td><td>null</td><td>Covered</td><td>Biological</td><td>BioOncology</td><td>TECENTRIQ</td><td>50242-917-01</td><td>null</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>891.45</td><td>2021-11-29</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PH1 DOSE FINDING OF CD20 CD3 TDB IN B CELL NHL</td><td>No</td><td>835912531</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500008</td><td>11198</td><td>UNIVERSITY OF WASHINGTON MED CTR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1959 Ne Pacific St</td><td>null</td><td>Seattle</td><td>WA</td><td>98195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1322052</td><td>1023317898</td><td>MICHAEL</td><td>J</td><td>WAGNER</td><td>null</td><td>825 EASTLAKE AVE E</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98109-4405</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>QINLOCK</td><td>73207-101-31</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>63.5</td><td>2021-07-01</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>INTRIGUE A STUDY OF DCC-2618 VS SUNITINIB IN ADVANCED GIST PATIENTS AFTER TREATMENT WITH IMATINIB INTRIGUE</td><td>No</td><td>827889699</td><td>2021</td><td>06/30/2022</td><td>NCT03673501</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>10033</td><td>10929</td><td>UNIVERSITY OF ALABAMA HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>619 19th St S</td><td>null</td><td>Birmingham</td><td>AL</td><td>35249</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>6366202</td><td>1982921268</td><td>NATHANIEL</td><td>null</td><td>ERDMANN</td><td>null</td><td>619 19TH ST S</td><td>619 19TH ST S</td><td>BIRMINGHAM</td><td>AL</td><td>35249-1900</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Merck Sharp & Dohme Corporation</td><td>100000000053</td><td>Merck Sharp & Dohme Corporation</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>INFECTIOUS DISEASE</td><td>PREVYMIS</td><td>0006-5004-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>17296.15</td><td>2021-07-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Letermovir Versus Valganciclovir for the Prevention of Human Cytomegalovirus CMV Disease in Adult Kidney Transplant Recipients</td><td>No</td><td>848756655</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>248828</td><td>1497711238</td><td>EMIL</td><td>FRANK</td><td>VALLE</td><td>null</td><td>11440 COMMERCE PARK DR STE LL4</td><td>null</td><td>RESTON</td><td>VA</td><td>20191</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>VA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1096.08</td><td>2021-02-16</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>AN ADAPTIVE PHASE 2, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF LY3471851 (NKTR 358) IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS</td><td>No</td><td>819443957</td><td>2021</td><td>06/30/2022</td><td>NCT04677179</td><td>https://clinicaltrials.gov/ct2/show/NCT04677179</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>260141</td><td>10617</td><td>Univ Of Missouri Health Care</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>One Hospital Drive</td><td>null</td><td>Columbia</td><td>MO</td><td>65212</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alkermes, Inc.</td><td>100000000255</td><td>Alkermes, Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>CNS</td><td>OLANZAPINE</td><td>0093-5245-65</td><td>null</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1990.9</td><td>2021-02-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Study to Evaluate the Effect of ALKS 3831 Compared to OLANZAPINE on Body Weight in Young Adults with Schizophrenia, Schizophreniform, or Bipolar I Disorder Who are Early in Their Illness</td><td>No</td><td>797819343</td><td>2021</td><td>06/30/2022</td><td>NCT03187769</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>380009</td><td>11212</td><td>OHSU HOSPITAL AND CLINICS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3181 Sw Sam Jackson Park Rd</td><td>null</td><td>Portland</td><td>OR</td><td>97239</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>147563</td><td>1265448864</td><td>PAUL</td><td>B</td><td>DUELL</td><td>null</td><td>3181 SW SAM JACKSON PARK RD</td><td>null</td><td>PORTLAND</td><td>OR</td><td>97239-3011</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>CARDIOVASCULAR AND METABOLISM</td><td>EVKEEZA</td><td>61755-010-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>384.0</td><td>2021-04-16</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>AN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF EVINACUMAB IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA</td><td>No</td><td>793088907</td><td>2021</td><td>06/30/2022</td><td>NCT03409744</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>523300</td><td>10556</td><td>Childrens Hospital Of Wisconsin</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9000 W Wisconsin Ave</td><td>null</td><td>Milwaukee</td><td>WI</td><td>53226</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>999419</td><td>1336253822</td><td>Robert</td><td>A</td><td>Niebler</td><td>null</td><td>9000 W Wisconsin Ave</td><td>null</td><td>Milwaukee</td><td>WI</td><td>53226</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Daiichi Sankyo Inc.</td><td>100000000195</td><td>Daiichi Sankyo Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Thrombosis</td><td>SAVAYSA</td><td>65597-201-07</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>8.95</td><td>2021-07-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>DU176b-D-U312</td><td>No</td><td>835064695</td><td>2021</td><td>06/30/2022</td><td>NCT02798471</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>160058</td><td>10604</td><td>UNIVERSITY OF IOWA HOSP & CLINICS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>200 Hawkins Dr</td><td>null</td><td>Iowa City</td><td>IA</td><td>52242</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>698436</td><td>1760464143</td><td>WARREN</td><td>N</td><td>SCHMIDT</td><td>null</td><td>200 HAWKINS DR</td><td>null</td><td>IOWA CITY</td><td>IA</td><td>52242-1009</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allergan, Inc.</td><td>100000000278</td><td>Allergan, Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>945.0</td><td>2021-06-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (NASH)</td><td>No</td><td>789015481</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>3152-201-002</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>306129</td><td>1750447660</td><td>RISHI</td><td>P</td><td>SINGH</td><td>null</td><td>9500 EUCLID AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44195</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Ophthalmology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000005656</td><td>F. Hoffmann-La Roche AG</td><td>null</td><td>Switzerland</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>344.07</td><td>2021-05-28</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, ACTIVE COMPARATOR CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RO6867461 IN PATIENTS WITH DIABETIC MACULAR EDEMA YOSEMITE, A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, ACTIVE COMPARATORCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RO6867461 IN PATIENTS WITH DIABETIC MACULAR EDEMA RHINE</td><td>No</td><td>835903907</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>33302</td><td>11161</td><td>PHOENIX CHILDRENS HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1919 E Thomas Rd</td><td>null</td><td>Phoenix</td><td>AZ</td><td>85016</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>524930</td><td>1679708002</td><td>SHAUNA</td><td>R</td><td>SCHROEDER</td><td>null</td><td>1919 E THOMAS RD</td><td>null</td><td>PHOENIX</td><td>AZ</td><td>85016-7710</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>INFLAMMATION AND  IMMUNOLOGY</td><td>DUPIXENT</td><td>0024-5914-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1134.69</td><td>2021-08-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN PEDIATRIC PATIENTS WITH ACTIVE EOSINOPHILIC ESOPHAGITIS</td><td>No</td><td>793089163</td><td>2021</td><td>06/30/2022</td><td>NCT04394351</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1081628</td><td>1235206285</td><td>EHAB</td><td>L</td><td>ATALLAH</td><td>null</td><td>9200 W WISCONSIN AVE</td><td>NEOPLASTIC DISEASES</td><td>MILWAUKEE</td><td>WI</td><td>53226-3522</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Astellas Pharma Global Development</td><td>100000005406</td><td>Astellas Pharma Global Development</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>XOSPATA</td><td>0469-1425-90</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>68.52</td><td>2021-09-21</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3 Open-label Multicenter Randomized Study of ASP2215 versus Salvage Chemotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with FLT3 Mutation.</td><td>No</td><td>801077531</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450076</td><td>11031</td><td>UT MD ANDERSON CANCER CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 Holcombe Blvd</td><td>null</td><td>Houston</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>2776390</td><td>1942743216</td><td>TIMOTHY</td><td>A</td><td>YAP</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>455</td><td>HOUSTON</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>38051.88</td><td>2021-03-04</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY EVALUATING SAFETY TOLERABILITY AND PHARMACOKINETICS OF PF 06952229 IN ADULT PATIENTS WITH ADVANCED SOLID TUMORS</td><td>No</td><td>832919827</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Study Drug</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390196</td><td>10211</td><td>AMERICAN ONCOLOGIC HOSPIAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>333 Cottman Ave</td><td>null</td><td>Philadelphia</td><td>PA</td><td>19111</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>233516</td><td>1144243858</td><td>MARGARET</td><td>null</td><td>VON MEHREN</td><td>null</td><td>333 COTTMAN AVE</td><td>null</td><td>PHILADELPHIA</td><td>PA</td><td>19111</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>QINLOCK</td><td>73207-101-31</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1742.3</td><td>2021-05-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A SAFETY TOLERABILITY AND PK STUDY OF DCC-2618 IN PATIENTS WITH ADVANCED MALIGNANCIES</td><td>No</td><td>827885689</td><td>2021</td><td>06/30/2022</td><td>NCT02571036</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>340040</td><td>10762</td><td>Pitt County Memorial Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2100 STANTONSBURG RD</td><td>null</td><td>GREENVILLE</td><td>NC</td><td>27834</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>6956</td><td>1134388051</td><td>VIJAY</td><td>null</td><td>CHAUDHARY</td><td>null</td><td>2100 Stantonsburg Rd</td><td>null</td><td>GREENVILLE</td><td>NC</td><td>27834</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Seagen Inc.</td><td>100000000279</td><td>Seagen Inc.</td><td>WA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Oncology</td><td>PADCEV</td><td>51144-030-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>675.0</td><td>2021-07-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Dose-escalation and Dose-expansion Study of Enfortumab Vedotin (ASG-22CE) in Combination With Pembrolizumab and/or Chemotherapy for Treatment of Patients With Locally Advanced or Metastatic Urothelial Cancer</td><td>No</td><td>792654759</td><td>2021</td><td>06/30/2022</td><td>NCT03288545</td><td>https://clinicaltrials.gov/ct2/show/NCT03288545</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>53302</td><td>11301</td><td>Childrens Hospital Los Angeles</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4650 W Sunset Blvd</td><td>null</td><td>Los Angeles</td><td>CA</td><td>90027</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1146597</td><td>1508031352</td><td>LILY</td><td>null</td><td>CHAO</td><td>null</td><td>3701 WILSHIRE BLVD</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90010</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4.5</td><td>2021-11-19</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9924-4437</td><td>No</td><td>811624157</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>363305</td><td>10350</td><td>NATIONWIDE CHILDRENS HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>700 Childrens Dr</td><td>null</td><td>COLUMBUS</td><td>OH</td><td>43205</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>852810</td><td>1205824331</td><td>MARK</td><td>A</td><td>RANALLI</td><td>null</td><td>5209 MILLER PAUL RD</td><td>null</td><td>WESTERVILLE</td><td>OH</td><td>43082</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>IBRANCE</td><td>0069-0187-21</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>99.85</td><td>2021-03-08</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PHASE 1 STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF PALBOCICLIB IBRANCEREGISTERED IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE AND IN COMBINATION WITH TOPOTECAN AND CYCLOPHOSPHAMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS</td><td>No</td><td>832921037</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Study Drug</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>30087</td><td>11159</td><td>HONORHEALTH SCOTTSDALE SHEA MED CTR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9003 E Shea Blvd</td><td>null</td><td>Scottsdale</td><td>AZ</td><td>85260</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>277405</td><td>1114929114</td><td>MICHAEL</td><td>S</td><td>GORDON</td><td>null</td><td>9055 E DEL CAMINO DR</td><td>SUITE 100</td><td>SCOTTSDALE</td><td>AZ</td><td>85258-2351</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>QINLOCK</td><td>73207-101-31</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>101.25</td><td>2021-04-03</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A SAFETY TOLERABILITY AND PK STUDY OF DCC-2618 IN PATIENTS WITH ADVANCED MALIGNANCIES</td><td>No</td><td>827885947</td><td>2021</td><td>06/30/2022</td><td>NCT02571036</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>30087</td><td>11159</td><td>HONORHEALTH SCOTTSDALE SHEA MED CTR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9003 E SHEA BLVD</td><td>null</td><td>SCOTTSDALE</td><td>AZ</td><td>85260</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>277405</td><td>1114929114</td><td>MICHAEL</td><td>S</td><td>GORDON</td><td>null</td><td>9055 E DEL CAMINO DR</td><td>SUITE 100</td><td>SCOTTSDALE</td><td>AZ</td><td>85258</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>BioOncology</td><td>TECENTRIQ</td><td>50242-917-01</td><td>null</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1941.94</td><td>2021-02-17</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE IA IB OPEN LABEL DOSE ESCALATION STUDY OF THE SAFETY AND PHARMACOKINETICS OF XMAB24306 ALO</td><td>No</td><td>835913491</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>763950</td><td>1063764207</td><td>GILBERT</td><td>ANTONIO</td><td>JENOURI</td><td>null</td><td>679 MAIN ST</td><td>null</td><td>JOHNSON CITY</td><td>NY</td><td>13790</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>18725.0</td><td>2021-08-24</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>RANDOMIZED, PLACEBO CONTROLLED, PHASE 2 CLINICAL TRIAL TO EVALUATE LY3556050 FOR THE TREATMENT OF OSTEOARTHRITIS PAIN</td><td>No</td><td>819444217</td><td>2021</td><td>06/30/2022</td><td>NCT04627038</td><td>https://www.clinicaltrials.gov/ct2/show/NCT04627038</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>160058</td><td>10604</td><td>University Of Iowa Hosp & Clinics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>200 HAWKINS DR</td><td>null</td><td>IOWA CITY</td><td>IA</td><td>52242</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1299200</td><td>1326207978</td><td>MARIKO</td><td>null</td><td>SATO</td><td>null</td><td>100 N MARIO CAPECCHI DR</td><td>null</td><td>SALT LAKE CITY</td><td>UT</td><td>84113</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>37.08</td><td>2021-09-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearranged and or JAK Pathway Mutant Acute Lymphoblastic Leukemia</td><td>No</td><td>831112787</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230297</td><td>10146</td><td>KARMANOS CANCER HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4100 JOHN R ST</td><td>null</td><td>DETROIT</td><td>MI</td><td>48201</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>945091</td><td>1437446820</td><td>HIRVA</td><td>MANSURALI</td><td>MAMDANI</td><td>null</td><td>4100 JOHN R ST</td><td>null</td><td>DETROIT</td><td>MI</td><td>48201</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IN</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>BioOncology</td><td>TECENTRIQ</td><td>50242-917-01</td><td>null</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4344.8</td><td>2021-12-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PHII PLACEBO CONTROLLED OF TIRAGOLUMAB AND ATEZO IN NSCLC</td><td>No</td><td>835914485</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220110</td><td>9985</td><td>Brigham And Womens Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>75 Francis St</td><td>null</td><td>Boston</td><td>MA</td><td>02115</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>838542</td><td>1700877982</td><td>GARY</td><td>M</td><td>HUNNINGHAKE</td><td>null</td><td>55 FRUIT ST</td><td>BUL 148</td><td>BOSTON</td><td>MA</td><td>02114-2621</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Boehringer Ingelheim USA, Inc.</td><td>100000061372</td><td>Boehringer Ingelheim Limited</td><td>null</td><td>Great Britain (Uk)</td><td>Yes</td><td>Covered</td><td>Drug</td><td>RESPIRATORY</td><td>OFEV</td><td>0597-0143-60</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>23.32</td><td>2021-01-26</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Nintedanib in PF-ILD (extension)</td><td>No</td><td>827034729</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>240960</td><td>1326011255</td><td>JOEL</td><td>null</td><td>ROSH</td><td>null</td><td>100 MADISON AVE</td><td>null</td><td>MORRISTOWN</td><td>NJ</td><td>07960</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NJ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>369.54</td><td>2021-04-27</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>MULTICENTER, OPEN-LABEL PK STUDY OF MIRIKIZUMAB IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS</td><td>No</td><td>819444477</td><td>2021</td><td>06/30/2022</td><td>NCT04004611</td><td>https://clinicaltrials.gov/ct2/show/NCT04004611</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor in connection with clinical studies during the reporting period.  For available study details, please visit clinicaltrials.gov.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50696</td><td>11289</td><td>KECK HOSPITAL OF USC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 SAN PABLO STREET</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90033</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>285051</td><td>1285822445</td><td>MAY</td><td>ANNE</td><td>KIM-TENSER</td><td>null</td><td>1540 ALCAZAR ST</td><td>204M</td><td>LOS ANGELES</td><td>CA</td><td>90089</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurocritical Care</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>CA</td><td>FL</td><td>GA</td><td>IN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1042.2</td><td>2021-02-17</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>TENECTEPLASE IN STROKE PATIENTS BETWEEN 4 5 AND 24 HOURS</td><td>No</td><td>835915369</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>110010</td><td>10785</td><td>Emory University Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1821 CLIFTON RD NE</td><td>null</td><td>ATLANTA</td><td>GA</td><td>30329</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>585635</td><td>1811160609</td><td>HONG</td><td>null</td><td>LI</td><td>null</td><td>OFFICE FOR CLINICAL RESEARCH</td><td>null</td><td>ATLANTA</td><td>GA</td><td>30322</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Medical Genetics|Clinical Genetics (M.D.)</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Moderna TX, Inc.</td><td>100000961851</td><td>Moderna TX, Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1390.0</td><td>2021-10-20</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A longitudinal, exploratory, natural history study to further characterize and describe the signs and symptoms of patients with organic acidemias.</td><td>No</td><td>806342189</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>31926</td><td>1700996931</td><td>STEPHEN</td><td>L.</td><td>HAUSER</td><td>null</td><td>1651 4TH ST</td><td>null</td><td>SAN FRANCISCO</td><td>CA</td><td>94143</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000005656</td><td>F. Hoffmann-La Roche AG</td><td>null</td><td>Switzerland</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>OCREVUS</td><td>50242-150-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2556.62</td><td>2021-07-21</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>LONG-TERM SUPPRESSION OF MRI DISEASE ACTIVITY AND REDUCTION OF GLOBALREGIONAL VOLUME LOSS RESULTS FROM OPERA III AND ORATORIO OPEN-LABEL EXTENSION</td><td>No</td><td>835904721</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390133</td><td>10231</td><td>Lehigh Valley</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1200 S CEDAR CREST BLVD</td><td>null</td><td>ALLENTOWN</td><td>PA</td><td>18103</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>40820</td><td>1891812905</td><td>ERIC</td><td>OWEN</td><td>MUELLER</td><td>null</td><td>1230 S Cedar Crest Blvd</td><td>Ste 201</td><td>ALLENTOWN</td><td>PA</td><td>18103</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Osteopathy</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Medtronic, Inc.</td><td>100000000106</td><td>Medtronic, Inc.</td><td>MN</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Pacemakers</td><td>Micra</td><td>null</td><td>00643169711761</td><td>Covered</td><td>Device</td><td>Leads</td><td>Sprint Quattro</td><td>null</td><td>00643169690042</td><td>Covered</td><td>Device</td><td>Leads</td><td>SelectSecure</td><td>null</td><td>00643169535848</td><td>Covered</td><td>Device</td><td>Leads</td><td>Capsure Sense</td><td>null</td><td>643169590519</td><td>Covered</td><td>Device</td><td>Implantable Cardioverter Defibrillators (ICDs)</td><td>Cobalt</td><td>null</td><td>763000178390</td><td>750.0</td><td>2021-09-14</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PSR-CVG</td><td>No</td><td>800997357</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>440039</td><td>10425</td><td>Vanderbilt University Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1211 MEDICAL CENTER DRIVE</td><td>null</td><td>NASHVILLE</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1269688</td><td>1851488985</td><td>KATHRYN</td><td>M.</td><td>DAHIR</td><td>null</td><td>1215 21st Ave S Ste 8210</td><td>null</td><td>Nashville</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alexion Pharmaceuticals, Inc.</td><td>100000005462</td><td>Alexion Pharmaceuticals, Inc.</td><td>MA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>634.0</td><td>2021-04-20</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>An Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)</td><td>No</td><td>781380205</td><td>2021</td><td>06/30/2022</td><td>NCT02306720</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>410007</td><td>10008</td><td>RHODE ISLAND HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>593 Eddy Street</td><td>null</td><td>Providence</td><td>RI</td><td>02914</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>72892</td><td>1629041074</td><td>ELEFTHERI</td><td>E</td><td>MYLONAKIS</td><td>null</td><td>164 SUMMIT AVE</td><td>null</td><td>PROVIDENCE</td><td>RI</td><td>02906-2853</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>RI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12672.95</td><td>2021-10-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A MASTER PROTOCOL ASSESSING THE SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-SPIKE (S) SARS-COV-2 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF AMBULATORY PATIENTS WITH COVID-19</td><td>No</td><td>793089419</td><td>2021</td><td>06/30/2022</td><td>NCT04425629</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>146932</td><td>1245316199</td><td>MAHA</td><td>HADI</td><td>HUSSAIN</td><td>null</td><td>1500 EAST MEDICAL CENTER DR</td><td>B1 FLOOR CANCER CTR RECP D</td><td>ANN ARBOR</td><td>MI</td><td>48109-5913</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Astellas Pharma Global Development</td><td>100000005406</td><td>Astellas Pharma Global Development</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>XTANDI</td><td>0469-0125-99</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>963.51</td><td>2021-04-15</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Matching-adjusted indirect treatment comparison of the efficacy of enzalutamide for the treatment of non-metastatic castration-resistant prostate cancer</td><td>No</td><td>801077793</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390111</td><td>10224</td><td>Hospital Of The Univ Of Penna</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3701 Market St</td><td>null</td><td>Phila</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>866275</td><td>1689608572</td><td>MARK</td><td>null</td><td>MORGAN</td><td>null</td><td>800 SPRUCE STREET</td><td>null</td><td>PHILADELPHIA</td><td>PA</td><td>19107</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NJ</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Clovis Oncology, Inc.</td><td>100000191752</td><td>Clovis Oncology, Inc.</td><td>CO</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>Rubraca</td><td>69660-201-91</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>17468.75</td><td>2021-01-04</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy (ATHENA)</td><td>No</td><td>796700063</td><td>2021</td><td>06/30/2022</td><td>NCT03522246</td><td>null</td><td>CO-338-087</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220086</td><td>9982</td><td>Beth Israel Deaconess Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>330 Brookline Ave</td><td>St 207</td><td>Boston</td><td>MA</td><td>02215</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1238506</td><td>1750366977</td><td>DOUGLAS</td><td>M</td><td>BEACH</td><td>null</td><td>330 BROOKLINE AVE</td><td>null</td><td>BOSTON</td><td>MA</td><td>02215</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AstraZeneca Pharmaceuticals LP</td><td>100000000146</td><td>AstraZeneca Pharmaceuticals LP</td><td>DE</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Respiratory</td><td>FASENRA</td><td>0310-1730-30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>13500.0</td><td>2021-02-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Randomised, Double-blind, Active-controlled 52-week Study with an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab Compared to Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA) in Patients Receiving Standard of Care Therapy</td><td>No</td><td>826501103</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50660</td><td>11290</td><td>Usc Norris Cancer Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1441 Eastlake Ave</td><td>null</td><td>Los Angeles</td><td>CA</td><td>90089</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>266439</td><td>1881629566</td><td>MARK</td><td>JOSEPH</td><td>CUNNINGHAM</td><td>null</td><td>PO BOX 31309</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90031-0309</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery)</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Abbott Laboratories</td><td>100000010680</td><td>Abbott Laboratories</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Vascular</td><td>Xience Sierra Coronary Stent</td><td>null</td><td>08717648227547</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1096.0</td><td>2021-11-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO)</td><td>No</td><td>827581017</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>30103</td><td>11162</td><td>MAYO CLINIC HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5777 E Mayo Blvd</td><td>null</td><td>Phoenix</td><td>AZ</td><td>85054</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>203751</td><td>1487781175</td><td>MAHESH</td><td>null</td><td>SEETHARAM</td><td>null</td><td>5777 E MAYO BLVD</td><td>null</td><td>PHOENIX</td><td>AZ</td><td>85054-4502</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>QINLOCK</td><td>73207-101-31</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2221.0</td><td>2021-07-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>INTRIGUE A STUDY OF DCC-2618 VS SUNITINIB IN ADVANCED GIST PATIENTS AFTER TREATMENT WITH IMATINIB INTRIGUE</td><td>No</td><td>827886203</td><td>2021</td><td>06/30/2022</td><td>NCT03673501</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100271</td><td>10837</td><td>Moffitt Cancer Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12902 MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>360901</td><td>1942266929</td><td>RAMI</td><td>S.</td><td>KOMROKJI</td><td>null</td><td>12902 USF MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>10.98</td><td>2021-01-11</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY</td><td>No</td><td>831097711</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450051</td><td>11035</td><td>Methodist Dallas Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1441 N Beckley Ave</td><td>null</td><td>Dallas</td><td>TX</td><td>75203</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>123736</td><td>1720042070</td><td>Islam</td><td>null</td><td>Shahin</td><td>null</td><td>1750 N HAMPTON RD</td><td>null</td><td>DESOTO</td><td>TX</td><td>75115</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Sirtex Medical Inc</td><td>100000010918</td><td>Sirtex Medical Inc</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Interventional Oncology</td><td>SIR-Spheres Microspheres</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>150.0</td><td>2021-04-01</td><td>Cash or cash equivalent</td><td>Patient Care</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Yes</td><td>No</td><td>Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Study</td><td>No</td><td>855363111</td><td>2021</td><td>06/30/2022</td><td>NCT02685631</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100271</td><td>10837</td><td>MOFFITT CANCER CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12902 Magnolia Dr</td><td>null</td><td>Tampa</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1294667</td><td>1073707170</td><td>MIHAELA</td><td>null</td><td>DRUTA</td><td>null</td><td>12902 USF MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612-9416</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>QINLOCK</td><td>73207-101-31</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>544.0</td><td>2021-04-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>INTRIGUE A STUDY OF DCC-2618 VS SUNITINIB IN ADVANCED GIST PATIENTS AFTER TREATMENT WITH IMATINIB INTRIGUE</td><td>No</td><td>827886459</td><td>2021</td><td>06/30/2022</td><td>NCT03673501</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>380009</td><td>11212</td><td>OHSU HOSPITAL AND CLINICS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3181 Sw Sam Jackson Park Rd</td><td>null</td><td>Portland</td><td>OR</td><td>97239</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>362051</td><td>1972511426</td><td>ERIC</td><td>L</td><td>SIMPSON</td><td>null</td><td>3181 SW SAM JACKSON PARK RD</td><td>null</td><td>PORTLAND</td><td>OR</td><td>97239-3011</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Kyowa Kirin, Inc.</td><td>100000010604</td><td>Kyowa Kirin, Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1000.0</td><td>2021-07-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo controlled Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects with Moderate to Severe Atopic Dermatitis (AD)</td><td>No</td><td>853000333</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>4083-006</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>348274</td><td>1689669293</td><td>JENNIFER</td><td>MARIE</td><td>BELLUCCI JACKSON</td><td>null</td><td>425 LAKE ST</td><td>null</td><td>ANTIOCH</td><td>IL</td><td>60002</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Family Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>810.0</td><td>2021-06-11</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PREVENTIVE TREATMENT OF MIGRAINE: OUTCOMES FOR PATIENTS IN REAL-WORLD HEALTHCARE SYSTEMS (TRIUMPH)</td><td>No</td><td>819444739</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>224007</td><td>9987</td><td>Mclean Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>115 Mill St</td><td>null</td><td>Belmont</td><td>MA</td><td>02478</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alkermes, Inc.</td><td>100000000255</td><td>Alkermes, Inc.</td><td>MA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>24530.44</td><td>2021-03-01</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>In vivo research observing brain lactate changes in first-episode schizophrenia using 3-T magnetic resonance spectroscopy</td><td>No</td><td>797820111</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50696</td><td>11289</td><td>Keck Hospital Of Usc</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 SAN PABLO STREET</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90033</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>102763</td><td>1275578957</td><td>ANN</td><td>F.</td><td>MOHRBACHER</td><td>null</td><td>1441 EASTLAKE AVE</td><td>STE 162</td><td>LOS ANGELES</td><td>CA</td><td>90089</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>47.0</td><td>2021-09-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 1b/2a Basket Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Combination Therapy With the Anti CD19 Monoclonal Antibody Tafasitamab and the PI3Kd Inhibitor Parsaclisib in Adult Participants With Relapsed/Refractory Non Hodgkin Lymphoma or Chronic Lymphocytic Leukemia</td><td>No</td><td>831114315</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>54144</td><td>11286</td><td>LANGLEY PORTER PSYCHIATRIC HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>401 PARNASSUS AVE</td><td>null</td><td>SAN FRANCISCO</td><td>CA</td><td>94143</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1137763</td><td>1205009115</td><td>JEFFREY</td><td>MARC</td><td>GELFAND</td><td>null</td><td>505 PARNASSUS AVE</td><td>39</td><td>SAN FRANCISCO</td><td>CA</td><td>94143</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>OCREVUS</td><td>50242-150-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>7020.0</td><td>2021-09-20</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>MNT OBOE</td><td>No</td><td>835916447</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50625</td><td>11293</td><td>Cedars-Sinai Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>8700 Beverly Blvd</td><td>null</td><td>West Hollywood</td><td>CA</td><td>90048</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>467133</td><td>1649290248</td><td>KAREN</td><td>null</td><td>RECKAMP</td><td>null</td><td>1500 E. DUARTE RD</td><td>null</td><td>DUARTE</td><td>CA</td><td>91010</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Janssen Research & Development, LLC</td><td>100000005592</td><td>Janssen Research & Development, LLC</td><td>NJ</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>32832.26</td><td>2021-09-27</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>An Open label Phase 11b Study to Evaluate the Safety and Pharmacokinetics of JNJ73841937 Lazertinib a Third Generation EGFRTKI as Monotherapy or in Combinations With JNJ61186372 a Human Bispecific EGFR and cMet Antibody in Participants With Advanced Non Sm</td><td>No</td><td>787577909</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390111</td><td>10224</td><td>HOSPITAL OF THE UNIV OF PENNA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3701 MARKET ST</td><td>null</td><td>PHILA</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>179546</td><td>1962546952</td><td>SUSAN</td><td>C</td><td>TAYLOR</td><td>null</td><td>800 WALNUT ST</td><td>null</td><td>PHILADELPHIA</td><td>PA</td><td>19107</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1889.62</td><td>2021-02-08</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, OPERATIONALLY SEAMLESS, ADAPTIVE PHASE 2/3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BARICITINIB IN ADULT PATIENTS WITH SEVERE OR VERY SEVERE ALOPECIA AREATA</td><td>No</td><td>819448081</td><td>2021</td><td>06/30/2022</td><td>NCT03570749</td><td>https://clinicaltrials.gov/ct2/show/NCT03570749</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500054</td><td>10477</td><td>Prov Sacred Heart Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>101 W. 8th Ave.</td><td>null</td><td>Spokane</td><td>WA</td><td>99220</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>249693</td><td>1508905522</td><td>ALMA</td><td>null</td><td>CHAVEZ</td><td>null</td><td>105 W 8TH AVE</td><td>null</td><td>SPOKANE</td><td>WA</td><td>99204</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Pulmonology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>VERTEX PHARMACEUTICALS INCORPORATED</td><td>100000000184</td><td>VERTEX PHARMACEUTICALS INCORPORATED</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>19117.03</td><td>2021-01-01</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Study Evaluating the Long-term Safety of VX-445 Combination Therapy</td><td>No</td><td>793094287</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220162</td><td>9984</td><td>Dana-Farber Cancer Institute</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>450 BROOKLINE AVE</td><td>null</td><td>BOSTON</td><td>MA</td><td>02215</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>260575</td><td>1730156324</td><td>FRANK</td><td>STEPHEN</td><td>HODI</td><td>null</td><td>44 BINNEY ST</td><td>RM DLI</td><td>BOSTON</td><td>MA</td><td>02115</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>35.16</td><td>2021-01-11</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 1 Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Select Advanced Solid Tumors</td><td>No</td><td>831072557</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>97323</td><td>1144275827</td><td>THOMAS</td><td>ROBERT</td><td>MURPHY</td><td>null</td><td>415 FISH TALE RD</td><td>null</td><td>DANIEL ISLAND</td><td>SC</td><td>29492</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Allergy & Immunology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>SC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000005656</td><td>F. Hoffmann-La Roche AG</td><td>null</td><td>Switzerland</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>Xolair</td><td>50242-040-62</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3100.0</td><td>2021-04-16</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>COVID-19 OUTCOMES IN PATIENTS WITH ASTHMA WITH OR WITHOUT EVIDENCE OF ALLERGY</td><td>No</td><td>835905523</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>26119</td><td>1588677736</td><td>HENRY</td><td>W</td><td>TRAYLOR</td><td>JR.</td><td>1615 DOCTORS CIR</td><td>null</td><td>WILMINGTON</td><td>NC</td><td>28401</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>6.5</td><td>2021-08-04</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9924-4473</td><td>No</td><td>810917185</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>440039</td><td>10425</td><td>VANDERBILT UNIVERSITY MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1211 Medical Center Drive</td><td>null</td><td>Nashville</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>319378</td><td>1033206149</td><td>MICHAEL</td><td>null</td><td>PORAYKO</td><td>null</td><td>1301 MEDICAL CENTER DR</td><td>null</td><td>NASHVILLE</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9180.4</td><td>2021-11-24</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 2 RANDOMIZED DOUBLEBLIND DOUBLEDUMMY PLACEBOCONTROLLED DOSERANGING DOSEFINDING PARALLEL GROUP STUDY TO ASSESS EFFICACY AND SAFETY OF PF06865571 DGAT2I ALONE AND WHEN COADMINISTERED WITH PF05221304 ACCI IN ADULT PARTICIPANTS WITH BIOPSYCONFIRMED NONALCOHOLIC STEATOHEPATITIS AND FIBROSIS STAGE 2 OR 3</td><td>No</td><td>832885949</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100087</td><td>10843</td><td>SARASOTA MEMORIAL HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1700 S Tamiami Trl</td><td>null</td><td>Sarasota</td><td>FL</td><td>34239</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>333556</td><td>1346347887</td><td>MANUEL</td><td>E</td><td>GORDILLO</td><td>null</td><td>1425 S OSPREY AVE</td><td>STE 1</td><td>SARASOTA</td><td>FL</td><td>34239</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3778.0</td><td>2021-04-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A MASTER PROTOCOL ASSESSING THE SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-SPIKE (S) SARS-COV-2 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF AMBULATORY PATIENTS WITH COVID-19</td><td>No</td><td>793089675</td><td>2021</td><td>06/30/2022</td><td>NCT04425629</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100007</td><td>10819</td><td>Adventhealth Orlando</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>601 E ROLLINS ST</td><td>null</td><td>ORLANDO</td><td>FL</td><td>32803</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>306919</td><td>1770576258</td><td>CARLOS</td><td>A.</td><td>ALEMANY</td><td>null</td><td>2501 N Orange Ave</td><td>null</td><td>ORLANDO</td><td>FL</td><td>32804</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Seagen Inc.</td><td>100000000279</td><td>Seagen Inc.</td><td>WA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>TUKYSA</td><td>51144-001-60</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>17929.35</td><td>2021-02-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer</td><td>No</td><td>792655531</td><td>2021</td><td>06/30/2022</td><td>NCT03975647</td><td>https://clinicaltrials.gov/ct2/show/NCT03975647</td><td>This study is designed to evaluate the efficacy and safety of tucatinib in combination with T-DM1 in subjects with unresectable locally-advanced or metastatic HER2+ breast cancer who have had prior treatment with a taxane and trastuzumab in any setting. Prior pertuzumab treatment is permitted, but not required. Subjects will be randomized in a 1:1 manner to receive 21-day cycles of either tucatinib or placebo in combination with T-DM1.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50077</td><td>11300</td><td>Scripps Mercy Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4077 5th Ave</td><td>null</td><td>San Diego</td><td>CA</td><td>92103</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>13194</td><td>1285612457</td><td>JAMES</td><td>T</td><td>HEYWOOD</td><td>null</td><td>10790 RANCHO BERNARDO RD</td><td>null</td><td>SAN DIEGO</td><td>CA</td><td>92127-5705</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Advanced Heart Failure and Transplant Cardiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Abbott Laboratories</td><td>100000010680</td><td>Abbott Laboratories</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Heart Failure</td><td>CardioMEMS HF System</td><td>null</td><td>05414734509800</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2000.0</td><td>2021-01-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>INvesTigation to OptimizE Hemodynamic Management of HeartMate II Left VentricuLar Assist DEvice Patients using the CardioMEMS Pulmonary ArTery Pressure Sensor in Advanced Heart Failure (INTELLECT 2-HF)</td><td>No</td><td>827581531</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100087</td><td>10843</td><td>Sarasota Memorial Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1700 S. Tamiami Trail</td><td>null</td><td>Sarasota</td><td>FL</td><td>34239</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>227609</td><td>1023086501</td><td>Justin</td><td>null</td><td>Lee</td><td>null</td><td>1700 S TAMIAMI TRL</td><td>null</td><td>SARASOTA</td><td>FL</td><td>34239</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Sirtex Medical Inc</td><td>100000010918</td><td>Sirtex Medical Inc</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Interventional Oncology</td><td>SIR-Spheres Microspheres</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>100.0</td><td>2021-09-28</td><td>Cash or cash equivalent</td><td>Patient Care</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Yes</td><td>No</td><td>Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Study</td><td>No</td><td>855363367</td><td>2021</td><td>06/30/2022</td><td>NCT02685631</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>330182</td><td>10053</td><td>St. Francis Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>100 Port Washington Blvd</td><td>null</td><td>Roslyn</td><td>NY</td><td>11576</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>354880</td><td>1811140627</td><td>RITA</td><td>A</td><td>JERMYN</td><td>null</td><td>475 SEAVIEW AVE</td><td>null</td><td>STATEN ISLAND</td><td>NY</td><td>10305</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2.65</td><td>2021-07-22</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9536-4665</td><td>No</td><td>811891925</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450018</td><td>11030</td><td>THE UNIVERSITY OF TEXAS MEDICAL BR.</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>301 University Blvd</td><td>null</td><td>Galveston</td><td>TX</td><td>77555</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>100000.0</td><td>2021-01-21</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>REPORTER SARSCOV2 VIRUS NEUTRALIZATION ASSAY</td><td>No</td><td>832925047</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100271</td><td>10837</td><td>MOFFITT CANCER CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12902 Magnolia Dr</td><td>null</td><td>Tampa</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1294667</td><td>1073707170</td><td>MIHAELA</td><td>null</td><td>DRUTA</td><td>null</td><td>12902 USF MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612-9416</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>QINLOCK</td><td>73207-101-31</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>312.8</td><td>2021-06-11</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>INTRIGUE A STUDY OF DCC-2618 VS SUNITINIB IN ADVANCED GIST PATIENTS AFTER TREATMENT WITH IMATINIB INTRIGUE</td><td>No</td><td>827886715</td><td>2021</td><td>06/30/2022</td><td>NCT03673501</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450056</td><td>11002</td><td>ASCENSION SETON MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1201 W 38TH ST</td><td>null</td><td>DALLAS</td><td>TX</td><td>78705</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1252953</td><td>1255507943</td><td>POOJA</td><td>null</td><td>VARSHNEY</td><td>null</td><td>1301 BARBARA JORDAN BLVD</td><td>SUITE 200</td><td>AUSTIN</td><td>TX</td><td>78723-3077</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Allergy/Immunology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AIMMUNE THERAPEUTICS, INC.</td><td>100000776814</td><td>AIMMUNE THERAPEUTICS, INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ALLERGY</td><td>PALFORZIA</td><td>71881-113-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>27.34</td><td>2021-06-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY</td><td>No</td><td>849611705</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>490009</td><td>10745</td><td>University Of Virginia Medical Cente</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1215 LEE ST PFS</td><td>null</td><td>CHARLOTTESVILLE</td><td>VA</td><td>22908</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>767059</td><td>1174812010</td><td>MICHAEL</td><td>E.</td><td>DEVITT</td><td>null</td><td>590 Peter Jefferson Pkwy</td><td>null</td><td>CHARLOTTESVILLE</td><td>VA</td><td>22911</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>VA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Seagen Inc.</td><td>100000000279</td><td>Seagen Inc.</td><td>WA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Oncology</td><td>PADCEV</td><td>51144-030-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>29592.0</td><td>2021-08-16</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Open-label, Randomized, Controlled Phase 3 Study of Enfortumab Vedotin in Combination With Pembrolizumab With or Without Chemotherapy, Versus Chemotherapy Alone in Previously Untreated Locally Advanced or Metastatic Urothelial Cancer</td><td>No</td><td>792665011</td><td>2021</td><td>06/30/2022</td><td>NCT04223856</td><td>https://clinicaltrials.gov/ct2/show/NCT04223856</td><td>This study is being conducted to evaluate the combination of enfortumab vedotin + pembrolizumab, with or without platinum-containing chemotherapy, versus standard of care gemcitabine + platinum-containing chemotherapy, in subjects with previously untreated locally advanced or metastatic urothelial cancer.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>54009</td><td>11327</td><td>RESNICK NEUROPSYCHIATRIC HOSPITAL AT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>150 UCLA MEDICAL PLAZA</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90095</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1381878</td><td>1174808224</td><td>SANDY</td><td>null</td><td>LIU</td><td>null</td><td>15503 VENTURA BLVD</td><td>370</td><td>ENCINO</td><td>CA</td><td>91436</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>BioOncology</td><td>TECENTRIQ</td><td>50242-917-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>8370.0</td><td>2021-05-05</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>CONTACT03</td><td>No</td><td>835923331</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>363300</td><td>10334</td><td>Childrens Hospital Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3333 BURNET AVE</td><td>null</td><td>CINCINNATI</td><td>OH</td><td>45229</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>368012</td><td>1164578761</td><td>SHEHARYAR</td><td>RIZWAN</td><td>DURRANI</td><td>null</td><td>3333 Burnet Avenue.,mlc 2000</td><td>null</td><td>Cincinnati</td><td>OH</td><td>45229</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Allergy/Immunology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Sanofi and Genzyme US Companies</td><td>100000000067</td><td>SANOFI US SERVICES INC.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>DUPIXENT</td><td>0024-5914-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4575.0</td><td>2021-05-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>One Year Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Pediatric Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study</td><td>No</td><td>838660919</td><td>2021</td><td>06/30/2022</td><td>NCT03560466</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220162</td><td>9984</td><td>DANA-FARBER CANCER INSTITUTE</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>450 Brookline Ave</td><td>null</td><td>Boston</td><td>MA</td><td>02215</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>31442</td><td>1689891129</td><td>JORGE</td><td>J</td><td>CASTILLO</td><td>null</td><td>450 BROOKLINE AVE</td><td>M221</td><td>BOSTON</td><td>MA</td><td>02215</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ABBVIE INC.</td><td>100000000204</td><td>ABBVIE INC.</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>VENCLEXTA</td><td>0074-0576-22</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>387216.0</td><td>2021-05-04</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Phase II study on the combination of ibrutinib and venetoclax in treatment na?ve patients with Waldenstr?m Macroglobulinemia</td><td>No</td><td>792382589</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>A19-325</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1164196</td><td>1134106487</td><td>SANDRO</td><td>null</td><td>BACCHELLI</td><td>null</td><td>750 S FEDERAL HWY</td><td>null</td><td>HOLLYWOOD</td><td>FL</td><td>33020</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Family Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>14415.78</td><td>2021-06-08</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 2 STUDY OF ONCE-WEEKLY LY3437943 COMPARED WITH PLACEBO AND DULAGLUTIDE IN PARTICIPANTS WITH TYPE 2 DIABETES</td><td>No</td><td>819446541</td><td>2021</td><td>06/30/2022</td><td>NCT04867785</td><td>https://clinicaltrials.gov/ct2/show/NCT04867785</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360137</td><td>10389</td><td>Uh Cleveland Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>11100 EUCLID AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44106</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>861978</td><td>1528084852</td><td>AFSHIN</td><td>null</td><td>DOWLATI</td><td>null</td><td>11100 Euclid Ave</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44106</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Seagen Inc.</td><td>100000000279</td><td>Seagen Inc.</td><td>WA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>68616.42</td><td>2021-02-03</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 1 Study of SGN-B6A in Advanced Solid Tumors</td><td>No</td><td>792665683</td><td>2021</td><td>06/30/2022</td><td>NCT04389632</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>140119</td><td>10441</td><td>RUSH UNIVERSITY MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1653 W CONGRESS PKWY</td><td>null</td><td>CHICAGO</td><td>IL</td><td>60612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>BioOncology</td><td>Avastin</td><td>50242-061-01</td><td>null</td><td>Covered</td><td>Biological</td><td>BioOncology</td><td>TECENTRIQ</td><td>50242-917-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>750.0</td><td>2021-05-19</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PH2 STUDY OF ATEZOLIZUMAB WITH OR W O BEVACIZUMAB</td><td>No</td><td>835924405</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>83300</td><td>10812</td><td>Alfred I Dupont Hosp For Children</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1600 Rockland Rd</td><td>null</td><td>Wilmington</td><td>DE</td><td>19899</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>740847</td><td>1255422531</td><td>MICHAEL</td><td>null</td><td>BOBER</td><td>null</td><td>AI DUPONT HOSPITAL FOR CHILDREN</td><td>1600 ROCKLAND ROAD</td><td>WILMINGTON</td><td>DE</td><td>19803</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Medical Genetics|Clinical Genetics (M.D.)</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>DE</td><td>FL</td><td>OH</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BioMarin Pharmaceutical Inc.</td><td>100000010405</td><td>BioMarin Pharmaceutical Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>MPS IVA</td><td>Vimizim</td><td>68135-100-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>6000.0</td><td>2021-03-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Morquio A Registry Study MARS)</td><td>No</td><td>831382151</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>931148</td><td>1952301632</td><td>LUIS</td><td>Z</td><td>OSTROSKY</td><td>null</td><td>6431 FANNIN ST</td><td>MSB 2112</td><td>HOUSTON</td><td>TX</td><td>77030-1501</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Astellas Pharma Global Development</td><td>100000005406</td><td>Astellas Pharma Global Development</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>HOSPITAL AND TRANSPLANT</td><td>CRESEMBA</td><td>0469-0420-99</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>175.38</td><td>2021-08-17</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Non-Interventional Registry Study of Systemic Antifungal Therapy in Adult Subjects with Invasive Mucormycosis or Invasive Aspergillosis Caused by a Non-fumigatus Species</td><td>No</td><td>801078055</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>30087</td><td>11159</td><td>HONORHEALTH SCOTTSDALE SHEA MED CTR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9003 E SHEA BLVD</td><td>null</td><td>SCOTTSDALE</td><td>AZ</td><td>85260</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>287588</td><td>1336128859</td><td>TODD</td><td>D</td><td>LEVINE</td><td>null</td><td>5090 N 40TH ST</td><td>STE 250</td><td>PHOENIX</td><td>AZ</td><td>85018</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000005656</td><td>F. Hoffmann-La Roche AG</td><td>null</td><td>Switzerland</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>OCREVUS</td><td>50242-150-01</td><td>null</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>6980.0</td><td>2021-02-23</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>STUDY OF OCRELIZUMAB IN PPMS PATIENTS ASSESSING UPPER LIMB FUNCTION</td><td>No</td><td>835913545</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>215989</td><td>1770549099</td><td>RAJENDRA</td><td>H</td><td>MEHTA</td><td>null</td><td>214 N WEST AVE</td><td>null</td><td>JACKSON</td><td>MI</td><td>49201</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Obesity</td><td>Wegovy</td><td>0169-4525-14</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4975.0</td><td>2021-06-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9536-4388</td><td>No</td><td>810764285</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500152</td><td>11176</td><td>SWEDISH ISSAQUAH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>751 Ne Blakely Dr</td><td>null</td><td>Issaquah</td><td>WA</td><td>98029</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>953859</td><td>1740436609</td><td>JASON</td><td>D</td><td>GOLDMAN</td><td>null</td><td>747 BROADWAY</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98122-4379</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>101.25</td><td>2021-01-21</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A MASTER PROTOCOL ASSESSING THE SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-SPIKE (S) SARS-COV-2 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF HOSPITALIZED PATIENTS WITH COVID-19</td><td>No</td><td>793089931</td><td>2021</td><td>06/30/2022</td><td>NCT04426695</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>53302</td><td>11301</td><td>Childrens Hospital Los Angeles</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4650 W Sunset Blvd</td><td>null</td><td>Los Angeles</td><td>CA</td><td>90027</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>460192</td><td>1396942470</td><td>Julie</td><td>Ann</td><td>Jaffray</td><td>null</td><td>4650 W Sunset Blvd</td><td>null</td><td>Los Angeles</td><td>CA</td><td>90027</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Daiichi Sankyo Inc.</td><td>100000000195</td><td>Daiichi Sankyo Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Thrombosis</td><td>SAVAYSA</td><td>65597-201-07</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>15.4</td><td>2021-09-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>DU176b-D-U312</td><td>No</td><td>835065069</td><td>2021</td><td>06/30/2022</td><td>NCT02798471</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>88255</td><td>1942268073</td><td>JONATHAN</td><td>E</td><td>ROSENBERG</td><td>null</td><td>353 E 68TH ST</td><td>null</td><td>NEW YORK</td><td>NY</td><td>10065</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Astellas Pharma Global Development</td><td>100000005406</td><td>Astellas Pharma Global Development</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>PADCEV</td><td>51144-020-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>227.5</td><td>2021-03-11</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>An Open-Label, Randomized Phase 3 Study to Evaluate Enfortumab Vedotin vs Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)</td><td>No</td><td>801078313</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220071</td><td>9988</td><td>Massachusetts General Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>55 Fruit St</td><td>Bulfinch 360</td><td>Boston</td><td>MA</td><td>02114</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1326119</td><td>1487929634</td><td>SARA</td><td>null</td><td>BOUBERHAN</td><td>null</td><td>55 FRUIT ST</td><td>null</td><td>BOSTON</td><td>MA</td><td>02114</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CT</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Clovis Oncology, Inc.</td><td>100000191752</td><td>Clovis Oncology, Inc.</td><td>CO</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>Rubraca</td><td>69660-201-91</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>30.0</td><td>2021-08-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients With Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer</td><td>No</td><td>796700575</td><td>2021</td><td>06/30/2022</td><td>NCT01968213</td><td>null</td><td>CO-338-014</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>503300</td><td>11178</td><td>Seattle Childrens Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4800 Sandpoint Way Ne</td><td>5371</td><td>Seattle</td><td>WA</td><td>98105</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>265829</td><td>1861507113</td><td>ROBERT</td><td>null</td><td>SIDBURY</td><td>null</td><td>4800 SAND POINT WAY NE</td><td>SEATTLE CHILDREN'S HOSPITAL A7916</td><td>SEATTLE</td><td>WA</td><td>98105-3901</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology|Pediatric Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>UCB, Inc.</td><td>100000010773</td><td>UCB SA</td><td>null</td><td>Belgium</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Immunology</td><td>Cimzia</td><td>50474-710-79</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2041.0</td><td>2021-04-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>MULTICENTER, RANDOMIZED, PARALLEL GROUP, DOUBLE BLIND, PLACEBO-CONTROLLED (12 17 YEARS) INCLUDING A SINGLE OPEN LABEL ARM (6 11 YEARS) STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF CERTOLIZUMAB PEGOL (CZP) IN PEDIATRIC STU</td><td>No</td><td>844224161</td><td>2021</td><td>06/30/2022</td><td>NCT04123795</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>60010</td><td>11138</td><td>Poudre Valley Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2121 E HARMONY RD UNIT 200</td><td>null</td><td>FORT COLLINS</td><td>CO</td><td>80528</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1303361</td><td>1083660708</td><td>DIANA</td><td>null</td><td>MEDGYESY</td><td>null</td><td>2121 E Harmony Rd</td><td>null</td><td>FORT COLLINS</td><td>CO</td><td>80528</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CO</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Seagen Inc.</td><td>100000000279</td><td>Seagen Inc.</td><td>WA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>TUKYSA</td><td>51144-001-60</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1401.3</td><td>2021-08-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer</td><td>No</td><td>792655787</td><td>2021</td><td>06/30/2022</td><td>NCT03975647</td><td>https://clinicaltrials.gov/ct2/show/NCT03975647</td><td>This study is designed to evaluate the efficacy and safety of tucatinib in combination with T-DM1 in subjects with unresectable locally-advanced or metastatic HER2+ breast cancer who have had prior treatment with a taxane and trastuzumab in any setting. Prior pertuzumab treatment is permitted, but not required. Subjects will be randomized in a 1:1 manner to receive 21-day cycles of either tucatinib or placebo in combination with T-DM1.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>140223</td><td>10437</td><td>ADVOCATE LUTHERAN GENERAL HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1775 DEMPSTER STREET</td><td>null</td><td>PARK RIDGE</td><td>IL</td><td>60068</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1306500</td><td>1477811610</td><td>KENNETH</td><td>W</td><td>DODD</td><td>null</td><td>701 PARK AVENUE</td><td>HENNEPIN COUNTY MEDICAL CENTER EM IM</td><td>MINNEAPOLIS</td><td>MN</td><td>55415</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Critical Care Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000005726</td><td>Hoffmann-La Roche Limited</td><td>null</td><td>Canada</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>Actemra</td><td>50242-137-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2992.0</td><td>2021-11-16</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>SAFETY EFFICACY OF A COMBINATION OF REMDESIVIR TOCILIZUMAB IN SEVERE COVID 19 PNEUMONIA</td><td>No</td><td>835906209</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230053</td><td>10500</td><td>HENRY FORD HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2799 W GRAND BLVD</td><td>null</td><td>DETROIT</td><td>MI</td><td>48202</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>134239</td><td>1952341414</td><td>DING</td><td>null</td><td>WANG</td><td>null</td><td>KARMANOS CANCER CENTER</td><td>4100 JOHN R HWCRC 4TH FL</td><td>DETROIT</td><td>MI</td><td>48201</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Amgen Inc.</td><td>100000000203</td><td>Amgen Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>LUMAKRAS</td><td>55513-488-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>23334.04</td><td>2021-02-23</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>AMG 510_P1/2 Monotherapy NSCLC/CRC/Tumor Agnostic_20170543</td><td>No</td><td>830979573</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100271</td><td>10837</td><td>MOFFITT CANCER CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12902 Magnolia Dr</td><td>null</td><td>Tampa</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1294667</td><td>1073707170</td><td>MIHAELA</td><td>null</td><td>DRUTA</td><td>null</td><td>12902 USF MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612-9416</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>QINLOCK</td><td>73207-101-31</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>544.0</td><td>2021-10-16</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>INTRIGUE A STUDY OF DCC-2618 VS SUNITINIB IN ADVANCED GIST PATIENTS AFTER TREATMENT WITH IMATINIB INTRIGUE</td><td>No</td><td>827886971</td><td>2021</td><td>06/30/2022</td><td>NCT03673501</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>30038</td><td>11158</td><td>Honorhealth Scottsdale Osborn Med Ct</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>7400 E Osborn Road</td><td>null</td><td>Scottsdale</td><td>AZ</td><td>85251</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>277405</td><td>1114929114</td><td>Michael</td><td>S</td><td>Gordon</td><td>null</td><td>10510 N 92nd St Ste 200</td><td>null</td><td>Scottsdale</td><td>AZ</td><td>85258</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Daiichi Sankyo Inc.</td><td>100000000195</td><td>Daiichi Sankyo Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>Turalio</td><td>65597-402-20</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>375.0</td><td>2021-11-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PL3397-A-U126</td><td>No</td><td>835068129</td><td>2021</td><td>06/30/2022</td><td>NCT03291288</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100271</td><td>10837</td><td>Moffitt Cancer Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12902 Magnolia Dr</td><td>null</td><td>Tampa</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>3589499</td><td>1982139655</td><td>MICHAEL</td><td>DAVID</td><td>JAIN</td><td>null</td><td>12902 USF MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Kite Pharma, Inc.</td><td>100000216809</td><td>Kite Pharma, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>CELLT</td><td>Yescarta</td><td>71287-119-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>22780.0</td><td>2021-05-24</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 1-2 Study Evaluating the Safety and Efficacy of KTE-C19 in Combination with 4-1BB DLBCL</td><td>No</td><td>826574951</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>;KTE-C19-111;KP26836;593238634;12983510</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>54063</td><td>1184829723</td><td>MARVIN</td><td>null</td><td>KALAFER</td><td>null</td><td>815 GREENWOOD AVE STE 12</td><td>null</td><td>JENKINTOWN</td><td>PA</td><td>19046</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Obstetrics & Gynecology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>29.0</td><td>2021-08-20</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A STUDY OF DONANEMAB VERSUS PLACEBO IN PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE OF ALZHEIMER'S DISEASE</td><td>No</td><td>819444997</td><td>2021</td><td>06/30/2022</td><td>NCT05026866</td><td>https://clinicaltrials.gov/ct2/show/NCT05026866</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor in connection with clinical studies during the reporting period.  For available study details,</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>110087</td><td>10799</td><td>Northside Hospital Gwinnett</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3620 HOWELL FERRY ROAD</td><td>null</td><td>DULUTH</td><td>GA</td><td>30096</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>211716</td><td>1679697791</td><td>AMELIA</td><td>B.</td><td>ZELNAK</td><td>null</td><td>1505 Northside Blvd</td><td>null</td><td>CUMMING</td><td>GA</td><td>30041</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Seagen Inc.</td><td>100000000279</td><td>Seagen Inc.</td><td>WA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>TUKYSA</td><td>51144-001-60</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4101.67</td><td>2021-09-07</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer</td><td>No</td><td>792661575</td><td>2021</td><td>06/30/2022</td><td>NCT03975647</td><td>https://clinicaltrials.gov/ct2/show/NCT03975647</td><td>This study is designed to evaluate the efficacy and safety of tucatinib in combination with T-DM1 in subjects with unresectable locally-advanced or metastatic HER2+ breast cancer who have had prior treatment with a taxane and trastuzumab in any setting. Prior pertuzumab treatment is permitted, but not required. Subjects will be randomized in a 1:1 manner to receive 21-day cycles of either tucatinib or placebo in combination with T-DM1.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>300003</td><td>9970</td><td>MARY HITCHCOCK MEMORIAL HOSP</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ONE MEDICAL CENTER DR</td><td>null</td><td>LEBANON</td><td>NH</td><td>03756</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>197685</td><td>1366598955</td><td>GABRIEL</td><td>ARNE</td><td>BROOKS</td><td>null</td><td>1 MEDICAL CENTER DR</td><td>null</td><td>LEBANON</td><td>NH</td><td>03756</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>NH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>BioOncology</td><td>Avastin</td><td>50242-061-01</td><td>null</td><td>Covered</td><td>Biological</td><td>BioOncology</td><td>TECENTRIQ</td><td>50242-917-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2630.0</td><td>2021-07-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>TECENTRIQ PLUS AVASTIN FOLLOWING CURATIVE RESECTION IN PATIENTS AT HIGH RISK OF RECURRENCE</td><td>No</td><td>835917871</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50077</td><td>11300</td><td>Scripps Mercy Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4077 5th Ave</td><td>null</td><td>San Diego</td><td>CA</td><td>92103</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>959048</td><td>1922105964</td><td>ATHENA</td><td>null</td><td>PHILIS-TSIMIKAS</td><td>null</td><td>10140 CAMPUS POINT DR</td><td>STE 200</td><td>SAN DIEGO</td><td>CA</td><td>92121</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>Ozempic</td><td>0169-4132-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>180.0</td><td>2021-02-16</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9535-4352</td><td>No</td><td>811450465</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3421</td><td>1063465284</td><td>MATTHEW</td><td>DAVID</td><td>MCCOLLOUGH</td><td>null</td><td>2630 GRANT LINE RD</td><td>null</td><td>NEW ALBANY</td><td>IN</td><td>47150</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2750.0</td><td>2021-04-01</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-ARM, PLACEBO-CONTROLLED MAINTENANCE STUDY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (LUCENT 2)</td><td>No</td><td>819445253</td><td>2021</td><td>06/30/2022</td><td>NCT03524092</td><td>https://clinicaltrials.gov/ct2/show/NCT03524092</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>140119</td><td>10441</td><td>RUSH UNIVERSITY MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1653 W CONGRESS PKWY</td><td>null</td><td>CHICAGO</td><td>IL</td><td>60612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>664388</td><td>1578661781</td><td>ADRIENNE</td><td>L.</td><td>ADAMS</td><td>null</td><td>2150 W HARRISON ST</td><td>null</td><td>CHICAGO</td><td>IL</td><td>60612</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Child & Adolescent Psychiatry</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000005656</td><td>F. Hoffmann-La Roche AG</td><td>null</td><td>Switzerland</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1000.0</td><td>2021-03-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>V1A 2 IN PEDIATRIC AUTISM</td><td>No</td><td>835924609</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>393303</td><td>10215</td><td>THE CHILDRENS HOSPITAL OF PHILADELP</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>34th & Civic Center Blvd</td><td>Parc Business Services</td><td>Philadelphia</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>137580</td><td>1043226996</td><td>JONATHAN</td><td>M</td><td>SPERGEL</td><td>null</td><td>3550 MARKET ST FL 3</td><td>CHILDREN'S HOSPITAL OF PHILADELPHIA - ALLERGY & IMMUN</td><td>PHILADELPHIA</td><td>PA</td><td>19104-3365</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Allergy/Immunology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NJ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>INFLAMMATION AND  IMMUNOLOGY</td><td>DUPIXENT</td><td>0024-5914-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1000.0</td><td>2021-12-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN PEDIATRIC PATIENTS WITH ACTIVE EOSINOPHILIC ESOPHAGITIS</td><td>No</td><td>793090187</td><td>2021</td><td>06/30/2022</td><td>NCT04394351</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1089207</td><td>1508029703</td><td>RUSSELL</td><td>Z</td><td>SZMULEWITZ</td><td>null</td><td>5841 S MARYLAND AVE</td><td>MC 2115</td><td>CHICAGO</td><td>IL</td><td>60637-1447</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Astellas Pharma Global Development</td><td>100000005406</td><td>Astellas Pharma Global Development</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>XTANDI</td><td>0469-0125-99</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>165.53</td><td>2021-02-28</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Multinational Phase 3 Randomized Double-blind Placebo-controlled Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC)</td><td>No</td><td>801078569</td><td>2021</td><td>06/30/2022</td><td>NCT02677896</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>263302</td><td>10622</td><td>Childrens Mercy Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2401 Gillham Road</td><td>null</td><td>Kansas City</td><td>MO</td><td>64108</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1358279</td><td>1699003590</td><td>ALVIN</td><td>null</td><td>SINGH</td><td>null</td><td>2401 GILLHAM RD</td><td>null</td><td>KANSAS CITY</td><td>MO</td><td>64108</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Pulmonology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>KS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>VERTEX PHARMACEUTICALS INCORPORATED</td><td>100000000184</td><td>VERTEX PHARMACEUTICALS INCORPORATED</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>40938.28</td><td>2021-07-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years</td><td>No</td><td>793095911</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220110</td><td>9985</td><td>Brigham And Womens Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>75 Francis St</td><td>null</td><td>Boston</td><td>MA</td><td>02115</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>116914</td><td>1588748883</td><td>VANITA</td><td>R</td><td>ARODA</td><td>null</td><td>221 LONGWOOD AVE</td><td># RFB-2</td><td>BOSTON</td><td>MA</td><td>02115</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>Ozempic</td><td>0169-4132-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>22.76</td><td>2021-03-16</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9535-4352</td><td>No</td><td>811821291</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>460009</td><td>11165</td><td>U OF U HOSPITALS & CLINICS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>50 N Medical Dr</td><td>null</td><td>Salt Lake City</td><td>UT</td><td>84132</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>821548</td><td>1104093392</td><td>JAMIE</td><td>null</td><td>RHOADS</td><td>null</td><td>6095 S FASHION BLVD</td><td>null</td><td>MURRAY</td><td>UT</td><td>84107-7397</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>HI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>INFLAMMATION AND  IMMUNOLOGY</td><td>DUPIXENT</td><td>0024-5914-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3934.05</td><td>2021-11-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT PATIENTS WITH BULLOUS PEMPHIGOID</td><td>No</td><td>793090445</td><td>2021</td><td>06/30/2022</td><td>NCT04206553</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450056</td><td>11002</td><td>ASCENSION SETON MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1201 W 38TH ST</td><td>null</td><td>DALLAS</td><td>TX</td><td>78705</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1252953</td><td>1255507943</td><td>POOJA</td><td>null</td><td>VARSHNEY</td><td>null</td><td>1301 BARBARA JORDAN BLVD</td><td>SUITE 200</td><td>AUSTIN</td><td>TX</td><td>78723-3077</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Allergy/Immunology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AIMMUNE THERAPEUTICS, INC.</td><td>100000776814</td><td>AIMMUNE THERAPEUTICS, INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ALLERGY</td><td>PALFORZIA</td><td>71881-113-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>30.38</td><td>2021-06-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY</td><td>No</td><td>849612469</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500008</td><td>11198</td><td>University Of Washington Med Ctr</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1959 NE PACIFIC ST</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>10408</td><td>1225041791</td><td>SHAILENDER</td><td>null</td><td>BHATIA</td><td>null</td><td>825 EASTLAKE AVE E</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98109</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>23.4</td><td>2021-11-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 2 Study of INCMGA00012 in Participants With Metastatic Merkel Cell Carcinoma</td><td>No</td><td>831099993</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450051</td><td>11035</td><td>METHODIST DALLAS MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1441 N BECKLEY AVE</td><td>null</td><td>DALLAS</td><td>TX</td><td>75203</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>80276</td><td>1770528697</td><td>PARVEZ</td><td>null</td><td>MANTRY</td><td>null</td><td>1411 N BECKLEY AVE</td><td>464</td><td>DALLAS</td><td>TX</td><td>75203</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hepatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000005726</td><td>Hoffmann-La Roche Limited</td><td>null</td><td>Canada</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>Actemra</td><td>50242-137-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>47.0</td><td>2021-07-01</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>SAFETY EFFICACY OF A COMBINATION OF REMDESIVIR TOCILIZUMAB IN SEVERE COVID 19 PNEUMONIA</td><td>No</td><td>835918885</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>330059</td><td>10070</td><td>MONTEFIORE MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>111 E 210th St</td><td>null</td><td>Bronx</td><td>NY</td><td>10467</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>276583</td><td>1104906692</td><td>SANJAY</td><td>null</td><td>GOEL</td><td>null</td><td>AECOM</td><td>1825 EASTCHESTER RD</td><td>BRONX</td><td>NY</td><td>10461</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1798.0</td><td>2021-07-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1B 2 STUDY OF REBASTINIB DCC-2036 IN COMBINATION WITH PACLITAXEL IN PATIENTS WITH ADVANCED OR METASTATIC SOLID TUMORS</td><td>No</td><td>827887227</td><td>2021</td><td>06/30/2022</td><td>NCT03601897</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>290001</td><td>11167</td><td>Renown Regional Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1155 Mill Street</td><td>null</td><td>Reno</td><td>NV</td><td>89502</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>775678</td><td>1477783264</td><td>Christopher</td><td>James</td><td>Rowan</td><td>null</td><td>1500 E 2nd St Ste 400</td><td>null</td><td>Reno</td><td>NV</td><td>89502</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NV</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Daiichi Sankyo Inc.</td><td>100000000195</td><td>Daiichi Sankyo Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Thrombosis</td><td>SAVAYSA</td><td>65597-201-07</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>750.0</td><td>2021-12-04</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>ENVISAGE</td><td>No</td><td>835068223</td><td>2021</td><td>06/30/2022</td><td>NCT02943785</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>363300</td><td>10334</td><td>CHILDRENS HOSPITAL MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3333 BURNET AVE</td><td>null</td><td>CINCINNATI</td><td>OH</td><td>45229</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>658528</td><td>1366491821</td><td>AMAL</td><td>H</td><td>ASSAAD</td><td>null</td><td>3333 BURNET AVE</td><td>ML 2000</td><td>CINCINNATI</td><td>OH</td><td>45229-3039</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Allergy/Immunology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AIMMUNE THERAPEUTICS, INC.</td><td>100000776814</td><td>AIMMUNE THERAPEUTICS, INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ALLERGY</td><td>PALFORZIA</td><td>71881-113-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>6789.0</td><td>2021-05-11</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY</td><td>No</td><td>849613229</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100007</td><td>10819</td><td>Adventhealth Orlando</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>601 E Rollins St</td><td>null</td><td>Orlando</td><td>FL</td><td>32803</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Janssen Research & Development, LLC</td><td>100000005592</td><td>Janssen Research & Development, LLC</td><td>NJ</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>27165.0</td><td>2021-03-29</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>COVID-19 Phase 3 Vaccine Trial Readiness Cohorts - Advent Health Orlando</td><td>No</td><td>787574801</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>330270</td><td>10067</td><td>Hospital For Special Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>535 East 70th Street</td><td>null</td><td>New York</td><td>NY</td><td>10021</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>159366</td><td>1528038841</td><td>DALE</td><td>J</td><td>LANGE</td><td>null</td><td>535 E 70TH ST</td><td>null</td><td>NEW YORK</td><td>NY</td><td>10021-4823</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>UCB SA</td><td>100000010773</td><td>UCB SA</td><td>null</td><td>Belgium</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>133.65</td><td>2021-01-25</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3, RANDOMIZED, DOUBL-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING EFFICACY AND SAFETY OF ROZANOLIXIZUMAB IN ADULT PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS</td><td>No</td><td>844222213</td><td>2021</td><td>06/30/2022</td><td>NCT03971422</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220162</td><td>9984</td><td>DANA-FARBER CANCER INSTITUTE</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>450 Brookline Ave</td><td>null</td><td>Boston</td><td>MA</td><td>02215</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1305770</td><td>1417116674</td><td>ZOFIA</td><td>null</td><td>PIOTROWSKA</td><td>null</td><td>55 FRUIT ST</td><td>YAWKEY 7B</td><td>BOSTON</td><td>MA</td><td>02114-2621</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ABBVIE INC.</td><td>100000000204</td><td>ABBVIE INC.</td><td>IL</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2444.0</td><td>2021-07-29</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase I Study of ABBV-011 as a Single-Agent and in Combination with Budigalimab (ABBV-181) in Subjects with Relapsed or Refractory Small Cell Lung Cancer</td><td>No</td><td>792382749</td><td>2021</td><td>06/30/2022</td><td>NCT03639194</td><td>null</td><td>M17-327</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>626005</td><td>1235161563</td><td>WAYNE</td><td>W</td><td>CHEN</td><td>null</td><td>555 ANTON PKWY STE 800</td><td>null</td><td>COSTA MESA</td><td>CA</td><td>92626</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>59417.5</td><td>2021-01-04</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 AND LY3832479 IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS</td><td>No</td><td>819446797</td><td>2021</td><td>06/30/2022</td><td>NCT04427501</td><td>https://www.clinicaltrials.gov/ct2/show/NCT04427501</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360137</td><td>10389</td><td>Uh Cleveland Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>11100 EUCLID AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44106</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>461071</td><td>1437100302</td><td>DEBORA</td><td>S.</td><td>BRUNO</td><td>null</td><td>11100 EUCLID AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44106</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Seagen Inc.</td><td>100000000279</td><td>Seagen Inc.</td><td>WA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>TUKYSA</td><td>51144-001-60</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4091.0</td><td>2021-12-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 2 Basket Study of Tucatinib in Combination With Trastuzumab in Subjects With Previously Treated, Locally Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations</td><td>No</td><td>792665939</td><td>2021</td><td>06/30/2022</td><td>NCT04579380</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50424</td><td>11298</td><td>SCRIPPS GREEN HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>10666 N TORREY PINES RD</td><td>null</td><td>LA JOLLA</td><td>CA</td><td>92037</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>258693</td><td>1700959426</td><td>CHARLES</td><td>RAYMOND</td><td>SMITH</td><td>null</td><td>10666 N TORREY PINES RD</td><td>113</td><td>LA JOLLA</td><td>CA</td><td>92037</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>OCREVUS</td><td>50242-150-01</td><td>null</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9384.0</td><td>2021-05-21</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>OCRELIZUMAB VACCINATION STUDY</td><td>No</td><td>835925339</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450076</td><td>11031</td><td>UT MD ANDERSON CANCER CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 Holcombe Blvd</td><td>null</td><td>Houston</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>612216</td><td>1740584507</td><td>FILIP</td><td>null</td><td>JANKU</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>null</td><td>HOUSTON</td><td>TX</td><td>77030-4009</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>QINLOCK</td><td>73207-101-31</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>491.04</td><td>2021-05-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A SAFETY TOLERABILITY AND PK STUDY OF DCC-2618 IN PATIENTS WITH ADVANCED MALIGNANCIES</td><td>No</td><td>827890921</td><td>2021</td><td>06/30/2022</td><td>NCT02571036</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>110010</td><td>10785</td><td>EMORY UNIVERSITY HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1821 Clifton Rd Ne</td><td>null</td><td>Atlanta</td><td>GA</td><td>30329</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>317132</td><td>1992741938</td><td>JIONG</td><td>null</td><td>YAN</td><td>null</td><td>1365B CLIFTON RD NE</td><td>BUILDING B RM 2401</td><td>ATLANTA</td><td>GA</td><td>30322</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Ophthalmology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Astellas Pharma Global Development</td><td>100000005406</td><td>Astellas Pharma Global Development</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>HOSPITAL AND TRANSPLANT</td><td>TACROLIMUS</td><td>45802-390-00</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2110.0</td><td>2021-02-04</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Staged Study Incorporating a Phase 1b, Multicenter, Unmasked, Dose Escalation Evaluation of Safety and Tolerability and a Phase 2, Multicenter, Unmasked, Randomized, Parallel-group, Controlled, Proof of Concept Investigation of Efficacy and Safety of ASP7317 for Atrophy Secondary to Age-related Macular Degeneration</td><td>No</td><td>801078829</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>100227</td><td>1205922655</td><td>IAN</td><td>C.</td><td>WEBER</td><td>null</td><td>80 HEALTH PARK DR STE 230</td><td>null</td><td>LOUISVILLE</td><td>CO</td><td>80027-4644</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Orthopaedic Surgery|Adult Reconstructive Orthopaedic Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CO</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Zimmer Biomet Holdings, Inc.</td><td>100000000103</td><td>Zimmer Biomet Holdings, Inc.</td><td>IN</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Knees</td><td>ROSA-Knee</td><td>null</td><td>889024619401</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2079.0</td><td>2021-02-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>ROSA Total Knee Post Market Study</td><td>No</td><td>834036305</td><td>2021</td><td>06/30/2022</td><td>null</td><td>http://medispend.com</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450076</td><td>11031</td><td>Ut Md Anderson Cancer Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>null</td><td>HOUSTON</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>79465</td><td>1740422823</td><td>NAVAL</td><td>G.</td><td>DAVER</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td># 0448</td><td>HOUSTON</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>338.0</td><td>2021-08-03</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis</td><td>No</td><td>831075481</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Transfer of value for editorial and or medical writing services. These services were funded by Incyte Corporation and paid to a third-party vendor to assist with the development of a publication at the direction of the authors. No payments were made directly to the authors for these editorial and or medical writing services.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>210029</td><td>10710</td><td>JOHNS HOPKINS BAYVIEW MED. CTR.</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4940 EASTERN AVE BLDG FLR1</td><td>null</td><td>BALTIMORE</td><td>MD</td><td>21224</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>263515</td><td>1801803127</td><td>JOE</td><td>null</td><td>POUZAR</td><td>null</td><td>1045 GEMINI ST STE 200B</td><td>null</td><td>HOUSTON</td><td>TX</td><td>77058</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Family Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Organon LLC</td><td>100000866821</td><td>Organon LLC</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>CONTRACEPTIVES</td><td>IMPLANON</td><td>0052-0272-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>376.43</td><td>2021-07-09</td><td>Cash or cash equivalent</td><td>Patient Care</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>8415-8415-060-PN060-Extended Duration Study (Celanese + 2 years)-Contraception-SC-imp-Supplemental Registration-USA-LD-B</td><td>No</td><td>836234935</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230046</td><td>10547</td><td>UNIV OF MI HOSPITALS & HLTH CTRS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 East Medical Center Drive</td><td>null</td><td>Ann Arbor</td><td>MI</td><td>48109</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>258698</td><td>1700962677</td><td>FRANCIS</td><td>PAUL</td><td>WORDEN</td><td>null</td><td>1500 EAST MEDICAL CENTER DR</td><td>B1 FLOOR CANCER CTR RECP C</td><td>ANN ARBOR</td><td>MI</td><td>48109-5912</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ONCOLOGY</td><td>LIBTAYO</td><td>61755-008-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3000.0</td><td>2021-09-29</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>CEMIPLIMAB SURVIVORSHIP EPIDEMIOLOGY (CASE) STUDY</td><td>No</td><td>793090701</td><td>2021</td><td>06/30/2022</td><td>NCT03836105</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50262</td><td>11328</td><td>RONALD REAGAN UCLA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>757 Westwood Plz</td><td>null</td><td>Los Angeles</td><td>CA</td><td>90095</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>38213</td><td>1851311930</td><td>GARY</td><td>J</td><td>SCHILLER</td><td>null</td><td>200 MEDICAL PLAZA</td><td>365530420120</td><td>LOS ANGELES</td><td>CA</td><td>90095</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Astellas Pharma Global Development</td><td>100000005406</td><td>Astellas Pharma Global Development</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>XOSPATA</td><td>0469-1425-90</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>800.0</td><td>2021-11-04</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Randomized Trial of Gilteritinib vs Midostaurin in FL T3 Mutated Acute Myeloid Leukemia</td><td>No</td><td>801079085</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>460009</td><td>11165</td><td>U Of U Hospitals & Clinics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>50 N MEDICAL DR</td><td>null</td><td>SALT LAKE CITY</td><td>UT</td><td>84132</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1071739</td><td>1881849669</td><td>JEREMY</td><td>MARK</td><td>GILILLAND</td><td>null</td><td>590 S WAKARA WAY</td><td>null</td><td>SALT LAKE CITY</td><td>UT</td><td>84108</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Orthopaedic Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Zimmer Biomet Holdings, Inc.</td><td>100000000103</td><td>Zimmer Biomet Holdings, Inc.</td><td>IN</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Knees</td><td>Knees-MyMobility</td><td>null</td><td>887868517747</td><td>Covered</td><td>Device</td><td>Hips</td><td>Hips-MyMobility</td><td>null</td><td>887868517747</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1823.0</td><td>2021-09-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>myMobility Phase 0 Clinical Study</td><td>No</td><td>834036421</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>828537</td><td>1346655099</td><td>BENJAMIN</td><td>LOUIS</td><td>HELLER</td><td>null</td><td>515 W BUCKEYE RD STE 104</td><td>null</td><td>PHOENIX</td><td>AZ</td><td>85003</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Ophthalmology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alcon Research LLC</td><td>100000000218</td><td>Alcon Research LLC</td><td>TX</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Ophthalmology</td><td>Acrysof IQ ReSTOR IOL</td><td>null</td><td>00380652268752</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>379.5</td><td>2021-11-04</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Approval Study of the AcrySof IQ ReSTOR Toric IOL</td><td>No</td><td>807675057</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390111</td><td>10224</td><td>Hospital Of The Univ Of Penna</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3400 Spruce Street</td><td>null</td><td>Philadelphia</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>986382</td><td>1871657882</td><td>ALEXIS</td><td>R</td><td>OGDIE-BEATTY</td><td>null</td><td>3400 SPRUCE STREET</td><td>828 PENN TOWER</td><td>PHILADELPHIA</td><td>PA</td><td>19104-4206</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>UCB, Inc.</td><td>100000010773</td><td>UCB SA</td><td>null</td><td>Belgium</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1000.0</td><td>2021-06-24</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A MULTICENTER, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS</td><td>No</td><td>844224771</td><td>2021</td><td>06/30/2022</td><td>NCT03896581</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230046</td><td>10547</td><td>Univ Of Mi Hospitals & Hlth Ctrs</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 East Medical Center Drive</td><td>null</td><td>Ann Arbor</td><td>MI</td><td>48109</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1032474</td><td>1497979678</td><td>AJJAI</td><td>SHIVARAM</td><td>ALVA</td><td>null</td><td>1500 E MEDICAL CENTER DR</td><td>null</td><td>ANN ARBOR</td><td>MI</td><td>48109</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AstraZeneca Pharmaceuticals LP</td><td>100000000146</td><td>AstraZeneca Pharmaceuticals LP</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>824.14</td><td>2021-12-31</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Study of MEDI4736 Durvalumab With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer</td><td>No</td><td>826503045</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500008</td><td>11198</td><td>University Of Washington Med Ctr</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1959 NE PACIFIC ST</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1143552</td><td>1386965952</td><td>RYAN</td><td>CHRISTOPHER</td><td>LYNCH</td><td>null</td><td>825 EASTLAKE AVE E</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98109</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Hospitalist</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MO</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>768.0</td><td>2021-06-25</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>An Open Label, Randomized Study Comparing INCB050465 to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL 203)</td><td>No</td><td>831100747</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>250001</td><td>10938</td><td>University Of Mississippi Medical</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2500 N STATE ST</td><td>null</td><td>JACKSON</td><td>MS</td><td>39216</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Draeger Medical Systems, Inc</td><td>100000000330</td><td>Draeger Medical Systems, Inc</td><td>PA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Ventilation</td><td>BABYLOG VN500</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5542.99</td><td>2021-01-29</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Babylog VN500 HFOV study</td><td>No</td><td>836742977</td><td>2021</td><td>06/30/2022</td><td>NCT02445040</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50008</td><td>11217</td><td>Cpmc-R.K. Davies Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>45 Castro St</td><td>null</td><td>San Francisco</td><td>CA</td><td>94114</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>170475</td><td>1740460088</td><td>CHRISTOPHER</td><td>E</td><td>WOODS</td><td>null</td><td>325 DISTEL CIR</td><td>null</td><td>LOS ALTOS</td><td>CA</td><td>94022-1408</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Abbott Laboratories</td><td>100000010680</td><td>Abbott Laboratories</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Electrophysiology</td><td>Agilis HisPro</td><td>null</td><td>05415067032287</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>150.0</td><td>2021-09-23</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>His Bundle Pacing Pacemaker Mapping Registry</td><td>No</td><td>827582301</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>130006</td><td>11100</td><td>ST. LUKES REGIONAL MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>190 E BANNOCK ST</td><td>null</td><td>BOISE</td><td>ID</td><td>83712</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>73913</td><td>1629117619</td><td>KAREN</td><td>S</td><td>MILLER</td><td>null</td><td>2347 E GALA ST</td><td>null</td><td>MERIDIAN</td><td>ID</td><td>83642</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ID</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000005726</td><td>Hoffmann-La Roche Limited</td><td>null</td><td>Canada</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>Actemra</td><td>50242-137-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>21.02</td><td>2021-05-25</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>SAFETY EFFICACY OF A COMBINATION OF REMDESIVIR TOCILIZUMAB IN SEVERE COVID 19 PNEUMONIA</td><td>No</td><td>835926433</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>380009</td><td>11212</td><td>OHSU HOSPITAL AND CLINICS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3181 Sw Sam Jackson Park Rd</td><td>null</td><td>Portland</td><td>OR</td><td>97239</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>341933</td><td>1548278005</td><td>MICHAEL</td><td>C</td><td>HEINRICH</td><td>null</td><td>3181 SW SAM JACKSON PARK RD</td><td>null</td><td>PORTLAND</td><td>OR</td><td>97239-3011</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>QINLOCK</td><td>73207-101-31</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>200.0</td><td>2021-03-04</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A SAFETY TOLERABILITY AND PK STUDY OF DCC-2618 IN PATIENTS WITH ADVANCED MALIGNANCIES</td><td>No</td><td>827887483</td><td>2021</td><td>06/30/2022</td><td>NCT02571036</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1114056</td><td>1366586521</td><td>HUNG</td><td>null</td><td>KHONG</td><td>null</td><td>PO BOX 413033</td><td>null</td><td>SALT LAKE CITY</td><td>UT</td><td>84141-3033</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Radius Health, Inc.</td><td>100000181748</td><td>Radius Health, Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>648.97</td><td>2021-12-22</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NEJM EMERALD manuscript</td><td>No</td><td>830711935</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100271</td><td>10837</td><td>MOFFITT CANCER CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12902 MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>6130378</td><td>1992096028</td><td>MICHAEL</td><td>RAHMAN</td><td>SHAFIQUE</td><td>null</td><td>12902 USF MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>BioOncology</td><td>Avastin</td><td>50242-061-01</td><td>null</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4676.4</td><td>2021-04-05</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>TECENTRIQ ONCOLOGY EXTENSION STUDY</td><td>No</td><td>835919095</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>63301</td><td>11125</td><td>Childrens Hospital Colorado</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>860 N POTOMAC CIR.</td><td>null</td><td>AURORA</td><td>CO</td><td>80011</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>743817</td><td>1356426092</td><td>TIMOTHY</td><td>A.</td><td>BENKE</td><td>null</td><td>13123 E 16th Ave # B155</td><td>null</td><td>Aurora</td><td>CO</td><td>80045</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CO</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GW Pharmaceuticals plc</td><td>100000486820</td><td>GW Research Limited</td><td>null</td><td>Great Britain (Uk)</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>331.05</td><td>2021-06-25</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>GWND18064</td><td>No</td><td>841423013</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>82021</td><td>1811984727</td><td>RAMON</td><td>G</td><td>REYES ALMODOVAR</td><td>null</td><td>12952 BANDERA RD STE 105</td><td>null</td><td>HELOTES</td><td>TX</td><td>78023</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Family Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2275.62</td><td>2021-09-09</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 2 STUDY OF ONCE-DAILY LY3502970 COMPARED WITH PLACEBO AND ONCE-WEEKLY DULAGLUTIDE IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS</td><td>No</td><td>819445511</td><td>2021</td><td>06/30/2022</td><td>NCT05048719</td><td>https://clinicaltrials.gov/ct2/show/NCT05048719</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor in connection with clinical studies during the reporting period. For available study details,</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100271</td><td>10837</td><td>MOFFITT CANCER CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12902 MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>17284</td><td>1376599340</td><td>JHANELLE</td><td>null</td><td>GRAY</td><td>null</td><td>12902 USF MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>Esbriet</td><td>50242-121-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>728.0</td><td>2021-01-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PIRFENIDONE COMBINED WITH STANDARD FIRST LINE CHEMOTHERAPY IN ADVANCED STAGE LUNG NSCLC</td><td>No</td><td>835919943</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230046</td><td>10547</td><td>Univ Of Mi Hospitals & Hlth Ctrs</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 East Medical Center Drive</td><td>null</td><td>Ann Arbor</td><td>MI</td><td>48109</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>11050</td><td>1235211764</td><td>RODICA</td><td>P</td><td>BUSUI</td><td>null</td><td>4029 AVE MARIA ST</td><td>STE 1300</td><td>ANN ARBOR</td><td>MI</td><td>48105</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>Diabetes</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>45.52</td><td>2021-10-28</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9536-4388</td><td>No</td><td>811768723</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50625</td><td>11293</td><td>Cedars-Sinai Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>8700 BEVERLY BLVD</td><td>null</td><td>WEST HOLLYWOOD</td><td>CA</td><td>90048</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>5691235</td><td>1841516184</td><td>ARTAK</td><td>null</td><td>LABADZHYAN</td><td>null</td><td>8700 BEVERLY BLVD</td><td>null</td><td>WEST HOLLYWOOD</td><td>CA</td><td>90048-1804</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Chiasma, Inc.</td><td>100000801820</td><td>Chiasma, Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Endocrinology</td><td>MYCAPSSA</td><td>69880-120-28</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2155.44</td><td>2021-02-12</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>OOC-AMC-303</td><td>No</td><td>816011637</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1008481</td><td>1659459113</td><td>NITIN</td><td>null</td><td>JAIN</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>null</td><td>HOUSTON</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Amgen Inc.</td><td>100000000203</td><td>Amgen Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Oncology</td><td>Blincyto</td><td>55513-160-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>22.38</td><td>2021-06-24</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Ph3 Adult ALLRandomised Confirmatory Study - TOWER study</td><td>No</td><td>831024783</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>440015</td><td>10348</td><td>UNIVERSITY OF TENNESSEE MEDICAL CENT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1924 Alcoa Hwy</td><td>null</td><td>Knoxville</td><td>TN</td><td>37920</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>172406</td><td>1801908223</td><td>TIMOTHY</td><td>J</td><td>PANELLA</td><td>null</td><td>1926 ALCOA HWY STE 410</td><td>null</td><td>KNOXVILLE</td><td>TN</td><td>37920-1545</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ONCOLOGY</td><td>LIBTAYO</td><td>61755-008-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>984.81</td><td>2021-11-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>CEMIPLIMAB SURVIVORSHIP EPIDEMIOLOGY (CASE) STUDY</td><td>No</td><td>793090969</td><td>2021</td><td>06/30/2022</td><td>NCT03836105</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>140209</td><td>10485</td><td>Methodist Medical Ctr Of Illinois</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>221 NE Glen Oak Ave</td><td>null</td><td>Peoria</td><td>IL</td><td>61636</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>313517</td><td>1912929118</td><td>Alexander</td><td>null</td><td>Adler</td><td>null</td><td>112 NE Crescent 2nd Floor</td><td>null</td><td>Peoria</td><td>IL</td><td>61603</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Vifor (International) Ltd.</td><td>100000081386</td><td>Vifor (International) Ltd.</td><td>null</td><td>Switzerland</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Potassium Binder</td><td>Veltassa</td><td>53436-168-30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>732.37</td><td>2021-07-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PAT-CR-302</td><td>No</td><td>840513003</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230046</td><td>10547</td><td>Univ Of Mi Hospitals & Hlth Ctrs</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 EAST MEDICAL CENTER DRIVE</td><td>null</td><td>ANN ARBOR</td><td>MI</td><td>48109</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BioNTech SE</td><td>100000971889</td><td>BioNTech SE</td><td>null</td><td>Germany</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>21937.67</td><td>2021-04-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Yes</td><td>No</td><td>null</td><td>No</td><td>851137359</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>210011</td><td>10696</td><td>St. Agnes Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>900 CATON AVE</td><td>null</td><td>BALTIMORE</td><td>MD</td><td>21229</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>20019</td><td>1457310856</td><td>CAROLE</td><td>B.</td><td>MILLER</td><td>null</td><td>900 CATON AVE</td><td>STE 60</td><td>BALTIMORE</td><td>MD</td><td>21229</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MD</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>32.94</td><td>2021-10-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY</td><td>No</td><td>831076995</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>10686</td><td>1245258045</td><td>SCOTT</td><td>T</td><td>TAGAWA</td><td>null</td><td>68 TH STPO  525 E</td><td>BOX 403</td><td>NEW YORK</td><td>NY</td><td>10044</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>XTANDI</td><td>0469-0125-99</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>780.0</td><td>2021-07-02</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>ENZALUTAMIDE CLINICAL PUBLICATION PROGRAM</td><td>No</td><td>832570979</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230130</td><td>10522</td><td>WILLIAM BEAUMONT HOSPITAL- ROYAL OAK</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3601 W 13 Mile Rd</td><td>null</td><td>Royal Oak</td><td>MI</td><td>48073</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>281724</td><td>1205863859</td><td>MICHAEL</td><td>T</td><td>TRESE</td><td>null</td><td>3555 W 13 MILE RD</td><td>LL-20</td><td>ROYAL OAK</td><td>MI</td><td>48073-6710</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Ophthalmology|Retina Specialist</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>OPHTHALMOLOGY</td><td>EYLEA</td><td>61755-005-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4365.88</td><td>2021-07-12</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>RANDOMIZED, CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF INTRAVITREAL AFLIBERCEPT COMPARED TO LASER PHOTOCOAGULATION IN PATIENTS WITH RETINOPATHY OF PREMATURITY</td><td>No</td><td>793091227</td><td>2021</td><td>06/30/2022</td><td>NCT04101721</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100009</td><td>10836</td><td>University Of Miami Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1400 NW 12TH AVE</td><td>null</td><td>MIAMI</td><td>FL</td><td>33136</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1238846</td><td>1750517959</td><td>JUSTIN</td><td>null</td><td>WATTS</td><td>null</td><td>1120 NW 14TH ST</td><td># 1182</td><td>MIAMI</td><td>FL</td><td>33136</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>7973.1</td><td>2021-05-05</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis</td><td>No</td><td>831101503</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>53302</td><td>11301</td><td>Childrens Hospital Los Angeles</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4650 W Sunset Blvd</td><td>null</td><td>Los Angeles</td><td>CA</td><td>90027</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1146597</td><td>1508031352</td><td>LILY</td><td>null</td><td>CHAO</td><td>null</td><td>3701 WILSHIRE BLVD</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90010</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3.25</td><td>2021-11-19</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9924-4437</td><td>No</td><td>811033407</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230053</td><td>10500</td><td>Henry Ford Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2799 W GRAND BLVD</td><td>null</td><td>DETROIT</td><td>MI</td><td>48202</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Beckman Coulter, Inc.</td><td>100000010876</td><td>Beckman Coulter, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Devices</td><td>DXH 900</td><td>null</td><td>15099590701574</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>25000.0</td><td>2021-03-31</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>COVID-19 Neutralizing Antibodies</td><td>No</td><td>844946691</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>380009</td><td>11212</td><td>OHSU HOSPITAL AND CLINICS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3181 Sw Sam Jackson Park Rd</td><td>null</td><td>Portland</td><td>OR</td><td>97239</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>183323</td><td>1033127584</td><td>CHRISTOPHER</td><td>W</td><td>RYAN</td><td>null</td><td>3303 SW BOND AVE</td><td>7TH FLOOR</td><td>PORTLAND</td><td>OR</td><td>97239-4501</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>28.82</td><td>2021-04-28</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>STUDY OF DCC-3014 IN PATIENTS WITH ADVANCED TUMORS AND TENOSYNOVIAL GIANT CELL TUMOR</td><td>No</td><td>827887739</td><td>2021</td><td>06/30/2022</td><td>NCT03069469</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>363300</td><td>10334</td><td>Childrens Hospital Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3333 Burnet Avenue  Mlc  4900</td><td>null</td><td>Cincinnati</td><td>OH</td><td>45229</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>464149</td><td>1538322755</td><td>CHRISTOPHER</td><td>null</td><td>TOWE</td><td>null</td><td>3333 BURNET AVE</td><td>MLC 2021</td><td>CINCINNATI</td><td>OH</td><td>45229-3026</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Pulmonology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Boehringer Ingelheim USA, Inc.</td><td>100000136460</td><td>Boehringer Ingelheim Italia S.p.A.</td><td>null</td><td>Italy</td><td>Yes</td><td>Covered</td><td>Drug</td><td>RESPIRATORY</td><td>OFEV</td><td>0597-0143-60</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>315.14</td><td>2021-03-25</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Pediatric ILD program</td><td>No</td><td>827025781</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>363300</td><td>10334</td><td>CHILDRENS HOSPITAL MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3333 BURNET AVE</td><td>null</td><td>CINCINNATI</td><td>OH</td><td>45229</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>658528</td><td>1366491821</td><td>AMAL</td><td>H</td><td>ASSAAD</td><td>null</td><td>3333 BURNET AVE</td><td>ML 2000</td><td>CINCINNATI</td><td>OH</td><td>45229-3039</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Allergy/Immunology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AIMMUNE THERAPEUTICS, INC.</td><td>100000776814</td><td>AIMMUNE THERAPEUTICS, INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ALLERGY</td><td>PALFORZIA</td><td>71881-113-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>24275.7</td><td>2021-03-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY</td><td>No</td><td>849614627</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230165</td><td>10504</td><td>ST JOHN HOSPITAL & MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>22101 Moross</td><td>null</td><td>Detroit</td><td>MI</td><td>48236</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>169543</td><td>1740302850</td><td>DANIEL</td><td>null</td><td>LEBOVIC</td><td>null</td><td>19229 MACK AVE</td><td>SUITE 24</td><td>GROSSE POINTE WOODS</td><td>MI</td><td>48236-2858</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pharmacyclics LLC, an AbbVie Company</td><td>100000136439</td><td>Pharmacyclics LLC, An AbbVie Company</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>IMBRUVICA</td><td>57962-420-28</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>158.0</td><td>2021-06-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>informCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL)</td><td>No</td><td>786499617</td><td>2021</td><td>06/30/2022</td><td>NCT02582879</td><td>null</td><td>PCYC-1134M-CA</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220086</td><td>9982</td><td>Beth Israel Deaconess Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>330 Brookline Ave</td><td>St 207</td><td>Boston</td><td>MA</td><td>02215</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>204021</td><td>1508884024</td><td>GEORGE</td><td>null</td><td>TSOKOS</td><td>null</td><td>330 BROOKLINE AVE # CLS-937</td><td>BETH ISRAEL DEACONESS MEDICAL</td><td>BOSTON</td><td>MA</td><td>02215-5400</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Janssen Research & Development, LLC</td><td>100000005592</td><td>Janssen Research & Development, LLC</td><td>NJ</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>71500.0</td><td>2021-07-06</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Harvard/George Tsokos RFA IL12 vs. IL23</td><td>No</td><td>787575431</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>310001</td><td>10178</td><td>HACKENSACK UNIVERSITY MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>30 Prospect Ave</td><td>null</td><td>Hackensack</td><td>NJ</td><td>07601</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>914264</td><td>1366402893</td><td>SCOTT</td><td>D</td><td>ROWLEY</td><td>null</td><td>92 2ND ST</td><td>null</td><td>HACKENSACK</td><td>NJ</td><td>07601-2105</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>DC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pharmacyclics LLC, an AbbVie Company</td><td>100000136439</td><td>Pharmacyclics LLC, An AbbVie Company</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>IMBRUVICA</td><td>57962-420-28</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1270.0</td><td>2021-04-01</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Subjects With New Onset cGVHD</td><td>No</td><td>786501341</td><td>2021</td><td>06/30/2022</td><td>NCT02959944</td><td>null</td><td>PCYC-1140-IM</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390111</td><td>10224</td><td>HOSPITAL OF THE UNIV OF PENNA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3701 MARKET ST</td><td>null</td><td>PHILA</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>421699</td><td>1053348367</td><td>DEVRAJ</td><td>null</td><td>BASU</td><td>null</td><td>3400 SPRUCE ST FL 5</td><td>RAVDIN SILVERSTEIN</td><td>PHILADELPHIA</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Otolaryngology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>30451.95</td><td>2021-10-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1 STUDY OF ORAL LOXO-292 IN ADULT PATIENTS WITH ADVANCED SOLID TUMORS HARBORING RET ALTERATIONS</td><td>No</td><td>819447055</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor in connection with clinical studies during the reporting period.  For available study details, please visit clinicaltrials.gov.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>340113</td><td>10768</td><td>CAROLINAS MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1000 BLYTHE BLVD</td><td>32861</td><td>CHARLOTTE</td><td>NC</td><td>28232</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>969299</td><td>1306063128</td><td>JOEL</td><td>A</td><td>KAPLAN</td><td>null</td><td>1001 BLYTHE BLVD</td><td>MEDICAL CENTER PLAZA STE 601</td><td>CHARLOTTE</td><td>NC</td><td>28203</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>JAZZ PHARMACEUTICALS INC.</td><td>100000005637</td><td>JAZZ PHARMACEUTICALS INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>HEMATOLOGY/ONCOLOGY</td><td>VYXEOS</td><td>68727-745-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>133381.05</td><td>2021-04-20</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A STUDY TO COMPARE STANDARD CHEMOTHERAPY TO THERAPY WITH CPX-351 AND/OR GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED AML WITH OR WITHOUT FLT3 MUTATIONS</td><td>No</td><td>838145847</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360180</td><td>10373</td><td>Cleveland Clinic Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9500 EUCLID AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>343069</td><td>1548455355</td><td>SHILPA</td><td>null</td><td>GUPTA</td><td>null</td><td>9500 Euclid Ave</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44195</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Seagen Inc.</td><td>100000000279</td><td>Seagen Inc.</td><td>WA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Oncology</td><td>PADCEV</td><td>51144-030-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>39480.0</td><td>2021-11-03</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Open-label, Randomized, Controlled Phase 3 Study of Enfortumab Vedotin in Combination With Pembrolizumab With or Without Chemotherapy, Versus Chemotherapy Alone in Previously Untreated Locally Advanced or Metastatic Urothelial Cancer</td><td>No</td><td>792666195</td><td>2021</td><td>06/30/2022</td><td>NCT04223856</td><td>https://clinicaltrials.gov/ct2/show/NCT04223856</td><td>This study is being conducted to evaluate the combination of enfortumab vedotin + pembrolizumab, with or without platinum-containing chemotherapy, versus standard of care gemcitabine + platinum-containing chemotherapy, in subjects with previously untreated locally advanced or metastatic urothelial cancer.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>330285</td><td>10135</td><td>STRONG MEMORIAL HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>601 ELMWOOD AVE</td><td>BOX 684</td><td>ROCHESTER</td><td>NY</td><td>14642</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>BioOncology</td><td>TECENTRIQ</td><td>50242-917-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500.0</td><td>2021-08-17</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>STUDY OF CABOZANTINIB WITH ATEZOLIZUMAB AS NEOADJUVANT TREATMENT FOR MUSCLE INVASIVE BLADDER CA</td><td>No</td><td>835926543</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>63301</td><td>11125</td><td>Childrens Hospital Colorado</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>860 N Potomac Cir.</td><td>null</td><td>Aurora</td><td>CO</td><td>80011</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>743375</td><td>1336303585</td><td>Emily</td><td>Anne</td><td>Mccourt</td><td>null</td><td>12605 E 16th Ave</td><td>null</td><td>AURORA</td><td>CO</td><td>80045</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|General Practice</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CO</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Travere Therapeutics, Inc.</td><td>100000061305</td><td>Travere Therapeutics, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Hepatology</td><td>Chenodal</td><td>68974-876-40</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>670.64</td><td>2021-08-31</td><td>Cash or cash equivalent</td><td>Other</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>CTX Prevalence: CTX Observational study in patients with early onset bilateral cateracts</td><td>No</td><td>849335753</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>286917</td><td>1316957350</td><td>SATISH</td><td>S</td><td>MODI</td><td>null</td><td>23 DAVIS AVENUE</td><td>null</td><td>POUGHKEEPSIE</td><td>NY</td><td>12603</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Ophthalmology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alcon Research LLC</td><td>100000000218</td><td>Alcon Research LLC</td><td>TX</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Ophthalmology</td><td>Acrysof IQ ReSTOR IOL</td><td>null</td><td>00380652268752</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>635.85</td><td>2021-12-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Approval Study of the AcrySof IQ ReSTOR Toric IOL</td><td>No</td><td>807675825</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>53214</td><td>1184676371</td><td>RAJU</td><td>S.</td><td>GHATE</td><td>null</td><td>680 N LAKE SHORE DR STE 924</td><td>null</td><td>CHICAGO</td><td>IL</td><td>60611-8701</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Orthopaedic Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Zimmer Biomet Holdings, Inc.</td><td>100000000103</td><td>Zimmer Biomet Holdings, Inc.</td><td>IN</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Knees</td><td>PSI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2500.0</td><td>2021-06-23</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>CSU2015-12K Evaluation of Zimmer CAS XPSI</td><td>No</td><td>834036883</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>116924</td><td>1598704371</td><td>BRADLEY</td><td>N</td><td>HINES</td><td>null</td><td>3445 POPLAR AVE</td><td>SUITE 7</td><td>MEMPHIS</td><td>TN</td><td>38111-4667</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Optometry</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eye and Vision Services Providers|Optometrist</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alcon Research LLC</td><td>100000000218</td><td>Alcon Research LLC</td><td>TX</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Ophthalmology</td><td>Precision 1 for Astigmatism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>250.0</td><td>2021-12-23</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Clinical Comparison of 2 Daily Disposable Toric Soft Contact Lenses</td><td>No</td><td>807676083</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>190036</td><td>10978</td><td>OCHSNER CLINIC FOUNDATION</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1516 Jefferson Hwy</td><td>null</td><td>New Orleans</td><td>LA</td><td>70121</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>411712</td><td>1700844594</td><td>JULIA</td><td>B</td><td>GARCIA-DIAZ</td><td>null</td><td>1514 JEFFERSON HWY</td><td>null</td><td>NEW ORLEANS</td><td>LA</td><td>70121</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>LA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>VACCINES</td><td>COMIRNATY</td><td>0069-1000-03</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1838.7</td><td>2021-12-04</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 2B OPENLABEL STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF VACCINE CANDIDATE BNT162B2 IN IMMUNOCOMPROMISED PARTICIPANTS 2 YEARS OF AGE</td><td>No</td><td>832574625</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>460009</td><td>11165</td><td>U Of U Hospitals & Clinics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>50 N MEDICAL DR</td><td>null</td><td>SALT LAKE CITY</td><td>UT</td><td>84132</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>363468</td><td>1003906603</td><td>SUMATI</td><td>V.</td><td>GUPTA</td><td>null</td><td>2000 CIRCLE OF HOPE DR</td><td>STE 2100</td><td>SALT LAKE CITY</td><td>UT</td><td>84112</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>UT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>465.0</td><td>2021-06-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 2, Open Label, Single Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations</td><td>No</td><td>831080023</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>160058</td><td>10604</td><td>University Of Iowa Hosp & Clinics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>200 Hawkins Dr</td><td>null</td><td>Iowa City</td><td>IA</td><td>52242</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1224086</td><td>1235421140</td><td>MARCELO</td><td>L</td><td>CORREIA</td><td>null</td><td>200 HAWKINS DR</td><td># 2857</td><td>IOWA CITY</td><td>IA</td><td>52242</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Obesity</td><td>Wegovy</td><td>0169-4525-14</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>130.5</td><td>2021-04-22</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9536-4388</td><td>No</td><td>811844557</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>340061</td><td>10767</td><td>University Of North Carolina Hosp.</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>101 MANNING DR</td><td>null</td><td>CHAPEL HILL</td><td>NC</td><td>27514</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>713628</td><td>1265688493</td><td>BRANDI</td><td>N.</td><td>REEVES</td><td>null</td><td>101 MANNING DR</td><td>null</td><td>CHAPEL HILL</td><td>NC</td><td>27514</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>20.26</td><td>2021-03-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis</td><td>No</td><td>831102261</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>53302</td><td>11301</td><td>Childrens Hospital Los Angeles</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4650 W Sunset Blvd</td><td>null</td><td>Los Angeles</td><td>CA</td><td>90027</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1146597</td><td>1508031352</td><td>LILY</td><td>null</td><td>CHAO</td><td>null</td><td>3701 WILSHIRE BLVD</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90010</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>40.0</td><td>2021-10-08</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9924-4437</td><td>No</td><td>811628143</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500027</td><td>11177</td><td>Swedish Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>747 BROADWAY</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98122</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>296106</td><td>1518986199</td><td>MICHAEL</td><td>A.</td><td>ELLIOTT</td><td>null</td><td>1100 9th Ave</td><td>PO Box 900</td><td>Seattle</td><td>WA</td><td>98101</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alexion Pharmaceuticals, Inc.</td><td>100000005462</td><td>Alexion Pharmaceuticals, Inc.</td><td>MA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5308.6</td><td>2021-01-12</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Study With an Open-Label Extension to Evaluate the Efficacy and Safety of Ravulizumab in Patients With Amyotrophic Lateral Sclerosis (ALS)</td><td>No</td><td>781390757</td><td>2021</td><td>06/30/2022</td><td>NCT04248465</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>380009</td><td>11212</td><td>OHSU HOSPITAL AND CLINICS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3181 Sw Sam Jackson Park Rd</td><td>null</td><td>Portland</td><td>OR</td><td>97239</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>341933</td><td>1548278005</td><td>MICHAEL</td><td>C</td><td>HEINRICH</td><td>null</td><td>3181 SW SAM JACKSON PARK RD</td><td>null</td><td>PORTLAND</td><td>OR</td><td>97239-3011</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>QINLOCK</td><td>73207-101-31</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>153.6</td><td>2021-07-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A SAFETY TOLERABILITY AND PK STUDY OF DCC-2618 IN PATIENTS WITH ADVANCED MALIGNANCIES</td><td>No</td><td>827887997</td><td>2021</td><td>06/30/2022</td><td>NCT02571036</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390111</td><td>10224</td><td>Hospital Of The Univ Of Penna</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3701 MARKET ST</td><td>null</td><td>PHILA</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>719238</td><td>1487842100</td><td>JENNIFER</td><td>null</td><td>EADS</td><td>null</td><td>3400 CIVIC CENTER BLVD FL 3</td><td>null</td><td>PHILADELPHIA</td><td>PA</td><td>19104-5127</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Seagen Inc.</td><td>100000000279</td><td>Seagen Inc.</td><td>WA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>TUKYSA</td><td>51144-001-60</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>20200.0</td><td>2021-04-14</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Randomized, Double-blind, Placebo-controlled, Active Comparator Phase 2/3 Study of Tucatinib in Combination With Trastuzumab, Ramucirumab, and Paclitaxel in Subjects With Previously Treated, Locally-advanced Unresectable or Metastatic HER2+ Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)</td><td>No</td><td>792657069</td><td>2021</td><td>06/30/2022</td><td>NCT04499924</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390028</td><td>10267</td><td>Upmc Mercy Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1400 Locust St</td><td>null</td><td>Pittsburgh</td><td>PA</td><td>15219</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>347278</td><td>1649242033</td><td>SILVA</td><td>A</td><td>ARSLANIAN</td><td>null</td><td>5230 CENTRE AVE</td><td>FL 2</td><td>PITTSBURGH</td><td>PA</td><td>15232</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4.5</td><td>2021-12-13</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9924-4437</td><td>No</td><td>811824681</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220071</td><td>9988</td><td>MASSACHUSETTS GENERAL HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>55 Fruit St</td><td>Bulfinch 360</td><td>Boston</td><td>MA</td><td>02114</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1250600</td><td>1184608176</td><td>LEE</td><td>S</td><td>COHEN</td><td>null</td><td>185 CAMBRIDGE STREET</td><td>SUITE 220</td><td>BOSTON</td><td>MA</td><td>02114</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Otsuka Pharmaceutical Development & Commercialization, Inc.</td><td>100000010725</td><td>Otsuka Pharmaceutical Development & Commercialization, Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>PSYCHIATRY</td><td>REXULTI</td><td>59148-037-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>56938.5</td><td>2021-11-03</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NATIONAL PREGNANCY REGISTRY FOR PSYCHIATRIC MEDICATIONS</td><td>No</td><td>844171111</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>605795</td><td>1518292960</td><td>MICHELLE</td><td>MARIE</td><td>MANGUAL-GARCIA</td><td>null</td><td>HOSPITAL MUNICIPAL DE SAN JUAN</td><td>GOBERNADOR PINERO PISO  NBR  4TO</td><td>SAN JUAN</td><td>PR</td><td>00921</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4423.27</td><td>2021-06-08</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 2 STUDY OF ONCE-WEEKLY LY3437943 COMPARED WITH PLACEBO IN PARTICIPANTS WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT-RELATED COMORBIDITIES</td><td>No</td><td>819445771</td><td>2021</td><td>06/30/2022</td><td>NCT04881760</td><td>https://clinicaltrials.gov/ct2/show/NCT04881760</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>110087</td><td>10799</td><td>NORTHSIDE HOSPITAL GWINNETT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3620 HOWELL FERRY ROAD</td><td>null</td><td>DULUTH</td><td>GA</td><td>30096</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>267951</td><td>1912988445</td><td>PAUL</td><td>D</td><td>BOYCE</td><td>null</td><td>960 JOHNSON FERRY RD</td><td>SUITE 500</td><td>ATLANTA</td><td>GA</td><td>30342</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2500.0</td><td>2021-03-27</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PHII IL22FC ANTI ST2 IN SEVERE COVID 19 PNEUMONIA</td><td>No</td><td>835920997</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>127674</td><td>1821050238</td><td>IMRAN</td><td>A</td><td>SIDDIQUI</td><td>null</td><td>2425 COUNTY ROAD 90</td><td>null</td><td>PEARLAND</td><td>TX</td><td>77584</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>Ozempic</td><td>0169-4132-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>17.07</td><td>2021-05-14</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9535-4352</td><td>No</td><td>811712545</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>360044</td><td>1922060219</td><td>RICHARD</td><td>S.</td><td>CHERLIN</td><td>null</td><td>15899 LOS GATOS ALMADEN RD STE 12</td><td>null</td><td>LOS GATOS</td><td>CA</td><td>95032</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Chiasma, Inc.</td><td>100000801820</td><td>Chiasma, Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Endocrinology</td><td>MYCAPSSA</td><td>69880-120-28</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>733.58</td><td>2021-02-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>MACRO Registry</td><td>No</td><td>816012411</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>INVESTIGATOR FEES</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100007</td><td>10819</td><td>ADVENTHEALTH ORLANDO</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>601 E ROLLINS ST</td><td>null</td><td>ORLANDO</td><td>FL</td><td>32803</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>330415</td><td>1285829564</td><td>ELVIS</td><td>null</td><td>CASTILLO GARCIA</td><td>null</td><td>36819 EILAND BLVD 33542 SUITE 1</td><td>null</td><td>ZEPHYRHILLS</td><td>FL</td><td>33542</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2211.21</td><td>2021-01-26</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 AND LY3832479 IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS</td><td>No</td><td>819446027</td><td>2021</td><td>06/30/2022</td><td>NCT04427501</td><td>https://www.clinicaltrials.gov/ct2/show/NCT04427501</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>120995</td><td>1679670822</td><td>STUART</td><td>L.</td><td>SILVERMAN</td><td>null</td><td>8641 WILSHIRE BLVD</td><td>STE 301</td><td>BEVERLY HILLS</td><td>CA</td><td>90211</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Radius Health, Inc.</td><td>100000181748</td><td>Radius Health, Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9413.0</td><td>2021-05-20</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Study Concepts on Patient Preference - to support the value story of ABL's MTS</td><td>No</td><td>830713281</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>470003</td><td>9973</td><td>University Of Vermont Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>111 COLCHESTER AVE</td><td>null</td><td>BURLINGTON</td><td>VT</td><td>05401</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>409563</td><td>1629241336</td><td>DMITRIY</td><td>G.</td><td>AKSELROD</td><td>null</td><td>111 COLCHESTER AVE</td><td>UVM MEDICAL CENTER, DEPT OF RADIOLOGY</td><td>BURLINGTON</td><td>VT</td><td>05401-1473</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ID</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Blue Earth Diagnostics Limited</td><td>100000151603</td><td>Blue Earth Diagnostics Limited</td><td>null</td><td>Great Britain (Uk)</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diagnostic Imaging</td><td>Axumin</td><td>69932-001-30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4800.0</td><td>2021-03-17</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy</td><td>No</td><td>844376563</td><td>2021</td><td>06/30/2022</td><td>NCT04234399</td><td>https://clinicaltrials.gov/ct2/show/NCT04234399</td><td>Product_ISS Study</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>639274</td><td>1699971556</td><td>SANJIV</td><td>J</td><td>SHAH</td><td>null</td><td>675 N SAINT CLAIR ST STE 19250</td><td>null</td><td>CHICAGO</td><td>IL</td><td>60611</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>CARDIOVASCULAR</td><td>VYNDAQEL</td><td>0069-8729-55</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>940.0</td><td>2021-09-13</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>TAFAMIDIS CLINICAL PUBLICATION PROGRAM</td><td>No</td><td>832575789</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>828537</td><td>1346655099</td><td>BENJAMIN</td><td>LOUIS</td><td>HELLER</td><td>null</td><td>515 W BUCKEYE RD STE 104</td><td>null</td><td>PHOENIX</td><td>AZ</td><td>85003</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Ophthalmology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alcon Research LLC</td><td>100000000218</td><td>Alcon Research LLC</td><td>TX</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Ophthalmology</td><td>Acrysof IQ ReSTOR IOL</td><td>null</td><td>00380652268752</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>379.5</td><td>2021-12-16</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Approval Study of the AcrySof IQ ReSTOR Toric IOL</td><td>No</td><td>807676601</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500008</td><td>11198</td><td>UNIVERSITY OF WASHINGTON MED CTR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1959 NE PACIFIC ST</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>184405</td><td>1073637732</td><td>JEANNE</td><td>E</td><td>POOLE</td><td>null</td><td>1959 NE PACIFIC ST</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98195-0001</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ATRICURE, INC.</td><td>100000005372</td><td>AtriCure, Inc.</td><td>OH</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>CARDIOVASCULAR</td><td>ATRICURE CRYOSURGICAL SYSTEM</td><td>null</td><td>10840143902543</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>200.0</td><td>2021-03-19</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>ATRICURE CRYOICE LESIONS FOR PERSISTENT AND LONG-STANDING PERSISTENT ATRIAL FIBRILLATION TREATMENT DURING CONCOMITANT ON-PUMP ENDO/EPICARDIAL CARDIAC SURGERY</td><td>No</td><td>849539979</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>140150</td><td>10495</td><td>Board Of Trustees Of The University</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1740 W TAYLOR ST</td><td>MC 732</td><td>CHICAGO</td><td>IL</td><td>60612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1009675</td><td>1699986158</td><td>IRUM</td><td>H.</td><td>KHAN</td><td>null</td><td>840 S WOOD ST</td><td>null</td><td>CHICAGO</td><td>IL</td><td>60612</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>11.4</td><td>2021-01-11</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY</td><td>No</td><td>831080783</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>30103</td><td>11162</td><td>MAYO CLINIC HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5777 E Mayo Blvd</td><td>null</td><td>Phoenix</td><td>AZ</td><td>85054</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1291170</td><td>1376832196</td><td>AARON</td><td>R</td><td>MANGOLD</td><td>null</td><td>13400 E SHEA BLVD</td><td>null</td><td>SCOTTSDALE</td><td>AZ</td><td>85259</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>7200.0</td><td>2021-12-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 2A DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF PF06823859 IN ADULT SUBJECTS WITH DERMATOMYOSITIS</td><td>No</td><td>832577007</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50262</td><td>11328</td><td>RONALD REAGAN UCLA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>757 Westwood Plz</td><td>null</td><td>Los Angeles</td><td>CA</td><td>90095</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>6606</td><td>1154356053</td><td>TIMOTHY</td><td>F</td><td>CLOUGHESY</td><td>null</td><td>300 MEDICAL PLAZA SUITE B-200</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90095-0001</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>QINLOCK</td><td>73207-101-31</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>18.9</td><td>2021-03-04</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A SAFETY TOLERABILITY AND PK STUDY OF DCC-2618 IN PATIENTS WITH ADVANCED MALIGNANCIES</td><td>No</td><td>827888253</td><td>2021</td><td>06/30/2022</td><td>NCT02571036</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230046</td><td>10547</td><td>UNIV OF MI HOSPITALS & HLTH CTRS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 EAST MEDICAL CENTER DRIVE</td><td>null</td><td>ANN ARBOR</td><td>MI</td><td>48109</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1167066</td><td>1235228107</td><td>GEORGIANA</td><td>M</td><td>SANDERS</td><td>null</td><td>24 FRANK LLOYD WRIGHT DR</td><td>SUITE H-2100</td><td>ANN ARBOR</td><td>MI</td><td>48105-9484</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Allergy & Immunology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AIMMUNE THERAPEUTICS, INC.</td><td>100000776814</td><td>AIMMUNE THERAPEUTICS, INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ALLERGY</td><td>PALFORZIA</td><td>71881-113-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>21.42</td><td>2021-12-31</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PEANUT ORAL IMMUNOTHERAPY STUDY OF EARLY INTERVENTION FOR DESENSITIZATION (POSEIDON)</td><td>No</td><td>849615143</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500008</td><td>11198</td><td>University Of Washington Med Ctr</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1959 Ne Pacific St</td><td>null</td><td>Seattle</td><td>WA</td><td>98195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>637484</td><td>1639269582</td><td>MICHAEL</td><td>DAVID</td><td>WEISS</td><td>null</td><td>UNIVERSITY OF WASHINGTON MEDICAL CTR</td><td>1959 NE PACIFIC ST</td><td>SEATTLE</td><td>WA</td><td>98195-6166</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>UCB, Inc.</td><td>100000010773</td><td>UCB SA</td><td>null</td><td>Belgium</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>17400.0</td><td>2021-03-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Phase 3, Multicenter, Open-Label Extension Study of Zilucoplan in Subjects with Generalized Myasthenia Gravis</td><td>No</td><td>844225935</td><td>2021</td><td>06/30/2022</td><td>NCT04225871</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>54144</td><td>11286</td><td>Langley Porter Psychiatric Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>401 PARNASSUS AVE</td><td>null</td><td>SAN FRANCISCO</td><td>CA</td><td>94143</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>532154</td><td>1922242932</td><td>AMY</td><td>JO</td><td>CHIEN</td><td>null</td><td>550 16th St</td><td>null</td><td>SAN FRANCISCO</td><td>CA</td><td>94158</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Seagen Inc.</td><td>100000000279</td><td>Seagen Inc.</td><td>WA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>TUKYSA</td><td>51144-001-60</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5946.19</td><td>2021-10-06</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer</td><td>No</td><td>792657327</td><td>2021</td><td>06/30/2022</td><td>NCT03975647</td><td>https://clinicaltrials.gov/ct2/show/NCT03975647</td><td>This study is designed to evaluate the efficacy and safety of tucatinib in combination with T-DM1 in subjects with unresectable locally-advanced or metastatic HER2+ breast cancer who have had prior treatment with a taxane and trastuzumab in any setting. Prior pertuzumab treatment is permitted, but not required. Subjects will be randomized in a 1:1 manner to receive 21-day cycles of either tucatinib or placebo in combination with T-DM1.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390028</td><td>10267</td><td>Upmc Mercy Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1400 Locust St</td><td>null</td><td>Pittsburgh</td><td>PA</td><td>15219</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>347278</td><td>1649242033</td><td>SILVA</td><td>A</td><td>ARSLANIAN</td><td>null</td><td>5230 CENTRE AVE</td><td>FL 2</td><td>PITTSBURGH</td><td>PA</td><td>15232</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3.25</td><td>2021-11-19</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9924-4437</td><td>No</td><td>811824765</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>310014</td><td>10167</td><td>Cooper University Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1000 S 10TH ST</td><td>null</td><td>CAMDEN</td><td>NJ</td><td>08103</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>2787297</td><td>1477825891</td><td>TANYA</td><td>SONALI</td><td>EGODAGE</td><td>null</td><td>1 FEDERAL ST # 100</td><td>null</td><td>CAMDEN</td><td>NJ</td><td>08103-1088</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Surgery|Trauma Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alexion Pharmaceuticals, Inc.</td><td>100000005462</td><td>Alexion Pharmaceuticals, Inc.</td><td>MA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3750.0</td><td>2021-11-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Prospective, Open-Label Clinical Study of Andexanet Alfa in Patients Receiving FXa (Activated Factor X) Inhibitor Who Require Urgent Surgery</td><td>No</td><td>781391219</td><td>2021</td><td>06/30/2022</td><td>NCT04233073</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360180</td><td>10373</td><td>CLEVELAND CLINIC HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9500 EUCLID AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>6038</td><td>1124251871</td><td>JITENDRA</td><td>null</td><td>SHARMA</td><td>null</td><td>513 BROOKWOOD BLVD STE 372</td><td>null</td><td>BIRMINGHAM</td><td>AL</td><td>35209</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Vascular Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>50.0</td><td>2021-03-31</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3, RANDOMIZED, OPEN-LABEL TRIAL COMPARING EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS SEMAGLUTIDE ONCE WEEKLY AS ADD-ON THERAPY TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES</td><td>No</td><td>819447311</td><td>2021</td><td>06/30/2022</td><td>NCT03987919</td><td>https://clinicaltrials.gov/ct2/show/NCT03987919</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>503300</td><td>11178</td><td>SEATTLE CHILDRENS HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4800 SANDPOINT WAY NE</td><td>5371</td><td>SEATTLE</td><td>WA</td><td>98105</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1002112</td><td>1427268416</td><td>SARAH</td><td>E</td><td>LEARY</td><td>null</td><td>4800 SAND POINT WAY NE</td><td>MAILSTOP B-6553</td><td>SEATTLE</td><td>WA</td><td>98105</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>JAZZ PHARMACEUTICALS INC.</td><td>100000005637</td><td>JAZZ PHARMACEUTICALS INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>HEMATOLOGY/ONCOLOGY</td><td>VYXEOS</td><td>68727-745-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>133381.05</td><td>2021-02-23</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A STUDY TO COMPARE STANDARD CHEMOTHERAPY TO THERAPY WITH CPX-351 AND/OR GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED AML WITH OR WITHOUT FLT3 MUTATIONS</td><td>No</td><td>838146031</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360239</td><td>10330</td><td>SYCAMORE HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4000 MIAMISBURG CENTERVILLE RD</td><td>null</td><td>MIAMISBURG</td><td>OH</td><td>45342</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>55915</td><td>1245296409</td><td>THOMAS</td><td>J A</td><td>REID</td><td>null</td><td>30 E APPLE ST</td><td>5258</td><td>DAYTON</td><td>OH</td><td>45409</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>BioOncology</td><td>Avastin</td><td>50242-061-01</td><td>null</td><td>Covered</td><td>Biological</td><td>BioOncology</td><td>TECENTRIQ</td><td>50242-917-01</td><td>null</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12560.0</td><td>2021-09-13</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM</td><td>No</td><td>835927485</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>30087</td><td>11159</td><td>HONORHEALTH SCOTTSDALE SHEA MED CTR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>10450 N 92ND STREET</td><td>null</td><td>SCOTTSDALE</td><td>AZ</td><td>85258</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Plexxikon Inc.</td><td>100000010983</td><td>Plexxikon Inc.</td><td>CA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9089.1</td><td>2021-06-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Study of PLX2853 in Advanced Malignancies</td><td>No</td><td>854605295</td><td>2021</td><td>06/30/2022</td><td>NCT03297424</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50348</td><td>11307</td><td>UCI MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>101 THE CITY DR S</td><td>null</td><td>ORANGE</td><td>CA</td><td>92868</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1297481</td><td>1942463377</td><td>ZAHRA</td><td>null</td><td>PAKBAZ</td><td>null</td><td>26520 CACTUS AVE</td><td>null</td><td>MORENO VALLEY</td><td>CA</td><td>92555</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Amgen Inc.</td><td>100000000203</td><td>Amgen Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Hematology</td><td>Nplate</td><td>55513-221-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>20255.1</td><td>2021-05-10</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>LCM:A Phase 3 Randomized Placebo Controlled Study of the Treatment of CIT for Solid Tumors- Study 1</td><td>No</td><td>830983295</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>340001</td><td>10755</td><td>Carolinas Healthcare System Northeas</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>920 Church St N</td><td>null</td><td>Concord</td><td>NC</td><td>28025</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>817790</td><td>1962601526</td><td>SAAD</td><td>null</td><td>USMANI</td><td>null</td><td>1021 MOREHEAD MEDICAL DR</td><td>STE A</td><td>CHARLOTTE</td><td>NC</td><td>28204-2990</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Janssen Research & Development, LLC</td><td>100000005592</td><td>Janssen Research & Development, LLC</td><td>NJ</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2940.0</td><td>2021-03-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3 Study Comparing Daratumumab VELCADE bortezomib Lenalidomide and Dexamethasone DVRd with VELCADE Lenalidomide and Dexamethasone VRd in Subjects with Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initi</td><td>No</td><td>787576735</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>110107</td><td>10804</td><td>Medical Center of Central Georgia</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>777 Hemlock Street, MSC 53</td><td>null</td><td>Macon</td><td>GA</td><td>31201</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>309422</td><td>1811976053</td><td>Michael</td><td>null</td><td>Klyachkin</td><td>null</td><td>688 Walnut St</td><td>STE 200</td><td>Macon</td><td>GA</td><td>31201</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Phraxis, Inc.</td><td>100000151551</td><td>Phraxis, Inc.</td><td>MN</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Access for Hemodialysis</td><td>Venous InterGraft</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4668.96</td><td>2021-03-31</td><td>In-kind items and services</td><td>Patient Care</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Clinical Evaluation of a Vascular Anastomotic Connector System for Minimally Invasive Connection of an Arteriovenous Graft for Hemodialysis</td><td>No</td><td>831382977</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390111</td><td>10224</td><td>Hospital Of The Univ Of Penna</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3701 MARKET ST</td><td>null</td><td>PHILADELPHIA</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1229960</td><td>1447282728</td><td>HARVEY</td><td>M</td><td>FRIEDMAN</td><td>null</td><td>3400 SPRUCE STREET</td><td>null</td><td>PHILADELPHIA</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BioNTech SE</td><td>100000971889</td><td>BioNTech SE</td><td>null</td><td>Germany</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>465.0</td><td>2021-11-11</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Yes</td><td>No</td><td>BNT163-01_HSV-2</td><td>No</td><td>851139181</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>110064</td><td>10795</td><td>Piedmont Columbus Regional Midtown</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>710 CENTER ST</td><td>null</td><td>COLUMBUS</td><td>GA</td><td>31901</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>309861</td><td>1831262922</td><td>ANDREW</td><td>W.</td><td>PIPPAS</td><td>null</td><td>1831 5TH AVE</td><td>null</td><td>COLUMBUS</td><td>GA</td><td>31904</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>20.0</td><td>2021-05-27</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY</td><td>No</td><td>831082301</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100007</td><td>10819</td><td>Adventhealth Orlando</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>601 E ROLLINS ST</td><td>null</td><td>ORLANDO</td><td>FL</td><td>32803</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>135898</td><td>1992752372</td><td>REGINO</td><td>null</td><td>GONZALEZ-PERALTA</td><td>null</td><td>1600 SW Archer Rd</td><td>null</td><td>Gainesville</td><td>FL</td><td>32610</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alexion Pharmaceuticals, Inc.</td><td>100000005462</td><td>Alexion Pharmaceuticals, Inc.</td><td>MA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>11500.0</td><td>2021-02-17</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate the Efficacy and Safety of ALXN1840 Administered For 48 Weeks Versus Standard of Care in Patients With Wilson Disease Aged 12 Years and Older With an Extension Period of Up To 60 Months</td><td>No</td><td>781384347</td><td>2021</td><td>06/30/2022</td><td>NCT03403205</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390111</td><td>10224</td><td>HOSPITAL OF THE UNIV OF PENNA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3701 Market St</td><td>null</td><td>Phila</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>66131</td><td>1457414625</td><td>ADAM</td><td>null</td><td>CUKER</td><td>null</td><td>3400 SPRUCE ST</td><td>null</td><td>PHILADELPHIA</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>24866.14</td><td>2021-07-14</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PHASE 3 OPEN LABEL SINGLE ARM STUDY TO EVALUATE EFFICACY AND SAFETY OF FIX GENE TRANSFER WITH PF06838435 RAAVSPARK100HFIXPADUA IN ADULT MALE PARTICIPANTS WITH MODERATELY SEVERE TO SEVERE HEMOPHILIA B FIXC LT2 BENEGENE2</td><td>No</td><td>832901317</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450054</td><td>11012</td><td>Scott And White Memorial Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1901 Sw H K Dodgen Loop</td><td>null</td><td>Temple</td><td>TX</td><td>76502</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>488699</td><td>1396933370</td><td>SHERRONDA</td><td>null</td><td>HENDERSON</td><td>null</td><td>2401 S 31ST ST</td><td>null</td><td>TEMPLE</td><td>TX</td><td>76508-3666</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Merck Sharp & Dohme Corporation</td><td>100000000053</td><td>Merck Sharp & Dohme Corporation</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>WELIREG</td><td>0006-5331-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>8687.05</td><td>2021-12-31</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Phase 2 Study of MK-6482 in Participants With Advanced Renal Cell Carcinoma</td><td>No</td><td>848752469</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50262</td><td>11328</td><td>RONALD REAGAN UCLA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>757 Westwood Plz</td><td>null</td><td>Los Angeles</td><td>CA</td><td>90095</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>6606</td><td>1154356053</td><td>TIMOTHY</td><td>F</td><td>CLOUGHESY</td><td>null</td><td>300 MEDICAL PLAZA SUITE B-200</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90095-0001</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>QINLOCK</td><td>73207-101-31</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>18.9</td><td>2021-03-04</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A SAFETY TOLERABILITY AND PK STUDY OF DCC-2618 IN PATIENTS WITH ADVANCED MALIGNANCIES</td><td>No</td><td>827888509</td><td>2021</td><td>06/30/2022</td><td>NCT02571036</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>330285</td><td>10135</td><td>STRONG MEMORIAL HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>601 Elmwood Ave</td><td>Box 684</td><td>Rochester</td><td>NY</td><td>14642</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>776949</td><td>1528200300</td><td>RICHARD</td><td>F</td><td>DUNNE</td><td>null</td><td>601 ELMWOOD AVE</td><td>601 ELMWOOD AVE</td><td>ROCHESTER</td><td>NY</td><td>14642-0001</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Merck Sharp & Dohme Corporation</td><td>100000000053</td><td>Merck Sharp & Dohme Corporation</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>LENVIMA</td><td>62856-712-30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4228.56</td><td>2021-12-31</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3 Multicenter, Randomized, Double-blinded, Active-controlled, Clinical Study to Evaluate the Safety and Efficacy of Lenvatinib E7080,MK-7902 in Combination with Pembrolizumab MK-3475 Versus Lenvatinib in First-line Therapy of Participants with Advanced Hepatocellular Carcinoma LEAP-002</td><td>No</td><td>848755661</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390111</td><td>10224</td><td>Hospital Of The Univ Of Penna</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3701 Market Street</td><td>null</td><td>Philadelphia</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1186987</td><td>1942256797</td><td>Daniel</td><td>null</td><td>Yoshor</td><td>MD</td><td>South Pavilion, 2nd Floor</td><td>3400 Civic Center Boulevard</td><td>Philadelphia</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Neurological Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Second Sight Medical Products, Inc.</td><td>100000041253</td><td>Second Sight Medical Products, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Device</td><td>Cortical Visual Prosthesis</td><td>Orion</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>27874.27</td><td>2021-09-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Early Feasibility Clinical Trial of a Visual Cortical Prosthesis</td><td>No</td><td>790256149</td><td>2021</td><td>06/30/2022</td><td>NCT03344848</td><td>https://www.clinicaltrials.gov/ct2/show/NCT03344848?term=Orion&draw=2&rank=1</td><td>Orion Visual Cortical Prosthesis</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>357686</td><td>1881661270</td><td>ANTERPREET</td><td>null</td><td>DUA</td><td>null</td><td>1120 15th St</td><td>null</td><td>AUGUSTA</td><td>GA</td><td>30905</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Anesthesiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>SC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Nevro Corp.</td><td>100000136428</td><td>Nevro Corp.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Spinal Cord Stimulator</td><td>Senza II</td><td>null</td><td>00813426020510</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>375.0</td><td>2021-10-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Market Observational Study</td><td>No</td><td>832288077</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>180067</td><td>10869</td><td>University Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>800 Rose St</td><td>null</td><td>Lexington</td><td>KY</td><td>40536</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1381979</td><td>1902193147</td><td>AMAN</td><td>null</td><td>CHAUHAN</td><td>null</td><td>800 ROSE ST</td><td>UK DIVISION OF MEDICAL ONCOLOGY</td><td>LEXINGTON</td><td>KY</td><td>40536</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>KY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alkermes, Inc.</td><td>100000000255</td><td>Alkermes, Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>KEYTRUDA</td><td>0006-3026-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>14804.23</td><td>2021-02-11</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 1/2 Study of ALKS 4230 Administered Intravenously as Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors - ARTISTRY-1</td><td>No</td><td>797816783</td><td>2021</td><td>06/30/2022</td><td>NCT02799095</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>460009</td><td>11165</td><td>U OF U HOSPITALS & CLINICS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>50 N Medical Dr</td><td>null</td><td>Salt Lake City</td><td>UT</td><td>84132</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1002319</td><td>1437258498</td><td>HOWARD</td><td>null</td><td>COLMAN</td><td>null</td><td>2000 CIRCLE OF HOPE DR</td><td>DEPT OF NEUROSURGERY AND HUNTSMAN CANCER INSTITUTE</td><td>SALT LAKE CITY</td><td>UT</td><td>84112-5550</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>UT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>QINLOCK</td><td>73207-101-31</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>327.0</td><td>2021-11-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A SAFETY TOLERABILITY AND PK STUDY OF DCC-2618 IN PATIENTS WITH ADVANCED MALIGNANCIES</td><td>No</td><td>827888765</td><td>2021</td><td>06/30/2022</td><td>NCT02571036</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>30038</td><td>11158</td><td>Honorhealth Scottsdale Osborn Med Ct</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>7400 E Osborn Road</td><td>null</td><td>Scottsdale</td><td>AZ</td><td>85251</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>277405</td><td>1114929114</td><td>Michael</td><td>S</td><td>Gordon</td><td>null</td><td>10510 N 92nd St Ste 200</td><td>null</td><td>Scottsdale</td><td>AZ</td><td>85258</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Daiichi Sankyo Inc.</td><td>100000000195</td><td>Daiichi Sankyo Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>Turalio</td><td>65597-402-20</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>715.0</td><td>2021-11-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PL3397-A-U126</td><td>No</td><td>835068789</td><td>2021</td><td>06/30/2022</td><td>NCT03291288</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>310001</td><td>10178</td><td>Hackensack University Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>30 PROSPECT AVE</td><td>null</td><td>HACKENSACK</td><td>NJ</td><td>07601</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>297826</td><td>1578528089</td><td>TATYANA</td><td>null</td><td>FELDMAN</td><td>null</td><td>92 2nd St</td><td>null</td><td>HACKENSACK</td><td>NJ</td><td>07601</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NJ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Seagen Inc.</td><td>100000000279</td><td>Seagen Inc.</td><td>WA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Oncology</td><td>ADCETRIS</td><td>51144-050-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>780.0</td><td>2021-09-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 1/2 Study Evaluating Brentuximab Vedotin in Combination With Nivolumab in Patients With Relapsed or Refractory Hodgkin Lymphoma After Failure of Frontline Therapy</td><td>No</td><td>792664339</td><td>2021</td><td>06/30/2022</td><td>NCT02572167</td><td>https://clinicaltrials.gov/ct2/show/NCT02572167</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>33302</td><td>11161</td><td>PHOENIX CHILDRENS HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1919 E THOMAS RD</td><td>null</td><td>PHOENIX</td><td>AZ</td><td>85016</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Hematology</td><td>HEMLIBRA</td><td>50242-920-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>18150.0</td><td>2021-11-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>AN OPEN LABEL STUDY TO DETERMINE PK AND PD OF HEMLIBRA IN SEVERE HEMOPHILIA A WITHOUT INHIBITORS</td><td>No</td><td>835922093</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>490052</td><td>10707</td><td>RIVERSIDE REGIONAL MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>500 J Clyde Morris Blvd</td><td>null</td><td>Newport News</td><td>VA</td><td>23601</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>310664</td><td>1851325328</td><td>KERMIT</td><td>A</td><td>LLOYD</td><td>null</td><td>12200 WARWICK BLVD</td><td>SUITE 110</td><td>NEWPORT NEWS</td><td>VA</td><td>23601-2344</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>VA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Adamas Pharmaceuticals, Inc.</td><td>100000226811</td><td>Adamas Pharmaceuticals, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1012.37</td><td>2021-11-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A MULTICENTER OPEN-LABEL SAFETY AND EFFICACY STUDY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN PATIENTS WITH MULTIPLE SCLEROSIS AND WALKING IMPAIRMENT</td><td>No</td><td>837698485</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>140158</td><td>10438</td><td>Mercy Hospital & Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2525 S Michigan Ave</td><td>null</td><td>Chicago</td><td>IL</td><td>60616</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1287150</td><td>1073732459</td><td>AZAZUDDIN</td><td>A</td><td>AHMED</td><td>null</td><td>2555 S MARTIN LUTHER KING DRIVE</td><td>null</td><td>CHICAGO</td><td>IL</td><td>60616</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>Ozempic</td><td>0169-4132-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9.0</td><td>2021-07-14</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9535-4352</td><td>No</td><td>811635379</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500027</td><td>11177</td><td>Swedish Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>747 Broadway</td><td>null</td><td>Seattle</td><td>WA</td><td>98122</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>60322</td><td>1336218171</td><td>PHILIP</td><td>J</td><td>MEASE</td><td>null</td><td>1101 MADISON ST STE 1000</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98104-3556</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>UCB, Inc.</td><td>100000010773</td><td>UCB SA</td><td>null</td><td>Belgium</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>450.0</td><td>2021-11-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A MULTICENTER, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS</td><td>No</td><td>844231713</td><td>2021</td><td>06/30/2022</td><td>NCT03896581</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1064246</td><td>1629285150</td><td>RAVIKUMAR</td><td>K</td><td>PATEL</td><td>null</td><td>509 BILTMORE AVE</td><td>null</td><td>ASHEVILLE</td><td>NC</td><td>28801</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Osteopathy</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>SC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>39.59</td><td>2021-04-16</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 AND LY3832479 IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS</td><td>No</td><td>819446283</td><td>2021</td><td>06/30/2022</td><td>NCT04427501</td><td>https://www.clinicaltrials.gov/ct2/show/NCT04427501</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>110010</td><td>10785</td><td>Emory University Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1821 CLIFTON RD NE</td><td>null</td><td>ATLANTA</td><td>GA</td><td>30329</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>262408</td><td>1780998229</td><td>BRIAN</td><td>THOMAS</td><td>CABANISS</td><td>null</td><td>12 Executive Park Dr Ne</td><td>null</td><td>ATLANTA</td><td>GA</td><td>30329</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Medtronic, Inc.</td><td>100000000106</td><td>Medtronic, Inc.</td><td>MN</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>MRI-guided laser ablation</td><td>VISUALASE</td><td>null</td><td>00643169792890</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>760.74</td><td>2021-12-01</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>SLATE</td><td>No</td><td>800998821</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50348</td><td>11307</td><td>Uci Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>101 THE CITY DR S</td><td>null</td><td>ORANGE</td><td>CA</td><td>92868</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>60796</td><td>1356421515</td><td>TAHSEEN</td><td>null</td><td>MOZAFFAR</td><td>null</td><td>200 S Manchester Ave Ste 110</td><td>null</td><td>Orange</td><td>CA</td><td>92868</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alexion Pharmaceuticals, Inc.</td><td>100000005462</td><td>Alexion Pharmaceuticals, Inc.</td><td>MA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>10619.0</td><td>2021-02-04</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Long-Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies</td><td>No</td><td>781384609</td><td>2021</td><td>06/30/2022</td><td>NCT04202341</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230046</td><td>10547</td><td>UNIV OF MI HOSPITALS & HLTH CTRS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 East Medical Center Drive</td><td>null</td><td>Ann Arbor</td><td>MI</td><td>48105</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>91194</td><td>1013094853</td><td>SCOTT</td><td>L</td><td>HUMMEL</td><td>null</td><td>1500 E MEDICAL CENTER DR</td><td>null</td><td>ANN ARBOR</td><td>MI</td><td>48109</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>CARDIOVASCULAR</td><td>VYNDAQEL</td><td>0069-8729-55</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>279.93</td><td>2021-03-05</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3 MULTICENTER OPENLABEL STUDY TO EVALUATE THE SAFETY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE PF0629182683 20 MG OR 80 MG OR TAFAMIDIS PF0629182600 61 MG IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY ATTRCM</td><td>No</td><td>832902501</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>340113</td><td>10768</td><td>CAROLINAS MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2001 Vail Ave</td><td>null</td><td>Charlotte</td><td>NC</td><td>28207</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1223061</td><td>1205035466</td><td>NILANJAN</td><td>null</td><td>GHOSH</td><td>null</td><td>1021 MOREHEAD MEDICAL DR</td><td>STE A</td><td>CHARLOTTE</td><td>NC</td><td>28204-2990</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pharmacyclics LLC, an AbbVie Company</td><td>100000136439</td><td>Pharmacyclics LLC, An AbbVie Company</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>IMBRUVICA</td><td>57962-420-28</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2146.71</td><td>2021-03-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (SYMPATICO)</td><td>No</td><td>786497989</td><td>2021</td><td>06/30/2022</td><td>NCT03112174</td><td>null</td><td>PCYC-1143-CA</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>370028</td><td>10993</td><td>Integris Baptist Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2601 Spencer Rd</td><td>null</td><td>Spencer</td><td>OK</td><td>73084</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>221153</td><td>1881688760</td><td>DOUGLAS</td><td>null</td><td>HORSTMANSHOF</td><td>null</td><td>5300 N INDEPENDENCE AVE</td><td>SUITE 280</td><td>OKLAHOMA CITY</td><td>OK</td><td>73112-5556</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>KS</td><td>OK</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Abbott Laboratories</td><td>100000010680</td><td>Abbott Laboratories</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Heart Failure</td><td>HeartMate 3 Left Ventricular Assist Device</td><td>null</td><td>00813024013297</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1190.0</td><td>2021-05-05</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>MOMENTUM 3 Extended Follow-up Post Approval Study</td><td>No</td><td>827577163</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220071</td><td>9988</td><td>Massachusetts General Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>55 Fruit St</td><td>Bulfinch 360</td><td>Boston</td><td>MA</td><td>02114</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>130235</td><td>1881696003</td><td>RYAN</td><td>J</td><td>SULLIVAN</td><td>null</td><td>55 FRUIT ST</td><td>null</td><td>BOSTON</td><td>MA</td><td>02114</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000231820</td><td>ARRAY BIOPHARMA INC</td><td>CO</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>BRAFTOVI</td><td>70255-025-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>14790.3</td><td>2021-01-15</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 2 OPENLABEL RANDOMIZED MULTICENTER TRIAL OF ENCORAFENIB  BINIMETINIB EVALUATING A STANDARDDOSE AND A HIGHDOSE REGIMEN IN PATIENTS WITH BRAFV600MUTANT MELANOMA BRAIN METASTASIS</td><td>No</td><td>832515465</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Study Drug</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>190036</td><td>10978</td><td>OCHSNER CLINIC FOUNDATION</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1516 Jefferson Hwy</td><td>null</td><td>New Orleans</td><td>LA</td><td>70121</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>411712</td><td>1700844594</td><td>JULIA</td><td>B</td><td>GARCIA-DIAZ</td><td>null</td><td>1514 JEFFERSON HWY</td><td>null</td><td>NEW ORLEANS</td><td>LA</td><td>70121</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>LA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>VACCINES</td><td>COMIRNATY</td><td>0069-1000-03</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>17697.83</td><td>2021-02-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS</td><td>No</td><td>832903691</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220071</td><td>9988</td><td>MASSACHUSETTS GENERAL HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>55 FRUIT ST</td><td>BULFINCH 360</td><td>BOSTON</td><td>MA</td><td>02241</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>482329</td><td>1174592448</td><td>WAYNE</td><td>GLENN</td><td>SHREFFLER</td><td>null</td><td>1 GUSTAVE L LEVY PL</td><td>BOX 1200</td><td>NEW YORK</td><td>NY</td><td>10029-6500</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Allergy/Immunology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AIMMUNE THERAPEUTICS, INC.</td><td>100000776814</td><td>AIMMUNE THERAPEUTICS, INC.</td><td>CA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1171.3</td><td>2021-12-01</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY</td><td>No</td><td>849615661</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450690</td><td>11068</td><td>Ut Health Center At Tyler</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>11937 US HIGHWAY 271</td><td>null</td><td>TYLER</td><td>TX</td><td>75708</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>161258</td><td>1558344903</td><td>JAMES</td><td>null</td><td>STOCKS</td><td>null</td><td>11937 US Highway 271</td><td>null</td><td>Tyler</td><td>TX</td><td>75708</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Grifols Shared Services North America, Inc.</td><td>100000005422</td><td>Grifols Therapeutics LLC</td><td>CA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Biological</td><td>Pulmonology</td><td>Prolastin-C</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>812.0</td><td>2021-06-30</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens 60 mgkg and 120 mgkg of Weekly Intravenous Alpha1 Proteinase Inhibitor Human in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin D</td><td>No</td><td>845837001</td><td>2021</td><td>06/30/2022</td><td>NCT01983241</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>10033</td><td>10929</td><td>UNIVERSITY OF ALABAMA HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>619 19th St S</td><td>null</td><td>Birmingham</td><td>AL</td><td>35249</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1303605</td><td>1437309283</td><td>REBECCA</td><td>null</td><td>AREND</td><td>null</td><td>619 19TH ST S</td><td>null</td><td>BIRMINGHAM</td><td>AL</td><td>35249-3720</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2072.0</td><td>2021-03-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1B 2 STUDY OF REBASTINIB DCC-2036 IN COMBINATION WITH PACLITAXEL IN PATIENTS WITH ADVANCED OR METASTATIC SOLID TUMORS</td><td>No</td><td>827888893</td><td>2021</td><td>06/30/2022</td><td>NCT03601897</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450051</td><td>11035</td><td>METHODIST DALLAS MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1441 N Beckley Ave</td><td>null</td><td>Dallas</td><td>TX</td><td>75203</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>80276</td><td>1770528697</td><td>PARVEZ</td><td>S</td><td>MANTRY</td><td>null</td><td>1411 N BECKLEY AVE</td><td>PAVILION III STE 268</td><td>DALLAS</td><td>TX</td><td>75203-1259</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allergan, Inc.</td><td>100000000278</td><td>Allergan, Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>10000.0</td><td>2021-07-12</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>AURORA: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis</td><td>No</td><td>789018615</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>3152-301-002</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230297</td><td>10146</td><td>Karmanos Cancer Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4100 John R St</td><td>null</td><td>Detroit</td><td>MI</td><td>48201</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>728247</td><td>1790982031</td><td>IRA</td><td>null</td><td>WINER</td><td>null</td><td>4100 JOHN R</td><td>KARMANOS CANCER CENTER</td><td>DETROIT</td><td>MI</td><td>48201-2013</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alkermes, Inc.</td><td>100000000255</td><td>Alkermes, Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>KEYTRUDA</td><td>0006-3026-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>15710.0</td><td>2021-08-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 1/2 Study of ALKS 4230 Administered Intravenously as Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors - ARTISTRY-1</td><td>No</td><td>797817295</td><td>2021</td><td>06/30/2022</td><td>NCT02799095</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1226491</td><td>1316999642</td><td>DAVID</td><td>JEAN</td><td>WILSON</td><td>null</td><td>3375 SW TERWILLIGER BLVD</td><td>null</td><td>PORTLAND</td><td>OR</td><td>97239</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Ophthalmology|Retina Specialist</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OR</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2053.33</td><td>2021-06-24</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE III STUDY TO EVALUATE FARICIMAB IN PATIENTS WITH BRANCH RETINAL VEIN OCCLUSION</td><td>No</td><td>835899065</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>10033</td><td>10929</td><td>UNIVERSITY OF ALABAMA HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>619 19th St S</td><td>null</td><td>Birmingham</td><td>AL</td><td>35249</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1303605</td><td>1437309283</td><td>REBECCA</td><td>null</td><td>AREND</td><td>null</td><td>619 19TH ST S</td><td>null</td><td>BIRMINGHAM</td><td>AL</td><td>35249-3720</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Deciphera Pharmaceuticals Inc.</td><td>100000776815</td><td>Deciphera Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2212.0</td><td>2021-05-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1B 2 STUDY OF REBASTINIB DCC-2036 IN COMBINATION WITH PACLITAXEL IN PATIENTS WITH ADVANCED OR METASTATIC SOLID TUMORS</td><td>No</td><td>827888997</td><td>2021</td><td>06/30/2022</td><td>NCT03601897</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>263302</td><td>10622</td><td>CHILDRENS MERCY HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2401 GILLHAM RD</td><td>null</td><td>KANSAS CITY</td><td>MO</td><td>64108</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>814133</td><td>1851322069</td><td>JENNIFER</td><td>J</td><td>DILTS</td><td>null</td><td>2401 GILLHAM RD</td><td>null</td><td>KANSAS CITY</td><td>MO</td><td>64108</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Osteopathy</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MO</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>28072.0</td><td>2021-07-13</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF GALCANEZUMAB IN PATIENTS 6 TO 17 YEARS OF AGE WITH EPISODIC MIGRAINE - THE REBUILD STUDY</td><td>No</td><td>819447567</td><td>2021</td><td>06/30/2022</td><td>NCT03432286</td><td>https://clinicaltrials.gov/ct2/show/NCT03432286</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230046</td><td>10547</td><td>UNIV OF MI HOSPITALS & HLTH CTRS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 EAST MEDICAL CENTER DRIVE</td><td>null</td><td>ANN ARBOR</td><td>MI</td><td>48109</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>251084</td><td>1548270176</td><td>RAJEN</td><td>null</td><td>MODY</td><td>null</td><td>1500 E MEDICAL CENTER DR</td><td>null</td><td>ANN ARBOR</td><td>MI</td><td>48109</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Amgen Inc.</td><td>100000000203</td><td>Amgen Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Oncology</td><td>Blincyto</td><td>55513-160-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2100.0</td><td>2021-05-21</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Long-term Safety in Paediatric Patients B-precursor ALL Treated with Blincyto or SOC then Transplant</td><td>No</td><td>830983419</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100271</td><td>10837</td><td>Moffitt Cancer Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12902 Magnolia Dr</td><td>null</td><td>Tampa</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1011346</td><td>1750543948</td><td>JULIO</td><td>null</td><td>CHAVEZ</td><td>null</td><td>12902 USF MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|General Practice</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Kite Pharma, Inc.</td><td>100000216809</td><td>Kite Pharma, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>CELLT</td><td>Yescarta</td><td>71287-119-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>15724.94</td><td>2021-08-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (ZUMA 5)</td><td>No</td><td>826576637</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>;KTE-C19-105;KP27304;593238634;11612756</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>340001</td><td>10755</td><td>Carolinas Healthcare System Northeas</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>920 Church St N</td><td>null</td><td>Concord</td><td>NC</td><td>28025</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Janssen Research & Development, LLC</td><td>100000005592</td><td>Janssen Research & Development, LLC</td><td>NJ</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3510.0</td><td>2021-12-21</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 2 Study of Erdafitinib in Subjects with Advanced Solid Tumors and FGFR Gene Alterations</td><td>No</td><td>787577385</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>54144</td><td>11286</td><td>LANGLEY PORTER PSYCHIATRIC HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>401 PARNASSUS AVE</td><td>null</td><td>SAN FRANCISCO</td><td>CA</td><td>94143</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>183398</td><td>1033176581</td><td>HOPE</td><td>S</td><td>RUGO</td><td>null</td><td>1825 4TH ST FL 3</td><td>null</td><td>SAN FRANCISCO</td><td>CA</td><td>94143</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eli Lilly and Company</td><td>100000000088</td><td>Eli Lilly and Company</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>86889.0</td><td>2021-09-27</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1A/1B STUDY OF LY3484356 ADMINISTERED AS MONOTHERAPY AND IN COMBINATION WITH ABEMACICLIB TO PATIENTS WITH ER+, HER2- LOCALLY ADVANCED OR METASTATIC BREAST CANCER</td><td>No</td><td>819447825</td><td>2021</td><td>06/30/2022</td><td>NCT04188548</td><td>https://clinicaltrials.gov/ct2/show/NCT04188548</td><td>The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>53303</td><td>11302</td><td>RADY CHILDRENS HOSPITAL - SAN DIEGO</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3020 CHILDRENS WAY</td><td>null</td><td>SAN DIEGO</td><td>CA</td><td>92123</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>712383</td><td>1245302561</td><td>WILLIAM</td><td>D</td><td>ROBERTS</td><td>null</td><td>3010 CHILDRENS WAY</td><td>2-WEST</td><td>SAN DIEGO</td><td>CA</td><td>92123</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>JAZZ PHARMACEUTICALS INC.</td><td>100000005637</td><td>JAZZ PHARMACEUTICALS INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>HEMATOLOGY/ONCOLOGY</td><td>VYXEOS</td><td>68727-745-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>97812.77</td><td>2021-11-19</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A STUDY TO COMPARE STANDARD CHEMOTHERAPY TO THERAPY WITH CPX-351 AND/OR GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED AML WITH OR WITHOUT FLT3 MUTATIONS</td><td>No</td><td>838146405</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390111</td><td>10224</td><td>Hospital Of The Univ Of Penna</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3400 Spruce Street</td><td>null</td><td>Philadelphia</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>350973</td><td>1740278704</td><td>NAMRATA</td><td>null</td><td>PATEL</td><td>null</td><td>3600 SPRUCE ST</td><td>8TH FLOOR</td><td>PHILADELPHIA</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Boehringer Ingelheim USA, Inc.</td><td>100000010823</td><td>Boehringer Ingelheim Pharma GmbH & Co.KG</td><td>null</td><td>Germany</td><td>Yes</td><td>Covered</td><td>Drug</td><td>RESPIRATORY</td><td>OFEV</td><td>0597-0143-60</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>79.92</td><td>2021-10-26</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Extension</td><td>No</td><td>827033569</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360137</td><td>10389</td><td>Uh Cleveland Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>11100 EUCLID AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44106</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1381936</td><td>1750677613</td><td>MOLLY</td><td>null</td><td>GALLOGLY</td><td>null</td><td>11100 EUCLID AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44106</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>23.4</td><td>2021-10-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>GRAVITAS 309-A Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease</td><td>No</td><td>831085743</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>200249</td><td>1417038910</td><td>ALICE</td><td>T</td><td>SHAW</td><td>null</td><td>32 FRUIT ST STE 7B</td><td>null</td><td>BOSTON</td><td>MA</td><td>02114</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>LORBRENA</td><td>0069-0227-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>940.0</td><td>2021-09-21</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>LORLATINIB CLINICAL PUBLICATION PROGRAM</td><td>No</td><td>832583029</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450076</td><td>11031</td><td>Ut Md Anderson Cancer Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 Holcombe Blvd</td><td>null</td><td>Houston</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>956458</td><td>1831300318</td><td>SHUBHAM</td><td>null</td><td>PANT</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>null</td><td>HOUSTON</td><td>TX</td><td>77030-4000</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Boehringer Ingelheim USA, Inc.</td><td>100000010823</td><td>Boehringer Ingelheim Pharma GmbH & Co.KG</td><td>null</td><td>Germany</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>382.36</td><td>2021-04-27</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Phase Ia/b study with expansion cohorts</td><td>No</td><td>827033825</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>60011</td><td>11146</td><td>Denver Health Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>145 PARSENN ROAD</td><td>null</td><td>WINTER PARK</td><td>CO</td><td>80482</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>669368</td><td>1730482977</td><td>CYRIL</td><td>null</td><td>MAUFFREY</td><td>null</td><td>777 BANNOCK ST</td><td>null</td><td>DENVER</td><td>CO</td><td>80204-4507</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Orthopaedic Surgery|Orthopaedic Trauma</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CO</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Zimmer Biomet Holdings, Inc.</td><td>100000000103</td><td>Zimmer Biomet Holdings, Inc.</td><td>IN</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Hips</td><td>Continuum</td><td>null</td><td>889024151192</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1398.0</td><td>2021-05-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>CMU2010-02H, Continuum MoP PMCF</td><td>No</td><td>834037713</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50348</td><td>11307</td><td>UCI MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>101 The City Dr S</td><td>null</td><td>Orange</td><td>CA</td><td>92868</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>722137</td><td>1588744635</td><td>JOHN</td><td>P</td><td>FRUEHAUF</td><td>null</td><td>101 THE CITY DR S BLDG 23</td><td>null</td><td>ORANGE</td><td>CA</td><td>92868</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000231820</td><td>ARRAY BIOPHARMA INC</td><td>CO</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>BRAFTOVI</td><td>70255-025-01</td><td>null</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>MEKTOVI</td><td>70255-010-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2264.0</td><td>2021-10-21</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 2 OPENLABEL RANDOMIZED MULTICENTER TRIAL OF ENCORAFENIB  BINIMETINIB EVALUATING A STANDARDDOSE AND A HIGHDOSE REGIMEN IN PATIENTS WITH BRAFV600MUTANT MELANOMA BRAIN METASTASIS</td><td>No</td><td>832685473</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>235443</td><td>1194794602</td><td>DEBASISH</td><td>null</td><td>TRIPATHY</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>1354</td><td>HOUSTON</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>IBRANCE</td><td>0069-0187-21</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>330.0</td><td>2021-07-08</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PALBOCICLIB CLINICAL PUBLICATION PROGRAM</td><td>No</td><td>832584241</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>330057</td><td>10103</td><td>ST. PETERS HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>315 South Manning Blvd</td><td>Suite 6408a</td><td>Albany</td><td>NY</td><td>12208</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>678147</td><td>1043484736</td><td>AJAZ</td><td>MOHIUDDIN</td><td>KHAN</td><td>null</td><td>317 S MANNING BLVD STE 220</td><td>317 S MANNING BLVD STE 220</td><td>ALBANY</td><td>NY</td><td>12208</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>141543</td><td>1114183795</td><td>Shail</td><td>null</td><td>Maingi</td><td>null</td><td>317 S Manning Blvd., Suite 220</td><td>null</td><td>Albany</td><td>NY</td><td>12208</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Merck Sharp & Dohme Corporation</td><td>100000000053</td><td>Merck Sharp & Dohme Corporation</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>LENVIMA</td><td>62856-712-30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>15696.47</td><td>2021-12-31</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3 Randomized, Double-blind Study to Compare the Efficacy and Safety of Pembrolizumab MK-3475 in Combination with  Lenvatinib E7080,MK-7902 versus Pembrolizumab and Placebo as First Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma in Cisplatin-ineligible Participants Whose Tumors Express PD-L1, and in Participants Ineligible for Any Platinum-containing Chemotherapy Regardless of PD-L1 Expression LEAP-011</td><td>No</td><td>848755971</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220071</td><td>9988</td><td>Massachusetts General Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>55 Fruit St</td><td>Bulfinch 360</td><td>Boston</td><td>MA</td><td>02114</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>582913</td><td>1710977038</td><td>OLIVER</td><td>null</td><td>FREUDENREICH</td><td>null</td><td>55 FRUIT ST</td><td>LIN PSYCHIATRY ASSOCIATES INPATIENT CONSULT</td><td>BOSTON</td><td>MA</td><td>02114-2696</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alkermes, Inc.</td><td>100000000255</td><td>Alkermes, Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>CNS</td><td>ARISTADA</td><td>65757-401-03</td><td>null</td><td>Covered</td><td>Drug</td><td>CNS</td><td>INVEGA SUSTENNA</td><td>50458-563-01</td><td>null</td><td>Covered</td><td>Drug</td><td>CNS</td><td>Abilify Maintena</td><td>59148-018-71</td><td>null</td><td>Covered</td><td>Drug</td><td>CNS</td><td>RISPERDAL CONSTA</td><td>50458-306-11</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1996.0</td><td>2021-08-06</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)</td><td>No</td><td>797817551</td><td>2021</td><td>06/30/2022</td><td>NCT03919994</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>330204</td><td>10075</td><td>BELLEVUE HOSPITAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>462 1ST AVE</td><td>C   D BUILDING RM 342</td><td>NEW YORK</td><td>NY</td><td>10016</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>349764</td><td>1710082847</td><td>JAZILA</td><td>null</td><td>MANTIS</td><td>null</td><td>8268 164TH ST</td><td>null</td><td>JAMAICA</td><td>NY</td><td>11432</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000089</td><td>Genentech, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>Actemra</td><td>50242-137-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>500.0</td><td>2021-02-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>TOCILIZUMAB THERAPY FOR COVID 19 PNEUMONIA IN HOSPITALIZED PATIENTS</td><td>No</td><td>835906991</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>53302</td><td>11301</td><td>Childrens Hospital Los Angeles</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4650 W Sunset Blvd</td><td>null</td><td>Los Angeles</td><td>CA</td><td>90027</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1146597</td><td>1508031352</td><td>LILY</td><td>null</td><td>CHAO</td><td>null</td><td>3701 WILSHIRE BLVD</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90010</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1.5</td><td>2021-12-01</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9924-4437</td><td>No</td><td>811036201</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>30022</td><td>11163</td><td>Valleywise Health Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2601 E Roosevelt St</td><td>null</td><td>PHOENIX</td><td>AZ</td><td>85008</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>843543</td><td>1871533000</td><td>MARC</td><td>R</td><td>MATTHEWS</td><td>null</td><td>2929 E THOMAS RD</td><td>null</td><td>PHOENIX</td><td>AZ</td><td>85016</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Surgery|Surgical Critical Care</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>KCI USA, Inc.</td><td>100000010396</td><td>KCI USA, Inc.</td><td>TX</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Negative Pressure Systems & Dressings</td><td>V.A.C. VERAFLO</td><td>null</td><td>849554001299</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>8950.0</td><td>2021-05-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Retrospective Post Market Clinical F/u (PMCF) Survey of V.A.C. VERAFLTM Therapy in Burns</td><td>No</td><td>770939808</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220071</td><td>9988</td><td>MASSACHUSETTS GENERAL HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>55 Fruit St</td><td>Bulfinch 360</td><td>Boston</td><td>MA</td><td>02114</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>109003</td><td>1417083122</td><td>MELISSA</td><td>S</td><td>PUTMAN</td><td>null</td><td>MASSACHUSETTS GENERAL HOSPITAL</td><td>55 FRUIT STREET</td><td>BOSTON</td><td>MA</td><td>02114</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>DEXCOM, INC.</td><td>100000010478</td><td>DEXCOM, INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>ENDOCRINOLOGY</td><td>DEXCOM G6 TRANSMITTER</td><td>null</td><td>00386270000385</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>316.18</td><td>2021-08-30</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>CONTINUOUS GLUCOSE MONITORING IN HOSPITALIZED PATIENTS: AN OBSERVATIONAL STUDY</td><td>No</td><td>845253439</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230077</td><td>10498</td><td>ST. MARYS OF MICHIGAN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>800 S Washington Ave</td><td>null</td><td>Saginaw</td><td>MI</td><td>48601</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>110236</td><td>1427089200</td><td>VIPIN</td><td>null</td><td>KHETARPAL</td><td>null</td><td>1015 S WASHINGTON AVE</td><td>null</td><td>SAGINAW</td><td>MI</td><td>48601-2556</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Esperion Therapeutics, Inc.</td><td>100000771817</td><td>Esperion Therapeutics, Inc.</td><td>MI</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ANTILIPEMIC AGENTS</td><td>NEXLETOL</td><td>72426-118-03</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>100.0</td><td>2021-01-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH, OR AT HIGH RISK FOR, CARDIOVASCULAR DISEASE WHO ARE STATIN INTOLERANT</td><td>No</td><td>838382705</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>53302</td><td>11301</td><td>Childrens Hospital Los Angeles</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4650 W Sunset Blvd</td><td>null</td><td>Los Angeles</td><td>CA</td><td>90027</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1146597</td><td>1508031352</td><td>LILY</td><td>null</td><td>CHAO</td><td>null</td><td>3701 WILSHIRE BLVD</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90010</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2.85</td><td>2021-11-19</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9924-4437</td><td>No</td><td>811746775</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>330285</td><td>10135</td><td>STRONG MEMORIAL HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>601 Elmwood Ave</td><td>Box 684</td><td>Rochester</td><td>NY</td><td>14642</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>407818</td><td>1568766731</td><td>ANGELA</td><td>R</td><td>BRANCHE</td><td>null</td><td>601 ELMWOOD AVE</td><td>null</td><td>ROCHESTER</td><td>NY</td><td>14642-0001</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>100000000337</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>IL</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>792.0</td><td>2021-05-11</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 2, LONG-TERM IMMUNOGENICITY FOLLOW-UP TRIAL OF ADULT AND ELDERLY SUBJECTS WHO HAVE PREVIOUSLY RECEIVED AN INTRAMUSCULAR INJECTION OF NOROVIRUS GI.1/GII.4 BIVALENT VIRUS-LIKE PARTICLE VACCINE</td><td>No</td><td>816665709</td><td>2021</td><td>06/30/2022</td><td>NCT03039790</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100069</td><td>10824</td><td>Adventhealth Carrollwood</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>7171 N DALE MABRY HWY</td><td>null</td><td>TAMPA</td><td>FL</td><td>33614</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>118841</td><td>1619291994</td><td>PAUL</td><td>Z.</td><td>GERCZUK</td><td>null</td><td>14320 BRUCE B DOWNS BLVD</td><td>null</td><td>TAMPA</td><td>FL</td><td>33613</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Acticor</td><td>null</td><td>04035479156701</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Solia</td><td>null</td><td>04035479118266</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Rivacor</td><td>null</td><td>04035479156794</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Plexa</td><td>null</td><td>4035479140014</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Sentus</td><td>null</td><td>4035479148942</td><td>50.0</td><td>2021-12-14</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIO-LIBRA</td><td>No</td><td>843814579</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>440039</td><td>10425</td><td>Vanderbilt University Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1211 Medical Center Drive</td><td>null</td><td>Nashville</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>4683914</td><td>1992148696</td><td>NATALIE</td><td>null</td><td>MCCALL</td><td>null</td><td>719 THOMPSON LN</td><td>null</td><td>NASHVILLE</td><td>TN</td><td>37204</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>Ozempic</td><td>0169-4132-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4.5</td><td>2021-03-24</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9535-4321</td><td>No</td><td>849762281</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230077</td><td>10498</td><td>ST. MARYS OF MICHIGAN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>800 S Washington Ave</td><td>null</td><td>Saginaw</td><td>MI</td><td>48601</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>110236</td><td>1427089200</td><td>VIPIN</td><td>null</td><td>KHETARPAL</td><td>null</td><td>1015 S WASHINGTON AVE</td><td>null</td><td>SAGINAW</td><td>MI</td><td>48601-2556</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Esperion Therapeutics, Inc.</td><td>100000771817</td><td>Esperion Therapeutics, Inc.</td><td>MI</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ANTILIPEMIC AGENTS</td><td>NEXLETOL</td><td>72426-118-03</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>224.0</td><td>2021-06-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH, OR AT HIGH RISK FOR, CARDIOVASCULAR DISEASE WHO ARE STATIN INTOLERANT</td><td>No</td><td>838383107</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230046</td><td>10547</td><td>Univ Of Mi Hospitals & Hlth Ctrs</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 East Medical Center Drive</td><td>null</td><td>Ann Arbor</td><td>MI</td><td>48109</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>11050</td><td>1235211764</td><td>RODICA</td><td>P</td><td>BUSUI</td><td>null</td><td>4029 AVE MARIA ST</td><td>STE 1300</td><td>ANN ARBOR</td><td>MI</td><td>48105</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>Diabetes</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>26.0</td><td>2021-10-28</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9536-4388</td><td>No</td><td>810993713</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>150113</td><td>10414</td><td>Community Hospital Anderson</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 N Madison Ave</td><td>null</td><td>Anderson</td><td>IN</td><td>46011</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>102864</td><td>1275552481</td><td>WA'EL</td><td>null</td><td>BAKDASH</td><td>null</td><td>1515 S MADISON AVE</td><td>null</td><td>ANDERSON</td><td>IN</td><td>46016</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>Diabetes</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>56.9</td><td>2021-10-28</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9536-4388</td><td>No</td><td>811271289</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50760</td><td>11221</td><td>KFH - ANTIOCH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4501 Sand Creek Road</td><td>null</td><td>Antioch</td><td>CA</td><td>94531</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>651669</td><td>1124233317</td><td>ELIZABETH</td><td>G</td><td>LILES</td><td>null</td><td>10060 NE EVERGREEN PKWY</td><td>null</td><td>HILLSBORO</td><td>OR</td><td>97124</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2160.0</td><td>2021-08-12</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER</td><td>No</td><td>832826057</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>460009</td><td>11165</td><td>U Of U Hospitals & Clinics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>50 N MEDICAL DR</td><td>null</td><td>SALT LAKE CITY</td><td>UT</td><td>84132</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>2790582</td><td>1699076224</td><td>ANGELA</td><td>Y.</td><td>PETERS</td><td>null</td><td>UNIVERSITY OF UTAH DEPT OF NEUROLOGY</td><td>175 N MEDICAL DRIVE EAST</td><td>SALT LAKE CITY</td><td>UT</td><td>84132-0001</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Clinical Neurophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ID</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NEUROPACE, INC.</td><td>100000010697</td><td>NEUROPACE, INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Epilepsy</td><td>RNS System</td><td>null</td><td>00855547005267</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>50.0</td><td>2021-04-05</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Approval Study</td><td>No</td><td>851397533</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>260196</td><td>1740256452</td><td>SAIMA</td><td>KANWAL</td><td>JEHANGIR</td><td>null</td><td>3407 GLENVIEW AVE</td><td>null</td><td>AUSTIN</td><td>TX</td><td>78703-1448</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Obstetrics & Gynecology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ABBVIE INC.</td><td>100000000204</td><td>ABBVIE INC.</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>WOMENS HEALTH</td><td>ORILISSA</td><td>0074-0038-28</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>305.0</td><td>2021-07-29</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Estradiol/Norethindrone Acetate in Subjects with Moderate to Severe Endometriosis-Associated Pain</td><td>No</td><td>792403809</td><td>2021</td><td>06/30/2022</td><td>NCT03213457</td><td>null</td><td>M14-702</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50146</td><td>11296</td><td>City Of Hope National Medical Ctr</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 E Duarte Rd</td><td>null</td><td>Duarte</td><td>CA</td><td>91010</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>534797</td><td>1023147014</td><td>JAE</td><td>YUL</td><td>KIM</td><td>null</td><td>1500 DUARTE RD</td><td>null</td><td>DUARTE</td><td>CA</td><td>91010</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery)</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AstraZeneca Pharmaceuticals LP</td><td>100000000146</td><td>AstraZeneca Pharmaceuticals LP</td><td>DE</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Oncology</td><td>IMFINZI</td><td>0310-4500-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>56882.5</td><td>2021-01-21</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase III, Double-blind, Placebo-controlled, Multi-center International Study of Neoadjuvant/adjuvant Durvalumab for the Treatment of Patients with Resectable Stages II and III Non-small Cell Lung Cancer</td><td>No</td><td>826473111</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>140119</td><td>10441</td><td>Rush University Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1653 W. Congress Parkway</td><td>null</td><td>Chicago</td><td>IL</td><td>60612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>310662</td><td>1851325088</td><td>TIMOTHY</td><td>M</td><td>KUZEL</td><td>null</td><td>675 N SAINT CLAIR ST</td><td>GALTER 21-100</td><td>CHICAGO</td><td>IL</td><td>60611-5975</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eisai Inc.</td><td>100000000136</td><td>Eisai Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>Ontak</td><td>62856-603-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>846.95</td><td>2021-05-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Clinical Study to Demonstrate Safety and Efficacy of E7777 (Denileukin Diftitox) in Persistent or Recurrent Cutaneous T-Cell Lymphoma</td><td>No</td><td>836178729</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>460009</td><td>11165</td><td>U Of U Hospitals & Clinics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>50 N MEDICAL DR</td><td>null</td><td>SALT LAKE CITY</td><td>UT</td><td>84132</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>2790582</td><td>1699076224</td><td>ANGELA</td><td>Y.</td><td>PETERS</td><td>null</td><td>UNIVERSITY OF UTAH DEPT OF NEUROLOGY</td><td>175 N MEDICAL DRIVE EAST</td><td>SALT LAKE CITY</td><td>UT</td><td>84132-0001</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Clinical Neurophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ID</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NEUROPACE, INC.</td><td>100000010697</td><td>NEUROPACE, INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Epilepsy</td><td>RNS System</td><td>null</td><td>00855547005267</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>475.0</td><td>2021-07-12</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Approval Study</td><td>No</td><td>851397641</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220162</td><td>9984</td><td>Dana-Farber Cancer Institute</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>450 BROOKLINE AVE</td><td>null</td><td>BOSTON</td><td>MA</td><td>02215</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>314270</td><td>1922086487</td><td>JACOB</td><td>P.</td><td>LAUBACH</td><td>null</td><td>44 Binney St D1B30</td><td>null</td><td>Boston</td><td>MA</td><td>02115</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Bristol Myers Squibb Company</td><td>100000005499</td><td>E.R. Squibb & Sons, L.L.C.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Oncology</td><td>OPDIVO</td><td>0003-3774-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>953.75</td><td>2021-03-12</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Ph I Hematology CA210-003</td><td>No</td><td>819887963</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>30024</td><td>11263</td><td>ST. JOSEPHS HOSPITAL & MEDICAL CTR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>7300 N 99TH AVE</td><td>null</td><td>GLENDALE</td><td>AZ</td><td>85305</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>5702859</td><td>1588074207</td><td>SANA</td><td>null</td><td>ASLAM</td><td>null</td><td>240 W THOMAS RD STE 301</td><td>null</td><td>PHOENIX</td><td>AZ</td><td>85013</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Osteopathy</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000000166</td><td>Roche TCRC, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1757.7</td><td>2021-02-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PHASE II STUDY IN EARLY STAGE PARKINSON S DISEASE PATIENTS</td><td>No</td><td>835926067</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>180103</td><td>10847</td><td>Baptist Health Lexington</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1740 NICHOLASVILLE RD</td><td>null</td><td>LEXINGTON</td><td>KY</td><td>40503</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>32625</td><td>1730127994</td><td>CRAIG</td><td>JENNINGS</td><td>MCCOTTER</td><td>null</td><td>1720 NICHOLASVILLE RD STE 601</td><td>null</td><td>LEXINGTON</td><td>KY</td><td>40503</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>KY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Plexa</td><td>null</td><td>04035479140014</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Acticor</td><td>null</td><td>04035479156701</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Solia</td><td>null</td><td>04035479118266</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Rivacor</td><td>null</td><td>4035479156794</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Sentus</td><td>null</td><td>4035479148942</td><td>26.25</td><td>2021-11-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIO-LIBRA</td><td>No</td><td>843839939</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>223302</td><td>9992</td><td>CHILDRENS HOSPITAL CORPORATION</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>300 Longwood Ave</td><td>Patient Financial Services Atn Steven Nicoll</td><td>Boston</td><td>MA</td><td>02115</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>987029</td><td>1891891826</td><td>LYNDA</td><td>C</td><td>SCHNEIDER</td><td>null</td><td>300 LONGWOOD AVE</td><td>null</td><td>BOSTON</td><td>MA</td><td>02115-5724</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Allergy & Immunology|Clinical & Laboratory Immunology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>INFLAMMATION AND  IMMUNOLOGY</td><td>DUPIXENT</td><td>0024-5914-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1539.72</td><td>2021-04-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 2/3 STUDY INVESTIGATING THE PHARMACOKINETICS, SAFETY, AND EFFICACY OF DUPILUMAB IN PATIENTS AGED >=6 MONTHS TO <6 YEARS WITH SEVERE ATOPIC DERMATITIS</td><td>No</td><td>793086073</td><td>2021</td><td>06/30/2022</td><td>NCT03346434</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>992195</td><td>1083608038</td><td>RISHI</td><td>K</td><td>AGRAWAL</td><td>null</td><td>2300 N CHILDRENS PLZ</td><td>OUTREACH PHYSICIAN SERVICES</td><td>CHICAGO</td><td>IL</td><td>60614-3363</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pharmacyclics LLC, An AbbVie Company</td><td>100000136439</td><td>Pharmacyclics LLC, An AbbVie Company</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>IMBRUVICA</td><td>57962-420-28</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>400.0</td><td>2021-09-27</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>IbrutiNib in SARS CoV-2 Induced Pulmonary Injury and Respiratory failure (iNSPIRE)</td><td>No</td><td>810151823</td><td>2021</td><td>06/30/2022</td><td>NCT04375397</td><td>null</td><td>M20-310</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450647</td><td>10892</td><td>Medical City Dallas</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>7777 FOREST LN</td><td>null</td><td>DALLAS</td><td>TX</td><td>75230</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>330777</td><td>1285677138</td><td>VIKAS</td><td>null</td><td>BHUSHAN</td><td>null</td><td>7777 FOREST LN</td><td>BLDG D</td><td>DALLAS</td><td>TX</td><td>75230</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1033.0</td><td>2021-07-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>GRAVITAS 309-A Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease</td><td>No</td><td>831062779</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>440015</td><td>10348</td><td>University Of Tennessee Medical Cent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1924 Alcoa Hwy</td><td>null</td><td>Knoxville</td><td>TN</td><td>37920</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>4219198</td><td>1528293701</td><td>ANDREW</td><td>DAVID</td><td>NICHOLSON</td><td>null</td><td>1932 ALCOA HWY STE C360</td><td>null</td><td>KNOXVILLE</td><td>TN</td><td>37920</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Penumbra, Inc.</td><td>100000010583</td><td>Penumbra, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Neurointervention</td><td>Smart Coil</td><td>null</td><td>00814548015286</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>75.0</td><td>2021-09-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>SURF</td><td>No</td><td>840451475</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>70034</td><td>10026</td><td>Norwalk Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>34 Maple St</td><td>null</td><td>Norwalk</td><td>CT</td><td>06856</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>234804</td><td>1174515803</td><td>RICHARD</td><td>null</td><td>FRANK</td><td>null</td><td>40 CROSS ST</td><td>4TH FL</td><td>NORWALK</td><td>CT</td><td>06851</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>EMD Serono, Inc.</td><td>100000000127</td><td>EMD Serono, Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>Bavencio</td><td>44087-3535-1</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>420.0</td><td>2021-04-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>MS100070_0176</td><td>No</td><td>842923011</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3258410</td><td>1487017059</td><td>JESUS</td><td>null</td><td>VARGAS</td><td>null</td><td>111 S FRONT ST</td><td>null</td><td>HARRISBURG</td><td>PA</td><td>17101-2010</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novartis Pharmaceuticals Corporation</td><td>100000000228</td><td>Novartis Pharmaceuticals Corporation</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>NEUROSCIENCE</td><td>AIMOVIG</td><td>55513-841-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5625.0</td><td>2021-10-25</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PUBLICATION SUPPORT PROVIDED IN CONNECTION WITH AIMOVIG RESEARCH</td><td>No</td><td>800639399</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220086</td><td>9982</td><td>BETH ISRAEL DEACONESS MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>330 Brookline Ave</td><td>St 207</td><td>Boston</td><td>MA</td><td>02215</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>349276</td><td>1689892481</td><td>EVANGELOS</td><td>null</td><td>MESSARIS</td><td>null</td><td>330 BROOKLINE AVE  6</td><td>null</td><td>BOSTON</td><td>MA</td><td>02215</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Colon & Rectal Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>100000000337</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>IL</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>16150.0</td><td>2021-12-20</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE-III, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, INTERNATIONAL, MULTICENTRE STUDY TO ASSESS EFFICACY AND SAFETY OF CX601, ADULT ALLOGENEIC EXPANDED ADIPOSE-DERIVED STEM CELLS (EASC) FOR THE TREATMENT OF COMPLEX PERIANAL FISTULA(S) IN PATIENTS WITH CROHN'S DISEASE OVER A PERIOD OF 24 WEEKS AND A FOLLOW-UP PERIOD UP TO 52 WEEKS</td><td>No</td><td>816648859</td><td>2021</td><td>06/30/2022</td><td>NCT03279081</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50348</td><td>11307</td><td>Uci Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>101 The City Drive South</td><td>null</td><td>Orange</td><td>CA</td><td>92868</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>62653</td><td>1376710434</td><td>FARSHID</td><td>null</td><td>DAYYANI</td><td>null</td><td>2946 E BANNER GATEWAY DR</td><td>null</td><td>GILBERT</td><td>AZ</td><td>85234-2165</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Ipsen Bioscience Inc</td><td>100000005526</td><td>Ipsen Bioscience Inc</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>ONIVYDE</td><td>15054-0043-1</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>45213.85</td><td>2021-06-14</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>An Open-label, Randomised, Multicentre, Phase III Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Leucovorin Versus Nab-paclitaxel Plus Gemcitabine in Subjects Who Have Not Previously Received Chemotherapy for Metastatic Adenocarcinoma of the Pancreas</td><td>No</td><td>771547968</td><td>2021</td><td>06/30/2022</td><td>NCT04083235</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360180</td><td>10373</td><td>Cleveland Clinic Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9500 Euclid Ave</td><td>null</td><td>Cleveland</td><td>OH</td><td>44195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>41807</td><td>1922293547</td><td>KEVIN</td><td>M</td><td>PANTALONE</td><td>null</td><td>29800 BAINBRIDGE RD</td><td># SO40</td><td>SOLON</td><td>OH</td><td>44139</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Osteopathy</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>23.06</td><td>2021-04-01</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9924-4473</td><td>No</td><td>811404955</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>137094</td><td>1013902444</td><td>MARK</td><td>null</td><td>LEBWOHL</td><td>null</td><td>5 E 98TH ST</td><td>null</td><td>NEW YORK</td><td>NY</td><td>10029-6501</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novartis Pharmaceuticals Corporation</td><td>100000000228</td><td>Novartis Pharmaceuticals Corporation</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>IMMUNOLOGY</td><td>COSENTYX</td><td>0078-0639-41</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>964.0</td><td>2021-10-21</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>THE EVOLVING TREATMENT APPROACH OF SECUKINUMAB IN BIOLOGIC-EXPERIENCED AND BIOLOGIC-NAIVE PATIENTS WITH PSORIASIS: KEY CLINICAL AND PATIENT CHARACTERISTICS BY YEAR OF TREATMENT INITIATION IN A US-BASED REGISTRY</td><td>No</td><td>800640167</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>160058</td><td>10604</td><td>University Of Iowa Hosp & Clinics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>200 Hawkins Dr</td><td>null</td><td>Iowa City</td><td>IA</td><td>52242</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1251566</td><td>1215167648</td><td>PASHTOON</td><td>MURTAZA</td><td>KASI</td><td>null</td><td>UIHC-DEPT OF INTERNAL MEDI</td><td>null</td><td>IOWA CITY</td><td>IA</td><td>52242</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AstraZeneca Pharmaceuticals LP</td><td>100000000146</td><td>AstraZeneca Pharmaceuticals LP</td><td>DE</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Oncology</td><td>IMFINZI</td><td>0310-4500-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>74399.6</td><td>2021-11-30</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Feasibility and safety of Yttrium Y-90 radioembolization combined with PD-L1 blockade in the treatment of liver-predominant metastatic colorectal cancer. A Phase I study</td><td>No</td><td>826473285</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230046</td><td>10547</td><td>Univ Of Mi Hospitals & Hlth Ctrs</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 EAST MEDICAL CENTER DRIVE</td><td>null</td><td>ANN ARBOR</td><td>MI</td><td>48109</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>811997</td><td>1760648109</td><td>RAKESH</td><td>null</td><td>LATCHAMSETTY</td><td>null</td><td>1500 E MEDICAL CENTER DR</td><td>null</td><td>ANN ARBOR</td><td>MI</td><td>48109</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Sentus</td><td>null</td><td>04035479148942</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Acticor</td><td>null</td><td>04035479156701</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Solia</td><td>null</td><td>04035479118266</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Rivacor</td><td>null</td><td>4035479156794</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Plexa</td><td>null</td><td>4035479140014</td><td>67.21</td><td>2021-05-12</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIO-LIBRA</td><td>No</td><td>843821039</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>132483</td><td>1932115524</td><td>MICHAEL</td><td>W</td><td>DEININGER</td><td>null</td><td>2000 CIRCLE OF HOPE DR RM 4280</td><td>null</td><td>SALT LAKE CITY</td><td>UT</td><td>84112</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>UT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>METABOLIC DISEASE;ONCOLOGY</td><td>BOSULIF</td><td>0069-0135-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>330.0</td><td>2021-02-17</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BOSUTINIB CLINICAL PUBLICATION PROGRAM</td><td>No</td><td>832501927</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>30103</td><td>11162</td><td>Mayo Clinic Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5777 E MAYO BLVD</td><td>null</td><td>PHOENIX</td><td>AZ</td><td>85054</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>693270</td><td>1578904173</td><td>MOHAMAD</td><td>B.</td><td>SONBOL</td><td>null</td><td>13400 E SHEA BLVD</td><td>null</td><td>SCOTTSDALE</td><td>AZ</td><td>85259-5452</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Bavarian Nordic A/S</td><td>100000796825</td><td>Bavarian Nordic A/S</td><td>null</td><td>Denmark</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1331.0</td><td>2021-05-28</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Bavarian Nordic TAEK-VAC-HerBy-001</td><td>No</td><td>771321326</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>219025</td><td>1831178151</td><td>STEPHEN</td><td>B.</td><td>TATTER</td><td>null</td><td>PO BOX 344</td><td>null</td><td>WINSTON SALEM</td><td>NC</td><td>27102-0344</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Neurological Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ARBOR PHARMACEUTICALS, INC.</td><td>100000005507</td><td>ARBOR PHARMACEUTICALS, INC.</td><td>GA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Neurology</td><td>Gliadel</td><td>24338-050-08</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3225.6</td><td>2021-11-24</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry (VIGILANT)</td><td>No</td><td>813747303</td><td>2021</td><td>06/30/2022</td><td>NCT02684838</td><td>https://www.clinicaltrials.gov/ct2/show/NCT02684838</td><td>Phase IV</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100007</td><td>10819</td><td>Adventhealth Orlando</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>601 E Rollins St</td><td>null</td><td>Orlando</td><td>FL</td><td>32803</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1266401</td><td>1740341726</td><td>MARK</td><td>A</td><td>SOCINSKI</td><td>null</td><td>601 E Rollins St</td><td>PO Box 37</td><td>Orlando</td><td>FL</td><td>32803</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BeiGene, Ltd.</td><td>100000826833</td><td>BeiGene, Ltd.</td><td>null</td><td>Cayman Islands</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12750.0</td><td>2021-07-28</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Randomized, Controlled, Open-label, Global Phase 3 Study Comparing the Efficacy of the Anti-PD-1 Antibody Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Patients With Advanced Unresectable/Metastatic Esophageal Squamous Cell Carcinoma</td><td>No</td><td>843873819</td><td>2021</td><td>06/30/2022</td><td>NCT03430843</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>490009</td><td>10745</td><td>UNIVERSITY OF VIRGINIA MEDICAL CENTE</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1215 Lee St Pfs</td><td>null</td><td>Charlottesville</td><td>VA</td><td>22908</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>441192</td><td>1720379019</td><td>MATTHEW</td><td>J</td><td>REILLEY</td><td>null</td><td>1240 LEE ST</td><td>null</td><td>CHARLOTTESVILLE</td><td>VA</td><td>22908-4000</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>VA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>100000000337</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>IL</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1300.0</td><td>2021-09-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1B/2 STUDY OF TAK-981 PLUS PEMBROLIZUMAB TO EVALUATE THE SAFETY, TOLERABILITY, AND ANTITUMOR ACTIVITY OF THE COMBINATION IN PATIENTS WITH SELECT ADVANCED OR METASTATIC SOLID TUMORS</td><td>No</td><td>816674583</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>381202</td><td>1639259062</td><td>CATHERINE</td><td>M</td><td>BOLLARD</td><td>null</td><td>111 MICHIGAN AVE NW</td><td>5TH FLOOR MAIN, SUI</td><td>WASHINGTON</td><td>DC</td><td>20010</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>DC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>SWEDISH ORPHAN BIOVITRUM AB</td><td>100000081405</td><td>SWEDISH ORPHAN BIOVITRUM AB</td><td>null</td><td>Sweden</td><td>Yes</td><td>Covered</td><td>Drug</td><td>HEMATOLOGY</td><td>GAMIFANT</td><td>72171-505-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>957.9</td><td>2021-04-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NI-0501 PROGRAM</td><td>No</td><td>833643573</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360180</td><td>10373</td><td>Cleveland Clinic Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9500 Euclid Ave</td><td>null</td><td>Cleveland</td><td>OH</td><td>44195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>41807</td><td>1922293547</td><td>KEVIN</td><td>M</td><td>PANTALONE</td><td>null</td><td>29800 BAINBRIDGE RD</td><td># SO40</td><td>SOLON</td><td>OH</td><td>44139</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Osteopathy</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>28.5</td><td>2021-10-08</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9924-4473</td><td>No</td><td>811592659</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>83300</td><td>10812</td><td>Alfred I Dupont Hosp For Children</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1600 ROCKLAND RD</td><td>null</td><td>WILMINGTON</td><td>DE</td><td>19899</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>740847</td><td>1255422531</td><td>MICHAEL</td><td>B</td><td>BOBER</td><td>null</td><td>THE NEMOURS FOUNDAT</td><td>null</td><td>WILMINGTON</td><td>DE</td><td>19803</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Medical Genetics|Clinical Genetics (M.D.)</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>DE</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>SWEDISH ORPHAN BIOVITRUM AB</td><td>100000081405</td><td>SWEDISH ORPHAN BIOVITRUM AB</td><td>null</td><td>Sweden</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>175.0</td><td>2021-02-04</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>SOBI003-002</td><td>No</td><td>833650833</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450076</td><td>11031</td><td>Ut Md Anderson Cancer Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 Holcombe Blvd</td><td>null</td><td>Houston</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>134212</td><td>1952497687</td><td>ALESSANDRA</td><td>null</td><td>FERRAJOLI</td><td>null</td><td>1515 Holcombe Blvd</td><td>null</td><td>Houston</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BeiGene, Ltd.</td><td>100000826833</td><td>BeiGene, Ltd.</td><td>null</td><td>Cayman Islands</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>BRUKINSA</td><td>72579-011-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>47000.0</td><td>2021-08-09</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared With Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma</td><td>No</td><td>843878015</td><td>2021</td><td>06/30/2022</td><td>NCT03734016</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>363300</td><td>10334</td><td>Childrens Hospital Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3333 BURNET AVE</td><td>null</td><td>CINCINNATI</td><td>OH</td><td>45229</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>609767</td><td>1669537478</td><td>MICHAEL</td><td>BRIAN</td><td>JORDAN</td><td>null</td><td>3333 BURNET AVENUE</td><td>null</td><td>CINCINNATI</td><td>OH</td><td>45229</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>SWEDISH ORPHAN BIOVITRUM AB</td><td>100000081405</td><td>SWEDISH ORPHAN BIOVITRUM AB</td><td>null</td><td>Sweden</td><td>Yes</td><td>Covered</td><td>Drug</td><td>HEMATOLOGY</td><td>GAMIFANT</td><td>72171-505-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500.0</td><td>2021-11-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NI-0501-04</td><td>No</td><td>833651091</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230046</td><td>10547</td><td>Univ Of Mi Hospitals & Hlth Ctrs</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 EAST MEDICAL CENTER DRIVE</td><td>null</td><td>ANN ARBOR</td><td>MI</td><td>48109</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>89197</td><td>1972695344</td><td>GEORGE</td><td>M.</td><td>DEEB</td><td>null</td><td>1500 E Medical Center Dr</td><td>null</td><td>ANN ARBOR</td><td>MI</td><td>48109</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery)</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Medtronic, Inc.</td><td>100000000106</td><td>Medtronic, Inc.</td><td>MN</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Transcatheter Valve Systems</td><td>CoreValve Evolut</td><td>null</td><td>00643169565623</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4408.0</td><td>2021-03-05</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Optimize Pro</td><td>No</td><td>800994217</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100007</td><td>10819</td><td>Adventhealth Orlando</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>601 E Rollins St</td><td>null</td><td>Orlando</td><td>FL</td><td>32803</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1266401</td><td>1740341726</td><td>MARK</td><td>A</td><td>SOCINSKI</td><td>null</td><td>2501 N ORANGE AVE STE 689</td><td>null</td><td>ORLANDO</td><td>FL</td><td>32804</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>17800.0</td><td>2021-06-04</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1 STUDY TO EVALUATE THE SAFETY PHARMACOKINETICS AND PHARMACODYNAMICS OF ESCALATING DOSES OF PF06939999 PRMT5 INHIBITOR IN PARTICIPANTS WITH ADVANCED OR METASTATIC NONSMALL CELL LUNG CANCER HEAD AND NECK SQUAMOUS CELL CARCINOMA ESOPHAGEAL CANCER ENDOMETRIAL CANCER CERVICAL CANCER AND BLADDER CANCER</td><td>No</td><td>832845865</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>130007</td><td>11101</td><td>St. Alphonsus Regional Med Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1055 N CURTIS RD</td><td>null</td><td>BOISE</td><td>ID</td><td>83706</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>53341</td><td>1174517775</td><td>MARGOT</td><td>E.</td><td>VLOKA</td><td>null</td><td>6140 W CURTISIAN AVE STE 200</td><td>null</td><td>BOISE</td><td>ID</td><td>83704</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ID</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Sentus</td><td>null</td><td>04035479148942</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Acticor</td><td>null</td><td>04035479156701</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Solia</td><td>null</td><td>04035479118266</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Rivacor</td><td>null</td><td>4035479156794</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Plexa</td><td>null</td><td>4035479140014</td><td>150.53</td><td>2021-07-13</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIO-LIBRA</td><td>No</td><td>843840553</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50696</td><td>11289</td><td>KECK HOSPITAL OF USC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 San Pablo Street</td><td>null</td><td>Los Angeles</td><td>CA</td><td>90033</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>838537</td><td>1700814209</td><td>HEINZ-JOSEF</td><td>null</td><td>LENZ</td><td>null</td><td>1441 EASTLAKE AVE STE 3440</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90089</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>BRAFTOVI</td><td>70255-025-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12580.11</td><td>2021-07-21</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>AN OPENLABEL MULTICENTER RANDOMIZED PHASE 3 STUDY OF FIRSTLINE ENCORAFENIB PLUS CETUXIMAB WITH OR WITHOUT CHEMOTHERAPY VERSUS STANDARD OF CARE THERAPY WITH A SAFETY LEADIN OF ENCORAFENIB AND CETUXIMAB PLUS CHEMOTHERAPY IN PARTICIPANTS WITH METASTATIC BRAF V600EMUTANT COLORECTAL CANCER</td><td>No</td><td>832870269</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>363300</td><td>10334</td><td>CHILDRENS HOSPITAL MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3333 Burnet Ave</td><td>null</td><td>Cincinnati</td><td>OH</td><td>45229</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>INFLAMMATION AND  IMMUNOLOGY</td><td>DUPIXENT</td><td>0024-5914-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>152901.0</td><td>2021-04-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE)</td><td>No</td><td>793086329</td><td>2021</td><td>06/30/2022</td><td>NCT03633617</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100151</td><td>10818</td><td>MAYO CLINIC FLORIDA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4500 SAN PABLO RD S</td><td>null</td><td>JACKSONVILLE</td><td>FL</td><td>32224</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>439558</td><td>1679737563</td><td>IVAN</td><td>E</td><td>PORTER</td><td>JR.</td><td>4500 SAN PABLO RD S</td><td>null</td><td>JACKSONVILLE</td><td>FL</td><td>32224</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GlaxoSmithKline, LLC.</td><td>100000005449</td><td>GlaxoSmithKline, LLC.</td><td>NC</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2547.5</td><td>2021-03-03</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P</td><td>No</td><td>809534933</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>HCP did not receive direct payment from GSK. HCP was listed as the Primary Investigator in accordance with the Sunshine Act requirements.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230046</td><td>10547</td><td>Univ Of Mi Hospitals & Hlth Ctrs</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 EAST MEDICAL CENTER DRIVE</td><td>null</td><td>ANN ARBOR</td><td>MI</td><td>48109</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1261230</td><td>1568607653</td><td>TYCEL</td><td>J.</td><td>PHILLIPS</td><td>null</td><td>1500 E MEDICAL CENTER DR</td><td>null</td><td>ANN ARBOR</td><td>MI</td><td>48109</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>390.0</td><td>2021-11-19</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 2, Open Label, 2 Cohort Study of INCB050465, a PI3Kd Inhibitor, in Subjects With Relapsed or Refractory Marginal Zone Lymphoma With or Without Prior Exposure to a BTK Inhibitor, CITADEL 204</td><td>No</td><td>831063545</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>223302</td><td>9992</td><td>Childrens Hospital Corporation</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>300 LONGWOOD AVE</td><td>PATIENT FINANCIAL SERVICES ATN STEVEN NICOLL</td><td>BOSTON</td><td>MA</td><td>02115</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Bristol Myers Squibb Company</td><td>100000005499</td><td>E.R. Squibb & Sons, L.L.C.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>ORENCIA</td><td>0003-2187-10</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>271980.0</td><td>2021-07-06</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A RANDOMIZED DOUBLE-BLIND TRIAL OF ABATACEPT EXTENDED DOSING VERSUS ABATACEPT SHORT-TERM DOSING FOR GRAFT VERSUS HOST DISEASE PROPHYLAXIS ABA3</td><td>No</td><td>819888563</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>140150</td><td>10495</td><td>BOARD OF TRUSTEES OF THE UNIVERSITY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1740 W Taylor St</td><td>Mc 732</td><td>Chicago</td><td>IL</td><td>60612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>137803</td><td>1033270046</td><td>VICTOR</td><td>R</td><td>GORDEUK</td><td>null</td><td>820 S WOOD ST</td><td>SICKLE CELL CTR SUITE 172 CLINICAL SCIENCES BUILDING</td><td>CHICAGO</td><td>IL</td><td>60612-4325</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>100000000337</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>IL</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2216.0</td><td>2021-10-25</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1/2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, ASCENDING DOSE, SAFETY AND PK/PD STUDY OF SHP655 (RADAMTS13) IN SICKLE CELL DISEASE AT BASELINE HEALTH AND DURING ACUTE VASO-OCCLUSIVE CRISIS</td><td>No</td><td>816649317</td><td>2021</td><td>06/30/2022</td><td>NCT03997760</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>330285</td><td>10135</td><td>Strong Memorial Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>601 ELMWOOD AVE</td><td>BOX 684</td><td>ROCHESTER</td><td>NY</td><td>14642</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>904734</td><td>1023280906</td><td>JESSICA</td><td>F.</td><td>ROBB</td><td>null</td><td>1351 Mount Hope Ave Ste 116</td><td>null</td><td>Rochester</td><td>NY</td><td>14620</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Sanofi and Genzyme US Companies</td><td>100000000297</td><td>GENZYME CORPORATION</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Neurology</td><td>LEMTRADA</td><td>58468-0200-1</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>909.0</td><td>2021-04-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Prospective 24-Month Observational Study of Neurocognitive Function and Safety in Patients with Relapsing Multiple Sclerosis Who Are Initiating LEMTRADA Treatment</td><td>No</td><td>838664441</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>440039</td><td>10425</td><td>VANDERBILT UNIVERSITY MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1211 Medical Center Drive</td><td>null</td><td>Nashville</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>340977</td><td>1508801556</td><td>JEFFREY</td><td>L</td><td>NEUL</td><td>null</td><td>2200 CHILDREN'S WAY</td><td>SUITE 30330</td><td>NASHVILLE</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ACADIA Pharmaceuticals Inc</td><td>100000141529</td><td>ACADIA Pharmaceuticals Inc</td><td>CA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>6426.0</td><td>2021-11-29</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>ACP-2566-004</td><td>No</td><td>837697047</td><td>2021</td><td>06/30/2022</td><td>NCT04279314</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>190036</td><td>10978</td><td>OCHSNER CLINIC FOUNDATION</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1516 Jefferson Hwy</td><td>null</td><td>New Orleans</td><td>LA</td><td>70121</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>52540</td><td>1154639839</td><td>SARAVANAN</td><td>null</td><td>THIAGARAJAN</td><td>null</td><td>9001 SUMMA AVE</td><td>null</td><td>BATON ROUGE</td><td>LA</td><td>70809-3726</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>LA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ABBVIE INC.</td><td>100000000204</td><td>ABBVIE INC.</td><td>IL</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>80.0</td><td>2021-09-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3, Randomized, Active-Controlled, Double Blind Study Comparing Upadacitinib (ABT-494) to Abatacept in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or Intolerance to Biologic DMARDs (bDMARDs) on Stable Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs (csDMARDs)</td><td>No</td><td>792395781</td><td>2021</td><td>06/30/2022</td><td>NCT03086343</td><td>null</td><td>M15-925</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>357629</td><td>1881743748</td><td>REGINA</td><td>R.</td><td>BERKOVICH</td><td>null</td><td>8727 Beverly Blvd, Ste B</td><td>null</td><td>West Hollywood</td><td>CA</td><td>90048</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>EMD Serono, Inc.</td><td>100000000127</td><td>EMD Serono, Inc.</td><td>MA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>23601.6</td><td>2021-05-25</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>MS200527_0082</td><td>No</td><td>842924517</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>223302</td><td>9992</td><td>Childrens Hospital Corporation</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>300 LONGWOOD AVE</td><td>PATIENT FINANCIAL SERVICES ATN STEVEN NICOLL</td><td>BOSTON</td><td>MA</td><td>02115</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Sanofi and Genzyme US Companies</td><td>100000000297</td><td>GENZYME CORPORATION</td><td>MA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>187.5</td><td>2021-08-23</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Pompe LSD Data Registry</td><td>No</td><td>838665143</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>380009</td><td>11212</td><td>OHSU HOSPITAL AND CLINICS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3181 SW Sam Jackson Park Rd</td><td>null</td><td>Portland</td><td>OR</td><td>97239</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>237710</td><td>1235160011</td><td>ADDA</td><td>null</td><td>GRIMBERG</td><td>null</td><td>3500 CIVIC CENTER BLVD</td><td>null</td><td>PHILADELPHIA</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>CARDIOVASCULAR</td><td>VYNDAQEL</td><td>0069-8729-55</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>76595.2</td><td>2021-03-19</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PRACTICAL STRATEGIES TO SCREEN FOR TRANSTHYRETIN AMYLOID CARDIOMYOPATHY IN PATIENTS WITH AORTIC STENOSIS</td><td>No</td><td>832765653</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>490046</td><td>10737</td><td>Sentara Leigh Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>830 KEMPSVILLE RD</td><td>null</td><td>NORFOLK</td><td>VA</td><td>23502</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>79249</td><td>1760451611</td><td>DEEPAK</td><td>R.</td><td>TALREJA</td><td>null</td><td>3241 WESTERN BRANCH BLVD</td><td>null</td><td>CHESAPEAKE</td><td>VA</td><td>23321</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Orsiro</td><td>null</td><td>07640130455948</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>213.75</td><td>2021-04-13</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIOFLOW-V</td><td>No</td><td>843821649</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>235443</td><td>1194794602</td><td>DEBASISH</td><td>null</td><td>TRIPATHY</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>1354</td><td>HOUSTON</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>IBRANCE</td><td>0069-0187-21</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>330.0</td><td>2021-02-03</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PALBOCICLIB CLINICAL PUBLICATION PROGRAM</td><td>No</td><td>832503547</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220071</td><td>9988</td><td>Massachusetts General Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>55 FRUIT ST</td><td>BULFINCH 360</td><td>BOSTON</td><td>MA</td><td>02114</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1394077</td><td>1174848279</td><td>ANAHITA</td><td>null</td><td>DUA</td><td>null</td><td>55 FRUIT ST</td><td>null</td><td>BOSTON</td><td>MA</td><td>02114</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Haemonetics Corporation</td><td>100000000340</td><td>Haemonetics Corporation</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Devices</td><td>TEG6s HEMOSTASIS SYSTEM</td><td>null</td><td>30812747018351</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>289.32</td><td>2021-12-31</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Utilization of Thromboelastography to Predict Arterial Thromboembolic Events in Revascularized Trauma and Peripheral Vascular Disease Patients</td><td>No</td><td>839385309</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1180072</td><td>1700024494</td><td>RISH</td><td>null</td><td>PAI</td><td>null</td><td>13400 E SHEA BLVD</td><td>null</td><td>SCOTTSDALE</td><td>AZ</td><td>85259-5452</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pathology|Clinical Pathology/Laboratory Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ABBVIE INC.</td><td>100000000204</td><td>ABBVIE INC.</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>IMMUNOLOGY</td><td>SKYRIZI</td><td>0074-2042-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4200.0</td><td>2021-07-29</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Assess the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Crohns Disease Who Failed Prior Biologic Treatment</td><td>No</td><td>792404599</td><td>2021</td><td>06/30/2022</td><td>NCT03104413</td><td>null</td><td>M15-991</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>349209</td><td>1689687147</td><td>WILLIAM</td><td>F</td><td>WILEY</td><td>null</td><td>2740 CARNEGIE AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44115</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Ophthalmology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>RxSight Inc</td><td>100000676811</td><td>RxSight Inc</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Ophthalmology</td><td>LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1945.0</td><td>2021-06-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS OF THE RXSIGHT LIGHT ADJUSTABLE LENS (LAL) IN SUBJECTS DESIRING AN EXTENDED DEPTH OF FOCUS</td><td>No</td><td>854610495</td><td>2021</td><td>06/30/2022</td><td>NCT04177771</td><td>null</td><td>Evaluate, for the visual correction of aphakia and presbyopia, the safety and effectiveness of the RxSight Light Adjustable Lens (LAL) to provide an extended depth of focus (improve intermediate and near visual acuity without compromising distance visual acuity) in subjects who have undergone bilateral implantation with the LAL and subsequent light treatments for refractive and presbyopia correction (LAL group).</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>160058</td><td>10604</td><td>University Of Iowa Hosp & Clinics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>200 HAWKINS DR</td><td>null</td><td>IOWA CITY</td><td>IA</td><td>52242</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>77182</td><td>1710172515</td><td>ALEXANDER</td><td>null</td><td>MAZUR</td><td>null</td><td>200 HAWKINS DR</td><td>null</td><td>IOWA CITY</td><td>IA</td><td>52242</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Solia</td><td>null</td><td>04035479118266</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Plexa</td><td>null</td><td>04035479140014</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Rivacor</td><td>null</td><td>04035479156794</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Sentus</td><td>null</td><td>4035479148942</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Acticor</td><td>null</td><td>4035479156701</td><td>25.2</td><td>2021-07-13</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIO-LIBRA</td><td>No</td><td>843822391</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500005</td><td>11179</td><td>Virginia Mason Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>925 Seneca Street</td><td>1930</td><td>Seattle</td><td>WA</td><td>98111</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>830279</td><td>1407902083</td><td>SARA</td><td>O</td><td>WEISS</td><td>null</td><td>1100 9TH AVE</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98101-2756</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Boehringer Ingelheim USA, Inc.</td><td>100000005541</td><td>Boehringer Ingelheim International GmbH</td><td>null</td><td>Germany</td><td>Yes</td><td>Covered</td><td>Drug</td><td>DIABETES</td><td>JARDIANCE</td><td>0597-0152-30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>22.72</td><td>2021-01-05</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Empagliflozin and heart failure (HFpEF)</td><td>No</td><td>828340685</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360180</td><td>10373</td><td>Cleveland Clinic Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9500 EUCLID AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>906598</td><td>1093743718</td><td>DILEEP</td><td>RAVI</td><td>NAIR</td><td>null</td><td>9500 EUCLID AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44195-0001</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NEUROPACE, INC.</td><td>100000010697</td><td>NEUROPACE, INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Epilepsy</td><td>RNS System</td><td>null</td><td>00855547005267</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>50.0</td><td>2021-04-05</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Approval Study</td><td>No</td><td>851399621</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450076</td><td>11031</td><td>Ut Md Anderson Cancer Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 Holcombe Blvd</td><td>null</td><td>Houston</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>3085405</td><td>1578981221</td><td>PREETESH</td><td>null</td><td>JAIN</td><td>null</td><td>C 1515 Holcombe Blvd</td><td>null</td><td>Houston</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BeiGene, Ltd.</td><td>100000826833</td><td>BeiGene, Ltd.</td><td>null</td><td>Cayman Islands</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>BRUKINSA</td><td>72579-011-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>15032.32</td><td>2021-04-13</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Phase 3 Randomized, Open -Label, Multicenter Study Comparing Zanubrutinib (BGB-3111) plus Rituximab Versus Bendamustine plus Rituximab in Patients with Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation</td><td>No</td><td>843878745</td><td>2021</td><td>06/30/2022</td><td>NCT04002297</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>140119</td><td>10441</td><td>Rush University Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1653 W CONGRESS PKWY</td><td>null</td><td>CHICAGO</td><td>IL</td><td>60612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>318704</td><td>1013996701</td><td>FRANK</td><td>null</td><td>PHILLIPS</td><td>null</td><td>1611 W HARRISON ST</td><td>null</td><td>CHICAGO</td><td>IL</td><td>60612-4861</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Orthopaedic Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NuVasive, Inc.</td><td>100000010655</td><td>NuVasive, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Spine/Spine Surgery</td><td>XLIF</td><td>null</td><td>00887517804112</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>8625.53</td><td>2021-08-03</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NUVA.X1801: A Prospective Multicenter Study Evaluating the Effect of Implant Material and/or Surface Structure on Progression of Fusion in XLIF?? Surgery</td><td>No</td><td>853300725</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500008</td><td>11198</td><td>University Of Washington Med Ctr</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1959 NE PACIFIC ST</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>844023</td><td>1891750808</td><td>ELENA</td><td>GABRIELA</td><td>CHIOREAN</td><td>null</td><td>1959 NE Pacific St Fl 3</td><td>null</td><td>Seattle</td><td>WA</td><td>98195</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Bristol Myers Squibb Company</td><td>100000005499</td><td>E.R. Squibb & Sons, L.L.C.</td><td>NJ</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>7451.5</td><td>2021-04-12</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Phase II Nivo Combo - Advanced Pancreatic Cancer</td><td>No</td><td>819882577</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>490009</td><td>10745</td><td>University Of Virginia Medical Cente</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1215 LEE ST PFS</td><td>null</td><td>CHARLOTTESVILLE</td><td>VA</td><td>22908</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>601536</td><td>1376609610</td><td>MICHAEL</td><td>null</td><td>RAGOSTA</td><td>null</td><td>1215 LEE ST</td><td>null</td><td>CHARLOTTESVILLE</td><td>VA</td><td>22908</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>VA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Linoxsmart</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>471.25</td><td>2021-03-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIOFLOW-VII</td><td>No</td><td>843830181</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>845647</td><td>1942337670</td><td>KATHARINE</td><td>null</td><td>BAR</td><td>null</td><td>3400 SPRUCE STREET</td><td>8 PENN TOWER</td><td>PHILADELPHIA</td><td>PA</td><td>19104-4206</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>151.08</td><td>2021-09-10</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ASSESSING THE EFFICACY AND SAFETY OF ANTI-SPIKE SARS-COV-2 MONOCLONAL ANTIBODIES IN PREVENTING SARS-COV-2 INFECTION IN HOUSEHOLD CONTACTS OF INDIVIDUALS INFECTED WITH SARS-COV-2</td><td>No</td><td>793081347</td><td>2021</td><td>06/30/2022</td><td>NCT04452318</td><td>null</td><td>The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360180</td><td>10373</td><td>CLEVELAND CLINIC HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9500 Euclid Ave</td><td>null</td><td>Cleveland</td><td>OH</td><td>44195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>754264</td><td>1720131766</td><td>DEEPA</td><td>null</td><td>JAGADEESH</td><td>null</td><td>119 BELMONT ST</td><td>DEPT OF HOSPITAL MEDICINE</td><td>WORCESTER</td><td>MA</td><td>01605-2903</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4375.42</td><td>2021-10-14</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>AN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND SAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA</td><td>No</td><td>793086585</td><td>2021</td><td>06/30/2022</td><td>NCT03888105</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50180</td><td>11269</td><td>John Muir Medical Center - Wc</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1601 Ygnacio Valley Rd</td><td>null</td><td>Walnut Creek</td><td>CA</td><td>94598</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>703467</td><td>1942249388</td><td>BABAK</td><td>null</td><td>EDRAKI</td><td>null</td><td>1479 YGNACIO VALLEY RD STE 100</td><td>null</td><td>WALNUT CREEK</td><td>CA</td><td>94598</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Obstetrics & Gynecology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AstraZeneca Pharmaceuticals LP</td><td>100000000146</td><td>AstraZeneca Pharmaceuticals LP</td><td>DE</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>LYNPARZA</td><td>0310-0657-58</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>70.82</td><td>2021-12-31</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>\"\"\";A Phase III</td><td> Randomised</td><td> Double Blind</td><td> Placebo Controlled</td><td> Multicentre Study of Olaparib Maintenance Monotherapy in Patients with a germline BRCA mutation and Stage III-IV Ovarian Cancer who are in Complete or Partial Response Following First Line Platinum Based Chemotherapy\\\"\";\"</td><td>No</td><td>826485917</td><td>2021</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>340001</td><td>10755</td><td>Carolinas Healthcare System Northeas</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>920 CHURCH ST N</td><td>null</td><td>CONCORD</td><td>NC</td><td>28025</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>332827</td><td>1326151424</td><td>JOHN</td><td>D.</td><td>SYMANSKI</td><td>null</td><td>1237 Harding Pl Ste 3100</td><td>null</td><td>Charlotte</td><td>NC</td><td>28204</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Bristol Myers Squibb Company</td><td>100000005499</td><td>E.R. Squibb & Sons, L.L.C.</td><td>NJ</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>24821.77</td><td>2021-03-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM</td><td>No</td><td>819888869</td><td>2021</td><td>06/30/2022</td><td>NCT03723655</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>70036</td><td>10025</td><td>John Dempsey Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>263 Farmington Avenue</td><td>null</td><td>Farmington</td><td>CT</td><td>06030</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>533924</td><td>1982868550</td><td>ALEX</td><td>null</td><td>MERKULOV</td><td>null</td><td>168 CENTRAL LN</td><td>null</td><td>SECAUCUS</td><td>NJ</td><td>07094</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Osteopathy</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GUERBET LLC</td><td>100000010729</td><td>GUERBET LLC</td><td>NJ</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>21226.0</td><td>2021-01-28</td><td>Cash or cash equivalent</td><td>Patient Care</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)</td><td>No</td><td>842725345</td><td>2021</td><td>06/30/2022</td><td>NCT03986138</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>330240</td><td>10077</td><td>HARLEM HOSPITAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>506 Malcolm X Blvd</td><td>Onr Room 101</td><td>New York</td><td>NY</td><td>10037</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>394616</td><td>1114011285</td><td>VIDYA</td><td>P</td><td>MENON</td><td>null</td><td>1717 S J ST</td><td>null</td><td>TACOMA</td><td>WA</td><td>98405-4933</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>48047.61</td><td>2021-01-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A MASTER PROTOCOL ASSESSING THE SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-SPIKE (S) SARS-COV-2 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF HOSPITALIZED PATIENTS WITH COVID-19</td><td>No</td><td>793086845</td><td>2021</td><td>06/30/2022</td><td>NCT04426695</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100007</td><td>10819</td><td>ADVENTHEALTH ORLANDO</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>601 E Rollins St</td><td>null</td><td>Orlando</td><td>FL</td><td>32803</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>306919</td><td>1770576258</td><td>CARLOS</td><td>A</td><td>ALEMANY</td><td>null</td><td>2501 N ORANGE AVE</td><td>2501 N ORANGE AVE</td><td>ORLANDO</td><td>FL</td><td>32804-4603</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Merck Sharp & Dohme Corporation</td><td>100000000053</td><td>Merck Sharp & Dohme Corporation</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ONCOLOGY</td><td>KEYTRUDA</td><td>0006-3029-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>8750.0</td><td>2021-06-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase III, Randomized, Double-blind, Matching Placebo-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab MK-3475 in Combination With Chemoradiotherapy CRT versus CRT Alone in Participants with Muscle-invasive Bladder Cancer MIBC KEYNOTE-992</td><td>No</td><td>848750019</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50625</td><td>11293</td><td>Cedars-Sinai Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>8700 Beverly Blvd</td><td>null</td><td>West Hollywood</td><td>CA</td><td>90048</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>625711</td><td>1225100183</td><td>PETER</td><td>null</td><td>CHEN</td><td>null</td><td>11311 BRIDGEPORT WAY SW</td><td>null</td><td>LAKEWOOD</td><td>WA</td><td>98499</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Gilead Sciences, Inc.</td><td>100000000108</td><td>Gilead Sciences, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>COVID-19</td><td>Veklury</td><td>61958-2901-2</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>7692.0</td><td>2021-08-16</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 1b/2a study in A Phase 1b/2a Study in Participants with Early Stage COVID-19 to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation</td><td>No</td><td>803513543</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>;GS-US-553-9020;G2760872;IPP;951644600;10601013</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500044</td><td>11187</td><td>Deaconess Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>800 W 5th Ave</td><td>null</td><td>Spokane</td><td>WA</td><td>99204</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>19189</td><td>1437178266</td><td>DANIEL</td><td>null</td><td>COULSTON</td><td>null</td><td>910 W 5TH AVE STE 1001</td><td>null</td><td>SPOKANE</td><td>WA</td><td>99204</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Gilead Sciences, Inc.</td><td>100000000108</td><td>Gilead Sciences, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>COVID-19</td><td>Veklury</td><td>61958-2901-2</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>18864.0</td><td>2021-05-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Remdesivir in Participants with Severely Reduced Kidney Function who are Hospitalized for COVID-19</td><td>No</td><td>803513799</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>;GS-US-540-5912;G2757529;GILDA;911352172;10049437</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>310019</td><td>10183</td><td>St. Josephs University Medical Cent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>703 MAIN ST</td><td>null</td><td>PATERSON</td><td>NJ</td><td>07503</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Sanofi and Genzyme US Companies</td><td>100000000297</td><td>GENZYME CORPORATION</td><td>MA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>850.0</td><td>2021-08-23</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Gaucher LSD Data Registry</td><td>No</td><td>838667105</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390111</td><td>10224</td><td>Hospital Of The Univ Of Penna</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3701 Market St</td><td>null</td><td>Phila</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>271387</td><td>1992848519</td><td>KUCHIKULA</td><td>RAJENDER</td><td>REDDY</td><td>null</td><td>3400 SPRUCE ST FL 3</td><td>null</td><td>PHILADELPHIA</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Gilead Sciences, Inc.</td><td>100000000108</td><td>Gilead Sciences, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>HCV</td><td>Harvoni</td><td>61958-1801-1</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4044.0</td><td>2021-08-23</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Long Term Follow-up Registry for Subjects with Cirrhosis Who Achieve a Sustained Virologic Response to Treatment for HCV Infection in Gilead-Sponsored Trials</td><td>No</td><td>803514055</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>;GS-US-337-1431;G2759861;GILDA;231352685;10077792</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50262</td><td>11328</td><td>Ronald Reagan Ucla</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>757 Westwood Plz</td><td>null</td><td>Los Angeles</td><td>CA</td><td>90095</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>6760</td><td>1144373739</td><td>GEOFFREY</td><td>PHILIP</td><td>COLBY</td><td>null</td><td>300 MEDICAL PLAZA</td><td>null</td><td>LOS ANGELES</td><td>CA</td><td>90095</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Neurological Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Penumbra, Inc.</td><td>100000010583</td><td>Penumbra, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Neurosurgery</td><td>Artemis</td><td>null</td><td>00814548017877</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4000.0</td><td>2021-11-04</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>MIND</td><td>No</td><td>840456285</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>223302</td><td>9992</td><td>CHILDRENS HOSPITAL CORPORATION</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>300 Longwood Ave</td><td>Patient Financial Services Atn Steven Nicoll</td><td>Boston</td><td>MA</td><td>02115</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1023620</td><td>1184980864</td><td>LISSETTE</td><td>null</td><td>JIMENEZ</td><td>null</td><td>300 LONGWOOD AVE</td><td>null</td><td>BOSTON</td><td>MA</td><td>02115</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>100000000337</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>INTERNAL MEDICINE</td><td>GATTEX</td><td>68875-0101-2</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>659343.48</td><td>2021-11-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>CLINICAL USE OF TEDUGLUTIDE IN CHILDREN WITH SHORT BOWEL SYNDROME: A MULTI-CENTER POST-MARKETING EVALUATION</td><td>No</td><td>816651623</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>340130</td><td>10756</td><td>Carolinas Healthcare System Union</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>600 HOSPITAL DR</td><td>null</td><td>MONROE</td><td>NC</td><td>28112</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>997485</td><td>1275557571</td><td>SHERRY</td><td>JOUEI</td><td>SAXONHOUSE</td><td>null</td><td>100 MEDICAL PARK DR STE 210</td><td>null</td><td>CONCORD</td><td>NC</td><td>28025</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Solia</td><td>null</td><td>04035479118266</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Plexa</td><td>null</td><td>04035479140014</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Rivacor</td><td>null</td><td>04035479156794</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Sentus</td><td>null</td><td>4035479148942</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Acticor</td><td>null</td><td>4035479156701</td><td>217.14</td><td>2021-02-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIO-LIBRA</td><td>No</td><td>843805635</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>833679</td><td>1528160199</td><td>ANDREW</td><td>J</td><td>ARMSTRONG</td><td>null</td><td>DUKE UNIVERSITY MED CTR</td><td>null</td><td>DURHAM</td><td>NC</td><td>27710</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>XTANDI</td><td>0469-0125-99</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>940.0</td><td>2021-02-13</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>ENZALUTAMIDE CLINICAL PUBLICATION PROGRAM</td><td>No</td><td>832505018</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>420004</td><td>10780</td><td>MEDICAL UNIVERSITY OF SOUTH CAROLINA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>169 ASHLEY AVE</td><td>null</td><td>CHARLESTON</td><td>SC</td><td>29403</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>10635</td><td>1245223452</td><td>RICHARD</td><td>JOEL</td><td>FRIEDMAN</td><td>null</td><td>171 ASHLEY AVE</td><td>null</td><td>CHARLESTON</td><td>SC</td><td>29425-8908</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Orthopaedic Surgery|Adult Reconstructive Orthopaedic Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>SC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>EXACTECH, INC.</td><td>100000010981</td><td>EXACTECH, INC.</td><td>FL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>ORTHOPAEDIC</td><td>ALTEON</td><td>null</td><td>10885862549181</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1125.0</td><td>2021-10-19</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Yes</td><td>No</td><td>null</td><td>No</td><td>852891909</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450076</td><td>11031</td><td>UT MD ANDERSON CANCER CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 Holcombe Blvd</td><td>null</td><td>Houston</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>6525</td><td>1144470758</td><td>HANS</td><td>CHULHEE</td><td>LEE</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>null</td><td>HOUSTON</td><td>TX</td><td>77030-4009</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>100000000337</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>IL</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>14343.75</td><td>2021-05-11</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A GLOBAL, PROSPECTIVE, NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF PRESENTATION, TREATMENT PATTERNS, AND OUTCOMES IN MULTIPLE MYELOMA PATIENTS - THE INSIGHT - MM STUDY</td><td>No</td><td>816675537</td><td>2021</td><td>06/30/2022</td><td>NCT02761187</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360068</td><td>10396</td><td>The Toledo Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2142 N COVE BLVD</td><td>null</td><td>TOLEDO</td><td>OH</td><td>43606</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>70978</td><td>1568487726</td><td>MARK</td><td>null</td><td>RICHARDS</td><td>null</td><td>2940 N MCCORD RD</td><td>null</td><td>TOLEDO</td><td>OH</td><td>43615</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ID</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Sentus</td><td>null</td><td>04035479148942</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Acticor</td><td>null</td><td>04035479156701</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Solia</td><td>null</td><td>04035479118266</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Rivacor</td><td>null</td><td>4035479156794</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Plexa</td><td>null</td><td>4035479140014</td><td>20.0</td><td>2021-03-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIO-LIBRA</td><td>No</td><td>843823011</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>801942</td><td>1417078221</td><td>NEERAJ</td><td>null</td><td>AGARWAL</td><td>null</td><td>2000 CIRCLE OF HOPE DR STE 5726</td><td>null</td><td>SALT LAKE CITY</td><td>UT</td><td>84112</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>UT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>XTANDI</td><td>0469-0125-99</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>330.0</td><td>2021-02-17</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>ENZALUTAMIDE CLINICAL PUBLICATION PROGRAM</td><td>No</td><td>832506717</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>140212</td><td>1083662894</td><td>ISAAC</td><td>null</td><td>THOMAS</td><td>null</td><td>3915 OGLESBY AVE</td><td>null</td><td>GURNEE</td><td>IL</td><td>60031-3358</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ABBVIE INC.</td><td>100000000204</td><td>ABBVIE INC.</td><td>IL</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>72.0</td><td>2021-01-14</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A First in Human, Single and Multiple Ascending Dose and Food Effect Study for the Assessment of Pharmacokinetics and Safety of ABBV-119</td><td>No</td><td>792405127</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>M19-775</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>310015</td><td>10713</td><td>Morristown Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>100 Madison Ave</td><td>null</td><td>Morristown</td><td>NJ</td><td>07960</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>324458</td><td>1144218215</td><td>CHARLES</td><td>M</td><td>FARBER</td><td>null</td><td>100 Madison Ave</td><td>null</td><td>Morristown</td><td>NJ</td><td>07960</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NJ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BeiGene, Ltd.</td><td>100000826833</td><td>BeiGene, Ltd.</td><td>null</td><td>Cayman Islands</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>500.0</td><td>2021-08-27</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Single-Arm, Expanded Access Study of Zanubrutinib (BGB-3111) in Patients with B-cell Malignancies</td><td>No</td><td>843874643</td><td>2021</td><td>06/30/2022</td><td>NCT04052854</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360180</td><td>10373</td><td>Cleveland Clinic Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9500 EUCLID AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>906598</td><td>1093743718</td><td>DILEEP</td><td>RAVI</td><td>NAIR</td><td>null</td><td>9500 EUCLID AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44195-0001</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NEUROPACE, INC.</td><td>100000010697</td><td>NEUROPACE, INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Epilepsy</td><td>RNS System</td><td>null</td><td>00855547005267</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>360.5</td><td>2021-07-19</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Approval Study</td><td>No</td><td>851399729</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>60024</td><td>11137</td><td>University Of Co Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>100 COOK STREET, SUITE 204</td><td>null</td><td>DENVER</td><td>CO</td><td>80206</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>667077</td><td>1659576163</td><td>SARAH</td><td>L.</td><td>DAVIS</td><td>null</td><td>1665 Aurora Ct</td><td>null</td><td>Aurora</td><td>CO</td><td>80045</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CO</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Bristol Myers Squibb Company</td><td>100000005499</td><td>E.R. Squibb & Sons, L.L.C.</td><td>NJ</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1280.0</td><td>2021-05-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Ph II Study Gastric 1L, multi-cohort all comers lag3 nivo</td><td>No</td><td>819882877</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100088</td><td>10820</td><td>BAPTIST MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>800 PRUDENTIAL DR</td><td>null</td><td>JACKSONVILLE</td><td>FL</td><td>32207</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>90104</td><td>1992017735</td><td>JENNIFER</td><td>ANN</td><td>CROZIER</td><td>null</td><td>1301 W PALM AVE</td><td>210</td><td>JACKSONVILLE</td><td>FL</td><td>32254</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000010364</td><td>Roche Products Limited</td><td>null</td><td>Great Britain (Uk)</td><td>Yes</td><td>Covered</td><td>Biological</td><td>BioOncology</td><td>TECENTRIQ</td><td>50242-917-01</td><td>null</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>154.0</td><td>2021-12-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE III MULTICENTER RANDOMIZED OPEN LABEL STUDY COMPARING ATEZOLIZUMAB ANTI PD L1 ANTIBODY</td><td>No</td><td>835906647</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>314007</td><td>1932115425</td><td>ANDREW</td><td>null</td><td>BLAUVELT</td><td>null</td><td>9495 SW LOCUST STREET</td><td>SUITE A</td><td>PORTLAND</td><td>OR</td><td>97223-6683</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>INFLAMMATION AND  IMMUNOLOGY</td><td>DUPIXENT</td><td>0024-5914-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>251.4</td><td>2021-10-04</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>AN OPEN-LABEL STUDY OF DUPILUMAB IN PATIENTS WITH ATOPIC DERMATITIS WHO PARTICIPATED IN PREVIOUS DUPILUMAB CLINICAL TRIALS</td><td>No</td><td>793081603</td><td>2021</td><td>06/30/2022</td><td>NCT01949311</td><td>null</td><td>The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500005</td><td>11179</td><td>Virginia Mason Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>925 Seneca Street</td><td>1930</td><td>Seattle</td><td>WA</td><td>98111</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>830279</td><td>1407902083</td><td>SARA</td><td>O</td><td>WEISS</td><td>null</td><td>1100 9TH AVE</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98101-2756</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Boehringer Ingelheim USA, Inc.</td><td>100000005541</td><td>Boehringer Ingelheim International GmbH</td><td>null</td><td>Germany</td><td>Yes</td><td>Covered</td><td>Drug</td><td>DIABETES</td><td>JARDIANCE</td><td>0597-0152-30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>21.75</td><td>2021-03-03</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Empagliflozin and heart failure (HFpEF)</td><td>No</td><td>828341197</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>140119</td><td>10441</td><td>Rush University Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1653 W Congress Pkwy</td><td>null</td><td>Chicago</td><td>IL</td><td>60612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1209197</td><td>1710253992</td><td>SEO-HYUN</td><td>null</td><td>KIM</td><td>null</td><td>1653 W CONGRESS PKWY</td><td>301 JONES</td><td>CHICAGO</td><td>IL</td><td>60612</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BeiGene, Ltd.</td><td>100000826833</td><td>BeiGene, Ltd.</td><td>null</td><td>Cayman Islands</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>BRUKINSA</td><td>72579-011-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>56400.0</td><td>2021-09-13</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Phase 3 Randomized, Open -Label, Multicenter Study Comparing Zanubrutinib (BGB-3111) plus Rituximab Versus Bendamustine plus Rituximab in Patients with Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation</td><td>No</td><td>843879483</td><td>2021</td><td>06/30/2022</td><td>NCT04002297</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>190036</td><td>10978</td><td>Ochsner Clinic Foundation</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1516 Jefferson Highway</td><td>null</td><td>New Orleans</td><td>LA</td><td>70121</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>345054</td><td>1598958316</td><td>MARC</td><td>R</td><td>MATRANA</td><td>null</td><td>1514 JEFFERSON HIGHWAY</td><td>null</td><td>NEW ORLEANS</td><td>LA</td><td>70121</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>LA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eisai Inc.</td><td>100000000136</td><td>Eisai Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>Lenvima</td><td>62856-710-30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2084.11</td><td>2021-01-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination With Everolimus or Pembrolizumab Versus Sunitinib Alone in First-Line Treatment of Subjects With Advanced Renal Cell Carcinoma (CLEAR)</td><td>No</td><td>836180651</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>310001</td><td>10178</td><td>Hackensack University Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>30 PROSPECT AVE</td><td>null</td><td>HACKENSACK</td><td>NJ</td><td>07601</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>184727</td><td>1063489243</td><td>BINDU</td><td>null</td><td>BALANI</td><td>null</td><td>20 Prospect Ave Ste 507</td><td>null</td><td>Hackensack</td><td>NJ</td><td>07601</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NJ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Moderna TX, Inc.</td><td>100000961851</td><td>Moderna TX, Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Infections and Infectious Diseases</td><td>Moderna Covid-19 Vaccine</td><td>80777-273-99</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>32705.7</td><td>2021-07-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older</td><td>No</td><td>806335389</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220086</td><td>9982</td><td>Beth Israel Deaconess Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>330 BROOKLINE AVE</td><td>ST 207</td><td>BOSTON</td><td>MA</td><td>02215</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Bristol Myers Squibb Company</td><td>100000005499</td><td>E.R. Squibb & Sons, L.L.C.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Oncology</td><td>OPDIVO</td><td>0003-3774-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>59109.0</td><td>2021-10-27</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Treatment Free Interval Melanoma</td><td>No</td><td>819889177</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>914590</td><td>1366754954</td><td>ALAN</td><td>P.</td><td>ZAUSNER SKARBNIK</td><td>null</td><td>125 QUEENS RD</td><td>250</td><td>CHARLOTTE</td><td>NC</td><td>28204</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>NJ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000005656</td><td>F. Hoffmann-La Roche AG</td><td>null</td><td>Switzerland</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>Actemra</td><td>50242-137-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>417.86</td><td>2021-06-29</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>TOCILIZUMAB AND REMDESIVIR IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA A RANDOMIZED CLINICAL TRIAL</td><td>No</td><td>835897265</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>276270</td><td>1083614879</td><td>ILEANA</td><td>JOSEFINA</td><td>TANDRON</td><td>null</td><td>2240 GAUSE BLVD E</td><td>null</td><td>SLIDELL</td><td>LA</td><td>70461</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>LA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>26.5</td><td>2021-07-19</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9924-4473</td><td>No</td><td>811761853</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>440039</td><td>10425</td><td>Vanderbilt University Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1211 Medical Center Drive</td><td>null</td><td>Nashville</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>35427</td><td>1790736759</td><td>JOSHUA</td><td>A</td><td>BECKMAN</td><td>null</td><td>2200 PIERCE AVE</td><td>null</td><td>NASHVILLE</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>TN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>Ozempic</td><td>0169-4132-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3.05</td><td>2021-04-30</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9535-4533</td><td>No</td><td>811865225</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390111</td><td>10224</td><td>HOSPITAL OF THE UNIV OF PENNA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3701 Market St</td><td>null</td><td>Phila</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>104812</td><td>1316979610</td><td>DANIEL</td><td>J</td><td>RADER</td><td>null</td><td>3400 CIVIC CENTER BLVD</td><td>EAST PAVILION 2ND FLOOR</td><td>PHILADELPHIA</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>CARDIOVASCULAR AND METABOLISM</td><td>EVKEEZA</td><td>61755-010-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>49275.0</td><td>2021-07-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF SAFETY AND EFFICACY, FOLLOWING REPEAT-DOSE ADMINISTRATION OF EVINACUMAB (ANTI-ANGPTL3) IN PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA (SHTG) AT RISK FOR ACUTE PANCREATITIS</td><td>No</td><td>793087101</td><td>2021</td><td>06/30/2022</td><td>NCT03452228</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>116924</td><td>1598704371</td><td>BRADLEY</td><td>N</td><td>HINES</td><td>null</td><td>3445 POPLAR AVE</td><td>SUITE 7</td><td>MEMPHIS</td><td>TN</td><td>38111-4667</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Optometry</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eye and Vision Services Providers|Optometrist</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alcon Research LLC</td><td>100000000218</td><td>Alcon Research LLC</td><td>TX</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Ophthamology</td><td>TOTAL 30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>511.2</td><td>2021-11-12</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Clinical Assessment of Two Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lenses</td><td>No</td><td>807671461</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50625</td><td>11293</td><td>Cedars-Sinai Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>8700 Beverly Blvd</td><td>null</td><td>West Hollywood</td><td>CA</td><td>90048</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>294911</td><td>1508959800</td><td>HOWARD</td><td>M</td><td>SANDLER</td><td>null</td><td>8700 BEVERLY BLVD</td><td>null</td><td>WEST HOLLYWOOD</td><td>CA</td><td>90048</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>XTANDI</td><td>0469-0125-99</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1000.0</td><td>2021-01-25</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A RANDOMIZED PHASE II TRIAL OF SALVAGE RADIOTHERAPY WITH STANDARD VS ENHANCED ANDROGEN DEPRIVATION THERAPY WITH ENZALUTAMIDE IN PATIENTS WITH POSTPROSTATECTOMY PSA RECURRENCES WITH AGGRESSIVE DISEASE FEATURES</td><td>No</td><td>832769239</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>160058</td><td>10604</td><td>University Of Iowa Hosp & Clinics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>200 HAWKINS DR</td><td>null</td><td>IOWA CITY</td><td>IA</td><td>52242</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Sanofi and Genzyme US Companies</td><td>100000000297</td><td>GENZYME CORPORATION</td><td>MA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>32350.5</td><td>2021-09-13</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Fabry LSD Data Registry</td><td>No</td><td>838667611</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>240115</td><td>10464</td><td>Mercy Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3960 Coon Rapids Blvd Nw Ste 220</td><td>null</td><td>Coon Rapids</td><td>MN</td><td>55433</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>81430</td><td>1801872502</td><td>MICHAELA</td><td>L</td><td>TSAI</td><td>null</td><td>910 E 26TH ST STE 100200</td><td>null</td><td>MINNEAPOLIS</td><td>MN</td><td>55404</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Gilead Sciences, Inc.</td><td>100000000108</td><td>Gilead Sciences, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONC</td><td>Trodelvy</td><td>55135-132-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4608.9</td><td>2021-10-12</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Phase III Study of Sacituzumab Govitecan (IMMU-132) in Refractory/Relapsed Triple-Negative Breast Cancer</td><td>No</td><td>803514313</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>;IMMU-132-05;G2799457;CLINENT;363261413;10223249</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>70034</td><td>10026</td><td>Norwalk Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>34 Maple St</td><td>null</td><td>Norwalk</td><td>CT</td><td>06856</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>234804</td><td>1174515803</td><td>RICHARD</td><td>null</td><td>FRANK</td><td>null</td><td>40 CROSS ST</td><td>4TH FL</td><td>NORWALK</td><td>CT</td><td>06851</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>EMD Serono, Inc.</td><td>100000000127</td><td>EMD Serono, Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>Bavencio</td><td>44087-3535-1</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>52.0</td><td>2021-04-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>MS100070_0176</td><td>No</td><td>842928265</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>150113</td><td>10414</td><td>Community Hospital Anderson</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 N Madison Ave</td><td>null</td><td>Anderson</td><td>IN</td><td>46011</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>102864</td><td>1275552481</td><td>WA'EL</td><td>null</td><td>BAKDASH</td><td>null</td><td>1515 S MADISON AVE</td><td>null</td><td>ANDERSON</td><td>IN</td><td>46016</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>Diabetes</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>28.45</td><td>2021-06-24</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9536-4388</td><td>No</td><td>811332325</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360180</td><td>10373</td><td>Cleveland Clinic Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9500 Euclid Ave</td><td>null</td><td>Cleveland</td><td>OH</td><td>44195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>41807</td><td>1922293547</td><td>KEVIN</td><td>M</td><td>PANTALONE</td><td>null</td><td>29800 BAINBRIDGE RD</td><td># SO40</td><td>SOLON</td><td>OH</td><td>44139</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Osteopathy</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2844.89</td><td>2021-06-28</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9924-4473</td><td>No</td><td>811406733</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>340130</td><td>10756</td><td>Carolinas Healthcare System Union</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>600 HOSPITAL DR</td><td>null</td><td>MONROE</td><td>NC</td><td>28112</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>997485</td><td>1275557571</td><td>SHERRY</td><td>JOUEI</td><td>SAXONHOUSE</td><td>null</td><td>100 MEDICAL PARK DR STE 210</td><td>null</td><td>CONCORD</td><td>NC</td><td>28025</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Rivacor</td><td>null</td><td>04035479156794</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Plexa</td><td>null</td><td>04035479140014</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Sentus</td><td>null</td><td>04035479148942</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Solia</td><td>null</td><td>4035479118266</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Acticor</td><td>null</td><td>4035479156701</td><td>276.89</td><td>2021-12-14</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIO-LIBRA</td><td>No</td><td>843805891</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>400016</td><td>10952</td><td>Auxilio Mutuo Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Ponce De Leon</td><td>191227</td><td>San Juan</td><td>PR</td><td>00919</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>728419</td><td>1811052707</td><td>FERNANDO</td><td>null</td><td>CABANILLAS</td><td>null</td><td>725 PONCE DE LEON</td><td>PARADA 37</td><td>SAN JUAN</td><td>PR</td><td>00918</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eisai Inc.</td><td>100000000136</td><td>Eisai Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>Ontak</td><td>62856-603-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>847.36</td><td>2021-05-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Clinical Study to Demonstrate Safety and Efficacy of E7777 (Denileukin Diftitox) in Persistent or Recurrent Cutaneous T-Cell Lymphoma</td><td>No</td><td>836179271</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360180</td><td>10373</td><td>Cleveland Clinic Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9500 Euclid Ave</td><td>null</td><td>Cleveland</td><td>OH</td><td>44195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>41807</td><td>1922293547</td><td>KEVIN</td><td>M</td><td>PANTALONE</td><td>null</td><td>29800 BAINBRIDGE RD</td><td># SO40</td><td>SOLON</td><td>OH</td><td>44139</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Osteopathy</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>900.0</td><td>2021-03-10</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9924-4473</td><td>No</td><td>811588807</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390028</td><td>10267</td><td>Upmc Mercy Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1400 Locust St</td><td>null</td><td>Pittsburgh</td><td>PA</td><td>15219</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>347278</td><td>1649242033</td><td>SILVA</td><td>A</td><td>ARSLANIAN</td><td>null</td><td>5230 CENTRE AVE</td><td>FL 2</td><td>PITTSBURGH</td><td>PA</td><td>15232</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5.7</td><td>2021-12-20</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9924-4437</td><td>No</td><td>811785299</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>276270</td><td>1083614879</td><td>ILEANA</td><td>JOSEFINA</td><td>TANDRON</td><td>null</td><td>2240 GAUSE BLVD E</td><td>null</td><td>SLIDELL</td><td>LA</td><td>70461</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>LA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>7.95</td><td>2021-03-08</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9924-4473</td><td>No</td><td>811812531</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>440039</td><td>10425</td><td>VANDERBILT UNIVERSITY MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1211 Medical Center Drive</td><td>null</td><td>Nashville</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>193914</td><td>1265551295</td><td>SARA</td><td>NICOLE</td><td>HORST</td><td>null</td><td>1211 21ST AVE S</td><td>SUITE 210</td><td>NASHVILLE</td><td>TN</td><td>37212-2717</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>100000000337</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>IL</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2000.0</td><td>2021-01-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3B OPEN-LABEL STUDY TO DETERMINE THE LONG-TERM SAFETY AND EFFICACY OF VEDOLIZUMAB SUBCUTANEOUS IN SUBJECTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE</td><td>No</td><td>816676017</td><td>2021</td><td>06/30/2022</td><td>NCT02620046</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>274057</td><td>1033132097</td><td>VICENTA</td><td>null</td><td>SALANOVA</td><td>null</td><td>550 UNIVERSITY BLVD</td><td>null</td><td>INDIANAPOLIS</td><td>IN</td><td>46202-5149</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NEUROPACE, INC.</td><td>100000010697</td><td>NEUROPACE, INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Epilepsy</td><td>RNS System</td><td>null</td><td>00855547005267</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>530.0</td><td>2021-07-04</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Approval Study</td><td>No</td><td>851398247</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>310015</td><td>10713</td><td>Morristown Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>100 Madison Ave</td><td>null</td><td>Morristown</td><td>NJ</td><td>07960</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>332771</td><td>1336113653</td><td>LAWRENCE</td><td>A</td><td>SILVERMAN</td><td>null</td><td>100 MADISON AVE</td><td>null</td><td>MORRISTOWN</td><td>NJ</td><td>07960</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NJ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>701.44</td><td>2021-01-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN8640-4263</td><td>No</td><td>811862329</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230053</td><td>10500</td><td>HENRY FORD HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2799 W Grand Blvd</td><td>null</td><td>Detroit</td><td>MI</td><td>48202</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>215472</td><td>1750434114</td><td>PETER</td><td>A</td><td>LE WITT</td><td>null</td><td>6777 W MAPLE RD</td><td>null</td><td>WEST BLOOMFIELD</td><td>MI</td><td>48322-3013</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Amneal Pharmaceuticals LLC</td><td>100000126368</td><td>Amneal Pharmaceuticals LLC</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>NEUROLOGY</td><td>CARBIDOPA AND LEVODOPA</td><td>0378-0085-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1546.87</td><td>2021-04-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in Parkinson's Disease Patients With Motor Fluctuations</td><td>No</td><td>830757643</td><td>2021</td><td>06/30/2022</td><td>NCT03670953</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500008</td><td>11198</td><td>University Of Washington Med Ctr</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1959 NE PACIFIC ST</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1143552</td><td>1386965952</td><td>RYAN</td><td>CHRISTOPHER</td><td>LYNCH</td><td>null</td><td>825 EASTLAKE AVE E</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98109</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Hospitalist</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MO</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>315.0</td><td>2021-08-03</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>An Open Label, Randomized Study Comparing INCB050465 to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL 203)</td><td>No</td><td>831049973</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Transfer of value for editorial and or medical writing services. These services were funded by Incyte Corporation and paid to a third-party vendor to assist with the development of a publication at the direction of the authors. No payments were made directly to the authors for these editorial and or medical writing services.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50180</td><td>11269</td><td>JOHN MUIR MEDICAL CENTER - WC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1601 YGNACIO VALLEY RD</td><td>null</td><td>WALNUT CREEK</td><td>CA</td><td>94598</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>82179</td><td>1821073636</td><td>GIGI</td><td>QIQI</td><td>CHEN</td><td>null</td><td>400 TAYLOR BLVD</td><td>null</td><td>PLEASANT HILL</td><td>CA</td><td>94523</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000010364</td><td>Roche Products Limited</td><td>null</td><td>Great Britain (Uk)</td><td>Yes</td><td>Covered</td><td>Biological</td><td>BioOncology</td><td>TECENTRIQ</td><td>50242-917-01</td><td>null</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5845.5</td><td>2021-08-16</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE III MULTICENTER RANDOMIZED OPEN LABEL STUDY COMPARING ATEZOLIZUMAB ANTI PD L1 ANTIBODY</td><td>No</td><td>835914227</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1231721</td><td>1508944794</td><td>RHONDA</td><td>M</td><td>BENTLEY-LEWIS</td><td>null</td><td>50 STANIFORD ST</td><td>null</td><td>BOSTON</td><td>MA</td><td>02114</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>Diabetes</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2720.0</td><td>2021-06-16</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9535-4352</td><td>No</td><td>811841043</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>227087</td><td>1013049188</td><td>ANNE</td><td>L</td><td>CHANG</td><td>null</td><td>300 PASTEUR DR</td><td>null</td><td>STANFORD</td><td>CA</td><td>94305-2200</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ONCOLOGY</td><td>LIBTAYO</td><td>61755-008-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>136.01</td><td>2021-09-08</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>LIBTAYO CLINICAL PUBLICATION PROGRAM</td><td>No</td><td>793081861</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>300003</td><td>9970</td><td>Mary Hitchcock Memorial Hosp</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ONE MEDICAL CENTER DR</td><td>null</td><td>LEBANON</td><td>NH</td><td>03756</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>263383</td><td>1790876696</td><td>BARBARA</td><td>C.</td><td>JOBST</td><td>null</td><td>1 MEDICAL CENTER DR</td><td>null</td><td>LEBANON</td><td>NH</td><td>03756-1000</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NEUROPACE, INC.</td><td>100000010697</td><td>NEUROPACE, INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Epilepsy</td><td>RNS System</td><td>null</td><td>00855547005267</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>15.0</td><td>2021-02-01</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Approval Study</td><td>No</td><td>851399945</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450076</td><td>11031</td><td>Ut Md Anderson Cancer Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 Holcombe Blvd</td><td>null</td><td>Houston</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>727133</td><td>1760701445</td><td>AMISHI</td><td>Y</td><td>SHAH</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>null</td><td>HOUSTON</td><td>TX</td><td>77030-4009</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eisai Inc.</td><td>100000000136</td><td>Eisai Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>Lenvima</td><td>62856-710-30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2773.0</td><td>2021-03-31</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors</td><td>No</td><td>836180757</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>149687</td><td>1306872288</td><td>CHRISTOPHER</td><td>null</td><td>BUATTI</td><td>null</td><td>2251 N SQUIRREL RD</td><td>SUITE 200</td><td>AUBURN HILLS</td><td>MI</td><td>48326</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>282902</td><td>1245353366</td><td>EMMY</td><td>null</td><td>GRABER</td><td>null</td><td>486 STUART ST, SUITE 404</td><td>null</td><td>BOSTON</td><td>MA</td><td>02116</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>269961</td><td>1962496265</td><td>HILARY</td><td>null</td><td>BALDWIN</td><td>null</td><td>142 JORALEMON STREET, SUITE 800</td><td>null</td><td>BROOKLYN</td><td>NY</td><td>11201</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Almirall LLC</td><td>100000011034</td><td>Almirall LLC</td><td>PA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Dermatology</td><td>Seysara</td><td>16110-247-30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4350.0</td><td>2021-11-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES)</td><td>No</td><td>819668565</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500129</td><td>11189</td><td>Tacoma General Allenmore Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>315 MARTIN LUTHER KING JR WAY</td><td>null</td><td>TACOMA</td><td>WA</td><td>98405</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1364649</td><td>1790014595</td><td>ANURADHA</td><td>A.</td><td>BELUR</td><td>null</td><td>121 N DIVISION ST</td><td>null</td><td>AUBURN</td><td>WA</td><td>98001</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>13.42</td><td>2021-04-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)</td><td>No</td><td>831066531</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>122454</td><td>1710904172</td><td>DARREN</td><td>D.</td><td>BRENNAN</td><td>null</td><td>157 Union St</td><td>null</td><td>Marlborough</td><td>MA</td><td>01752</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Bristol Myers Squibb Company</td><td>100000005499</td><td>E.R. Squibb & Sons, L.L.C.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Oncology</td><td>OPDIVO</td><td>0003-3774-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5940.0</td><td>2021-03-11</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Phase III Nivo Ipi vs Placebo in Adjuvant RCC</td><td>No</td><td>819889861</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1167345</td><td>1245294206</td><td>CRISTINE</td><td>null</td><td>RADOJICIC</td><td>null</td><td>1821 HILLANDALE RD</td><td>null</td><td>DURHAM</td><td>NC</td><td>27705</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Allergy & Immunology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000005656</td><td>F. Hoffmann-La Roche AG</td><td>null</td><td>Switzerland</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>Xolair</td><td>50242-040-62</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1331.11</td><td>2021-05-18</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>RETROSPECTIVE COHORT STUDY OF PREGNANT WOMEN WITH MODERATE TO SEVERE ASTHMA IN THE QUEBEC DATABASE AN EXTERNAL ASTHMA COMPARATOR COHORT FOR THE XOLAIR PREGNANCY REGISTRY EXPECT</td><td>No</td><td>835898843</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>54144</td><td>11286</td><td>LANGLEY PORTER PSYCHIATRIC HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>401 Parnassus Ave</td><td>null</td><td>San Francisco</td><td>CA</td><td>94143</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1245547</td><td>1003028580</td><td>ALEJANDRA</td><td>null</td><td>DE ALBA CAMPOMANES</td><td>null</td><td>400 PARNASSUS AVE</td><td>null</td><td>SAN FRANCISCO</td><td>CA</td><td>94143-2202</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Ophthalmology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>OPHTHALMOLOGY</td><td>EYLEA</td><td>61755-005-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4923.5</td><td>2021-02-25</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>RANDOMIZED, CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF INTRAVITREAL AFLIBERCEPT COMPARED TO LASER PHOTOCOAGULATION IN PATIENTS WITH RETINOPATHY OF PREMATURITY</td><td>No</td><td>793087613</td><td>2021</td><td>06/30/2022</td><td>NCT04101721</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>54144</td><td>11286</td><td>Langley Porter Psychiatric Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>401 Parnassus Ave</td><td>null</td><td>San Francisco</td><td>CA</td><td>94143</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>183398</td><td>1033176581</td><td>Hope</td><td>S</td><td>Rugo</td><td>null</td><td>1825 4th St Fl 3</td><td>null</td><td>San Francisco</td><td>CA</td><td>94143</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Daiichi Sankyo Inc.</td><td>100000000195</td><td>Daiichi Sankyo Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>Enhertu</td><td>65597-406-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>65.0</td><td>2021-07-27</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>DS8201-A-U303</td><td>No</td><td>835064219</td><td>2021</td><td>06/30/2022</td><td>NCT03734029</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50146</td><td>11296</td><td>CITY OF HOPE NATIONAL MEDICAL CTR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 E Duarte Rd</td><td>null</td><td>Duarte</td><td>CA</td><td>91010</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>259259</td><td>1700938180</td><td>SUMANTA</td><td>K</td><td>PAL</td><td>null</td><td>1500 DUARTE RD</td><td>null</td><td>DUARTE</td><td>CA</td><td>91010</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>54507.95</td><td>2021-04-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY TO EVALUATE SAFETY TOLERABILITY PHARMACOKINETIC PHARMACODYNAMIC AND ANTITUMOR ACTIVITY OF PF07209960 IN PARTICIPANTS WITH ADVANCED OR METASTATIC SOLID TUMORS</td><td>No</td><td>832770463</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>363302</td><td>10388</td><td>Rainbow Babies & Childrens Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5805 Euclid Ave Ste 100</td><td>null</td><td>Cleveland</td><td>OH</td><td>44103</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>7218624</td><td>1700229812</td><td>LEILA</td><td>null</td><td>HOJAT</td><td>null</td><td>11100 EUCLID AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44106</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CO</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Gilead Sciences, Inc.</td><td>100000000108</td><td>Gilead Sciences, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>COVID-19</td><td>Veklury</td><td>61958-2901-2</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500.0</td><td>2021-03-17</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>The Simple Study in Coronavirus, Severe Subjects</td><td>No</td><td>803514569</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>;GS-US-540-5773;G2757100;IPP;341567805;11860198</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450076</td><td>11031</td><td>UT MD ANDERSON CANCER CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 Holcombe Blvd</td><td>null</td><td>Houston</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>58837</td><td>1316000771</td><td>COURTNEY</td><td>D</td><td>DINARDO</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>null</td><td>HOUSTON</td><td>TX</td><td>77030-4009</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ABBVIE INC.</td><td>100000000204</td><td>ABBVIE INC.</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>VENCLEXTA</td><td>0074-0576-22</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>34419.2</td><td>2021-10-21</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Phase Ib/II Investigator Sponsored Study of the IDH1-mutant inhibitor AG120 with the BCL2 inhibitor Venetoclax in IDH1-mutated hematologic malignancies</td><td>No</td><td>792396675</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>A16-338</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230053</td><td>10500</td><td>Henry Ford Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2799 W GRAND BLVD</td><td>null</td><td>DETROIT</td><td>MI</td><td>48202</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>76692</td><td>1689864779</td><td>JIAN</td><td>null</td><td>LI</td><td>null</td><td>2799 W GRAND BLVD</td><td>null</td><td>DETROIT</td><td>MI</td><td>48202-2608</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AKEBIA THERAPEUTICS INC</td><td>100000521827</td><td>AKEBIA THERAPEUTICS INC</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>34.0</td><td>2021-04-06</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>AKB-6548-CI-0015</td><td>No</td><td>855448081</td><td>2021</td><td>06/30/2022</td><td>NCT02680574</td><td>https://clinicaltrials.gov/ct2/show/NCT02680574</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>270051</td><td>10252</td><td>Kalispell Regional Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>75 CLAREMONT ST</td><td>SUITE E</td><td>KALISPELL</td><td>MT</td><td>59901</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>54041</td><td>1184823643</td><td>JONATHAN</td><td>M.</td><td>BRUNSON</td><td>null</td><td>310 SUNNYVIEW LN</td><td>null</td><td>KALISPELL</td><td>MT</td><td>59901</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Rivacor</td><td>null</td><td>04035479156794</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Plexa</td><td>null</td><td>04035479140014</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Sentus</td><td>null</td><td>04035479148942</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Acticor</td><td>null</td><td>4035479156701</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Solia</td><td>null</td><td>4035479118266</td><td>21.13</td><td>2021-03-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIO-LIBRA</td><td>No</td><td>843806151</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>10033</td><td>10929</td><td>University Of Alabama Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>619 19th St S</td><td>null</td><td>Birmingham</td><td>AL</td><td>35233</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>775991</td><td>1497775241</td><td>ALAN</td><td>T</td><td>TITA</td><td>null</td><td>1700 6TH AVE S STE 10270</td><td>null</td><td>BIRMINGHAM</td><td>AL</td><td>35233</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Obstetrics & Gynecology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>7228.45</td><td>2021-04-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY</td><td>No</td><td>832771699</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50599</td><td>11287</td><td>Uc Davis Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2315 Stockton Blvd</td><td>null</td><td>Sacramento</td><td>CA</td><td>95817</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>2145394</td><td>1376832550</td><td>SARAH</td><td>null</td><td>WALDMAN</td><td>null</td><td>4150 V ST STE 1110</td><td>null</td><td>SACRAMENTO</td><td>CA</td><td>95817</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Gilead Sciences, Inc.</td><td>100000000108</td><td>Gilead Sciences, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>HIV</td><td>Biktarvy</td><td>61958-2501-1</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>945.0</td><td>2021-01-20</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9883/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in HIV-1 Infected, Antiretroviral Treatment-Naive Adults</td><td>No</td><td>803514825</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>;GS-US-380-1489;G2755216;GILDA;946036494;11477909</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50599</td><td>11287</td><td>Uc Davis Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2315 STOCKTON BLVD</td><td>null</td><td>SACRAMENTO</td><td>CA</td><td>95817</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>27304</td><td>1598747800</td><td>UMA</td><td>N.</td><td>SRIVATSA</td><td>null</td><td>4860 Y ST</td><td>null</td><td>SACRAMENTO</td><td>CA</td><td>95817</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Solia</td><td>null</td><td>04035479118266</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Rivacor</td><td>null</td><td>04035479156794</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Acticor</td><td>null</td><td>04035479156701</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Sentus</td><td>null</td><td>4035479148942</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Plexa</td><td>null</td><td>4035479140014</td><td>243.26</td><td>2021-05-12</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIO-LIBRA</td><td>No</td><td>843824113</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>73300</td><td>10017</td><td>Connecticut Childrens Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>282 Washington St</td><td>null</td><td>Hartford</td><td>CT</td><td>06106</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>14760</td><td>1316108913</td><td>HEATHER</td><td>O</td><td>TORY</td><td>null</td><td>282 WASHINGTON ST</td><td>null</td><td>HARTFORD</td><td>CT</td><td>06106</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Rheumatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT</td><td>XELJANZ</td><td>0069-1001-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1252.48</td><td>2021-06-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A LONGTERM OPENLABEL FOLLOWUP STUDY OF TOFACITINIB FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS JIA</td><td>No</td><td>832510163</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>490009</td><td>10745</td><td>University Of Virginia Medical Cente</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1215 Lee St Pfs</td><td>null</td><td>Charlottesville</td><td>VA</td><td>22908</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>631489</td><td>1427218205</td><td>CRAIG</td><td>A</td><td>PORTELL</td><td>null</td><td>PO Box 9007</td><td>null</td><td>Charlottesville</td><td>VA</td><td>22906</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>VA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BeiGene, Ltd.</td><td>100000826833</td><td>BeiGene, Ltd.</td><td>null</td><td>Cayman Islands</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>BRUKINSA</td><td>72579-011-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>48405.53</td><td>2021-05-24</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>An International, Phase 3, Open-Label, Randomized Study of BGB-3111 Compared With Bendamustine Plus Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL)</td><td>No</td><td>843875209</td><td>2021</td><td>06/30/2022</td><td>NCT03336333</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>110010</td><td>10785</td><td>Emory University Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1364 Clifton Road</td><td>null</td><td>Atlanta</td><td>GA</td><td>30302</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>717921</td><td>1447432471</td><td>VALERIA</td><td>null</td><td>MONCAYO</td><td>null</td><td>1364 CLIFTON RD NE</td><td>null</td><td>ATLANTA</td><td>GA</td><td>30322-1059</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Nuclear Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GE HEALTHCARE</td><td>100000005511</td><td>GE Healthcare</td><td>WI</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1670.0</td><td>2021-10-21</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3 Open label Multicenter Study of Flurpiridaz (18F) Injection for Positive Emission Tomography (PET) Imaging for Assessment of Myocardial perfusion in patients referred for Invasive coronary angiography because of suspected coronary artery disease</td><td>No</td><td>839212039</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>320386</td><td>1073570586</td><td>ANGELA</td><td>E</td><td>SCHEUERLE</td><td>null</td><td>PO BOX 845347</td><td>MC 9036</td><td>DALLAS</td><td>TX</td><td>75284-5347</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Mylan Specialty L.P.</td><td>100000005574</td><td>Mylan Technologies Inc.</td><td>VT</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>16.67</td><td>2021-12-01</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Antiretroviral Pregnancy Registry (APR)</td><td>No</td><td>851443589</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>310002</td><td>10198</td><td>Newark Beth Israel Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>201 Lyons Ave</td><td>null</td><td>Newark</td><td>NJ</td><td>07112</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>16411</td><td>1376510578</td><td>MARC</td><td>null</td><td>COHEN</td><td>null</td><td>201 LYONS AVE</td><td>null</td><td>NEWARK</td><td>NJ</td><td>07112-2027</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NJ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Abbott Laboratories</td><td>100000010680</td><td>Abbott Laboratories</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Structural Heart</td><td>MitraClip System</td><td>null</td><td>08717648231025</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1330.0</td><td>2021-07-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>AMPLATZER PFO Occluder Post Approval Study</td><td>No</td><td>827562793</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>310001</td><td>10178</td><td>Hackensack University Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>30 Prospect Ave</td><td>null</td><td>Hackensack</td><td>NJ</td><td>07601</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>171721</td><td>1790773356</td><td>DAVID</td><td>H</td><td>VESOLE</td><td>null</td><td>92 2ND ST STE 340</td><td>null</td><td>HACKENSACK</td><td>NJ</td><td>07601</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NJ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>21200.0</td><td>2021-05-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>MAGNETISMM3 AN OPENLABEL MULTICENTER NONRANDOMIZED PHASE 2 STUDY OF ELRANATAMAB PF06863135 MONOTHERAPY IN PARTICIPANTS WITH MULTIPLE MYELOMA WHO ARE REFRACTORY TO AT LEAST ONE PROTEASOME INHIBITOR ONE IMMUNOMODULATORY DRUG AND ONE ANTICD38 ANTIBODY</td><td>No</td><td>832511549</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>195456</td><td>1295829927</td><td>WILLIAM</td><td>null</td><td>RAND</td><td>null</td><td>RAND EYE INSTITUTE</td><td>5 WEST SAMPLE ROAD</td><td>POMPANO BEACH</td><td>FL</td><td>33064-3542</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Ophthalmology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alcon Research LLC</td><td>100000000218</td><td>Alcon Research LLC</td><td>TX</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Ophthalmology</td><td>Acrysof IQ ReSTOR IOL</td><td>null</td><td>00380652268752</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>362.5</td><td>2021-09-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Approval Study of the AcrySof IQ ReSTOR Toric IOL</td><td>No</td><td>807663489</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>310015</td><td>10713</td><td>MORRISTOWN MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>100 MADISON AVE</td><td>null</td><td>MORRISTOWN</td><td>NJ</td><td>07960</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>444356</td><td>1831349745</td><td>ANGELA</td><td>TATIANA</td><td>ALISTAR</td><td>null</td><td>300 S HAWTHORNE RD</td><td>null</td><td>WINSTON SALEM</td><td>NC</td><td>27103</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>NJ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000010364</td><td>Roche Products Limited</td><td>null</td><td>Great Britain (Uk)</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>6981.0</td><td>2021-08-16</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>MORPHEUS PANCREATIC</td><td>No</td><td>835920511</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>892108</td><td>1588788921</td><td>MADHAV</td><td>null</td><td>DHODAPKAR</td><td>null</td><td>1365 CLIFTON RD NE</td><td>null</td><td>ATLANTA</td><td>GA</td><td>30322-1013</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>236.23</td><td>2021-04-22</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PHASE 1/2 FIH STUDY OF REGN5458 (ANTI-BCMA X ANTI-CD3 BISPECIFIC ANTIBODY) IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA</td><td>No</td><td>793082117</td><td>2021</td><td>06/30/2022</td><td>NCT03761108</td><td>null</td><td>The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220162</td><td>9984</td><td>Dana-Farber Cancer Institute</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>450 Brookline Ave</td><td>null</td><td>Boston</td><td>MA</td><td>02215</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>88160</td><td>1942259098</td><td>ROBERT</td><td>I</td><td>HADDAD</td><td>null</td><td>44 BINNEY ST</td><td>44 BINNEY ST</td><td>BOSTON</td><td>MA</td><td>02115</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Merck Sharp & Dohme Corporation</td><td>100000000053</td><td>Merck Sharp & Dohme Corporation</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ONCOLOGY</td><td>KEYTRUDA</td><td>0006-3029-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12755.03</td><td>2021-12-31</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase III, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma LA HNSCC</td><td>No</td><td>848748197</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360180</td><td>10373</td><td>Cleveland Clinic Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9500 Euclid Avenue</td><td>null</td><td>Cleveland</td><td>OH</td><td>44195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>151679</td><td>1356438014</td><td>SAMIR</td><td>RAMESH</td><td>KAPADIA</td><td>null</td><td>9500 EUCLID AVE</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44195-0001</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Siemens Medical Solutions USA, Inc.</td><td>100000010755</td><td>Siemens Medical Solutions USA, Inc.</td><td>PA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>AT - Fixed interventional x-ray/angiography fluoroscopy</td><td>Artis zee multi-purpose</td><td>null</td><td>04056869010076</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3464.0</td><td>2021-12-31</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Cardiac Clinical AT Fusion</td><td>No</td><td>768161692</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>393303</td><td>10215</td><td>The Childrens Hospital Of Philadelp</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>34TH & CIVIC CENTER BLVD</td><td>PARC BUSINESS SERVICES</td><td>PHILADELPHIA</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Bristol Myers Squibb Company</td><td>100000005499</td><td>E.R. Squibb & Sons, L.L.C.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Oncology</td><td>OPDIVO</td><td>0003-3774-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>245110.41</td><td>2021-01-28</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Phase IIA Nivo in HL Pediatric nivo bv</td><td>No</td><td>819883799</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500027</td><td>11177</td><td>SWEDISH MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>747 BROADWAY</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98122</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>430197</td><td>1346484821</td><td>KRISH</td><td>null</td><td>PATEL</td><td>null</td><td>1221 MADISON ST</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98104</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000010364</td><td>Roche Products Limited</td><td>null</td><td>Great Britain (Uk)</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>Actemra</td><td>50242-137-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>567.0</td><td>2021-01-21</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>COVACTA ACTEMRA COVID 19 PNEUMONIA STUDY</td><td>No</td><td>835927085</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>330285</td><td>10135</td><td>Strong Memorial Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>601 ELMWOOD AVE</td><td>BOX 684</td><td>ROCHESTER</td><td>NY</td><td>14642</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>105456</td><td>1336177310</td><td>PETER</td><td>A.</td><td>KNIGHT</td><td>null</td><td>601 Elmwood Ave</td><td>null</td><td>ROCHESTER</td><td>NY</td><td>14642</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery)</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Medtronic, Inc.</td><td>100000000106</td><td>Medtronic, Inc.</td><td>MN</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Transcatheter Valve Systems</td><td>CoreValve Evolut</td><td>null</td><td>00643169565623</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>450.0</td><td>2021-04-20</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>TAVR Low Risk</td><td>No</td><td>800994735</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500008</td><td>11198</td><td>University Of Washington Med Ctr</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1959 Ne Pacific St</td><td>null</td><td>Seattle</td><td>WA</td><td>98195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>184535</td><td>1063745727</td><td>LAURA</td><td>QUAN MAN</td><td>CHOW</td><td>null</td><td>1601 TRINITY ST STOP Z1100</td><td>null</td><td>AUSTIN</td><td>TX</td><td>78712</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AstraZeneca Pharmaceuticals LP</td><td>100000000146</td><td>AstraZeneca Pharmaceuticals LP</td><td>DE</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>IRESSA</td><td>0310-0482-30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>861.02</td><td>2021-12-31</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>IRESSA PD L1 combination Phase 1 study</td><td>No</td><td>826487463</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>428904</td><td>1285614461</td><td>LINDA</td><td>null</td><td>DANIEU</td><td>null</td><td>40 W Park Pl Apt 509</td><td>null</td><td>Morristown</td><td>NJ</td><td>07960</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NJ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Bristol Myers Squibb Company</td><td>100000005499</td><td>E.R. Squibb & Sons, L.L.C.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Oncology</td><td>OPDIVO</td><td>0003-3774-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>135.0</td><td>2021-05-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Phase III Peri-Adjuvant NSCLC Nivo Mono</td><td>No</td><td>819890301</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>151158</td><td>1336221241</td><td>FERNANDO</td><td>J</td><td>MARTINEZ</td><td>null</td><td>525 E 68TH ST</td><td>null</td><td>NEW YORK</td><td>NY</td><td>10065</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Critical Care Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000005656</td><td>F. Hoffmann-La Roche AG</td><td>null</td><td>Switzerland</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>388.33</td><td>2021-10-18</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS IPF</td><td>No</td><td>835899687</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>30103</td><td>11162</td><td>MAYO CLINIC HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5777 E Mayo Blvd</td><td>null</td><td>Phoenix</td><td>AZ</td><td>85054</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1291170</td><td>1376832196</td><td>AARON</td><td>R</td><td>MANGOLD</td><td>null</td><td>13400 E SHEA BLVD</td><td>null</td><td>SCOTTSDALE</td><td>AZ</td><td>85259-5452</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>INFLAMMATION AND  IMMUNOLOGY</td><td>DUPIXENT</td><td>0024-5914-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4000.0</td><td>2021-06-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT PATIENTS WITH BULLOUS PEMPHIGOID</td><td>No</td><td>793087871</td><td>2021</td><td>06/30/2022</td><td>NCT04206553</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220046</td><td>9994</td><td>BERKSHIRE MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>725 North St</td><td>null</td><td>Pittsfield</td><td>MA</td><td>01201</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1217019</td><td>1982821906</td><td>TREVOR</td><td>J</td><td>BAYLISS</td><td>null</td><td>165 TOR CT</td><td>null</td><td>PITTSFIELD</td><td>MA</td><td>01201-3001</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pharmacyclics LLC, an AbbVie Company</td><td>100000136439</td><td>Pharmacyclics LLC, An AbbVie Company</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>IMBRUVICA</td><td>57962-420-28</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>150.0</td><td>2021-02-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>informCLL: A Disease Registry for Patients With Chronic Lymphocytic Leukemia (informCLL)</td><td>No</td><td>786496423</td><td>2021</td><td>06/30/2022</td><td>NCT02582879</td><td>null</td><td>PCYC-1134M-CA</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>779536</td><td>1619110038</td><td>VIVIANNE</td><td>C.</td><td>BEYER</td><td>null</td><td>1025 S 6th St</td><td>null</td><td>Springfield</td><td>IL</td><td>62703</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Bristol Myers Squibb Company</td><td>100000005499</td><td>E.R. Squibb & Sons, L.L.C.</td><td>NJ</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2606.33</td><td>2021-04-13</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Multi-Center, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase 3 Study to Evaluate the Clinical Efficacy and Safety of BMS-986165 in Subjects with Moderate to Severe Psoriasis</td><td>No</td><td>819890701</td><td>2021</td><td>06/30/2022</td><td>NCT03624127</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4227411</td><td>1255719597</td><td>IVAN</td><td>null</td><td>LEE</td><td>null</td><td>65 HARRISON AVE</td><td>308</td><td>BOSTON</td><td>MA</td><td>02111</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Allergy & Immunology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000005656</td><td>F. Hoffmann-La Roche AG</td><td>null</td><td>Switzerland</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>Actemra</td><td>50242-137-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>474.32</td><td>2021-06-14</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA</td><td>No</td><td>835900499</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>130006</td><td>11100</td><td>St. Lukes Regional Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>190 E BANNOCK ST</td><td>null</td><td>BOISE</td><td>ID</td><td>83712</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>836390</td><td>1629248661</td><td>CONG ZHI</td><td>null</td><td>ZHAO</td><td>null</td><td>520 S EAGLE RD</td><td>null</td><td>MERIDIAN</td><td>ID</td><td>83642</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BOSTON SCIENTIFIC CORPORATION</td><td>100000005674</td><td>Boston Scientific Corporation</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>DBS</td><td>Vercise</td><td>null</td><td>8.71473E+12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>371.52</td><td>2021-06-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>REGISTRY OF DEEP BRAIN STIMULATION WITH THE VERCISE SYSTEM:</td><td>No</td><td>800042915</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>490063</td><td>10733</td><td>Inova Fairfax Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3300 Gallows Rd</td><td>null</td><td>Falls Church</td><td>VA</td><td>22042</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>303786</td><td>1689895153</td><td>HENRY</td><td>AN</td><td>TRAN</td><td>null</td><td>3580 JOSEPH SIEWICK DR</td><td>STE 401</td><td>FAIRFAX</td><td>VA</td><td>22033</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>VA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Non-Covered</td><td>Drug</td><td>Diabetes</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>16.25</td><td>2021-05-28</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9536-4388</td><td>No</td><td>811780173</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>270051</td><td>10252</td><td>Kalispell Regional Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>75 CLAREMONT ST</td><td>SUITE E</td><td>KALISPELL</td><td>MT</td><td>59901</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>54041</td><td>1184823643</td><td>JONATHAN</td><td>M.</td><td>BRUNSON</td><td>null</td><td>310 SUNNYVIEW LN</td><td>null</td><td>KALISPELL</td><td>MT</td><td>59901</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Acticor</td><td>null</td><td>04035479156701</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Plexa</td><td>null</td><td>04035479140014</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Rivacor</td><td>null</td><td>04035479156794</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Solia</td><td>null</td><td>4035479118266</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Sentus</td><td>null</td><td>4035479148942</td><td>21.13</td><td>2021-09-14</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIO-LIBRA</td><td>No</td><td>843806413</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>291335</td><td>1427255876</td><td>JONATHAN</td><td>MATTHEW</td><td>VIGDORCHIK</td><td>null</td><td>535 E 70TH ST</td><td>null</td><td>NEW YORK</td><td>NY</td><td>10021</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Orthopaedic Surgery|Adult Reconstructive Orthopaedic Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OMNIlife science, Inc</td><td>100000010553</td><td>OMNIlife science, Inc</td><td>MA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>20000.0</td><td>2021-10-20</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>COC</td><td>No</td><td>855325381</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100039</td><td>10842</td><td>Broward Health Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>201 E SAMPLE RD</td><td>null</td><td>POMPANO BEACH</td><td>FL</td><td>33064</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>185658</td><td>1104815943</td><td>AHMED</td><td>null</td><td>OSMAN</td><td>null</td><td>1841 NE 45TH ST</td><td>null</td><td>FORT LAUDERDALE</td><td>FL</td><td>33308</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BOSTON SCIENTIFIC CORPORATION</td><td>100000005674</td><td>Boston Scientific Corporation</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Device</td><td>Therapies</td><td>General Therapies</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>600.0</td><td>2021-03-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>INTERRUPT AF</td><td>No</td><td>800043719</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360180</td><td>10373</td><td>CLEVELAND CLINIC HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9500 Euclid Ave</td><td>null</td><td>Cleveland</td><td>OH</td><td>44195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>752399</td><td>1669482790</td><td>YUEBING</td><td>null</td><td>LI</td><td>null</td><td>9500 EUCLID AVE  DESKS90</td><td>null</td><td>CLEVELAND</td><td>OH</td><td>44195-1754</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>100000000337</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>IMMUNOLOGY</td><td>HYQVIA</td><td>0944-2510-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>451.6</td><td>2021-12-16</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>THIS IS A PHASE III, PROSPECTIVE, MULTICENTER STUDY WITH TWO STUDY PARTS (EPOCHS) TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF HYQVIA/HYQVIA (IGI, 10% WITH RECOMBINANT HUMAN HYALURONIDASE (RHUPH20) ADMINISTERED SUBCUTANEOUSLY) FOR MAINTENANCE THERAPY TO PREVENT RELAPSE (EPOCH 1) AND GAMMAGARD LIQUID/KIOVIG (IMMUNOGLOBULIN G INTRAVENOUS (IGIV) 10% ADMINISTERED INTRAVENOUSLY) FOR THE TREATMENT OF CIDP (EPOCH 2)</td><td>No</td><td>816653657</td><td>2021</td><td>06/30/2022</td><td>NCT02549170</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450076</td><td>11031</td><td>UT MD ANDERSON CANCER CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 Holcombe Blvd</td><td>null</td><td>Houston</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>2776390</td><td>1942743216</td><td>TIMOTHY</td><td>A</td><td>YAP</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>455</td><td>HOUSTON</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5201.27</td><td>2021-11-05</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY EVALUATING SAFETY TOLERABILITY AND PHARMACOKINETICS OF PF 06952229 IN ADULT PATIENTS WITH ADVANCED SOLID TUMORS</td><td>No</td><td>832774167</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>410007</td><td>10008</td><td>Rhode Island Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>593 Eddy Street</td><td>null</td><td>Providence</td><td>RI</td><td>02901</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>72892</td><td>1629041074</td><td>ELEFTHERI</td><td>E</td><td>MYLONAKIS</td><td>null</td><td>593 EDDY ST</td><td>null</td><td>PROVIDENCE</td><td>RI</td><td>02903</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>RI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12500.0</td><td>2021-09-03</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS</td><td>No</td><td>832512911</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>460009</td><td>11165</td><td>U OF U HOSPITALS & CLINICS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>50 N Medical Dr</td><td>null</td><td>Salt Lake City</td><td>UT</td><td>84132</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>454156</td><td>1184899460</td><td>KEVIN</td><td>MICHAEL</td><td>WATT</td><td>null</td><td>295 S CHIPETA WAY</td><td>null</td><td>SALT LAKE CITY</td><td>UT</td><td>84108</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Critical Care Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>UT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>16320.0</td><td>2021-05-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1 OPENLABEL SINGLEDOSE STUDY TO ASSESS THE PHARMACOKINETICS SAFETY AND TOLERABILITY OF CEFTAZIDIMEAVIBACTAM CAZAVI IN CHILDREN FROM 3 MONTHS TO LESS THAN 18 YEARS OF AGE WHO ARE HOSPITALIZED AND RECEIVING SYSTEMIC ANTIBIOTIC THERAPY FOR SUSPECTED OR CONFIRMED NOSOCOMIAL PNEUMONIA INCLUDING VENTILATORASSOCIATED PNEUMONIA</td><td>No</td><td>832837289</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100007</td><td>10819</td><td>Adventhealth Orlando</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>601 E Rollins St</td><td>null</td><td>Orlando</td><td>FL</td><td>32803</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1266401</td><td>1740341726</td><td>Mark</td><td>A</td><td>Socinski</td><td>null</td><td>2501 N Orange Ave Ste 689</td><td>null</td><td>Orlando</td><td>FL</td><td>32804</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Daiichi Sankyo Inc.</td><td>100000000195</td><td>Daiichi Sankyo Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>20550.0</td><td>2021-04-28</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>U3-1402-A-U201</td><td>No</td><td>835061157</td><td>2021</td><td>06/30/2022</td><td>NCT03260491</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1003306</td><td>1467789107</td><td>PATRICIA</td><td>C.</td><td>DUGAN</td><td>null</td><td>223 E 34TH ST</td><td>null</td><td>NEW YORK</td><td>NY</td><td>10016-4852</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Clinical Neurophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NEUROPACE, INC.</td><td>100000010697</td><td>NEUROPACE, INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Epilepsy</td><td>RNS System</td><td>null</td><td>00855547005267</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>50.0</td><td>2021-07-04</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Approval Study</td><td>No</td><td>851398667</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1295309</td><td>1942245147</td><td>DIONISIO</td><td>B</td><td>YORRO</td><td>JR.</td><td>68 AMBROGIO DR</td><td>SUITE 104</td><td>GURNEE</td><td>IL</td><td>60031-3339</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Emergency Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ABBVIE INC.</td><td>100000000204</td><td>ABBVIE INC.</td><td>IL</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4624.0</td><td>2021-08-12</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Assessment of Multiple-Dose Pharmacokinetics and Safety of the Co-administration of Galicaftor, Navocaftor and ABBV-119 and Potential of Navocaftor and ABBV-119 on CYP3A Induction in Healthy Volunteers</td><td>No</td><td>792406179</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>M20-065</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450076</td><td>11031</td><td>Ut Md Anderson Cancer Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 Holcombe Blvd</td><td>null</td><td>Houston</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>727133</td><td>1760701445</td><td>AMISHI</td><td>Y</td><td>SHAH</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>null</td><td>HOUSTON</td><td>TX</td><td>77030-4009</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eisai Inc.</td><td>100000000136</td><td>Eisai Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>Lenvima</td><td>62856-710-30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2773.0</td><td>2021-06-11</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors</td><td>No</td><td>836179693</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>410007</td><td>10008</td><td>Rhode Island Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>593 Eddy Street</td><td>null</td><td>Providence</td><td>RI</td><td>02901</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>72892</td><td>1629041074</td><td>ELEFTHERI</td><td>E</td><td>MYLONAKIS</td><td>null</td><td>593 EDDY ST</td><td>null</td><td>PROVIDENCE</td><td>RI</td><td>02903</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>RI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>920.0</td><td>2021-09-20</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 23 RANDOMIZED DOUBLEBLIND DOUBLEDUMMY PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF 2 REGIMENS OF ORALLY ADMINISTERED PF 07321332RITONAVIR IN PREVENTING SYMPTOMATIC SARSCOV2 INFECTION IN ADULT HOUSEHOLD CONTACTS OF AN INDIVIDUAL WITH SYMPTOMATIC COVID19</td><td>No</td><td>832514377</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>767675</td><td>1194837476</td><td>RICHARD</td><td>null</td><td>PRATLEY</td><td>null</td><td>2415 N ORANGE AVE STE 502</td><td>null</td><td>ORLANDO</td><td>FL</td><td>32804</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>CARDIOVASCULAR</td><td>STEGLATRO</td><td>0006-5363-03</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>940.0</td><td>2021-11-15</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>ERTUGLIFLOZIN CLINICAL PUBLICATION PROGRAM</td><td>No</td><td>832529225</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>40468</td><td>1891834016</td><td>RHONDA</td><td>W</td><td>GENTRY</td><td>null</td><td>8901 CARTI WAY</td><td>null</td><td>LITTLE ROCK</td><td>AR</td><td>72205-6523</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AR</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ONCOLOGY</td><td>LIBTAYO</td><td>61755-008-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>37.46</td><td>2021-01-18</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>LIBTAYO CLINICAL PUBLICATION PROGRAM</td><td>No</td><td>793082387</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>440039</td><td>10425</td><td>Vanderbilt University Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1211 MEDICAL CENTER DRIVE</td><td>null</td><td>NASHVILLE</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>930543</td><td>1932153244</td><td>NANCY</td><td>B.</td><td>DAVIS</td><td>null</td><td>2220 PIERCE AVE</td><td>null</td><td>NASHVILLE</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2000.0</td><td>2021-02-19</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib Plus Pembrolizumab Versus Pemigatinib Alone Versus Standard of Care as First-Line Treatment for Metastatic or Unresectable Urothelial Carcinoma in Cisplatin-Ineligible Participants Whose Tumors Express FGFR3 Mutation or Rearrangement (FIGHT-205)</td><td>No</td><td>831052245</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>490007</td><td>10738</td><td>Sentara Norfolk General Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>600 Gresham Dr</td><td>null</td><td>Norfolk</td><td>VA</td><td>23507</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1382945</td><td>1184913501</td><td>ERICH</td><td>LEARNED</td><td>KIEHL</td><td>null</td><td>1031 LOFTIS BLVD STE 100</td><td>null</td><td>NEWPORT NEWS</td><td>VA</td><td>23606-2981</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>VA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Abbott Laboratories</td><td>100000010680</td><td>Abbott Laboratories</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Structural Heart</td><td>Amplatzer Amulet LAA Occluder</td><td>null</td><td>00811806013527</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>21414.0</td><td>2021-05-26</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>The Sync AV Post-Market Trail is a prospective, randomized, multi-center trail</td><td>No</td><td>827566385</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1136517</td><td>1154421485</td><td>JULIAN</td><td>null</td><td>MACKAY-WIGGAN</td><td>null</td><td>9897 HAGEN RANCH RD  9897</td><td>null</td><td>BOYNTON BEACH</td><td>FL</td><td>33437</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>940.0</td><td>2021-11-06</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>RITLECITINIB CLINICAL PUBLICATION PROGRAM</td><td>No</td><td>832530443</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>27882</td><td>1619192911</td><td>JUNE</td><td>null</td><td>HOU</td><td>null</td><td>1695 EASTCHESTER RD</td><td>601</td><td>BRONX</td><td>NY</td><td>10461-2374</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>390.58</td><td>2021-03-19</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1/2 STUDY OF REGN4018 (A MUC16XCD3 BISPECIFIC ANTIBODY) ADMINISTERED ALONE OR IN COMBINATION WITH CEMIPLIMAB IN PATIENTS WITH RECURRENT OVARIAN CANCER</td><td>No</td><td>793082643</td><td>2021</td><td>06/30/2022</td><td>NCT03564340</td><td>null</td><td>The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230053</td><td>10500</td><td>Henry Ford Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2799 W GRAND BLVD</td><td>null</td><td>DETROIT</td><td>MI</td><td>48202</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>353670</td><td>1780752220</td><td>MARCUS</td><td>J.</td><td>ZERVOS</td><td>null</td><td>3601 W 13 Mile Rd</td><td>null</td><td>Royal Oak</td><td>MI</td><td>48073</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Moderna TX, Inc.</td><td>100000961851</td><td>Moderna TX, Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Infections and Infectious Diseases</td><td>Moderna Covid-19 Vaccine</td><td>80777-273-99</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1530.02</td><td>2021-08-25</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older</td><td>No</td><td>806336137</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450076</td><td>11031</td><td>Ut Md Anderson Cancer Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>null</td><td>HOUSTON</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>892588</td><td>1598864100</td><td>SRDAN</td><td>null</td><td>VERSTOVSEK</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>UNIT 428</td><td>HOUSTON</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>77.6</td><td>2021-04-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 1/2 Open-Label, Multicenter Study of INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders</td><td>No</td><td>831065775</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>117176</td><td>1588641591</td><td>BRIAN</td><td>G</td><td>WEINSHENKER</td><td>null</td><td>200 1ST ST SW</td><td>null</td><td>ROCHESTER</td><td>MN</td><td>55905</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>MN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Genentech, Inc.</td><td>100000005656</td><td>F. Hoffmann-La Roche AG</td><td>null</td><td>Switzerland</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Immunology</td><td>Enspryng</td><td>50242-007-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>678.45</td><td>2021-06-30</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EFFICACY AND SAFETY STUDY AS ADD-ON THERAPY OF SATRALIZUMAB SA237 TO TREAT NMO AND NMOSD, A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SA237 AS MONOTHERAPY IN PATIENTS WITH NEUROMYELITIS OPTICA NMO AND NMO SPECTRUM DISORDER NMOSD</td><td>No</td><td>835898059</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>276270</td><td>1083614879</td><td>ILEANA</td><td>JOSEFINA</td><td>TANDRON</td><td>null</td><td>2240 GAUSE BLVD E</td><td>null</td><td>SLIDELL</td><td>LA</td><td>70461</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>LA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>45.0</td><td>2021-05-24</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9924-4473</td><td>No</td><td>811761965</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>10033</td><td>10929</td><td>University Of Alabama Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>619 19th St S</td><td>null</td><td>Birmingham</td><td>AL</td><td>35233</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>991339</td><td>1043572191</td><td>TIFFANY</td><td>T</td><td>MAYO</td><td>null</td><td>500 22ND STREET SOUTH</td><td>DEPARTMENT OF DERMATOLOGY SUITE 3400</td><td>BIRMINGHAM</td><td>AL</td><td>35223</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>30810.0</td><td>2021-08-05</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 2A MULTICENTER RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED 16WEEK STUDY EVALUATING THE SAFETY AND EFFICACY OF PF06650833 PF06700841 AND PF06826647 IN ADULTS WITH MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA</td><td>No</td><td>832875181</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230297</td><td>10146</td><td>KARMANOS CANCER HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4100 John R St</td><td>null</td><td>Detroit</td><td>MI</td><td>48201</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>157764</td><td>1467611475</td><td>STEVEN</td><td>D</td><td>DAVELUY</td><td>null</td><td>18100 OAKWOOD BLVD</td><td>SUITE 300</td><td>DEARBORN</td><td>MI</td><td>48124-4085</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Osteopathy</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ONCOLOGY</td><td>LIBTAYO</td><td>61755-008-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500.0</td><td>2021-04-01</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 2 STUDY OF REGN2810, A FULLY HUMAN MONOCLONAL ANTIBODY TO PROGRAMMED DEATH-1 (PD-1), IN PATIENTS WITH ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA</td><td>No</td><td>793087357</td><td>2021</td><td>06/30/2022</td><td>NCT02760498</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>195456</td><td>1295829927</td><td>WILLIAM</td><td>null</td><td>RAND</td><td>null</td><td>RAND EYE INSTITUTE</td><td>5 WEST SAMPLE ROAD</td><td>POMPANO BEACH</td><td>FL</td><td>33064-3542</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Ophthalmology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alcon Research LLC</td><td>100000000218</td><td>Alcon Research LLC</td><td>TX</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Ophthalmology</td><td>Acrysof IQ ReSTOR IOL</td><td>null</td><td>00380652268752</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>362.5</td><td>2021-06-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Approval Study of the AcrySof IQ ReSTOR Toric IOL</td><td>No</td><td>807651647</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>160083</td><td>10594</td><td>Mercy Medical Center-Des Moines</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PO BOX 9170</td><td>null</td><td>DES MOINES</td><td>IA</td><td>50306</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>129569</td><td>1861601841</td><td>DWAYNE</td><td>null</td><td>CAMPBELL</td><td>null</td><td>5880 UNIVERSITY AVE</td><td>null</td><td>WEST DES MOINES</td><td>IA</td><td>50266</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BOSTON SCIENTIFIC CORPORATION</td><td>100000005674</td><td>Boston Scientific Corporation</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Device</td><td>Clinical Trial Product</td><td>VARIOUS RELEASED ICD FAMILIES</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>915.75</td><td>2021-03-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>APPRAISE ATP</td><td>No</td><td>800044545</td><td>2021</td><td>06/30/2022</td><td>NCT02923726</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50599</td><td>11287</td><td>UC DAVIS MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2315 Stockton Blvd</td><td>null</td><td>Sacramento</td><td>CA</td><td>95817</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>740262</td><td>1235174822</td><td>HERMAN</td><td>L</td><td>HEDRIANA</td><td>null</td><td>4860 Y ST STE 2500</td><td>null</td><td>SACRAMENTO</td><td>CA</td><td>95817</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>26334.0</td><td>2021-09-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY</td><td>No</td><td>832775363</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>220162</td><td>9984</td><td>Dana-Farber Cancer Institute</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>450 Brookline Ave</td><td>null</td><td>Boston</td><td>MA</td><td>02215</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1037285</td><td>1669765988</td><td>HANNY</td><td>null</td><td>AL-SAMKARI</td><td>null</td><td>55 FRUIT ST</td><td>null</td><td>BOSTON</td><td>MA</td><td>02114-2696</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Agios Pharmaceuticals, Inc.</td><td>100000181751</td><td>Agios Pharmaceuticals, Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1950.0</td><td>2021-01-28</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>An Open-Label, Multicenter, Extension Study Of AG-348 In Adult Subjects With Pyruvate Kinase Deficiency Previously Enrolled In AG-348 Studies</td><td>No</td><td>849456765</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>303222</td><td>1679551444</td><td>BRADLEY</td><td>S</td><td>GIEDD</td><td>null</td><td>1928 HOWELL BRANCH RD</td><td>null</td><td>WINTER PARK</td><td>FL</td><td>32792-1013</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Optometry</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eye and Vision Services Providers|Optometrist</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alcon Research LLC</td><td>100000000218</td><td>Alcon Research LLC</td><td>TX</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Device</td><td>Ophthalmology</td><td>DAILIES Total1 for Astigmatism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>369.3</td><td>2021-06-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Dispensing Clinical Performance Evaluation of Silicone Hydrogel Soft Toric Contact Lenses</td><td>No</td><td>807651911</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>310015</td><td>10713</td><td>Morristown Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PO BOX 48328</td><td>null</td><td>NEWARK</td><td>NJ</td><td>07101</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>148398</td><td>1275527707</td><td>BARRY</td><td>null</td><td>COHEN</td><td>null</td><td>211 MOUNTAIN AVE</td><td>null</td><td>SPRINGFIELD</td><td>NJ</td><td>07081</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NJ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BOSTON SCIENTIFIC CORPORATION</td><td>100000005674</td><td>Boston Scientific Corporation</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Device</td><td>CLINICAL TRIAL PRODUCT</td><td>CLINICAL TRIAL PRODUCT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1000.0</td><td>2021-09-07</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>REPRISE III</td><td>No</td><td>800044923</td><td>2021</td><td>06/30/2022</td><td>NCT02202434</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>110010</td><td>10785</td><td>EMORY UNIVERSITY HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1821 Clifton Rd Ne</td><td>null</td><td>Atlanta</td><td>GA</td><td>30329</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1201336</td><td>1447437538</td><td>ANA</td><td>G</td><td>ANTUN</td><td>null</td><td>1670 CLAIRMONT RD</td><td>null</td><td>DECATUR</td><td>GA</td><td>30033-4004</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>100000000337</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>IL</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>707.81</td><td>2021-03-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3, RANDOMIZED, CONTROLLED STUDY OF PROPHYLACTIC AND ON-DEMAND TREATMENT OF CTTP WITH BAX 930 (RADAMTS13)</td><td>No</td><td>816654595</td><td>2021</td><td>06/30/2022</td><td>NCT03393975</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>380007</td><td>11204</td><td>Legacy Emanuel Hospital & Health Ctr</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1225 NE 2ND AVE</td><td>null</td><td>PORTLAND</td><td>OR</td><td>97232</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>6095.1</td><td>2021-06-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Yes</td><td>No</td><td>iLP - Leadless Pacer</td><td>No</td><td>843807189</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360137</td><td>10389</td><td>Uh Cleveland Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>11100 Euclid Avenue</td><td>null</td><td>Cleveland</td><td>OH</td><td>44106</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>461071</td><td>1437100302</td><td>Debora</td><td>Santos</td><td>Bruno</td><td>null</td><td>11100 Euclid Ave</td><td>null</td><td>Cleveland</td><td>OH</td><td>44106</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Daiichi Sankyo Inc.</td><td>100000000195</td><td>Daiichi Sankyo Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>23700.0</td><td>2021-04-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>DS1062-A-U301</td><td>No</td><td>835061257</td><td>2021</td><td>06/30/2022</td><td>NCT04656652</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Non-Physician Practitioner</td><td>null</td><td>null</td><td>null</td><td>null</td><td>10703716</td><td>1124012596</td><td>BRIAN</td><td>KIETH</td><td>BONOMO</td><td>null</td><td>525 N DACIE PT</td><td>null</td><td>LECANTO</td><td>FL</td><td>34461-8399</td><td>United States</td><td>null</td><td>null</td><td>Physician Assistant</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ABBVIE INC.</td><td>100000000204</td><td>ABBVIE INC.</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>IMMUNOLOGY</td><td>HUMIRA</td><td>0074-0554-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>430.0</td><td>2021-06-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA (Adalimumab) in Adult Patients with Chronic Plaque Psoriasis (PS)</td><td>No</td><td>792406399</td><td>2021</td><td>06/30/2022</td><td>NCT00799877</td><td>null</td><td>P10-023</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>330154</td><td>10065</td><td>Memorial Hospital For Cancer And All</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1275 York Avenue</td><td>null</td><td>New York</td><td>NY</td><td>10065</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>789835</td><td>1972769800</td><td>VICKY</td><td>null</td><td>MAKKER</td><td>null</td><td>1275 YORK AVENUE</td><td>null</td><td>NEW YORK</td><td>NY</td><td>10065</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eisai Inc.</td><td>100000000136</td><td>Eisai Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>Lenvima</td><td>62856-710-30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1267.65</td><td>2021-07-14</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors</td><td>No</td><td>836179801</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500044</td><td>11187</td><td>Deaconess Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>800 West Fifth Avenue</td><td>null</td><td>Spokane</td><td>WA</td><td>99210</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>622375</td><td>1104832351</td><td>STEVEN</td><td>A</td><td>PHILLIPS</td><td>null</td><td>315 MARTIN LUTHER KING JR WAY</td><td>null</td><td>TACOMA</td><td>WA</td><td>98405-4234</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eisai Inc.</td><td>100000000136</td><td>Eisai Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Neurology</td><td>Fycompa</td><td>62856-272-30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2783.0</td><td>2021-09-13</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase of Perampanel as Adjunctive Treatment in Subjects at Least 2 Years of Age With Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome</td><td>No</td><td>836179907</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450076</td><td>11031</td><td>UT MD ANDERSON CANCER CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1515 Holcombe Blvd</td><td>null</td><td>Houston</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>2776390</td><td>1942743216</td><td>TIMOTHY</td><td>A</td><td>YAP</td><td>null</td><td>1515 HOLCOMBE BLVD</td><td>455</td><td>HOUSTON</td><td>TX</td><td>77030</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>122746.51</td><td>2021-05-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 11B STUDY EVALUATING THE SAFETY TOLERABILITY PHARMACOKINETICS PHARMACODYNAMICS AND ANTITUMOR ACTIVITY OF PF07220060 AS A SINGLE AGENT AND AS PART OF COMBINATION THERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS</td><td>No</td><td>832840889</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>330154</td><td>10065</td><td>Memorial Hospital For Cancer And All</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1275 York Avenue</td><td>null</td><td>New York</td><td>NY</td><td>10065</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>789835</td><td>1972769800</td><td>VICKY</td><td>null</td><td>MAKKER</td><td>null</td><td>1275 YORK AVENUE</td><td>null</td><td>NEW YORK</td><td>NY</td><td>10065</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eisai Inc.</td><td>100000000136</td><td>Eisai Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Oncology</td><td>Lenvima</td><td>62856-710-30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1267.65</td><td>2021-09-30</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors</td><td>No</td><td>836180013</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360137</td><td>10389</td><td>Uh Cleveland Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>11100 Euclid Avenue</td><td>null</td><td>Cleveland</td><td>OH</td><td>44106</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>265659</td><td>1841266756</td><td>Norman</td><td>null</td><td>Kumins</td><td>null</td><td>3999 RICHMOND RD</td><td>null</td><td>BEACHWOOD</td><td>OH</td><td>44122</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Bolton Medical Inc</td><td>100000005629</td><td>Bolton Medical Inc</td><td>FL</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Device</td><td>Device</td><td>RelayPro?A</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1506.0</td><td>2021-10-14</td><td>Cash or cash equivalent</td><td>Medical Research Writing or Publication</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>RelayPro?A</td><td>No</td><td>850457909</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1458973</td><td>1306139597</td><td>TIFFANY</td><td>L.</td><td>FISHER</td><td>null</td><td>30 HOPE DR # EC037</td><td>null</td><td>HERSHEY</td><td>PA</td><td>17033-2036</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NEUROPACE, INC.</td><td>100000010697</td><td>NEUROPACE, INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Epilepsy</td><td>RNS System</td><td>null</td><td>00855547005267</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>150.0</td><td>2021-03-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Approval Study</td><td>No</td><td>851400285</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>440039</td><td>10425</td><td>Vanderbilt University Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1211 MEDICAL CENTER DRIVE</td><td>null</td><td>NASHVILLE</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>853101</td><td>1215193255</td><td>SANJAY</td><td>R.</td><td>MOHAN</td><td>null</td><td>1301 MEDICAL CENTER DR</td><td>STE 3927</td><td>NASHVILLE</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2.84</td><td>2021-08-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A 2-Part, Phase 2, Open-Label Study of the Safety, Tolerability, and Efficacy of Itacitinib Immediate Release in Participants With Primary Myelofibrosis or Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis or Post-Essential Thrombocythemia Myelofibrosis) Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy</td><td>No</td><td>831053007</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>380061</td><td>11205</td><td>Providence Portland Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2705 E BURNSIDE ST</td><td>SUITE 114</td><td>PORTLAND</td><td>OR</td><td>97214</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>258695</td><td>1700960671</td><td>GINA</td><td>M.</td><td>VACCARO</td><td>null</td><td>9135 SW Barnes Rd Ste 261</td><td>null</td><td>Portland</td><td>OR</td><td>97225</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Bristol Myers Squibb Company</td><td>100000005499</td><td>E.R. Squibb & Sons, L.L.C.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>Oncology</td><td>OPDIVO</td><td>0003-3774-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4800.0</td><td>2021-02-23</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Phase III Adjuvant HCC mono vs placebo</td><td>No</td><td>819884395</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1139881</td><td>1255594206</td><td>NOMEN</td><td>null</td><td>AZEEM</td><td>null</td><td>9360 BALM RIVERVIEW RD</td><td>null</td><td>RIVERVIEW</td><td>FL</td><td>33569-5104</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pain Medicine|Interventional Pain Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PAINTEQ LLC</td><td>100000966847</td><td>PAINTEQ LLC</td><td>FL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>PAIN MANAGEMENT</td><td>PAINTEQ</td><td>null</td><td>00190776149833</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1140.0</td><td>2021-02-25</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>SECURE Study</td><td>No</td><td>852953179</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>390100</td><td>10225</td><td>Lancaster General Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>950 OCTORARA TRAIL</td><td>null</td><td>PARKESBURG</td><td>PA</td><td>19365</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>84134</td><td>1861586133</td><td>SANDEEP</td><td>null</td><td>BANSAL</td><td>null</td><td>217 Harrisburg Ave</td><td>null</td><td>LANCASTER</td><td>PA</td><td>17603</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Medtronic, Inc.</td><td>100000000106</td><td>Medtronic, Inc.</td><td>MN</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiac Diagnostics and Monitoring</td><td>Reveal LINQ</td><td>null</td><td>00643169845749</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>405.0</td><td>2021-08-12</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Stroke AF</td><td>No</td><td>800994923</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1058656</td><td>1427258367</td><td>ALI</td><td>null</td><td>JABBARI</td><td>null</td><td>200 HAWKINS DR</td><td>null</td><td>IOWA CITY</td><td>IA</td><td>52242</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>940.0</td><td>2021-11-06</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>RITLECITINIB CLINICAL PUBLICATION PROGRAM</td><td>No</td><td>832531725</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1393487</td><td>1174943013</td><td>WALTER</td><td>null</td><td>LE</td><td>null</td><td>9209 COLIMA RD STE 1000</td><td>null</td><td>WHITTIER</td><td>CA</td><td>90605-1813</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>250.0</td><td>2021-03-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of REGN6490 in Healthy Japanese Volunteers</td><td>No</td><td>793082905</td><td>2021</td><td>06/30/2022</td><td>NCT04616105</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Non-Physician Practitioner</td><td>null</td><td>null</td><td>null</td><td>null</td><td>11153537</td><td>1346774866</td><td>MEGHAN</td><td>G.</td><td>GOLSON</td><td>null</td><td>832 Princeton Ave Sw</td><td>null</td><td>Birmingham</td><td>AL</td><td>35211</td><td>United States</td><td>null</td><td>null</td><td>Nurse Practitioner</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Sanofi Pasteur Inc.</td><td>100000000299</td><td>SANOFI PASTEUR INC.</td><td>PA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>40.0</td><td>2021-10-27</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Parallel-group, Phase III, Multi-stage, Modified Double-blind, Multi-armed Study to Assess the Efficacy, Safety, and Immunogenicity of Two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (Monovalent and Bivalent) for Prevention Against COVID-19 in Adults 18 Years of Age and Older</td><td>No</td><td>838359925</td><td>2021</td><td>06/30/2022</td><td>NCT04904549</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>270963</td><td>1972734119</td><td>VLADIMIR</td><td>null</td><td>ROYTER</td><td>null</td><td>125 MALL DR STE 209B</td><td>null</td><td>HANFORD</td><td>CA</td><td>93230</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>EMD Serono, Inc.</td><td>100000000127</td><td>EMD Serono, Inc.</td><td>MA</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>85.0</td><td>2021-09-30</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>MS200527_0082</td><td>No</td><td>842905219</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>778816</td><td>1588912869</td><td>LUCIA</td><td>null</td><td>SEMINARIO VIDAL</td><td>null</td><td>12901 BRUCE B DOWNS BLVD</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Dermatology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Ichnos Sciences Inc.</td><td>100000806847</td><td>Ichnos Sciences Inc.</td><td>NY</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1750.0</td><td>2021-01-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>GBR830-204</td><td>No</td><td>834357095</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>GBR830-204</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>450051</td><td>11035</td><td>Methodist Dallas Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1441 N Beckley Ave</td><td>null</td><td>Dallas</td><td>TX</td><td>75203</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>75418</td><td>1659573780</td><td>PAUL</td><td>MICHAEL</td><td>DEROSE</td><td>null</td><td>2805 E PRESIDENT GEORGE BUSH HWY</td><td>null</td><td>RICHARDSON</td><td>TX</td><td>75082</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novocure Inc.</td><td>100000005413</td><td>Novocure Inc.</td><td>NH</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>250.0</td><td>2021-09-30</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EF-27 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 150lHz) concomitant with gemcitabine and nab-paclitaxel) for front-line treatment of locally-advanced pancreatic adenocarcinoma</td><td>No</td><td>827905927</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>90004</td><td>10716</td><td>GEORGETOWN UNIVERSITY HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3800 Reservoir Rd NW</td><td>null</td><td>Washington</td><td>DC</td><td>20007</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>766528</td><td>1164414751</td><td>CLAUDINE</td><td>J</td><td>ISAACS</td><td>null</td><td>3800 RESERVOIR RD NW</td><td>null</td><td>WASHINGTON</td><td>DC</td><td>20007</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>DC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>IBRANCE</td><td>0069-0187-21</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9.0</td><td>2021-05-06</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A RANDOMIZED MULTICENTER DOUBLEBLIND PHASE 3 STUDY OF PD0332991 ORAL CDK 46 INHIBITOR PLUS LETROZOLE VERSUS PLACEBO PLUS LETROZOLE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ER  HER2  BREAST CANCER WHO HAVE NOT RECEIVED ANY PRIOR SYSTEMIC ANTI CANCER TREATMENT FOR ADVANCED DISEASE</td><td>No</td><td>832732557</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Study Drug</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230046</td><td>10547</td><td>Univ Of Mi Hospitals & Hlth Ctrs</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2301 Commonwealth Blvd</td><td>null</td><td>Ann Arbor</td><td>MI</td><td>48105</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1201996</td><td>1467517797</td><td>RYAN</td><td>W</td><td>STIDHAM</td><td>null</td><td>1500 E MEDICAL CENTER DR</td><td>null</td><td>ANN ARBOR</td><td>MI</td><td>48109-5000</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>UCB Biosciences Inc.</td><td>100000010780</td><td>UCB Biosciences Inc.</td><td>NC</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Immunology</td><td>Cimzia</td><td>50474-710-79</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>100.0</td><td>2021-06-21</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Non-Interventional, Long term, Post-Marketing Registry of Patients Treated with Certolizumab Pegol (CIMZIA) For Crohn's Disease</td><td>No</td><td>844213153</td><td>2021</td><td>06/30/2022</td><td>NCT00844285</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>853101</td><td>1215193255</td><td>Sanjay</td><td>R</td><td>Mohan</td><td>null</td><td>3601 THE VANDERBILT CLINIC</td><td>null</td><td>NASHVILLE</td><td>TN</td><td>37232-0001</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Ichnos Sciences Inc.</td><td>100000806847</td><td>Ichnos Sciences Inc.</td><td>NY</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>34214.4</td><td>2021-11-01</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>ISB 1342-101</td><td>No</td><td>834357809</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>ISB 1342-101</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>503300</td><td>11178</td><td>Seattle Childrens Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4800 Sand Point Way Ne</td><td>null</td><td>Seattle</td><td>WA</td><td>98105</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>606125</td><td>1538326632</td><td>NAVIN</td><td>R</td><td>PINTO</td><td>null</td><td>8246 15TH AVE NE MB8501</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98115</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>IBRANCE</td><td>0069-0187-21</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2137.6</td><td>2021-05-24</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PHASE 1 STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF PALBOCICLIB IBRANCEREGISTERED IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE AND IN COMBINATION WITH TOPOTECAN AND CYCLOPHOSPHAMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS</td><td>No</td><td>832776589</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Study Drug</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50146</td><td>11296</td><td>City Of Hope National Medical Ctr</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1500 E DUARTE RD</td><td>null</td><td>DUARTE</td><td>CA</td><td>91010</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>156689</td><td>1467408948</td><td>TANYA</td><td>null</td><td>SIDDIQI</td><td>null</td><td>1500 Duarte Rd</td><td>null</td><td>Duarte</td><td>CA</td><td>91010</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Celgene Corporation</td><td>100000000343</td><td>Celgene Corporation</td><td>NY</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>23017.0</td><td>2021-01-15</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>LONG-TERM FOLLOW-UP PROTOCOL FOR SUBJECTS TREATED</td><td>No</td><td>807111773</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500025</td><td>11175</td><td>Swedish Medical Center Cherry Hill</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PO BOX 94085</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98124</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>710172</td><td>1164614731</td><td>MING</td><td>null</td><td>ZHANG</td><td>null</td><td>550 17TH AVE</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98122</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BOSTON SCIENTIFIC CORPORATION</td><td>100000005674</td><td>Boston Scientific Corporation</td><td>MA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Device</td><td>CLINICAL TRIAL PRODUCT</td><td>CLINICAL TRIAL PRODUCT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1477.0</td><td>2021-11-01</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>REPRISE IV</td><td>No</td><td>800045709</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>110010</td><td>10785</td><td>EMORY UNIVERSITY HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1821 Clifton Rd Ne</td><td>null</td><td>Atlanta</td><td>GA</td><td>30329</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1016783</td><td>1942336920</td><td>LEON</td><td>null</td><td>BERNAL</td><td>null</td><td>80 JESSE HILL JR DR SE</td><td>null</td><td>ATLANTA</td><td>GA</td><td>30303-3031</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>100000000337</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>NINLARO</td><td>63020-078-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1560.0</td><td>2021-05-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>AN OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY TO EVALUATE THE EFFECTIVENESS AND SAFETY OF IXAZOMIB (NINLARO?) IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE (IRD) IN PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY RECEIVING A BORTEZOMIB-BASED INDUCTION REGIMEN (US MM-6)</td><td>No</td><td>816655075</td><td>2021</td><td>06/30/2022</td><td>NCT03173092</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>910828</td><td>1245284348</td><td>GARY</td><td>L.</td><td>CUTTER</td><td>null</td><td>1100 Marshall Way</td><td>null</td><td>Placerville</td><td>CA</td><td>95667</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Anesthesiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Celgene Corporation</td><td>100000000343</td><td>Celgene Corporation</td><td>NY</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1800.0</td><td>2021-05-03</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Multi-Center, Multi-National, Randomized, Double</td><td>No</td><td>807112685</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360068</td><td>10396</td><td>The Toledo Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2142 North Cove Blvd.</td><td>null</td><td>Toledo</td><td>OH</td><td>43606</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>65449</td><td>1447202163</td><td>RISHI</td><td>null</td><td>GUPTA</td><td>null</td><td>61 WHITCHER ST</td><td>SUITE 3110</td><td>MARIETTA</td><td>GA</td><td>30060</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Neurological Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ZOLL Circulation Inc</td><td>100000010423</td><td>ZOLL Circulation Inc</td><td>CA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Device</td><td>Temperature Management</td><td>Temperature Management System</td><td>null</td><td>Temperature Management System</td><td>Non-Covered</td><td>Device</td><td>Temperature Management</td><td>Catheter</td><td>null</td><td>Catheter</td><td>Non-Covered</td><td>Device</td><td>Temperature Management</td><td>Temperature Management System Start-Up Kit</td><td>null</td><td>Temperature Management System Start-Up Kit</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>17179.81</td><td>2021-08-25</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>ReCCLAIM II</td><td>No</td><td>837669553</td><td>2021</td><td>06/30/2022</td><td>NCT03804060</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>310001</td><td>10178</td><td>HACKENSACK UNIVERSITY MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>30 Prospect Ave</td><td>null</td><td>Hackensack</td><td>NJ</td><td>07601</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>282795</td><td>1215983382</td><td>HELIO</td><td>FERNAN</td><td>PEDRO</td><td>null</td><td>185 S ORANGE AVE</td><td>MSB F-653</td><td>NEWARK</td><td>NJ</td><td>07103-2757</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NJ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>100000000337</td><td>Takeda Pharmaceuticals U.S.A., Inc.</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>GENETIC DISEASE</td><td>ELAPRASE</td><td>54092-700-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12169.5</td><td>2021-04-30</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>AN OPEN LABEL EXTENSION OF STUDY HGT-HIT-094 EVALUATING LONG TERM SAFETY AND CLINICAL OUTCOMES OF INTRATHECAL IDURSULFASE ADMINISTERED IN CONJUNCTION WITH ELAPRASE IN PATIENTS WITH HUNTER SYNDROME AND COGNITIVE IMPAIRMENT</td><td>No</td><td>816655910</td><td>2021</td><td>06/30/2022</td><td>NCT02412787</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360180</td><td>10373</td><td>Cleveland Clinic Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9500 Euclid Ave</td><td>null</td><td>Cleveland</td><td>OH</td><td>44195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>618396</td><td>1962510826</td><td>Alberto</td><td>J</td><td>Montero</td><td>null</td><td>11100 Euclid Ave</td><td>null</td><td>Cleveland</td><td>OH</td><td>44106</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Daiichi Sankyo Inc.</td><td>100000000195</td><td>Daiichi Sankyo Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>Enhertu</td><td>65597-406-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>13971.6</td><td>2021-03-24</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Yes</td><td>No</td><td>null</td><td>No</td><td>835056645</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>500008</td><td>11198</td><td>University Of Washington Med Ctr</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1959 Ne Pacific St</td><td>null</td><td>Seattle</td><td>WA</td><td>98195</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>1005961</td><td>1568758431</td><td>DAVID</td><td>BING</td><td>ZHEN</td><td>null</td><td>1959 NE PACIFIC ST</td><td>null</td><td>SEATTLE</td><td>WA</td><td>98195</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AstraZeneca Pharmaceuticals LP</td><td>100000000146</td><td>AstraZeneca Pharmaceuticals LP</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>255709.16</td><td>2021-01-14</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Durvalumab or Placebo in Combination With Gemcitabine Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer TOPAZ-1</td><td>No</td><td>826467939</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>10033</td><td>10929</td><td>University Of Alabama Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>619 19th St S</td><td>null</td><td>Birmingham</td><td>AL</td><td>35249</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>697259</td><td>1710085782</td><td>MICHAEL</td><td>null</td><td>STALVEY</td><td>null</td><td>100 KIMEL FOREST DR</td><td>null</td><td>WINSTON SALEM</td><td>NC</td><td>27103</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AL</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1084.59</td><td>2021-08-25</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN8640-4263</td><td>No</td><td>810994117</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>330285</td><td>10135</td><td>Strong Memorial Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>601 ELMWOOD AVE</td><td>BOX 684</td><td>ROCHESTER</td><td>NY</td><td>14642</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>307547</td><td>1790713477</td><td>DAVID</td><td>T.</td><td>HUANG</td><td>null</td><td>601 ELMWOOD AVE</td><td>BOX 679</td><td>ROCHESTER</td><td>NY</td><td>14642</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Plexa</td><td>null</td><td>04035479140014</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Rivacor</td><td>null</td><td>04035479156794</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Acticor</td><td>null</td><td>04035479156701</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Solia</td><td>null</td><td>4035479118266</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Sentus</td><td>null</td><td>4035479148942</td><td>21.13</td><td>2021-04-13</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIO-LIBRA</td><td>No</td><td>843815033</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50047</td><td>11215</td><td>California Pacific Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2333 Buchanan Street</td><td>null</td><td>San Francisco</td><td>CA</td><td>94115</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>84421</td><td>1851485056</td><td>KEVIN</td><td>null</td><td>KIM</td><td>null</td><td>2100 WEBSTER ST STE 326</td><td>2100 WEBSTER ST STE 326</td><td>SAN FRANCISCO</td><td>CA</td><td>94115-2378</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Merck Sharp & Dohme Corporation</td><td>100000000053</td><td>Merck Sharp & Dohme Corporation</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ONCOLOGY</td><td>KEYTRUDA</td><td>0006-3029-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>28085.3</td><td>2021-12-21</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Adjuvant immunotherapy with anti-PD-1 monoclonal antibody Pembrolizumab MK-3475 versus placebo after complete resection of high-risk Stage III melanoma A randomized, double- blind Phase 3 trial of the EORTC Melanoma Group</td><td>No</td><td>848743877</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>340091</td><td>10794</td><td>THE MOSES H. CONE MEMORIAL HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1200 N Elm St</td><td>null</td><td>Greensboro</td><td>NC</td><td>27401</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>50029</td><td>1093778227</td><td>BRIAN</td><td>S</td><td>CRENSHAW</td><td>null</td><td>3200 NORTHLINE AVE STE 250</td><td>null</td><td>GREENSBORO</td><td>NC</td><td>27408-7619</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Esperion Therapeutics, Inc.</td><td>100000771817</td><td>Esperion Therapeutics, Inc.</td><td>MI</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ANTILIPEMIC AGENTS</td><td>NEXLETOL</td><td>72426-118-03</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>572.0</td><td>2021-01-21</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH, OR AT HIGH RISK FOR, CARDIOVASCULAR DISEASE WHO ARE STATIN INTOLERANT</td><td>No</td><td>838383873</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>83300</td><td>10812</td><td>ALFRED I DUPONT HOSP FOR CHILDREN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1600 Rockland Rd</td><td>null</td><td>Wilmington</td><td>DE</td><td>19803</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>244579</td><td>1407051527</td><td>KATHERINE</td><td>E</td><td>MCGOOGAN</td><td>null</td><td>807 CHILDRENS WAY</td><td>NEMOURS CHILDRENS CLINIC</td><td>JACKSONVILLE</td><td>FL</td><td>32207-8426</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allergan, Inc.</td><td>100000000278</td><td>Allergan, Inc.</td><td>NJ</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>6000.0</td><td>2021-12-01</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Clinical Trial (LIN-MD-66: PED Longterm safety study)</td><td>No</td><td>789009801</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>LIN-MD-66</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1458973</td><td>1306139597</td><td>TIFFANY</td><td>L.</td><td>FISHER</td><td>null</td><td>30 HOPE DR # EC037</td><td>null</td><td>HERSHEY</td><td>PA</td><td>17033-2036</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NEUROPACE, INC.</td><td>100000010697</td><td>NEUROPACE, INC.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Epilepsy</td><td>RNS System</td><td>null</td><td>00855547005267</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>425.0</td><td>2021-10-03</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Approval Study</td><td>No</td><td>851400427</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>420027</td><td>10777</td><td>Anmed Health</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>800 N FANT ST</td><td>null</td><td>ANDERSON</td><td>SC</td><td>29621</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>260312</td><td>1740266725</td><td>BRENT</td><td>TINDAL</td><td>MCLAURIN</td><td>null</td><td>100 PERPETUAL SQ</td><td>null</td><td>ANDERSON</td><td>SC</td><td>29621</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Orsiro</td><td>null</td><td>07640130455948</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>48.75</td><td>2021-07-13</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIOFLOW-VII</td><td>No</td><td>843833987</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>520098</td><td>10572</td><td>University Of Wi Hospitals & Clinics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>600 Highland Ave</td><td>null</td><td>Madison</td><td>WI</td><td>53792</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>722976</td><td>1629039078</td><td>GLENN</td><td>null</td><td>LIU</td><td>null</td><td>600 HIGHLAND AVE</td><td>null</td><td>MADISON</td><td>WI</td><td>53792</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>WI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>TALZENNA</td><td>0069-0296-30</td><td>null</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>XTANDI</td><td>0469-0125-99</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>38051.88</td><td>2021-05-30</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY OF TALAZOPARIB WITH ENZALUTAMIDE IN METASTATIC CASTRATIONRESISTANT PROSTATE CANCER</td><td>No</td><td>832533079</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Study Drug</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>716637</td><td>1407152283</td><td>DANIELE</td><td>null</td><td>MARIN</td><td>null</td><td>2100 ERWIN RD</td><td>null</td><td>DURHAM</td><td>NC</td><td>27705-3941</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ONCOLOGY</td><td>LIBTAYO</td><td>61755-008-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>3622.5</td><td>2021-06-10</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A TWO-PART RANDOMIZED, PHASE 3 STUDY OF COMBINATIONS OF CEMIPLIMAB (ANTI-PD-1 ANTIBODY) AND PLATINUM-BASED DOUBLET CHEMOTHERAPY IN FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER</td><td>No</td><td>793083171</td><td>2021</td><td>06/30/2022</td><td>NCT03409614</td><td>null</td><td>Payment made to RADMD LLC</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>9765</td><td>1205898681</td><td>WILLIAM</td><td>A</td><td>MAXWELL</td><td>null</td><td>1360 E HERNDON AVE</td><td>SUITE 401</td><td>FRESNO</td><td>CA</td><td>93720-3326</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Ophthalmology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alcon Research LLC</td><td>100000000218</td><td>Alcon Research LLC</td><td>TX</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Ophthalmology</td><td>Acrysof IQ ReSTOR IOL</td><td>null</td><td>00380652268752</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>248.4</td><td>2021-10-13</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Post Approval Study of the AcrySof IQ ReSTOR Toric IOL</td><td>No</td><td>807667601</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100271</td><td>10837</td><td>Moffitt Cancer Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12902 MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>218562</td><td>1811934755</td><td>AHMAD</td><td>null</td><td>TARHINI</td><td>null</td><td>12902 USF MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Incyte Corporation</td><td>100000000263</td><td>Incyte Corporation</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>20.26</td><td>2021-04-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase 1-2 Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies</td><td>No</td><td>831054523</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>340002</td><td>11122</td><td>Mission Hospital  Inc</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>509 Biltmore Ave</td><td>null</td><td>Asheville</td><td>NC</td><td>28801</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>244210</td><td>1376690362</td><td>MARK</td><td>A</td><td>GROH</td><td>null</td><td>257 MCDOWELL ST</td><td>null</td><td>ASHEVILLE</td><td>NC</td><td>28803-2606</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery)</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Abbott Laboratories</td><td>100000010680</td><td>Abbott Laboratories</td><td>IL</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Vascular</td><td>Xience Sierra Coronary Stent</td><td>null</td><td>08717648227547</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>6807.69</td><td>2021-01-20</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO)</td><td>No</td><td>827567155</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>393303</td><td>10215</td><td>THE CHILDRENS HOSPITAL OF PHILADELP</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>34TH STREET & CIVIC CENTER BLVD</td><td>null</td><td>PHILADELPHIA</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>2091068</td><td>1336438464</td><td>SAMUEL</td><td>null</td><td>JOHN</td><td>null</td><td>5323 HARRY HINES BOULEVARD</td><td>null</td><td>DALLAS</td><td>TX</td><td>75390-7201</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novartis Pharmaceuticals Corporation</td><td>100000000228</td><td>Novartis Pharmaceuticals Corporation</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ONCOLOGY</td><td>KYMRIAH</td><td>0078-0846-19</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>23447.88</td><td>2021-02-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A SINGLE ARM PHASE II TRIAL IN FIRST LINE HIGH RISK HR PEDIATRIC AND YOUNG ADULT PATIENTS WITH BCELL ACUTE LYMPHOBLASTIC LEUKEMIA ALL WHO ARE MINIMAL RESIDUAL DISEASE MRD POSITIVE AT END OF CONSOLIDATION EOC THERAPY</td><td>No</td><td>800616829</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>140010</td><td>10431</td><td>Northshore University Healthsystem</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2650 Ridge Ave</td><td>null</td><td>Evanston</td><td>IL</td><td>60201</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>376100</td><td>1457528101</td><td>LIANA</td><td>K</td><td>BILLINGS</td><td>null</td><td>9977 WOODS DR</td><td>STE 300</td><td>SKOKIE</td><td>IL</td><td>60077</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>Ozempic</td><td>0169-4132-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>4.5</td><td>2021-03-08</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9535-4321</td><td>No</td><td>811249707</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>263302</td><td>10622</td><td>Childrens Mercy Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2401 GILLHAM RD</td><td>null</td><td>KANSAS CITY</td><td>MO</td><td>64108</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>913107</td><td>1326099714</td><td>DOUGLAS</td><td>S.</td><td>SWANSON</td><td>null</td><td>2401 Gillham Rd</td><td>null</td><td>Kansas City</td><td>MO</td><td>64108</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Infectious Diseases</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>KS</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Sanofi Pasteur Inc.</td><td>100000000299</td><td>SANOFI PASTEUR INC.</td><td>PA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>7124.0</td><td>2021-03-03</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PSK0008 Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine (PCV) when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Toddlers and Infants</td><td>No</td><td>838362961</td><td>2021</td><td>06/30/2022</td><td>NCT04398706</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>393303</td><td>10215</td><td>THE CHILDRENS HOSPITAL OF PHILADELP</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>34th & Civic Center Blvd</td><td>Parc Business Services</td><td>Philadelphia</td><td>PA</td><td>19104</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>187891</td><td>1154339570</td><td>STEPHAN</td><td>A</td><td>GRUPP</td><td>null</td><td>3401 CIVIC CENTER BLVD</td><td>CHILDREN'S HOSPITAL OF PHILADELPHIA - HEMONC</td><td>PHILADELPHIA</td><td>PA</td><td>19104-4319</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Servier Pharmaceuticals LLC</td><td>100000291815</td><td>Institut de Recherches Internationales Servier</td><td>null</td><td>France</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1300.0</td><td>2021-05-12</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>STUDY OF UCART19 IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA (PALL)</td><td>No</td><td>851687627</td><td>2021</td><td>06/30/2022</td><td>NCT02808442</td><td>https://clinicaltrials.gov/ct2/show/NCT02808442</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>68772</td><td>1528102670</td><td>JAMES</td><td>null</td><td>TATUM</td><td>null</td><td>1820 PRESTON PARK BLVD</td><td>null</td><td>PLANO</td><td>TX</td><td>75093</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Neurological Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MicroVention, Inc.</td><td>100000010928</td><td>MicroVention, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Neurological Product</td><td>HydroCoil Helical</td><td>null</td><td>00812636021409</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2950.0</td><td>2021-09-09</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Yes</td><td>No</td><td>NULL</td><td>No</td><td>843596669</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>303222</td><td>1679551444</td><td>BRADLEY</td><td>S</td><td>GIEDD</td><td>null</td><td>1928 HOWELL BRANCH RD</td><td>null</td><td>WINTER PARK</td><td>FL</td><td>32792-1013</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Optometry</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eye and Vision Services Providers|Optometrist</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alcon Research LLC</td><td>100000000218</td><td>Alcon Research LLC</td><td>TX</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>Device</td><td>Ophthalmology</td><td>Mercury Silicone Hydrogel (SiHy) Sphere</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>329.0</td><td>2021-03-24</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Clinical Characterization of an Investigational Frequent Replacement Daily Wear Silicone Hydrogel Sphere Contact Lens</td><td>No</td><td>807643919</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>26119</td><td>1588677736</td><td>HENRY</td><td>W</td><td>TRAYLOR</td><td>JR.</td><td>1615 DOCTORS CIR</td><td>null</td><td>WILMINGTON</td><td>NC</td><td>28401</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>10.6</td><td>2021-08-04</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9924-4473</td><td>No</td><td>811658781</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>460009</td><td>11165</td><td>U Of U Hospitals & Clinics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>175N MARIO CAPECCHI DR</td><td>null</td><td>SALT LAKE CITY</td><td>UT</td><td>84132</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>358775</td><td>1891748687</td><td>DOUGLAS</td><td>null</td><td>ADLER</td><td>null</td><td>1525 W 2100 S</td><td>null</td><td>SALT LAKE CITY</td><td>UT</td><td>84119</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CO</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BOSTON SCIENTIFIC CORPORATION</td><td>100000005674</td><td>Boston Scientific Corporation</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Clinical Trial Product</td><td>AXIOS Stent and Electrocautery Enhanced Delivery System</td><td>null</td><td>8.71473E+12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>620.0</td><td>2021-06-21</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>POCS IN PSC</td><td>No</td><td>800047429</td><td>2021</td><td>06/30/2022</td><td>NCT03766035</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>440039</td><td>10425</td><td>VANDERBILT UNIVERSITY MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1211 Medical Center Drive</td><td>null</td><td>Nashville</td><td>TN</td><td>37232</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>156923</td><td>1457331803</td><td>ROBERT</td><td>J</td><td>CORNELL</td><td>null</td><td>1315 ST JOSEPH PKWY STE 1700</td><td>null</td><td>HOUSTON</td><td>TX</td><td>77002</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Urology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TX</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>81040.64</td><td>2021-05-20</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE I OPEN LABEL STUDY TO EVALUATE THE SAFETY PHARMACOKINETIC PHARMACODYNAMIC AND CLINICAL ACTIVITY OF PF06863135 A BCELL MATURATION ANTIGEN BCMA  CD3 BISPECIFIC ANTIBODY AS A SINGLE AGENT AND IN COMBINATION WITH IMMUNOMODULATORY AGENTS IN PATIENTS WITH RELAPSEDREFRACTORY ADVANCED MULTIPLE MYELOMA MM</td><td>No</td><td>832781557</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>223302</td><td>9992</td><td>CHILDRENS HOSPITAL CORPORATION</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>300 Longwood Ave</td><td>Patient Financial Services Atn Steven Nicoll</td><td>Boston</td><td>MA</td><td>02115</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>801431</td><td>1396790788</td><td>IRINA</td><td>null</td><td>ANSELM</td><td>null</td><td>300 LONGWOOD AVE</td><td>FEGAN 11</td><td>BOSTON</td><td>MA</td><td>02115-5724</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PTC Therapeutics, Inc.</td><td>100000191753</td><td>PTC Therapeutics, Inc.</td><td>NJ</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>11083.19</td><td>2021-09-06</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EFFICACY AND SAFETY STUDY OF VATIQUINONE FOR THE TREATMENT OF MITOCHONDRIAL DISEASE SUBJECTS WITH REFRACTORY EPILEPSY</td><td>No</td><td>849319527</td><td>2021</td><td>06/30/2022</td><td>NCT04378075</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>464009</td><td>11166</td><td>U OF UTAH NEUROPSYCHIATRIC INSTITUTE</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>50 N Medical Dr</td><td>null</td><td>Salt Lake City</td><td>UT</td><td>84132</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>913884</td><td>1346330966</td><td>WALLACE</td><td>L</td><td>AKERLEY</td><td>null</td><td>1950 CIRCLE OF HOPE</td><td>CLINIC 1A</td><td>SALT LAKE CITY</td><td>UT</td><td>84112-5500</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>UT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>ABBVIE INC.</td><td>100000000204</td><td>ABBVIE INC.</td><td>IL</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5215.0</td><td>2021-05-03</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase I Study of ABBV-011 as a Single-Agent and in Combination with Budigalimab (ABBV-181) in Subjects with Relapsed or Refractory Small Cell Lung Cancer</td><td>No</td><td>792398011</td><td>2021</td><td>06/30/2022</td><td>NCT03639194</td><td>null</td><td>M17-327</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100271</td><td>10837</td><td>MOFFITT CANCER CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12902 MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>344689</td><td>1609810779</td><td>RICHARD</td><td>D</td><td>KIM</td><td>null</td><td>12902 USF MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>GlaxoSmithKline, LLC.</td><td>100000005449</td><td>GlaxoSmithKline, LLC.</td><td>NC</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2200.0</td><td>2021-05-11</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 1 DOSE ESCALATION AND COHORT EXPANSION STUDY OF TSR-033, AN AN</td><td>No</td><td>809491759</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>HCP did not receive direct payment from GSK. HCP was listed as the Primary Investigator in accordance with the Sunshine Act requirements.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>70034</td><td>10026</td><td>NORWALK HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>34 Maple St</td><td>null</td><td>Norwalk</td><td>CT</td><td>06856</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>234804</td><td>1174515803</td><td>RICHARD</td><td>C</td><td>FRANK</td><td>null</td><td>34 MAPLE ST</td><td>null</td><td>NORWALK</td><td>CT</td><td>06850</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>6224.86</td><td>2021-11-20</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE I DOSE ESCALATION AND EXPANDED COHORT STUDY OF PF06821497 IN THE TREATMENT OF ADULT PATIENTS WITH RELAPSEDREFRACTORY SMALL CELL LUNG CANCER SCLC CASTRATION RESISTANT PROSTATE CANCER CRPC AND FOLLICULAR LYMPHOMA FL</td><td>No</td><td>832782757</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230089</td><td>10520</td><td>Beaumont Hospital  Grosse Pointe</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>468 Cadieux Rd</td><td>null</td><td>Grosse Pointe</td><td>MI</td><td>48230</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>904085</td><td>1003875600</td><td>CHRISTOPHER</td><td>FRANCIS</td><td>CARPENTER</td><td>null</td><td>3601 W 13 MILE RD</td><td>null</td><td>ROYAL OAK</td><td>MI</td><td>48073</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AstraZeneca Pharmaceuticals LP</td><td>100000000146</td><td>AstraZeneca Pharmaceuticals LP</td><td>DE</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>38795.28</td><td>2021-12-31</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Phase III Randomized Double-blind Placebo-controlled Multicenter Study in Adults to Determine the Safety Efficacy and Immunogenicity of AZD1222 a Non-replicating ChAdOx1 Vector Vaccine for the Prevention of COVID-19</td><td>No</td><td>826468331</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>117983</td><td>1598924995</td><td>JULIUS</td><td>M</td><td>WILDER</td><td>null</td><td>2301 ERWIN RD</td><td>null</td><td>DURHAM</td><td>NC</td><td>27705</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>RYBELSUS</td><td>0169-4303-13</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>250.0</td><td>2021-06-18</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>EX9924-4473</td><td>No</td><td>810687377</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100069</td><td>10824</td><td>Adventhealth Carrollwood</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>7171 N DALE MABRY HWY</td><td>null</td><td>TAMPA</td><td>FL</td><td>33614</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>162269</td><td>1588730113</td><td>VASCO</td><td>M.</td><td>MARQUES</td><td>null</td><td>3010 E 138TH AVE STE 12</td><td>null</td><td>TAMPA</td><td>FL</td><td>33613</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Orsiro</td><td>null</td><td>07640130455948</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>81.25</td><td>2021-12-14</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIOFLOW-VII</td><td>No</td><td>843815263</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>100271</td><td>10837</td><td>Moffitt Cancer Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>12902 MAGNOLIA DR</td><td>null</td><td>TAMPA</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>158609</td><td>1487736856</td><td>JAVIER</td><td>A.</td><td>PINILLA-IBARZ</td><td>null</td><td>12902 Usf Magnolia Dr</td><td>null</td><td>Tampa</td><td>FL</td><td>33612</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>FL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TG Therapeutics, Inc.</td><td>100000961857</td><td>TG Therapeutics, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Hematology</td><td>UKONIQ</td><td>73150-200-12</td><td>null</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>258.0</td><td>2021-09-01</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>ULTRA-V: Phase 2/3 Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL)</td><td>No</td><td>850450923</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>340091</td><td>10794</td><td>THE MOSES H. CONE MEMORIAL HOSPITAL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1200 N Elm St</td><td>null</td><td>Greensboro</td><td>NC</td><td>27401</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>50029</td><td>1093778227</td><td>BRIAN</td><td>S</td><td>CRENSHAW</td><td>null</td><td>3200 NORTHLINE AVE STE 250</td><td>null</td><td>GREENSBORO</td><td>NC</td><td>27408-7619</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NC</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Esperion Therapeutics, Inc.</td><td>100000771817</td><td>Esperion Therapeutics, Inc.</td><td>MI</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ANTILIPEMIC AGENTS</td><td>NEXLETOL</td><td>72426-118-03</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>200.0</td><td>2021-07-22</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH, OR AT HIGH RISK FOR, CARDIOVASCULAR DISEASE WHO ARE STATIN INTOLERANT</td><td>No</td><td>838384649</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>470003</td><td>9973</td><td>University Of Vermont Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>111 Colchester Ave</td><td>null</td><td>Burlington</td><td>VT</td><td>05401</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>138989</td><td>1073634531</td><td>MATTHEW</td><td>P</td><td>GILBERT</td><td>null</td><td>62 TILLEY DR</td><td>STE 202</td><td>SOUTH BURLINGTON</td><td>VT</td><td>05403</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Osteopathy</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>VT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Novo Nordisk AS</td><td>100000000163</td><td>Novo Nordisk AS</td><td>null</td><td>Denmark</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Diabetes</td><td>Ozempic</td><td>0169-4132-12</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>13.5</td><td>2021-04-16</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>NN9535-4321</td><td>No</td><td>810893545</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>230236</td><td>10496</td><td>Metropolitan Hospital</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>5900 BYRON CENTER AVE SW</td><td>null</td><td>WYOMING</td><td>MI</td><td>49519</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>192983</td><td>1255312302</td><td>MATTHEW</td><td>W.</td><td>SEVENSMA</td><td>null</td><td>5900 BYRON CENTER AVE SW</td><td>null</td><td>WYOMING</td><td>MI</td><td>49519</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Osteopathy</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MI</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>BIOTRONIK INC.</td><td>100000010579</td><td>BIOTRONIK INC.</td><td>OR</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Plexa</td><td>null</td><td>04035479140014</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Solia</td><td>null</td><td>04035479118266</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Rivacor</td><td>null</td><td>04035479156794</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Sentus</td><td>null</td><td>4035479148942</td><td>Covered</td><td>Device</td><td>Cardiology/Vascular Diseases</td><td>Acticor</td><td>null</td><td>4035479156701</td><td>65.0</td><td>2021-04-13</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BIO-LIBRA</td><td>No</td><td>843815671</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>60107</td><td>11020</td><td>National Jewish Health</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1400 JACKSON ST</td><td>null</td><td>DENVER</td><td>CO</td><td>80206</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Bristol Myers Squibb Company</td><td>100000005499</td><td>E.R. Squibb & Sons, L.L.C.</td><td>NJ</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>54447.0</td><td>2021-01-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Identification of Disease Progression Biomarkers in the National Jewish Health IPF cohort</td><td>No</td><td>819884983</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1125287</td><td>1750480950</td><td>FRANCIS</td><td>J</td><td>GILES</td><td>null</td><td>175 E DELAWARE PL APT 7204</td><td>null</td><td>CHICAGO</td><td>IL</td><td>60611</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>METABOLIC DISEASE;ONCOLOGY</td><td>BOSULIF</td><td>0069-0135-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>620.0</td><td>2021-12-14</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>BOSUTINIB CLINICAL PUBLICATION PROGRAM</td><td>No</td><td>832534339</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>249435</td><td>1487734646</td><td>BRADLEY</td><td>J</td><td>MONK</td><td>null</td><td>2222 E HIGHLAND AVE</td><td>SUITE 400</td><td>PHOENIX</td><td>AZ</td><td>85016-4872</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>AZ</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ONCOLOGY</td><td>LIBTAYO</td><td>61755-008-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>343.5</td><td>2021-05-12</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>LIBTAYO CLINICAL PUBLICATION PROGRAM</td><td>No</td><td>793083445</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>116924</td><td>1598704371</td><td>BRADLEY</td><td>N</td><td>HINES</td><td>null</td><td>3445 POPLAR AVE</td><td>SUITE 7</td><td>MEMPHIS</td><td>TN</td><td>38111-4667</td><td>United States</td><td>null</td><td>null</td><td>Doctor of Optometry</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Eye and Vision Services Providers|Optometrist</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alcon Research LLC</td><td>100000000218</td><td>Alcon Research LLC</td><td>TX</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Ophthamology</td><td>TOTAL 30</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>475.2</td><td>2021-10-14</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Clinical Assessment of Two Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lenses</td><td>No</td><td>807667857</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>311623</td><td>1861452815</td><td>AMY</td><td>SUSAN</td><td>PALLER</td><td>null</td><td>2515 N CLARK</td><td>null</td><td>CHICAGO</td><td>IL</td><td>60614</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Pediatrics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Regeneron Pharmaceuticals, Inc.</td><td>100000000069</td><td>Regeneron Pharmaceuticals, Inc.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>INFLAMMATION AND  IMMUNOLOGY</td><td>DUPIXENT</td><td>0024-5914-01</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>429.83</td><td>2021-04-23</td><td>In-kind items and services</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB ADMINISTERED CONCOMITANTLY WITH TOPICAL CORTICOSTEROIDS IN PATIENTS, >=6 YEARS TO <12 YEARS OF AGE, WITH SEVERE ATOPIC DERMATITIS</td><td>No</td><td>793083703</td><td>2021</td><td>06/30/2022</td><td>NCT03345914</td><td>null</td><td>The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication.</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>360027</td><td>10369</td><td>Akron General Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1 Akron General Ave</td><td>null</td><td>Akron</td><td>OH</td><td>44307</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>150131</td><td>1295939734</td><td>Rupesh</td><td>null</td><td>Raina</td><td>null</td><td>155 5th St Ne</td><td>null</td><td>BARBERTON</td><td>OH</td><td>44203</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|General Practice</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>OH</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Travere Therapeutics, Inc.</td><td>100000061305</td><td>Travere Therapeutics, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>939.0</td><td>2021-04-12</td><td>Cash or cash equivalent</td><td>Other</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>DUET</td><td>No</td><td>849330003</td><td>2021</td><td>06/30/2022</td><td>NCT01613118</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>166155</td><td>1659372043</td><td>SATISH</td><td>C</td><td>MULUK</td><td>null</td><td>320 E NORTH AVE</td><td>null</td><td>PITTSBURGH</td><td>PA</td><td>15212</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Surgery|Surgical Critical Care</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Cook Medical LLC</td><td>100000005386</td><td>Cook Research Incorporated</td><td>IN</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Aortic Intervention</td><td>Zenith Spiral-Z</td><td>null</td><td>10827002552385</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>250.0</td><td>2021-06-08</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>PRESERVE: Zenith Iliac Branch System Clinical Study</td><td>No</td><td>842541251</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>440015</td><td>10348</td><td>University Of Tennessee Medical Cent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1924 Alcoa Hwy</td><td>null</td><td>Knoxville</td><td>TN</td><td>37920</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>172406</td><td>1801908223</td><td>TIMOTHY</td><td>J</td><td>PANELLA</td><td>null</td><td>1926 ALCOA HWY STE 350</td><td>null</td><td>KNOXVILLE</td><td>TN</td><td>37920</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>TN</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Pfizer Inc.</td><td>100000000286</td><td>PFIZER INC.</td><td>NY</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>BRAFTOVI</td><td>70255-025-01</td><td>null</td><td>Covered</td><td>Drug</td><td>ONCOLOGY</td><td>MEKTOVI</td><td>70255-010-02</td><td>null</td><td>Non-Covered</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>2372.96</td><td>2021-08-20</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A PHASE 3 RANDOMIZED DOUBLEBLIND STUDY OF ENCORAFENIB AND BINIMETINIB PLUS PEMBROLIZUMAB VERSUS PLACEBO PLUS PEMBROLIZUMAB IN PARTICIPANTS WITH BRAF V600EK MUTATIONPOSITIVE METASTATIC OR UNRESECTABLE LOCALLY ADVANCED MELANOMA</td><td>No</td><td>832738659</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50075</td><td>11228</td><td>Kfh - Oakland</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>280 W Macarthur Blvd</td><td>null</td><td>Oakland</td><td>CA</td><td>94611</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>616253</td><td>1891810305</td><td>SYLVIA</td><td>K</td><td>FOWLER</td><td>null</td><td>13652 CANTARA ST</td><td>13652 CANTARA ST</td><td>PANORAMA CITY</td><td>CA</td><td>91402-5423</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Merck Sharp & Dohme Corporation</td><td>100000000053</td><td>Merck Sharp & Dohme Corporation</td><td>NJ</td><td>United States</td><td>Yes</td><td>Covered</td><td>Biological</td><td>ONCOLOGY</td><td>KEYTRUDA</td><td>0006-3029-02</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>180.0</td><td>2021-12-31</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with  1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy</td><td>No</td><td>848738895</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Physician</td><td>null</td><td>null</td><td>null</td><td>null</td><td>157483</td><td>1477547206</td><td>THOMAS</td><td>null</td><td>MALDONADO</td><td>null</td><td>530 1ST AVE</td><td>6 F</td><td>NEW YORK</td><td>NY</td><td>10016</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>NY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Cook Medical LLC</td><td>100000005386</td><td>Cook Research Incorporated</td><td>IN</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>Aortic Intervention</td><td>Cook Medical Advanced Tech</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>815.0</td><td>2021-02-17</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Zenith p-Branch Endovascular Graft - Pivotal Study</td><td>No</td><td>842541515</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>50625</td><td>11293</td><td>Cedars-Sinai Medical Center</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>8700 Beverly Blvd</td><td>null</td><td>West Hollywood</td><td>CA</td><td>90048</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>316955</td><td>1982815262</td><td>SRINIVAS</td><td>null</td><td>GADDAM</td><td>null</td><td>8700 BEVERLY BLVD</td><td>null</td><td>WEST HOLLYWOOD</td><td>CA</td><td>90048</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>CA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Cook Medical LLC</td><td>100000005386</td><td>Cook Research Incorporated</td><td>IN</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>10450.0</td><td>2021-11-02</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>Gastral Jejunal Feeding Tubes Study</td><td>No</td><td>842541805</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>330270</td><td>10067</td><td>HOSPITAL FOR SPECIAL SURGERY</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>532-560 WEST 33RD STREET</td><td>null</td><td>NEW YORK</td><td>NY</td><td>10001</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>108062</td><td>1376710665</td><td>HAN</td><td>JO</td><td>KIM</td><td>null</td><td>535 E 70TH ST</td><td>null</td><td>NEW YORK</td><td>NY</td><td>10021-4823</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Orthopaedic Surgery|Orthopaedic Surgery of the Spine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>MO</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>SI-BONE, INC.</td><td>100000011102</td><td>SI-BONE, Inc.</td><td>CA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Device</td><td>SACROILIAC JOINT DYSFUNCTION</td><td>IFUSE IMPLANT</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>810.0</td><td>2021-12-31</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>SILVIA</td><td>No</td><td>845529711</td><td>2021</td><td>06/30/2022</td><td>null</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>160058</td><td>10604</td><td>University Of Iowa Hosp & Clinics</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>200 HAWKINS DR</td><td>null</td><td>IOWA CITY</td><td>IA</td><td>52242</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>4895086</td><td>1215439708</td><td>ERNESTO</td><td>ANIBAL</td><td>RUIZ DUQUE</td><td>null</td><td>200 Hawkins Dr</td><td>null</td><td>Iowa City</td><td>IA</td><td>52242-1009</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Internal Medicine</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IA</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Alnylam Pharmaceuticals Inc.</td><td>100000481817</td><td>Alnylam Pharmaceuticals Inc.</td><td>MA</td><td>United States</td><td>Yes</td><td>Covered</td><td>Drug</td><td>Genetic Disease</td><td>ONPATTRO</td><td>71336-1000-1</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1870.0</td><td>2021-08-12</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>APOLLO-B: A Phase 3, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Patisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)</td><td>No</td><td>828416195</td><td>2021</td><td>06/30/2022</td><td>NCT03997383</td><td>null</td><td>null</td></tr><tr><td>NEW</td><td>Covered Recipient Teaching Hospital</td><td>null</td><td>140119</td><td>10441</td><td>RUSH UNIVERSITY MEDICAL CENTER</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>1653 W Congress Pkwy</td><td>null</td><td>Chicago</td><td>IL</td><td>60612</td><td>United States</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Covered Recipient Physician</td><td>755347</td><td>1760419311</td><td>PETER</td><td>T</td><td>HEYDEMANN</td><td>null</td><td>1725 W HARRISON ST</td><td>710</td><td>CHICAGO</td><td>IL</td><td>60612-3841</td><td>United States</td><td>null</td><td>null</td><td>Medical Doctor</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>IL</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>PTC Therapeutics, Inc.</td><td>100000191753</td><td>PTC Therapeutics, Inc.</td><td>NJ</td><td>United States</td><td>No</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>997.07</td><td>2021-06-01</td><td>Cash or cash equivalent</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>No</td><td>No</td><td>AN OPEN-LABEL, SAFETY STUDY FOR PREVIOUSLY TREATED ATALUREN PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY</td><td>No</td><td>849320037</td><td>2021</td><td>06/30/2022</td><td>NCT01247207</td><td>null</td><td>null</td></tr></tbody></table>Showing the first 571 rows.</div>"]}}],"execution_count":0},{"cell_type":"code","source":["%sql\nselect count(*) from openpayment;"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{"implicitDf":true},"nuid":"99b63f6c-7c02-4679-9589-7559810ca3f1","inputWidgets":{},"title":""}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"data":"\u001B[0;31m---------------------------------------------------------------------------\u001B[0m\n\u001B[0;31mAnalysisException\u001B[0m                         Traceback (most recent call last)\n\u001B[0;32m<command-2047437461969043>\u001B[0m in \u001B[0;36m<cell line: 1>\u001B[0;34m()\u001B[0m\n\u001B[1;32m      5\u001B[0m     \u001B[0mdisplay\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0mdf\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m      6\u001B[0m     \u001B[0;32mreturn\u001B[0m \u001B[0mdf\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0;32m----> 7\u001B[0;31m   \u001B[0m_sqldf\u001B[0m \u001B[0;34m=\u001B[0m \u001B[0m____databricks_percent_sql\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0m\u001B[1;32m      8\u001B[0m \u001B[0;32mfinally\u001B[0m\u001B[0;34m:\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m      9\u001B[0m   \u001B[0;32mdel\u001B[0m \u001B[0m____databricks_percent_sql\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\n\u001B[0;32m<command-2047437461969043>\u001B[0m in \u001B[0;36m____databricks_percent_sql\u001B[0;34m()\u001B[0m\n\u001B[1;32m      2\u001B[0m   \u001B[0;32mdef\u001B[0m \u001B[0m____databricks_percent_sql\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m:\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m      3\u001B[0m     \u001B[0;32mimport\u001B[0m \u001B[0mbase64\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0;32m----> 4\u001B[0;31m     \u001B[0mdf\u001B[0m \u001B[0;34m=\u001B[0m \u001B[0mspark\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0msql\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0mbase64\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0mstandard_b64decode\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0;34m\"c2VsZWN0IGNvdW50KCopIGZyb20gb3BlbnBheW1lbnQ=\"\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0mdecode\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0m\u001B[1;32m      5\u001B[0m     \u001B[0mdisplay\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0mdf\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m      6\u001B[0m     \u001B[0;32mreturn\u001B[0m \u001B[0mdf\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\n\u001B[0;32m/databricks/spark/python/pyspark/instrumentation_utils.py\u001B[0m in \u001B[0;36mwrapper\u001B[0;34m(*args, **kwargs)\u001B[0m\n\u001B[1;32m     46\u001B[0m             \u001B[0mstart\u001B[0m \u001B[0;34m=\u001B[0m \u001B[0mtime\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0mperf_counter\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m     47\u001B[0m             \u001B[0;32mtry\u001B[0m\u001B[0;34m:\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0;32m---> 48\u001B[0;31m                 \u001B[0mres\u001B[0m \u001B[0;34m=\u001B[0m \u001B[0mfunc\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0;34m*\u001B[0m\u001B[0margs\u001B[0m\u001B[0;34m,\u001B[0m \u001B[0;34m**\u001B[0m\u001B[0mkwargs\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0m\u001B[1;32m     49\u001B[0m                 logger.log_success(\n\u001B[1;32m     50\u001B[0m                     \u001B[0mmodule_name\u001B[0m\u001B[0;34m,\u001B[0m \u001B[0mclass_name\u001B[0m\u001B[0;34m,\u001B[0m \u001B[0mfunction_name\u001B[0m\u001B[0;34m,\u001B[0m \u001B[0mtime\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0mperf_counter\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0;34m)\u001B[0m \u001B[0;34m-\u001B[0m \u001B[0mstart\u001B[0m\u001B[0;34m,\u001B[0m \u001B[0msignature\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\n\u001B[0;32m/databricks/spark/python/pyspark/sql/session.py\u001B[0m in \u001B[0;36msql\u001B[0;34m(self, sqlQuery, **kwargs)\u001B[0m\n\u001B[1;32m   1117\u001B[0m             \u001B[0msqlQuery\u001B[0m \u001B[0;34m=\u001B[0m \u001B[0mformatter\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0mformat\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0msqlQuery\u001B[0m\u001B[0;34m,\u001B[0m \u001B[0;34m**\u001B[0m\u001B[0mkwargs\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m   1118\u001B[0m         \u001B[0;32mtry\u001B[0m\u001B[0;34m:\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0;32m-> 1119\u001B[0;31m             \u001B[0;32mreturn\u001B[0m \u001B[0mDataFrame\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0mself\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0m_jsparkSession\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0msql\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0msqlQuery\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m,\u001B[0m \u001B[0mself\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0m\u001B[1;32m   1120\u001B[0m         \u001B[0;32mfinally\u001B[0m\u001B[0;34m:\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m   1121\u001B[0m             \u001B[0;32mif\u001B[0m \u001B[0mlen\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0mkwargs\u001B[0m\u001B[0;34m)\u001B[0m \u001B[0;34m>\u001B[0m \u001B[0;36m0\u001B[0m\u001B[0;34m:\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\n\u001B[0;32m/databricks/spark/python/lib/py4j-0.10.9.5-src.zip/py4j/java_gateway.py\u001B[0m in \u001B[0;36m__call__\u001B[0;34m(self, *args)\u001B[0m\n\u001B[1;32m   1319\u001B[0m \u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m   1320\u001B[0m         \u001B[0manswer\u001B[0m \u001B[0;34m=\u001B[0m \u001B[0mself\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0mgateway_client\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0msend_command\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0mcommand\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0;32m-> 1321\u001B[0;31m         return_value = get_return_value(\n\u001B[0m\u001B[1;32m   1322\u001B[0m             answer, self.gateway_client, self.target_id, self.name)\n\u001B[1;32m   1323\u001B[0m \u001B[0;34m\u001B[0m\u001B[0m\n\n\u001B[0;32m/databricks/spark/python/pyspark/sql/utils.py\u001B[0m in \u001B[0;36mdeco\u001B[0;34m(*a, **kw)\u001B[0m\n\u001B[1;32m    200\u001B[0m                 \u001B[0;31m# Hide where the exception came from that shows a non-Pythonic\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m    201\u001B[0m                 \u001B[0;31m# JVM exception message.\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0;32m--> 202\u001B[0;31m                 \u001B[0;32mraise\u001B[0m \u001B[0mconverted\u001B[0m \u001B[0;32mfrom\u001B[0m \u001B[0;32mNone\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0m\u001B[1;32m    203\u001B[0m             \u001B[0;32melse\u001B[0m\u001B[0;34m:\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m    204\u001B[0m                 \u001B[0;32mraise\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\n\u001B[0;31mAnalysisException\u001B[0m: Table or view not found: openpayment; line 1 pos 21;\n'Aggregate [unresolvedalias(count(1), None)]\n+- 'UnresolvedRelation [openpayment], [], false\n","errorSummary":"<span class='ansi-red-fg'>AnalysisException</span>: Table or view not found: openpayment; line 1 pos 21;\n'Aggregate [unresolvedalias(count(1), None)]\n+- 'UnresolvedRelation [openpayment], [], false\n","metadata":{},"errorTraceType":"ansi","type":"ipynbError","arguments":{}}},"output_type":"display_data","data":{"text/plain":["\u001B[0;31m---------------------------------------------------------------------------\u001B[0m\n\u001B[0;31mAnalysisException\u001B[0m                         Traceback (most recent call last)\n\u001B[0;32m<command-2047437461969043>\u001B[0m in \u001B[0;36m<cell line: 1>\u001B[0;34m()\u001B[0m\n\u001B[1;32m      5\u001B[0m     \u001B[0mdisplay\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0mdf\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m      6\u001B[0m     \u001B[0;32mreturn\u001B[0m \u001B[0mdf\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0;32m----> 7\u001B[0;31m   \u001B[0m_sqldf\u001B[0m \u001B[0;34m=\u001B[0m \u001B[0m____databricks_percent_sql\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0m\u001B[1;32m      8\u001B[0m \u001B[0;32mfinally\u001B[0m\u001B[0;34m:\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m      9\u001B[0m   \u001B[0;32mdel\u001B[0m \u001B[0m____databricks_percent_sql\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\n\u001B[0;32m<command-2047437461969043>\u001B[0m in \u001B[0;36m____databricks_percent_sql\u001B[0;34m()\u001B[0m\n\u001B[1;32m      2\u001B[0m   \u001B[0;32mdef\u001B[0m \u001B[0m____databricks_percent_sql\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m:\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m      3\u001B[0m     \u001B[0;32mimport\u001B[0m \u001B[0mbase64\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0;32m----> 4\u001B[0;31m     \u001B[0mdf\u001B[0m \u001B[0;34m=\u001B[0m \u001B[0mspark\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0msql\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0mbase64\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0mstandard_b64decode\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0;34m\"c2VsZWN0IGNvdW50KCopIGZyb20gb3BlbnBheW1lbnQ=\"\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0mdecode\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0m\u001B[1;32m      5\u001B[0m     \u001B[0mdisplay\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0mdf\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m      6\u001B[0m     \u001B[0;32mreturn\u001B[0m \u001B[0mdf\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\n\u001B[0;32m/databricks/spark/python/pyspark/instrumentation_utils.py\u001B[0m in \u001B[0;36mwrapper\u001B[0;34m(*args, **kwargs)\u001B[0m\n\u001B[1;32m     46\u001B[0m             \u001B[0mstart\u001B[0m \u001B[0;34m=\u001B[0m \u001B[0mtime\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0mperf_counter\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m     47\u001B[0m             \u001B[0;32mtry\u001B[0m\u001B[0;34m:\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0;32m---> 48\u001B[0;31m                 \u001B[0mres\u001B[0m \u001B[0;34m=\u001B[0m \u001B[0mfunc\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0;34m*\u001B[0m\u001B[0margs\u001B[0m\u001B[0;34m,\u001B[0m \u001B[0;34m**\u001B[0m\u001B[0mkwargs\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0m\u001B[1;32m     49\u001B[0m                 logger.log_success(\n\u001B[1;32m     50\u001B[0m                     \u001B[0mmodule_name\u001B[0m\u001B[0;34m,\u001B[0m \u001B[0mclass_name\u001B[0m\u001B[0;34m,\u001B[0m \u001B[0mfunction_name\u001B[0m\u001B[0;34m,\u001B[0m \u001B[0mtime\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0mperf_counter\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0;34m)\u001B[0m \u001B[0;34m-\u001B[0m \u001B[0mstart\u001B[0m\u001B[0;34m,\u001B[0m \u001B[0msignature\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\n\u001B[0;32m/databricks/spark/python/pyspark/sql/session.py\u001B[0m in \u001B[0;36msql\u001B[0;34m(self, sqlQuery, **kwargs)\u001B[0m\n\u001B[1;32m   1117\u001B[0m             \u001B[0msqlQuery\u001B[0m \u001B[0;34m=\u001B[0m \u001B[0mformatter\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0mformat\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0msqlQuery\u001B[0m\u001B[0;34m,\u001B[0m \u001B[0;34m**\u001B[0m\u001B[0mkwargs\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m   1118\u001B[0m         \u001B[0;32mtry\u001B[0m\u001B[0;34m:\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0;32m-> 1119\u001B[0;31m             \u001B[0;32mreturn\u001B[0m \u001B[0mDataFrame\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0mself\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0m_jsparkSession\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0msql\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0msqlQuery\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m,\u001B[0m \u001B[0mself\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0m\u001B[1;32m   1120\u001B[0m         \u001B[0;32mfinally\u001B[0m\u001B[0;34m:\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m   1121\u001B[0m             \u001B[0;32mif\u001B[0m \u001B[0mlen\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0mkwargs\u001B[0m\u001B[0;34m)\u001B[0m \u001B[0;34m>\u001B[0m \u001B[0;36m0\u001B[0m\u001B[0;34m:\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\n\u001B[0;32m/databricks/spark/python/lib/py4j-0.10.9.5-src.zip/py4j/java_gateway.py\u001B[0m in \u001B[0;36m__call__\u001B[0;34m(self, *args)\u001B[0m\n\u001B[1;32m   1319\u001B[0m \u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m   1320\u001B[0m         \u001B[0manswer\u001B[0m \u001B[0;34m=\u001B[0m \u001B[0mself\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0mgateway_client\u001B[0m\u001B[0;34m.\u001B[0m\u001B[0msend_command\u001B[0m\u001B[0;34m(\u001B[0m\u001B[0mcommand\u001B[0m\u001B[0;34m)\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0;32m-> 1321\u001B[0;31m         return_value = get_return_value(\n\u001B[0m\u001B[1;32m   1322\u001B[0m             answer, self.gateway_client, self.target_id, self.name)\n\u001B[1;32m   1323\u001B[0m \u001B[0;34m\u001B[0m\u001B[0m\n\n\u001B[0;32m/databricks/spark/python/pyspark/sql/utils.py\u001B[0m in \u001B[0;36mdeco\u001B[0;34m(*a, **kw)\u001B[0m\n\u001B[1;32m    200\u001B[0m                 \u001B[0;31m# Hide where the exception came from that shows a non-Pythonic\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m    201\u001B[0m                 \u001B[0;31m# JVM exception message.\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0;32m--> 202\u001B[0;31m                 \u001B[0;32mraise\u001B[0m \u001B[0mconverted\u001B[0m \u001B[0;32mfrom\u001B[0m \u001B[0;32mNone\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[0m\u001B[1;32m    203\u001B[0m             \u001B[0;32melse\u001B[0m\u001B[0;34m:\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\u001B[1;32m    204\u001B[0m                 \u001B[0;32mraise\u001B[0m\u001B[0;34m\u001B[0m\u001B[0;34m\u001B[0m\u001B[0m\n\n\u001B[0;31mAnalysisException\u001B[0m: Table or view not found: openpayment; line 1 pos 21;\n'Aggregate [unresolvedalias(count(1), None)]\n+- 'UnresolvedRelation [openpayment], [], false\n"]}}],"execution_count":0},{"cell_type":"code","source":["df.printSchema()"],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{},"nuid":"234ba52a-14c4-4e9c-b148-afe2ae6ca0eb","inputWidgets":{},"title":""}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"root\n |-- Change_Type: string (nullable = true)\n |-- Covered_Recipient_Type: string (nullable = true)\n |-- Noncovered_Recipient_Entity_Name: string (nullable = true)\n |-- Teaching_Hospital_CCN: integer (nullable = true)\n |-- Teaching_Hospital_ID: integer (nullable = true)\n |-- Teaching_Hospital_Name: string (nullable = true)\n |-- Covered_Recipient_Profile_ID: integer (nullable = true)\n |-- Covered_Recipient_NPI: integer (nullable = true)\n |-- Covered_Recipient_First_Name: string (nullable = true)\n |-- Covered_Recipient_Middle_Name: string (nullable = true)\n |-- Covered_Recipient_Last_Name: string (nullable = true)\n |-- Covered_Recipient_Name_Suffix: string (nullable = true)\n |-- Recipient_Primary_Business_Street_Address_Line1: string (nullable = true)\n |-- Recipient_Primary_Business_Street_Address_Line2: string (nullable = true)\n |-- Recipient_City: string (nullable = true)\n |-- Recipient_State: string (nullable = true)\n |-- Recipient_Zip_Code: string (nullable = true)\n |-- Recipient_Country: string (nullable = true)\n |-- Recipient_Province: string (nullable = true)\n |-- Recipient_Postal_Code: string (nullable = true)\n |-- Covered_Recipient_Primary_Type_1: string (nullable = true)\n |-- Covered_Recipient_Primary_Type_2: string (nullable = true)\n |-- Covered_Recipient_Primary_Type_3: string (nullable = true)\n |-- Covered_Recipient_Primary_Type_4: string (nullable = true)\n |-- Covered_Recipient_Primary_Type_5: string (nullable = true)\n |-- Covered_Recipient_Primary_Type_6: string (nullable = true)\n |-- Covered_Recipient_Specialty_1: string (nullable = true)\n |-- Covered_Recipient_Specialty_2: string (nullable = true)\n |-- Covered_Recipient_Specialty_3: string (nullable = true)\n |-- Covered_Recipient_Specialty_4: string (nullable = true)\n |-- Covered_Recipient_Specialty_5: string (nullable = true)\n |-- Covered_Recipient_Specialty_6: string (nullable = true)\n |-- Covered_Recipient_License_State_code1: string (nullable = true)\n |-- Covered_Recipient_License_State_code2: string (nullable = true)\n |-- Covered_Recipient_License_State_code3: string (nullable = true)\n |-- Covered_Recipient_License_State_code4: string (nullable = true)\n |-- Covered_Recipient_License_State_code5: string (nullable = true)\n |-- Principal_Investigator_1_Covered_Recipient_Type: string (nullable = true)\n |-- Principal_Investigator_1_Profile_ID: integer (nullable = true)\n |-- Principal_Investigator_1_NPI: integer (nullable = true)\n |-- Principal_Investigator_1_First_Name: string (nullable = true)\n |-- Principal_Investigator_1_Middle_Name: string (nullable = true)\n |-- Principal_Investigator_1_Last_Name: string (nullable = true)\n |-- Principal_Investigator_1_Name_Suffix: string (nullable = true)\n |-- Principal_Investigator_1_Business_Street_Address_Line1: string (nullable = true)\n |-- Principal_Investigator_1_Business_Street_Address_Line2: string (nullable = true)\n |-- Principal_Investigator_1_City: string (nullable = true)\n |-- Principal_Investigator_1_State: string (nullable = true)\n |-- Principal_Investigator_1_Zip_Code: string (nullable = true)\n |-- Principal_Investigator_1_Country: string (nullable = true)\n |-- Principal_Investigator_1_Province: string (nullable = true)\n |-- Principal_Investigator_1_Postal_Code: string (nullable = true)\n |-- Principal_Investigator_1_Primary_Type_1: string (nullable = true)\n |-- Principal_Investigator_1_Primary_Type_2: string (nullable = true)\n |-- Principal_Investigator_1_Primary_Type_3: string (nullable = true)\n |-- Principal_Investigator_1_Primary_Type_4: string (nullable = true)\n |-- Principal_Investigator_1_Primary_Type_5: string (nullable = true)\n |-- Principal_Investigator_1_Primary_Type_6: string (nullable = true)\n |-- Principal_Investigator_1_Specialty_1: string (nullable = true)\n |-- Principal_Investigator_1_Specialty_2: string (nullable = true)\n |-- Principal_Investigator_1_Specialty_3: string (nullable = true)\n |-- Principal_Investigator_1_Specialty_4: string (nullable = true)\n |-- Principal_Investigator_1_Specialty_5: string (nullable = true)\n |-- Principal_Investigator_1_Specialty_6: string (nullable = true)\n |-- Principal_Investigator_1_License_State_code1: string (nullable = true)\n |-- Principal_Investigator_1_License_State_code2: string (nullable = true)\n |-- Principal_Investigator_1_License_State_code3: string (nullable = true)\n |-- Principal_Investigator_1_License_State_code4: string (nullable = true)\n |-- Principal_Investigator_1_License_State_code5: string (nullable = true)\n |-- Principal_Investigator_2_Covered_Recipient_Type: string (nullable = true)\n |-- Principal_Investigator_2_Profile_ID: integer (nullable = true)\n |-- Principal_Investigator_2_NPI: integer (nullable = true)\n |-- Principal_Investigator_2_First_Name: string (nullable = true)\n |-- Principal_Investigator_2_Middle_Name: string (nullable = true)\n |-- Principal_Investigator_2_Last_Name: string (nullable = true)\n |-- Principal_Investigator_2_Name_Suffix: string (nullable = true)\n |-- Principal_Investigator_2_Business_Street_Address_Line1: string (nullable = true)\n |-- Principal_Investigator_2_Business_Street_Address_Line2: string (nullable = true)\n |-- Principal_Investigator_2_City: string (nullable = true)\n |-- Principal_Investigator_2_State: string (nullable = true)\n |-- Principal_Investigator_2_Zip_Code: string (nullable = true)\n |-- Principal_Investigator_2_Country: string (nullable = true)\n |-- Principal_Investigator_2_Province: string (nullable = true)\n |-- Principal_Investigator_2_Postal_Code: string (nullable = true)\n |-- Principal_Investigator_2_Primary_Type_1: string (nullable = true)\n |-- Principal_Investigator_2_Primary_Type_2: string (nullable = true)\n |-- Principal_Investigator_2_Primary_Type_3: string (nullable = true)\n |-- Principal_Investigator_2_Primary_Type_4: string (nullable = true)\n |-- Principal_Investigator_2_Primary_Type_5: string (nullable = true)\n |-- Principal_Investigator_2_Primary_Type_6: string (nullable = true)\n |-- Principal_Investigator_2_Specialty_1: string (nullable = true)\n |-- Principal_Investigator_2_Specialty_2: string (nullable = true)\n |-- Principal_Investigator_2_Specialty_3: string (nullable = true)\n |-- Principal_Investigator_2_Specialty_4: string (nullable = true)\n |-- Principal_Investigator_2_Specialty_5: string (nullable = true)\n |-- Principal_Investigator_2_Specialty_6: string (nullable = true)\n |-- Principal_Investigator_2_License_State_code1: string (nullable = true)\n |-- Principal_Investigator_2_License_State_code2: string (nullable = true)\n |-- Principal_Investigator_2_License_State_code3: string (nullable = true)\n |-- Principal_Investigator_2_License_State_code4: string (nullable = true)\n |-- Principal_Investigator_2_License_State_code5: string (nullable = true)\n |-- Principal_Investigator_3_Covered_Recipient_Type: string (nullable = true)\n |-- Principal_Investigator_3_Profile_ID: integer (nullable = true)\n |-- Principal_Investigator_3_NPI: integer (nullable = true)\n |-- Principal_Investigator_3_First_Name: string (nullable = true)\n |-- Principal_Investigator_3_Middle_Name: string (nullable = true)\n |-- Principal_Investigator_3_Last_Name: string (nullable = true)\n |-- Principal_Investigator_3_Name_Suffix: string (nullable = true)\n |-- Principal_Investigator_3_Business_Street_Address_Line1: string (nullable = true)\n |-- Principal_Investigator_3_Business_Street_Address_Line2: string (nullable = true)\n |-- Principal_Investigator_3_City: string (nullable = true)\n |-- Principal_Investigator_3_State: string (nullable = true)\n |-- Principal_Investigator_3_Zip_Code: string (nullable = true)\n |-- Principal_Investigator_3_Country: string (nullable = true)\n |-- Principal_Investigator_3_Province: string (nullable = true)\n |-- Principal_Investigator_3_Postal_Code: string (nullable = true)\n |-- Principal_Investigator_3_Primary_Type_1: string (nullable = true)\n |-- Principal_Investigator_3_Primary_Type_2: string (nullable = true)\n |-- Principal_Investigator_3_Primary_Type_3: string (nullable = true)\n |-- Principal_Investigator_3_Primary_Type_4: string (nullable = true)\n |-- Principal_Investigator_3_Primary_Type_5: string (nullable = true)\n |-- Principal_Investigator_3_Primary_Type_6: string (nullable = true)\n |-- Principal_Investigator_3_Specialty_1: string (nullable = true)\n |-- Principal_Investigator_3_Specialty_2: string (nullable = true)\n |-- Principal_Investigator_3_Specialty_3: string (nullable = true)\n |-- Principal_Investigator_3_Specialty_4: string (nullable = true)\n |-- Principal_Investigator_3_Specialty_5: string (nullable = true)\n |-- Principal_Investigator_3_Specialty_6: string (nullable = true)\n |-- Principal_Investigator_3_License_State_code1: string (nullable = true)\n |-- Principal_Investigator_3_License_State_code2: string (nullable = true)\n |-- Principal_Investigator_3_License_State_code3: string (nullable = true)\n |-- Principal_Investigator_3_License_State_code4: string (nullable = true)\n |-- Principal_Investigator_3_License_State_code5: string (nullable = true)\n |-- Principal_Investigator_4_Covered_Recipient_Type: string (nullable = true)\n |-- Principal_Investigator_4_Profile_ID: integer (nullable = true)\n |-- Principal_Investigator_4_NPI: integer (nullable = true)\n |-- Principal_Investigator_4_First_Name: string (nullable = true)\n |-- Principal_Investigator_4_Middle_Name: string (nullable = true)\n |-- Principal_Investigator_4_Last_Name: string (nullable = true)\n |-- Principal_Investigator_4_Name_Suffix: string (nullable = true)\n |-- Principal_Investigator_4_Business_Street_Address_Line1: string (nullable = true)\n |-- Principal_Investigator_4_Business_Street_Address_Line2: string (nullable = true)\n |-- Principal_Investigator_4_City: string (nullable = true)\n |-- Principal_Investigator_4_State: string (nullable = true)\n |-- Principal_Investigator_4_Zip_Code: string (nullable = true)\n |-- Principal_Investigator_4_Country: string (nullable = true)\n |-- Principal_Investigator_4_Province: string (nullable = true)\n |-- Principal_Investigator_4_Postal_Code: string (nullable = true)\n |-- Principal_Investigator_4_Primary_Type_1: string (nullable = true)\n |-- Principal_Investigator_4_Primary_Type_2: string (nullable = true)\n |-- Principal_Investigator_4_Primary_Type_3: string (nullable = true)\n |-- Principal_Investigator_4_Primary_Type_4: string (nullable = true)\n |-- Principal_Investigator_4_Primary_Type_5: string (nullable = true)\n |-- Principal_Investigator_4_Primary_Type_6: string (nullable = true)\n |-- Principal_Investigator_4_Specialty_1: string (nullable = true)\n |-- Principal_Investigator_4_Specialty_2: string (nullable = true)\n |-- Principal_Investigator_4_Specialty_3: string (nullable = true)\n |-- Principal_Investigator_4_Specialty_4: string (nullable = true)\n |-- Principal_Investigator_4_Specialty_5: string (nullable = true)\n |-- Principal_Investigator_4_Specialty_6: string (nullable = true)\n |-- Principal_Investigator_4_License_State_code1: string (nullable = true)\n |-- Principal_Investigator_4_License_State_code2: string (nullable = true)\n |-- Principal_Investigator_4_License_State_code3: string (nullable = true)\n |-- Principal_Investigator_4_License_State_code4: string (nullable = true)\n |-- Principal_Investigator_4_License_State_code5: string (nullable = true)\n |-- Principal_Investigator_5_Covered_Recipient_Type: string (nullable = true)\n |-- Principal_Investigator_5_Profile_ID: integer (nullable = true)\n |-- Principal_Investigator_5_NPI: integer (nullable = true)\n |-- Principal_Investigator_5_First_Name: string (nullable = true)\n |-- Principal_Investigator_5_Middle_Name: string (nullable = true)\n |-- Principal_Investigator_5_Last_Name: string (nullable = true)\n |-- Principal_Investigator_5_Name_Suffix: string (nullable = true)\n |-- Principal_Investigator_5_Business_Street_Address_Line1: string (nullable = true)\n |-- Principal_Investigator_5_Business_Street_Address_Line2: string (nullable = true)\n |-- Principal_Investigator_5_City: string (nullable = true)\n |-- Principal_Investigator_5_State: string (nullable = true)\n |-- Principal_Investigator_5_Zip_Code: string (nullable = true)\n |-- Principal_Investigator_5_Country: string (nullable = true)\n |-- Principal_Investigator_5_Province: string (nullable = true)\n |-- Principal_Investigator_5_Postal_Code: string (nullable = true)\n |-- Principal_Investigator_5_Primary_Type_1: string (nullable = true)\n |-- Principal_Investigator_5_Primary_Type_2: string (nullable = true)\n |-- Principal_Investigator_5_Primary_Type_3: string (nullable = true)\n |-- Principal_Investigator_5_Primary_Type_4: string (nullable = true)\n |-- Principal_Investigator_5_Primary_Type_5: string (nullable = true)\n |-- Principal_Investigator_5_Primary_Type_6: string (nullable = true)\n |-- Principal_Investigator_5_Specialty_1: string (nullable = true)\n |-- Principal_Investigator_5_Specialty_2: string (nullable = true)\n |-- Principal_Investigator_5_Specialty_3: string (nullable = true)\n |-- Principal_Investigator_5_Specialty_4: string (nullable = true)\n |-- Principal_Investigator_5_Specialty_5: string (nullable = true)\n |-- Principal_Investigator_5_Specialty_6: string (nullable = true)\n |-- Principal_Investigator_5_License_State_code1: string (nullable = true)\n |-- Principal_Investigator_5_License_State_code2: string (nullable = true)\n |-- Principal_Investigator_5_License_State_code3: string (nullable = true)\n |-- Principal_Investigator_5_License_State_code4: string (nullable = true)\n |-- Principal_Investigator_5_License_State_code5: string (nullable = true)\n |-- Submitting_Applicable_Manufacturer_or_Applicable_GPO_Name: string (nullable = true)\n |-- Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID: long (nullable = true)\n |-- Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name: string (nullable = true)\n |-- Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State: string (nullable = true)\n |-- Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Country: string (nullable = true)\n |-- Related_Product_Indicator: string (nullable = true)\n |-- Covered_or_Noncovered_Indicator_1: string (nullable = true)\n |-- Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_1: string (nullable = true)\n |-- Product_Category_or_Therapeutic_Area_1: string (nullable = true)\n |-- Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_1: string (nullable = true)\n |-- Associated_Drug_or_Biological_NDC_1: string (nullable = true)\n |-- Associated_Device_or_Medical_Supply_PDI_1: string (nullable = true)\n |-- Covered_or_Noncovered_Indicator_2: string (nullable = true)\n |-- Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_2: string (nullable = true)\n |-- Product_Category_or_Therapeutic_Area_2: string (nullable = true)\n |-- Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_2: string (nullable = true)\n |-- Associated_Drug_or_Biological_NDC_2: string (nullable = true)\n |-- Associated_Device_or_Medical_Supply_PDI_2: string (nullable = true)\n |-- Covered_or_Noncovered_Indicator_3: string (nullable = true)\n |-- Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_3: string (nullable = true)\n |-- Product_Category_or_Therapeutic_Area_3: string (nullable = true)\n |-- Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_3: string (nullable = true)\n |-- Associated_Drug_or_Biological_NDC_3: string (nullable = true)\n |-- Associated_Device_or_Medical_Supply_PDI_3: string (nullable = true)\n |-- Covered_or_Noncovered_Indicator_4: string (nullable = true)\n |-- Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_4: string (nullable = true)\n |-- Product_Category_or_Therapeutic_Area_4: string (nullable = true)\n |-- Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_4: string (nullable = true)\n |-- Associated_Drug_or_Biological_NDC_4: string (nullable = true)\n |-- Associated_Device_or_Medical_Supply_PDI_4: long (nullable = true)\n |-- Covered_or_Noncovered_Indicator_5: string (nullable = true)\n |-- Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_5: string (nullable = true)\n |-- Product_Category_or_Therapeutic_Area_5: string (nullable = true)\n |-- Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_5: string (nullable = true)\n |-- Associated_Drug_or_Biological_NDC_5: string (nullable = true)\n |-- Associated_Device_or_Medical_Supply_PDI_5: long (nullable = true)\n |-- Total_Amount_of_Payment_USDollars: double (nullable = true)\n |-- Date_of_Payment: date (nullable = true)\n |-- Form_of_Payment_or_Transfer_of_Value: string (nullable = true)\n |-- Expenditure_Category1: string (nullable = true)\n |-- Expenditure_Category2: string (nullable = true)\n |-- Expenditure_Category3: string (nullable = true)\n |-- Expenditure_Category4: string (nullable = true)\n |-- Expenditure_Category5: string (nullable = true)\n |-- Expenditure_Category6: string (nullable = true)\n |-- Preclinical_Research_Indicator: string (nullable = true)\n |-- Delay_in_Publication_Indicator: string (nullable = true)\n |-- Name_of_Study: string (nullable = true)\n |-- Dispute_Status_for_Publication: string (nullable = true)\n |-- Record_ID: string (nullable = true)\n |-- Program_Year: string (nullable = true)\n |-- Payment_Publication_Date: string (nullable = true)\n |-- ClinicalTrials_Gov_Identifier: string (nullable = true)\n |-- Research_Information_Link: string (nullable = true)\n |-- Context_of_Research: string (nullable = true)\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["root\n |-- Change_Type: string (nullable = true)\n |-- Covered_Recipient_Type: string (nullable = true)\n |-- Noncovered_Recipient_Entity_Name: string (nullable = true)\n |-- Teaching_Hospital_CCN: integer (nullable = true)\n |-- Teaching_Hospital_ID: integer (nullable = true)\n |-- Teaching_Hospital_Name: string (nullable = true)\n |-- Covered_Recipient_Profile_ID: integer (nullable = true)\n |-- Covered_Recipient_NPI: integer (nullable = true)\n |-- Covered_Recipient_First_Name: string (nullable = true)\n |-- Covered_Recipient_Middle_Name: string (nullable = true)\n |-- Covered_Recipient_Last_Name: string (nullable = true)\n |-- Covered_Recipient_Name_Suffix: string (nullable = true)\n |-- Recipient_Primary_Business_Street_Address_Line1: string (nullable = true)\n |-- Recipient_Primary_Business_Street_Address_Line2: string (nullable = true)\n |-- Recipient_City: string (nullable = true)\n |-- Recipient_State: string (nullable = true)\n |-- Recipient_Zip_Code: string (nullable = true)\n |-- Recipient_Country: string (nullable = true)\n |-- Recipient_Province: string (nullable = true)\n |-- Recipient_Postal_Code: string (nullable = true)\n |-- Covered_Recipient_Primary_Type_1: string (nullable = true)\n |-- Covered_Recipient_Primary_Type_2: string (nullable = true)\n |-- Covered_Recipient_Primary_Type_3: string (nullable = true)\n |-- Covered_Recipient_Primary_Type_4: string (nullable = true)\n |-- Covered_Recipient_Primary_Type_5: string (nullable = true)\n |-- Covered_Recipient_Primary_Type_6: string (nullable = true)\n |-- Covered_Recipient_Specialty_1: string (nullable = true)\n |-- Covered_Recipient_Specialty_2: string (nullable = true)\n |-- Covered_Recipient_Specialty_3: string (nullable = true)\n |-- Covered_Recipient_Specialty_4: string (nullable = true)\n |-- Covered_Recipient_Specialty_5: string (nullable = true)\n |-- Covered_Recipient_Specialty_6: string (nullable = true)\n |-- Covered_Recipient_License_State_code1: string (nullable = true)\n |-- Covered_Recipient_License_State_code2: string (nullable = true)\n |-- Covered_Recipient_License_State_code3: string (nullable = true)\n |-- Covered_Recipient_License_State_code4: string (nullable = true)\n |-- Covered_Recipient_License_State_code5: string (nullable = true)\n |-- Principal_Investigator_1_Covered_Recipient_Type: string (nullable = true)\n |-- Principal_Investigator_1_Profile_ID: integer (nullable = true)\n |-- Principal_Investigator_1_NPI: integer (nullable = true)\n |-- Principal_Investigator_1_First_Name: string (nullable = true)\n |-- Principal_Investigator_1_Middle_Name: string (nullable = true)\n |-- Principal_Investigator_1_Last_Name: string (nullable = true)\n |-- Principal_Investigator_1_Name_Suffix: string (nullable = true)\n |-- Principal_Investigator_1_Business_Street_Address_Line1: string (nullable = true)\n |-- Principal_Investigator_1_Business_Street_Address_Line2: string (nullable = true)\n |-- Principal_Investigator_1_City: string (nullable = true)\n |-- Principal_Investigator_1_State: string (nullable = true)\n |-- Principal_Investigator_1_Zip_Code: string (nullable = true)\n |-- Principal_Investigator_1_Country: string (nullable = true)\n |-- Principal_Investigator_1_Province: string (nullable = true)\n |-- Principal_Investigator_1_Postal_Code: string (nullable = true)\n |-- Principal_Investigator_1_Primary_Type_1: string (nullable = true)\n |-- Principal_Investigator_1_Primary_Type_2: string (nullable = true)\n |-- Principal_Investigator_1_Primary_Type_3: string (nullable = true)\n |-- Principal_Investigator_1_Primary_Type_4: string (nullable = true)\n |-- Principal_Investigator_1_Primary_Type_5: string (nullable = true)\n |-- Principal_Investigator_1_Primary_Type_6: string (nullable = true)\n |-- Principal_Investigator_1_Specialty_1: string (nullable = true)\n |-- Principal_Investigator_1_Specialty_2: string (nullable = true)\n |-- Principal_Investigator_1_Specialty_3: string (nullable = true)\n |-- Principal_Investigator_1_Specialty_4: string (nullable = true)\n |-- Principal_Investigator_1_Specialty_5: string (nullable = true)\n |-- Principal_Investigator_1_Specialty_6: string (nullable = true)\n |-- Principal_Investigator_1_License_State_code1: string (nullable = true)\n |-- Principal_Investigator_1_License_State_code2: string (nullable = true)\n |-- Principal_Investigator_1_License_State_code3: string (nullable = true)\n |-- Principal_Investigator_1_License_State_code4: string (nullable = true)\n |-- Principal_Investigator_1_License_State_code5: string (nullable = true)\n |-- Principal_Investigator_2_Covered_Recipient_Type: string (nullable = true)\n |-- Principal_Investigator_2_Profile_ID: integer (nullable = true)\n |-- Principal_Investigator_2_NPI: integer (nullable = true)\n |-- Principal_Investigator_2_First_Name: string (nullable = true)\n |-- Principal_Investigator_2_Middle_Name: string (nullable = true)\n |-- Principal_Investigator_2_Last_Name: string (nullable = true)\n |-- Principal_Investigator_2_Name_Suffix: string (nullable = true)\n |-- Principal_Investigator_2_Business_Street_Address_Line1: string (nullable = true)\n |-- Principal_Investigator_2_Business_Street_Address_Line2: string (nullable = true)\n |-- Principal_Investigator_2_City: string (nullable = true)\n |-- Principal_Investigator_2_State: string (nullable = true)\n |-- Principal_Investigator_2_Zip_Code: string (nullable = true)\n |-- Principal_Investigator_2_Country: string (nullable = true)\n |-- Principal_Investigator_2_Province: string (nullable = true)\n |-- Principal_Investigator_2_Postal_Code: string (nullable = true)\n |-- Principal_Investigator_2_Primary_Type_1: string (nullable = true)\n |-- Principal_Investigator_2_Primary_Type_2: string (nullable = true)\n |-- Principal_Investigator_2_Primary_Type_3: string (nullable = true)\n |-- Principal_Investigator_2_Primary_Type_4: string (nullable = true)\n |-- Principal_Investigator_2_Primary_Type_5: string (nullable = true)\n |-- Principal_Investigator_2_Primary_Type_6: string (nullable = true)\n |-- Principal_Investigator_2_Specialty_1: string (nullable = true)\n |-- Principal_Investigator_2_Specialty_2: string (nullable = true)\n |-- Principal_Investigator_2_Specialty_3: string (nullable = true)\n |-- Principal_Investigator_2_Specialty_4: string (nullable = true)\n |-- Principal_Investigator_2_Specialty_5: string (nullable = true)\n |-- Principal_Investigator_2_Specialty_6: string (nullable = true)\n |-- Principal_Investigator_2_License_State_code1: string (nullable = true)\n |-- Principal_Investigator_2_License_State_code2: string (nullable = true)\n |-- Principal_Investigator_2_License_State_code3: string (nullable = true)\n |-- Principal_Investigator_2_License_State_code4: string (nullable = true)\n |-- Principal_Investigator_2_License_State_code5: string (nullable = true)\n |-- Principal_Investigator_3_Covered_Recipient_Type: string (nullable = true)\n |-- Principal_Investigator_3_Profile_ID: integer (nullable = true)\n |-- Principal_Investigator_3_NPI: integer (nullable = true)\n |-- Principal_Investigator_3_First_Name: string (nullable = true)\n |-- Principal_Investigator_3_Middle_Name: string (nullable = true)\n |-- Principal_Investigator_3_Last_Name: string (nullable = true)\n |-- Principal_Investigator_3_Name_Suffix: string (nullable = true)\n |-- Principal_Investigator_3_Business_Street_Address_Line1: string (nullable = true)\n |-- Principal_Investigator_3_Business_Street_Address_Line2: string (nullable = true)\n |-- Principal_Investigator_3_City: string (nullable = true)\n |-- Principal_Investigator_3_State: string (nullable = true)\n |-- Principal_Investigator_3_Zip_Code: string (nullable = true)\n |-- Principal_Investigator_3_Country: string (nullable = true)\n |-- Principal_Investigator_3_Province: string (nullable = true)\n |-- Principal_Investigator_3_Postal_Code: string (nullable = true)\n |-- Principal_Investigator_3_Primary_Type_1: string (nullable = true)\n |-- Principal_Investigator_3_Primary_Type_2: string (nullable = true)\n |-- Principal_Investigator_3_Primary_Type_3: string (nullable = true)\n |-- Principal_Investigator_3_Primary_Type_4: string (nullable = true)\n |-- Principal_Investigator_3_Primary_Type_5: string (nullable = true)\n |-- Principal_Investigator_3_Primary_Type_6: string (nullable = true)\n |-- Principal_Investigator_3_Specialty_1: string (nullable = true)\n |-- Principal_Investigator_3_Specialty_2: string (nullable = true)\n |-- Principal_Investigator_3_Specialty_3: string (nullable = true)\n |-- Principal_Investigator_3_Specialty_4: string (nullable = true)\n |-- Principal_Investigator_3_Specialty_5: string (nullable = true)\n |-- Principal_Investigator_3_Specialty_6: string (nullable = true)\n |-- Principal_Investigator_3_License_State_code1: string (nullable = true)\n |-- Principal_Investigator_3_License_State_code2: string (nullable = true)\n |-- Principal_Investigator_3_License_State_code3: string (nullable = true)\n |-- Principal_Investigator_3_License_State_code4: string (nullable = true)\n |-- Principal_Investigator_3_License_State_code5: string (nullable = true)\n |-- Principal_Investigator_4_Covered_Recipient_Type: string (nullable = true)\n |-- Principal_Investigator_4_Profile_ID: integer (nullable = true)\n |-- Principal_Investigator_4_NPI: integer (nullable = true)\n |-- Principal_Investigator_4_First_Name: string (nullable = true)\n |-- Principal_Investigator_4_Middle_Name: string (nullable = true)\n |-- Principal_Investigator_4_Last_Name: string (nullable = true)\n |-- Principal_Investigator_4_Name_Suffix: string (nullable = true)\n |-- Principal_Investigator_4_Business_Street_Address_Line1: string (nullable = true)\n |-- Principal_Investigator_4_Business_Street_Address_Line2: string (nullable = true)\n |-- Principal_Investigator_4_City: string (nullable = true)\n |-- Principal_Investigator_4_State: string (nullable = true)\n |-- Principal_Investigator_4_Zip_Code: string (nullable = true)\n |-- Principal_Investigator_4_Country: string (nullable = true)\n |-- Principal_Investigator_4_Province: string (nullable = true)\n |-- Principal_Investigator_4_Postal_Code: string (nullable = true)\n |-- Principal_Investigator_4_Primary_Type_1: string (nullable = true)\n |-- Principal_Investigator_4_Primary_Type_2: string (nullable = true)\n |-- Principal_Investigator_4_Primary_Type_3: string (nullable = true)\n |-- Principal_Investigator_4_Primary_Type_4: string (nullable = true)\n |-- Principal_Investigator_4_Primary_Type_5: string (nullable = true)\n |-- Principal_Investigator_4_Primary_Type_6: string (nullable = true)\n |-- Principal_Investigator_4_Specialty_1: string (nullable = true)\n |-- Principal_Investigator_4_Specialty_2: string (nullable = true)\n |-- Principal_Investigator_4_Specialty_3: string (nullable = true)\n |-- Principal_Investigator_4_Specialty_4: string (nullable = true)\n |-- Principal_Investigator_4_Specialty_5: string (nullable = true)\n |-- Principal_Investigator_4_Specialty_6: string (nullable = true)\n |-- Principal_Investigator_4_License_State_code1: string (nullable = true)\n |-- Principal_Investigator_4_License_State_code2: string (nullable = true)\n |-- Principal_Investigator_4_License_State_code3: string (nullable = true)\n |-- Principal_Investigator_4_License_State_code4: string (nullable = true)\n |-- Principal_Investigator_4_License_State_code5: string (nullable = true)\n |-- Principal_Investigator_5_Covered_Recipient_Type: string (nullable = true)\n |-- Principal_Investigator_5_Profile_ID: integer (nullable = true)\n |-- Principal_Investigator_5_NPI: integer (nullable = true)\n |-- Principal_Investigator_5_First_Name: string (nullable = true)\n |-- Principal_Investigator_5_Middle_Name: string (nullable = true)\n |-- Principal_Investigator_5_Last_Name: string (nullable = true)\n |-- Principal_Investigator_5_Name_Suffix: string (nullable = true)\n |-- Principal_Investigator_5_Business_Street_Address_Line1: string (nullable = true)\n |-- Principal_Investigator_5_Business_Street_Address_Line2: string (nullable = true)\n |-- Principal_Investigator_5_City: string (nullable = true)\n |-- Principal_Investigator_5_State: string (nullable = true)\n |-- Principal_Investigator_5_Zip_Code: string (nullable = true)\n |-- Principal_Investigator_5_Country: string (nullable = true)\n |-- Principal_Investigator_5_Province: string (nullable = true)\n |-- Principal_Investigator_5_Postal_Code: string (nullable = true)\n |-- Principal_Investigator_5_Primary_Type_1: string (nullable = true)\n |-- Principal_Investigator_5_Primary_Type_2: string (nullable = true)\n |-- Principal_Investigator_5_Primary_Type_3: string (nullable = true)\n |-- Principal_Investigator_5_Primary_Type_4: string (nullable = true)\n |-- Principal_Investigator_5_Primary_Type_5: string (nullable = true)\n |-- Principal_Investigator_5_Primary_Type_6: string (nullable = true)\n |-- Principal_Investigator_5_Specialty_1: string (nullable = true)\n |-- Principal_Investigator_5_Specialty_2: string (nullable = true)\n |-- Principal_Investigator_5_Specialty_3: string (nullable = true)\n |-- Principal_Investigator_5_Specialty_4: string (nullable = true)\n |-- Principal_Investigator_5_Specialty_5: string (nullable = true)\n |-- Principal_Investigator_5_Specialty_6: string (nullable = true)\n |-- Principal_Investigator_5_License_State_code1: string (nullable = true)\n |-- Principal_Investigator_5_License_State_code2: string (nullable = true)\n |-- Principal_Investigator_5_License_State_code3: string (nullable = true)\n |-- Principal_Investigator_5_License_State_code4: string (nullable = true)\n |-- Principal_Investigator_5_License_State_code5: string (nullable = true)\n |-- Submitting_Applicable_Manufacturer_or_Applicable_GPO_Name: string (nullable = true)\n |-- Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID: long (nullable = true)\n |-- Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name: string (nullable = true)\n |-- Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State: string (nullable = true)\n |-- Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Country: string (nullable = true)\n |-- Related_Product_Indicator: string (nullable = true)\n |-- Covered_or_Noncovered_Indicator_1: string (nullable = true)\n |-- Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_1: string (nullable = true)\n |-- Product_Category_or_Therapeutic_Area_1: string (nullable = true)\n |-- Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_1: string (nullable = true)\n |-- Associated_Drug_or_Biological_NDC_1: string (nullable = true)\n |-- Associated_Device_or_Medical_Supply_PDI_1: string (nullable = true)\n |-- Covered_or_Noncovered_Indicator_2: string (nullable = true)\n |-- Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_2: string (nullable = true)\n |-- Product_Category_or_Therapeutic_Area_2: string (nullable = true)\n |-- Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_2: string (nullable = true)\n |-- Associated_Drug_or_Biological_NDC_2: string (nullable = true)\n |-- Associated_Device_or_Medical_Supply_PDI_2: string (nullable = true)\n |-- Covered_or_Noncovered_Indicator_3: string (nullable = true)\n |-- Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_3: string (nullable = true)\n |-- Product_Category_or_Therapeutic_Area_3: string (nullable = true)\n |-- Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_3: string (nullable = true)\n |-- Associated_Drug_or_Biological_NDC_3: string (nullable = true)\n |-- Associated_Device_or_Medical_Supply_PDI_3: string (nullable = true)\n |-- Covered_or_Noncovered_Indicator_4: string (nullable = true)\n |-- Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_4: string (nullable = true)\n |-- Product_Category_or_Therapeutic_Area_4: string (nullable = true)\n |-- Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_4: string (nullable = true)\n |-- Associated_Drug_or_Biological_NDC_4: string (nullable = true)\n |-- Associated_Device_or_Medical_Supply_PDI_4: long (nullable = true)\n |-- Covered_or_Noncovered_Indicator_5: string (nullable = true)\n |-- Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_5: string (nullable = true)\n |-- Product_Category_or_Therapeutic_Area_5: string (nullable = true)\n |-- Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_5: string (nullable = true)\n |-- Associated_Drug_or_Biological_NDC_5: string (nullable = true)\n |-- Associated_Device_or_Medical_Supply_PDI_5: long (nullable = true)\n |-- Total_Amount_of_Payment_USDollars: double (nullable = true)\n |-- Date_of_Payment: date (nullable = true)\n |-- Form_of_Payment_or_Transfer_of_Value: string (nullable = true)\n |-- Expenditure_Category1: string (nullable = true)\n |-- Expenditure_Category2: string (nullable = true)\n |-- Expenditure_Category3: string (nullable = true)\n |-- Expenditure_Category4: string (nullable = true)\n |-- Expenditure_Category5: string (nullable = true)\n |-- Expenditure_Category6: string (nullable = true)\n |-- Preclinical_Research_Indicator: string (nullable = true)\n |-- Delay_in_Publication_Indicator: string (nullable = true)\n |-- Name_of_Study: string (nullable = true)\n |-- Dispute_Status_for_Publication: string (nullable = true)\n |-- Record_ID: string (nullable = true)\n |-- Program_Year: string (nullable = true)\n |-- Payment_Publication_Date: string (nullable = true)\n |-- ClinicalTrials_Gov_Identifier: string (nullable = true)\n |-- Research_Information_Link: string (nullable = true)\n |-- Context_of_Research: string (nullable = true)\n\n"]}}],"execution_count":0},{"cell_type":"code","source":[""],"metadata":{"application/vnd.databricks.v1+cell":{"showTitle":false,"cellMetadata":{},"nuid":"2ec415c6-c4e3-4816-8fb7-59fc72e861a5","inputWidgets":{},"title":""}},"outputs":[],"execution_count":0}],"metadata":{"application/vnd.databricks.v1+notebook":{"notebookName":"OpenPayments - Research Payments File","dashboards":[],"notebookMetadata":{"pythonIndentUnit":4,"mostRecentlyExecutedCommandWithImplicitDF":{"commandId":2047437461969043,"dataframes":["_sqldf"]}},"language":"python","widgets":{},"notebookOrigID":2047437461969037}},"nbformat":4,"nbformat_minor":0}
